Content-Type: text/html

#

    Reference sequence (query): batch____
    Identities normalised by aligned length.
    Colored by: property

    HSP processing: ranked
    Search cycle: 3

                                                                                                           1 [        .         .         .         .         :         .         .         .         .         1         .         .         .         .         :         .         .         .         .         2         .         .         .         .         :         .         .         .         .         3         .         .         .         .         :         .         .         .         .   ] 394
         batch____                                              bits   E-value  N 100.0%  1:394              MKRQRNVNLLLMLVLLVAVGQMAQTIYIPAIADMARDLNVREGAVQSVMGAYLLTYGVSQLFYGPISDRVGRRPVILVGMSIFMLATLVAVTTSSLTVLIAASAMQGMGTGVGGVMARTLPRDLYERTQLRHANSLLNMGILVSPLLAPLIGGLLDTMWNWRACYLFLLVLCAGVTFSMARWMPETRPVDAPRTRLLTSYKTLFGNSGFNCYLLMLIGGLAGIAAFEACSGVLMGAVLGLSSMTVSILFILPIPAAFFGAWFAGRPNKRFSTLMWQSVICCLLAGLLMWIPDWFGVMNVWTLLVPAALFFFGAGMLFPLATSGAMEPFPFLAGTAGALVGGLQNIGSGVLASLSAMLPQTGQGSLGLLMTLMGLLIVLCWLPLATRMSHQGQPV
       1 UniRef50_B8NG20        Efflux pump antibiotic resi...   298     3e-79  1  13.8%  3:392 628:1068     --TKKKWGAVLIVSCFTFISPVMSSMVAPALQTMKTDFHidEVTSQLMLSVFVLAYAFGPLFLGPLSEIYGRVIVLQLANLFFLIFNIACGVSRTAAQMIVFRFLAGLGGSAPLAVSGGVLSDCFLPEERGKSIAIYSLAPLLGPAVGPIAGGFIAERTTWRWVFYATSIADGVIQVMGLFFLRETYAPKILRTrlVRPFRLLATQPIVQALAIYMAYVYGILYLMSSTFPALWteYYNESTGIGGLNYISLGIGYCLGSQICARLNdrPEFRTPLLAIAAILNPVGLFIYGWTAQTHCHWIApgAMLLAMGNIVAMQCIQTYIVDAYTRFAASAMAAGSFLRSIAGFGFPLFAPYMYQALHYGWGNSLLAFISIViiPAPIFLWKYGERMR--
       2 UniRef50_C7Z6L4        Predicted protein n=6 Tax=L...   286     1e-75  1  15.8%  2:393  134:571     -SKAYKWWCTMCVAITCFVVAFASSVITADIKGVTEDLNVSNELALVSVSLFVVGFGVGPMIFAPLSEIYGRRVIYASTLLIAVIFIIPCAVAKNIETLLVCRAIDGIAFSAPMTLVGGTLADLWRNEERGVPMAAFSAAPFIGPAIGPLVGGFLSDAAGWRWLYWIQLILAGIVWVLITFTVPETYTpeRLRIFLIRPFQLLFGELIVFLISLYMSVLYGLLYMFFVAFPIIYQKGKGYSSGKTGLMFIPVAVGVVLSALCSPFVNKHyeVRLIPMMISCWCIPIGLFIFAWTSYADLSWAGPAMGGFPVGFGFIfnAANNYLVDSYQHQAASALAAKTCIRSFWGAAVVLFTEQMYDRLNDQWASTLLAFISLACCAIPFMFWKFGARIRQ-
       3 UniRef50_A1CMZ0        MFS transporter, putative n...   284     3e-75  1  16.4%  3:393   68:503     --KMKKAPSIIIVSLMTLITPLASSMFSPGVLQVLHDFHSTNTVLgfTVSVYILGFAFGPPIVAPFSETVGRLPVYHVCNVLFLVFIIACALSNSIGMLIAFRFLAGVAGSCPITIGAGTIADLVRPENRAKVMSLWTMGPILGPIIGPVAGGFVSQYKGWRWNFWIIAIISGACTIASLVSMRETFHPVLLKraIVRPLKLLLFSPIVLFLSLYCAVVYGVLYLLFTTLSATFSYKYGFSQGTVGLSFIGIGVGCMVGLVAFGALSDTveYRLPPLVVGAAFLPVGLFWYGWSAQAQVHWICPIIATSFVGIGMifMSISMYLIDCYPMYAASATAANSILRSLGGALLPLAGGPMFDSLGLGWGNSLLGFIGLVIVPAGFWLYKYGAGIRT-
       4 UniRef50_B8M0T9        MFS multidrug transporter, ...   284     4e-75  1  13.0%  2:392   57:494     -SKTAKWGITMLVAVSTLAVALASSAYSGGILQTMLAFGISQEVATLGISLFVLGFAIGPLVWAPMSELFGRQILFTVTYCLLTVFSAGCTGSKNPQTLIILRFFAGAFGSSPLTNAGGVIADMFSASERGLATTFFAVAPFLGPVLGPIIGGFLGEYAGWKWVVGFIAIFAGVVWIIGTLLIPETYAPVLLRrsLLRPWILLLREPIVLLLSVYMAIIYGTLYMLFGAFPIVFEGTRHWSQGITGLSFLGVMVGMLFAVMYSIWDNKRyeARLPPCLVGCVALPVGLFWFAWTNYPSIHWIVCILapFGFGMVLVFLGVMNYLIDAYTIFAASVLAANSVLRSLCGAAFPLFTTYMYHNLGIHWASSVPAFLALACVPFPFLFYKYGAQIR--
       5 UniRef50_B6GWX8        Pc12g14890 protein n=21 Tax...   279     1e-73  1  14.1%  2:392  150:591     -SNKKKWAATITVSLFTFISPVSSSMVAPALPSLAADLKVTDEVvqLMLSIFVLAYAVGPLFLGPLSEIYGRTIVLQLANLFFLVFNIGCAVSQTKVQMIVCRFFAGLGGSAPLAIGGGVLSDCFRAEERGKGVAIYSLAPLLGPALGPIAGGFIAENTTWRWVFYSTSITDGLIQVMGLFFLRESYgpEVLRSSLVRPFRLLLTQPIVQVLALFMAYIYGIMYLVLSTFPTLWtsYYNESTGIGGLNYISLGLGFWLGSQICAPLNDRIYRRlpLLFVGAFFIPAGFFIYGWTAQYRCHWIApgAVLFGTGNIIAFQCIQTYMVDTYTRFAASALAAGAFLRSIAGFGFPLFAPYMYSSLEYGWGNSLLAFVAIVivPAPVFLWKFGETLR--
       6 UniRef50_A2RB43        Remark: alternate name in S...   277     6e-73  1  15.9%  2:392   95:531     -SFPYKAMGIAILSYNTLIIVLYSTSYTSGESQIAAEFGTSTTIVTLGLTLYLIGLAVGSMFMAPLSELYGRKPVCIACLFIFTVLIIPCALAKNLATLLVVRFIAALFGSVMISTAPGMVADIVEDDQRALAMSVWSLGPVNGPVLGPIIGGFVTQYLGWRWMDWIALILSGVALVLSCI-MKETYGpeLLKINLGRPFVMAVTEPICIFWNIYIAIVYGILYLCFTAYPIVFRDIRGWSLGLSGLAFLGIGTGCVITipLIRRLINSheAMVAFVCICALLIPAGELWFAWtsPASIPWIVPILalFGTGNTGVFIYATNYLAGSYGVYAASALAGNSVIRSILGGVLPLVGTYMYAGIGPNWSGTLLGLLEVAIVPIPFIFYKYGYKIR--
       7 UniRef50_B6HN82        Pc21g09220 protein n=6 Tax=...   276     1e-72  1  14.0%  2:393   63:500     -TSKRKITATCSIALITFLTPLGSSMFAPGVGQLVKDFNVTSTELsfVVSVYLLGYCFGPLIIAPLSELYGRQYVYHVCNILYVIWTIACAFAPEIGSLVVFRFFAGLAGSCPLTIGAGSIADMFVQEQRGGAMAAWALGPLIGPVVGPVAGAYLAQAKGWRWSFYVLAMAAGAITISSLFSIRESYAPTLLArsIVRPTKMLFRSPIVFLLSLYVGVIYGYLYLLFTTITSVFQQQYNFSQGAVGLTYLGLGVGSLIGLFLIGATSDRleYRLPPMVPGAIFVPISLFMYGWTAYYQTHWIVPIIgfLGTGMMITFMCVSTYLVDAFTNYAASVMAANTVFRSLAGALLPLAGPKMYAVLGLGWGNSLLGFIALAFCALPVIFWIYGERIRT-
       8 UniRef50_B8M537        Bicyclomycin resistance pro...   272     2e-71  1  13.9%  5:393   95:529     ----KKWTNVGLISAITFIVPLASSMFAPGVAQVSSDFNETNPLLqlVVSIYVIGLAIGPLVQAPMSEVYGRWIVYATCNILYVVFTVACAVSSNISMLIVFRFFAGCFGSAPVTIGGGTIADLFPPQQRGRALSLYTLGPVAGPAIGPIAGGFLSQSEGWKWIFWVLAIASGVITVGHIIFCHETSAveVLKRAIVRPAKLTILSPISVLMSVSTAVVYGNLYLMLTTITAVFEVSYGWSTGISGLAYIGMGVGNVIGLLSFSITSDKyeDRLPLMLLSGPAIAAGMFWYGWSAKAQTHWIVPILglVGAGNMFFFMPMMGYLVDAYTIYAASALAANTVLRSIGGGLLPLAGQSMYKSLGYGWGNSLLGFIMIGFTPVVLFIYRYGEYIRT-
       9 UniRef50_B8M194        Bicyclomycin resistance pro...   271     4e-71  1  18.2%  2:392   95:534     -SRLQKWTWIWLLSAITLLTPFATSILSPAINIMDADFGNENSTLgmTVTIYLLGYVVGPIFIGPLSEIHGRKMVLCVANAFFCLWQIGCALAPNIEILIVSRFFSGVGGAACLSLGGSIIGDMFRPDNRGFAIGMWNLGPLFGPVVGPLLGGFVTQYIGWRWDFWIVLAAASPVTLLIAVCTRETCHkqILRTNLLRPLNLIVFSPIVLTLSLYISFVFGLVYLLYTTIPTVFEDKYGFNTGETGFPYISLGLGNVLAWLLFTIYSDKleMRLILSIPFGLLLPLSLFWYGWSSDYNLHWaiISLVPFGFGIVGLFLPISTYIVDSYPIYAASATSANVILRSVTGALLPLAGPSLYGSLGLGWGNSLLGFIAIVMAPLPFVFYKFGARLR--
      10 UniRef50_C8VL09        Putative uncharacterized pr...   270     6e-71  1  13.8%  2:392   33:473     -STLRKTLTTTVIGLIGFATTVNASIYSSGHEQVKRDFNVSTTVSLLPLSAYSLGLAFGPMISSPLSETFGRKFVYLLTLPMVDLFTLGVGASQGIASLIVCRFVAGVFAAPGVSVAAATITDYTPPSRRVIPLGIYYAIPTIGSSMGPLIGSFVVEQRGWRWTAWTPLIMAAVVHPPAIF-IRESYKPILLQRriVRPLHMLFTEPLVGFICLYCGFQFALLYTFIVASPRVFADVYGFSPSGQGLSFLGMVAGC-ICAPLVLFTVDRieLKLYTAMFGSLILPTGLFLFAWTAKPHIHWMAPIValTFLGSMLIYIPCNFYMLDVYgkYGASASGASSLTRYTLSTAFPLFVPQMYDALGVDWATSLLGFLATVMAPIPWVFFYKGPGFR--
      11 UniRef50_Q6C539        YALI0E21241p n=2 Tax=Dikary...   269     1e-70  1  14.2%  5:392  136:573     ----KKVATTVIVSLYTFVSPLTSSIISPAVPAIAAEYNETRPVVqlMVSIMILAWAICPLFVAPLSEMYGRKIVMDVSILVLLAFTLGCGGAQNTAQMAVCRFFAGVGGAAPLSVGAGVLADLYSPQKRGTALAWYAIGPTVGPVVAPIAAGWIVQETnwRWVMWVDGIFIGCVAACGFLFYSETYPPVLLQrsMTRPLRILVTHPIVMGLGLFMAFTYGFMYIMIVTFPALWTERYGFSLGIMGLTFLGMGIGFLAGTWFWCVYTQKveFRLPCIFAAPFLECIGLIWYGWSAESHVHWiiIGTGIFSFAVMDVFQTIQTYLIDMNPRFSASYVASASLFRSLFGFAMPLFGRQMYDAMGYGWANTMCGILAVVllPFPIIVWFYGERIR--
      12 UniRef50_B6QUA4        MFS multidrug transporter, ...   269     1e-70  1  17.4%  3:392   87:529     --ESRKWGLLALMSSMTLVSPLASSMFAPALTSAAADFHVtvTLLSFSVTIYLLGYTFGPLVLAPLSEIYGRRIVLSCANWFFVVWQIGCALSPNISALIVFRLLAGIGGSGCITLGAGVIADLFPMRERARATALWSMGPLLGPVAGPICGGFIGETIGWRWVYWLLLIVAGALSVGIEILNRETYARVLIrqGLKRPVILFCKSPIVFLLCIYMSLVYGLLYLFFTTIPAVFETQYNFSPGLSGLAYIGIGAGFFLGLIIVGTTNDRieMRLPTMIIFSAIAPISFFWYSWSADKHVHWIVpgMFPYGLAMMGLFLPIQTYVIDSYQTYAASAVACLTATRSLFGALLPLAGPSMFNALGLGWGNSLLGFVALAFVPIPILFTRYGKMIR--
      13 UniRef50_B6HKM9        Pc21g20360 protein n=4 Tax=...   268     3e-70  1  16.9%  2:385   77:508     -SHARKWSATLLVSCFTFISPVSSTMVAPALGEIAHDFNITSdeRYLVMSIFLLAYALGPFILAPLSEMYGRVVVLQSANMVYLIFNTVCGFATSREQILAFRFLSGLGGSAPQAIGGGVLSDCWRKNERGAATAVYSVMPFIGPAIGPIAGGYLTQYMSWRWIFWIVSMADAVVQILAFLFLRETYApqLLRKNLVRPFRMLFTQPAIQAVALYRGYQYGLMYLVLASFPTVWEGKYGQSKGRASLNYISLGVGFVIGLQFCGRLIdrPEYRLPLMIPGGLIVPTGLFIYGWTAEYKTHWIApgAALFAIGLIICFQCCQTYVIDAYTRYAASATGVTAFVRTMAGFSFPLFADSLYRSLGLGWGNSLLGFISLGMGIVAPALL---------
      14 UniRef50_B9WDV1        Polyamine transporter, puta...   268     3e-70  1  13.4%  5:393  172:612     ----KKVFLLGFVSLYALVAPMSSSMLSPAMTFIAKDFHITSPIisMVVSIQILAWAFGPLIIAPLsdYIGRKLVLDVSCWMSLFFNLGCAFSQTTAQMMVCRFIGGLFGCVPMNVCAGVISDMFDAQSRNAALAGYSLVPLLGPVIAPVISGFIVDHKQWRWTFYVLCIFNGFVAITATFLFKETYSPTLLKRkmVRPIKLLFTHPMIVGLGSFMAFTYGFMYLMIVTFPEIFGNQYGYSKSVTGLMYIPMGIGFIIGVIFWtrLTRRneFRLPCLIASSIFIPIGLIWFGWSAQRKLHWIMPGiaIFAMGLVCVFQTIQNYLIDMNVRYAASSVAAAALFRSLFGFSFPLFANKMYSALGYGWANTMCAFIGilGVPFPIFCYMYGEKIRH-
      15 UniRef50_A2R0S7        Putative frameshift n=1 Tax...   267     4e-70  1  16.2%  5:393   69:503     ----RKVAITLIVASCTLTVSLTSSVYSGSVSEITAYFNVSDEVATIGLSLFVLGFAVGPLLWAPFSEVFGRQLPFFFSCMGMAAFSAGCAGAQNIWTLCILRFFAGAFGSAPFTNAGGTISDMFAARQRGLALSLYAAAPFLGPAIGPIIGGFLGMRAGWRWVEGFLAALAGFIWLLMAISIPETYapRLLKTTMSRPWVLLFREPIVLLFALYIAIVYGTLYMFFAAFPIVYEDVRGWNPGVGGLAFLGIAVGMILGCACTIPANLHyeTRLIQCMPGALAIPISQFWFAWTDYPSIHWIVSIIATAPFGFGVILIYlvIYLIDSYTIYAASVLAANTVLRSIFGAVFPIIAPYMYDGVGIHWAPSIPAFLSLLCMPAPFLFYKYGAMIRT-
      16 UniRef50_B0YBJ2        MFS multidrug transporter, ...   267     6e-70  1  16.7%  4:393  186:619     ---SKKWRNVVMVSALTFVTPFASSMFAPAINQVMVEMGTSNRDIgfGVSIYLLGYAFGPLVLAPCSELYGRLIVYHISAALFILCNVACALSISMPMLIIVRFLTGLVGAAPLTIGPGTVADCFRQEQRGRAMAIWTMPVLLGPCLGPAIGAYVSRSLGWRWNFWLLIIVSGAVSLFCLVFQRETHAPTLLKrsIVRPVKMLFLSPVVFGLSLLTAVAYGTLYLFFTTVTDVFASRYGI-ITNVGLIYLGCGCGQFAGLFILGLVSDAieYRLPPTILGGSMIPIGLLIYGWTAEYRVFWFVpgTFLIGFGMITVFTPVGTYLVDAFPMYAASATAANTVFRSVGGAFLPLAGPRMYSSLGQGWGNTLLAGISLLMMGMIFMSLKYGDRLRT-
      17 UniRef50_Q5KL96        Multiple drug resistance pr...   266     8e-70  1  12.6%  4:392   78:513     ---TYKWFTIFIVSSMTLAVALSSSAYSGGIESLIKELGASRELLIAGISLFVVGFAFGPLFWAPLSEVFGRRYIYIASYALLTLWSGAAAGAPNVGALLVFRFLAGFFGSSPLANAGGTISDVLDANQRGLGMAFFSAAPFLGPSLGPITGGFLGLTSGWRWVEGFLTIFCGVLFIIGIVFCGETYAPVILRasLIRPWKFLFLEPIVTILSLYTALIYGILYLFFAAYPIIFQSGHGWNTGVGGLAFLGVLVGTVLSVLLSIFIskKGGrrLPPAMWGGVLIVIGLAGTAATDGPDIHWIAPIIFGVPFGCGIifLSILGYLVDSYTIYAASVLAANSVLRSLFGAAFPLFTVQMFDKMGVHWGVALPGFLSLACIPATWVFYKYGAAIR--
      18 UniRef50_B6H7H6        Pc16g06630 protein n=13 Tax...   265     2e-69  1  16.5%  5:392   75:512     ----KKWSLLALISVMTLISPLASSMFSPAISYVAMEFGvdQTILSFSVSIYILGYAFGPLLLAPLSEVYGRRVVLSGANWFFVVWQIGCALANNIETLIICRLFAGIGGSGCLTLGAGVIADLFPREQRGMATSVWAMGPLIGPVVGPIAGGFLGQEAGWRWVFWLLLIVGGVVSFGVEVLNKETYatQTLVQSFKRPVLLFVKSPIVFLLCVYMSFIYGLLYLFFTTIPSVFTQKYGFSVGLSGLAYLGIGFGFIGGLAMIAFTNDRleMRLPTMIIFACILPISFFWYGWSADKHVFWIVpgMFPFGVGMMGVYMPIQTYIIDCYPKYAASANATLTATRSLVGALLPLAGPKMFDTLGLGWGNSLLGFLALAFIPIPILFIKYGKVIR--
      19 UniRef50_B8M560        MFS multidrug transporter, ...   264     3e-69  1  12.6%  5:393 693:1132     ----KRRLISAILSLSTMFVAGTSSIFSSAIPSIMAIHGISREVGTLGVSLYVLGFALGPMIWASFSELKGRYMPFTISMFGFSVFCFATARshDPASIFICRFFAGLFGAGPLTLAGAVFSDMYPPRERNIMMVMFSLTVFIGPMVSQPIGGFIvhSLGWVWTEYLPGILGSAALVAVVIFQEETypKVIVREYLLLPLRMLTSDPIVLFMCIFGAFVYGLLYLFLTAYPAVFQGVHGMTPGVAGLPFLAIIVGQFIFLIIMgwLVPRieWMLPIAIPGAASFSAALFWFGWSGYksVHWMVPTASGLFSGFGlmFVPSISYLILARPQRAASAVAAHTFIRSLFGATFPLFATYMYENLGIEWASTLLGCLAALMIPIPVLLYIYGAKIRQ-
      20 UniRef50_A8Q4B6        Putative uncharacterized pr...   264     3e-69  1  16.9%  6:389  248:682     -----RVSILAMYAMFSLIGPFASSVVSPASAAIAEDLDmsKLEQNLLVGLFMLAFVVGPLCSAPVSETYGRRVVVLVCSLFFIVFNIGCAVANTAAQLLVLRFFSGAFGGAIIPMGGGTVSDMFEVHERGTAMALYTIAPVLGPSLAPIISGWIIQGWgwRWVFWVSTILAGFICVLGIFFVRETYAPRLlkRILLRPLIFLATEPLVTLPALYMSIVYACFYLNVASLPYVFRDHYEYNVGIASLHYIGLMIGLVGFGQFGgrLSRKHGRRrpLLMITVYVLPAGMLLFGWTADYHKFWIApgLVLVGSGIIGSMLLIQMYLADLMTIYAASAISAVTSSRSLMAFVFLLFSNAMLTNLGVGWTMSVLALIVAVviPAPFLLYRYGP-----
      21 UniRef50_A6SJX1        Putative uncharacterized pr...   264     6e-69  1  17.8%  2:389   86:520     -SNTKRWANTGVISVMTFSTPLASTMFAPGVPLVMEEFQSTDMILqlVVSIFVLGFAAGPIIAAPMSELYGRKPVYLTANFLFLMFTLGCGLSTDLNMLIVFRFLAGCAGGTPTALGGASIGDMFHRDQRGLAMALWGMGPLMGPIVGPIVGGVLAANAGWRWAFWLEAIIACVTLIGGFFLLQETYPVVILEraIVRPLKTLFRSPIVFLLSVYYAVLFGYLYLFITTFPFTFSNQYHFSLSLTGLAYLGLGCGIAIGLFISGKVSDPieYRLPALMLTSPLIAIALFVYGWTAEKKIHWIVPIVGTSFFGIGMifLSINMYLVDSFPTYAASAIAATKVFQSIGGAFLPLAGQPLYSTLGLGWGNSVLGFIALAFFPVPILFFRYGA-----
      22 UniRef50_C5M2R7        Putative uncharacterized pr...   263     6e-69  1  15.6%  3:392  219:663     --HWKKWMVTYTGAVMCLVCSLGSSMYTGGIPEIMVRFGASQELCLSGLTFYLIGLALGPTLAAPLSEVYGRKPIYIFSLPIAMLFTMGVGLSKNIGSILVLRFFCGFFSSPALSVASGTISDVwdPADQSFAVAIFCLCPFLGPVLGPIIGGFASEHKNWQWSSAWILLMFFGAVWPFTIILPETYKPVIlrYNLLLPIKLIYSEPIVFILSLYISFIFAVLFGFFEAFPVIFRGVYHMDLGVSGLPFISVGIGLFLGVLLYVIL-DKveKKLLVGKIGAPCLPIALFWLGWTGRtsVHWMAPTASGVPFGFGLifSVVLYFAMSFPPMFVASAIAANNLMRYIMASVFPLFTVQCFENLGIGWAGSLFAFISLAMVPVPFIFGRYGPKFR--
      23 UniRef50_Q0CPQ9        Predicted protein n=1 Tax=A...   263     8e-69  1  18.9%  2:392   54:490     -SRWRKGLTILALCGLRLVTPFATSMMAPAIVEIKKDLNfsDEAASFSISAYVIGFGVGPIFLAPMSEIYGRTIVYHIGNLLFTAFTVGCALSQNIETLIVCRILAGLCGGATMTNPGGTIADMIPVGRRGAVLSILAGVDVISPVLGPSAGGYIASAWGWRWMFWFLSILSGSIGVFSVFVLRETYAPVILARKalRPLRILIFSPIILALSLYMSLVYGIIYILFTTISVVFQGVYGFDTGNAGLTFLGFAAGMVLSLMVAGYFNdkPEFRLPFLMGGALFLPIGMLLYGWCVHYRVHWivIGTSFAGVGVTFCFVPTQAYIIDAFPLHCASALAGNNLLRSISGGTVPLAGPALYSRLGVGWGNTLLALLAAMFGGLPILFYKYGERLR--
      24 UniRef50_Q6BY60        DEHA2A12166p n=11 Tax=Sacch...   263     9e-69  1  12.1%  4:392  219:659     ---RSKILQTAIVSIYTLVPPMSSSVCSPAMPDIAESLGmsQFLQSFSVSIMVLAWALGPIIIAPLsdKIGRRWVLNISVWISFIFNLACAFAKTTTQLCVFRFLGGLGGAAPLNVGAGTIADLWDDRGRQFAMAAYSISPSLGPVISPIMSGFIVENTHWKWVFIVLAILNGVVAAVGTLLFKETYSPKLLssTVTRPLQLLFSHPMCFGLGSFMAFIYGFMYLMVVTFPSVFERNYGFSVGISGLMFLPMGIGYVVGIAFWTWLIDYfeYRLPCLCFAGIGIPIGLVWYGWSAEKKIHWIMPAiaIFAFSYIPVFQTIQNYLIDMNTRLSASSIASCSIYRSVFGFALPLAANPMYEKLNYGWGNTMCAFIAFAliPFPIFCLIYGERLR--
      25 UniRef50_C4QVK5        Polyamine transport protein...   262     1e-68  1  14.3%  2:393  142:582     -SKARKWVITFVLGLVCFNVAIGSAIVTGEMLGPQVDLHASEEVVIlsVTMFVLAFGIGPLILSPLSEEFGRNMVYIPTLFLAIVFIIPCALAQNIATLIVCRFIDGLFFSGPMTLIGGSLADCWLEDERGLAMAIFSAAPFLGPVIGPLIGGYLGMYKGWRWNYWLLMIFTGFCYCLLLVTIPETHAGTLLKRRalLRPLILLREMIVFLITVYMSIIYGLLYMFFFAYPIVFMEGKGWNAGKTGLTFIPIAVGIFIAVALAPLFNKDyeLRLIPMMIGCWTVPMGLFAFAWSSYPRLSWAGPSilACGIGFTLLYNPANNYIVDSYQHYAASGLAAKTFLRSIWGASVPLFTVQMYHRLGYQWATSLMAFISLACCAIPFMFFIFGARIRQ-
      26 UniRef50_Q0CUG7        Predicted protein n=2 Tax=L...   261     4e-68  1  17.0%  4:392  126:563     ---WKKWLLLGLVSLVTLTTPFASSILSPAIGSVGKEFhtSETVGALTVSIYLVGYVIGPLFMAPLSEIYGRRLVLASANVFFCVWQIGCALAPNMAALIVFRLLCGIGGAGCLTLGGGVIADLFRTDQRGFAMGFWTLGPLFGPVIGPLIGGFVVETIGWRWDFWIVLILGGVIVVTLEIFNRETNHrqILVHGLVRPMKLLVLSPLVFFLSLYVAFVYGVLYLLFTTIPTLFEDVYGFNVGLTGLVYLALGLGNFTGWLVITLYSDKseMRLATSIFFGFFLPITFFWYGWCAYYKAHWiiLSLIPFGFGIMGIFLPIMTYLVDCYPIYAASAIAANTVLRSLVGAFLPLAGPAMYQSLGLGWGNSLLGFICVGMIPLPIIFYKFGGKLR--
      27 UniRef50_B6QJR3        Putative uncharacterized pr...   260     5e-68  1  15.9%  3:392  124:559     --RWRKSWIIVILSVLRLLIPFASSMMAPAILNIHDEFHssITLDTLSISIFMLGVGAGPLLFAPLSELYGRNLIYHLSNFFFSISSVGCARAPSLKSLIGFRLIAGIAGSAVISNGGGTIADIVPKESRGLITTLMVLGQLIGPVIGPTVGGYVSQGVGWRWIFWLLTIVSGAFTCLGFIFLRETHPPTLLKWKAarPLRMLFTNPVIFMVSIYIALVLGYAYILFTSFAFVFQQQYGFGEGTTGLLYFGIGIGMLVALVWMSRYSDRieFRLIPLLYGTFFIPVGFIIYGWAIQFHVYWVVpgTMLMGVGTVLALVVTQTYLIDAFTVHAASANAANSPIRCLAAALLPLSGTSLYDALTFGWGNTMLALIALIFSVLPWITYRYGEQLR--
      28 UniRef50_B6QET7        MFS multidrug resistance tr...   259     1e-67  1  18.7%  3:392  120:572     --RRTKWYITAIAAVGGVAAPLGSAIFLPSLHQVATDLNSTPTIVNLSIALYMLAMSIFPLWWSSFSEAFGRRSIYIVSFALFALFNVLGAISHSIGMLIVMRLLAGGASASVQAVGAGTIADIWEIKERGQAMGYFYLGPLCGPLFAPIIGGALAERWGWRSTMWFMVIFGGIVWILILFGLPETLAVRKSPikVLKTLKIMLVDPLSIILYLKFfiALTIYYAAISFGSLYVLNiyNFSTLILGLLYIPNSLGYLIASIVGGKWMDKIMHREAVKAggACLYPAALLMYGWTVEYHVHWIVPMIANFGFGIglIFALVTTMLTEILPRKSSAGVALNNFVRNIFSCIGAVVTSPIISGIGNGWLFTILALVgiSGVTVLVLMKKYGPRWR--
      29 UniRef50_B8MVD0        MFS multidrug transporter, ...   259     1e-67  1  15.1% 10:392   92:525     ---------VGIVSALTFITPLASSMFAPGVPLLMEEFHTTNTLLgfVVSVYVLGFAIGPLILAPASELVGRAIIYHICNLGFTVFTIACAVSTDMGMLIAFRFFQGCFGSAPVTNGGGTIADLIVQEKRGGVIAIYALGPLLGPVIGPVAGGYLTAAKGWRWVFWVLTMVGGFCTIVSLLFLRETYPTVLLKraLTRPFKILFLSPIVFVSSIYVGIVYGYQYLMFSTFTEVFEEQYRWPTKSSGLSFLGIGIGSLLGLFVIGAASDRieYRLPPLVVGAFFIPAGLFMYGWSAYYKTHWIVpgTAIMGIGNIAVFMCITSYLVDAFTIYAASALAANTVVRSIMGALLPLAGPAMYNSMGLGWGNSLLGFIAVVCIPVPWAMIRYGERMR--
      30 UniRef50_B2VR75        Membrane transporter n=1 Ta...   259     2e-67  1  16.6%  2:392   81:509     -TTKMKITLLALVSAITFVSPLASSIFAPGIPFVNSDFhtSQLLGSFAVSVYVLGFALGPLFLSPLSEIYGRYIILNCANVFFCAFTLGCALAPNLGGLIGMRFLAGVGGSACLTIGTGVIADMFIAQQRGKAVSIYSLGILFGPILGPICGGFIAQRAGWRWDMWVVLIVGVLLTIALFIFNRETYHPVILSrgITRPLKMLAFSPIVLLCSLYVSFLFGLLFLLFTTITSVFIKTYGWAPEMTGLAYLGIGLGNFMGIAVVAKTSDATIIRLAKKNNGVYEPEMRLPMYGWTSYYHVHWIVPIISLMPFGFGmiFAPLQTYMIDCFPQYAASAIAGMTALRCLFGAMLPLAGPKMYESMGLNWGNSMLGFLGVAFIPVPALLFKYGKVIR--
      31 UniRef50_B6GY57        Pc12g00860 protein n=14 Tax...   258     3e-67  1  12.8%  3:392   96:532     --PRRKWVITIMLGMMTICVTFGSSVFSTATKQTARKFGVSPEVMVLAVSLFVLGFAFGPIIFGPLSELYGRKRPLFVGIFIFAIFQIPVAVAQNLQTIFICRFLGGLFASAPLAIVSGILADMFDPVERGIAMAIFAAATFIGPVAGPIIGGFVtsYLGWRWTEYITAIWAFATAAVALLVIPETFEPTLlvRYLLRPFQMLLQEPILLLVTLYTGFIYAFLYTCFVAYPISFQEERGWNGGVGALPFVAVICGVFCACLIIIAFsvKPEERLIPMILGGILLPAGMFWFGWTSNPHITWvvVSGSFLGSGVILIFLQGLNYIIDVYPMYANSAIAANCFFRSWLGAGFPMFATAMFHNLGVAWAMTLLGCLTAALFPVPIVFYIYGPKIR--
      32 UniRef50_Q5KNV1        Membrane transport protein,...   257     4e-67  1  14.1%  2:392  151:587     -SKSRRWIITGIVSCAVIQVALSSAIVTGDFPDQEEYFGVSSEVIALTVSLTVCGFGTGPLLWSPLSELLGRRWLWAIPTAIYIIFNIPCALAPNIGCLLASRFLCGFFGSAPLTLAGGTIADVWGPEERGFAIAIFAAAPYTGPVIGPLIGGFIGKYAGWRWIYWVNMISAGVVWLASLI-IPETFAPAILKKrlIRPFEMLATEPVLLCMSLYISLVYGLLYAFFFSFPVVFNEDYGWDDAKTGLTFIPVFIGVGLALCVTPWLEKKyeDRLPGMLIGGPFVPISLFIFGWTSPpsWVGPVSAGIPFGLGMVLVYFSANAYLIEAFPDYVASALAAKTVVRSAAGAAMPLFIPQMFHGLGNGGAASLLAGIAIIMACIPFAFAKWGKKIR--
      33 UniRef50_A2R6I1        Contig An16c0010, complete ...   257     7e-67  1  14.6%  3:393   48:483     --RWKKGRQLVLMAFNTFITPLASSMFAPGVEDVMIDFHSTSTmaSFVVSVYVLGYMIGPFLIAPLSEIYGRVYLYHACNILFLIFTIACAVAQTMPQLIVFRLLAGTAGVCPLTIGSGTVADMVPKEKRAGIMAIWAMGPILGPVVGPVAGGFLAEAEGWRWVFWVIAIATAVMSILCMIWYRETYAPVILEraLARPVKLLVKSPIVLLMVLFAAITYGYLYLMFTTITSIFEDVYHFSPGVAGLAYLGFGVGCLIGLVICGAVSNHIArrLPPMVFGCWAIPIGLFWYGWAAKAQTHWIVPIlgVFAIGLMTVFMSASTYLVDSYLRYAASVTAANTGLRSLVGALLPLAGPSMYDALGLGWGNSLLAFIALVMCACPLLFWRYGARIRT-
      34 UniRef50_B8NIB5        Bicyclomycin resistance pro...   256     7e-67  1  14.8%  2:393   94:530     -STPKKARQLVFMAFNTFVSPLASSMFAPGVQYVMRDFHTTDQMLgfVVSVYILGYMLGPFLIAPLSEIYGRVPLYHACNVIFLVFTIACAVAQTLPQLIVFRLFAGIAGVCPITIGSGTVADMVPVEKRAGIMAIWALGPILGPVVGPIAGGFLAESVGWRWVFWVLAIATGVMTIGCLLSYRESYAPVLLRraLSRPMKLLFRSPIVFLLSLFAAVTYGYLYLMFTTLTPIFRNTYGFSSGLAGLAYLGFGIGSILGLGICGVVSNRieSRLPPMLFGSWAIPAGLFWYGWSAQAHTHWIVPIlgVFAIGLMVVFMASNTYLVDSYLRHAASVTAAATVLRSLIGAVLPLAGPSMYDALGLGWGNSLLAFIALAMCACPLLFWKYGEFIRT-
      35 UniRef50_A2QEA4        Contig An02c0300, complete ...   256     9e-67  1  14.6%  2:392   87:525     -SKAFKWYCTMVVSFTCFVVAFASSVITADIEGPAEQFGVSREVSPCCCYCFVIGFGVGPMAFAPLSEMVGRRIIYASTLFLAVIFIIPCAVAPNIGTLIVCRAIDGIAFSAPMTLVGGTLADLWKNEERGVPMAAFSASPFIGPAIGPLAGGFLADATNWKWLYWLQLILAFVAWVLITFTVPETYAPTLLKRrlFRPFQLLFLEPIVLFIALYMSVLYGLLYMFFVayPVVYQSGKGWSAGSTGLMFIPLAIGVLMSAACAPFVNKHyeARLIPMMASCWFIPIGLFIFAWTSYPTIHWIGPAIGGWPVGFGFIfnSANNYLVDTYQHQAASALAAKTFLRSMWGASTVLFTEQMYDRLGYQWASSLLAFIALACCAIPYVFYFKGASIR--
      36 UniRef50_B6H7V2        Pc16g07090 protein n=1 Tax=...   256     1e-66  1  15.9%  3:392   48:484     --TRKKAPIVFVVTLSRFLTTFASSMMSPALGQIQNEFKTTETVATLTLSIYMVGYAIGPLLFAPLSEVYGRSRIYHTGHIWYTVVSVGCALSPNTGALLVFRFMAGFTGGVPVANAGGTIADMIPRSRHGLMMSIFNAALLLSPTLAPVAGGFLAETKGWRWIFWLMTILSGVTTIVSFILLRETYSPVLLQraLRRPAVLLCTHPLLMLGSVYMGYVYGVTYLLFTSIPLVFRDLYGWSEGRLGLAPLGVGIGSLLALLVTGRYSDRmeCRLFFLFPATIALPFGLILYGWTAHFQTHWIVpgTAIFGGGMIFAFNSVNTYLVDVFSKYAASALAAVSFIRCISGGALPLCGPRLYERLGYGWGNNLLGFLALFFGAGSLAIWRFGTKLR--
      37 UniRef50_B6QAI2        C6 transcription factor, pu...   256     1e-66  1  18.3%  4:392  175:616     ---SRRIICTFTISLISSVVGFASAIDSTIIPQAAAEFGVGEIIEALASGLFLIGFGAGALVAGPFSETLGRNPVYITTIALYMLFLVGAGASPNIGSQLVCRFFAGMFGATPLVCAGGSLSDIWTPQERVFAFPLFACSSFLGPLLAPIVGDWIGqtLSWRWTEWVTLIASGVILTIVVLTQPETYApvRLRRVLYRPFLMFIQEPILILFGLYLTMVYIVLFTFLTGYTYIFTGIYGLSTGMTRVCFVGQMVGILSCspLNMHLRKriGprLYWAMIGGPAVPISLFWMGWTAHpsIWSPLLASVLFGFGIICVFITTYQYLMDTYEIYAASALASVTFLRYTISGAFIEISIPFYENMGVACTLTILGSLSGVLVAIPYMFCQYGPAIR--
      38 UniRef50_C5FD46        Polyamine transporter 4 n=9...   255     2e-66  1  13.5%  2:393  113:543     -SSTKKIVIVTSIGLITLLTPLGSSMFAPGVGEVMKEFhsSPELASFVVSVYLLGFSFGPLIIAPLSEMYGRVPLYTVCNILFVVFNIACAVANSLGSLIGFRFLAGAAGSAPLTIGAGTISDMIRQEKRGGAIAAWALGPLLGPVIGPVAGGFLTEALGWRWTFWVLSIAAGAVTINTFIWLNESYHPTILarSIIRPTKMLLFSPIVFLLSLYAAVVYGYLYLLFTTISGVFIGKYHFTQGVGIGCLLGLGILGAMSDRLLKSLAAKNgyRLPPLIPGSLFVPIGLFWYGWTAEKGVHYMIpgTAFVGIGMIFTFMTISTYLVDAFTLHSASALAANTVLRSIFGAVLPLCGQRMYRALGLGWGNSLLGFVALALAPLPVVFYVYGERIRT-
      39 UniRef50_A4RGV4        Putative uncharacterized pr...   255     2e-66  1  15.9%  3:393  118:588     --EWKKWVNTIFVSTLTFLTPLASSIFAPGVPQLMEEFRITNSELgfVVSIYILgfALGPLVIAPLSEIYGRSIVYHVCNLGFLAFVIACAVAPSMNSLIAFRFISGIFGSCPISNGGGTIADMIVQEKRGFAMSIYTLGPLIGPVVGPVAGGFLSGAKGWRWCFWVLAIATGFMSICMMVFMKETYAHVIlkRSIVRPLKLMAFSPITQIFAIYLAIVYGYLYLVFTTITSVFTETYGFSSSTAGLAFLGIGIGFLIGQGIFTYTSDAyeYRLLWLPFGGAVLPIGFFIYGWTAEYKVHWiiIGMGVIGIANILLFMSVTVYLIDSFNMYAASAMAANTVIRSVAGAVLPLAGPAMYAALGLGWGNSLLAFIALAMLPVPFVIQRYGEYLRT-
      40 UniRef50_B8MVV1        Bicyclomycin resistance pro...   255     2e-66  1  16.1%  1:392  104:544     MSSVRKWVIVLIVCTGTLCVTCTSSIYTTTYTQMDPEFQTSTLISTVGLSSFVLGIGTGPLVTGPLSEHYGRRPIYLVAWSMFLIWTIPSAVAKNVQTIIVSRYFNGFTGGTFLSVAGGTAGDVFSRNQIQAPMALVSSVPFIGPSLGPVLGGFINSHLDWRWTYWIMIIWSAVLLVCMIFFAPETYHPIILRasLLRPFQLLFLEPMCLCLDIYSAILLGILYLFFGTFPMVFRTTYDMNLWQGGLTFVGIIVGMMIAAATTPLWSNIRErrLPPAIVGGILIPVGLFWFGWTTYSRIHWIVPIiaVFGGGLLLAYTGIFTFLVDAYPQCAASALAANGFARCTFAAAFPLFGTQMYDKLGYQWATSLLAFLTVAMMPFPWLFFKYGKALR--
      41 UniRef50_B2AE97        Predicted CDS Pa_4_9800 n=7...   254     3e-66  1  14.1%  4:394  157:601     ---KKRWQNIAVISVLTIITPLGSSMFAPGIPRILAEFesSSTVATFILSVYILGFAFGPLLVAPLSEIYGRSVMYNTGNVFFFIFTICTALSNGIPMMMAFRFLMGVAGSVPITLGSGSISDMMPVEFRGRAMAVWAIGPLLGPCIGPVAGGYLIRAAGWRWVYWLIAIVTGLIAVFTFFTLRESYApeKLKTALVRPMYFLFRVPIVTLLSLYVAVTYGILYLLFTTFSLVFGQnyGFGEGEVGLVFIPSAIGMALGIAIFGAMSDKLVTQKilTIPAGVTLPIGLFLYGWTTHYGVHWIVPMIGVVIFCFGliMMACQNYLLDVYPQNAASVTAALAVLRSLAGALLPLGAIDMYIALGLGWGNSLLGFISLGLIPIPLLFFLFGERIRGV
      42 UniRef50_Q4PIM9        Putative uncharacterized pr...   252     2e-65  1  14.3%  2:392   68:509     -SSLYKWLQTIQVAIATLSVALASSAYSGALDSLQARFHPEKQIitLGVSLFVLGFAFGPLFWAPFSEVVGRRNLFIFTYAIFTLWQAVSIASPNIESLLVFRFLSGFFGSSPLVNTGGTLADMFNAKQRGLAMAIFASAPFLGPALGPITGGFLGETSGWQWVIGFLAIFAGVITLIGAISLPETYAPVLLrvALGRPWLLLIYEPIVSLLSVYIAIIYGVLYSLFGAFPIVFQRYRGWSPGIGGLAFLGVLVGMIFanPRYGRICDKNgaRLPPAMIGAVSVVVGLAIFAATDSPDLPWIAPIigPFGMGMVLIFLACMNYLTDSYLIYAASVLASNSVIRSLFGFAFPLFTSNLYSIggIHWGPAIAGLLALICLPFPFIFYKYGAGIR--
      43 UniRef50_A2QFG6        Remark: MDR1 of C. albicans...   252     2e-65  1  15.4%  5:354  129:530     ----RRWLIVIICSAGSLCVTCTSSMYTVTYDQIMVEFDCSREIATLGLSFFIWGLAVGPLFLGPLSEFYGRRRIYLCSFTFFLIWLIPCAVAKNIQTMIVCRFLNGIAGSAFLSVAGGTVGDLFARHELSAPMMLYTSSPFIGPEVGPLVGGFINQFTTWRWTFYVLLIWTGVLLVLICFFVPETYHPVLLrrSIYRPLLLLTLEPMCLNLCIFSAILLGILYLFFGAFQLVFETVYGFELWQRGLCFLGLFVGMLFAIFSDPFWRRNYTrrLPPAIAGGPLVTIGLFIFAWTIYPHVHWIAPLiaLFGAGTILVYSGIFTFLVDAYPTYAASALAANSFARSIFGGVFPLFG----------------------------------------
      44 UniRef50_Q6CGW3        YALI0A15576p n=1 Tax=Yarrow...   252     2e-65  1  15.3%  2:392  195:629     -TMKRKCISAVILALDTFAVSWCSSVYSAGMPQLIAEFKVGQVVLLLGVSLFIMGFASGPIVWAPMSELMGRRPPILIGMLGFTLFTFATATAKDLQTVMLTRFFSGFFGASPLAIVAASYSDMFPANQRGYALAAFTMCVFVAPSLAPMVGGFIAKntGWRWDEYMTGILGALVTVLTLFFCEETFAPVLLarNVLRPVKMLFTEPTLFLVTLFVAFLYGIMYMALGVYPIIFAEGYGMHQGVAMLTYLGLIIGEAIGCIVSMAFEPVYTrrLPPMIVGGCCLPLGLFWLTWTGHyhIHWMVPTalLTGVGFITIFLASINYIVDCYTLFAASAMAANTMMRSSFGAAFPLFTPALFHNLGVNWAGTLVGGIAVLMLPVPILFYIFGKRIR--
      45 UniRef50_A2QCH8        Contig An02c0090, complete ...   251     4e-65  1  14.2%  5:392   68:502     ----SKWLYTILVSFVTLTVALVSSAYSGSISQVVIEFQCEEEVAILGISLFVLGFAFGPLLWAPMSEVFGRRNVFSVTFALLTAFNAGAAGSKNIQTLVILRFLAGFFGSSPFGNAGGTIADLFPAAKRGIAISLFAAAPLCGPTIGPVIGGFLGAGAGWRWVEGFLAAFSGVMWLCLIFFLPETYAPVLLRRrlSRPWLMLFREPIVLLLCIYMSIIYGTLYMLFAAYPIVFQQARGWSEGIGGLAFLGILVGMVIAVSlnGRLPP--EVRLPPSILGGIALPIGLFWFAWTNYPSIHWmvAAGAPFGFGLVLVFLSVFNYLIDAYTIYAASVLAANSALRSLFGFAFPLFTTYMYENLGIHWASSIPAFLSLACIPFPIVFYLYGVRIR--
      46 UniRef50_B6HRS7        Pc22g03710 protein n=8 Tax=...   250     8e-65  1  20.2%  2:392   94:546     -TRGMKWFITFVVALAGATAPMGSAIFLPSLSQVTKELNTTTTITNLSIALYMLAMSIFPLWWSSFSERLGRRTIYLTSFALFVVFNCLCAISDSIAMLVVMRMLSGGASASVQAVGAGTIADLWEPRERGRAMGIFYLGPLCGPLFAPIIGGVLAQRWGWRSTMWFLSAFGAVTLIFILFALPETLTVQKPVLawLKTMKMVFIDPliILYLRFLPVLLTVYYASVAFGSLYVLNiyNFSTIIVGLLYIPNSLGYMVTSIFGGKWMDSIMQrrENAWLGAFLYPAALIWYGWTAEKGVFWLVPMifFFGMGSMLIFSMVTTMLTEFMPKKSSEGVALNNFMRNIFSCVGSVVTAPIINGIGNGWLFTILGLVSFASSSVIFLMRVNGPKWR--
      47 UniRef50_Q4PB97        Putative uncharacterized pr...   249     1e-64  1  13.1%  4:392  210:646     ---RRKIMLLSVVTACAFCVTNTSSIISNAYQGIQDEFHISRTVAILGLSLFVIGLGIGPMLLGPLSEFYGRRPVYLVSYTAFTLLGLPVSFANNLAVFLVFRFLTGFCGSAFLSVAGGSVSDIFAPTDIFVPMSIYTNGPFLGPVAGPLLSGFINQHTNWRWTFWTINIWSSVMLAILVLFGPETYAPALLaiSTTRPFQLLVREVMLLLLCLWSALLLGVLYLFFVAFPIVF-EAHGFNLQEIGLSFLGIGIGMVIAVLTMPYWARHyeFRLPVAMVGAVCLPIGMFWFAFTTYASIHWIVPIlvVFGFGISYIYTSVFTYTTHAYRPVAASAMAANSFCRSSWAAAFPLIAKPMYDRMTTPGATAFLAGLNVLMIPVPFVFYRYGKKIR--
      48 UniRef50_Q5A6T2        Potential polyamine transpo...   249     2e-64  1  15.1%  3:392  198:642     --KWKKWMITYTAAILCLVCSLGSSMYTGSVPEIMKRFGASQELCLAGLTFYLLGLAFGPALSGPLSEVFGRKPLYMFSLPIAMLFTMGVGLAKNIETILVLRFFCGFFSSPALAVASGTISDCWapAEQSFAVALFCLCPFLGPVLGPIIGGFAGEYKGWQWASAWVLLMFFGAVWPFTIILPETYRPIILArnLFMPLKLLIEEPIVLVLSVYISFVFAVLFGFFEAFPVIFRGVHHMDLGISGLPFISVGIGLFLGVVTYVILDKTieKKLLNGKIGAPFLPIALFWLGWSgsDSIHWMAPTASGVFFGYGLifSVVSYFSMSFPPIYVASAIAANNLLRYTLASVFPLFTVQCFENLGIGWAGSLFAFIALAMVPVPYVFGYFGPHLR--
      49 UniRef50_O59814        Uncharacterized transporter...   248     2e-64  1  12.8%  4:393  105:539     ---WKKIYTLLVASFIAIVITANSSIFSDGGGIAAQQYHVGATVGDLCSATFLLGFAAGSVLFAPLSEVYGRLPLYSVTLVIFVVFQIGGGCSKNIWSLVIFRFFHGFFGCTPMSACGGTISDLFNPIQRTGALLVFCAAAFVGPLVGPVMGGYITEslGWRWDFWINMIWAGLTWVIVCFTMPETHSETLlrTALTRGVRLLCTEPIVQAFCMYLVFINILLYICMVGYPLIF-YQYGFNAGEVGLAILGILVGILLGLALTPIIYVHYRrrLFPLFFGSFFIPIALFWLGWTCYPSVHWAAPMVSGIFLGWGfvLAVCYSYLVDCYHEMAASALSVATFTRYAAGGGMTIVARPMYNNLNYHWATSLLAFVGCGLVPIPFIFFFWGRRIRQ-
      50 UniRef50_C4Y6D6        Putative uncharacterized pr...   248     3e-64  1  12.0%  2:392  163:605     -SKSKKWFITFVTANVCLCVSLGSSLFVEGVPELEIKMGISQTLGLSGLTFYLIGLALGPVIAAPLSEMVGRRYIYILTFPASMLFTMGVGLSKNIRTILVLRFFAGFIASPPMSLAGGTISDIwsPIDMSIAMALFCVAPFLGPVIGPIVGGFAAEHKGWKWTMWVSLMFSGAILPF-LLLVPETYKLAILRKriIRPVEMLFVEPIVGLTSLYIAFVFAVLFGFFEAFPIIFRGLYRMDFGVSGLPFLAVGIGLIFGVVLYVAlwDAPERKLTIAMAGSVFLPIALFWLAWTAKKSIHWIAPTLAGLPFGFGLifGIVLYYSMSFPPAYVASALAANNLLRYLLASVFPLFMVQMYERLHIDWATTLLAFISLAMVPIPFAFKKYGPKLR--
      51 UniRef50_B6GW46        Pc06g01070 protein n=4 Tax=...   248     3e-64  1  16.1%  2:392   81:519     -RTGRKFLVLTAGVMQVMNSTIGSSICSNAIPQIAEEFNIteTTLVLPISIFLIGYILGPLLWGPSSEYFGRKPPLLIAFVLFMIFTLACAVADSYASLLVFRLFNGMVASAPIATVGGLFADVhdPTLRGRLMAYFMACTTFGPIIGPWVSGFVA-VVSWRWCFWIGLILSGVTLPLVIL-MPETYAPVILKRriSRPFRMIIHEYIVSLTSLYLALAYAIFYLYFEAYPIIFQGIYKMSPGVSGLMFLPIGIGAILACGVfgYLARAKarRLPLACIGGPLYVISLFWVGWTASPNIHWVVPFLSGIPFGMglIFMAMLNYLTDAYETLSASAQSAASCTRSILGAVLPLAAKPMFNRLGVPWACSLIAFLSLGVSVIPFAFIRYGDRIR--
      52 UniRef50_A2R6P8        Putative frameshift n=1 Tax...   247     4e-64  1  16.4%  2:392   49:489     -SFWYRWCHIVVISLLTFVTSLGSSMLAPAVPDVMRSLGSDNAElsFVVSIYVIGYALGPLIAAPMSEIYGRSIDYNVSNVLFLGATIGCALSTNVGMFLVFRLISGCAGVTPLALGGGSIGDLMAPEKMGTAMAIWGLGSLVAPVFAPIAGGYLSENVGWRWIFWVITIPMAVLTILSIVTLRETYAPILLEraLVRPLKMLLTSPVVMMLAFDVAVVYGYQYLVFTTLSYIFQDVYHLSTGLSGLVYLGDGIGTILGIFSIGYASDKVAErlWPMIPASLLTPIGLLWYGWSLQAGLFPVVpgLGVFGFGMMGIFQPVQIYLVNAFPIHSASALAASNLLRSLVGALLPLGGHRMYDTMGLGWGNSLLAFIALAMAPVPIILMKFGERMR--
      53 UniRef50_C4Y7S6        Putative uncharacterized pr...   247     5e-64  1  12.6%  4:392  142:582     ---SKKIYVVIFVSFYTLISPMSSSILSPAMKEVSAEFNisPVIQALVISIHILAWAIGPLVIAPLsdRLGRKTVLSVSCWLSLAFNIGCALSQNTTQLVVLRFVSGLFSATPLNVSPAVVSDLFDAKSRNLSLAGVFLIPFVGPAIAPIVGGYIAQAKGWRWVLYTLSIINGTVALLGTFLYVETYSPALLKktVTRPIVLLFTHPMIVGLGSFMAFIYGFLYLMIVTFPSVYEKSYGFSQSTAGLMYLSLGVGFLLGVLFWTYavSKPEYRLPCLFVTAIIIPIGLLWYGWSVQKKLHWMmvGSGLFAFGLVCVFQTLQAYLIDMNPKFAASSIAAAAIFRCFFGFSFPLFAPAMYAKLDYGWANTMCAIIAllGVPFPYLCYKYGERIR--
      54 UniRef50_A2R218        Contig An13c0090, complete ...   247     5e-64  1  13.6%  3:392   35:457     --KARKWVCTVIVAVMTGVIAFCSSIYTAGTSLITATYGCSRTVATLGVTTFLLGFASGPLIFAPLSEVYGRNHIFRVTLGLFVLFQIGCALAPNISSLIIFRFFAGFFGSPSVTNSGGSITDLWPQSERSVPLALFSAGSFLGPVFAPVAGGFISEYLSWRWNFWVVLIVSGVVYAACVLFLPETYAPKLLrtSLTRPWLMLFAEPILFLLSLYMAFIYGILYLDFTAYPIVYEQSRDWTPGIAGLSFLGMGTGMGIATIASPyyVTKLGprLPHIIILAWLIPASLFWFGWTAMPPIHWIVGIvaPFGFSLILLFLAITSYLTDCYGPYGASALAANAVFRSVFGAVFPLFGPYLYDGLGVPWGSSLLGFFALAFAPLPWVFYHFGPRIR--
      55 UniRef50_B6K1P4        Fluconazole resistance prot...   247     7e-64  1  15.3%  2:394  105:542     -STLRKWIVIFQISMIAFVVTFGSSIYSCAVDEVHDDFHVSIPVATLGSCVYLVGFGMGSMAFAPLSEVYGRLIVYLITLLGFVLFQIGGGAATNIQTLIIMRYFQGVFGSTPLANAGGTISDLFTPAQRTYVLPGFCTFPYLGPVLGSIIGSFIVQslRWRWCFWINMIWAGSTWAMAFFILPETHGPTILsqAATKSVTIICTEPIVVCFTLYLTLVYGVVYINFESYPIIF-KGYGFNTGEVGLSFIGNGLGIIIAGLATPLVYKHyeDRLYPLLPASFLLPISLFWFAWTSYTSVPWIVPIISTIFFGIGLLItvSYNYIIDSYQGFAASALSSATLVRYSASGGLTMLARPMFLHLGTQWAMSLLAFLAVVMVPIPFLFLKYGKRIRQI
      56 UniRef50_C1HAR3        Caffeine resistance protein...   246     1e-63  1  15.7%  4:392  233:667     ---RSKAMMIGSLSWSTFTVIHYSTSYTAGLTEIAKEFGTSEIIVTLGLTFYLVGLAVGSVILAPLSEMYGRKPVSITSMSLFMILIIPCGVCKSVAVLIAMRFLGAIAGSAMVSSAPGSVADLVDDEHRALAFSIWSIGPLNGPVFGPIIGGYVTQYLGWRWTNWLSMIFAGIALAL-LCFVKETYTpeVLKVNLSRPFAMAVLEPICIFWNFYIAVVYGILYLCFVAYPIVFRQIRGWAVGESGLAFLGIGVGSLITvpLLRRMINRheSMVSVVCIAAVLIPAGELWFAWtaPKEIHWIAPILAGMPFGAgaVFIYASNYLTFSYGVYAASAMAGNSVIRSTLGGVLPLVGPALYKKIGPNWAGTLLGLLEVMIIPIPFVFYKYGYKIR--
      57 UniRef50_C5FIR6        Polyamine transporter 3 n=2...   246     1e-63  1  15.3%  2:392   55:489     -TLARKWKAVFAISSFVLMSPLSSTIVAPGLEIISTDLNItpAEQTMVVSIFVLGFAFGPLIASPLSEIYGRVRVVQSWNLLYLIFNTGCGAANSKETLLVLRFISGFFGSATLGIGGGTLSDLFTADDRGKAVAIYSLAPLVGPVLGPIMGGLIAQHAHWSWVFYSASILDAVVQLLGILFLEETYAPVLLRrnLGRAIRLLLTQPIVQVLALYNAFLYGIIFILYATFPELWTEIYHQSTSIAGLHYISMAVGTAFASEVCTHINDRieFRIPIMAPATVLLSVGLFWYGWSAQKKLHWIMpgSAFFMAGAVVCGICVNAYIIDTYGKYSASALAAVAILRSLAAFAFPLFAPYVYIALGYGWTGSLLGFCGLGilPAVLLLWKFGKALR--
      58 UniRef50_B3FWT8        Major facilitator superfami...   245     2e-63  1  15.9%  2:392   92:530     -TLSKKWLNISVVGLITFNVPLASSMFAPAVPQLLQDFHTDNASLsfVVSVYILGLAAGPLILAPMSELYGRLNVYHVGNVLFIIFTVACGLATNINMLVAFRFLAGLVGAAPIAIGAGTIADVTNLQQRGTAMSIWSLGPLLGPSIGPVIGGFLAQAAGWRWIFWLLAIIAGAVAIISFFVLQETHAPTLLkrAIVRPCKMLLFSPVCLILSFYSAFVYALIYFMFSTFSFIFKASYGFNQGTVGLVYLACGIGMLLGlqLTgrLADKreYRFPPMFMAGGLLPAGLFMYGWAVQHHVQWAVPLllIAGIGICIISICINTYLVDTFTMYAASALAASAVLRSVFAAVLPLFALQMYNKLGLGWGNSLLAFVGLGMWPITFLFFVHGEKLR--
      59 UniRef50_B6GZT7        Pc12g13380 protein n=10 Tax...   244     5e-63  1  15.2%  2:389  100:535     -STPRRIMLVCILCYGTFAGSFTSAVFSAAIPGFSEEFNTSTEIGSLGVALYVLGFAAGPTIWAPGSELIGRRWPLSLGLFGCAIFTIACAVAKDIQTIMICRFFGGLFSASPISVVPAVFADLFNNTQRGVVMSIFCMAVFIGPFSAPFVGGFIasSLGWRWTMYISAIMVFLGFVLVFVFLDETYApeLLRNNFARPVVMLVTEPILLLVSLYISFVYGLIYALLGAYPVVFQGVYGMSTGVGGLAFVGLIIGELLGGVYILLIQGSyeWRLAPAIIGAVLFAGGLFWFGWTGYtsIHWIAPValLTGGGIFLIFLQCFNYIVDCYPSLAASTIAANTILRSAIGCSFPLFSRQMMENLGVQWAGTMLGCIAVVMIPIPVLFKVYGP-----
      60 UniRef50_B6Q499        MFS transporter, putative n...   243     8e-63  1  16.3%  2:393  125:554     -SPTRKVIIVVILSACSFLAPISSTMILTAIPEVAETFNTTGSVINASNAVYILAMGLSATFWGTFSQIYGRRPMSFWSSFLFFVFSLATALSPNLAAYFIFRALTAFQGTSFLVVGSASISDIYTPTERATALAWFLSGTLIGPAIGPFLGGVIVTFCSWRVIFWLQTALGGCTFILVALFIPETIPHKthRMNPIRVIKLLFQYPNLFFAALASASLVWNQYSLLTPIRYVLNPRFNltPIESGLFYLAPGCGYVFGTFFGGRYADYIVRKWicLFFLGLSIPGWVLIYGWTIdgGIPVPVIALFLQGVSQTFVFPSLNTYCLDVmkGRSAEVVAGNYMFRYAFGALGTGVVLPGIGAMGVGWFNTISAIFVGISGFFMWLITIKGATWRQ-
      61 UniRef50_Q2UR34        Synaptic vesicle transporte...   242     2e-62  1  16.6%  2:392   49:485     -SAWRRGMLVGIITCVVFSTSIASSAVAPAVPQILREFNSNNAEIglVVTIELLGTGVGPILMGPMSEVVGRRIIYNCANVGFSAFTIGCALTPSLGGLVVLRFLQGCAASCSLNNAGGTISDLVPIHRRGFAMSMYSVGFLLGPAVGPVAGSFLAAAKGWRWVFWLLLILNGTMGVICALAYTETYAptVLKRAITRPVKMFLFCPVVTGLAVYNAVVYGFTYLLFSTFSVVFEDQYHFDQGRLGLVYLGLAIGFLVSLSIaaRLSRKHGarLESLIYGAIAIPIGFFIYGWTAQYYvaVPIVATGIVGFGVMFTFIPFNVYMIDAYTKYAANAIAAGNILRSLSAALLPLVGVPLYNRLGYGWGNSLLAFVSLGLGAMSLLFRKYGEEWR--
      62 UniRef50_Q6BQE6        DEHA2E05786p n=9 Tax=Saccha...   242     2e-62  1  12.6%  5:393  136:574     ----KKVYSCVVVGLTALSVSLGSAMFSAANPIIMETYHVGTSVAALGVSLFVLGFAAGPVVWGPLSELYGRKVVMVPSCLGYVCFSFAVATAKDIQTIMICRFFAGLIGAAPLVVVPASIADMYGAAKRGQAMAIFAMVLFGGPMLAPIFGGFIIKnlGWRWTSYFSGIVGVIALIGVVFFYEETHHPIILVktISRPLVMLLKEPILLLITIYNAFIYGLLYLFLTAVPLIFAGNYHFSSGVSELPYLSMLIGIVIGGFVCVFFDGRyeERLPAMMIGSFAFAGGLFWLGWAGDYpvHWIVpgAAPIGFGLIVIFLPSINYIIECYLVLAASALAGNAFLRSAFAAAFPLFAKQMFVNMEIKWASTLLGCLAAVMIPVPFMFYIYGARIRH-
      63 UniRef50_Q2TXG1        Synaptic vesicle transporte...   242     2e-62  1  15.3%  2:392   64:496     -SFAYRAFVTAIWVYGNLCTCIASSIFSSGSGQIAQRFHVGSTVVTLGISLFLLGYTVGPPVWGPLSERFGRKWPMVIGMALFTIFCIPVAVAKNLQTVLIGRFLTGVFGAAPLSLVGGSLVDMWNPAQRGVAMACCIGTIFGSPVLAPLMGNFIVeyLGWRFTQWLSCIMGGSCTVLVVFGLPETFAGSILRKklLRPFALLVTEPILLLVTIYQAFIYGILYLVFVSYPIAFREVRGWSLGISALPYIGMMVGILIGCAIVVIQTRRneQRLPLMIAGGCLLPVGLFIFAWTSNPNIHwmVIGSAPVGTGMYMVFVQCLNYLVDVYPTIANSAIGANTFVRSFFGAGFPLFGPFMYHNLGVAWASSTLGFISIAMIPIPVLFYRYGARIR--
      64 UniRef50_A2QCI3        Contig An02c0090, complete ...   242     2e-62  1  13.3%  2:393   76:512     -TTLRKWVIIGLISLSSFNVSMVSTVFAPGVPQVLKEFNvnPSISSLMISIYVMGSALGPLVLTPLTEISGRLPMTHLANILFAVAAVVCAASVNISMLIMARFVMGIASSVPVTVGGGFVADMIPMEKRGTAMTIWTVGPLMGMVTGPIYGGYIVQNIGWRWTIWIEAILGGIIVIASLIFLRETYAPTLLQrsISRPIKFLFLSPIVMIVSLYSSITYSYMYTLFTTFTSVFENVYGFTPGEAGLGYLGLGLGFCSGQIVVGYYSDRyeDRLPPLVVGCILVPIGLFWYGWAAEYRLHWIVpgTFFVGAGIFFVHLVTQVYLIDSYTLYAASAVSAELALRCLFGATIPLAGTPLYDALGLGWGNSLLGFIALLFVPASLFLLKYGERIRT-
      65 UniRef50_C0NQ95        Caffeine resistance protein...   241     3e-62  1  15.5%  5:392   68:503     ----RKWMVTDVLSATGFNRIMVSTIMAPALSTIATDLDMSATESAMSLSIYLLASAFGPLVMSPLSEMYGRRVILHSSNVWFLVWNVVCGFAATKEVLIASRFLAGFGASGIYALAGGVMGDIWRPEQRGRGLGIYLLIPLLGAAVGPIIGGFIAERSHWRWIFWSTSAFQAAMTIMSFFCFYESYGPHILRRriTRPLRLLMFHPIIQVSSILQGFNYGILYITLSTFSTLWIFHYHQSLEISGLHYIACSLGELAGSQASARLMDHFYSRrpLMIPGIIAAWSGALIYGWTAEYRVHWLAVDVGVFTLLAGMQmmSIMAYVIDSYGEHTSSAMAAQQFVTSLVAFLFPLFAPSMYHALGYGWTNSVLALAglLMIMLPLFVWKYGARLR--
      66 UniRef50_B2WE23        Putative uncharacterized pr...   241     3e-62  1  15.9%  4:392  109:544     ---WKKTINIACIFYLCLVSPFTSSVVAPAIPDIMADFASTDAYLsfVLSVYVLGYAFGPLLISPLSEQYGRLPLYHAGNVLFTVCTLACGRANSLGMLAVLRFLAGAGASNVFALAPSSLADLVAKEERGRAMALVGMAYNLGPAISPTAGSYLNAAQGWRWVFYLTGILGGAGTLLSMICMSETYEPVILRraMVMPFAMLFFSRPIFFTSLLTAVGYGYVYILYTTIPSTFLETYHWAPKKLGLAYLGTAVGNLIGMVGASVMSdrPEIRLLPMIFWWPLVSVGLFMYAWTAQHAVHWIAPLIGTTIFGMGAMSAIFftYILDAYPLHSASGMAACSVMRSLIGGLAPLFSHKMYQDLGVGWAFSLLALIALAFAPVPVVFYKFGEKWR--
      67 UniRef50_B2W3H6        Benomyl/methotrexate resist...   241     3e-62  1  15.6%  2:392   82:529     -SLTRKWYQTFTISGIALVGTFASSVFTPAIEQAAAELNSTRLIATLAYSIYVLGLAFGCPFAAPLSETFGRRPVIFISLPIFSLFILGTGFAQSISSLVVLRFFAGFFASPSLSMGSGTLSDIWPPEKRSGPMSLYVATPFFGPALGPILGAIVTQARAWRWTAWLILFFTVVLVLAPAPFFVESFKPVLLrrTLTRPMHMLFTEPIVATFNTYSAFNFGVLYAFFAAFPYVFEREYGFDSISTGLTFLGLGVGVLIASVGIVSFTkkPEKRLPLAMAGGPILTIGLFLFGWSAAYRVHWIVPTiaLFGLGNMLVFMACMMYITDTypLYSASAMASNAILRYVLGAFFPLFAVQMFQHLGTQWACTLLGCLSVLGACIPFVLVKYGEALR--
      68 UniRef50_B8M2R7        Bicyclomycin resistance pro...   241     4e-62  1  13.5%  2:393   78:517     -SFKYKLWITAAWVYSCFVTTVASSIFSSGTEVIAAEYDVGTTIVTLGVSLFLVGYTVGPPLYGPLSEHYGRKTPLVIGMTLFTIFSIPVAVAKNIATILVGRFFQGAFGAVPLALIGGGLVDIWNPHQRAMAVTGAVGTLFWSPSLAPVMGNFMTENISWRWNQWLSCIMGGVCTILLLFFFPETYApdVLRIYLIRGFVLLGTQPILQAVTLYQGFIYGVSYLFFVSYPIEFQEARHWDLGVSSLPFLGIVIGVLIGCAVVIFTIQrpEDRLPVAIFGACLIPIGLFIFAWTSNPTIHwmVLGSIPVGMGMYIVFLQCFNYIIDCYMTMANSALGGNAMVRSLFGASFPLFGPAMYHRLGVAWATSVLGFIGIVMIPIPVLFWKYGATIRT-
      69 UniRef50_A3WJW9        Sugar permease, MFS-like n=...   241     4e-62  1  22.9%  8:391   19:405     -------FVVIILALLTAFAPLSIDMYLPAFTAIAADYQTDTHRVELSLSAFFFGLFIGQLLYGTATDKFGRKKPLYIGLAIYVVTSIACAWAPDIEWLIVLRFFQAIGACAGIVIARAVVRDLYTPQASARVFSFLILVMGVAPILAPLFGNYVTEWFGWRAIFWIVSVLGVACAFVIHLVLPETRGRrvRMRHSGRTYWDVLKDRSFLRYSLTGGIAQAGLFAYITGSPLMFIELFDFTPSAYSWLFGANAVGIIGFSQLNGWLLKYYPARKILNVSLPILAVVSVGMAVAAYvaPVWGILVPLFAYISTLGLVFPNAMAGALANQQERAGSASAVTGSLQFLIAGLVSMGVNSVSGLTDYAMAWVIGSTGIIAVVTYRLMRYEEPESA---
      70 UniRef50_C8W084        Drug resistance transporter...   241     4e-62  1  16.7%  6:358   52:458     -----PWGALLILVLGAFMAILDTSIVNVALPKMMVIFGASADEIQWILTGYMLTSGMVIPMTGFLGDRYGNKLMYIWSLIIFTIGSALCGLAWSNNSMIAFRVIQAIGGGMVMPVTMAIIYRIVPMRKIGTALGVWGIGAIMGPAIGPTLGGYLVDKFSWHWIFTINIPVGILTIILAYVLLKETPLMPHLKIDIPGMIlrLLKNKVIVASLLSTSLVTVGLFSAVFLVPIYAQNLMGYTPMQTGLMMMPAALVTGFMMPISGKLFDKYGALPLGLVGLTILAVLTYQMKYISTDTTFTHVQVLLSIRAIGLGLAMMPLTTAGMNTVPrlVSRASALNNVVRQISGSMGIAYLTYVM------------------------------------
      71 UniRef50_C5GF32        MFS multidrug transporter n...   240     5e-62  1  14.4%  1:381  118:546     MRLGRKWVVVLVLAVGTCTSSLYTMTYA----QIMEEFNCSRIVATLGLSLFIFGLGVGPLVLAPLSEFYGRRIIYVTSFTFFLIWLVPCAVAQNIETMLVARFFTGISGSAFLSVAGGTVGDMFARHELAAPMMIYTASPFIGPELGPLLGGFICQYTSWRWAFYMLLIWAASILIAIALLVPETYHPVLFrrSIYRPMLLLTMEPMCLSLCIFSAILLGILYLFFGAFHLVFSTLYGFTLSQIGLSFIGLFVGMIFAIMsyARLVQKREarLPPAIAGAPIVSIGIFIFAWTIFRDVHWiiIGSAVFGLGTILVYSGIFTFLVDAYPLYAASALAANSFLRSSFGAAFPLFGIQMYNRLGFNWASTLLAFLTVAMAPFP-------------
      72 UniRef50_B6HFZ9        Pc20g11070 protein n=10 Tax...   240     5e-62  1  15.7%  4:392   66:499     ---WYKGLTVAAMSLGATVASLSSTLYTSGIPGLQDDFHVSKIVALLGVTTYLLGMGVGSIIFAPLSELVGRRPVYIASMTIFLLLLLPSALAQNIESILMSRFFGGFFASALMSNSPASINDIVSDKHRALAFGFWSIGPTNGPVYGPIIGGFIFQYLGWRWTNWIVLIIGGVVLVLIA-SVKETYApsSLRINLKRPFVMLLKEPICMFWDGYVAIVYGVLYLCFVVYPIAFQQERGWSPGIGGLSFVGIGVGVLI-AIACEPLFRKveAMVSIVFFGATLLAIGQLWFSWTCTPNVHWVVPIlvPFGVGNACVFIYASNYIARSYGIYAASALAGNMFTRSVMGAFLPLAGPSMYKALGLNWASTILGIVEAACISIPVVFYFYGHRIR--
      73 UniRef50_Q9USN4        Uncharacterized transporter...   240     6e-62  1  13.3%  4:394   42:481     ---ARKWTQLILVSAFALLGPMASSMVAPCLDQIADRFHinSTEKALILSIYLLVFAISPMISAPLSEVFGRRMLLQVGNVIFIVFNMACGLARTKAQMYIFRFLAGFGSATPMGLGSGTISDLFTPDERGKAVAVMSLAPLLGPTIGPVVSGFIAEYTTYKWIFWSTTIFSGFIFALSLPLLAETYPKTLltPALMRPIRMLFTQPIVILCSTYMAIQYGILYLVLTTYPTLWTEEYHERPSIAGLNYIASGIGLIFGSQASGIFIDKTFrrVPVILLGTFFFPAGLFIYGWTAQYHTHWIGPDIGAAMFNIGLMLggIQTYLIDSFMIYAASSTAVACCVRSIAAFAFPLFGQDMYDTLGYGWGNSLLAFIVLgsIITCSLLWFGGKRLRAL
      74 UniRef50_A6RZ43        Putative uncharacterized pr...   240     7e-62  1  14.9%  4:392   63:495     ---WRKWSIVSCTALMFMLVNLGTITIVPAVPKVMEEFHVTNELYslLVSIWELGEVFGPFLVGPLSELYGRMPVYHTGNILFILCLTGGALSTNMSMLIAFRFLCGLVVSS-VTLGPSIVGDLFRKEDRGTAMSVAIAFPLLGPFAGPVIGSYITEAKGWRWSIWIVVIAVGAVTCFGFLTFRETYKVKLVQrsLLRPIKMLFLSPIVFIISFFTALVYGISYVILTTLTPILEDNYGLGQGPVGLAFLGRAAGNVIAMLLYAMVSDRyeHRLPLMLLGAIVLPIGLFLYGWSAEKHVHWIVPIIGTAIVGFSFILSILPtyLVDVHELHAASAVAVCCILRALFAAILPLVGPPLYNRLGLGWGNSLLAFICIAFLPALVGLMIYGERMR--
      75 UniRef50_Q06451        Polyamine transporter 3 n=3...   240     7e-62  1  14.1%  4:393  176:609     ---WIRWSYTVLLSILVICVAYGSACISGGLGTVEKKYHVGMEAAILSVSLMVIGFSLGPLIWSPVSDLYGRRVAYFVSMGLYVIFNIPCALAPNLGSLLACRFLCGVWSSSGLCLVGGSIADMFPSETRGKAIAFFAFAPYVGPVVGPLVNGFISVSTG-RmiFWVNMAFAGVMWIISS-AIPETYAPVILKRklLRPLYFSVTEPVLVATCFYVCLIYSLLYAFFFAFPVIFGELYGYKDNLVGLMFIPIVIGALWALATTFYCENKyeDRLLGAKIGAPFAAIALWILGATAYKHIIWVGPASAGLAFGFGMVLisLNNYIIDCYVQYASSALATKVFLRSAGGAAFPLFTIQMYHKLNLHWGSWLLAFISTAMIALPFAFSYWGKGLRH-
      76 UniRef50_B0RY73        MFS transporter n=9 Tax=Xan...   239     1e-61  1  27.0%  2:382  103:491     -TTPSTRRMALLLAGLAMFGPFSIDTIFPAFSQLSRSLAVDEVAIQQTISVYLLAYGLMSIAHGPLSDAWGRKRVILGGLVLFIAGTIGCALSRDLPTLLAFRALQGLSAGVGMIVGRAVIRDLFQGHDAQRLMSQVSMIFGIAPAIAPIIGGwlLSGAGWPLIFWFLAVFGLVLLIATVTWLPETHPVEARtrRLLHDYVRIGFNPRFQRLAAAGAFNFAGIFLYIASAPVLVMRHLHLGEGDFAWLFIPTIGGMTLGSFLSGRMAGRMDPVRQVRIGFIYCGVAALVNLGYtaQISLPWAVLPIFLAGLGMALIFPILALAVLDMYPQQRGLASSLQAFTQLMTNTVVAGVLSPLLSEHPRHLAFGMTGFFLLGWLFWRW------------
      77 UniRef50_Q5KEB6        Polyamine transport-related...   239     1e-61  1  13.2%  6:392  304:739     -----RWCLTTIAGLLVLNSTFASSSPSGIVKDMMAYFGFGQEVAVLTISLFVAGYCVGPILWGPLSESYGRRPVFIGTFFVYTCFQVGCALSKNTASILVFRFLGGTFAAAPLTNSGALLADIWDGDNRGRAMSLFALAPFVGPSIGPIVSGFivSGTNWRWVYWILTIFAGVCLAIIVLFVPETYAPKILAQKAKrpFIILALEPMLQAVTLYMSFVYGVVYLLFEAYPFVFVENHGFNTGEEGLAFLGFFLGGCLSVLFfpRFLrkPEKRLELCVISGVSLVIAMFWFGWTSYSSIHWISPVLalIGVGVLGMFVSLFNYIIDVYLWSAASALASATVVRSLFGAGFPLFAVQMYERLGTQWASSLLGFLALLMAPIPLVLMKYGPSLR--
      78 UniRef50_P38124        Fluconazole resistance prot...   239     2e-61  1  15.4%  5:393  101:541     ----KKSLVVFQIMLLTCVTYMGSSIYTPGQEYIQEEFHVGHVVATLNLSLYVLGYGLGPIIFSPLSerYGRLNLYMVTLFFFMIFQVGCATVHNIGGLIVMRFISGILCSPSLATGGGTVADIISPEMVPLVLGMWSAGAVAAPVLAPLLGAAMVDAKNWRFIFWLLMWLSAATFILLAFFFPETQHHNILYRRAlrPLKMIIKEPAILAFDLYIAVAYGCFYLFFEAFPIVFVGIYHFSLVEVGLAYMGFCVGCVLAYGLFGILNMRieAFLIVAMCVCWCLPLSLFLFGWTARVHWILPVISEVFFVLAVFNIFQATFAYLATCYPKYVASVFAGNGFCRASFACAFPLFGRAMYDNLavAWGSSLVGFLTLGLAIIPFILYKYGPSLRT-
      79 UniRef50_C7ZDA1        Predicted protein n=11 Tax=...   239     2e-61  1  15.6%  3:392  127:577     --RWRKVLNCALVSSLTFVTPLASSMFAPGVPELMLEFGssSELASFCVSVYVLGFAAGPMVFAPMSELYGRVIVYHIGNIGFLVFVIACAKAPSLGALIAFRFLSGVFGSCPMANGGGSIADMIVQEKRGTAMASFSIGPLLGPIIGPIIGGVVTDSLGWRWVFWIITIISGTITIVFFIFAVETYAPVIlkRGILRPFKMLLFSPICIICGLYVGLSYAYLYLMFTSLTPLFMRIYHFNTINSGLTFLGLGIGSMIGVIYFSISSDRneYRLPPLRAGAIFLPAGLFIYGWTAEYKVHWiiIGTAVMGVGNLIIFMTLQMYLVDSFTVYAASALAANAVMRSIAGGVLPLAGLPMFDKLGMGWGNSLLGFIAAALIPAPWLFIKYGEHLR--
      80 UniRef50_C7YRV1        Predicted protein n=1 Tax=N...   238     3e-61  1  19.4%  2:392  108:555     -KNSTKWGLTFIIALATAAAPLGSTIVYPALPVLTREFNTSETVTNLSVALYMISMAIFPLWWSSFSEQFGRRTIYLISFTLFVIFSVLSAISKNITMLVVFRMCAGGASASAHSTGAGSIADLFEVFERGRAMSIFYLGPLLGPLVAPVIGGVLTQELGWQATMWFLAIYGLIVLLMILFFLPETLLRRRprRFLIDPLLVvlRFPAVFITVLLAAIAFGSLYVVNIAIQqfTRDPYNYGQLLLGLLYIPSGAGYIVGSLCGGRWIDRIMArrENAWIMVTAYPLALLMFGWTLRYGLPTPVPCVALFFFGIslVFSSATTMLTEFIRKSTSSGAALNNLVRNTLSCIGAIVAAPWINAINVGWVftICFFALLVSYTSVWLLRTNATKWR--
      81 UniRef50_C7QKK3        Drug resistance transporter...   238     3e-61  1  18.4%  8:360   18:425     -------LVFAGVMLGMLLAALDQTIVSTALPTIVSDLG-GANHISWVVTSYLLASTALTPLWGKLGDQFGRKRIFQTAIVVFLIGSALCGLSQNMTQLIASRALQGVGGGGLMVLAMALIADVVPPRDRGKYQGVVGAVFGVASVIGPLIGGFFVDNLSWRWVFYVNLPVGAIALVVVAIGLRTHTAHRKPVIDYLGTFLIAAAASSLIlvYLCGAVAAACLIAWftFLPLYQQVVHGATPTASGLQLLPLMAGLLFASITSGQLISRTGRYKipIVGTAVMTVGAWLLSRMTDTTSTASNAVAMLVFGLGLGLVMQVLIIAVQNNVdeELGTATSAVTFFRSIGGAFGASLFGTIFNN----------------------------------
      82 UniRef50_A8KYD1        Drug resistance transporter...   238     3e-61  1  20.0%  2:356    5:414     -TSRRRFAVLAICCMSLLIVGLDGTIVNVALPALRRDLGASPAGLQWTIDSYTLVLASLLMLGGSTGDRLGRRRIFQTGLALFTAGSLLCSLAPGLGWLVVFRMVQAVGGSMLNPVAMSIITNTfdPRERARAIGLWGAVIGISMALGPVLGGILVETVSWRAIFWINIPIGLAALVLTHRFVPESRAPSPRRLDPVGQLLVifRSAPFSGATAIAVCAFGALAGFLFLNTIYLQDVRGYSALHAGLLTLPMALATLVIAPLSGRAVGRFGPRPSLLAAGVALTAGSAAMTGLSPQTSVTTLMVAYVLFGTGFGLVNAPITNTAVSGMpeQAGVAAAVASTSRQVGQSLGVAVIGS--------------------------------------
      83 UniRef50_A7EKU9        Putative uncharacterized pr...   237     5e-61  1  15.9%  2:392   48:484     -SKTRRWYITVVSVLLVVNATFASSSPSGCLTGIEREFHVSAEVSALVISVFLLGYCFGPLFWAPLSEFFGRRWIFYISFTLYLAFNFLCAFANNFAALLIGRFITGTMASSPLSNAPGVLADIWGPVERGNAMALFSMMTFAGPALGPVISGFLELKKDWRWNFYVMLWLAGVTELLM-FTIPETLPSKLLVNKARrrPWQLLVDPISFAVAVYLSVVYALLYMLFTIYPIIFQEKRGWNSGVGELPLIGTIIGAIIGGIAIFIVSHraEDRLPVAMAGGIIFPITMFWFAWSGNysVHWIVPTLAGIFLSTslIFVAYLNYLTDTYLMYAASAVAANTVCRSAAGAAAPLFTTYMFDALGVGGGGSLIGGLAICLAPIPFLFYKYGGAIR--
      84 UniRef50_Q5KNB5        Dityrosine transporter, put...   237     6e-61  1  15.9%  2:392  110:539     -SKRQKNVIVAVISYSAFIAPMTSSIFLPSIPTMAVDLHSSAEVINYTVAIFLVTIGVASVFWSPYSGFYGRRPVYLASMPIMVIASIGVAQSKNIGAIIGTRILQGIGSSCVLSVGAGTIGDIFRPTERSRGMATYYMgvLIGPALSPILGGIFTEYTswRSAQYFLAGCGALSVVLTFFFLPETFHpeRLKKERGKKFVMYWVNplLRWPNIAMA-----------------KDRYNinTAIAGCLFLVNGAGNIISSRIAGPYADRigYRRpsFWGTLILMPISVLIYGwfGKGGMAPPLIMVFLNGISLMLCLTPLNTYLVDCMQSRSAEVVAINNCIRYIFSAAASAFVLPLANAIGWGWTMTMCAFVSvlAAGSLFILCRYGERWR--
      85 UniRef50_B2B1Y3        Predicted CDS Pa_6_4840 n=1...   237     6e-61  1  13.8%  2:392  267:706     -SPGKKACILITCMMLIINSTMGSALPANALPFISDKWDITNESQqlPISVYLIGYVMGPILWAPLSEQFGRKIPTMITFLIFTAFTLATALANSWIFFLIFRLLTGTFASAPIAIVPGIIADISppRTRGRNMGLFFMTTVSGPLLAPIISGYCSETIGWRWAFWIGLIYAGCTLVP-LFFLPETYGPVLLKRrlYRPIKMLVTEPIVNTSCAYLALCYAIFYMCFEAFPIIFTGVYGLSPGECGLTYLAVGAGCLLALPIFFVwmARNkrRLPLACVGGPMFVISLFWLGWTAKEGVHFFVPMLapFGVGFMCIFQALLNYLTDAYEVYAASANAAASTSRSLLATVLPLATLPMFEKLGISGACSLLGGVSTLMCAIPFVFLWQGDKIR--
      86 UniRef50_A2QF25        Contig An02c0430, complete ...   237     6e-61  1  16.7%  2:384   39:468     -STRRKWLAVISISGFVLMSPLPTTIVSPAIDTIAEELNVTVTVQkmVMSIFLLGYAIGPMFISPMSEIWGRTRVLQTFNFVFLIFNTACGVARSIEQLLAFRFFAGLFGSCTVGIGAGTLGDLFNAKDRGKAMAIYSIFPLMGQVLGPIAGGFLTMRTSWRWAFYATSIIDGCVQLFGLLFLDESYTPVLLRRkmIRPIKLLSTQPIVQVMALYQGYLYGNIYILYSSIAILWTTRYHEKLDIASLHYLALGLGTAFAAEVATHINDRIFrrIPIMIPATVILSIGLFWYGWSAEARMFWLMpgIALFAAAAYICTVSNNIYVVDTYGRYSASALAATSMLRCLAGFVFPLFSPYAYERIGYGWTSSILGIIALCIGLTGVIF----------
      87 UniRef50_B6HNM6        Pc21g05310 protein n=4 Tax=...   236     1e-60  1  16.7%  4:392   48:480     ---KRKWMILGMVSVITFLSPLASSIPAPGTSLMDSEFGVTStlASFSVSVFVLGFTVGPLILSPLSEIYGRQPVLNVMDVFFTLWQIGCALAPNIASLIVFRFLAGVGGSACLSVGGGVIADLFPIHQRGKANAMFTIGPLIGPVLGPLLGGFISQRAGWRWVYWFLLITCGVMTCVNFVVGQETNppALVVQSIMRPLR-IMSSPMLFLLALYMSFVFGLLYLIFTTTTTLFTGSYGWSLELTGLAYLGIGIGFCAGNFTVAKISdhPEMRLAPCLFFAPFIPISFFWYGWTADKHVHWIVPIIGLLPFGFggIFASIQTYFIDASGAYAASAVAGLTAMRCLFGAFLPLAGPSMYSALGLGWGNSLLGFIALGLMPGPFLIYKFGTALR--
      88 UniRef50_B6K551        Membrane transporter n=1 Ta...   236     1e-60  1  12.6%  2:381   38:465     -RASRKWAQLIVVSNFALLGPFASSMIAPCLDQISQRFNItsTERALVLSIYLLAFAISPMISAPLSEVFGRRMLLQYGNVIFVVFNMACGLATNKTQMYIFRFLAGFGSATPMGLGSGTISDLFYPSERGKAVAVMSLAPLLGPTVGPVIGGFIAQYTTYKWIFWSSTILSGSILLVSIPILRETYPKTLLAaaLMRPVRMVFTQPLVIICSGYMAIQYGILYLVLTTFPILWTQHYHETPSIAGLNYIASGIGLVLGSQASGVFIDKVFrrVPIILLGTMFFPTGLFVYGWTAEKHTHWIGPDIGAAMFNVGLMLggIQVYLIDTYIIYAASSTAVACCVRSVAAFAFPLFGQAMYDKMGYGWGNSLLAFVVLGSSIIV-------------
      89 UniRef50_Q10084        Uncharacterized transporter...   235     1e-60  1  15.9%  2:392  101:537     -SHSYKWWIVIQVSVITIVVTFASSVYSSGIIDIASELHSSIPVSTLGSCTFLVGFGVGSLPFAPLSDIYGRFIIYFVTLLIFTIFQVGGGCAHNVWTLAIVRFFQGVFGSTPLANAGGTISDLFTPVQRTYVLPGFCTFPYLGPIIGPIIGDFITqyLEWRWTFWINMIWAAAVIVFVFIFFPEThpKNAMIQAATQAVSLIFTEPIVVCFTLYLTVVYIINYINFEGYPIVF-AKYGFNKGEQGLSFIGVGVGIVCAGLCTPFIYWHyeDRLYPLFIGCFLLPISMFWFAWtyPHHIHWIVPIIASAFFGFSlvFFVSYNYIIDSYQHMAPSALAAATLVRYSASGGISMVARPMYLNLGDHWATSVLGFISVAMVPIPFIFYRFGKSIR--
      90 UniRef50_A8QD28        Putative uncharacterized pr...   235     2e-60  1  12.1%  6:392  246:705     -----RCYLTLLAGSLTLCTAFASSVPSGIVTEMIVEFNTSLNVVKASVFLFVGSFCVAPLLWAPLSEMFGRKIIFIISFAGFTAFNIGCAFAPNIAAMIVMRILAGAFGSSSMSNAPSMIATLFPLKYLMIGIVFFALAPIAGPCVGPIVSGYIsdHANWRWVFRVCAILSGVLLLLVIFTMPETLDGKRLQMKARrpVKMLFTEPMLMLVTIYISFIYGVLYLLFVAYPIVFIRDHNMNNGEEGLAFLGFFCGCALSAAYcpRYVKSmeRRLETCMIGSPCLVIALFWFAWTAFPSiwSTIVAGGVFGIGLFFIFLSLMTYVTEVYLMNSASAIAANTVVRSAFGAGFPMFGQQMYEKLNPRWATTVLAFIALVMMPIPFVFYKFGSKLR--
      91 UniRef50_B6H0M8        Pc12g03190 protein n=1 Tax=...   235     2e-60  1  11.0%  1:392   59:498     MQDWLKWSIIILQAASFLSITFASSALSAANPQIQERFGTSTELVVADTSLFVLAFAIGPAMWAPLSELWGRQIIYFVTYGLTTLFAGLTIASPNIATLLVLRFFAGALGSSAISNAGGVVSDMYTARDRGLATIAFIGAPFLGPSLGPITCNFLAVSKGWKWVQGLTTIFNGVVFLVGIAFIPETYTPVLLQKrmVRPWILLLMEPIVLLLSIYMAIIYGTMYMEFAAFPIIFEENLKWPQSTSGLSFLGMMIGQILGCAYSikVADRteARLIPAMVGAVTLPIGLFWFAWTNFPHIHWIviGTVLFGFSHVSIFLSVVNYLVDGYTIYAASALAGNAVIRALFGAAFPLFTTPMYQNLGIQWASSISAFLAVACLPFPWIFYKYGPAIR--
      92 UniRef50_A6SI60        Putative uncharacterized pr...   235     2e-60  1  17.1%  2:392  217:661     -SLWRRGFCTIMIASIGFIVGFASSIDSAALTQAAEDFGVSEVAESLATGLFLVGFGLGALFAGPISETIGRNPVYISTLFIYMIWIMASALAPNLTAQLIFRFLAGFFGSTPLTCAGGSISDLWSPMERVYAFPVFANAAFMGPIFGPIVGGFVgqLVSWRWCEWITLILSGLILLLITLFQPETFAptRLLRALYRPCLLITREPIVMLFALYLTVVYIILFTFLDGYTYIFGETYNFSEGLTGLAFLGIAIGLCFATCLVPLisARLPprLWFAMFGAPFIPISLFWMGWTNYPSiwSGLVASLFFGFGILCIFISTYQYIIDSYEMYAASALASLTLVRYVAAGGMVEVGIPFYENLGVHWTLTVLGGISAVMVPVPYLFYVYGEKVR--
      93 UniRef50_B6HSU2        Pc22g17370 protein n=42 Tax...   235     2e-60  1  13.6%  4:392  136:572     ---KRKCYISAILAFTSICSTFDSAVFSASSNNVSSYFSVGLEVAVLSSSLYIIGYASGPLIWAPLSELKGRRLPIIVAMFGFGVFNIAVAVAKDLQTLMICRFFCGIFGSCPLAVVAAVFSDIWDNRTRGVAIAMFSSTVFLGPLLAPFIGGFimSYLGWRWTAYIPAFMGFAAFLLNVVFLKESYPPVVLVdnFSRPLRLLINEPLILAVTVYLSFIYGLLYCFLTAYTLVFQGVYGMNAGVGGLPLFGMVVGLFIAATYIIIASKGYNKKlpVMAGGALFAAGLFWFGWTGFNGTIHWIVPTLSGLFTGFGliFIQLFNYLIDTYLMFAASAIAANTFCRSMVAASFPLFSRQMFQGMGIQWASTLLGCVAAVLVPIPIGFYFFGKRLR--
      94 UniRef50_C5JZ13        MFS multidrug transporter n...   235     3e-60  1  13.4%  3:389  143:573     --HSAKWAAVLIVSSFTFISPVSSTMVAPALATIGKEFDITSSMEqlVMSIFLLAYAVGPFVLGPLSEIFGRVAILQLANLFYLVFNTACGFAQTKQQILAFRFLSGLGGSAPQALGGGVISDCWRAEERGKSIAVYSLAPFIGPAIGPV-----AKHTTWRWIFWSVSIADAGVQVVAFLFLKETYAPklLRKSLVRPFIMLGTQPTIQALALYRAYLYGLMYLVLSSFPLVWEGVYKQTTDIASLNYLSLGVGFVIGLQICAPIMDRieFRIPLMLPGGLLVPIGLMTYGWTAQPHIHWIIpaSAIFATGLIIGFQCAQAYVVDAYTQYAASATGAAAFLRTLAGFSFPLFAPTLYARLGLGWGNALLAFISAGliVAPVLLWRYGE-----
      95 UniRef50_Q1H3C0        Drug resistance transporter...   235     3e-60  1  24.9% 21:390   30:405     --------------------PLSIDMYLPGFPAIEKSLLAQAGSAQLTLASYFIGLAIGQLFYGPLSDRFGRRLPLLIGLVIYILASFGCAFTSSIPELIFWRFLQALGGCAGMVITMAVIRDRCSANDAARAFSMLILVMGLAPILAPLIGGWIVTSFDWRVLFITLGVAGILGLIAVYFWLEETHDTRHEPprILRNYGRLFMDRRFIGYTLSGGLARAGMFAYIAGSPFVFIEYYHIPAQHYGWIFGMNAAGLILVSQINVWRLKKHRATVLlaLWLPGGIGVLLLGLSLTGHVTLPLLLIGIFLFVASIGYIGPDAGAATLATHGQQAGTASALMGSLQFGLATIAGGLVNLLHDGTTFPMVTVMAGCGIGAWLAHRLIIVRYIRR----
      96 UniRef50_B6K396        Membrane transporter n=2 Ta...   234     4e-60  1  15.6%  4:394   37:476     ---RQRLINLALFSAMAFLNPFGSSIFVTSMNDIAVTFGSSVSSLKLGVTMYVIGMIIGPMVASPLSEQYGRRPLYLIGYTVFTLLQIPTALAVNLPMFLVFRFFSGTFGSFSQGMGGGSINDMFTKVERGKYIGYYLLGVTCGPTLAPVISGFISSTGKWRWDFWLLLILSAVVTVFSFLFLKETYKPVLDQKnlARPLLILITRPIAICMALIQSMLSGVLYIFFTGIPEIWEGEYHFSVQMVGLTYLGLMVGMLFSLllYIFLVKKRGgrIPMGILGCLLCSTSMFVFGWTVQYKVFWFVPVLffLGAGMILVFTTLNMYIVDIYGRYAASAIAGTNIPKNICGATFPLFAGKLFDKLNYGWGFSLLGFCTIGLSGTLPFLYFFGERLRRI
      97 UniRef50_C1EU34        Drug resistance transporter...   234     4e-60  1  24.7%  3:390   16:408     --KTNRLWMILVLGTLTAIGPLSIDMYLPSLPKLTDDLQTGASLAQLTLTACLLGLSVGQLFVGSISDIYGRRKPLIIALIIYVASSLLCAVAPSIWTLVLLRFLQGASGSAGIVISRAMVRDMYSGSEMTKFFSLLMLVNGAAPILAPIIGGQLLQFTTWRGVFIVLGAISVFMLISATFVLRETLPPEEResGTLATYGKLLKDRLFMGYALSQGLVTAAMFAYISGSPFVLQNIYGASPQQFSLFFAINGIGIIIASQVTGRLAGKVNEKTLFVSGIVIAAVGGLSLLLTILLGIGLIGVLclFLVVSSVGVVSTTGFSLAMRNQKQAAGTASALLGLLQFISGALVAPLVGIGGSNTALPMGVVIALCEIGAVLCYLFMARRSEKQ----
      98 UniRef50_Q5KAC4        Spermine transporter, putat...   234     4e-60  1  14.3%  2:392   86:520     -SKRRKWWATTTASILCLAVALGSAMPTGDLPGTAETLHVSDEVIYISISLFVAGFGIGPLIFAPLSEVVGRRPIYAVSMLFYFLFTLPSCLAKNIATMLAGRMIAGLASSAPFTNVGGTISDVWAVEERGFPMAVFSSTLFMGPCLGPLFGGWIAEKTgwRWIYWVLFILCGACVILCIFT-PETLAPVLLRkaLTRPLVFMFQEVIIIFFTVYLSFIYALLYSTFFAFPIAFEEIRGWSMGMTGVSFVSIIIGIAIANLCMprLYKKheGRLYPMMLGALTLPVSMFILAFTSYPGIIWVGPCviIFGFSMVIIYISGNTYIVDSYSNYAASAISAKNMTRSLIGASVPLWITQLLHNLKFQYGMLFLALFSVVIAPIPFVFYVKGGAVR--
      99 UniRef50_Q6BLC6        DEHA2F14564p n=5 Tax=Saccha...   234     4e-60  1  14.4%  3:392  159:600     --QWKKWYITFTVALICLCVSLGSSLYVAGIPSLMVEFGVSQELCISGLTFYLIGLAVGPAIAAPMSEVFGRRWIYFFSLPISMLFAMGIGLSKNIHSILILRFFCGFFASPAMAVAGGSISDIWSFQDMGFAMAMFCLAPFLGPVLGPIIGGFAAEQKGWKWTMWIYLMASGLILPFVLL-LPETYKPIILAHrlLRPVQMLMVEPIVSIFTIYIAFVFAVLFGFFEAYPIIFQGTYGMSLGVSGLPFLGVGIGLIGGVIFFIILDKTieNKLLSGKVGAICLPIALFWLAWTGRtsVHWMAPVAAGVPFGFGLifAVIYYFSMSYPPASLASALAANNLVRYLLASVFPLFTVQMYERLHIDWATSLFAFIALAMVPVPFIFQRYGAKLR--
     100 UniRef50_Q6CJJ7        KLLA0F18106p n=5 Tax=Saccha...   234     6e-60  1  14.9%  4:393  144:580     ---KKKLVICIMLGLDCIAITMGSSIFASAVTTISEIYEVANVVSILGITLYVLGFAASPVIYAPLSELYGRQGVLLIASFGFALFQFAVATAENLQTILICRFFGGFIGAAPLAVVPASFSDMFDNTQRGTAVTMFALGVFVGPILAPVFGSYIVQYTSWRWTEYVTGIFASVIFVLLCYFFEETHHPTIlqKTITRPIYMLFTEPIIFLITVYNSFVYGILYLLLEAYPIVFVKGYHFYANGE-LPYIALIIGMFFAAVVNIYmvRRveARLFPMMVGSIIFPIGILWFCWTGNYpvHWIVPTIGGSFIGYGliFLPCFNYLIDSYLFLAASAIAGNTFMRSSFGAAFPLFAGFMFENMGTNWAGLLLGLFAACLIPVPFLFYKYGRRLRQ-
     101 UniRef50_Q2GV62        Putative uncharacterized pr...   234     6e-60  1  14.3%  2:392   73:506     -TPARKWFITFIVTISILAITLTSSAYSSSAAQVMAEFDSSPEVFALGVSLFVLGFAIGPAFWAPLSELYGRQILFITTHALVVTFVAASAGCTSMAQLLVFRFLAGTFGASPMTNSGGVIADLFPPAQRGLAMTIFAAAPFMGPVLGPVIGGFITMNVGWRWVHGVCSIFIGVVWIAGSLLLPETYGPVILRRrlKRPWVLLFLEPIVLISAIYLAILYGIIYMFLGAFPIVYQDIRGWSEGIGGLAFLGLAVGMIMGLIYTIYDNRRyeSRLPPSLIGALVLPASMFAFAWTNAPSIHwsLILSAPFGFGCVLVFLSCLNYLLDAYTIYAASVLAAGAILRSLFATAFPLFVGKMYTNLGIHWASSIPAFLTVACMPFPFLAYKYGAAIR--
     102 UniRef50_Q4PD17        Putative uncharacterized pr...   233     8e-60  1  13.0%  2:392  143:585     -SRAYRWYLTMLAGLLVLNSTFTSSAPSGVIPELEVEFGFGREVATLSLSIFVAGYCLGPLLWGPLSEQFGRKPVFILAMIIYTCFNIGCALSKNTASILVFRFLSGTFAASPLTNSGGVIADLWDAKTRGIALSLFSLAPFAGPALGPIVSGFivGGASWRWLFWVCTIFSGVCLALVVLTLPETYApdRINKTILKPFIMLGQEPMLLVMTIYLSFVYGVVYLLFEAFPIVFTLGHGFNAGISGVMFVPFFlgCAAVALYVIYFNPKyeERLYPIMLAGPCLTIAFFWFGWTSYasFWSPMMAGSLIGFGVLFCFLGVFNYLIDVYLANAASALAANTVCRSLAGFGFPLFATQMFTVLTPRWASTLLGFISLIMVPIPFLLYKYGSKIR--
     103 UniRef50_Q3AB00        Drug resistance transporter...   233     8e-60  1  16.7%  5:357   11:417     ----NKWLTMFVVVIGTFMAILDTSIVNIAIPKMMQVFAVGTEEIQWVLTGYMLVMGVVIPVTGYLGDTYGYKRLYIAALFFFTLGSALCGFAWSNNSMIAARVVQAIGGGMMMPASMTIIFNTFPKEERGMALGIWGISVMVAPAIGPTLSGYLVEYFNWRLIFTINIPIGLFGMVMALLFLKESVRRPHATFDLPGFilSVLKNPTFAMSLVITMINTMGLFGGLFLFPIFFENLRGYPPMDTGLIMLPAALASGLVMPIAGRLFDRFGAKPVVLFGLTLAIISSYGLSLTHINTELWWLQTLLIIRAMGIGFSMMPVNTAGMNALPNYqgRASAINNTLRQVSSSLGVAIITTI-------------------------------------
     104 UniRef50_B6Q6Q8        MFS multidrug transporter, ...   233     1e-59  1  12.8%  2:392  113:551     -TPAKKWAITTFLSSLTIWVTFSTSVFSQATQITAAEFGVSDEVMILATSLPLFGFALGPLLWGPISELFGRKKPLFFGFFVFVIFHIPVAVAQNVETIMLARFFIGFFGCAPLAIIGGALADMWDPVDRGVAMASFAGGTFGGPTLGPILGGFIVqhLGWRWTAWINLIAAGFFMVIAFFVVPETYAPVLLQKRAarPLQMLFLEPILLCVTIYLSLIYGILYLLFEAYPYSFQEIRGwsAGVAALPFLGILIGVLLGCAFIIYLTkrfeERLVPMFLGSVLLPIGLFWFGWTSNKDISWvvLAGIPIGAGILIIFMQGLNYMIDVYLMFANSALAANTLFRSGLGGGFPLFATQMYKTLGVPWATSLLGFLTAAMIPVPILFYLYGAKLR--
     105 UniRef50_Q1BYA8        Drug resistance transporter...   232     1e-59  1  23.8%  1:390   58:453     VRRRPDARLILLLGALAACGPIATDMYLPSLPSIAAGFSVSAGAAQRTLTSFMAGFSIGMLLYGPLSDTWGRRPVLLGGIALFTLASIGCFVAGSIDMLIVVRFLQALGAGAASVLARAIARDAHEPSDAAKVLSMVAIVTAVGPLLAPLIGGQILRFSGWRGVFVVLAVFGALCATTAYLRVPETWPKERRKSAafASYGRILSDPVAWGHMLCGGMAFASMFSYITATPFVYIEYFHVSPQHYGLLFGLNVVGIMIGNFANSRLVGRIGSLRIIAAASLVSCIASlaFVALTGLGGLWSIVVCLFFVVGVVGILSANCTTDLMHRYPHNAGASAAVFGAMQLALGALASVAIGALADGTPFAMGVTIGVSGLLCFAGRYLVLRWHGRP----
     106 UniRef50_A4R590        Putative uncharacterized pr...   232     1e-59  1  16.1%  2:392   75:527     -STLNKKWIIGMVSFSSFISPMTANIYFPSITPIANELGVSIGLMNLTITTYMIMQGLSPTIIGDLGDMTGRRPAFIIAFTIYIVANIGLALQSNYAALLVLRCVQGAGSSGTLALGFAVVADLAVSAERGKYMGFVGAGIQVGPSIGPVIGGALSEYLGWRSIFWFCAILTIVWLIPFILAVPEtrHPTDRPETPKRKflAVVFEKDLGLLLMLNASVYLMFMLILATMSPQLHSIYNLNEFQVGLCYLPYGFGCFFSAIVQGYLLDWNYRRtqLIAPMLGIGIISTICYSWIMQtaLGLVLFFGFLIGVTVNGSFSMMNTLIVDLYTDAPATAVAANNLFRCSLGAICMSFIENMVQTMGRGWCYTFWALLTASLMPILWLLVQRGPRWR--
     107 UniRef50_C9S7V3        Fluconazole resistance prot...   232     2e-59  1  16.6%  2:392  127:547     -SAKRKWTIVGFVAAITFLTPFASTILAPAIGFLAEDFR--------------------PLFLSPLSEIYGRHVVLSSANAFFCVWLIGCALAPSLNALIVFRFLTGVGGSGCLTIGGGIIADIIPVHQRGRAITIWMLGPLIGPTIGPLIGAFVAQDIGWRWTGWIVLAASVPMVVAIAILSQETNARVllARGLTRPLKMLFLSPLLFSLSLYIAFCYGVLYLLFNTIPLVFQDQYGFSLGMTGLVYIPMGVGYGVSLALFNYISDRTVIRLTAavYFACLLPLTFFWYGWSAYAQVHWISPILALLPFGLGlvWQPIQAYIIDAFPEYAASALAAFTVFRSVVAAFLPLAGPKMYDALGLGWGNSLLGFVAIALIPVPALICKYGARFR--
     108 UniRef50_B8MN53        Efflux pump antibiotic resi...   232     2e-59  1  13.4%  6:392   58:491     -----KWRVTDVLSATGFNRIMVSTIMAPALSTIAYELDMNSTESAMSLSIYLLATAFGPLFIGPLSEIYGRQIILHASNVWFLVWNLLCGFAHTKGTLIAARFLAGFRASAIYALAGGVIGDIWRPEQRGRSLGTYLLIPLLGAAVGPIIGGFITAHTTWRWMFWSTSIFQMVMIFVSFFTFQESYGAvlLWKAMTRPLRLLIFHPFIQVSATLQGLNYGILYITLSTFSNLWIDQYNESIEISGLHYIACTLGELVASQVGGPLMDIleSRLPLMYPGILAACIGALLYGWAANYRLFWfdVGVVVLMFGMQLSGMPMMVYIIDTYGEHTSSAMAATQFARSLTAFLFPLFAPSMYQALGFGWTNTVLALVVISivPLTLLIWKFGPKLR--
     109 UniRef50_Q5A6K1        Potential dityrosine transp...   232     2e-59  1  15.1%  1:392   62:497     LSLKRKTIIIGIVTIAGCLGPISGNIYIPILPQLENEFHVSTQVINGTVSAFMFVFAIAPLIWASWADYGGRKTLYLIPLIFFILANILLAATpnIVGLYILRVLQAFGASSVISVGAGTVADIIEPKHRAKAISVFMWGPQLGPVLGPVL-SIIASKGQWRWIFGFLALFGFAVYLMILFFLPETLryPVPPKPSFKNYWILIKFKPVLLCSINSGLLFATFYGLMVTFAHVLKIEYSFTDAQISASYLCPGISLIIGSTIGGWASDKieYRFSLQFLGLIISMTGVIGYGWTvhTNVVAVFIFTFLGGFGMTWVFVANTTYLTECTTGQPATNVAIGNFARNISATICTAVIDPLISSMGFGWCLTGLGLTNILGIVFVVILLKWGPSWR--
     110 UniRef50_B6JZL6        Polyamine transporter 1 n=1...   232     2e-59  1  11.3%  4:393   89:526     ---WLKLRNVFVMGCACLSAGWGSSVFSAALPQVMRKFNLSHEVALLSITLYVLGFASGPVIWAPMCELFGRRRPMTAAVFIFCIFHIAVATAKDVHTILICRFFCGFFGSSPITTVAGSFADMFTPQTRGLVIAVYSAIIFNGPLISPIVGGFIasYLGWRWVSYITAIMGFIAFFNMLIFHRETYTRTITERrfTLPLRLLVTEPMLLLVSTYTAFVYGILYGLLEAYPIVFGEARGWSQGVECLPYLAVFIGVCFGCASVALFQPYyeARLPPMMIAAVLFPIGIFWFAWTgsTSIHWIVPTLalIGFGIITIFQQSLNFVVDCYAGCTASAVAANTILRSIAGAVFPLFTTQMYHGLGIGWAGSLIGFVAVGLIPIPFLFFHYGPKIRQ-
     111 UniRef50_Q7Z9I0        Uncharacterized MFS-type tr...   231     3e-59  1  14.3%  2:392   96:531     -SRLWKWYITIVNSLLVVCSAFGSSVIAGDLEDVSRDLKVGPEVANLSCSLMVVGFGIGPLVISPLSEMIGRRIVYLVTLMIYIVLQIPCALAPNIACLLIVRFFCGCFGCTPLTLAGGVISDVWETRERGLAIAFFAAGPYAGPTLGPLVGGWIGVGTgfRWIFWVNMIYMFV-MYLTLLPVPETYAPVLLRWRAQrpLTLLLTEPILVCISGYIALIYALLYGYFFAYPNVFVKGKGYNEGITGLMFIPILVGVVGALSTTPFLEKQyeWRLVGMCIASPFIPTGLLIFAWTSFPRLIWIGPAfaPFGYGMVLFYFSANNYLIDVYQNYCASALAAKTMVRSAGGAAFPLFIDYMMDGMTRQWAFFLLGMVAVAAIPIPFTFYLFGDKIR--
     112 UniRef50_A0KLA9        Bicyclomycin resistance pro...   231     3e-59  1  25.6%  3:388    5:396     --PLSPRFLFILLGALAGLTPLAVDMYLPAIPAIARDLATSIDGAQLTISAFLGGFAIGQLFYGPLADSYGRKPVILAGLSMFAVASVGCAMADSLPELLAWRMLQAAGGAAGSVVVNALLRDLFEKDAFSRAMSFVILVMTLAPLVAPVVGGYISAHSDWRVIFWLLVGISLFICLVLQWKIPETLKPEHKQpqVLRNYWGVLSHRGAMGYVLCGALSSSGMFAFLSASPYVYIEYFHVPTEHYGWLFGLNILLMMVVTFVNSRLVKGVGAERMLQYGLTMLPLAGALLiaWSQTGGLWGIVIPVVLFVGHISLVGANAMTGLMGHFPQSAGTASALAGTLRFGVGALVGILVNLDPPESPLPMAIAIASCGFGSALCYWLLTGKKK------
     113 UniRef50_C0S1S9        Membrane transport protein ...   231     3e-59  1  14.7%  6:392   63:496     -----KWAVALLTSLGGLVTLMSGAMLAPALETIGKDLNTSPDTTNMCLSIFVLAFAFGPMVLAPMTEIFGRRHVWIACSAWYIIWNGVCGFANSQGLMLAARLLSGLGASAEFAVSNPVLGDTWRPEERGRSFAVATFIPLLGPALGPILGGVITNSVGWRWLFWVLSIFDAVLTIAAIWLFPECYEqqKLKRSVVRPVWMLFTQPVIQLVSIFLAYNFGTLYFVLTSFASIWITQYHQSVSASGLHYIALVIGSTIGAQLGAALTDRleYRIPLMIPGSIVIPISLFWFGWAAETKQKWIVVDIAAALFNFGIIMssQQQYVMEAYRGYVASATAASQFLRSIFAFTFPLFAPALFSRLGYGWGHSLLAFVFLGliPSPFILWKFGAKLR--
     114 UniRef50_B8M543        MFS transporter, putative n...   231     3e-59  1  14.8%  2:393  127:556     -SPARKIVIVAILSACSFLSPISSTTILPAMPEVAETFNTTGSVINASNAVYIVAMGLSATFWGTFSQIYGRRPMSFWSSFLFFVFSFATALSPNLAAYFIFRALTAFQGTSFLVVGSASISDIYTPTERATALAWFLSGTLIGPAIGPFLGGVIVTFCSWRVIFWLQTALGGTAFLLVALFIPETIPHKthRMNPLRVIILLFKYPNLFFAALASGSLVWNQYSLLTPIRYVLNPRFNltPIESGLFYLAPGCGYVVGTFFGGRYADYIVRKWicLFFLGVSIPGWVLIYGWTVdgGIPVPVIALFLQGVSQTFVFPSLNTYCLDVmkGRSAEVVAGNYMFRYALGALGTGVVLPGIGAMGVGWFNTISALFVGASGFFMWLTTIKGAAWRQ-
     115 UniRef50_C6CZM5        Major facilitator superfami...   231     3e-59  1  20.3%  4:393    1:390     ---MNRKFVLYIVAFAAFFGPFTQTIYTPILPEVASQLHSTSFVVNLTISVFTLFLAIMQVVYGPLTDLKGRRKVMLFGITLYVIASIGCFFSETITFLLVFRALQAIGIAAGTVVAVTVISDLFEGKERGEAMGTFQMLVSLGPVLGPVIGGFLGGKFNFHSVFLALAATGMIVLVFNYLYLKETKPDNVQarFQLRDFTGILQNRIGSSIIYLGFIQYYVFYYFLVFMPNILTDRYGLSGEQKGLVFLPMSLGIVIGSYLGGKIQSRIDGEKLLVL-TSFLNAVSVLFFLLFYSISLPWLLAAIIFFGLSLGLSLPVQTTLLTGAFTNNRATAVGAYNLFRYMGMALSPILGSLFYNMGGYVLLYGFIIIVYLAFALLLSRRHLGGQAKRP-
     116 UniRef50_Q4P3R5        Putative uncharacterized pr...   231     3e-59  1  14.0%  6:392  135:570     -----RVYLTFLACVVVLASTFTSSISSGIAESLMKHYSFGKEVAALTISVFVAGYILGPWLWGPLSERIGRRKVFAASLLIYTGWNVGCALAPNTGALLTFRFLAGTAAAAPLSNSGGLIADLWPTRVRGIATGLYACAPFAGPALSPIVSGFisSGANFRWAFWVCAIFSGVCWLLVVLTLPETYAPVLLKRklIKPLIMSIQETMLLASILFMAFLYGVVYLLFEALPIVFGEGYGFSAGVVGLMFIPFALGACVGVlfFPRYAHKveERLPMAMLGAPVLTIGFFWFAWTSDpsFWAPMLSTALLGFGIFFVFQGLFNFMIDAYTVNAASALAAGVIVRSCFGAAFPLIARQLYARLGTKWGSSLLGFLALAMTPIPFLLYHYGPRLR--
     117 UniRef50_Q5YPQ7        Putative transporter n=2 Ta...   231     4e-59  1  19.5%  8:366   20:433     -------WTLVVVALATFMLMLDLTVVNVALPDIRAAFGSSFSALQWILDAYALGLAAVLLAAGSLADRLGRKRVFDAGLVIFVLSSLACGLAPNDLVLIVARFVQGLGGAILFAVGPALLGHEFRGKDRGMAFGVFGGVTGLAIAFGPLIGGGLTETAGWRWIFLINVPVTIAALVIGYLKVRESRSDTPPPVDWPGMITFSawTSLTIIGCFALAVVLLAVFtaLFLLISYVQNMLGYSAFASGLRFLPLTLLLFVAAAVAGSLVTKLPPAVLVGVSQLLIAGGLLAVVLVDVDSAWTALIPAMILIGLGMGVFNPPRAAFSIAvtPDKSGMASGINETFQQAGVAIGIAAVGAFFQNRVAGAF----------------------------
     118 UniRef50_C8V981        MFS multidrug transporter, ...   231     4e-59  1  16.1% 26:392  134:556     -------------------------IFSSANSVVSAKFNVSTEVGTLGMSLYVLGFAFGPTLFSPLSELFGRRLPILIGIFGFTVFQFGVATAENLQTVIICRFFGGFFGACPIAVVAAVFSDIYDNRHRGLAITIFTMMVFTGPLFAPFIGGFIVdyLGWRWTEYLAGILGATAFVLDLFFVHETYPpeLIAKNFSRPVRILFSEPVLLLLSIYMAFLYGLLYLFMTAYPIVFQRIHGFNKGVGGLPYFGLILGEFLGGFFIIAMQPWYNrrLPPAIIGSMAFAAGLFWFGWTGYtnTHWIVPTviLTGFGLLCIFLQCLNYIIDTYLVFAASALAANSILRSFAGAGFPLFAPYmfNAIGVNWTGTLLGCVAAVLMPIPLLFYLYGHRIR--
     119 UniRef50_B8NQ10        Caffeine resistance protein...   231     4e-59  1  14.4%  4:393  140:578     ---WYKCFTVWSVSLTTTCVILYTTSYTSGSPGIQESFGVTSRIVVLilTTYMIGLGLGCLVLAPLSEVYGRRIIYISTSVLFTILVLPVALAPNFPAVVISRFFGGFFGSASVVAGPGTINDIIQPKYRALAFSLWSLGAMNGPVLGPIIGGFVYQYLGWRWINWIVLICGGAST-ACLCLVKETYAPVLLKrsLSRPLIMAVFEPICLFWNVYVGVVYAVLFLCFVGYPIVFQQLREWSPGLAGLGYLGIGTGIALAVfvRNFLIAKHPPDPvpICIGGILIPIGEFWFSWTARPPVHWivLAGVPFGLGNGLVFIYATSYLAASYGMYAASAIAGNSVVRYVFGGVLPLAGSKMYRAMGVNWAGTMLALVEVFLTFIPFVFYRYGARIRQ-
     120 UniRef50_Q6MQR5        Drug resistance transporter...   230     5e-59  1  26.4% 19:386   24:394     ------------------FGPLSIDMYLPAFPAIAENLNVPLSSVQMSLASFFIGLATGQIFYGPITDRFGRKKPLYVGLGIYALASLVCAFTKNVEMLILFRFLQALGSCAGVVISRAIVRDLFTHQETARVFSLLMLVMGVAPILAPFFGGYISEFFGWRAIFALMVIISTSCIVMLAIFLPETHQPDQRvkDSLKNYVQIIKDRHFMGYALAGGAAQAGLFAYITGSSFVFINLFEIPAKSFGWVFGSNAIGLIACSQINARLLKRLSYDVIlkIFVVLGVLGVILAMAGIFNWGFWGLAIPLFLFIAALGMTFPNATAGAMATQRKAAGSASALLGTLQYGIAALSSAAVSRLHDGTTLPMCAMIGFCGVLALALHRLLVKK--------
     121 UniRef50_A7E9R8        Putative uncharacterized pr...   230     5e-59  1  14.4%  5:392   60:495     ----RKMRTAAVLGFDTLIASWGSSVYSAAVEPVAYEFGVSRIVAVLGLTLYICGFATGPLFFGPISELYGRKKPITVACFVFTCFMFAAATAKDFQTLMLCRFFAGVFASCPLTVVGGAFADMFGNETRGVAIAAFSALVFIGPFISPIVGAFItsHLGWRWTEYITGIMGAFALILDILFLEETYVKTLlkKHLLLPFKLLFGEPIVFLITIYTAFIYGILYLFLEAYPIVFAEYRGIDPAVATLPYLGMIVGVLLGCSIVIAFEPRYNrrLVPMMVGACLFPCGLFWFAWTgyPSISWAAPTviLTGAGIMTIFLQALNYLVDSYLFVAASAIAANTFLRSFFGAGFPLFATAMFHNLGVQWAGSLLGFLSIAFLPIPFLFYKYGERLR--
     122 UniRef50_Q2J7M8        Drug resistance transporter...   230     5e-59  1  18.6%  2:388   30:489     -SLRERQWALLVLCTGALAIVIDTSIVNVALPSIGQDLGFSAAGLSWVVNAYLIPFGGLLLFAGRLGDLVGAKRMFLAGIALFTPASLVCGLAQNPETLVAARFVQGVGGALAAAVVLGLVVSTFPNaeQAKAIGLYAFVSSAGAALGLLLGAWITEALSWHWTFFIntPLTWALVGISAALLAAFVVRQRTARNPLVPL-SIFRARNVAWANMVQALMIAGMGGMFFLGTLYLRQVLGLSAMEVGLAFLPTALMVAVISlaTPRLMEKIDPKTVLVPGLLLITAGLALLAVAPADGDYwdVLPAMVLLGAGAGLGYPSSLTMVmdATAADRGLRSGLVNTTQQVGPAIGLAVLATVAatGGYHLAFWIGSGASLVALVLTVLFLRPA------
     123 UniRef50_C4R931        Polyamine transport protein...   230     6e-59  1  13.8%  2:392  185:627     -SSRKKWFSTMTVAFLCLVVSLGSSLYVCGVPELMMEMGISQELGFAGLSLYLLGLSVGPIIAAPLSELIGRRPIYIVTLPLSMLFTMGVGLSPNIWTILVLRFFSGASASPCLAVASGSIVDVFLPHEVGLAMALFCLAPFMGPVLGPIIGGFVAENKGWKWTLWVNLMFAGALLPFVL-MLPETYAPVllSITLVKPLQMLVVEPIVIVFSIYISFVFAILFGFFEAYPVIFRGVYRMSLGISGLTFIGIGVGLFLGTGfgNQLPPTPESRLLSGKFGALALPISLFWLAWTSRESIHWIVPVLAGVPFGFSLifTVVTYFSMSYPPLSLASALAANNLARYTIAAAFPLFTVQMYDKLGIDWATSLFAFVAIGLVPVPWIFEYYGESLR--
     124 UniRef50_Q4P486        Putative uncharacterized pr...   230     9e-59  1  18.7%  2:380  199:631     -TKRSKLFIVLTVSLAGFFSPFAINIYIPALPQIAGMLHTSEAATNVTVTVYMIAQGLSPVIWAPLSDVFGRRPIYILTFFIFFIANLGLSFTNVYWLLVVLRMVQAAGACSAIAIGAGTIGDVTERKERGSYMGYYALAQYTGPAIGPVVGGALSQRWDYHATFFFLTAISGPFLLFMLLFLVETLrpRPGIKNPLHGTLDFGFHRPFllAILAFSMVYASYYLSSGSLPYLFKQVYGLDELLIGVCFVPSGVGCAVGTVLAGKILDwtRARLQSAWIYLPCYCASLLAYGWCVRAHTHIAAPIVFQFTLGMfmYFTNVNTLIVDLYPGKAASATAAVNVGRCLLGAVAVAVVQPMIDAMGAGWTFTLGALLTLIVGLI--------------
     125 UniRef50_D1ZPR5        Whole genome shotgun sequen...   229     1e-58  1  14.7%  4:392  154:591     ---WYRCWTIFACSYSTWVVVLYSSSYTAIVPGLMKEYHVtqPVATLGLTTYLFGLAFGCLALAPLSELYGRRPIYLVSLGVFALLILPCAMPSSLAEIIIVRFFGALFGAVMVSNSPATVVDIAHPDYLALCMAVTSIAPLNGPVTGPLIGGFAYQYLGFRWANWIVLILSGAAVIFMA-TIRETYAPAILRanLSRPFILAATEPILWFFNTWISLVYAILYLCFVAYPIVFKEHRGWSTGQVGLAFLGMGCGTVASIVLEPFWRSIINKRhvMTIGAILTAFGQLAFSWTCLPIKIHWIVPIIFGVPFGMgiSFIYGSNYLAGAYGLYAASALAANSFLRSVAGGVLPLAGPSMYRNLTPQIAGTILGVLEVLLIPIPIVFYKYGERIR--
     126 UniRef50_C2G4A4        Bcr/CflA family drug resist...   229     1e-58  1  21.7%  2:392    5:401     -SKFKRSTIIFILGLLSAIGPFSIDMYLPAFKTIATDFDTSVDRVQLSLSSFFIGIAIGQLVYGPLLDKFGRKKPLIVGISLYIFASIMCIFSTSIEQLIVFRFIQALGSCSGMVASRAMVRDYFGPQESAKIFSMLMLIVGISPILAPSVGAFVMSHFEWHMIFTILTVMAVLILISVIFLLPESFAGNkaPKQVTINFWTVCKNPQFLSFCLVSALTASALYAYLAGSPFVMQELYGLTESEYGIVFAIIASALILATQINRIALNRWSSSDISKFalQVSISALFIVVTLGGWITLPTMVGFIFLILLAQGFIFPNTSALALAPFKELAGSASALLGCFQMGIGALASGAVSILHNNTSLPMVIVMSACSFLGLIIYSYLPKLLKPATE--
     127 UniRef50_C6QHH0        Drug resistance transporter...   229     1e-58  1  18.0%  3:364   16:432     --TRRRLAIFGALALVLLLASLDQTIVSTALPTIVREIG-GLSHLSWIVTAYLLATTVVVPLYGKLGDLFGRRLILQAAVIIFLVGSALCGLAQNLPELIAFRIVQGLGGGGLIVTAIAVVGDVVPPRERGRYQGFFGGIFGLSTVLGPLIGGFIVDNMSWRWIFLINVPFGLAALLVINRTFRPHARKERVEIDYVGAGLLAITLTCvlGVLAFAWFLYaaLFGSITLMPVYLQIVQGLDPTSAGLHMTPMMLGVFVSSVTSGQIISRIGRYKmpVLGTGLMTLGLVFLSRMTLATSAETASVYMLCLGLGLGMVMQILVMSVQNAVaeQLGVATSGTTLFRSIGGAVGAALFGGIFSFTLHH------------------------------
     128 UniRef50_C9SES7        Polyamine transporter 1 n=1...   229     2e-58  1  11.8%  2:392   77:470     -SQTKKWSITVVNAVATLAVAFASSAYSGGVRAVIEDFGVSQIVAILGVSLFVLGFAIGPLLWAPMSEIFGRQRLFIVTFFALTAFNAGAAGSQNIQTLIILRFFGGAFGSSPLTNAGGVIADMFSASERGMASALFASAP-----------------FPWP-RYWPYCPVAFLRAVELSrlSKHDLRKVPQLTALMRPWVLLFCEPIVTLTSIYMAIIYGTLYMLFAAFPIVYQVHRGWTPGIGGLAFIGVAVGMIFAVSYCIYDNKRyeARLPPAIIGSVLLPVGLFWFAWTNGPEIHWVviASGFFGAGLVLVFLSLMNYLIDSYVVFAASALAANSVLRSLFGAAFPLFTSNMYDDLGIHWASTIPAFLALACVPFPYLFWRYGKAIR--
     129 UniRef50_C5G0U2        Fluconazole resistance prot...   229     2e-58  1  16.9%  5:389   47:480     ----KRWAHVVVIAIICLVMNIAPTMCAPSINLLVAEFNisFVVSTFAVTLYLLGLSVGPMFISPLSEVYGRLPVYHISNVVFVGFVIGNALSKNIGQFLAFRFLSGCAGGTPMALGGGSIADVTPIQRRAIAMALFSLGPLTGPVLGPVIGGFIAAGKGWRWIFWILAIIGAAATITGFVILREThpRQLLAGALIRPTRLLIRSPILLVISLYVALVFGLMYLLFTTFTDVFEGEYGFTTSTSGLVYLGLGVALVICMFLFGALNERveYRLVLMIFFSPLVGVGLFIYGWTVQYRVHWIVpgTMIMGFGAFFVLMPAQLYLVDLFgeAAASALGANNLMRYLSSTFLPLAGPSMYKTLHYGWGNTLLGFLALAFVPAPIFFYKYGE-----
     130 UniRef50_C7Z7N4        Putative uncharacterized pr...   229     2e-58  1  13.8%  2:392   25:456     -SKLKKTVNLGIVSMLAFITPLESSVIVPGVPLLKDDFHETrpVTSLVVSIFVLGFAFGPLLLSPLSELYGRRLLFNISNLVTLGFSIGSALAPNIASFIVFRFIAGSFGAGPMNIGGGSIADQVALGKRGFVMSIFFTGIFLGPVIGPVMGGFIAKSLGWRWVFWVMAIVKGLMTIVTFVFLSESHAPTIQkrAVSRPMRMLIRSPIVTGLSLYLALVYGYLYLLFTTFSTVFPEQYGFGIDTLGLAFLGLGIGCMLALIVLSWLSDWveYRLLPIVLGIPLLPIGLFVYGWTAQYKVHWIVPIIFTGFTGAGLIFspTQIYMVDAFTTYAASALAATSVVRSIVGGCLPIAGLPLYSTLGYGWGNSLLGFIAMVVSIAPLLFWRYGEMLR--
     131 UniRef50_B5I5W3        Bicyclomycin resistance pro...   229     2e-58  1  24.7% 18:393   54:438     -----------------ATPPLAMDMYLPSLPEVTDSLHAPAATVQLTLTACLLGMALGQLVVGPMSDRWGRRRPLLAGLLVYVVATALCAVAPTVEFLVGFRLVQGLAGAAGIVIARAVVRDLYDGVAMARFFSTLMLIGGVAPIVAPLIGGQILRVTDWRGVFVVLTAIGALLAVLVWARLPETLPAAERHtdALHSMRRLLADLPFTGYMLTGGFAFAALFAYISASPFVIQEIYGASPQTFSLLFGVNSVGLVVVGQINGklVGRVGLDRVLGVgtAAAAALLLMTTGVFGEVGLFPVAAGLFVLMSAMGVTLPNAQSLALLRTKHSAGSASALLGTSSFLIGAVASPLVGMAGEGTAVPMAVVQLAAALVALLCFMAMCRPWNRRATT-
     132 UniRef50_B8LX36        Bicyclomycin resistance pro...   228     2e-58  1  17.4%  3:392   92:530     --RSTKWILTCTISLATLIAPMGTSIFYPALHQVETDLHTSATGTNLSLAFYLLAMAIFPLWWSNWAEAFGRRTIYLISFVLGVVFAILAAISNSIGMLIAVRLLSGGSSASVQAVGVASISDLWEPRERGRAMGIFFLGPQLGPFLAPIIGGALADRWGWRSTMWFAVILAAAMLLMLSIILPEtlLLRILLIDPFRALL-VLRYPAMFLPMFYIGIVTIYFYILNISIQNTFAspYNFSTLIVGLLYIPSSLGYICGSIFGGRWMDYveRMKENAWAGALLPVVALLWYGWTADKGIYWLCPMifFTGFGMIIIISVGITMISEFMPGdrGLAASV--FIRNVLGCVGTVVAAPMLDELGNGWTFTLWALVALASASVIVAITKFGPQWR--
     133 UniRef50_A3LMY7        A(Acid, azole) Q(Quinidine)...   228     2e-58  1  13.6%  2:392  106:532     -SKRTKNICVVIASLSGFLSPMSSLAFLPAVPEIADRFNTTGEVINISSAVYCIFMSISPCIFSPCSDIYGRRITFLVCALLFSICTVLVAVSPDLPTFFIFRALTALFGTSFFSIAAHIIGDLFIPEERGTNMSWVISGAQIGTAFGSVLGGIIVNYTSWRVIFWVMAGLGLVMTVTAFVFLPETSRQTKHSILLalRIIVALKYPNLSIDGFITIAVVYAMYALLTPIRYVVDPRFNltPIYSGLFYLAPGMGYLVGSFFGGKWADHvgRrrTVLIPLGIVYPSCMLIYGWSIegGMPVPIIFMFISGIAQTCIFPASNAYCVDCLPELGGDAIGSSYFSRYLAAAVASATCLRSVDSIGVGWTSTISAFVLWIGFGCALVLIYWGEAMR--
     134 UniRef50_C5ACF6        Drug resistance transporter...   228     3e-58  1  23.7%  1:392  141:538     VRRRPDARLILLLGALAACGPIGTDMYLPSMPSVAESLGTSAAAVQWTLTSFIAGFSLGMLLYGPLSDALGRRPVLLGGIVLFTVAGVGCFVAPSIGALIVLRFLQALGAGAASVLSRAIARDAHEPADAARVLSMVAIVTSVGPLLAPLLGGQILRFAGWRTVFVVLAVFGLGCAIAAFLKVPETWPKERRRSSafASYGRIIGDPVAWGHMLCGGMAFASMITYITATPFVYIEYFHVSAQHYGLLFGLNIIGIIIGNFINTRVVGRLGSLRLISAASLviASFAVAFFALTGIGGLWSIVAGLFFVVGVIGLLSANCSTDLMHRYPHNAGAAAAVFGAMQLGLGAVASAVVGLLADGTPFGMGVTIAITGALCLMGRRLVLRWHGRPVR--
     135 UniRef50_B8LXZ4        MFS multidrug transporter, ...   228     3e-58  1  13.0%  4:394  121:558     ---ARKWTITMLLSFLTIWVTFSTSVFSQATRITAAEFGVSDEVMILATSLPLFGFALGPLLWGPFSELFGRKRPLFFGFFVFIIFQIPVAVAQNVETIMLSRFFIGFFGCAPLAIIGGALADLWDPIDRGVAVATFAGGTFGGPTLGPILGGFIVqhLGWRWTAWITMIAGGAFMIIAFIFVPETYPPVLLQRrvGRPFEMLFLEPILLCITIYLALIYGILYLLFEAYPYSFQGVRGwsAGVAALPFLGILIGVFLGCAYIVYlmRKHgeRLVPMFLGSVLLPIGLFWFGWTSNKHVSWvvLAGIPIGAGILIIFMQGLNYMIDVYLMFANSAIAANTLFRSALGGGFPLFATQMYKTLGVPWATSLLGFLTAAMVPIPVLFYLYGAKLRAL
     136 UniRef50_C6VW73        Drug resistance transporter...   227     6e-58  1  22.5%  1:391    7:403     MSRKQYFFIILILGSLATVSPFSIDMYLPGFPRIASDLQTTIDKVQLSLTSYLIGICIGQVLYGPLLDRFGRKKPLYVGLALYVIASFGCAMTSSVDALIAMRFFQAMGGCVGLVASQALVSDLFPADKRAEVFSLITLVIAVSPMIAPTIGGYVTASIAWYWIFVILAGIVSLIILAIYFFLPTGRDasLRPEAVLGGYLTVISQPQFLIYTLAGGLATAAPFAYISGSSDVFMNIYKVSEQQYGWIFAFLAVAMIGSTQLNHFLLKKYSSEQIIRFTLisVVGVVLILGVYNNWFGLYSLIGTMFVFLTGQGLTGPNASALSLAPFRKHTGSASALMGSWRMGAGAVISAIVSFLHNNTAMPMVGMMAFCAFGGLVILQAGNVVVRHRA---
     137 UniRef50_B9WIQ2        Membrane transport protein ...   227     6e-58  1  13.9%  1:389   53:497     LSRVHKWTIVGIISIGSVCVTCISSSVALATPQIMEHLNVSHEVAILNISFFILGLGTGGCFLSPISEFHGRRIVYIGGLTSMIAFEFLTAFTSNIGAMVFGRFMSGFCGSSYMSVASGSFADLFKAreLSLALILYSVAPFLGPSLGSLISGFINTHLYYRWTFYVFIIWSGVLLLAVIFFVPETYEPVNLQrsSKRPILLLLRDNMTALLNLYTGFTLAVVYLFFVAFPYIFSTVYHFTISEQGMSFLGLVVGMVSTCLISPYFIDKgeFRFIPLMVGAFVVPIGLFIIAWTSYSHIHWiiIGSAVYGSGTILVFNSIFAYTVEAYRLYAASAMATNSLTRSVLSCIFPLFGLQMYKGLGIQWATTLLALFACLMIPIPFLFFKYGE-----
     138 UniRef50_B5GBY2        Bicyclomycin resistance pro...   226     9e-58  1  25.8%  3:386   49:441     --RRTSLLTTFVLGGLTATPPLSMDMYLPALPKVTEALGSPAATVQLTLTACLTGMALGQLVVGPLSDRFGRRRPLLVGLVIYVLATAACALAPGTAPLIAFRLIQGLAGAAGIVIARAVVRDLYDGLAMARFFSTLMLISGVAPIVAPLIGGQILRFTDWRGIFLVLTVVGTLLTLLVVRSLPETLPPARRhrEALATMRGLLADRVFTGHVLVGGFTFAALFAYVSASPFVIQEIYGASPQVFSLLFGINSVGLIVMGQVNGrlVGRVSLERATGVGLSLItaLLLMTSGVFGHVGLVPLAVGLFVLMSSMSLVMPNAQTLGLQRAPHAAGSASALIGTSSFLIGAIASPLVGIAGEDTAVPMALVQLVSVLVAGAAFVLLCRP--------
     139 UniRef50_C9PNB3        Bicyclomycin resistance pro...   226     1e-57  1  23.5%  8:386   37:420     -------IFIVTLGILSMLPPLGVDMYLPAFLLIAQDLNVTPEKVQHTLTFFAAGMAIGQLFWGPVGDSYGRKPIILLGVTISAIAALILTNIQSIGNFTALRFVQGFFGAAPVVLVGAILRDLFNKNELSKIMSSITLVFMLAPLLAPIIGGHLVSWFHWHSIFYVISFMGLLSCLLVLVLIPETHHKEKRIPLRlrNFLSLCKQKEVLGYMFASAFGFGGLFALITAGSIVYVGLYGVPVDQFGYFFMLNIGVMTIGSALNGKIVNKVGTETMLRVGLAifIAGIGLIMVSILDLGFWTMTCFLAIFAGQNPLISSNAMASILEKFPTMAGTANSMVGSVRFGTGAIVGSLVALMPMKTPAPMLLTMALCSIIGVSCYYFLTYR--------
     140 UniRef50_Q6BTW2        DEHA2C15466p n=2 Tax=Debary...   226     1e-57  1  15.3%  2:392   80:520     -SPRKKIILIFAIMSTCFTSTFGSSALSEAAVDISEKYHVGLEVATLCTSLFVLGYASGPVLWGPLSDVYGRKIILISSGFIYLTLNFAVATAENIQTIIICRFFSGFASAAPVVVCAAIIAEVSNTSNRGNIITMFVMVLLVGPLLAPIVNGFIvnSLGWRWCVYLVGILSSGALVLLVFLYPETHshDILTKSVTLPIRMLFSEPILLSVTLYNSFIFGLLYLLLTAIPIIFgtGYGFSQGVSSLPYIATILGVEVGGIMNLFFDRRyeERLLPMMIGAVAFPCGLFWIAWTGQYpvHWIVpgTFFIGFGLICIFLPSLSYLVECYLPYTTSAVAGNTMVRYIFGAIFPLFSRQMFERLKVNWGGSLLGFISVLLLPIPFLFYKYGQLLR--
     141 UniRef50_A6SIP3        Putative uncharacterized pr...   226     1e-57  1  15.8%  6:392  100:535     -----KCYIVLVGMLVVINSTMGSSLPSNAIPFIAPYFHITSESAelPISMYLLGYVLGPLVFCPLSETFGRRTIMLATFFCYSAFTLGCALTPTWGGLLAFRILAGINASSPISVSGGIYADIydPVTRGRAMAVFTAGTCVGPLVAPIISGFISPALGWRWTFWIGLIVAGASWAP-LVFLPETYGPVLLLKrlTRPIRMLFFELIVLAACTYLALAYGIFYMYFEAYPIIFEGIYGQSSGVSGLMFLPIGGGAILAIIVFLWWDTFlsRRLPLAIFGGPLYVISLFWLGWTSRASIPFYVPMLAGIPFGMglIFIALLNYLTDAYEVFAASAMAASSCCRSLAGAVLPFAAKPMYTKLGVPWASSLLAFLSLLMCGVPVIFTWKGDRIR--
     142 UniRef50_B8MVJ6        Florfenicol exporter, putat...   226     1e-57  1  17.7%  4:392   28:466     ---SRKFFIVLLVSGFGFLTPATSSMVAPALDQIATDLHItsAESQLILSIFLLGLGVGPLLLGPLSEIYGRAPVIRWGNLFYLVFNTAGGFARTNSEMLIFRLLAGVGGSAPLVVGSGVISDCYHPEQRGFAVSIYNIVPLLGPALGPIAGAFITQSISWRWVFFIVSLADVTLQLMAAVVLRETYPptVLRQSLFRCLQLLVTQPILQVLAIYLAYVYGLIYLVFSTFPSVWETQYHQSSTIGSLNYISLGLGYLSGSLICAVFVDRieYRVPIMAAASLLVPVGIVLYGWSAGKSLFWLiiGGFIFSCGIIMIMQSVNNYVLDAYPLYAASAIGAVTVVRNIPGVVFPLFAPYLYDAVGFGWGGSLLALVAVCifPAPVIIWIYGRRLR--
     143 UniRef50_C3DZQ3        Drug resistance transporter...   226     1e-57  1  27.2%  1:386    1:392     MVKNKNNLLLITLICLVCIPQLSISLYLPSLPHMSNDFNTGNDLMQLTLSIYMVGYAISTLACGIFSDRYGNKPVITFGLFLYLLATVICLYTSNIYVLILGRFLQALGGGCGTVLARVIAKEKFKDKEQLNVLTNLSTAIAVTPAIAPAIGSFIQTYLNWRYCFVFLLVLVSIVLILTLCILEKEKNVQGKkkSIFNNYKLLLTHKIFLAYSVAIGLAWCAYYTFIQSSSFVLQGFFHVSPKSYSLMYALVIIGYIMGTTFTRRNGSRVGLNKVIMyyIALFSSILMVIAVWIIPYNPFGIIFPMMLLMIGVGGIFPACQAAVMKPFNEIVGTASGLFFFIQMIFGFCCGLILSAFNMTSQLPMVLTILVCCILLVASFYQLIYR--------
     144 UniRef50_C2AN99        tRNA-guanine transglycosyla...   226     1e-57  1  19.4%  1:360   22:443     LTHKQILYILAGLMTGMFLAALDQTIVSTAIRTIADDLSGYQLQV-WVTTAYLITSTIVTPLYGKLSDIYGRKPFFMFAITVFVLGSLLCSFSTSMYELAAFRAVQGLGAGGLMSLALTIVGDIVPPRERARYQGYFLAVFGTSSVLGPVLGGviLGITGWRWVFLVNVPIGVIALLVVYRVLQLPHTRREGVRIDWVGAFMliPLRIFRNRIFAQGvvGAAMFGGISLLPQYFQVVRGASPTVAGFMMLPMVLGLMMGSILAGQMISRTGRYRipIIGAVLLTVGMWALHYVTADVRLAAVMAGAALIGFGLGNLMQPLTLAMQnlPPQDMGVSTAAATFFRQIGGTLGVAVFLSVLFS----------------------------------
     145 UniRef50_UPI000187F2D3 hypothetical protein MPER_1...   225     2e-57  1  15.1%  2:392  168:607     -SPFKRGFVAFSIALLTFSVYMGSAIYTSSIPGLMSEFGVPQVIGSLGLTLYVLAYGIGPMFLTPLQEllGRNPVYIFGLILFLLFNIPIAKATNMSTVLAFRFLTGFVGSPALATGGASMADIFEGHRLSYMIGIWSLGAVAGPILGPVIGGFAAQAKDWRWPTYELMWISAFAIIFLSLLLPETYEATILLKRARrrPFVLSMEPAVLFLNLYLGLVYSVFYLWFEAFPLVFNEIYHMNLGVGSLPFLAFVVSGSATYTVYCLYLKYyeIRLYIGLIASIFIPVSLFIFGWASRPSVHWIVPViaLYLPGIFLTFQSILIYLSNSYKKYTGSILASNDLFRSTMASVFPLFGSPFFKNLGLGPGSSLLAGISILLMVVFYLLIRFGGKLR--
     146 UniRef50_B0DMC8        MFS polyamine transporter n...   225     2e-57  1  13.7%  2:389  105:542     -SIRRKWMITVVCIIMTVNVTFASSAPSSAAPRIMQEFHTSKEVSYLVTTVFLLGYVFGPMFWGPGSELVGRRPIFIITMTLYTLFHLGQGLAKNMQTLLVTRFFVGFFAVAPVTNCGGVVADIWSAAGRGPAMSMFTASVFLGPVLGPIVAGFIVqhASWRWIFWVMMIFAGVCTAIMIPTLPETYAPVIlkRTLFRPFEMLFMEPILFLITIYLSIVYGLLYALFQAFPIIFITIRHFTTGHDGLMFIGIGIGTTIGAFLNWVFSRHyeERLYGAMLGSSLLVIGIFWLGWTgyASVPWYVPGLsaIGAAIALIFVSFLSFLVDTYLQYSASAFAANTMVRSAIAAAFPLFTTQMFTNLGVNWACTLVGLLGLLFVPAPFLFYKYGA-----
     147 UniRef50_UPI0000EFD095 hypothetical protein An18g0...   225     2e-57  1  14.8%  2:392   35:467     -STTYKWITVVLVAGLSTMVQLSTIIAAPVSPSILAHFHSDNALytLIVSIWELGEIVAPLLWGPLSELYGRQWPLNIANLFFVAFLAGTAASTSIQMLIAFRFLSGAATAA-SAIGPGIVSDLFPEESRGRAMSIMSLTGALGPVVGPIIGSYLGEKAGWRWAFWLPTIATGTLSLLILVVYRETYSVTLQKraILRPLRLLIRSPMLILVTFYLSVVYGYTYLVMTTIAPLFQDVYGFSEGASGLAFLGLCLGLILGAFLCSFLLDRyeQRLPPVLIACFVMSGGLFLFGWTAQYHVQWIAPIIGTGIIGFGLVSttLQTYVVDLFGIYAASATSAMLVPRNACAAFLPLAGPPLFDRLGYNWGGTLLALIVLVFSLMPLIFINYGERLR--
     148 UniRef50_C8VWC5        Drug resistance transporter...   225     2e-57  1  16.5%  3:383    9:443     --NPKRWLILFAVMTGSVMGPIDGSVVNVALPTFAKAFNAGLHTVGWISMSYLLVLGSLILTYGRLGDMYGYRKIFLTGILIFTLSSAVCALAPNIWTLIAFRAVQAVGAGMFMAIGPAIITSVFPPHERGRALGTNGMIVAIGLALGPTLGGFLLNRFGWPSIFAINIPIGILSYIFCLKVIPPYRDLKPQKFDIAGAilSLFQNKVFSAANFAALMNFVSQSAMIFLLPFYMQQVLHFNSEYIGLILTVSPLTVLLLARISGTLSDRLGTRWLAFTGQSIVCAALFLMSGLTANSHTIDIVWRLFLFGLGIGIFQSPNNSAVMGSVPRHrgIGSGVLATVRNVGMVMGIAVSSAIVTIHTSGNASANIANFMVGLKTAYWV-----------
     149 UniRef50_C5DLN9        KLTH0G02266p n=2 Tax=Saccha...   225     3e-57  1  12.9%  4:392  198:630     ---WLRWVYTILLSILVIAVAYGSACITGGLGTVSDKFHVSQEVSILTCSLMVLGFSLGPLIWSPVSDLLGRRVAYFISLGLYVIFNIPCALAPNIGCLLACRFLCGVWSSSGLCLVGGSIADMFPPETRGRAIAFFAYAPYCGPVFGPLVNGFISVATN-RmiFWVNMAFAGVMWIIVAL-IPETFAPVILKRrlLRPLYLAVTEPVLDLMCFYVCLIYSLLYAFFFAYPVIFGELYGYKDNLIGLMLIPILIGASVALATtiKITRRRKprLLGAMIGAPFAAIALWILGATAYKHIIWVGPASSGLAFGYGMVLisLNNYIIDCYAVYASSALATKVFLRSAGGAAFPLFTEQMYHKLGLHWASWLLAFISTAMVAIPFAFFHWGKDLR--
     150 UniRef50_C5G0H8        Cycloheximide resistance pr...   225     3e-57  1  15.1%  2:392   52:488     -SLGKKTATIAMVTTMTLLSPIGSTISSAAAADIKMYFNasETLLTFATTIYLLGYAFGPVMIAPLSEMYGRAILYKVCIVLFLIFSVTCAVANNLSALIVFRLLAGIAGSCPVTLGTGSIADMVAQEKRAGAMAAYIIGAVLGPSIGPIVGGYLTPTAGWRWAFWLMAIATAPIAIMVVLFMQESypSQLFAFSILRPLKMLL-LPIVFSLSLYAAIVYSYLYLCFTTFPQVFGEQYGFGSGPSGLATLGIGIGSIFGVFFCGAVSDKLSarLPTIVIGGIFVPTGLFWYAWTSENKLHWIVPIIGTGFLGGGMVimASTLYLVDAYTVYAASVTASSTIFRCLCATFLPLAGPAMYGKLGVGWGTSLLGFIAVAFIPLPFIFYIYGQRLR--
     151 UniRef50_D2UC81        Probable major facilitator ...   225     3e-57  1  24.9%  1:385    3:395     LPNVSTRRMTLLLAGLTMFGPFSIDTIFPAFPQLAQRLHEDPVAIQQTVSVYLLAYALMGLAHGPLSDAWGRRRVIVGGLTLFILASVGCALSHDLPTLLAFRALQGICAGVGMIVGRAVIRDLFHGDDAQRLMSHVSMLFGIAPAIAPIIGGLILSSggWPMIFWWLVGFSSLLLLATLRWLPETHPPQVRTptLLRDYLGIAFNPHFQRLAAAGAFNSAGVFLYIASAPAFVIDLLGMSEQDFAWLFMPTIGGMTLGAFLSGRMAGRLGPLRQVRIGFICCGASVaaYTALAPQIALPWAVLPIFGGGLGMALIFPILALAVLDMYPRQRGLASSLQAFTQLMVSVAVAGGLAPLLSGHPLHLALGSGGFFLLGWAFWRWERR---------
     152 UniRef50_B6QUI8        Putative uncharacterized pr...   225     3e-57  1  15.4% 11:392   68:509     ----------FLISAMTFLTALASSVIAPAVPQILAEfsANLQVAAFVVSVYILGFAAGPLVIAPLSELYGRVPVYHVCNLGFTIFSAACALSPSIRALIIFRFFSGLFGSCPATIGSGSITDLIPQERRASVVAAYSVGALFAPIVGPMAGGFVAYELDWRWDCWLLAISGAIISIVMLFVLKETYHTVIlwRNIIRPVKMLTRSPIIIITSLFIAITYGYMYLLFTSFTEVFQRYYGFTTSNVGVCFLGLGLGSFIGVAIFSATSDKmeYRLPPLPFAVLCLPVGLLIYGWTAEWGLHWIIpgTVLIGIGQLLLYMVLQMYLIDSFTIYAASAVAAITAVRSIAGGLLPLFGLSIYDKFGVGWGNTLLAFVCLPLVLVSVLLIRYGQTLR--
     153 UniRef50_B4EX10        MFS-family transporter n=5 ...   225     3e-57  1  18.6%  7:382    6:380     ------RSLFYLVCFSALLGSLAQNIYTPVLPLIQQQFNTTLSLVNLTVSAFTFAMAVMQLCYGSLIDKWGRKPILLSGLTISIIGALICIWANSINLLIFGRVIQAIGIAAIPVVAATILGDLYQGNERAKAMGSYQMLLALAPASGPLLGGYLAQHYHYQSIFVFLSMVGLVLLIAHLFYLPETRPEQKQSVKSLSAMRQVLAAPEGKSVFVISFMVFYNYFCLLVFLPLIAFHLYHLNSSEIGGLYVPMSIALVLGSYLYRKVCHLFSAE-YGVIITSCINLAMLSLFALFWQISLPIMLILTVLYGLSLGLTMPTHTTLITSHFSSVRATAMGIYNFIRYCGMAAGPMVASYFVTDNHYQYVFYSCVILTSLALCFAI------------
     154 UniRef50_Q1LE12        Drug resistance transporter...   225     3e-57  1  26.3%  2:392   27:423     -SSSRFPLWLLICASLTAIAPLSIDMYLPSFPALAADLHTDIGQVQLTLGTFLVGLAIGQAFYGPISDRFGRKPPLYVGLTIYGAAAAGCAMASTVDSLMLWRFLQALGGCTGLVVSRAVIRDRMEAHESARAYSSLMLVMGLAPILAPLIGGAVLAASGWRAIFWIHCGAAVLLLWFVHVRMEESLDVQRRRtaVLRSYWELLRDREFLGYSLAAGCVQGGMFAYIAGSPFVLIELHGIDPSHYGFVFGANAFGLIGMSQVNTRLVRARALDDVLRVALfcVAGLVLAGTALIGWATLPVLLVCFFAFLSGLGCITPNASALALSHQSHRAGTASALMGTLQFGFGTLAGAAVSLWHDGTALPLAVVMAVCGSGAVVLRLYGRAGMRQRSQ--
     155 UniRef50_A1U797        Drug resistance transporter...   224     3e-57  1  21.6%  8:391    8:397     -------WTTILLAAAVALGPLAVDMYLPALPQIGADFHAGTDQVQLTLSVYLAGFAIAQLICGPLADRFGRKPIMIGGFLLFTVASIGCAMANNIETLQLFRFLQALGGSAGPVLGRAIIRDIYTPREAAKILALLASIMALAPAVAPTLGGLMVGGLSWHWIFIAMGGYALVMAAVTAFGIPEPLKPEYRQphLFANYRRISTDASFIGYTLTNAAIYGGLFAFLSGASFVLIDVLGVQPEHFGFYFAAIVVGYIAGNLGSIRLARYLGPDQILFYGLITALAGGAIMALLAYqySPWAVMIPQAIFMAGTGLVLPQCMAGALANFPTMAGSASALFGFTQMTAAAIAGAIVGALHNGTPMVMATVIAACAGLAMIGYLLLVQRHPAKA---
     156 UniRef50_Q2UR56        Synaptic vesicle transporte...   224     4e-57  1  16.4%  2:392   46:485     -TKKRKWGVTAAISGTGFVRIMVSTMMAPSIDTMAEELDTSITESTMALSVYLLATAFGPLIIGPVSEIYGRKSIFHITNIWFLVWNLVCGFAHSKGLLMAARLLAGFGASAVYSLGYGVLGDVWSAEQRGRSLSLYLLIPLTGSAVGPIVSGFIVKYSTWRWMFWSTAILQ-LTLDLSSLLFHESypPRKLSRSLSRPLRLLAFHPIIQMQAILEGIDYGLLYFALSSFSALYVAAYGESVEISGLHYIVICIGTVSGSQLCGPLMDYaeLRIPLLLPGALITPIGFLLYGWAAQYHLIWVvvGAALLSLGMQIFDTTLHAYVMDSYPEHVSSASAATQVLRSLLAFAFPLLSNSLYDSLGYGWGNSLLACLSIgaLPATGILWRWGATLR--
     157 UniRef50_Q8X060        Related to fluconazole resi...   224     4e-57  1  14.4%  2:328  198:575     -SSGRKAAILLTAVMLILNSSMGSALPSNAIPFIVEEWKisEQETVLPISIYLIGYVMGPILWAPLSEQYGRRRLSIGTFAMFTLFTLACALAPHWISFIIFRLFSGIFASAPIALVPGIIADIyePRQRGRSMGIFMAVI-FGPLIAPIISGYAATTIGWRWAFWIGLMYAGLTLLPLFFLLPETYGPILLLRrlTRPIRMILMEPIVSTSCAYISLCYAIFYMTFEAYPFIFIDLYGLTPGQCGLTYLAIGVGCLIALPIFmrARHRNarRLPLACLGGPMFVVSLFWLGFTSRFSVPFWIPMliPFGMGFMCVFQALLNYLTDAY------------------------------------------------------------------
     158 UniRef50_A1HMH9        Drug resistance transporter...   224     5e-57  1  16.6%  6:360   14:422     -----KWWALGVTIIGGFMSILDTSIVNIAVPKMMAVFAVDTDQAQWILTAYMLTMGVLQPATGYFCDVYGTRAMYLFSLAVFTVGSALCGAAWSNDSMIVFRIIQAVGGGMIIPVTMAIVYHVFPPQERNMAMGIWGISAMVAPAVGPTLSGYLVEYWDWRWIFTINIPIGILGYVLAVLVLKETPRIRGQKFDYGGFilSLFKDWNFTLSSIVIFIGTIGLFGGIFLVPLFMENIRGYTAMQTGILMFPSALTAGLMMPVAAKLADKFGAKPVVVVGLFFLAAGTWPLMYLDLDTSYEHVMLVMILRGMGLGLFMMPVTVLGLNTVppKISRASALNNAIRQVSGSFGIAVLSTVLQN----------------------------------
     159 UniRef50_A5FFZ3        Drug resistance transporter...   224     5e-57  1  20.3%  1:380    1:386     MTTKKYLKLILILGSLTALGPFSIDMYLPGFSGIAKDLNTSVAKVSMSLSSYFIGISAGQLLYGPLLDRFGRKKPLFLGLMVYILASLGCSYVTDIDTFIFLRFIQAIGSCAATVASVAMVRDLFPVKDIPKVFSLLMLVLGLSPMLAPTIGGYVTEDYGWHTVFSILMFMGIAILIAAQIGLPNSYKpsLKPKPIISNFLKVLKEPQFYTYAFTGAIAFSGLFTYVAASPIIFMDIYHVDAKTYGWIFAFMSVSFIGSSQLNSVLLKRFSSEQMIFGALIlvVSIIFLILSLNNLLGLYETIAILFIFLGCLGISNPNTAGLTMAPFAKNAGSASALMGAIQLGLGSLASFAVGIFVKDSVAPMVLIMTVTTIIAFIVL--------------
     160 UniRef50_B8M5U2        Bicyclomycin resistance pro...   224     6e-57  1  16.4%  4:393   48:484     ---WRKWSIVICVALMYMLANFGTIIIVPGVPLILSEFNESGKLYqlIVSIWELGEGVGSFLVGPLSERYGRKIIYHIGNAIFILCSVASALSVNVSMLVAFRFINGMAV-TVLTLSPSIIGDLFVREERGTAMAVAISVPLIGPCVAPIVGGYVASALGWRWAIWLIAIAVGCVSMFSLLVFKETypQETKLQSFLRPVRLLFSSPVVLVTSLFTSLIYGFSYLILTTLAEIMQETYGFGSGPVGLTFLGRAIGNLIGLALYGLTSDRyeDRLPLMILGTALLPVGLFLYGWSAHFHVQWSVPLIGTGIVGLSMLLtpTDNYLVDAFAPQGTSAssADATLKALFGAIFPLLGPSLYRNLGLGWGNSLLAFIGLVFLPLFIILWREGQELRT-
     161 UniRef50_A2QQU6        Function: FLU1 from C. albi...   224     6e-57  1  12.5%  2:392  136:568     -TTAKKIYITANLAILTCLSTFASSILSPASLHLMTEFGISKEVSILATSLFVLGYVFGPLAFGPASEVLGRKYPLSLGIFIFGIFSIPVAVAKNVATIFICRFICGVFGAAPLAIVRGSLADLYDPLFRGIAVAGFASATFLGPVLGPLVGGFVTmhLGWRWTQWLVVILSLSFGLLYFLTVPETYSAVLLTRriFKPFLMLSQEPILALITLYMGFIYGFLYLCFEAYPITFEHQRGWNLGVGALPFLAITIGVLVGVVIVirMQRKleERLVPMMVGSVLLPIGMFWFAWTSNPHIIWvvVAGGFMGCGILLIFLQGVNYLIDVYKMNANSAISANAMFRGLLGAGFPLFATYMFNNLGVPWAMSLLGFLSTALVPVPFLFYIYGANIR--
     162 UniRef50_A2QXI8        Remark: alternate name for ...   224     6e-57  1  13.6%  2:392  158:598     -SISKKLAVVSQIYLYTLVVYMGSSIYTPSAPQIQERFGVSSTAASLGLALYVLGYGIGPMIFSPLSEivGRNPPYIITFLLFILFSIAAAVVNTFGGLLVLRFLQGFFGSPCLATGGASIGDVFSLLKLPYGLSAWAAFATLGPALGPVISGFSVPVEGWRWSLWETVWMSSPILVVMFFFLPETFPDSILLqaLYRPLQIVVLDPAILFVNIYTSLIYGIYYSFFEVFPIVYIDMYHFNLGQMGLVFLSIAVALAIAVPAYFIYLNKveRRLIPALFACFLPPIGLFLFGWTSRTSVHWivIGILIYTIGIYVVIQCIFIYIPMTYPQYAASLFAGNDLMRSALACGAVLFARPLYVNLGVGPGISLLAGLTVGCIAGMFALYRFGAALR--
     163 UniRef50_Q5SBL3        Putative ABC transporter n=...   224     6e-57  1  14.4%  2:389   53:501     -KNPKNWPHSAFLIHTILVSMLSTTMYAPGAAQLAVEFKtdTTTIALTVSIYLLGFALAPMVTSPLSEVYGRLIVYHTSNIFFLGFNLACAFSSNIGMFIAFRFLAGCAGSAPMTVGGGTIAdaASPEKNNTALRLFALGPLLGpvIGPIVGGFVAENIGWRWTFRIMSIVIAVLSILSCIFLREtpTKEIVSRSLVRPMKMLIFLPQVLILSFYTAFVFGLIYLLFTTFPAVFEGQYGFSPGVSGLSYIGIGFGMVGALFLFNFINMKMSNrlPLMTWFSPLLPIGFFWYGWSADKQTHWVVPILGTFFVGFgiIMPTTAYLVYAQGPQGAASVLAASNMMRYVFAAFLPLAGQNMYDQLGLGWGNSLLGFLCVVLAPVPAIFQRYGH-----
     164 UniRef50_C0NFI5        Polyamine transporter 1 n=2...   224     6e-57  1  15.3%  6:391  101:537     -----RWSMVIIISLCSLCTICTSALYTMTYEQITVEFNCSRLTATLGLSLFILGLGVGPLFLAPLSEFYGRRPLYLVAMALFVLWLIPCATAQNIQTMLVARFFGGFSSSAFMTVAGGSISDLFSHDELQRPMMVYTATPFLGPIIGPVVGAFINQYTSWRWSFYFAIIWSSVLLIFMVLFMSETYHPVLLRhsFSRPLQLLLLEPMVTCLCVYTSIALGILYLFLDAFYAIFTNNYGFELYQVGLSFLGLLFGTVTSAAtyRRLVRKREarLPPAIASSILLPLGMFWFGWTTHGSIHWIVPIigFFSAGVVLAFNGVLTFLVHAYPVYSASAMGANLILRSIFAAAFPIFGMQLYEKLGDQWATSLLGFVTVAMMPFPYGARLRAKSR---
     165 UniRef50_B2AP79        Predicted CDS Pa_7_170 (Fra...   224     6e-57  1  19.6%  2:383  183:632     -SPLRRKFILSAITIAGFFGPLAGGIYLPALPVLEKEFNVSPTAINVTVSVFMMTFAFGPLFWSTFADWKGRRPLYLISLAIYILANVLLAVVpnYGALVFLRVVQAFGSASVVSMGAGTVAdiTEPKKRAFAMSIFLMGPQCGPVLGPVLGGALAE-ANWRWIFGFLAISSGILWLVILSSLPETLRArpPPIPTLKGYWNLFIYPPIGIVSFNTAMLYSTYFAIAVQLPTELSQRYKWGPSGIGAGFLAVGIAMIVGSLLGGRASDWreFRLVDQIWGVLICVLGTLLYGWMVDGspAAVLFATFLTGFGMNWVFVTTTAFLTECVAQQAAGAFALGNLLRNPWAAIVSVITPTLVAKMGSGWCFTGLAVLDLLLVGTAVI-----------
     166 UniRef50_Q2U1S2        Synaptic vesicle transporte...   223     8e-57  1  14.9%  5:392  128:567     ----KRLMVTIVVSFMGVIVGWSSSIDSGIIPQYAEEFGVSEVVASLPTGLFLVGFGTGAVMSGPFSETVGRNPIYIITLIVFMLLLVGAGLAQNLAGQLVSRTLAGIFAATPLACAGGTIADVWTPEEQVFTFPIYAIISFSGPVLGPVVGGWIGqnLSWRWTEWVTLIGAGIILVTVILFQPETYapARLLLAMYRPVVMLFQEPTIFLFSLYLTVAYIIIFTFFTGYEFIYEGIYGLTQGETALCFLGLAIgcIPLIPLNAKLRSrpESRLYWATIGAPALPISMFWMAWTagIPFWSTLAASVLTAFGMLCIFITCYQYLIDTYGTYAASALSSLTLMRYLVSGAMIEVSIPFYKNMGVPYTLTILGCISAVLVPIPYVFYKYGPEIR--
     167 UniRef50_C6CV95        Drug resistance transporter...   223     8e-57  1  16.0%  5:366   10:425     ----RKGPIMASLLIAAFVALLSQTVLNVALPKMMADLDVGESTIQWLSNGYMLVNGVLVPISAYLINRFTTRKLFLVASSLFAIGTVVCALSGDFSSLLAGRLVQACGAGILMPLMTIVTLTIFPVEERGKAMGLMGVAMIFAPAVGPTLSGWVVEHYDWHVLFYIVLPLAILAVVFGAFSMKDVIKTSRPNLDILSVVlrVFKYSMFSLTALINAIITMAMFSGMILLPIFLQNIRGFTPLESGLLLLPGAILMGIMSPITGMVFDKIGARWLAVIGLIITTVTTYEFSHLEIDSSYNHMMLFYTLRMFGMSMLMMPIQTAGLNQLPRRlaHGSAMSQTLRNVSGALGTAILVTIMTNKAASHA----------------------------
     168 UniRef50_A1VXC0        Drug resistance transporter...   223     9e-57  1  20.6%  6:388   12:399     -----KFKLIVILALMSSIAPLSTDMYLPALSHVEQSFQTNSFLTQLSIASFFIAFALGQLIYGPLSDIFGRKIPALVGIFFFIVSSLFCVIIDDIYAFIALRFFEALGGCAGVVIARAIVNDLFEIKEAAGIFALMMVFSSLAPMLSPTFGGFLLEYFSWHSIFATLFALGILLFLMILFGLKESAPHLKNKKfaMKSYKFVLSDKRFLVYILCASFALAAMFAYITGSSFVFTQFFGLSEQKFALLFGANALGFVICANINARLVLKYESEKILAKALMIMFISTVILLvaFFHPNFLLFELSIFTSIAMLGFIAPNTTTLAMARFKEHSGTASAVLGTVQFGFAGLISFVVGAINANTPIILAFVMCACVLVANMIYFLIKIKEK------
     169 UniRef50_Q4WFK6        MFS multidrug transporter, ...   223     1e-56  1  13.6%  2:392   47:483     -SQFRKWFITAIVTFSVFAITFTSSAYAASANELIPDFSISTEVFTVGLSLFVLGFAIGPAVWGPLSELYGRQALWIVSHIAMVAFIGGSAGSHNVATLLVLRFFSGTFGGSPLVNSGGAIADIFPPAQRGLAMTLYCVAPFLGPILGPIVGGFVSENVGWRWVQGVCCIFIGGIGIIGVIFVPETYGPVLlqRALIRPWVLLFREPIVLVASLYMAIIYGTVYMFMSAMPIVYNEQRGWSEGIGGLAFMGIAVGIIIGLAYAIYDNNRreSRLPPAIVGAVALPVGMFAFAWTNSPRIHWSviLSAPFGFGCVLVILPIVNYLIDAYTIYAASVLAAAAIFRSIVGAVFPLFTTQMYGSLGIHWASSLPAFLTVACMPFPFVMYRYGGALR--
     170 UniRef50_B2W5F4        Membrane transporter n=1 Ta...   223     1e-56  1  15.9%  2:392  161:596     -TAGRKWFNAMLLAFACFMVSIASSGFSQGTEQLKTEFHITQTTALLTTSAFVLGFAVGALILSPLSEVYGRRDLYVMTFGAFVAFSGLVGLSSSMNVVIALRFFGGLAGSFTQAVAPAVVADMFSAQDRGLVMSIFTLAGLVGQNLGPIVCGFLVKEYGWRAIPMLISIVSGPTWFVLILTFPETYAPVLLQRraLRPWIMLIYEPIVTLLSLFLSVVHGTLFLLFAAYPIVFQQVRGWPQGVASLPFLAIIVGIMISLVYVALVDQKreARLPPAMLGSAALPIGLFWFAWTNAPELPFMICVSalFGFGMVLLYMSLTNYIVDAYQGYAASALAASTVLRSIAGAVFPLFGADLYRNLGIHWASSLPGFLALAFIPSLFAFYKWGHVLR--
     171 UniRef50_B2W057        Citrinin biosynthesis trans...   222     1e-56  1  14.3%  2:393   71:509     -TTERRWAITVSMGLMVFTVTFASSIFSVNIGVVQEKFNVELVTATLGVALFVLGFVFGPIAFGPMSEVLGRKPPLMFGFALFAIFQIPVALAQSITTVCIGRFLGGFFASAPLAVVGGALADLWDPIPRSYAICIFAAGGFAGPVAGPIAGGFITqhLGWRWTSWITLIMAGLFGIIGFFIIPETSAARILQLrlLRPFIMFLQEPILALFTAYMSFLYGIVYLLFEAFPVSFYEQRGWSLGVSQLPFGAFIVGIILGAACIarAYHKHgeRLPPMIIGAIALPVGLFWFAWTSNPNITWvvLSVALLGFGCMVPFWQGMSYLIDCYGFYSNSAIAVNTFIRSFAGAFFPLFTHAMYHKLGVPWASSLLAFICIAFLPVPVLFYIYGARIRT-
     172 UniRef50_A1TNE2        Drug resistance transporter...   222     1e-56  1  26.3%  1:392    8:405     LWRAPRWTLAVLLAVLGMLGPFSIDTYIPAFSGIAAALGATPVEMQQTLSAYLFGFAFMTLFHGALSDSFGRRPVVLWGIAVFTLASAGCALSQSIGQLVLFRALQGLSAGAGIVVSRAVIRDMFPPAQAQQVMSQVTIYFGVAPAIAPIVGGWLFVHAGWHSVFWFLTGVGLLLWIANYRLLPETLHADHRqrHLLQGYWQLGSSPRFLLLALASGVPFNGMFLYVLAAPAFLGEHLHLSPTHFFWFFILTISGIMGGAWLSGRLAGRIAPKRQIRHGFLIMFIMSMLNLAANatAHVSWALLPIAVFAFGWALMVPVVTLLVLDLYPERRGMASSLQAFVGSTANGLVAGVVAPLVMHSTLLLACASLAMMCVGLVAWVYLHHRWPDIGR--
     173 UniRef50_A2R6Q1        Contig An16c0020, complete ...   222     1e-56  1  14.4%  5:393  143:579     ----RRTVLVTILCYCTFATAFTSAVFSAAVSAVSEEFHVGREVSTLGVTLYVLGFAAGPTIWAPASELIGRRWPLSIGLFGCGIFTIASATGKDIQTIMISRFFAGLFAASPVSLVPAVFADLFSAAHRGVVMSIFCMAVFIGPFAAPFVGGFIAAslGWRWTMYISSIMVFLAFVLVFFFLDESYAPVILVrnFTRPLSMLITEPILLLISLYISFVYGLIYALLGAYPVVFDDVYGMSAGVGGLAFIGLILGELIGGVFILCLQGSYKrrLPAAIVGAVAFAIGMFWFGWTGYTniHWIApaGILIGFGILCIFLQCFNYIVDCYPTLAASTIAANTILRSAVGCVFPLFSRQMMVNLGVQWAGTLLGCIAAIMIPMPVAFMIFGPWIRQ-
     174 UniRef50_B8NW99        Amino acid transporter, put...   222     1e-56  1  14.1%  2:392  485:923     -TTFKKVGITVVVSTATLAVALASSAYSGSTKQVMEGLDVGTEVATLGLSLFVIGFALGPLFWAPLSEFIGRQYPFIVSFGAMTVFLAGCAGAQNIQTLLVLRFLAGTAGSSPLTNAGGVISDMFRAEQRGLALCLFAAAPFMGPVIGPVIGGFLGMNAGWKWVEGFLAALSGVLWLMMACFVPETYAPVLLrtSLLRPWVLLFREPIVFMLSIYIAIIYGALFMMFAAFPIVYQRGRGWNQGVGGLAFMGIAVGMIVGTIYTIPDNRRyeSRLPPVMLSAVCIPVGLFWFAWTNSPSVHWmiAAGVPFGCGIVLLYLGIMGYLIDSYTIFAASVLAANAVLRSLFGGIFPLFTAYMYEGLGIHWASSIPAFLTVACMPFPFIFYRYGEAIR--
     175 UniRef50_A1DLG1        MFS transporter, putative n...   222     2e-56  1  15.8%  2:393  110:548     -SSCKRNLHIAVVGLLTLNANLAATMFAPGAEQLAKEFGVTDSTiaMTVSLYVLGFAFGPLLFAPLSELYGRLILYHICNAVYFAFTAGCAFSTNVGMFLVFRFICGCAASGPMSIGGGTVADVTPPQKRGKAMALFAMGPNLGPVLGPIIGGFVSQYAGWRWTLRIILILSGALGIATGVLMRETSAAVLLNrgLTRPMKLLIFSPIVLLISLYTGIMFGLIFLLFTTFPSVFQGVYGFDAGTSGLAYLGLGLGMFFGLVLFSILSDKleQCLILMKWLGPIAPLGCFMYGWSAQYHTHWIVpgTFIIGFGSLFVVIPGQMYLVDAFgaAAASALAANLLIRSPFGAFLDLAAAPLYDTLGLGWGNSVLGFITLSFMPVPWLFYRYGEALRT-
     176 UniRef50_A2QTI3        Contig An09c0050, complete ...   222     2e-56  1  16.6%  3:388   46:484     --ERKRWAHVIVVALISLVMNMAPTMCAPGINEILSTFNisSTISTLAVTLYVLGLAMGPMFMSSLSEVFGRLPVYHLANLFFVAFVIGNALSQNIATFMICRFISGCAGGTPMALGGGTIADVTTIQQRAVAMSLYSLGPMAGPVLGPLIGGFVASNLTWRWTFYLLAIFSGTIGLASLLVMRETHppQLLLQALTRPTKLLFRSPILLIISIYMALIFGLMYLLFTTFTDVFETQYGFSTATSGLVYLGLGVSLVTCMFIAKPLGERleYRLLPMIYFSPCVAIGLFIYGWTVYYKVHWIVPIIgvIGFGSFFVMMSAQLYLIDLFgsASASALAANNVLRFICSTFLPLAGPAMYRSLGYGWGNTLLGFLALGFLPAPVVFYRYG------
     177 UniRef50_D1XNB1        Drug resistance transporter...   222     2e-56  1  16.9%  1:360   71:485     ISPRRVRLVFLGLMLTLLLAALDQMIVATALPKIVGELH-GLDKMSWAVTAYLLASTIGLPLYGKLGDLFGRKGVFQFAIVVFVIGSALAGWSRTMDELIAFRAVQGIGGGGLMIGVQAIIADIVPSRERGRYMGLIGAVFGIASVAGPLLGGFFTDHVSWRWCFYVNVPFGLVTLAVIAVVLKLPKPAVRPRLDvwGGTEYAWGSRTILGLalVGAVVGVALFGAASYLPTYLQMVEGVSATESGLLMLPMMGGIVVASVVSGQLVSRTGRYRipLVGGAVSAVGMWLLSFLDTETSPLEYGLWQAILGLGIGLGMSVLVLAVQNSvpADLGTATSAHNYFRQIGGSVGAAIFGTLFAG----------------------------------
     178 UniRef50_C7ZE45        Putative uncharacterized pr...   222     2e-56  1  16.1%  2:392   32:475     -SPRKKWMNIALMSLLTIISIsgSSMFAPGVAKIMVEFNSTSSlaTFVVSIYFIGYAFGPLVFAPLSEIYGRVYIYHGGNSAFVLVCVGAALSHSMGMLLALRFLMGIFGSAPTTVGVGSIIDVVDLEWRGRAVSIWAMGPLLGPCVGPVVGGYVVEYIGWRWVYWILAIMGGVLGIVGLLLMRETYAPTLLEraIIRPIKFLIKTPMVTIIALYVSIAYGILNLLIATFSFVYADQYNFSEGTLGLSFLPAGIGMMIGVLSYGNLADYLVQrpWATVPVGFAFCAGMFIYGWTTEERVHWIVPMLAVAVLCFGLmlMSLQNYQIDSYPAYASSGSAAITLFRSLVGGLLPLSGLRIYDSLGLGWGNTVLGLIAVSLIPVPVLLYFYGERLR--
     179 UniRef50_P38776        Uncharacterized transporter...   222     2e-56  1  13.8%  1:392   67:505     MSTARRYYISSLITFTSMVITMISSSWTLPSTHIIEHFHISHEVSTLGITLYVFGLGIGPLFLSPLSELYGRRITFLYALTLSIIWQCLTIWSKTITGVMFGRFLSGFFGSAFLSVAGGAIADIFDKDQIGIPMAIYTTSAFLGPSLGPIIGGALYHQ-SYKWTFITLLITSGCCLVMIIFTIPETYKPMLLIrsTKRPFGLLLRDRMMGVLCFYTGLELAIIYLYFVAFPYVFKKLYNFGPMEIACSYIGIMVGMILSAPTCLLFQKTfeMRFEPLFYGAFLTPVGLFIFAFTCYKHVHWiiIGSAIFGSGVYFVFTGVFAYTVDAYRRYAASGMACNTFVRCIMAGVFPLFGLQMYKSMGVNWAGFLLAMVTVAMIPVPFLFTKYGARLR--
     180 UniRef50_A8TRZ5        Drug resistance transporter...   221     3e-56  1  24.7%  1:385    1:390     MSDKPISPPIWILIAATATGPLALNIFVPSMPGLVHVFNTDYATIQLTLTLYLVGVALAQLAYGPLSDRFGRRPAMLYGLAIYAAASLLCAVAWSVETLIVGRILQAVGGCAGMVLGRAIVRDVYERDRAAGAIALITMAMAVAPAIAPTLGGYLETGFGWHATFLAPMVMGLVVLAASFRGLNETNLTPIPRIDvlRHYGELLRSRAFIGYAGNSAMSVGAFFAFLAGAPYVVIEILHRPPGEYGLYFVLISVGYMIGNFGASRLSQRLGVDRMIPLGVASSTVGGLISAGFLLAdtPASVFLPMMLVAVGNGLSQPNSIAGAISVNPRIAGAASGLMGFGQMTVGAIFTVIVGHLQNDHDHAAMAGMILFSCVASYLFYLLAK---------
     181 UniRef50_B8M827        MFS multidrug transporter, ...   221     3e-56  1  19.2%  3:393   44:463     --RHKRWAHVIVISILALITNMAPTMCAPGISEIATDLNMTSSVVslAITLYVLGVAIGPMHMAPLSEKYGRRPIYHTANTIFVAFIIGNALSQTPAQFMVFQFISGCAGGTPMALGGGTIADITTIKQRATAMSLFSIGPLAGpvLGPVIGGFLAVGKGWRWKFWLLAILGGFFGIATAIIMRETHPEILRQRrlVHPILLLVKSPILLVISLYVTLVFGIMYLLFTTFTDVFEGQYGFSISISGLVYLGLGV--------ARRKHVPLQHCEWPGPRCTPCVALGLFIYGWTAYYRVHWIVpgTVLIGFGAFFVIMPAQLYLIDVFgeAAASALGANNFLRFISSTFLPLAGPKMYQTLNHGWGNTLLGFLALAFVPGPLLFYKYGEKLRT-
     182 UniRef50_Q2GQ33        Putative uncharacterized pr...   221     3e-56  1  15.8%  1:392   75:515     MRPALKWIISIFVSLGGFVTLMSGSMIAPALPALGLDLGMTASEAESALSIFILAFAVGPLLLAPFAEVYGRKPVWIVSGFIYSGWSVVSGFSHNKPTLVASRFLAGIGGSVDFVIALPITSDIWPPEQRGQSFALVNAVPLLGPALGPLLGGAIADTIGWRWIFWVAAIFCSALMLLALVLLPETShpRQLLVSIARPARMLATQPILQLVSVFMAFNFGVLYYLLATFAILHADVYHESVAQTGLHYIAIAIGNLSANFLGAYAMDRleYRIPLTFPGAIFIPTGLLWYGWSANARLHWImvGAAIVGFGLLLHTSAMSAYVLDSFPDYTASAMGASQVLRMVCGFVFPIFAPPMQQRLGWGWSNTVLALIAVVFGVvpLVQWNFGARIR--
     183 UniRef50_A1CD38        MFS transporter, putative n...   221     3e-56  1  13.7%  6:393   55:490     -----KWLHVAIISSGTFTIPLASSIVAPGVIQLANDFHTNDQLrtIVVSIFVLGLAFGPLLVAPLSELYGRWICYTVSNTLYTVFTIACAVSSNMSMLIVFRFFAGATGSTPLTIGGGTIADMFPVQERGLALSFFTLGQAAAPAIGPVagGFLTQGLSWRWVFWLLTIVNGVIAAAQILLSRETYapRLLVHNFIRPSKMLLLSPITLLIALACAVMYGILYLLVTTFLSVFQTTYHFSIGISGLAYLGMGIGNILGLIVFSMTSDRyeHRLPLMILSGPIIAIGLFWYGWSARAKLHWIMPIlgIVGLGNMFFFMPMVGyvSDAFPVYAASAIAANAVLRSIGGALLPLAGFRMYDTLGYGWGNSVLAFMALVFTPLLIVIYWYGEYIRT-
     184 UniRef50_Q2HBJ5        Putative uncharacterized pr...   221     3e-56  1  14.7%  5:392  178:612     ----KKVLTTLLYGLVTMSATWASSCYSAGTAQVAAEFGVGGQTAVLGTSLFLVGFGVGPLLWAPLSEVYGRRLAVFVPMFVAACFSFGSAASKDFQTLMLTRFWGAFFASAPVTNTGGVLGDLFGPEARGVAMAGYAMAVVAGPALGPIVSTALVVqlGWRWTEHLAGILQATILLLAVVFIDETYPpaELARKFLVRPIQLLCTPICFLVALYASFCYGILYMQLGSIPIIFGEVRGWSQLVAALPFVCVFIGAILgnVYNQVLYNKaeRRLPPMMLGSVLFAGGQFMTGWTAGPSIHWIVPCLGLVMLGTGfiFQAALNYLVDTFTEYAASAVAANTFLRSCFACAFPLVVGPMYHNLGVGPGSSIPAGFSVLLIPVPFVFFVYGKRIR--
     185 UniRef50_Q9CKS3        Bcr n=1 Tax=Pasteurella mul...   221     3e-56  1  21.6%  2:386    7:394     -TTWNQTALICFLGTLVGFGPLSIDMYLPSLPTIAKALHTSIEWVQLSVSTFLTGFCVGMLFYGPLSDKYGRRIILLIGMTIYIVASIACSIATSIEQLLVARFLQAFGGGVGPVLGRAIVRDSFPPQRITHVLSMMQLVTMLAPLLAPFIGGIVLLWFGWETQFLLLALIGVVCWLIAYFFLAETNQDRHQRptFFQAYCGILKQPQSFGNILCLSAMFGGMFAYVAGTPFVYIDYFHIPPQDYGFYFGINVVGIVLATLINNYCVKRYAVQRVLMAEMGLVALAGMAFFLADPD-SLFAIMLPLFIFVGLTGALTPNVMTSLLKQHSHAAGAAMALVASMQFAGGFVASGALSYFFNNSPQTMLWVMSTCAGVAIVGFMITLKP--------
     186 UniRef50_A2QAH5        Contig An01c0340, complete ...   221     3e-56  1  13.9%  4:392   51:487     ---RVRLYISVILAFTCISSTFDSAVFSPSMSAVAKEFDVSIEVAALASSVYIAGYAFGPLIWAPLSERHGRRLPIIVAMLGFGIFNTAVAVSKDLQTLIICRFFCGVFGSSPLINVAAIFADMYDNRTRGIAIALFANTVFLGPLVASCVGGFInsYLGWRWTAYIPSFMGYTTCLLNLLFLRETYAPAILTsnLGRPLQMLFKEPLIMAVTVYLSFVYGLLYCFLSAYSSIFQGVYAMSAGVSGLPMLSNVVGLLGATAYMIYVNKNyeWRLPPVIVGGVLFSAGLFWLGWTGFttIHWIVPTllFTGAGLLMIFIQLFNYLIDTYLAYAASALAANTFCRSLVAAGFPLFSRQMFGNMGIQWAGTLLGCLAVALVPIPLAFLRYGKRLR--
     187 UniRef50_B6HCA0        Pc18g01290 protein n=11 Tax...   221     4e-56  1  15.9%  2:392   71:499     -SPARKVVIVGVLSFCSFLAPISSTSILAGIPEVAKTYNTTGSVINASNALYMAFMGIAAPFWGPFSQVWGRRMVFLVSAFLFFAFSIGTALAPNLPAYYIFRVLTAFQGTSFLVVGSSALGDIYEPRARATALGWFLSGTLIGPAFGPFLGGVIVTFCSWRVVFWLQTALGGCGTLLVFFFFPETYPHLthRISPLQVAIMLSKYPNLFCTGLAAGALVWNQYSLLTPIRYVLNPRFNlsPIQTGLFYIAPGCGYLVGTLMGGRWAdrGGVRVpcLIFLGGVIPGCILIYGWtaVGGIPVPVLAMFFQGVAQLFCFPSLNTYSLDVmsGRSAEVVAGSYLFRYVFGALGSGLVLPAVERMGVGWFSTISALFLIASGVGVWLTTIFGDQWR--
     188 UniRef50_A6T249        Drug (Bicyclomycin) resista...   221     4e-56  1  25.9%  8:381   21:400     -------ALAIMLALLSMLGPFSIDTYLPAFPNIQASLDASALEVQQTLTAYLFSFAVMILWHGALSDAFGRRNIILVSLAVFAVATLACAAVHSIEYLWVFRMLQGISAGAGVVIGRAIIRDLYAGSAAERLLSLVTMIFSIAPAIAPILGGWIVKHSNWRNIFLALFAYAVLLLIYCYKRLPESLPPEKRQpfLYHSYKRVFRSPLFHLKGGTVAFNFAGMFLYVAAAPVFLVQHLGLGPDQFGWQFIPTVAGIFCGALAANRLAGNIPISRQVLIGFVFLIGAGIftYHALFPPALPWSVAPLFFYTFGMSMVAPGATLLVLDLFPNIRGTVASCQSFTLTLLGALVAGVIAPALSHSPLALAAGQMIFTLIALSLWL-------------
     189 UniRef50_C6PUA3        Drug resistance transporter...   221     4e-56  1  15.0%  1:360    1:415     MNKKHQIISFLAIILGFFMALLDTTVVNITLPKMAEYFNTTMDHISWVVNSYNLATAVILVTVSRLADQFGRKKLFIAGVFLFTISSLLCGISNSLQALILFRTIQGLAAAFVVTISAPLSLEIFPPEKRRNIMALWGAFSGLAAASGPSIGGIVTQFFNWRYIFFINVPIGCICILLTMKFIKESYDPTASKSIDFGGIITigWTSSFILSLFAvfLLGLGMMSGTYLLSFFLIQVKGLEQLSAGLIISTMSLTSMFFSLLATILTKKLGSRVTSALGILLLSTSCYLNSSLTQNSSNIDIILRLIVAGSGTGLSMATIIGSIVANVpdKIGIASGINNMTRTLGTVLGVALFLTIFTS----------------------------------
     190 UniRef50_A2QQE9        Similarity to fluconazole r...   221     4e-56  1  13.7%  5:392  101:539     ----RKKAITTVLYGLTTMGMCdfFSFSTGTKQIDAEFHVGEEVGTLGTTLLLFGFGLGPLVWAPLSEVYGRKPAVLAPYFIAAIFSFGTATAKDLQTVMLTRFFCGFFGSAPVTNTGGVLSDIWTAEQRGAAIVGYAMAVVGGPVLGPIVGGAICqyLGWRWTEYITGIMMMFFLAMDLIFLDESYPAVLLVYKAQrrPFALLTTPICFLVAIYASFVYGILYLSLASFPIEFQEVRGWNQVVGALPFLAYLVGILFGACInkFYIARfeARLPPMMLGSIVFAAGLFIFAWTSDPHIHWIAPIivCMGFGFFTIFQAALNYLIDTFQKVSASAVAANTFLRSLFAGCFPLFANIMFHRLGVDWAASVLGFVAVALIPIPYLFYIFGKRIR--
     191 UniRef50_C6IWM4        Major facilitator superfami...   221     4e-56  1  16.9%  3:356   22:429     --QRKRWLILIVLNLFTFMSTLDGSIVNIALPVISKELHLTVAQAEWIVSAYLMMTCAAILFFGKLGDIVGKIKVFKWGMVIFTVGSLLCGFSHNLPLLVGSRLLQALGASLTMANSQGIVTDIFPAGERGKALGFTGTFVSLGSITGPSLGGVIVSALGWEYIFWVNVPVGLIAIVIGWKLLPADRTKLKVKIDKAGSTLflFRNPLFSLSILSGFLVFVANFCFNIIAPFYTQSILNLSPSHAGFLMMLFPIVMVIVAPLSGALSDKIGSELLTFVGLIVMVIAQIGLARLHDSSSIAQVGVWIAMLGLGNGLFQSPNNSLIMSKVPkqLGIAGSINSLVRNMGMVVGITVATT--------------------------------------
     192 UniRef50_O74829        Uncharacterized MFS-type tr...   221     4e-56  1  11.3%  4:393   71:508     ---AKKLRNVAVMGSACLCAGFGSSIFSGAVPEVMVKFHVCRTVALLGISLYVLGFASGPVVWAPMCELFGRRRPMIIAVFIFCIFHIAVATAKDIQTVMICRFFCGFFGSSPITTVAGSFSDMFSARTRGLVIAVYSAIIFNGPLMSPIVGGFIgsYLGWRWTSYITAIMGFTAFTSMIIFHRETYTRTITEIRASkpLRLLIFEPILLVVSTYTAFVYGILYGLLEAYPVIFGESRKWRLGVESLPYLAIFVGVCIGCSSVALFQPYyeARLPSMMIGCIVFPIGIFWLAWTGNYPwhWIVPTLAGSFIGFGiiFQQTINYIIDCYSGCSASAIAANTLLRSSFGAAFPLFTTQMFNNLGIGWAGSLVGFVAVGLIPVPFMLFLYGPKLRQ-
     193 UniRef50_Q4R0K5        ChaT1 protein n=1 Tax=Strep...   220     5e-56  1  18.2%  3:360   12:429     --TQRPWLVLAIMCVGFFMALLDGSIVNIAIPTLIDGLDASYDQVLWIIDGYMLVFSVLLITTGRLGDIYGYRRLFLIGITLFTVASALCGLSESPDWLLAARVLQGLGGALLFPQVISSILTIFPPQLRGRAFGLFGAIVGFAPIVGPVVGGFLLAHLSWRWIFFINVPIGIVTALLAVRYVPVMRPGRSNSLDLTGVALalWQHRRKTDSLMPLALFNARNFSVGNGVGFIfqTARGYSALETAAVMLPNAILTAVGSTYAGRLSDKFGGKYVLMAGLAMLTVGLLVLVAStaHSDAWSLLPGLIIIGIASGATFAPLQQATMDGvpQLAGAASGVSNTTRQVGGVLGTAVLGALLSA----------------------------------
     194 UniRef50_D1X4W1        Drug resistance transporter...   220     5e-56  1  23.6%  3:392   64:462     --RRTGLLVTLVLGGLTALPPLSMDMYLPALPAVTDSLSAPAATVQLTLTACLAGMALGQLVVGPMSDRWGRRNPLLLGMVVYVLATAICALAPTAELLIGFRLLQGLAGAAGIVIARAVVRDLYDGVEMARFFSTLMLISGVAPVIAPVIGGQVLRITDWRGIFVVLTAVGLVLTLVVWKWLHETLPPADRhtDALRTMRGLLADRVFTGYMVAGGLAFAVLFAYIAASPFVVQEIYGASPQTFSLLFGLNSIGLITVGQINGklVGRISLDKVLGFGLAVIVLAAVALLLMTAgvGLVPVAAGLFVLMSAMGLAMPNTNAQALMRTKHAAGSASALLGTSSFLIGAVASPLVGIAGEDTAVPMAVVQVVCAVAAVGCFLLLCRPWQRAGR--
     195 UniRef50_Q5KL87        Polyamine transporter, puta...   220     7e-56  1  14.4%  3:392   74:510     --NWKRYAIVGLASLLNNLVCLCVSGYSTGIAQMEEEMGFSSEVGTVGLSLYVLGFAIGPMLLAPLSEYWGRRPVYLVSWTIFTIFQIPLALAQNVATILVCRFIQGLAGSTPLANTGGVVHDVFAVKEAGYAVAIYALSSADGPPLGNVISGFLAQNAGFRWLFWAYLIIFGFFLIVIFFCLPETrpGHLWKVTIFRPFKFLFTERITYLCAGINGFVYGMIFLSNEAFPLVFgnGHGWtsGVVNLTFGAYVVGSFLGfaWYRKASKAKGrrWWSALWATPFMPLGLMVAAWTSYPDLPWIAPIIGFTMFGFgiILAAILNYVVDGYAHYSASALGGVVFVRNIIGAVFPLFSSQMFKGMGNQWALFLLSMVSFLMIPIPVYLYYRGKVVR--
     196 UniRef50_Q1YU96        Efflux pump protein FarB n=...   219     1e-55  1  19.7%  1:360    7:420     LTPRAKSAVTLAVMLASIMQMLDTTIANVALPHMQGSLSATQDQLAWVLTSYIVASAIMTLPIGWLSGRYGRKNVFLISIAGFTLTSLLCGAATSLNEMIGFRILQGLFGAALVPLSQTIMLDINAKEDHVKAMAMWTVSIMIGPILGPTLGGFLTEYYSWRWVFYINLPFGVVVLFIILTLMPETEREERphLDWLDSIEIQFYCAVVLSALWvmFFMGLILLATMALLPNYLQRIMGYPVLDVGTILAPRGIGTMLSMFLLGKFADRFDPRALVVVGLLLTAYSLWLMTHFDTFVPAHRIVSTGFLQGLGLGFVFMPLSTLalTLEPQYRTEAAGLFSLVRNFGSSIGVSAAFVLFSR----------------------------------
     197 UniRef50_B7HDG2        MFS transporter n=77 Tax=Ba...   219     1e-55  1  19.5%  1:379    2:379     MKNSKLTFILYVVCISALFGSFAQNIYTPILPMIQNSFHTSLYLVNITVSLFTFVLAIMQLVYGPLIDTKGRKSVLIPSLVISTIGSIGCAFSANIYLFLFFRAVQAIGIAAIPVVSATIIGDLFEGKERGEAMSLYQMLLALAPAMAPLIGGYLGSIHGHLSVFLFLSTLGIILLIINISLLPETKPNIIKQAKAQKNYSLILKNKTGFSITLIGFIQFCIYFCFLVFLPSILTNSFHLTVNKIGLMFVPMSLSIMLGSFCYKFLQKRLTTKQ-ALFITSFFNIICVVLFSFIYNINIPFIIIVTSLYGFSMGLSMPTHTTLLTEEFVQERATAIGMYNFIRYLGMGTGPLIGGFLLFNQNYFWIFFLGAIMFLLVIL---------------
     198 UniRef50_C7M7F9        Drug resistance transporter...   219     1e-55  1  21.8%  8:387   15:399     -------LFILIMGLLSMLTPLAIDMYLPAFVKIANDLNVSEEMISQTLALFTLGFAFGQLFWGPLSDSYGRKPIILIGIITSALVSLVITQIHHIHHFYILRFVQGFFGASPAVVTGALLRDLFAKNEFARQMSMIMIVTMIAPLIAPVLGGHLTDWFHWHIIFYVLMVLGLLAALLVSYKIPETLPKFKRVpnTLRIYGKLLSNKKVLGYIFCNSLSYSGMFCFITTGSIVYTKLFGVAPQHFGYFFLLNVIVMMTATSLNGKFVTKIGVEKSLRLGLTIQLIAGAWLVICgfHLGLWATVAGVSMFVGLVSVVSSSANAAILDMYPEVAGTANSLTGMLRFGIGSVVGAVLSLFAITSERPMVFAMAICIGVGALSYLLLVARR-------
     199 UniRef50_C1XTU0        Drug resistance transporter...   219     1e-55  1  20.9% 20:359   36:431     -------------------AALDQTIVSTALPKIIADLNGT-ELYAWVTTAYLLASTVSAPIFGRLTELFSRKSILLIAILIFLGGSALCGLSQNMPELILFRGIQGIGGGALFALALTTIAVLFPPRERGRVGGLFGAIFGVSSAVGPWLGGLLTDHLSWHWVFYINMPVGAVALWFIGRFMPRLRPDHRETFDFLGAALLiwSSPRILGLFAMSAVALaaFLGAVAFLPLYLQVVKGVSASASGVTVLPLTVGVVLGATGSGVLSGRLGRYKPLLLIGTLWLLAVFLtlVLSVNTPLWLAVVLFFLLGLGLGPSQSLLQVAAqnIPPQRLGSATAATQLIRQIGSTIGIALLGTVLT-----------------------------------
     200 UniRef50_A1AMA2        Drug resistance transporter...   219     1e-55  1  26.9%  1:390   24:419     MPRGQMVRMVLILGVLTAFGPMSIDMYLPAFPQIARDLGVPLGTVQLSISAFLFGSAAGQLLYGPLADRFGRRRPLLCGLTLYIAAALGCACVHTGEGLLIWRLVMAVGGGAGMVISRAVVRDLYDTAEAARMFSLLMLVMGAAPILAPIAGGQILLITGWRGIFAFLGLFALVSIAAAARWLPESLPPERRIreMVAGYGQLLANRDYIRYSIALGCVAGFTFAYIAGAPFFFIELHGMSPQRFALLFGANAVGLIGASQLNRRLLHRFSAQRImcFALNAAATLLLVAVVMAGIGGFPGQGLLIFFCVSMTGFLYPNVTALTLAPFGKAAGSASALLGTIQYSIGASAGALVGALHNGTALPMTASMALCGVVGWLAVALSASAEDHP----
     201 UniRef50_D0KYI8        Drug resistance transporter...   219     1e-55  1  16.9%  1:362   13:430     LTSFERVMITFAVMTATVMQVLDTTIASVALPYMAGDLGASPDQISWVLTSYLVASAIVMPLTGYFTDKFGQREYLMFSIGLFVVASALCGLSANLPQIVSFRLLQGVAGAALVPLSQAIMVQVFPPDQRGKAMAIWGIGVMVGPILGPTIGGWITEAINWRWTFYVNLPVGLLSFFIVGRFVPRLPRKHGRTMDWWGFTLlwFSSSTIVTAAVVSVIAFigMFGAIFVQPLMLEQEMNYPVLTTGMVLAPRGIASMIAMMIVGRIIGKVDIRAIILMGIVLSLVGSWGMTQYNLEINTWQIVWPLLFQGAGIGMIFVPLSTAAFslSPQFAAEAAGIYSLVRTVGSSIGISLVATLVSRHA--------------------------------
     202 UniRef50_D1BR56        Drug resistance transporter...   219     1e-55  1  22.4%  7:381   18:394     ------WLFTSILSALMAFTSLSTDIYLPAMPEMGRDLN---GDAELTLTGFLIGFALAQLFWGAVSDKIGRKKPLIIGIVLFIIGSVGCALSSSMMELLAWRVFQAFGACVGPMLSRAMIRDLYGRTEAAKMLSTLAIVMAIAPIAGPMLAGHLLVWYTWHSIFWLLVAIGILMLVAVL-VIPETHPLEKRSKKSIgnYWILLRNKGFMKYTLCVSSFYIAIYAFLTGSPYVYIDVYEVPKEYFGYLFSVNIIGVMLLSAINRRIVsrLDRLLKYATLFAAICVSIVMGLMFLGYHSLWLIVIGCFLFFSMNGIIAAVTNALALDRAGRMAGSGAALLGAMQYGSGIVSSLILTFLPNDTAYPMMGVIAIFVIICAMIAF-------------
     203 UniRef50_A6LQ19        Drug resistance transporter...   219     2e-55  1  18.5%  5:361    8:418     ----KMAFTLLALAIGTFMSALDSSVVSIVIPVIQKYFNVNIAFVEWVITAYLLVVSSVLLTFGKLSDLYGHKKIYLMGFTAFTLGSFLCGISLNIQMLIVFRIFQALGAGMMFSTSSAIITASVPSNKRGKSFGIIAIAISAACCAGPVIGGILASMMGWQSIFYINIPIGILGIYLSYRYIPEDKKKISVPFDLGGAVLilFKNKTFSAGLIATTFNYMAQFIMAFLVPLYFQNTLQLSPMMTGVLFLPMPVSSILIAPISGSFSDKHDSRIMSSTGMGILAIALFMLSFLNMGTSSWYIVIAMILSGVGSGLFQSPNNSAVMGSVpqHRGVASGTLSTMRNLGMVMGVAVSGALFSYS---------------------------------
     204 UniRef50_B6HNK5        Pc21g05100 protein n=32 Tax...   219     2e-55  1  12.3%  3:392   48:486     --QSRKWFIAAIATLSVFAVTFTSSAYSVSANEVFKDFDISTEVFIVGLSLFVLGFAIGPAVWANisELYGRQILWIITHIAMVAFLGGSAGSQNVATLLILRFFAGTFGGSPLVNSGGTIADLFPPAQRGLALTIYCVAPFLGPILGPIVGGFVSESVGWRWVQGVCVIFIGVVGILGIVFIPETYGPVLlkRALFRPWIFLFLEPIVLIASVYMAIIYGTVYMFMGAMPIVYNEDRGWSVGIGGLAFLGIAVGIIFGLVYAIwfAAKseSRLPPAIVGGVALPIGMFAFAWTNYPSIHWSviLSAPFGFGCVLVILPIMNYLIDTYTIYAASVLAAAAIFRSVVGAVFPLFTTQMYHNLGIHWASSIPAFLTLLCMPFPLIMYRYGEAVR--
     205 UniRef50_D1C6K4        Drug resistance transporter...   219     2e-55  1  17.9%  4:360   39:449     ---RHKWLVLSTVSVGTFMATLDSSIVNISLPTIQQHFGVSLSTVEWVVVAYLLTLGTLLLSVGRLGDMVGYKRVYLGGFALFTLASVLCGASQSIWMLIGFRVLQAVGGTMLQAMGPAITTRTFGSQERGRALGLNAISVSLGLTIGPTLGGVLTEFASWRWIFYINLPVGIFAILWAWRVLEPEGRRARQMFDIPGAavRLFRIRSFWAGNLSLLIVFSGLFTATFLMPFFLQQGQGLSPFAAGLLLTPVPLTTLVVAPISGALSDRIGPRLPATLGAAVMTLGLYTLTQLHVGSSASDLIWRLVVLGVGQGLFFSPNSSAILGAVPrrLGTASATVAQMRIFGQVLGIAVAGAVVAS----------------------------------
     206 UniRef50_A8QD23        Putative uncharacterized pr...   218     2e-55  1  12.4%  2:389  194:630     -SYLTRCYITLLVGALAIASSMTSSLPSMLIEGISEHFQVSEEVVKLSSFIFVAGYCLGPLIWAPYSELFGVRWPFILSTAGSTIFNMACALSPNIGGLIIFRFLAGAFGSCPLVVGGGAMANIWPKELLGLGMCLFSMSPMAGPSCGPLIGGYIaeKASWRWGYWACTILTGFLTLLSFLTLRETNprEILTRWILLPILMFIYEPMLQAMTMYMSFVYGVLYLFFEAFPIVFGVYHGLNELQIGLTFMGFFTGCIMGGSFYSLVENRreQRLMVALYGAPLLVISLFWFAWTSYssIWSTIAASTVYGIAMFFIFFALMTYIADAYRAQTACALSANTIVRSAFGFGFPLFATQMYNRLNPQWATCLLAFIAVLLFPIPFILFRYGP-----
     207 UniRef50_A5CYH9        Hypothetical transporter n=...   218     3e-55  1  18.2%  2:370   33:455     -TGRIPLAALMTLIIGAFMAILDGSIVNVALPRMMSIFNSTPDQIQWVITAYLLASGVVVPVTGYLSDRFGAKRLYIVSLGAFTAGSALCSLAWSNHSLVAFRVVQAIGGGMMMPVTMTMIYHIVPRDKIGTALGIWGISAMAAPTVGPTLGGYLVDNFSWHWIFTINIPIGAVAVFLAAMILEETPKKAGLKVDIPGILlrLLKNKVFTASLVCVSITTIGLFSAIFLVPLFVQNVQGLTPMQTGLLMMPAALASGIMMPISGRLFDKIGALPLCLVGLSVTVVTTYQLHTITYDTSYRELQWLLVERSLGLGLCMMPMATAGMNTVPrlIGRASALNNLVRQISASFGIAFITYVMMNRQEQHTAWLA------------------------
     208 UniRef50_Q7ZA72        Putative uncharacterized pr...   218     3e-55  1  13.6%  2:392  138:572     -SKTRKWCITILGVLFTAEVAATASAYVPGIPSMERDLDITNHQLSLliAIYPLGFALPPLVLAPLSEVFGRNPMYIVCHLCYTVLFVGLGFANNAATVIILRFLQGAFGSTGSTMVGGTISDIWNSKERGQPMALFATAAIFGTGIGPVWAGWVEQnlQWRWIQYIQAIYTGFILLLLLIFLRETRGSILLTrsLTRPLVFLIKEPIVTFFSLWIAFTWGFMYMLLSSIGLI-TAQHGFTPGQNGLVFLSIAGAGILGNVLNpyLYRKneARLYLACVGAVFFPVGCFIYAWTSFPHVSIviVGIVVTMTSVFHVYLCCFSYLADCYLTYASSALAAQSFARNIFGFIFPLFVEQFYHRLGYQWASTLSALLGAVLGVVPFILFFYGKKIR--
     209 UniRef50_B2HEY4        Conserved transmembrane tra...   218     3e-55  1  20.3%  2:391   37:491     -RQPSPATVLLVAAFGAFLAFLDSTIVNVAFPDIQRYFHSGISDLSWVLNAYNIVFAAFLVAAGKLADLLGRKRLFVYGVVLFTIASGLCAAADSVEQLVAFRVLQGIGAAVLVPASLGLVVESFPAERRAHGVNLWGAAGAIAAGLGPPIGGALVEALNWRWVFLVNLPLGIVAVLAARRALVESRACGRRRVPDVRGAAMlwSSLPAIGSLVAAALAmaGFYAYLLTHVLFLNYVWGYTLLQAGLAVCPAAIIAAVTAGLLGRVADRHGYRVIIGVGALIWAGSLLWYLTCVGTTPNFlwLPGQILQGIGVGAAFPLLGSAALaaSGSSYATASAVTGTIRQVGAVIGVALLVILVGTPAPGAawTMAAICFVAVALGAVWLGRIRPAP---
     210 UniRef50_A8U140        Permease of the major facil...   218     3e-55  1  24.0%  8:391   10:399     -------AVAALLTMLVAFGPISTDMYLPSLPALVSDFGSDVPTVQLTLSVFLVAFAVSMLVYGPLSDRFGRRPVLIGAIAIYVVASVACALAPTIEALIAARAMQAVGCCAGPVLARAVVRDVYGRERAAAVLSYMGTAMALAPAIGPVLGGWLQVVYGWQATFWVLTAFSGVALVGVLTMLDETNAHRNpmRGMLHAYRTLLSHRGYVGYVATIAACYSIIFSFISGSSFVLIQVVGLTADVYGLCFAAMVIGYMSGTFISGRFGRRIGLDRLILTGATIATAAGVAmfAWAGETHIETIVIPQVIAMLGVGLVFPNCQAGAIGPFPTMAGAASSLLGFSQMGVAAAVGLAIGLTFDGTARPMATAIAIAALMTLLSFRLIVWPVRPRA---
     211 UniRef50_Q1QXI0        Drug resistance transporter...   218     3e-55  1  25.4%  1:386    1:391     MTRLNARRLALLVAANTALAPFAIDAYLPAMPTLAEAVNASVHHTELSLSVFLFGFAIGQLLCGPLSDRFGRRPVLLTGLVVFLVASLGIMQVSSLETLWGLRFVQALGGGACVVNSAAIVRDCFSGREAAKVMSTMAMILMLAPLVAPTVGSVLLGFFNWQSIFLFLALYAAFLLFFLGTRLPEThpDAPSMRQVLRNYASVIRHREAMGYICAVSMSFAGMFAFITGSPYLYMEHYGISAAVYPFVFGANILVMASSNRLNIYLLKRRTPQQNLVVGLglCAGVALVALILSGMDSIYSVAPLMVVFVGMQGLIAPNAMSSMLDHFPNMSATATALQGCLQFSSGAFAGMLVGAFEIASAWPTVLTMLGASLLGNIGVRVLAGR--------
     212 UniRef50_C1DP43        Drug resistance transporter...   218     3e-55  1  24.0% 17:391   40:419     ----------------MSFASVSTDMYLPALPTISRALHTTSASIELTFSAFLVGFSLGQLLWGPISDRYGRRLPIAIGLVLFTIGSVGCALSTTVTQMMVWRVVQALGACVGPVLSRAMVRDLYGREQSARMLSTLILIMGVAPLVGPLLGGQVLAFWSWQGIFWTLAGIGVLTLASLAAllPPARRSATPLRHTLGSYWELLGDVRLMGYALSGGFFYGGAYAFIVGTPFAYIDYYHVSPQAYGWLFGLNIVGMMVANFVNRRLLERFGSERLFHIGTWILALTGIVLaaRFGWGGLPGLVVPIFFYMSMNGLIVANSVAGALSAFAHKAGSASSLLGAMHYGSGILSAAMLGWFSDGTPWTMAWIMALAGIGSLATSAISTRIRAARG---
     213 UniRef50_Q6CCP4        YALI0C07722p n=3 Tax=Yarrow...   218     3e-55  1  13.2% 13:392  123:556     ------------VLILTFSVYIGSSIYTPALPEIMADFHISQVAGLIPLSVFVFGYGIGPVVFSPLSEhvGRMWIYIVTLAIFVILQVPTALCHNIGSLIILRFLGGIFSSPALATSGATFGDMYEIAYIPFALALWAISSICGPVFGPVLGGVFAQVKGWKWTFWVLAMISGLCLVVLFFFFPETSEGNILHRrlLRPILITFTEPVVFALGLYIALLYSTLYSWFEAFPIVFTETHRFNTIESGLAYLGLIVGGFVgaMYLPIIYNKFTRPVllCLIGSTIFPASLFFFAWTAHKSIHWIVPIIalCIIGMLFIFQTVFNYLSGSYPKYIASVFAGNGLFRAFVAGGFPLFAHQMFTTLgvGWGTTLVGCIGVLMGLIPLVLIKWGDKLQ--
     214 UniRef50_C7PW41        Drug resistance transporter...   217     4e-55  1  20.6%  4:357   13:424     ---PRRWKALAFVGLAQLMVVLDGTVVNIALPSAQRDLGFSDADRQWVVTAYALPFGALLLFGGRLADRLGRKRTFQIGVIGFALASALGGASADTAMLLGARALQGCFGAMLAPSALSLVTVMFtpAERAKAFGIWGSIAGGGAAVGLMLGGLLTQYLSWRWTMFVNVVFAVIAFSGAAITVREprRHDHGRLDFLGIFlhVVWNRNRGGAYLSLGLAIVGMFGAFLFLTYYLQSVQGMSPIRSGAAFLPMVGGMLIGaqISARLMTRVRPRYLMPPGFVLGSAGMLALTRITVGGSYhwILPGTIALGLGMGCAFMPAMNVATGGvpRDAGVASAMVNTSQQVGGAVGTALLSTL-------------------------------------
     215 UniRef50_P45123        Bicyclomycin resistance pro...   217     4e-55  1  21.1%  3:391    4:397     --QKSTFIFILTLGILSMLPPFGVDMYLPSFLEIAKDLDVSPEQVQHTLTSFAYGMAFGQLFWGPFGDSFGRKPIILLGVIVGALTALVLTEINSVGNFTALRFVQGFFGAAPVVLSGALLRDLFSKDQLSKVMSTITLVFMLAPLVAPIIGGYIVKFFHWHAIFYVISLVGLLAAALVFFIIPETHKKENRIpiIARNFLLLWKQKEVLGYMFAASFSFGGLFAFVTAGSIVYIGIYGVPVDQFGYFFMMNIVTMIFASFLNSRFVTKVGAETMLRIALAifLSGMWLILTALLDLGFWPMAIGVAFFVGPNPVISSNAMASALERCPQMAGTANSLIGSVRFAVGAIMGSLVASMKMDTAAPMLFTMGACVVISVLAYYFLTSRNLKSR---
     216 UniRef50_B9YYL5        Drug resistance transporter...   217     4e-55  1  24.7%  2:389   10:403     -SATRSRGLALVLALLATLGPFSIDTFLPAMRAIGASLGASPVEIQQALTVYLFCYGMMMLWHGSISDAVGRRPVVLVTTLLFGAASVGCALADNLTTLLIFRGLQGLCGGAGLVVGRAIIRDRFDGAEAQRMMSQVTMLFSLSPAIAPVVGGWLFGAFGWHSIFVFMALIGFGLFVMSWFSLPETHGHERRQrtLLANYTRVARQREFQLLAAAVSFNFAGFFVYIPAAPVFLMQHLGLGPEQFLWMFGPAVGGIMLGAFLSGRLAGRRGAREIVNLGYGVMFTALalLYNLLFPPALFWNVAPLMLYTTGMSLVAPSITLILMDQFPELRGTVSSLQGFTQTMMSSLVAGVIAPLVWGSPLTLALTMACFLCLGFAFRMAFRRRLAR-----
     217 UniRef50_A5DD57        Putative uncharacterized pr...   217     4e-55  1  13.4%  4:392   80:498     ---KKKLVNTISILWAPFNIQIGSAIIAPSTKEIAKVFHVCHTVATLSTSLFIFGFAAGPVIWGPLSELYGRRPILLLSAFGYLCFAFGAATAKDIQTLMICRFFCGFIGGAPAVVTPSSLSDMFPKSQRGIAMSGFGLIIFSGPMIAPIIGGYTTSNLGYRWNLYFAGFFGCVSFMLLLWF-KESHHPTLLTQriARPLKMLVSEPILALVSLYNAFMYGILYLLLTAIPLAF-GYLGETEN---LPYLALFIGIIFGTLIIIFFDNKkeDRLPPMLVGSILFPIGMFWFGWTTSVHWIVPTLGLVFVGAGLITVFLPCLTYIVDVYLHISASALASNAFLRAGFGGAFPLFAHQMFAAMSIKWGTTLIGCFSLVLVPVPFIFYRYGSIIR--
     218 UniRef50_A2QUV7        Contig An10c0020, complete ...   217     5e-55  1  14.0% 14:392   52:477     -------------ALFNLVVTISSSIFASAEDKVATEFAVGQEVTVLGTSLFLVGYIVGPLLFGPLSEKFGRKWPLIVGVCLSSVFGLMTTLGQNLATIFIGRFFAGLFGVAPIAVLGGIITDCWNALYRGVALAFCICLVFAGPTFGPIVGGFIVENTSWRWTMWVVVIAGLALGFVAVFTYPESYPPKVLQIrlVRPWVLFFTEPILVSLTFYQAFIYGLMYVCYQSYPIAFMEVRGWSQGFASLALIGIIVGVVMGTATVVIYNQLyeARLPLMIFGGCLVPTGLFWYAWTSDPSIPWpvCAGILVGWGMYTIFIQCFSYIIDCYTDMANSAMAANGAVRSVFGAVFPLFANYMYHNLGVDWASSLVGFLALVMVPVPIIFYYYGARIR--
     219 UniRef50_C6D8J1        Drug resistance transporter...   217     5e-55  1  18.8%  5:356    6:415     ----RKWWVLITVSLAVFMAMLDITIVNVALPDIQRSFSSDFSNLQWVLNAYTLVYAAMLLPVSKLGDIIGRKKVFLMGLGIFVIGSLTSGLAGSDLWLNIFRGVQGVGGAAMMSLSLTIVTASFPEKQRGLALGIWSSVVGLAISGGPLIGGALVDSFGWRSIFLVNIPFGIAAILLGMFFIQESNKNSKGKIDYLghVLSLLGLSIVLLIAFIifVLGAGLYGGFTYLTILMQNYMGYSAFETGVKMLLISGFTIILGPLAGMVSGKIGNRWLISGALFIGAIGIIViqTIKVPVEWSYLMPGFVLLGISNALVNPPIANAAMSSikKQVGMASGILNVFRQVGISFGVVMLGI--------------------------------------
     220 UniRef50_Q2UFT9        Synaptic vesicle transporte...   217     5e-55  1  10.4%  2:394  104:547     -SKGKKWTFTVVASLMTFSATFASSVFSTAEKQTAAEFHVSHEVTILGLSLFMLGYCFGPLLCGPLSESHGRSLPLMLGVIVFCIFQVPVAVAQNIPTTVICRFIGGLFACSPLSIVGAILANIWDPVERGIAACIYSGATFSGPVLGPIVGGFVVdyLGWRWTAWLTLIREVYFWVLGMVFVPGTHAPTLLrkYLARPLVMLASEPILLLTTLYMSLVYGTLYLFFEAYPISFQDQRGWNAGVGALPFLSITIRVVFGNLTIahLKRKyeERLIPMMVGAVVLPPGLFWFAWTSSTHITWvvLAGIPIGMGIQVIYTMGLNYILDVYTPYAASAVSEYTFVRSMAAAGFPLFATPMYDRLGISWATSLLGFVSVLMMPVPLLFYVYGERLRKL
     221 UniRef50_C6VP74        Multidrug transport protein...   217     8e-55  1  18.3%  2:362    4:417     -RKTNVMAVTVAIYVATFMSAIEGTIVSTALPTIVGDLH-GVSLMNWVFSIYLLTNAMMTPIYGKLTDLVGRKPVMQAGLIIFIVGSMMSGLSNSMPVLIFWRAIQGIGAGALMPVSMTIIADIYSFERRAKVLGFNSSAWGIASVLAPLIGGLIVDKLSWHWIFFINVPVGLITLFLFQFYLREPKRHNNVKIDYLGSFWllFKNHTFIIQNAVAALVSGFLMAVEVYIPTWTQGILGVPASLAGFAVTPSSLMWIVGSFVTGRLLAKWAPRRILYLSLAFILVTSICLAWLPVNTAFPWFFLITAIGGVGFGITITATTVTSQHLVpeNVGVATSFNTLSRTIGQTLMISIFGIALNVGM--------------------------------
     222 UniRef50_Q1IM05        Drug resistance transporter...   217     8e-55  1  15.0%  1:361   18:435     VREINPWWVTAAVMMAVFMEVLDTTIVNVSLPHIAGNLSASVDESTWVLTSYLVANAIILPMTGWLANHFGRKRILMSSIIGFTLASVACGMAPNLSSLIFFRVVQGATGGGLQPLSQAIMLEAFPGKKRGKAMAIWALGIVVAPMLGPMLGGWITDSYSWRWIFYINLPVGLLATMMSQWFipPYIKRSSDVVDYWgaEHPIVDLRVFRVRTYATGVFLmvLYGSTVLIPIWLQTLMGYSSLEAGFAVLPRGLGSFLFMPLVGVLMGFVEPRKLLATGLITAGGSLYFLSLLNTQAGYWDFFWPQLIQGAAMGLLFVPLTTITNDpaPENMGNATSIFNLMRNIGGSIGIAMTTTIVARS---------------------------------
     223 UniRef50_C5DHQ1        KLTH0E06138p n=2 Tax=Saccha...   217     8e-55  1  14.1%  4:393  170:606     ---RKRAFLCLLLGLNAVTVAMGSSIFASAVPQICAKYHVAQVVGVLGVTLYVFGFAASPVIYAPLSELYGRQKLLIISSFGFVLFMFATATAKDLQTIMICRFFAGFIGAAPLAIVPACFFDMFDNETRGTAVVVFAMGVFMGPILAPVFGSYIVQHTTWRWTQYCVGMFAALVTILLAIFYEETHHpeIAQKTVTRPIYMLVTEPILFAITLYHSFVYGILYLLLEAYPIVFVKKYHF--YVNglPYIALLIGMGVNAAYNIwyVRKveERLKTMILAGIVFPIGILWFCWTGNYsvHFMVPTVAGSFIGFGliFLPCFNYIIDSYLFLSASAIAGNTFMRSSFGAAFPLFAGFMFNNMGVNWAGLLLGLFALAMVPVPILFIKYGKALRQ-
     224 UniRef50_C5SHV1        Drug resistance transporter...   216     9e-55  1  22.2%  4:391   12:405     ---KNPFLVIFTLGALSTISPFAIDMYLPAFGQIAADFKTSSAAVGLSLSSYFAGMALGPLIYGPLLDRYGRKPPLYAGLALFVLTSVGCVFAPNIDVLIWLRLFQALGGCAASVAAMSLVRDLFPPKDTAKIISLIILTIGVSPLLAPTLGGLVTTWLDWHWVFAFLAAIVGLTLILVITVLPDGKPADpkPLPILKTFLGLYRNPAFVTYLFAGGFSFGCLFIYVSASPVIFMEIFHIKPEIYGLIFAGLSVGFIGSSQLNVFVNRRYSSKQILRVGLSvvFVLAFLLAAANGWLNVWGTVIMLFLILSCLGFIGPNSSATAIGSLTRDIGSGSALMSFTQIGLATIVSAVVSALQAQTLTPIVVVMTMSVVIGRVVLFVGERLGSHSH---
     225 UniRef50_B6QRQ5        Putative uncharacterized pr...   216     1e-54  1  15.8%  3:389   58:487     --ERKKMGILVMVAVMTFITPMSPAMLSSAIPEILTEFPTTNTvaSMSVSIYALGLAVGPLIIAPLSEAYGRLVLYHATAILFIIFSIACAVSTNLNMLIAFEFFQGCMGSAPITMGGGSVADMYSREERGARIAFLATGPLIAQFVGPVGGSFLAAARGWRWVFWLVTILTGVIEIGYCFLMHETYQprLVGSSILRPLKMLFLFPIIFGLGTHAAVGYAYFYLLITTLANIFIGTYGLEPKIVGLVYLGIATGMALGAATFAIYSDRmeDRLVPMVAGGVAIPTGLLIYGWTAQYGVHWIVPIIgfLGLGLMWLLLSIDTYLVDAYPLYAASSIGATTVFRSFISAFLPLAGPSMYARLGLGWGNSLLAFIAIALVPIPLLFLRYGE-----
     226 UniRef50_UPI000023E6CD hypothetical protein FG0320...   216     1e-54  1  12.8%  3:392   78:501     --KWKKWFFTGLQAIATLATTFASSAYSGGMKQVIRYFNVSSEVATLGISLYVLGFALGPLVWAPLSEEFGRRKIFFVSFMAGTAFAAGAAGADSIAALLVLRFLTGSIGSAPLSNAPAVIADMFEKSERGMAMC-------------PIIGGFLAQTEGWRWLLGLMAIFTGTIWIVASLIIPETYAphHLKATLTRPWVLLFKEPIILILSIYISIIYGTMYMCFAAFPIVFQGGRGWNQGVGGLAFLGIVVGVALAILTFVYEDKRyeDRLPPAMVGSVLIPVGLFWFAWTSFDSIHWIVPIIGTVFFAWglVFMALLNYLIDSYVVFAASVMAANSVIRSLFGAAFPLFTKQMYQNLGIHWASSVPAFLALACVPFPFLFFKYGRKIR--
     227 UniRef50_C6XDZ4        Drug resistance transporter...   216     1e-54  1  26.1%  1:379    4:387     MHKASALTLSFLLAGLAALAPFTIDTYLPAFHTLAQDFHTDNLAIQQSLTAYLLPYALMTLWHGAISDAIGRLRTIYIGLGIFTLASIGCAFATNVETLWFFRVIQGLSAGAGNVVARAMVRDLFEGVMAQRVMAQLQMMFGLAPAIAPIMGGWLLG-IHWQAIFVFLALYAGLAMLCVQRWLPETMPPEKRrrAVWQGYAQVFGDREYLKLVVAVGANFAGFFVYVLAAPVFLVEHLGLGPQQFGWMFIPTVCGMMLGSYLARHSAGRYSAHRIIRlgWMAMAAILNLLVCWLLPPQPLWNIAPIVLYNIGSALVLPNLSIAALDRMPKLRGTASSGQAFMQMVLATVSAGLLIPLLWHHPAGLALGMAGYLLLGFLA---------------
     228 UniRef50_C6CYV8        Drug resistance transporter...   216     1e-54  1  17.7%  2:357    4:415     -KKSSVKLVIAGLLLGLFMSALDQTIVSTAMAKIIEKLG-GMDKFVWVYSAYMIAMVVATPIFGKLSDMYGRKRFFISGLIFFLIGSILCGTATDMNQLIIYRAIQGVGGGAIMPIVFTIIFDLFPPEKRGKMMGLFGAVFGISSVFGPIMGGAITDNISWRWIFYINVPIGILSLIFIMRGYQESKNHRKQAIDWAGAIILmfKTISLLAGAGILAIVfgIMIAVATYIPLFMQGVFHLSATSTSTVLTPMMLGVVISAQVGGRIANKVRFRDVMIVSSIVLMVGTYLlyVMDASSSRALITVFMVIIGLGIGVSFSLLNISTLNSvpQYKGSASSLITFFRTIGSALGITVFGAM-------------------------------------
     229 UniRef50_A4E746        Putative uncharacterized pr...   215     1e-54  1  19.4%  4:374   22:395     ---KNKWAILFTVLIMTFMVCLDSTVVTVALPVMQKELGVGLDRIQLVSSVYLLATCVAMLPFGRLGDVRGKVGVFQLGVIVFTVGSLLCGLSASLEVLILARIVQGVGCAAAMANNMGIITESFPACERGRAMGILATFVALGMMCGPVLGGMLVASFPWESIFLINLPIGVISFIVGLYTLPHVKPEAgrSMSLIEAARRCFANSAFTINLVCMLIVFVGIGASEFILPFYFQDAHGFGSDISGLLFLALPMVNAFIGPLSGTVSDRVGCEGPTAVGLGVYVCGLFAVSTLDECSSIPVIVCCAAFMSCGTSIFQSPNNSLYMGSAPREagFAGSLGSLARYAGMALGITVAsiLYGQMSVAMGEAVTSFVA--------------------
     230 UniRef50_C8XGB2        Drug resistance transporter...   215     1e-54  1  17.8%  1:360   17:431     MGRTQMNLVFVTVMLGMLLSALDQTIVSTALPTIVGDLG-GAGHMSWVVTSYLLAETISTVLAGRFGDMFGRKIVFQISVAVFIIGSFFCGLAQNMEMLIASRAIQGLGGGGLAVTATALIGEVIPLRERGKYQGALGAVFGVTTVIGPLLGGLFTDHLSWRWAFYVNVPIALIVIAMAATTIPRLSERSKVPVDYLGVLfyAWGSPTIIGLFVGSVVALaaMMGSITYLPAFLQFVGGASATESGLRMLPMVVGLLITAIASGNFVSRTGRYRmpIAGAVVTGLGLYLFSTMGVGTSYWLEALFMLVLGAGIGLMMQILTLIVQNTVseDLGSATSGVSFFRTLGGSFGASIFGTIYAN----------------------------------
     231 UniRef50_Q7M9C7        PUTATIVE EFFLUX PROTEIN n=1...   215     2e-54  1  26.5%  9:386   13:395     --------LIIILGMMTSLAPLSIDMYLPALPFLQGFFHADASAIQLTLASFFVAFALGQLFYGPLSDAYGRKKPLYAGVILFIVASIGCVWAKSVEMLIFLRFLQALGACAGIVIARAIVSDLFRAEEAAGIYSSMMMISGVAPILAPIIGGSILGTIGWEAIFYLLAFLGAIVLLSSFLGISETREPSKRssKALESYSSLLHHRHYLTYTLTGGLAMAGLFAYIAGSPFLFIEHFGLSEQGYAILFGANAVGLVLGSQINARLLRRYSSTSILSRALLCQSLCALLLLVQAYAThlFSFVIPLFGYITALGFILPNTTALAMAHFTSHAGSASALLGTIQFVLAGILTWGVGSLGATTPLMLGFLIAVCGWSAIAVFLMLKKR--------
     232 UniRef50_C5P4Y8        Major facilitator superfami...   215     2e-54  1  16.4%  2:392   47:481     -SMTWRLVISGIYIVLSLNSTLGSSMPAGAIKVIAEGLSVTNkqLVLPISVFLIGYIVGPLFLAPLSEVYGRRPLLLWTFVLYLFFTLGTALVSNFPGLLILRFFAGTAAAAPLAIVGGVFADCFPDshRGRVMSMWAAGTIFGPTLSPLISGFLGK-VSWRWPFWLELIFGGFTLIPMVF-VPETFGPVILAQrlSRPVKMLFTEPIVPAVCSYMAYVYAILYLFFQAYPIIFQDEYGMSPGIAGLAYLPVGVGSVISAVMVVLWDERMrhRLTLACIGGPLIIMSLFWLGWTGRRSVHWIVPILalYGTGNTTIFMALFNYLTDAYGIYSASAMAAGACTRSISGALLPLAAKPMYERLGIGWASSVLGLMGLPLVVIPFLFLRYGQQLR--
     233 UniRef50_C3JIB8        Efflux membrane protein n=2...   215     2e-54  1  19.2%  1:385   14:460     LDARRRWGILAICCTSLFVVGLDTTIVNVALPTIGEGFRVGTRGLEWVVNAYTLVLASLLISSGAVADRFGRRRVFQIGLVVFGVASIACALAPSVEVLIAARIVQGVGGSMLSPVALAIVVnmTDPKERAKAIGVWAAVFGLSMAAGPIVGGVLIESFGWRSVFWINVPVILAVLVLTAVFVPESRAQQSRRLDLPGQLLllFRRRPFSSAVIGAVVVFVALNATLLLGTFYLQHSRGMSPALAGAITLPMAVAATVCAPLSGILVGRFGPRRPLLIAGSFTTLGGLCLVSLDNNTAIPMLLAAYLFLGIGFGFSNAPITNTAVNGLPrqAGLAGGITSSARQFGAALGVALAGGIIGGsaSRLGWILVAGCGIAVLLIALASR---------
     234 UniRef50_B8M0D7        Bicyclomycin resistance pro...   215     2e-54  1  14.6%  2:392   98:536     -STSKKIFVVISGMMQVLNSTIGSSLPSGAIKYIARDFNVTDEtlVLPISLFLVGYVLGPLLYGPLSEQYGRRYPLLIGYVLFDIFVMACALAPTFNALLVFRLFNGMAASAPIAIITGTFSDVFdpTVRGRTMAWYMSCTAVGPIISPFMSGFI-STVSWRWSFWLGLLIAGTSCPLVILY-PETYGPVLLKSrlTRPIRMIAKEYMVSLTCLYCALAYAIFYLYFQAYPLIFEGIYGMSTGIAGLIYLPIALGCFLACGIFIWyaKARgrRLPLACVGGPLYVISLFWLGWTASPNVHWAVPMCSGIIFGLalIFMAMLNYLSDAYQVFAASAQSASSCCRSILGAVLPLAAKPMFSAVGIDWGCSIIGFASLGVSVIPFGFIYFGERIR--
     235 UniRef50_B8NVQ3        Bicyclomycin resistance pro...   215     2e-54  1  16.2%  4:392   37:471     ---SYRWLCIAVISVYGLISPVIAAIIVPAMPQIATDLNVtpGMLQAFVSVYVLGWSFAPLVVGPLSEVYGRISLLNTGHGLFLVFNALCAFARSDYELLILRFITGAVGSAPLSIGAGIIGDLWAPEERGLSISLYTLGPLLGPAIAPITGAYIVSHTSWRAIFAWCSLYILITWVVGLCTLRETFRPVLIQrdLRRPFTFLGTQPIIQVLSLFMGYLFGLNHLSITTFESVWTDIYNQTPSRAALNYISIAGGFILGSQITGSLNDRieLRTILMLPAALLVPTGLLIYGWSAQTHSHWIMpgISIYALGLIMSYQCIQAYVLDCYAVYAASAMGALTILRSLLGFVLPILAPLIYRTLGYGWGSSLLALWALVmgLVPVLLWRYGAVLR--
     236 UniRef50_C1YG27        Drug resistance transporter...   215     2e-54  1  17.5%  5:364   18:432     ----RIAVIMSALMLTVLLAALDQTIVSTALPTIVSDLG-GLNHLSWVITAYLLAVTAVTPLWGKLGDQFGRKQFFLVCIAVFVAGSALCGTAQSMLQLILFRALQGVGGGGLMVLASAIIGDVVSPRERGKYQGLFGAVFGISSVAGPLLGGLFVDHLSWRWVFYVNLPLGVLAFVTVLVVLPRRQPTGRQSIDywGGSLYPWTSPQVLgaMAIGFCVGFAMMGSMAFLPLFLQVVHGLSPTASGLHLLPMVLGLFLTSITSGRLVTRTGHYKvpVLGMAVTSLGLFLLSRLGPESSMTQMGFYFFVLGLGLGLVMQVVVVVVQNAAsaNLGVATSAATFFRSIGGSFGTAVFGAVFSGQLAA------------------------------
     237 UniRef50_Q4PBM3        Putative uncharacterized pr...   215     2e-54  1  13.6%  2:392  164:617     -RMPRKAFVTALLCLLTVSVYMGSAIYTPGVELFSSWFGIGVVPATLGLSLFVFGYGLGPMifSAASEiiGRLLPYLLTLFIFVILQVPTALVTNVAGFMILRFLAGLFGSPPLATGGASIGDLYSARNRPLALGVWGLSAVCGPVLGPLIGGFAAQSfgWRWTIWPLLMLSGFTLVVLVVTLPEtyRRAKRLrtFVRPFVLSFTEPIVLGINFHIGLVYGILYIWLEAFPIVFVQTYGFNSGELGLAFMGIFVGAILTYIPfgPLFDRNGGklEPAILGAWAIPICMFGFGWTANASIHWIVPIIlfFAVGTFLLFQSGLSYLGDCYPESIASVYAGNDFFRASIGAALPLVARAMFNnfPVAWGCVLIGSISIIMAPIPFVLYKFGPKLR--
     238 UniRef50_A5G512        Drug resistance transporter...   215     2e-54  1  15.1%  5:362   29:443     ----NKWLITITVMLPTIMEIVDTSVANVALPHMQGSLNAGTDEITWVLTSYLVSNAVVLPMTGWLARMFGRKRFLITCIILFTLSSLLCGAAPTLATLIFFRILQGAAGGALIPTSQAIMMETFPPYQQGMAMAIFGVGAMFGPIIGPALGGWITDNMNWRWIFYINIPIGIVAVTMATYFipPYLKRAKVAIDYWGLALLvwFNSSFILSCSVVSAvgFCLYSSIMLIPLFLQTLMGYNATMAGMVLAPGGVATLITMPFVGAIIQRYDGRKVVFCGLLIGAFSMYIMRGFTLDAAYWDFVWPRIVLGVGLAMIFVPLTTVTLATikEEMGNATGIFNLLRNVGGSVGIAIAATLLSRYA--------------------------------
     239 UniRef50_A6CHD2        Major facilitator family tr...   215     2e-54  1  16.9%  1:362    4:420     LEPRKKILIMLAIMSAMLFAALNQTIVGTALPTIISDLG-GIEYYSWVFTIFMLTSSVTAILVGKLSDMYGRKPFILIGIGVFTLGSFLNGLSGSIIELIAYRGIQGFGAGMIMSTSFTAVGDLFAPRERGRWQGLMSGIFGLASVFGPTLGGWIVDNAEWHWVFWVFLPFGLLAFIMIWKLFPSQQVQEKKKVDYLGSLMLSLTIIPMLLAFTWGgfQIIGLfgAIMYMPFFIQGVIGTSATKSGFVMMPMTLSMVFASAIGGQLITKTGKYKLIalGLFIMASGLASLSMMDSNTTNTTAVINMIIVGTGLGLSFPVFTLTVQNAVQhyLGVSTAATQLFRQIGGTVGVAVMGTVMNNSM--------------------------------
     240 UniRef50_A6CLZ7        Putative transporter n=2 Ta...   215     2e-54  1  20.0%  2:361   15:428     -KRTKRPFVLAAVMLAMFMGAIEATIVSTAMPAIVGDLG-GFSLYSWVFSAYLLMNAVTVLIYGKLSDLFGRKPIITFGIILFMTGSILCGFSQSMEQLIAFRLIQGVGAGAVLPIATTIVGDIYTREERAKIQGYLSSVWGISAISGPAIGGLLVEYVSWHYVFWVNVPLGVLSIVALWLFLHENVKKEKHNIDYLGAVLLTISISSLMFILviVSLTTGVMLIGISSfpAFVQGVMERSPTVAGFTLTTMSIGWPIAATVAGRLLLKIGYYRTSLAGGISLIVGSTFFVTMGADSGPVWAAIGSFFIGAGMGLTSTSFIVSIQSTVekQRGIATAANMFMRSIGSTLGAALLGGILNSS---------------------------------
     241 UniRef50_A1T2G7        Drug resistance transporter...   215     3e-54  1  20.7%  1:391    9:462     LSRRHKAFVLASCCLSVLIVSIDVTIANVAIPSIRADLSASPSQMQWVIDIYTLMVASLLLLSGAMADRFGRRRTLQIGLTIFASASLLCSVAPNVETLIGARFLQAIGGSMLTPAGLSIVTQVFTGreRARVIGIWGGVVGISMALGPIMGGILLEYVDWRAVFWINVPICALAVLLTAIFVPESKSVTMRHVDLIGLVLGmfRSIPFASATAIAVCAFAAWGAFLFMMSIYLQGERGLSAVNTGLMFLPVAVGAFIFSPLSGRLVGRFGARPSLMIAGALIVAATLMFAQMSDATPQWQMLVAFAVFGVGTSMVNAPVTTAAVSGMpdRAGAAAAITSTSRQVGVAIGVAICGPVAGafAVSAQPLWLVFAGVGVLIFTLGVYSTSKRA---
     242 UniRef50_A2QDM0        Function: CYHR of C. maltos...   215     3e-54  1  14.8%  2:392   66:494     -SPTRKIIVVIILSYSAILGPISSTAILASVPEIARTFRTDADIITASNALYLASMGIAALLWGPLSQISGRRPILIASSILFFLFTVATALAPNLEAYFIFRICAAFQGTAFLVLGSATVGDIYEPMSRALPLGWVLSGSVTGPALGPVLGGIMATFRPWRYIFWLLAALNGFAAVLFMIFFPETISHKsnHISPLRIARLVFSYPNIFLTSLTAGALVWNQYALLTPIRYVLNPRFHlsPIEAGLFYLGPGGGYIAGTFFGGRWAdrNGRRIpcVSFILIAIPACILVYGWTVdgGIPVPVVAMFLQGVATMFCFPSLNTYGLDVIQerSEEVVAANFVCRYMFAALGTGVVLPALKAMGVGWFSTISALFLIAVGGGLYLTAEYGPRWR--
     243 UniRef50_B0D961        MFS polyamine transporter n...   215     3e-54  1  14.8%  2:392   85:518     -SLSRKWFVTMATSFLCLAVAMGSSIITGDMVGPSLTLHIQQEITMLTVTCFVMGFGFGPLIFAPLSELFGRKPIYCVSIFLYFIFTLPSALAKNGATLIIGRMLAGLAASAPMCNVGGTIADVWSIEQRGAPMAIFSTTIFLGPCVGPLVGGWIGMRAGWRWIYWVLFIFVGVCFIFTLI-MPETLAPVLLRkaLVRPLVMMFTEPIIIFMSFYLAFVYCLLYLLFFAFPIAFTEIRGWNAGMTGVSFVSIMLGSFLAIIIIpkIYKRaeARLYLMMIAAFVLPFGLFIFAFtaYANVHWIAPLivIFGFAMILLYISANSYIIDSYSSYAASAIAAKTLLRSEAGAMVPLFAEQMFHKMGFQYAGLLLALFSCVIGPIPFVFFFYGHKIR--
     244 UniRef50_A2R1R4        Contig An13c0070, complete ...   215     3e-54  1  14.4%  4:392   67:503     ---WHKVYITCQLSMLTFVAALASSILSPGQSDIAEYTNISSEVAVLATSLYILGWAVGPTIWGPISEVYGRKWGMLPALFCLGLFSIGTAVSKNAASIFITRFIGGIFGSAPISNANAALSDVYAPKERGIAVAFMMLCITGGPSVGPLIGSAVVAnlGWRWTMYIEAICCFGLFALATLTLSETYSPVLLrkHFIRPLRMLTSESIMACVAAYASFSYSLIYLCLQVYPIVFEEERGYSPVIASLPFLGILVGTACAVGITFAYRTQyeARLPPLVLGGIVLPAGFFWLGWTAAPKYSWVLPTVafVGAGNNIIFQQCVNYLIDTYGPYAASAISATTILRSLLAAGLPLAAKPMFHNLGVGPAASLMGGIACLALPIPFVFMKYGRTLR--
     245 UniRef50_C6IYY7        Drug resistance transporter...   214     4e-54  1  20.6%  5:359    7:415     ----KRNYILTGLLLSTFLAAIEGTVIGPAGPRIVGDLG-GARLLSWVFTAYLLTMSVTTPIFGKISDLYGRKPVFVISSLLFLAGSVLSGTAHSMGQLIGFRALQGIGAGGLLPVTFTIIGDIYSIEERSKIQGWISSVWGISSLIGPLLGGYVVDSLNWRWAFYFNVPFGLLSLYFIIVYLHEQIEKRKVKVDYLGAVTFtwVSPWLIGIFAVAACFLVLFfgLTSYLPLWVQGVQGQNATTSGLVLAPMSIGWMLGSVLGGRWIITRGSRNTSLIGMVIIALGALGLATIQGGTPIWPLLIYNALYGIGFGFSFTVFTIISQSSVgnLRGASTALNSFVKSIGQTIGVTAFGTLIN-----------------------------------
     246 UniRef50_B7H8Z0        Drug resistance transporter...   214     4e-54  1  17.1%  5:360   12:421     ----KTKFVVAGLLLGILMAAMDNTIVATAMATIVGDLG-GFDKFVWVTSAYMVATMAGMPIFGKLSDMYGRKRFYIGGLILFLFGSALCGTASSIEQLSIYRAIQGIGGGALMPIAFTIMYDIFPPEKRGKMTGLFGAVFGTSSVFGPLLGAYITDYISWHWVFYINIPLGLISFFFITKYYSESLEFRKQKIDWAGAITLViwNSTVIIGLFTTVVITLIIFFFvvYIPIFIQGVLGGSASNAGLILTPMMVGSVIGSQTGGQLASRTSYRNIMMVSGVFFVLGIYLLSTLTMDTPRLLVTLFMILAGLGVGFSFSVLSMSSIHKLerDRGSATSTNSFFRSLGMTLGVTIFGTIQNH----------------------------------
     247 UniRef50_Q8GFB9        Orf16 n=7 Tax=Enterobacteri...   214     4e-54  1  21.9%  3:394    7:400     --QHPPRWLIPLLGALVAFGPLSIDMYLPALPEMARQLQATQGQMQHTLGVFFAGFCIGMLLYGPLSDHLGRRKLLLSGIALFVVASALCTLVTQVEQLILLRALQAFGSGAAVVMGRAIARDIYSPQELPRVLSLMTLVTMIAPLIAPLLGGFLLTYFNWQAIFTLLGLFGCISGILLLFFLPETLPAqgKLITAFKNYGKLLTDGEAMATIGTLAFTCAAMFAFISGSPFVYINYFQVPANYYGLLFACNALGMMAIVLLNVRLLKVYDVSRLLFIQTSAQLLFGILLVIFYQQSLTVVVILVVLFISL-VNAIGTNSLSLLLQHRGQLAGSASALAISAQFGMAALASVAVSLLQDETPFAMAFVMAVCAGLCWLCQQLVTFYQRKLLTQV
     248 UniRef50_C8WB01        Drug resistance transporter...   214     5e-54  1  15.3%  1:365   36:456     LSGSKQAIACIILALTNFMVVLDTTIANVSVPHIAGDLAVSNSQGTWVITSYAVAEAICVPLTGWLSRRFGTVLLFFISIIGFTSFSCLCGFSHSLMVLLIFRCLQGFFGGPLMPITQTLLLRVFRKEQHAQAMGIWAMTTITAPIIGPIMGGWLSDNWSWPWIFYINIPIGIICAMGVFALLRSVETRTLKEYIDKGGLTImlSSRMIVTLLILAafSFGVFFASAVIIPQWLQRVMGYTATDSGLVTAMSGILAVCFSPIVAKLSGKVDARILVSFGILWLGGCTALRTFWDTNSSYWIFAVPQFLQGIGMPFFFVPLTTLALSSvpEETTSAAGLMNFLRTLAGAIGTSWSTTVWEDYARKM-----------------------------
     249 UniRef50_B7FAY6        CefM protein n=1 Tax=Acremo...   214     5e-54  1  13.8%  4:393   40:474     ---ARKWLNVFVLAAMTFIAALGSSIAAPGVNQAIVDFDSTSSILSSLIVsyNVGLAIGPLIVAPLSEMYGRLIPYHVTNVLFVLFTIGCALSPNLPALVIFRMLAGMEASAVMTIGGATVADLFIQEERGRAMAIWTFGPLMGPAVGPAVGGYLAEAKGWRWVFWVVAIGGGFITGMFFLIARETYPPVLLQRKVNrpLVLLFRSPIVFLFSVFIAVVFSYQFLLFVTIPSVFGEIYDFSLGQIGLSYLGIAAGLLLGNAIFGQASDRieFRLPLMIPGAFCIPMCFFIYGWATYYKLHWMMpaTSLLGIGLNLSLMTIQVYLVDTYTLYSASALAAATILRSLFGAFLPLAGPPLYDALGLGWGNSTLGFIAVALIPVPFLFIRYGEAIRT-
     250 UniRef50_C7D2V9        Efflux protein n=20 Tax=Ent...   214     5e-54  1  18.7%  5:383   11:452     ----RKKVILYTCCMSLFVVTMDVTVVNVALPSIQSDFHTNLSTLQWVTDGYTLMVASLLLLSGSTADRIGRKRVLQLGLACFGLASFLCGISQTPGQLIAFRMLQGIGGSMLNPVAMSIITQVFTEkeRAKAIGLWGSVTGISLGMGPIIGGLIVSYFSWRYVFFVNVPIIAAAIILTQKFVPESKVEKTAKNDFVGQALMILfnPRFFLSIPFTSASFLAIFGFifLNTLYLQEMRGFSPLEAGLSTIPLAFVSFLVAPRAGEMVGRIGTKRPIMLCGISMLAVSFLQLFVTKTTPMIILFIIYIFLGIGFGMLNSPITITAIEGMpsQSGTAAAIAVTCKQIGNSLGVALPSLllTRTPFTNVWLLFGCCAIAIIFLSYL-----------
     251 UniRef50_C6D475        Drug resistance transporter...   214     5e-54  1  26.0%  2:386    5:394     -KKSNFIRQALLLGLFSTLGPFTIDMYLPAFPEIVEQLGSSASLVQFSLTACLLGLGIGQLVMGSLSDVYGRRIPLLISMAFYVASSLACAFSPNIVLLILFRFIQGVAASAGIVISRAIVRDLYSGHELTKFFSLLLLVGNLGPLVAPVAGSGVLSVTSWIGVFIFLAVLGIYLLSVTKWSLKETLPVDRRSPsqLRNYGSLLRDRQFVGYMLAQGIMIAGVFAYVSGTPFIYQNIYGVSPTVFALLFGSNGVSLIIGSQIVGRLAHRVSERSLLLFGLCLALLASMIVVVVTlhGPLFTLVIPLFIFVASIGITSTAAFPLAMESQANQAGSAAALLGVVPFLLGAVVAPLVGIAGEDTAVPLGIIILITSIAAMLAYFLLVRR--------
     252 UniRef50_A1CT66        MFS transporter, putative n...   214     6e-54  1  13.2%  2:388   48:497     -SPVRKWLITAIVTFSVFAVTFTSSAYSVSANELIPDFDISTEVFIVGLSVFVLGFAIGPAVWGPlsELYGRQIFWLTSHIAMVAFIGGSAGSRNVATLHVLRFFGGTFGGSPLVNSGGAIADLFPPAQRGLAMTLYCVAPFLGPILGPVVGGFVSENIGWRWVQGVCCIFIGLLGIFGVIFVPETYGPVLlqRALIRPWVLLFREPIVLVASLYMAIIYGTVYMFMGAMPIVYNEERGWSEGIGGLAFMGIAVGIIVGLIYAIwkSATAESRLPPAIVGAVALPIGMFAFAWTTYRSIHWSviLSAPFGFGCVLVILPIVNYLIDAYTIYAASVLAAAAIFRSVVGAVFPLFTPQMYETLGIHWASSIPAFLTLVCMPFPFIMYRYG------
     253 UniRef50_D0KAF8        Drug resistance transporter...   214     6e-54  1  23.2%  4:386    9:397     ---SRSFVLIGILGILCAFDAMSIDMYLPAFPAIQQDIGADAAGMQTSLSVFLIGLALGQLVYGPLIDRYGRKGPLLLGIVLFSISSLLIAHASTLSWFVFFRLMQGLGGAAGLVIPRAIVADLYSERDAAKVFSLLMQVMAIAPIIAPPLGGVLLGTLGWSAIFWVLTFVGMLMLFATWRCVPESLPRRDRTrsALTGYAVLLRQKKFMGYTLSGSFVMGGLFTYIGASAFIFIEYFHLSPTTYSYIFASNALGMVLLGQINIFLLNRWREYQILPIGIALHVAGGVAlvLLAGITSLWIITGLIFLTMSFLSLVFGNGVAVAMNAAPGQTGSASSLLGVLQYVFGGVAGVIMGIVHDGTLLPPVMLLTVYAIGALLSWWYAWRQ--------
     254 UniRef50_Q5LBX2        Putative membrane protein n...   214     6e-54  1  13.3% 13:359    4:408     ------------IMIGTFMAVLDSTVVNTGLPVIMGTLGADINVAEWVLTGYMLSMASILPAAGWLSERFGYKKIYFLSLLVFTAGSFMCGSSSTIEELIFWRVIEGFGCGMLLPVGMAIVSDVFPPEQRGTALGFWSIASAASVSFGPAIGGYLVDYMDWNYIFYVNIPIGILALIVTAIVQKEHVKGTGVPFDIPGFITSAIFLPVfmWIAVVTFILfiGMFGSTFLIPLYLQDNLGYSALQAGMFFMPVGIIQGVASPLSGKLMQRINPKVFIVSGILLMALSFYMNYYLSFLTEKWYIILSLYLRGLGMGLLFTPLLTllVNIRNSDMAQASSITNIVRQMGGSFGVAIFSHLLT-----------------------------------
     255 UniRef50_A8U143        Permease of the major facil...   214     6e-54  1  24.7%  3:391    7:401     --HATRPGSIALLTFMVALNQMSMGLYLPSMPTMAGALGTSVGQVQLTLTVFIAGFAVSQLVWGPVTDRFGRRPALLVGLACFTAASVACAFAETIEQLIVYRFFQALGACAGQVVSRSIVRDTTEGAESAKVMSYIALAMSLSPAVTPSIGGQLHAFFGWRSNFVLLAAIGLILAAITVVRLPETTRraLHLVPMLRNYGSLLRDRRYVGYILMIGGMFGCLMAYQTGSPFVLMTELGWSPQAYGLLILFNVFGFLTGSLIAARIAPRFGIPRMVRLSSIVVLVSGFLLLalAGHLSTVAVIAPMMLFLFGMGIGIPSAMAGTLQGFPYIAGSASALMGFSQMGVGVLTSLAVSRIDGDHHLVMGAVFAASGLMCFLSQALVLPRPPAAR---
     256 UniRef50_Q21Z49        Drug resistance transporter...   214     7e-54  1  27.4%  1:394    8:407     LWRAPRWALAVLLAVLGMLGPFSIDTYIPAFSGIAQSLGATPVQMQQTLSAYLFGFAFMSLFHGAISDSVGRRPVVLWGLAAFTLASMGCALSQSIGQLVFFRAVQGLTTGAGIVVSRAVVRDMFAPAQAQKVMSQITIYFGVAPAIAPIIGGTLFVHLGWHSVFWFLTAVGVLLWVANYKLLPETLHLTQRQpnLLQGYWQLGLDPRFLLLALASGVPFNGMFLYVLSAPAFLGGILGLAPTQFFWFFVLTISGIMGGAWVSGRMAGKLAPKQQIKYGLLIMLLIAslVANWLFKAHVAWSLFPIAIFAFGWAMMVPVITLLVLDLHPERRGMASSLQAFIASSANGLVAGLIAPLVMHSAVSLAVASLSMMCVGLFAWLYLHRRWPDIGRVV
     257 UniRef50_A4A910        Drug resistance transporter...   213     8e-54  1  25.8%  7:390   32:419     ------KATLMFLAALVALGPLSVDMYLPAMPAMQQAFNTDIVHMHFTLSAYLWGFAVFHLACGPLADRFGRKPVLLGGTGLFVLASAGCALANSVEELTTYRFMQGVGACVGPTLARTITRDIFGPKGAARALSLIAMLMALAPAVAPGLGGLMLRYVEWPAVFVFLSVYGSIVMVIIGFRIPETlpQSLRPGNIAANYLVLLRDPVFLPIAAASALVYAGLMAYLACSGFVFIDMLGVPVEYFGFIFLSSVFGYMGGSAVSARLAVRYATSELLLLGGVIATVAVLSmlHLLAPTSILALILPMSFYSAALGLVLPQAMAMAMEHFPRIAATNSSLFGFLQMGLSAVITVAVGSVLVSSPLPMIITMAVTQVLALLLMVYGRAQSKKH----
     258 UniRef50_B2HY14        Permease of the major facil...   213     9e-54  1  24.3% 10:388   15:399     ---------IMLLALLTALGPLSIDMYLPALPQMAHDFGVSTQMVANTLPAYFFGLAIGQLVYGPLSDRIGRKKPLYFGLALYAVASLFCVLATNEWSLIAARILQALGGCVGVVMARAAIRDRLDVQGSAQAFSSMMIVMGLAPILAPMIGAWILIWFPWQAIFIALSIVGAICWLCVHFFFKETLAVDKRLkqVATLYGAIFKDASFRLPMFAGCLTGAALFCYISSAPAVFMDQYGLNQQEFAYVFGLNAFGIMLMSSLNKHLTTRVEITKRLKAGSMVQVTGavLIAGLISAAPLWLVMLGLFLAISGIGLTGPNAMALAMSKQGARAGTASAIMGSMQFACGLLGGVLLNFLIWSASLNMGVMMVLFTLSGFIVVLKAIRQAK------
     259 UniRef50_B8FSV1        Drug resistance transporter...   213     1e-53  1  18.9%  6:385   19:400     -----RKGLIAFIVLMNMFIPLSMDLYLPALPKMNEYFGSSAAITNLTLSLFFLFYAIAILVWGPLSDRYGRKPIIMVGSAIYIVSSIACALSTNITLLIISRACQGIGSGGITSASMAIIKDCFTGKSRETILAVTQAISGLAPMLAPIVGAWILYFTDWRGSFWLLAFISVINLVLTILylREEERYRGSLIGSWSRLAVVAGNKSFIIPTLIFALGSIHFMGYIAVSSYVYIDYFGLSEQMYSYFFAANAFISILGPAIYIRFFLNFNKKRLAVLCFGLSALSGILIMTL-GQLSPYIFLMGIVLMSLAGTVMRPFSTNILMEQQKGDAGSMSSILNMSFTLFGSLGMAIASISWGNIVAGLGALIAVGSGISILAWYAFMK---------
     260 UniRef50_A8KZV5        Drug resistance transporter...   213     1e-53  1  20.0%  2:386  278:737     -RRVPAWAVLAVCCFAQFMVVLDVSIVNVALPSMQTELGLSSSGLQWVVNSYTLAFAGLLLFGGRAADLFGRRRVFITGLTLFTAASLAGGLANDQTMLIVARAVQGLGGAVLAPATLSMLMTSFppRERARALGMWGATAAGGGAMGALAGGVLTEIADWRWVLFVNVPIGLVLIVGARAALIESRGQARGVRDlvRTESSSWGSPVTIAWLAGAVVLLAamFGLFFFLTLYLQQVKGQGPLEAGLALVPMPIMIIVGSQVSSRTVGRFGPRPLIIGASVIVASSVGWLSALSAHGSYWavFGPLALLGFGMGINMVAVTTAATavPPQLAGLASGLLNTARQIGAAVGLAVLAIIAdtSGYSLGFLVCAALMLGAAVLAVFMPR--------
     261 UniRef50_A7HNZ9        Drug resistance transporter...   213     1e-53  1  26.1%  8:386    9:392     -------AFTVFLASLTAVGPLSTDMYLPSLPAIGEDFNADAGTVQLTLSTHLIAFAGSQLFYGPLSDRYGRRPVLLGGFLLFMAGCFASLFVTSIEQLILARLLQAVGGGASVVLARAIVRDLFEGPEAGQMLAKMAAIMGLVPALAPMLGGVVQDLYGWKANFIAMGAFGAVLALMVAVNLDETLPRDRrpLSILRSYRRLLADRHFLKYLAIATVAFCGLFAFVSGSSFVLQGLYGYSPIAYGLCFGAMAGGFVAGSLAGGRLVRRRGIDGTLRFGGFCAALGGLLMLSGLFLtsAMAIVLPVVIYGFSMGVTMPQAMAGALTPFPDIAGTASSLLGFLQSFAGALAGLYVGYGAEASALPMAGTIAAGGVLSFVIAMSGRRK--------
     262 UniRef50_B3PG88        Drug resistance transporter...   212     1e-53  1  23.9%  1:394    1:395     MTKESHPWLIVLLAAIIATTPLAVDMYLPAMPVIAGDLNAHIGSVQQSLSIFLAAYAAGMLLFGPLADMIGRRPLALFGLGGFTLSSVALAFSSQIDQFLLLRVIQAFCGAAATVVAPGVVRYLYQ-EHTAKGMSYISMMMMLAPLLAPGVGSLVLWVSDWRSIFWLLAVYGLLIWVLIWRYLPepRAENQPKPNLLSGYRTVFGHSGARPLIVSMMFGSFAFFCFITAVPFVYIQYFGASEQQFSLLFGFNVVMLMLANWVNSRWVIRVGSLTMLRAGLVLATVSALVLAGvlAELNLWFTVFSVAPLMMGLTLIGTNTDALVLMQFPHNTGTATAVNGTLRFGSGAFAGPLLAWFYNGTALPFALLMLTGVLGVMLCQIYYGYLHRKPRHIV
     263 UniRef50_A8PMU8        Putative transporter n=1 Ta...   212     1e-53  1  19.7%  5:360    9:417     ----RKWWILLAMSTSLSLIFIDQTALVVALPAIQRELNLTSSLTQWVINAYLLTLSTFILLGGKIGDRWGHKRAFLLGVIVFLMGSVGCALSHSSSWLILLRGLQGIGGALMMPSTNALITNAFPDKERGRALGMYVALAAIFLALGPLLGGFLTQFFDWRAVFWINVPIALISIILAFASVPGWTRTEKLNIDWLGFFiwGWTSPSIVGLLFFSFISLGVFIVwfVFWSLFLQNILHYTPLKAGLFLLPAMLPLIFMAPIGGHLRDRYGPKKPMSWGALLVILSLIWIGIFSHHQRYVLLLPGFLGFGIGMPLILSGIMATAMTIVgqQRGIASALLNGARQLGTSMGLAVLAGLLSS----------------------------------
     264 UniRef50_Q26IA3        Drug resistance transporter...   212     1e-53  1  20.8%  1:389   11:405     VSKGRKTSVILVLGTLIAIGPFSIDAYLPAFKQIAGDFKVETSAIGFTLTTYFIGIGLGQLAYGPLMDRYGRRRPLIAGLILYITTSVLSAYAWDVSSLATLRFFTALGACAGMVASKAIVRDLFDDDKVAEVLSTLMLIMGIAPIIAPTIGGFIIEHYHWDMIFYGLAGFAALMLFNVIFILPESSKPNphPVPVLKEYWTIYKDKAFFLFSTARGFVIGALLGYVAAAPFIFLDFFNMAQSDFAIIFGSNAAGLIAGSQINRFLLRRFTTFQITYTISILLVVTTLLLVgsFFEPEFWVVYPLLFLMMTFIGFQNPNVTALALQPFTVRAGSASAFVGAVSMIFGSFASWYVSRYVTVSVLPLALMLAGCALLGYAAIETFRIKYAR-----
     265 UniRef50_UPI0001788C5E drug resistance transporter...   212     1e-53  1  19.5%  1:364    4:422     LRQDKRSYILVGILLSTFMAAIEGTVVGPAGPAIISSFG-SVSLMSWIFTAYLLTMAVTTPIFGKISDLYGRKPVFLYGSLIFLVGSLLCGLSQNMTQLIIFRAIQGIGAGAVIPVTFTIVGDIYNLEERGKIQGMISSVWGISSLIGPLLGGYFVDYLSWHWIFVFNVPFGLLSIWLIFRYFKEERNAREVSIDYGGAALFTvwNSPFMLGLMIGSVVLLAAfgLTTYLPLWIQGVRGGNATLSGLTLAPMSIGWLIGSIISGRLIVKSGSRKTALIGVVLLIIGAVGLAFMHKDTALGVLLVFTFIYGVGFGYISTLFQIIAQSSVgeVRGASTALNSFIRTFGQTVGVAVFGLWVNAGIAG------------------------------
     266 UniRef50_A1CLK7        MFS transporter, putative n...   212     1e-53  1  15.0%  6:385   65:444     -----KWKNTWAVSLFVFISPVSSAMIAPAMQDLAETLGmtQIEVYLSMAIFILAYAIGPTFFGPASELYGRVRILQVSNVWYLAWNLGCGFAQTKAQLFAFRFLAGIGGSAPLAIGGVAVSDMWSAEERGKAMGVYTLGPLLGPVVGPIAGGFIAQYSTWRWVSWSTSAAAVAVQIVGFIWL----------------LLLFLTQPIVFCMATYMAYLFGITYLMFATFPEIWTVVYRESSGIGGLNYLSIAIGSFIGLVFNLKLVDRieFRMPSLAVGSVISTIGLFWYGWSIGNTHWVMpiGALIFTMGTISCLQGMQTYIVDSYQTYGASAMAACAILHSLTGFGFPLFAPYMYEALGYGWGTSMLAFITMGIGWVAPFAF---------
     267 UniRef50_P54585        Uncharacterized MFS-type tr...   212     2e-53  1  14.0%  4:360   10:420     ---KNPMSLLIVLMAGLFLAILNQTLLNVAMPHLMTEFGVSATTIQWLTTGYMLVNGVLIPLSAFLITRFGQRSLFLVAMFCFTLGTLVCGIAPNFSTMLIGRLIQAVGGGILQPLVMTTILLIFPPESRGKGMGIFGLAMMFAPAVGPTLSGWIIEHYTWRIMFYGLVPIGAIVIIVAFFIFKNMVEPQKIKLDTLGAILSiwTDPIVLSTVIIGAIAIVAfyTGMFLLPIYLQNLVGFTALQSGLLLLPGAIVMLIMSPISGILFDKFGPRPLAIIGLLVTVVTTYQYTQLTIDTPYTHIMLIYSIRAFGMSLLMMPVMTAGMNQLPARLNsgTAMSNTLRQISGSIGTSLITTIYTN----------------------------------
     268 UniRef50_Q1IRM2        Drug resistance transporter...   212     2e-53  1  16.9%  2:362   12:430     -SATSPWLIAIAVMLATFMEVLDTSIASVALPHIAGSLSATNDEATWVLTSYLVANAIILPASTWFALRFGRKRFLIICIAIFTVSSFACGAATSLWMILAARAIQGAGGGALQPLSQAILLESFPPQKRGLAMAVFALGVVVAPVLGPTFGGWLTDTYSWRWAFYINIPIGILAVFMILRYVVDPpaKPGRIDAIGLGLLAVwwLRWATLVLLVTFIAfaVIYGMVTLLPLFYQELMGYTALNAGIAVSPRGVGAIVAMPIIGILTSRIDNRWLIAFGFALFGICSIWFGEVYLGIGPWTFIWAIILSGFASGCVFVPLSTTTMAGLreEIGNASGLYNLLRNIGGSIGISIVNMIVARHS--------------------------------
     269 UniRef50_B2HKA0        Integral membrane transport...   212     2e-53  1  17.7%  2:379   16:447     -RPGHQGLVLAVTCLALGTVVAAMASLNVALPDIARQTHADQTQQAWIVDAYSLVFASLLLPAGAVGDRYGRRLALLVGLVVFGAGSGVATLTTDPTALAGLRALLGVGAALIMPATLSTITSSFPAQRRAAAVSIWTAVAGASGVVGLLASGLLLQWWSWQSIFWLNVLLAAVALTGTLLFVPESAERDPAPLDVVGAVlrLFTNRRFAAGSLSITLQFFALFGFLFVIMQYLQSVRHYSALTAALGLLAMPIGMIPSSRLSPYLTERFGIRLPWVAGLLIVAEGLMVLAHLDSADPYWHIASGLIPLGAGLGLAMPPATTAITGALPSrqNVGSAVNDLARELGGALGIAVLGSLLTATYRNHLPTAGAVSAFCTGL---------------
     270 UniRef50_A6GTB8        Major facilitator superfami...   212     3e-53  1  22.4%  6:385   24:411     -----KRPMFFLLAALAAFAPLAIDLYLPSLAAIGAELQAPAGRVQQTVTVFLAGFALGMLFYGPLSDRFGRRRMIFAGTTVFVLASVACMLAQTIEQLLVFRLIQAFGGGAAAVISRAVIRDLFGETDSARVMAMVAMVTSLAPMIAPLLGAYILELGSWRYEFLALALFGALCTVAAYALLPETLSKVRSQSSlfRGYRTVWEQRDARLLIIAGGAHFAAMFAYITGTPFVYIEFFGLSEKTYAVLFGSNILTLIGFGYASTRLVKRTGTTPLVKTGSALGLLGALmwSAGTASWNLGLMVAGFLLCVGSLGFVAPNTTAQLLGKHPKNAGAASALYGCAQFGLGGLASWAVSVVHDDTSLPMAATVVAFAALACWASIRLKR---------
     271 UniRef50_C6PTT6        Drug resistance transporter...   212     3e-53  1  15.5%  1:361   13:427     LSKSKRKLAVAAVALGTFMSALDSSVVNIALPNISAHFNTNLSTIEWVVMSYLLIISSLLITYGRMGDMYGHKKVYVRGFIIFTLGSFLCGISPNIIILIISRIIQAVGAGMLMSMSSAIITNITPPKERGKSLGIIAVSVSIALATGPVIGGILTSLLGWESIFYINIPIGIFGCFFAEKVIPKSTIIDKQPFDIKGSvlTMFKNKLFSMSNLSALLSFIAQFSVVLIMPFYLQQLRGLPPSKAGFLMIPMPLTTMFIAPISGAVSDRIDSRYISALGMAIASFGIYLLSNLKIGSSHSYIAMSLMITGLGTGLFQTPNNSAIMGSVanRRGIASSILATMRNIGMVLGIAISGAIFSTH---------------------------------
     272 UniRef50_C6XPG3        Drug resistance transporter...   211     3e-53  1  22.6%  1:385   22:413     MKHLPVWELICIIAGLMALNATAVDIMLPALSDIQNTFQfdDNNRQKMVIVYLMGMGLSQIFYGPLIDRFGRKPILVVSLIVYIIASVACLVAPDYQMLIFARAVQGAAAGATRVVAAAVVRDCYTGRAMAEIMSIVMLIFMAAPILAPSLggILFFFGDWRAIFWALVVLGSVMMIWSYVRLPETLAPEDRRptIARSYYTVFTNRYAMGYSIASALIFGTLFGYISASEQIYVEAFNKGAS-FPLWFAGVSAGMAVSNLLNSRLVRNLGMRFLSHWALIIMIliLHAIVSHSGNESFVVFYVLMIISFVCIGFIGPNFSSTAMEPLGHIAGSASALYGFATTFLAAAIGGFVADQYDGTLGPLFAVNAICLILALVVILWTER---------
     273 UniRef50_A4J1P8        Drug resistance transporter...   211     3e-53  1  15.1% 11:380    1:425     ----------MILVIGAFMAILDSSIVNVALPRFMTLFGSSADEIQWILTGYMLTSGVVVPITGYLGDRFGNKRMYIWSVAAFTIGSLLCGLAWSTNSLTIFRVIQAIGGGMIIPISMAMIYRIIPRQKIGMALGIWGIAAIMAPAIGPTLGGYLVDHFSWQWIFTINIPIGIAAIMLSIAYLEETPIQKNLKPDIPGILlrLLNNPVLSASLLATCIATIGLFSAVFLIPIYAQNLLGYTPMETGLMMMPMALVTGFMMPISGKLFDKFGAFWLGIVGMSIVVGVTYYLHTLGLDTSYHHIQIILSIRAVGLGLATMPLTTAGMNTVPrlVGRASALNNTVRQISGSMGIAYLTymLQRQAYHTAILTEGVSISSMAAV--------------
     274 UniRef50_D2S5D9        Major facilitator superfami...   211     3e-53  1  21.5%  3:364   23:438     --RSERGPVLGAVMLSTALIALDSTIIATAVPAVVDDLG-GFSQFPWLFSVYLLTQAVTVPVYGKLADVYGRKPVLLFGIAVFVAASLFCGLAWSMPALIVGRALQGIGAGAVQAIGMTVIGDIYTVEERAKVQGYLASVWGVSSVLGPTLGGVFSDYLSWRWIFLVNLPLGAVALVVLYRRFSERVERREHRLDVAGAVLlwAWTSGVSVAVLVTAVALLAAFTVvsYLPTWAQGVLGASALEAGFALAALTLGWPIAASQAGRLYLRIGFRNTALIGVVLAVLGTTGTALLGLHAQLWQVAASMFVTGIGLGLSSSPLIVAVQSVVgnRRGVVTATNMFARSIGSAVGAAVFGAIANTTLAG------------------------------
     275 UniRef50_D2NPF3        Permease of the major facil...   211     3e-53  1  21.6%  8:386   15:398     -------LFIVVLALLTAIAPLATDMYLAALPAVAENLNTTSTNASLTLSGFMVGMALGQLVVGPLSDKTGRRKPLLIGAVICFIATVACGFAPNIELLIFARFMMGFTGSIGAVLARSIVADTTEGLATAKLMGVMMMINGFAPVLAPLFGGWVLSWGSWRDIFHVLGVVTAIMMLGVVFVVKETLPVEEraLSVYSELPKVFKIRRYLGFMLTMCFAFGALFSYISGSTFVLQKILGMSETEFTVVFGVNSIGIVLFSAIATKLVGRVAQRRIVNVGVVSLLVVSSLLVVSFLVgsLVPTLILLFLLTSSCGLIFGNASALALNEARHMAGSASAVMGTVQAMLGALAAPLVSFAGEHEYLPMGFSILGFAVLTALVLWTTPRK--------
     276 UniRef50_Q6BVR7        DEHA2C00506p n=1 Tax=Debary...   211     4e-53  1  14.6%  2:392   37:476     -SKRKRFGCTVMLAFISFLVTLASSIGSGTYESIMEDFKVTKEVAGMTTSLFLVGFAMGAPVLAPLCEEFGRLPIYIVSMFVFSCFQVGAATSKNMASLGICRFFAGFFGTTPLSNAGGSIADMWQPDKRTLAFPFFGVSGFLGPCLGPVIGSYLtsYLGWRWTNYMVAILAFAFSLACFFFMPETykSPFSLSVFMRPFLFAVGEPIVTCFTICISITYIVLFSDFESFPIIFAT-WGFSTAKSSLPFIAVTIGifIVAPIAYIIYMkpESRLIPLMFCCWLIPISLLWISWTTYdsPWSSIVSTFFFGVGMMQVFLTTYSYIIDAYGVNSASALSSLTLVRYNVSAAMIHITDPMYNNLGIHWAASLLAFLSLIICAVPFVFYVFGPKIR--
     277 UniRef50_C7QBP0        Drug resistance transporter...   211     4e-53  1  17.9%  3:360    7:427     --QRRRWAILGVLVFSLLVVVLDNTILNVALKIISqgLGASQSDLEWAINSYTLVFAGLLFTFGIVGDRFGRKKILMAGMVGFGIASVLCAYAGSPGALIATRAVMGFFGAAIMPATLAIIANVFEPKEQPKAIGIWAGGVGLGVAIGPVLGGLLLDHFWWGSVFLINVPIIVVALIAMAILVPDSKNPKPGKLDPLGVFLSmwGNPQIWGSLAAggLSFFAMMGVLFFLSFYLQSVLNYSPLKAGLFLTPFALAQLIFSPLSARLVQRFGARAVSTFGMVVIGVTFLMYQFVNQTSAAWLLLLIFFLQGMGMANVMPPATTTIMTSLPReaGVGSSVSNTVRQVGGALGVAVLGTLLTT----------------------------------
     278 UniRef50_A5ABT3        Contig An11c0340, complete ...   211     4e-53  1  19.0%  5:357   57:455     ----KKWATIIPMSLFTLLTSMSSAIMAPALNNIQQDLHFSSSTMgiSLSVYLLGVAIVPLFTAPLSEVFGRMIVLQVTDMFFIIFNTLCGIAKTPNQLIGFRFLAGLGGAGANTMGAGLTTDLFESDKRGSALSLYLLAPSIGMTVSPIAGGFLVQYTTWPWCFYLVSLVAGAVQIFGLPFFRETYapHLLRLSLIRPIKLLATQPVVQVWSVYCAYIYGILYLLISSFPNVWTGIYGESVSIGSLNYISLFLGMTFASQVGMRLANRSYrrLPALMIGAVIIPIGLLWYGWSARPNVHWIMpgAAIYGAGVLHEIQCIVGYIMDTYPKYAASAVAAVMCIRSLLSFALPLAAPRL-------------------------------------
     279 UniRef50_C3Q2R4        Molybdopterin biosynthesis ...   211     4e-53  1  21.3%  5:379    7:379     ----SKLYILVVIGIVSAFGPFVTDFYLPALPVLAGYFDTTASLIQLSLTFSMVGLAVGQLVIGPLSDKYGRKKTLMASLVLFCISTIGCLYASDIYVFIFFRLLQGLSGAGGVVISKSIATDLYEGRELTRFFSMLSSVQGIAPVCAPVLGGVLLEVTDWKGIFWILVLIGILLIMALAFF-KESLNNEQQhfATFRNYIPVFQNAQFMRYVLVQAFAMGVMFTYIAASPFIFQEHFNMSPLAYSLCFGANAIAIMLGSLTVSLFHDATDALRVGSIGFGIM--SLFVAAALFFSTSVWPVEVSLFVFMLFLGVILPSSTTLALDLERKNSGNASALLGFLMFLFGGVLSPLTG--LGNMLYTTGIIIVACCIGTWFC---------------
     280 UniRef50_UPI0001C424B6 drug resistance transporter...   211     4e-53  1  14.8%  2:360    4:421     -RKTKRPIVLTAVILAMFMAAVEATIVATAMPQIVADLG-GFSLFSWVFSSYLLMQVVMIPVYGKLSDMYGRKIIFAIGISIFLIGSILCGFSATMEMLIISRFIQGLGAGAVQPIATTIVGDMYTKEERANIQGYLASVWGISAIMGPVLGAVFIEYLHWAWIFWVNIPFGIIALIGVTLFLheSMKKNRQSIDYKGALLLLLAITPFMLVliASFTAGAILLAVSTFLPTYVQGVMNQPPIIAGLALTAISIGWPISSTIAGKMMLKKGFRTTALIGGCALVTGGLFYMLLPVINHPLWAGAGSFVIGVGMGFSTTTFIVSIQSSVdnVRGEATSMNMFMRLLGGAVGVAFLGGLLNR----------------------------------
     281 UniRef50_C5D2D1        Drug resistance transporter...   211     4e-53  1  14.3%  5:360   70:479     ----SRAKVVATIMLGAFVAILNQTLINVALPHMMNDFNVETSTIQWLVTGYMLVNGVLIPISPFLIAKFPTKKLFLSGMLFFAIGAFICSVSPSFAIVLIGRLIQAIGAGIIMQLMMVIMLNIFPPEKRGVAMGTVGIAMMFAPAVGPTLSGWIVEHYSWRLLFYVVLPIAIIDIVLAFLWLKDTSRTGNPPLDLRGAifRVFKYNVFTLSTIIGCVINMAMFAAMVLLPVYLQNLRGFTPLDAGLLLLPGAIVMAIMSPISGWIFDRIGARMLAIVGLVITVVTTWEFSKLTMDTPYSHILALYIFRMFGMSMLGMPIMTEGLNALPRHlsHGTAMANTLRQVAASLGTAFLVTVMSN----------------------------------
     282 UniRef50_C4L8C2        Drug resistance transporter...   211     5e-53  1  24.7%  8:380   23:397     -------WLMSILGALMAFTSLSTDIYLPAMPQMASEL---QGNVELTVTGFLLGFMVAQLIWGPISDHLGRRIPLFIGMVLFVIGSIGCAGSQSLEQIVFWRVFQALGACTGPMLARAMIRDLFSRTEGARMLSTLVIIMAIAPIAGPVLGGQIIKFSTWHSIFWLLAIIGSLMFV-SLFWLPETLAAEKRVksVFTNYQRLLKNGAFMKYTLCVTLYYVGAYAFITGSPAVYISYFGIDAQYYGWLFAVNIVGVMTVSFINRSLVRHISLQRLLRVSSLVAAVAMIIMALSvnVGGLYIILVMVFIYFSMNGVIAASSTAAALDEVPEIAGSASALIGALQYGSGIISSLLLAYFGNDTPWTMTWIMMLFTCGSALVV--------------
     283 UniRef50_P28246        Bicyclomycin resistance pro...   211     5e-53  1  20.4%  2:389    4:396     -RQHSSFAIVFILGLLAMLMPLSIDMYLPALPVISAQFGVPAGSTQMTLSTYILGFALGQLIYGPMADSFGRKPVVLGGTLVFAAAAVACALANTIDQLIVMRFFHGLAAAAASVVINALMRDIYPKEEFSRMMSFVMLVTTIAPLMAPIVGGWVLVWLSWHYIFWILALAAILASAMIFFLIKETLPPERRqrTTIGNFAALFRHKRVLSYMLASGFSFAGMFSFLSAGPFVYIEINHVAPENFGYYFALNIVFLFVMTIFNSRFVRRIGALNMFRSGLWIQFIMAAWMViaLLGLGFWSLVVGVAAFVGCVSMVSSNAMAVILDEFPHMAGTASSLAGTFRFGIGAIVGALLSLATFNSAWPMIWSIAFCATSSILFCLYASRPKKR-----
     284 UniRef50_B4ETY4        MFS-family transporter n=3 ...   211     5e-53  1  18.4%  1:358    1:413     MSYTKRLSLICAICLGTFMATLDISIVNVALPTIQNDINANMATLQWIVDAYALCLSACILSSGPLSDRFGRKKVWLWGVIIFTLGSLICAIAQQHEILILGRIIQGIAAAALIPGALSLITHAFPVdeRIRIIGIWSSVSALSLIIGPILGGALVHASGWASIFLINIPIGAITVLLGWYGLSESADPEDVALDPLGQllSLFKDRSFFQYNLSSFTLGFATYSNVFFIAFFLQKAQGWSALETGLRMAPEFIAMALFSMLFGRFSRYISVRKLMIFGFLLIAISSCLLATLATNSSYTITGSYLFILGAGMGLATPAIGVLVmsVAPSRSGMASATMNALRQTGMTMGIALLGTLM------------------------------------
     285 UniRef50_Q2RJ64        Drug resistance transporter...   210     6e-53  1  20.1%  3:360   11:422     --NPRRWLILFAVMAAGIMGPIDGSVVNVALPTIGRVFNVDLNTVGWVSMAYLLVLGSLILTYGRLGDMYGFRRVLLTGIVIFTIASGICALAPNIWVLIVFRAVQAIGAGMFMAMGPAIITSVFPPYERGRALGTNGMIIAVGLALGPTLGGFLVTVAGWEAIFTINIPIGIISYIMCRQVVPESRDLKPQQFDLIGAalTLFHNKVFSAANFAALMNFMSQYALIFLLPFYLQQILNYTAGHTGLILTASPLVVLMLAPVSGALSDRLGTRWLAFTGQAIVSLALFLMVGLKVTSRAFDIIWRLCLFGLGTGIFQSPNNSAVMGSVPRHrgIGSGVLATVRNVGMVLGIAVSSGVFTW----------------------------------
     286 UniRef50_Q133Y5        Drug resistance transporter...   210     7e-53  1  26.8% 19:388   49:423     ------------------AAPIALYIFVPALPILASDLGSDISVAQMTVSLYMVGLACSQLIMGPLSDRFGRRPVLLGGLMLMVAASIGCIFAQTLPQLIAARFLQALGGASGMVISRAIIRDLYSRDRVGGMISLVIAVMMIAQMLSPLFGGVIETALGWRAIFYVVTAGAIIVTVAIALALPETRRRGGppGGFRGDVGSLFRSRTFVGYVLCQVLASAIIFTFAGGGPYVVVTQMGRSSAEYGAWFASSGFAYLIGNLFCVRFSPRYSLDRLIWFGLALQIGGAllWGMLGYNQVPSWLFITHMVIMFGNASVMANAAAAAISVRPQAAGTASGLMGFTQMGFGALCSQFGAWLGGHFATPLPLNIAVMGLAIACASAMIFLVPR------
     287 UniRef50_C9W392        Putative sisomicin exporter...   210     8e-53  1  17.8%  2:384   31:485     -SLRERQLALIVLCVGILISVIDGSAVYVALPSIQEGLGFSQANLAWVVNAYLIPFGGLLLLAGRLGDLIGTKRVFLSGLSVFTVASMVCGLATDQAVLVGARFVQGVGGALTTAVVLSMVVNMFppREQARALGLYAFVAASGSAIGQLAGAALTASLSWHWIFFVNAPIGLVTILMGARLLDNVRDAKAGKGIDWIGAVAllRARNVAWSNVVLALMIAGPTAMFFLCALYLQNVLGFSVYELGFAFVPAALAIGIGSlvAPRLIRKNDAKVLLVPAMALMALGLLLLARIPADGSYWvvLPAILLIGIGSGLATPPVLRIALADAtdDSGIRSGLLNTTQQIGSALGLAVLAPVAANvgFQMAFLVGFGTMVAAIVLAIFA----------
     288 UniRef50_Q5FSN5        Putative drug transport tra...   210     8e-53  1  22.3%  6:382   15:408     -----PAWLPVLLGIFTAVGPVSTDVYLPALPEMERQLHTAAGSGSATMAAWVIGLAIGQITIGPISDRFGRRWPLLLGMLGYTLGEIGCALAPSMTFLCICRVFSAIMASAGLVVPNACIRDLTEGDASSKMMSRLIVIQGTVPILAPMLGGFALKFVDWRVIFWVTAVYGGICTLLLMTIFPETLAPHDRriSIIERYVYILRTRSFVTNGLVWSFLGFVTFTYLTAAPMLFEDVFGMSPFHYGMLFGLFAICMIGASAINGQLVGRVSTGRMLFSALGVSLAGCAILLLLAVVSNywPLIIALIITMGPTGIIGPNSMVGVLSEQSDRAGSASALAGTMQYLFGAVASALFGLMPSGTAVPMALFLSFAFVAAMGFALL------------
     289 UniRef50_C5FMU7        Caffeine resistance protein...   210     9e-53  1  13.1%  4:392   39:444     ---SRKWVTITLVSVNTFNVSIAASIFAPGIPQVLRDFHSTNSELsfMVSVYIVGFVIGPLVFSPTSEIYGRLPITHASNICFVIATVLCAVSVNMTMLIVFRLLMGLSGCVPVTLGGGIIADLMPVEKRGTSLTIW--------AIGPLLAG--------------------IATIACWFFMEETYSPTILqtSIARPSKMLIQSPIVLILSLYLAVVYSYLYLLLTTFPKIFEDLYGFNSGEAGLVYLGLGVGFCIGQFSVGPVSDWyeDRLPPLILGSFLVPIGLFWYGWSANAQSHWIVPIIGTTFLALGmmFLPIQIYLIDTFTIYAASAIAANTVVRSLFGAVIPLAGNALYMQLGLGWGNSLLAFIAIAFVPFSIFLVKFGARIR--
     290 UniRef50_B8LTV7        Bicyclomycin resistance pro...   210     9e-53  1  15.9%  2:392   59:496     -STPKKIYHVLVPTIFAFVVSLGTSIISPAIDSMADALHASSEVALLSFSSYVLGLAFGPLLGSPMSEAFGRRAVYLLSIPISLLFTLGVGFAQNIETVIITRFFAGAFGGPVLAIGAGTNADLFIQEQRSTMTAVFSLAPFCATGIGPVIGAYVNAYKDWRWVEW-TLIFFLVASYFFALFEEETYKKTILQRrlLKPIHMLFTEPIVTSFSVYISFNFSVLFSFLAAVPLVFRNVYGFTPEHQNLTFIGIFFGCVLALPtsGAIAIAPEHRLYGAMLGSIGLPVGIFWFAWSSRSDIHWIVPIIALVPFAWglVFISAVLYTVDVYQanGASAVAANGLLRYIMAAAFPLFTIQMYEGLGHEWASSLLGFATLALLPVPWALYRWGPMIR--
     291 UniRef50_B6GXV0        Pc12g00670 protein n=7 Tax=...   209     1e-52  1  15.9%  2:392   36:489     -TPTQKRLIILTAALASSFSPLSANIYYPALNSIAKDLRVSPSQINLTITTYMICQGLAPMLTGSLADQAGRRPAYILCFAIYIFGNIALALQHSFPALLALRAVQSCGSSGTVALASAVAADIITSAERGIYMGFTSLGNILAPSIGPILGGVLSKYLGWEAIFWFLAIAAGTFFVPLLLFFPEtvPKRRVNVPNPCSTLRLLFQRPVGLVLLANGVVFSSYYAVTAGIPALFQRIYDLDDLGIGLCFIPAGLGSLLSATANGVLVDWNYrrLQIGLPMTVLAAASIVVYGVLIPLKPPLLVALMVVfcFCITAAYNVMNILIVDLYYETPATAMAANNLVRCFLGAGAAAMVNPLIRQIDVQWTYCSVSGAIALVTPLISMVYAQGWEWR--
     292 UniRef50_A6VW64        Drug resistance transporter...   209     1e-52  1  23.3%  8:393    6:397     -------PIILVLGLLSGLTPLAIDAYLPSIPTISKSLNTDIGLIQMTLSIYLLVFAFLQILFGPISDAIGRRKVVVGGLTVFAIGSFVCALTQSYELLMIGRAIQALGGAAVAVCVPALVKDGMSINQFAKAMSMIMLVMSLAPLAAPIIGGAILTILNWHYIFVMLGILAIIAIALFLRTIPETLPVEKRTpnAIRNYITLLKNRSVMGYIAASAFYFAGMMSFITGCSFVYIEIYNVDPANFGFLVGLNVISMMLASTINGRYVEKLGTEALsaIYIPLIASILMIVLSFFSHPPLWLIIISSMLFIGPMGILGGGFMAGALKYAGNNNGSVTALAGTSRFAFGALGGVVISILHNGTFVPMLGTIAACGIIAFVCFKVTVRYAEPTTEH-
     293 UniRef50_Q02B98        Drug resistance transporter...   209     1e-52  1  17.8%  8:360   29:428     -------WILAATILGSSMAFIDGTVVNVALPALQSALRATLADVQWVVESYALFLAALLLTGGSLGDRYGRRKIFVIGVVLFSIASAWCGMAPNIRQLVLARAVQGIGGALLVPGSLALISANFYQAERGRAIGTWSGFTSITAAIGPVLGGWLTEHGSWRWVFFINLPLGIAVVALSLTKVPESRSGTESRRFDWQGglRLFGSRDFSGANLLTLFLYAALSGVLFFFPLNLIQVQGYTPTQAGAALLPFILLMFLLSRWSGGLLDRYGAKLPLVVGPIIAATGFALFARPGIGGSYwtFFPAVLTLGFGMAVSVAPLTTTVMNAVDeyAGAASGINNSVSRVAGLLAVAVFGALLSG----------------------------------
     294 UniRef50_Q2H3G7        Putative uncharacterized pr...   209     1e-52  1  19.6%  2:363   50:472     -TPVQLALILVALCLAVFLAAIDSVIITPAMPTITKELNASDAGFAWIGSAYLLALSATSPFWSKVSDIFGRKPILIVANVIYLIGSLVAALSNSLVMLIAARAVQGTGGGGLITLVEISVGDMFSQRERGLFYGIYGAVWAVSTAIGPVIGGVFTERATWRWCFWFNLPFDALSLIITIIFLHTHNPKTPLVKGLigGVSHPWGSAFVICLILFGVVAyaGFIAPIFFLPLYFQVALGATPIQSGVWMLAIAISFTLSGIIMGIVIQRTGHYLWIIRgmALFTLAVGLMVTFGPTRDWPRIIIFQILLAAGIGANMQTLVIAIQavAPEDIGVATGTLNFVRNIATAISVVLGQVIFQSMLA-------------------------------
     295 UniRef50_Q7MLK0        Permease n=69 Tax=Gammaprot...   209     1e-52  1  26.6%  8:386   40:423     -------FLFAVLGAIGALTPLAIDMYLPAMPTIARDLGVDAGAVQFTLTAYTAGFALGQLIHGPLADSFGRRPVLLLGVLFFGLAAVVSATTNGIDALTYVRTAQGFAGAAAAVIIQAVVRDMFDREDFARAMSFVTLVITIAPLVAPMIGGHLAIWFGWRSIFWVLAFFAVIVIALVWWQIPETLKVENRQptTMRNYLKLCCNKTAMGLILSGAFSFSGMFAFLTAGSFVYIDIYGISPDQFGYLFGLNIVAMIIMTSLNGRMVKKVGSHFMLRLGLTvlIAGLGLFVSWLLDLGLWGTVPFVVLFIGTLSTIGSNAMALLLSGYPNMAGTASSLAGTLRFGTGSLVGALVAILPSGVTWPMVLVMSACSVLSALFYWIFGRK--------
     296 UniRef50_A9WJU2        Drug resistance transporter...   209     1e-52  1  20.4%  1:373   25:452     LDQRSKVLILIGVLLGLFLSALDQTIVSTALPRIVADLQ-GIELIGWVSTSYLLASTAMVPIYGKLSDIYGRKYVLLFGIVVFLLGSLLCGLAADMTQLVVFRGLQGFGAAALTSTAFAIPADLFAPAERARYMGLFGAVFGLSSVVGPFIGGLLTDNLSWHWVFFVNLPLGVIALGFIVAKLPRLHSGLMPAIDYAGAATLLLTVIPFLLAllSMFAVSAvlFAAIFFLSLYLVNVLGVSATAAGTTLIPLTLSLVVGAMVSSQIVQRTgyKWVIIVGMAIIVGSLWWLTTLTPDTSIWMVRLRMIALGLGLGPSMPILNLAMQNAVPrdLGAATASRQFFQQIGQVVGSAVFGALLTGVLTTSLSTSLAPI---------------------
     297 UniRef50_Q3AEJ0        Drug resistance transporter...   209     2e-52  1  15.2%  6:360    4:412     -----RWRVMWVVALGTFMAPLDASVVNIALLSIIKDFKASLATGEWVILIYLLFISTLLLTYGRLGDLYGKKLVYVTGFVVFTVGSLLCGLSPTLGFLIGARVIQSLGAGMMMAMAPAIVTEVFPSQERGKALGINGMMVAAALAFGPSAGGFLTHFFGWRSVFFINLPIGLIGSILAFKIIKNDFTREKHSFDFLGAflGLFKNRDFSFSNLSAFLSYVALYQVVFLMPIYLQQLRHFTPEKAGMVMSVHPLLTMIVAPLSGSLSDKIGSKVLAPLGMTVMALGLFALSRLNSETTVGIIILSLMLIGLGSAIFQSPNNSTIMGSVPKNrgTASGFLATMRNVGMVMGVAVAGAVFTG----------------------------------
     298 UniRef50_Q6US34        LacCD (Fragment) n=5 Tax=Cl...   209     2e-52  1  15.0%  4:362    5:412     ---KQKWIVLIIICIGVFMSTLDGSILNIANPTIAADFKINMSQIQWVVTAYMLVVTATMLFFGKLGDKVGSNRLYTLGFFIFTIGSFLCSMSNNLSTLISSRIFQAVGASILMATGLGIVSNAFPANEKGKAIGITGAVVGIGNMSGPVIGGIILEHFGWPSIFIINIPIGIIAVFLGIKFLPKPVLDEQNKSFDIPGLLllFKNRNFTVGNIIGVACYFPQMAVSFLLPFYLEQLKNLSPMMAGYVMTVHPLIMVLIAPIAGSLSDKHGAKNILTASFSFMTISLVGMALLKADSPLYLLIVCLVIFGLGLgfSSPNNSSILADVPPQKQGYGGSFLATIRNLSFALGTAFFSSFFAQSL--------------------------------
     299 UniRef50_A9KFF5        Multidrug resistance protei...   208     2e-52  1  15.1%  4:361   14:425     ---SRRWLIIVTIMMVAILEVLDTTIVNVALPNMMSSLGANQNQITWVLTSYVVASAIMLPLTGFFSNRLGQKQLLLINITGFMITSFLCGIAQSLPEIVFFRIFQGLFGASLIPLSQSILRETFPLEEQGKAMAIWGIGIMAAPVFGPTLGGFITEHMNWRWIFYINMPICLLGLMLTLFVIPSS-ERHYQRIDWGGLLLMiwLNSNLILALFItaLFAGSMFALITLEPIMLERLFNYPAVTAGWTMAPLGIGGAVVMMFVPFLMKHLNIKIILTVGILCCFYGAILFAGVNLNSTMQEFLINNTVLGFGMGFLMVPLTTYSLATLPadITEAAGLYSYSRMLGTSIGISLLSTLVSRT---------------------------------
     300 UniRef50_A4C850        Putative efflux protein n=1...   208     2e-52  1  24.1% 16:388    1:377     ---------------MAAIPAFSLDIYLPLLEQIREQLATSVTSAQMTISLFVISFAFIQLVIGPLSDNYGRKKVLYVGLLLFILGSLVAIFSADINTLMFARVLQGAGACTGVVSAFAIARDGFSLDERATVLATIGMYVALAPIIAPVIGGLLSESMGWRYIFLLLAVLSFIILLLVTVKLPETLAQKnkIKSLLLNYKEMLCHRDFVVFTAIGMCAFTSLFCFISMSPHIFINQLGYNSNDFGFIFAFNALVFFAGSKLSIKLSKTKTHSFSITLGLTLLISGGVVMALLGMypKMELVLLPMALASVGISIVLPNATSLMLEPFGDKAASASALNGFIRFVFAGSASVLVTFLDFPPHLILAFSLVSLSVLSWFIWLVSKYNYA------
     301 UniRef50_Q5ZTC8        Multidrug resistance protei...   208     2e-52  1  25.1%  2:383   59:446     -TPKIDPWLIFVILMLMALMQTTTDQYIPSLPAITTALNSTEASIQLTISMFMLGLSLSHIFYGPLSDKIGRKPPLMFGVGLSILGSLVCFVAPNVSVLILGRFLQGFGIGCCNSVGRSLVRDLFTDRLLAKIGSYVGVVSIFIMAASPTLGGFIQEMAGWKANFMFLFVFGILVWLLAFCILPEtnPEATKIKVMAKNYFTLLRSKIFVGYTMCACFAFAGMVSYLTIAPFLFQNTMGLSPLEFGRLTFFIAGAICFSGIVNSQLVMRKGISFMVCTGVLFMIVGGLSLLLItgWSQIYFIMISMTLFSAGAGFTFINAFAGAFHPFPQMAGTVGALYASMQDLSAALTSGFIAGIKGYGQYSLAIILLILGLSSLVAWYYL-----------
     302 UniRef50_C4LJI9        Permease of the major facil...   208     3e-52  1  17.3%  7:393    8:457     ------WRALVALCIGFFMILLDQTIVAVATPDFQSALNADYSQVLWVTSVYLLTYAVPLLVTGRLGDHIGPKNVYVAGMVVFTLSSLGCGLAPDIHWLIAARAVQGLGAALLTPQTMSVINRIFARERRGAAMGLWGATAGMAGLAGPVLGGLLTTWIGWEWIFFVNVPIGVVSVIMVLKWVPQLPTRNHgvTSVIAVFLLVfwAPWIWIMIAASVVVFGIFIMimVPIMIYFQQFHHMSALKAGLMMVPMALISGLLSPFVGRLSDTVPPRRLSLTGFTFMTLSMLCYFLVmpDTSVWWMFVPIALQGLGNAFVWAPNSTTTMRDLpeKTGAGSGVYNTTRQVGSVIGSATVAATLDVFMQhlGWTMIFPAAVLLIGLVVVTQFQGTTAAT-
     303 UniRef50_A4F7E6        Drug resistance transporter...   208     3e-52  1  24.9%  2:394   15:413     -SLSRKARFALILGGLTAFGPLSIDMYLPALPELTRELGATEAQAQLTLTAVLLGLAFGQLFAGPVSDAVGRRKPLLAGLAVYIAATVLCALTESVHTLAVLRAVQGFGAAAGMVIARASVRDLYSGAEAARFFSSLMLVVGLAPILAPVIGGQVLAHTTWRGVFVVLTAFGVVLMAVAAFALPETKPKQWRQpsTFRTFGTLLAKPSFLGCALAAGLAMAAMFAYVSGSSFVMQNIYGMSPQTYAMVFGANAIGLVAAGQVNARLVGRveAQLLTTALLTASVAGAVLVTTALLGLPLPVLLGALFVMISSLGFVMPNTTTLALAEHREVSGSASALLGVSQFVVGALAAPLVGMGGVGSALPMVSVMFGVILASAAVFLTLGRRGGPSQRIV
     304 UniRef50_C0A726        Drug resistance transporter...   208     3e-52  1  26.0%  6:386   32:418     -----RWPLIAILGALAAFGPLAIDMYLPALPAIARDLRADDGAVQFTLSIFLVGVSLGQLIYGPLSDRIGRRGPLLFGMALFTVASLGCALSRSVEALIGWRLVMALGGSAGMGLSRTVVRDRFEVHEAADVFSMLMLVMGAAPILAPLIGGQMLLFTGWRGIFATLVAAGALVWVAVWRYLPESLPVERRTSaaLAGYGRLLVDRRFLGFALVMAFTSGAMFTYITCAAHVFIELNGVSPQVFAVFFGINAGGMIAGSQLNRWLLRRFTSRRILGGVLTVVACAGVLLaaLTGWGGFPALAGLLFVTLASGGLIGPNASALALAPFGRGAGSAAALMGTMQFGMGGLAGALAGMFAGDSALPMCATQAVCGIAAWCALRWLCAR--------
     305 UniRef50_C8WXY9        Drug resistance transporter...   208     3e-52  1  16.9%  1:360   13:427     ITGSRKWWAFATVLVTMFFSSLDQTVVSTAMPTVISDLH-GLNLYTWVFTAYMITSSITVPIYGKLSDVFGRKPFYLFGLVMFGIGSAISGQAHSMLELVWARAVQGVGAGAMMSMPRATIGDIFSPKERARWMGVMMAVFGLSSIVGPAIGGFITDDWSWRWVFYVNLPFVVVAIVGVVFALPTVRTKDQVKVDWQGAALLTVGLVPILLAliVGMLAGGamFGSLMYLPIFVQGVIGLNAQNSGWVMTPMMGGFMVGSMVSGQVMSKTGrrHVAWISGAVIVVGSVLLNRVDVHTSWPTIMVDMVVLGLGIGALMPLMNMAVQNAFprVMGTVNASQQFVSSLGGVIASPVFGTVLNH----------------------------------
     306 UniRef50_D2LUR6        Drug resistance transporter...   208     3e-52  1  16.6%  4:389    3:460     ---RYQRNIIIALLIATFLAAIEVTVISTAMPVITRDLG-GLDLISWVFAIYLLTYAVMTPIFGKLADLFGRKKIFIIGATLFLIGSGLCGLSQSMEQLIFFRAIQGIGAGALMPMSFTIVGDVFKYEQRGKVQAILGSIWGIAGICGPLVGGFFVDYFTWHWIFYINIPFGIISMYLIGKYLEEKIEKRKRKIDYGGAVTFIIGMGALLYALLSGgiIIACLFLFIfyLPLWVQGVLLLAATSSGLTLIPMSIGWPLGSFLSGRFLVKLGTKLISLTGVIVISLGTFGLTFIHSGTPNIILIIIMFFIGLGFGLSMTVFTVIVQSSVsnNRGTAASSNAFLRTLGQTLGITILGVVLnaAGLHNIFIILAVIALICVVVTCLLPKEQP-----
     307 UniRef50_D1Y9V4        Drug resistance MFS transpo...   208     3e-52  1  20.4%  4:360   39:450     ---RRFWVVYFCLMMVMFLSSLDQTIVATALPTIVGDLS-GVEHMAWVITAYTLAITVGMPLYGRLSDLIGRKTLYLIAIGLFLLGSALCGTAGTMITFIFYRFIQGLGGGGLMILSQAITGDLIPPRVRAAYMAPMGAMFGVSSVLGPLLGGWLTDSISWRWVFWINLPLGVVAWIACLFALKLPKHELAAKIDWLGLTFMDAGAVAIVLLATWGgiGMLAMGAMfaYLPTYMQMTYGYSATVSGLLLIPMTIGILLASTVTGLLTSRIGRYRiiIIGPIVAAGGMVLMSTLNENSPVWRIMGDTFVLGLGMGMFFQLLVMAVQNDvpTLLGTATSHNNFFRQIGVCLGASLIGVAFTT----------------------------------
     308 UniRef50_C8XHY0        Drug resistance transporter...   208     3e-52  1  15.3%  7:360   48:457     ------WRIAGVVVLGAIMSILDVTVVSVALPTFQTTFDASYATVAWTMTGYTLALATVIPLTGWAADRFGTKRLYMLALTLFLLGSIACGLAWSIESLIAFRVLQGLGGGMLMPLGMTIMTHAAGPHRIGRVMAVLGVPMLLGPIFGPILGGWLIETASWHWIFFINVPIGIVALIAAWRVLAKDEPSPSESFDFVGMLLLsvIIPLVVGLLLMTGFVfiAFFGAMLLLPTYFIQVREESTLTAGLLLAPQGIGAMLTMPIAGRLTDKMGPGKFVITGLFLILIGMSVFTQISSTTPIPLLLGALFINGLGMGMTMMPIMTAALATLRHavARGSTLMNIVQQSAASVGTAVMSVILTN----------------------------------
     309 UniRef50_B5S1P8        Drug transport protein n=1 ...   208     3e-52  1  23.6%  3:392    8:403     --RSLPAFFALLVAGLSMIGPFSIDTYLPALPAIATSLGTSPLHAQQTLTAYMLPFAFMILWHGALSDALGRRVVILAGLALYVLASLLCATAGRIEVLLLGRALQGLVAGAGMVVARAMISDLLDGAAAQRMMAQVTILFATGPAVAPILGGRIFLAFDWHAIFIFMALFGALMLALCIRYLPETLPPEKRqrDMGRAYRQIFGHGPFRGISLTLAFNLNGMFVYALSAPAFMMLLLGFRPDEFGWLFIPSIAGMMVGSWISGRLAGNWPGRRTIVLGMGIMLATALalVNALVPTSRLAALLPMPFYTLGVGLAMPSLQLMTLNDFPERRGMASSCQGAIQTGLNVISGGIVAPLVWGSVLSLSLASLAFISLGWLAFGLSGSPESESKR--
     310 UniRef50_C6WDC2        Drug resistance transporter...   207     5e-52  1  26.1%  6:385    9:393     -----RGKLVALLGVLCCLGPLSIDAYLPAFPDMAKEFGAGESQIQLSLTTFIIGLSVGQLLIGPLSDSIGRRKPLLFGIGSYVVLSLVCAMAPSAVALAAFRLLQGLGVAAGFVVAMAVARDRFSGLAMAKFMSLIMLVNGLGPMLAPVLGGQVLRYASWRATFVVLAVIAVVLLVLMAVGLKETLPPEKRRPLDLGgfGGLLTDRVFVGYVLASAFALGAIFGYVSGSSFVLQGVFGLSPQEFSLVFALNSAGIFVAGVINTALTGRIMPRGLLRIGLSTAVLAGVALVVAGagGGLVAFLVPLFLVTCSIGLLMPNAATLAMARHPEAAGSSSALLGVSQFLMGGLMAPVVGAGGSTSVLPLALVMAACTALALTSFLVLTR---------
     311 UniRef50_Q46ST6        Drug resistance transporter...   207     5e-52  1  24.6% 16:381   41:412     ---------------LSMLGQFAIATYLPAFAIMSDALHATNAQVQQSLTAYLLPFALMLPWHGAISDAVGRRRMVLLGCALFTIGSLVCAGATGIDMLHAGRVLQGISAGIGVIVGRAMVRDVFDGMQAQQVMALVAMIFALAPAIAPVCGGWLLLWTGWRSIFVFLALVSASLLVACWRWVPETLPPARRHplLARGYGSMLTHWRFVALTLANAGVNVGIYVYIFAAPTFVTRHLGLGAQSFGWLFIPIVAGIMLGSLVSHRMAGRISPVRSVLLGHAVMLFAGIlvLTALHAPAMPWALIALPVYGAGMTITQPSLQLLALDCFPERRGLASSGYVTVQQLGNFLMSALLVPLLLDSTVKLAVCMAALQLFGLAMFM-------------
     312 UniRef50_B8ML36        Putative uncharacterized pr...   207     6e-52  1  12.0%  2:393   48:480     -SPTRQWGIIVLLWGANTVASICSTAFEPALPFVLDDFGtsDTLSSFTISIYLIGFCFGPLLIAPVSELYGRVIVLYPSFVVYLGALAICGSSNNIAVFIVFRALMGFAGITFLICGRAVVADIIAPKRRGLAVTFITSGATFVtsPGPIVGGYIAETIGWRWIFWISMTFLGACMLGCLLTLRETYPPIVLARHltRPLRFIFRTRLIPLFTLYTSILNSYLFILLSTLGTTFQSSYRFSPGASGLAYLGMMAGFVLSQATLGVFSdkPEDRLPPLILGAVILPGALLFYGWTLERHTMWiiIGSGLVAFAAMYSYIPVQIYVIDVYTLHTASATGAMSIIRSAISAAVPLGADPLYARLGYGWGYTLLAGLALPFIILGVVLVRWGERIRQ-
     313 UniRef50_Q4P7K5        Putative uncharacterized pr...   207     6e-52  1  17.1%  2:392   94:531     -SVGRKWLTTALLCSMCLFIGLATAAFSTGIGPMTQEFGVSNEVGQVGMLLFNGAFSIVPLFLGPLSEFVGRNPIYLGCYALFTVWFIPLALAKNIQTVLVARFLSGAFGAAGTTIIPGTLADIWKTRDRGLPVALFSLVAVAGTVGAPLYCGYILQEKGWRWIQWVQLIVNGAVVVLEFLLLRETRgkALLHASTTRAALLLVSEPVVFCFSLYIAYAWALIFAFFAAIPIVFQEIHGWSVGNGGLAYIGPLIACFLasFHGKYLYDRaeARLYYAAVGGILATIGMFIFAFTSYQHVHWIAPEIALVPLVMGiiFEAIQNYLADAYgeYGASAISAQGFVRNALAASFPLFSAQMFHNLTVPYAGLLLACLLALAVPLPFVLIKYGAQIR--
     314 UniRef50_A3I2R5        Drug resistance transporter...   207     7e-52  1  24.8% 34:380    1:353     ---------------------------------MSKDLGTSIANIQLSLTAYLVGIAIGQLFYGPLLDKFGRKKPLYVGLGIYVIASIGCAFTDSVNTLIIMRFLQAVGGCAGMVAAQAMVRDIFPITKTAQVLALLTLVIAVSPMIAPTLGGFLTAYYEWHWVFIVLALLTIIIWMAVIWVLPDGANPDkrPKQVWKNYILVMQNRQFLVYMLAGGLAGAAPFAYIAGSADVFMNIYGLSETQYGWIFAVLAFAMIGSTQLNHLLLRRFSSQQIINFSlqVAVGLALVFGIYFQWLDVGSLLVLMFIFLTAHGLNGPNTAALSMAPFSRNAGSASAILGSIRMAFGGLASAGVSFFHDGTSLPMVSGMAACALAGFIVL--------------
     315 UniRef50_Q4FUU0        MFS multi-drug efflux pump,...   207     8e-52  1  23.4% 10:381   28:407     ---------IMMLGLIVAVGPLSIDMYLPALPSMADDFGVSTAFMANSVPAYFVGLVFGQLFYGPFSDRVGRVKPLYIGMVLYVIASIICATTNNEYVLFTGRTLQALGACVGAVVTRAAIRDRLTAKQTAKAFSIMILVMGLAPILAPSLGAVFLQFFSWHSIFWFLAAFGTLNLLLTKFFFFETLSEENraKEILSQYWELLKDPTFNYPAIGGGLLMGAMFVYISSASELIMDTYGLSATHFGWLFGMNAAGFVALTQLNQWLTNRFRILSILRFGAMMQVISAGALFTlgTDAWLPLVLACIFFCIAGLGLTQPNSSAIALAFQQRRAGMASALQGSLMFSVGIFGGLLLNLFPVNPVLKIGIAMFSLMSLGCYLIW-------------
     316 UniRef50_A1WQM4        Drug resistance transporter...   207     8e-52  1  27.0% 19:388   74:449     ------------------IQPVTTDLYLPALPAITNSLAAPMAAAQLTLSGLLLAFGCSQMVWGPLSDRFGRRPILLTGLCIYTLASLGSAFASTIAQLVLWRIAQGAAMGAAVMCARAIVRDLYTPLEGARAMSKALTGLGIVACVCAPLGGLLSQWLGWRAALLVLTGYALVTLALVAWRLPETlpQALQPRTLLRTWQQVLRNPTFWAFSLLTTTSYGGLFTFLAASPFVYIDVLGLTRTQYGWVMASACLAYFAGTLLCRRLLSRHGLLRTVAIAGGLSVSGglALVALLGWHQPWALLLPFYLFMLGHGMHQPCGQSGAVGPFPKAAGVASALSGCMTMLAAFAMGGWLGLRLDGSIWPLVNGIWFWSVLLALVAWTLVQKFG------
     317 UniRef50_C4JSZ1        Predicted protein n=1 Tax=U...   207     8e-52  1  15.4%  4:392   33:464     ---WKRIYMTSIPAFLCVNVSFASSIYTSGADSIAQHFDVSYTVALLGLSLFLWGLGLGAIIAAPVSEYYGRRIVYLSTVPIFGLFILGSGLAQNFATLIVCRTLGGFFGSAVVSVGGGTNADLWPPALAGFVYPFYFVSPFLGPALGPVIGGFVNEQKDFRWLEWVILFMLAFNYLYSIPQfkQTRTPQkvQRIVLKPFKMLFVESIVLFMTIYMAFNFAVFYSFFAAFPYIFGGQYDFTTGQQGLTFLSIALGCVIGFLAVVYIDRRteYRLYGAMVGCALNPVSLFWFGWTADRGVYWlvIAAVPFAVGNIMVYSSGALYIMNSYGshGASALSANSLLRYAAGGAFPLFTVQMFSSLGIGWASSLLGFVSVALVPVPWVLYKYGHRIR--
     318 UniRef50_A9B1V7        Drug resistance transporter...   207     9e-52  1  16.8%  4:361   17:429     ---AYKWKVLISVIFGIFMVILDTTVVNVAFRTVQQDLGATINEAQWILSIYVLMLGISTPISGYMADRFGLKRTYVIGLSIFVLGSFLCGVAPTIETLVVARAIQGLGGGLSTPLGTAFIYGAFPPNERGKALGVFGIAMVLGPALGPILGGLLVDNDLWRWIFFINVPIGVLGVSLAIRWLKPTPPTGKPKLDVLgaAEQGWESGSVTMWFIIGGISLLLffGAEFLLPLYLQVLRGRTALETGFILLPLAIAAGFATPTAGRLYDKIGPRPLIVTGYAILILNTWQLSKLQADTSIGWIMFLLALRGLALGMTVQTTFVTALSDVdpKVPRGSALINATRQVIQSIGVAVLATILAST---------------------------------
     319 UniRef50_A0AHA0        Complete genome n=22 Tax=Li...   206     9e-52  1  15.0%  1:360    1:414     MEQTKVKAVTIAVFVATFMAAIEGTIVSTAMPTIVSQLD-GIELMNWIFSVYLLTSAVTVPIYGKLSDLYGRKNIFVIATIIFIIGSSLCGFAQNMEQLIIFRAIQGIGAGGILPSTMTIIADVYPFEKRAKVLGFMGSAWGIAGVFGPLVGGFLVDQLSWHWIFFINVPIGLLTILLILLYLREQVEHVKLPIDYLGASLFtwTEPLVVILFVASILLFITFygINVYIPMWAQGMLGHGATIAGFMLAPLSITWIIGSFIGGKLLMTLGNRHTVGIGVLITAASGLILALFPASTNDIFFYLNSAFMGFGFGIIFTTTTVTVQDAVPrqTGIATASNTLFRTVGQTIGVAVFGTIFNS----------------------------------
     320 UniRef50_A2QXB5        Contig An11c0270, complete ...   206     1e-51  1  15.2%  2:370  108:528     -STVKKFLVSCLVWILTFAIYIGSAIYSPGIPDVAEQFGVSNVAATLGLTLFVLGYGIGPMIWSPLSemVGRSPIYVLTLFVFVFLNFAVVYAKNFGMLLAFRFLTGLIGSPALATGGASMADLWSPRARDYMIVIWGAFAIAAPVLGPLVGGFASSANGWTWTIWQLIWVSGLALVLLFFLLPETYGPNILYRrlVRPFQLCFLEPIVLVMNVYISLVYGILYIWFEAFPIVFQEIHGFNSGESGMSFLGVITGTVAFAIPGYFTWKYfeYELPPACVGSICLPISLFWFGWTgfESVHWiiAAAALFSVGGCLIFNPIFCYLARAYPRYAASVLAGNDFMRSSFGAGFPLFAAAMFHHLGVGWASLLL------------------------
     321 UniRef50_D2LJS6        Drug resistance transporter...   206     1e-51  1  23.3%  4:394   29:424     ---PSQWHVLAILSALMGFASISTDFYLPAMPTMARALNATTGSVEYTISGFLIGFSLGQLVWGAVSDRYGRRVPLAAGLILFVIGSAGCALSGSVETIIIWRIVQALGACAGVVLSRAMVRDLYQGPRAAQMLSTLIAIMAIAPLLGPILGGQIAELAGWRAIFWTLVGVGILTL-AALFTLPETLPAARRQTAPlgEYGRLLLNRKILGYAGAGAFFYGGMYAYIAGTPFAFITYHHVAAEFYGFLFGAGILGIIATNILNTRLVLHYGIDRMLVSGTAAAALAGIIVAafTDWGGLWGLFVPLLLFVSVTGFIVANSIAGAMADFPEQAGAVSALVGALQYGAGIASSGLVGGFADGTPWPMGWVIAVTGIGSLLCAFLVVHKNVPAINEV
     322 UniRef50_A3MZ73        Bicyclomycin resistance-lik...   206     1e-51  1  19.7%  1:391    2:397     VTQRPHPCFFIILGMMAMLPPLAIDMYLPSFLDIARDLQVSQEKVQTTLAVFTFGFAVGQLFWGPMADSFGRKPIILFGLTGSALAAYFLTQVMTIENFYLLRLIQGLCAAAPAVVLGALVRDLFDRNMFAQMMSVIMIISMLAPLLAPILGGYIAKYFHWHSIFYTLVLMGISCVLLISWKIPETLAIEKRQpiVFKNFWTLLSDKATLGYVLVGGLTFAGMFCFLTSGSLVYIGIYGVSQEYFGYFFGLNMIVMVSMTALNGRIVVKVGSEKMLKIGLLVQLLAGIWLACVAIflGFWAMAIGIPFYVGMLSTIGSNATAAILDRYPQMAGTANGLAGTARFGIASLVGAMLSHIAVTSERPMLYAMAMCTIAASIAYYLLCKNKSKQA---
     323 UniRef50_O28026        Multidrug resistance protei...   206     1e-51  1  17.6%  2:370    7:429     -SVLKAWIAFLPVSAGLFMVLLDVSVLNVALPRIAEDFGAKMSDLQWIMNAYTLTMVVLLVLAGRIGDMVRRDRFFILGMVIFVLGSFLCAQSWNTQSMIAFRTLQAIGGTILSGNVLAIAAELFPPGRRGEVMGLNAILTASSFTLGPIIGGWLTTHLSWHWVFYINIPIGIVAIAAAWFTLPPLGGREKVPIDWVGAVLllFKIRNFSVGVVATAILFFGVSASLFVFPYFLQGLKFLSAEEAGYWLVAIPIMNTFVAPVAGRLSDRMNPKYLMSLGPLFFAIGLINITSIDVDIKYWDFFAKIAPMGIGMGMLMSPSFNVILSSVpeKVGMANGTVRSVNTLGQAMGIAVGGVLLTTRMSDWIPGYA------------------------
     324 UniRef50_B6HLC0        Pc21g12350 protein n=1 Tax=...   206     1e-51  1  16.0%  6:392   69:498     -----KWGLTFIVAMGGLVVPLSSGVLFPCLIEIAEDMHTTVSVVNLSIAFGSLSVAFTPLWWSYLAELYGRRLVYISSFFFLGIFNILAAISPNISMFVVMRLLGSASSASLQAVSAGTISDIFETQDRGKAMGAFMLGPMLGPMFAPIIGGALTMRWSWRSTQWFMVIYGWVVFTVMVVLMPETaqRNDATSPGKKALYFLLKPMEAAKLLQYPPILITVYYTSIVFATYYLICvySWSSIIVGVAYIPGGLGLLFGAIIGGRWQDYIMARTArcLLGGILFPGALLWWGWAADKHEFWLVPLlfFYGFGGMILTNVTMTMLTEFTPKNSTIGVAVNNLMRNSLSCVSAIIAQPLFDAIGTGWSFTAVCLFCLLSGVPLILLRIKRDEWS--
     325 UniRef50_C4LHP2        Permease of the major facil...   206     1e-51  1  14.4%  8:360   63:470     -------AVMVAIMSAMLLASLDQMLFSTAFPTIVGDLG-GVEHMSWVITSYLLCQTIMMPIYGKLGDQIGRKPIFVGAIAIFLIGSIIGGLSQSMAQLIIGRGIQGLGGGGLMILSQAIMADVVPPRERGKYAGWMGSVFGVSSVLGPVLGGWFTDGPGWRWAFWINLPVGLLAVAIALFALKLPKRGTGLKLDYFGIIFMawSSPTIIGltLGGLCVGIVMFGVMSYMPTYFQMVHNMNPTTSGFMMISMMVGLMGTSIGLGNVVTRTgyRIYPPIGMLIVVASCVLLHRITVDTSLWYLGLCLFIMGVGLGMTMQILILVVQNSFPIQkgVATGSNNFFRQIGSSLGSALVGGIFTN----------------------------------
     326 UniRef50_D2L762        Drug resistance transporter...   206     1e-51  1  15.6%  5:362   16:434     ----NPWLIAASVMLATFMEVLDTSVANVALPYMAGNLSATLSESTWVLTSYLVSNAIVLPMTGWLSTNFGRKRFLMTCVAGFTLASAACGAAPTMALLVVSRILQGAAGGALQPMSQAILMESFPPHKRGMAMAIFGMGVVVAPIVGPLLGGWITDNMSWRWIFFINLPIGIAALLMCQAflKEAKAKRGGSIDYVGFAFMVLWlrWFAGISLTSMIAfvVLYSAITLLPLFLQNLMGYSAFASGLALSPRGVGAVIAMILVGRLIGKVDTRVLIGLGFLLMAYSSYRFAEINLDISISAIVWPGFILGLAIAMVFVPLTTQAMSNLpeQIGNAAGIFNLMRNIGGSIGISALIAVVDRGA--------------------------------
     327 UniRef50_Q469F0        Membrane transport protein ...   206     1e-51  1  22.1%  3:386   15:398     --QKNLKLTVPLLALLSAFPPLTTDMILPALPYLAKSWNVSLSLINLNLVFFFVTYGLFLLFYGPISDRYGRRRPLLVGLAVYIVTSLLGAFVSGAPMLIGTRILQAAGAAAGSSISMAMTKDIFVGQERERILAYIAVIMGLAPMFAPIIGGWILLYLSWHWIFLMEAFMGIIAMFGVLRF-PETLPeeTPLSQVINTYGRLLLNTPYMIMVLVMSVSFFPLFSFIAGSSAIYINEFGLSEQKYSYFFAFNALAIMTGAFFCLRLIKSVNSKHLMTIGFAGVFLGGIFLLFM-GQRGPWSFALPMFMVSFSLGLSRPPSNNLVLEQVDRDIGSASSLLIFTYFTFGAVSMWFISLEWADKIPVLGTTAVGCGALVLAAWFIIQKR--------
     328 UniRef50_Q395I2        Drug resistance transporter...   206     1e-51  1  24.2% 22:389   24:396     ---------------------VTIDAYLPSLPAMADALHGTDAQLQLTLTLYMVGYALSMLVSGPLSDRYGRRPVLLGGLCLYVVASVACAWSTSITAIVAARIFQALGGCSGTVIGRVIVRERFPTAMQATMLGRISAGMALSPVIAPLAGSAVAEWLGWRGVFGLLAAGGLVATAMVLRYLPETRESDARpkGLLRTYAGLLRDRSFLRYSLAISFAYCTYYPFIAESSTLFQRQRGVSGPVYAAIFGLTVLGYLIGSNLFARTGTRWKADSVIAAAAglASAAVLWIGGAIAPTAVAALVVPMFFVMVAVGIAIPACQFAVMQPYTTIAGTASGLFFFIQMAITAACGGVLAWLSDGTARPMIVVTVGASVAFLAVAVGLRERRPA-----
     329 UniRef50_P31442        Multidrug resistance protei...   206     1e-51  1 100.0%  1:394    1:394     MKRQRNVNLLLMLVLLVAVGQMAQTIYIPAIADMARDLNVREGAVQSVMGAYLLTYGVSQLFYGPISDRVGRRPVILVGMSIFMLATLVAVTTSSLTVLIAASAMQGMGTGVGGVMARTLPRDLYERTQLRHANSLLNMGILVSPLLAPLIGGLLDTMWNWRACYLFLLVLCAGVTFSMARWMPETRPVDAPRTRLLTSYKTLFGNSGFNCYLLMLIGGLAGIAAFEACSGVLMGAVLGLSSMTVSILFILPIPAAFFGAWFAGRPNKRFSTLMWQSVICCLLAGLLMWIPDWFGVMNVWTLLVPAALFFFGAGMLFPLATSGAMEPFPFLAGTAGALVGGLQNIGSGVLASLSAMLPQTGQGSLGLLMTLMGLLIVLCWLPLATRMSHQGQPV
     330 UniRef50_UPI00016C47A1 drug resistance transporter...   206     1e-51  1  22.4%  3:386    4:393     --KRSGLFVISLLGALSVVSPFAIDMYLPAFPELATGFGVPSTTIALTLSSYFIGLALGQVVYGPLLDRFGRKPPLVVGLVLFIVTSVGCAFAPDVYTLIGLRFVQALGGCVAQVASVAMVRDFFPRKEAARVLSRLFLFIAVSPLLAPTVGTLVIEAGGWPAAFLALAVVVAGILALVVTLLPEGHKPDrrPGPILSEYGSILRHPRFHTFAGAGAFSFAGLFTFVAGSPILFRDGFGVDGKTYSLIFALLAGGFIGASQLNVALLRYWPSEVLFRRFLTAQVVFGWLFLavAGWLDLYGTLAVLFAFLCCVGVTNPNASALAIAPFSKNAGSASALLGFFQLGTGAVISMAIGAVEPNNQVPIVAIFGTTASIGLAILVVGRKR--------
     331 UniRef50_C4LL17        Permease of the major facil...   206     1e-51  1  24.0%  8:390   52:439     -------AVLTSLALLSAAGPLGTDMYLPTFIDIAKDLSTTASSVQLTLSAFMIGLAVGQLFAGPISDGVGRRRPLAIGSLLFFLFSAGCALTPSIGLLIAFRLLQGIAGGTTVVVARSVIPDVAHGRAAASAFSALMAIQGLAPAIAPLLGGFLSPIIGWRGIFWVIAVFNVIMVVVSRFVVPESLPADRRTPGAIRNLlrCFGRPAFIGYCFAFAVGFGTFFSYISASPFVLQDQLGLPTHVYSITFAINSLAIAGMSALNGKLVNRFEVRSVLVFGLILYVATSVILLvaLLGPRLWPTLICLFVMTSATGLLLGNATALGVEAVRDIGAGAGSGAMGALQFLAAGIVSPLVGIGSDPSLSMALCMLVCSIIAIVGCVTLTSSSDRA----
     332 UniRef50_C9A449        Major facilitator superfami...   206     1e-51  1  18.3%  1:389   26:414     LSKGRIIWLSLLLGTLSAYGPLLMDAYLPAFPVIQEELGISASLTQMSLTMCLIGLALGPLAIGTLSDRIGRKKPLAIGITVAILCCLLVPFVRNIWLFLALRLLQGIASSAGIVLTRAIAKDLFTGERLTKFFAMLIAVNGIFPIISPLLGSAILAVASWQTIFLFLGGLGILLLLGILFGYQETLQPQEHIHQMESGWRAVLSDRIFMLLVLIQGFIYGALFSYISGSSFMFQNVYGLSDQMYSLLYGINGIGIIVTAELSGILSRRLSLVQQLGSGLVIGFIGSVLVMLSGIRNSIALAIIGLFLVVATLGIVNSVVTTLAMDRQGEHAGVASSILGIGMYSIGIICTPLVGIMGSHTYLPLALLIFLCEIGALGVYRVMKQEARP-----
     333 UniRef50_A2R782        Function: S. cerevisiae Flr...   206     1e-51  1  13.9%  2:375  113:538     -STFKKLFASSLIWLLTFAIYIGSAIYTPGIPDVCEQFGVSRVAATLGLTLFVLGYGLGPMVWSPLSElvGRSPTYVLTLFVFVFFQFAVIYATNFGMLLAFRFLTGFIGSPALATGAASMGDIWNPKMRDYMIIIWGAFAISAPVLGPLVGGFAAQAEGWKWTIWQLLWVSGFAFVLLFFFLPETYAPNILYRrlVRPFELCFFEPIVLIMNLYIALIYGILYIWFEAFPIVFSEIHGFNTGESGLAFLGILVSTCCITIPCYFWWKWkeMQLPPACIGCFALPISLFWFGWTGqaSVHWIVPIIalFSVGGCLIFNCIFCYQAHAYPKYAASVLAGNDFLRSSFGAGFPLFATAMFHNLGVGWACTLLGCFAL-------------------
     334 UniRef50_C9RAJ9        Drug resistance transporter...   205     1e-51  1  18.0%  3:363    5:419     --RALPWGSLGVLVLGTFMGVLDSSIVNVALPHLMALFSATEDQIQWVMTIYLLVGGMVIPAAGFLGDRFGYKKAYLGSVLAFVLASALCGLSWNTTSIIVARAIQALGGGMVIPLSMAYLFRIWPREKIGVATGLWGMTITVAPAIGPTLGGYLVDYVSWHWIFYINLPIGIFTVLWGWLALKETPIQEDLKLDWLGLFlrLILNPTFMASLVASNLTSVALFVGIFLVPLFCQNIQGYSAMQTGLILMPAALTTAFFMPIAGKLFDTVGAVFPGLLGMGIVAAVTHALIHLTADMPIHHLQILLCIRNAGLALAMMPLMTAGINTIPTArgQATAIASVTRQVAASFGIALVSYVLTNRTV-------------------------------
     335 UniRef50_C7MAI0        Drug resistance transporter...   205     2e-51  1  20.3%  4:367   30:448     ---RQGKLVFVGLMLGMFVASLSQTIVGPALPRIVAELG-GVEYYSWVATAAMLVSAVAVPIVGKLSDLYGRRWFYLAGLAIFMLGSILAGMATNFWFLVGARAVQGLGMGTLMPLSQTIIGDIIPPRQRGKYQGIMGAVFGVTSVVGPLLGGTVTDNLGWRWLFYLTLPIGVVAFAFILRYLHLPRAAQRGKVDLLGIATlaWGSPVIIGMYAVAAVLLiaMFGAIIYIPVYAQGVMGVSATSSGAILIPLSVAMIVTSIVVGLLISRFGNYKvlLLGGAVLVAGYLLLSRIQYGDSPWHLTLAMVVIGLGLGLCMQVYTLVVQNVVSQrlGVATAAIQFFRNIGSTIGTAVLGTVMSAQMGSAIA---------------------------
     336 UniRef50_Q7NZZ8        Probable MFS transporter n=...   205     2e-51  1  27.4% 19:379   21:388     ------------------LGPFSIDTFLPAMRAIGDTLSASPLEMQQALTVYLFCYALMMLWHGSISDAVGRRPVVLATTLLFGLASVGCALSNTLGQLLLFRALQGLCGGAGLVVGRAIIRDRLEGAAAQRLMSQVTMLFSLSPAVAPVVGGWLFGAFGWHSIFAFMALIGFALFALCWFGLPETHPKAArpRPLLASYWRVGRTVNFQLLTAAVSFNFAGFFLYVPSAPVFLMQHLRLGPTEFLWLFGPAVSGIMFGAYLSGRMAGHFSSREVVSRAYWLMFAAALANllLAPEQALPWAVLPLALYTTGMSLAAPSITLNLMDQFPELRGTASSLQGFCQTMVSSLVAGVIAPLAWASPLRLALVMNLLLLLGFIC---------------
     337 UniRef50_C6XAP4        Drug resistance transporter...   205     2e-51  1  25.3%  8:391   23:412     -------LLTLMLAGLAMLGPFTTDTYFPFFPDIQTHFAISQAAAQQSLSVYLFTFTFMMLFHGAISDSVGRKPVIVISLIGFVITSFGCAMADSYALLLAMRAGQGFFVGAGTVVGQAIIRDQFHGAEAQKRIAMVTMLFGISPAIAPMVGGWLHVYFPWQSAFVFLAALGLILTWLCASRLPETLPKDQRRssLLRNYCAIAGNVRFMMLSLCIGTGFGGFLVYVAGAPDFVLHMMRLSELQFGWLFIPIVIGLITGSALAGRLVSTLPGRTIIRmgLLALASIGNLAYNWLTTPELPYAVAPILIYTLGVTMLMPAVLTLALDIFPEKKGMAASVQGFVQSIIFTLISAFIVPFVLGNSLHYAVAMSGLFVLNLAAWCIYKKRTVRSA---
     338 UniRef50_Q07824        Polyamine transporter 1 n=6...   205     2e-51  1  14.4% 17:392  156:577     ----------------SIAIAMCSSIFASAVPQICEIYHVIEVVAILGITLFVLGFAASPVIYAPLSELYGRKGVLVLSAFGFALFQFAVATAENLQTIFICRFFGGFIGAAPMAVVPAAFADMFDTNVRGKAIALFSLGVFVGPILSPVMGSYIAQRTTWRWLEYVVGCFASAVFVAIVLFFEETHHPTIlqKTVTRPIIMLFVEPLLLFVTIYNSFVYGILYLLLEAYPLVFVEGYGFTENGE-LPYIALIIGMMVCAAFigKLVP--EARLYAMVIAGTVFPIGILWFCWTGYYpiHWMVPTVGGAFIGFGliFLPCLNYIIESYLLLAASAVAANTFMRSAFGACFPLFAGYMFRGMGIGWAGLLLGLFAAAMIPVPLLFLKYGESIR--
     339 UniRef50_C9SF72        Polyamine transporter 4 n=1...   205     2e-51  1  14.1%  2:392   40:463     -STLKKFHVVFVGTWFTANSAIGSSLPSGAVSWIADDFSVtpTHLVLLNSLFLVGYSVGPLFLGPMSEYAGRSRVLLAAYVGYCIFTLACAVAPSYPALLIFRLLGGVNAACTNAVVGGLFADIYdpIQRGRVLAYFMTATTIGPPLGPIISGF-ASTIDWRLTFWIGLALLGIGLP-ALITLPETQAEKTSRDdfARPFTMIVREPVVLFSSLYMALVYSILYLFFQAYPIIFQGVYDMEPGFVGLAFLPVLGGSAAALAIFMWFSAYHAAALRPRRGLDAslSLSLFWLGWSSRATVHPVVPMmfLFGAGYLLIFMAMLNYLTDAYRQFSASAHTAASTTRSVCAVCLPLATRPMYARLGIAWACSLLGFVALAMAVIPFVFIRCGRSIR--
     340 UniRef50_C8SZ68        MFS family major facilitato...   205     2e-51  1  24.6% 11:335   10:335     ----------LILGLLSGIGPLCTDFYLPALPEITQQLQATSTQTQLSLTAALIGLGLGQLFFGPLSDRIGRLKPLALSLLLFIFSSAMCALTRDINMLIVWRFLQGFAGAGGSVLSRSIARDKYQGTLLTQFFALLMTVNGIAPVLSPVLGGYVITAFDWRILFWTMAAIGGVLLVMSLAILRETRPATAAHASRQRPGQPVLKNRRFLRFCLIQAFMMAGLFSYIGSSSFVMQSEYGMSAMQFSLLFGLNGIGLIIAAMIFSRLARRFSAERLLRGGLTLAVSCAAIMLLFAWLHLPVLALVGLFFTVSLMSDISTVAGAEAMSAvaAQSGTA-----------------------------------------------------------
     341 UniRef50_C9SS83        Putative uncharacterized pr...   205     2e-51  1  15.1%  2:392   51:476     -SDIQKQSVAWFVAFCGLLASMSTTSILSAVPEIMETFDTTPTVINISNALYLVVIGLSSCFWGPLADTFGRKPVYTMSTTMFLLASIGTALSPTLVPFFFFRALTAVQVSTFLILGSSCISDIYHPIERATAMGWFLRGTVFGLAFGPIISGIIVTYTSWRIIFWVQASLSGLASLLCFFIMKETLQTTPRHRELRGqvFRLLSEKNLFCVSLASASMAFNMYSLLTPIRYILNPRLGltPLQSGLLYLAPGGGYLLGSLIGGRLSDRtdRLRGSVILLGLSLPGSTLLYGWTVDRGFGGivVCMFVQGISQTSAFPSLNTYIMDVMQQNSGKASASHYFVRYALSAAATASCIPMIDAIGIGWTATISSSMVLAGSGLVLLTIHSGGSWR--
     342 UniRef50_D1C5K1        Drug resistance transporter...   205     2e-51  1  20.2%  5:360   11:420     ----RRWWTLAVLSLALAVISLDNMILNVALPTLVRDLNATSSQLQWIVDSYVLVFAGLLLTAGALGDRFGRKLALMVGLGVFGAFSALAAMSGTANQLITTRALMGIGGALIMPSTLSILTNVFPPAERAKAIGIWAAVNGLSIPLGPVLGGWLLEHYSWGSIFLINLPVVVVSLIAATILVPESRDAKALPLDPVGAVlrLFKNPRFSAASLSVTMVFFGLFGATFFLTQHMQFVLGFDTLQTGVRMIPVAVGVGIAAPLSARLTARFGSKVMVAAGLTVVALGLGLMSTATVESGYGLVATCMIVAGAGMGLAMTPATDAVMGAVPKdaGVGSAVNDTTRQVGGALGVAVLGSLLAT----------------------------------
     343 UniRef50_D2PP46        Drug resistance transporter...   205     2e-51  1  18.1%  1:360   22:436     LSHKQIMVVLGGLMAGMFLAALDQSIVGTALPQIVSEFN-SLDKLSWVVTAYLLTSTASTPLWGKISDLYGRRPLFIAAILTFLAGSVLSALAQNIEELIGFRAVQGLGAGGLLSLAFATIGDVIPPRERGKYMGYFGAVFGLSSVAGPLLGGLLTDGPGWRWIFWINLPIGAVALAVVAAVLKLPHVRRSHKIDYLGAAIVTAAVTSLLLaaGYAGYTFLLGFAMfiFLPLYLQAVKDMSPTRSGLALLPMIFGIFCASIPSGQLMSRTGRYKipIISAVLVGGAMVMLSTLSMSTPYWQLAVYMFVMGSGLGLSMQITVTAAQNSVPrhMGTATSTMTFFRSMGGAIGTAVYGAVLTS----------------------------------
     344 UniRef50_Q1R0S4        Major facilitator superfami...   205     2e-51  1  18.6%  5:392    3:389     ----HKKAIAYSVSFAAFLGPFTQTVYVPILPELQDTLATSQLLINASISVFTFIIAFMQILYGPLTDTWGRKKVLLPGIALYVGASIGCFYADHIASLLFFRVFQAVGIATGSVVAVTVIGDLFRDEERLKAMGTFQTMVALGPVIGPVAGGFIADQLDYHYVFLALAVAGTLIGILNLALLRETKPAGPARRIDMAEYVRIARDRQGLTIGILGFVQFYIYYNFLVYLPVILDQGYTLSVAQKGLMFLPLSVALMLGSFLSSRVQKRLSTESLLVITALLCAVDVMAFLA-TSMHSLASLITTTCLFGFLLGLSLPAQTALLTRVFVTHRATAVGLYNFFRFMGMASGPFLGALLFDLGGLTLLFSIAALLFLLIAMLAHRNLMPVRRAR--
     345 UniRef50_UPI0001C316E6 drug resistance transporter...   205     3e-51  1  17.5%  6:364   18:435     -----KWRVFAVMMIAWFMSMLDMSIMNTALPELQHDFETDLPNASWVVNVYSIVFAVLLIATGRLADQFGRKKMFIGGLVVFTVGSALCAVAWDIGWLIGFRALQAIGAGMLAPLGFAMTALVFPPRERGKGLAMIAVVALVANGLGPVIGGGLIEIASWHWIFVINLPLGVIGVVLAWRWWPETYDLSASRHIDWQGMVLlwDDAAILFFIQISIVLGIGFVVwiFLLAQVFVNLWGFSQLEAGLSLLPIGVCGGLVWPLVARAADNAPAYRLAVPALGSLALGLLWFSFMpgVGDYLFVLPGLILIGMGIGVGFPTLNVGAMNAagPNLGVASGVVNTSRQLGSALGIALLITVFTTTAGW------------------------------
     346 UniRef50_B6J7J7        Multidrug resistance transp...   205     3e-51  1  24.9%  1:381    1:386     MSVPSIRKTVWTLAPMAMALALAMDVYVPAVPHMATLFHVSAGQMQLTLSLFMFTCGIVQLVIGPLSDQYGRRRVSFFSIVIFSIGSILCATAHSVPELIVYRIIQAIGAVGMMVCGFAIVRDRYHGEKSGKTYSYLNGIIAFSPMFAPFVGSYLDVHLGWQSTFLILLLISLWAFLSLFFSLPESLPRNKRirRIFHEYKTIFTNRVFLNYTLSTAMGLSYLFIFCSISPYIIIQLLRIPELNYGYYFAFMGISFFVGSLLSGYFVGKIGIYKTVVVGFFISLIGGTIMALWYFITGLTifIWPMLLIGIGGTFGLGAGSGGAMEPLGDTAGAAAALSGSFRFLFSAILGMVVINKNISSTLPLALPAVLFSLVGLILFL-------------
     347 UniRef50_A7KH09        NapR6 n=6 Tax=Streptomyces ...   205     3e-51  1  20.0%  1:360    1:414     MAVKNRWLALIGLTISVLVIGFDTTILNVALPTLAADTGASAGELQWIIDSYAVVYAAAMLPAGFLGDRFGRRKLLIVGLVIFLGGSIIGTLVDTPGALIGARTVMGLGAALIMPLTLSLIPTLFKGEEQTKAIAIITVGLSIGLPLGPLISGWLLDHFWWGSVFVINIPLVAIGILATVLLIPETKDPAAPKVDIISTvlELLRNPTFGWNTVFLILGMFVFMGLLFVLPQYLQVIQGNDAFGTGLRLMPLMAGMIVVAKIVPPLSLRFGTRPQVIAGLLIMAGAMFMGSATDANTGYGYAVVWMILVGLGTSLVMVPALDTALGVLPKGkgTGSGLSTTLRQVGGAIGIALLGSVLNA----------------------------------
     348 UniRef50_Q2BHQ6        Putative uncharacterized pr...   205     3e-51  1  24.0%  1:384    1:389     MDQHKPLPPIAYFTVMSMVSPIALNILLPALPDVAENLGVTTSEVQLSLTLYLFSLAIGQLICGPLADRFGRRPILLTGIALHFIGCLLGAYADDLNSLLAARVLQALGGCTGMVLARTIMLDRYTRDQAAGKIGYITLSIALSQAIAPTLGGHINLQFGWQYLFHFSLLLSTVSWLIVMFMIPETAKesLRITRVLSQYWQVLKAPNYLGYALSTTFIACAFYLFIGSAPYIVDSEMGGTSADFGNWFLIVSLGFMLGSFTAAKISARLGIQRMIILglSTLAAVTMLLCILSFGLHYFTLFIPMALFTLGRGFSQPSGQSAGISCSQGSPSTASGLMGFIQLLTGAVIAQVTPFILAAGSVWIIVTLLLCPLLAFVAFYTTR----------
     349 UniRef50_Q2WAN0        Permease of the major facil...   205     3e-51  1  28.2%  4:390    6:404     ---SPSRRMAVLLTLLVAFGPVCTDLYLASLPDMARDLATTTTMVQLTLSAFVGGFAVMQLVYGPLSDRFGRRPLLLGGVAIYVVASVYCVFAPSIEALIAGRFFQAVGACCGPVLGRAVVRDLYARDQAAKVMSYMASAMALAPLVAPTVGGWFHTLFGWRSNFLLLALFGVILLVLVWRMLGETNQHKDPAALDLgnYREILTHRLFLGYVLTMTAAFGGLFSFISASSFVLIDVMGMEPRHFGLAFAFASAGFLVGGFIGARLTHRFGIERMVFTGTLGCTIAGVTLAAlgGIAGIVMIMGPVMAFFASCALVLPNATAGAIAPFPRAAGAASSAMGFIQMSGGAVAGWLVGTLYDGSARPLAAMVAVMGLLSLLVYLRLVRPAARP----
     350 UniRef50_D0L8R8        Drug resistance transporter...   205     3e-51  1  19.9%  4:360    2:412     ---SRKWLTLTAVCTGVFMLLLDITIVNVALPDIQADLGASLSGLQWVIDVYALTLAALLLTSGTIADIVGRKVVFATGIVVFTAGSLACGLAPTIEFLVTARAVQGVGGAIMFATSLALLAQAFPPRERGVAFGVFGAVTGVSVAVGPVLGGLLTSGISWHWIFYVNIPVGIAALAVTIWGVDESKAPGVHRIDWLGCVSFSAALAFLVFGLiaAWAISASMFSVLTYLVIYLQSIMGYSALEAGLRFLPFSGVVFVAAGVAGRLSDIVPIRWLIAPGFVLVAVGLWLLRGTDPTGGWTQLIPGFVIAGVGTGMINPPLASTAVGVVEqrAGMASGINSTFRQIGIATGVALLGSLLAA----------------------------------
     351 UniRef50_UPI0001C318BD drug resistance transporter...   205     3e-51  1  19.3%  5:362   15:427     ----RRWWTLGAMCFALFMLMLDNTVVNVALPSIQSDLNADLASLEWTINAYTLSLAVLLVVGGRLGDIFGRRKIFLIGVSVFALSSAAIGLAPSDTALIVGRAIQGIGAAMMMPATLSIVTNAFPPHERGKALGTWAGVSALALAIGPVVGGFLTEQVSWRAIFFLNLPVAAAAIAMTLFSTRESRDETVGRQLDYAGIATlwGSARIVGLFALAVVSlfGMMAMFFFTALYMQNILGFSALEAGVRFLPTTLVLIVMGPLAGRLTDRIGPKPLLVSGMLITGASQIWQSFLTADTGYSFLLPSFVLMGIGMGLVMSPMTTAAMNSVDrkAGVASGVLSMGRMVGSSLGVAIFGAVVASVG--------------------------------
     352 UniRef50_C0ZBH9        Putative multidrug resistan...   205     3e-51  1  18.4%  3:372    5:423     --KRRVGLVTCGVLMGLVLSALDQTIVSTAMPTITKELG-GLSLYSWVFAIYMLTSTTSMPIYGKMADLFGARKMYLIGLFVFLLGSLLCGMANSMTGLIAARGVQGLGAGALMPVAFIIVGELYPPEKRGKFQGLFGAVFAMTSIFGPSLGGMIVEHLPWGWIFFINLPIGIVAFLIIALAFRDQRHYDKKSVIDWYGalSLFRIPAIGYGNLAGFFVSAALFGAIAYVPLFVQGVRGASPSEAGFLLVPLMLSAAISSTIGGRWMAKASFRAILIPSLLIMATGFFLLSTMDGETTNAQLVIYMIVTGLGMGAIYPALGTAAHSAvpEDRGVAMSTSQLFRSIGGTIGVSVFGSIVEWRMRAGLVFSEAL----------------------
     353 UniRef50_UPI00018742B6 permease of the major facil...   204     4e-51  1  22.5% 21:385   62:431     --------------------PFGADTYLASFVDIASEFSTTESMVQLTLTTFMVGMATGQLVIGALSDSLGRKKLLLIATLVFLGSSILCAVAPNIGTLIAMRLFQGLAGGSTIVLARSVVPDLLTGKASAKAFSTLMGISSIAPAVAPLVGGFLGPAFGWRSVFWFLAAINVAMVAIVVLMVPETLPPEKRSTGALRNLlrLLRRPVFVGYMLAFAGGFAVMFSYIAASPFIFQELLGLTPTQFSLVFASNAAMLTFVSILNGKMINRFHPHKSILIGLTVMLVTSilIINALVGITFFTTWLLLFITVPMMPLIFANATALGIEEVRDiiGSGSGLMGFAQFLAAATVAPLVG-LGSNLPLSMAISMLTCALIALIAVLTLTR---------
     354 UniRef50_B8FM40        Major facilitator superfami...   204     4e-51  1  21.3%  7:382    2:377     ------KRIVPLLAFLTAFPALSTDMYLPAIPMLVEQWNQPLVVVNLTLIAFFASFCTFIAVYGPLSDRYGRRPLLLAGITIYIGASIGCALSPSVYTLIAARIGQGAGAASAQTLALAIIRDKFDGLERGRILAHMVGIMAVAPMLGPVFGGWMLKWRHWPWLFVSQACLGVIGFIGVYFMEESLKDpkVSALQVFARYGVVFKNGRFMKLNVLMSLFGLPFFGFIASSSYLYIKVFGLTEQQFGYFFAFTSGGFMLGPMVLNRLANHMSYNKIIGIGLSGVTLGGLALAF-NSHATPWHLALPIFLFVFSFGVFRPAATNMALEQVTTDVGSASSMLVFLYSMVGAVGMWMISLEWPDKMTVLGSLAAGIGILSLIFWFL------------
     355 UniRef50_C6BK10        Drug resistance transporter...   204     4e-51  1  23.4% 10:390    9:394     ---------LLLLGALTAIGPLSVDMYLPSLPTIARDLNTSSAAAGLTLTVFLISLAIGQLIYGPASDRFGRKPPLYIGLAMYVAASIGCAFAKDATMLAVLRGVQGFGGCAGMVIARAAVRDRMDPAGAAQAYSTLMLVMGVAPILAPMIGGAVLQFTTWRVIFALLTAFGVLSLVAVHYLMRESLAPEQARkhVLRDYWELLRDHHYAAYMGCGAVFLSGMFAYITVSSFVLIDGYGLTPSQYAWVFGSNAAGMIAASRVNVRLVRKYSPARVLRRALWVPAITSVlaAAAAGFTPLPLVLAALFCYIASIGCISPNTGALAMAGQGARAGTGSALMGAMQFGLGMVTGTVVATI-GQTALPLLGMMAVCAIVALLLGLRITREEPAA----
     356 UniRef50_UPI0001B4F865 major facilitator superfami...   204     4e-51  1  16.1%  2:393   23:480     -RRKPLWVIIVACSVPMFMVALDNLVVSTALRTMAVDLDASTTELQWFVNAYVLSFACLLLTGAALGDRFGRRRIFVAGIALFTLASVGCGLADSSEQLILMRAVQGLGASAVMPLSLTLLAEEVPDKKRNLALGLWSAVSGLAVALGPVVGGAVVDGLDWQWIFWINIPVCLVAIPLVLVVLRESSLAGTRLDLLggIILSAFAGGAVLLALFVmaSMYFGVFGSIFLLSQFFQIAPVRTPLEAGVLTLAWTLMPMFVAPVAGALTDKVGGGRLMALGLFLQAIGLAWilVATSDTPYSRMVGAMVVAGIGMGLVFAPTAAVVLGSvpQYRGKASGANNTVREIGGALGTAILSSVFVHYGdpGIWIGVAVVLVGALCALAIPRPRPEDNVP-
     357 UniRef50_B9QVG0        Drug resistance transporter...   204     4e-51  1  24.3%  2:392   11:410     -REPKRIAFVVMLMGISTLSPFAMNIYLPSVDGMMSAFSATAAEIQLTLAFYFIAIAVAQIFLGPISDQFGRRPVIVAGMVLFVIGSVLCLMAPTVEALIAARIVQAIGGGAGLVLARAIVRDVYGRDKAASMIGYVAMGMAVAPTIGPAIGGFLDAHYGWRGGFVLMLIFGIGVTICAWLFLPEthKKAVSLKQIGQGYADLFKEKMFWVFCGASTFMAWLYFAYLGGAPFVAAGVFNMAPAEIGLYLMVVSIGYIIGNFITGRIAARAGIARMIALGVivFGVSLLVVGTLTDSLTGPLFFMPMFFIGLGNGLGIPSAISGAVSIRPDLAGTASGMLSFLQVGAGALVSSAVAYMFsgGEMPMILVMVVGGVFGLACVLAVFLGERQDTQ--
     358 UniRef50_C3JMK8        Major facilitator superfami...   204     4e-51  1  21.3%  6:386   13:461     -----RRATLLAVCVSTAMLMLDIAVVNTALPSIASDLDTGVSALQWVIDAYTLALATVVLSAGSWADRRGRRHVFVIGILWFTTASLFCALAPNIWVLDLARAAQGIGGAVLFACSLALLADVFegPQRATALAAYGATIGGAFAVGPLVGGLLTELLDWRAIFLINVPIGLITLAMTVRWVPESRDPRPRRADVPGQIlhLLANRAFAGAQIAAFSISASLFAVFVYTTIYLQNVLHLSPVDAGLVYLPATIAMFVVAGATAKLDGRIPVSVSLTCSLLLVSVGLVMMTVVDVTSSPYAILPGFVVACVGAGVFNPVMSGLVleSTSNHSGLAAGINDAFRQTGIAVGVAVLGAFLPagGLRLALFVAAFIAALGALVCAATLR--------
     359 UniRef50_B5HBC1        Transmembrane efflux protei...   204     4e-51  1  17.3%  4:361    9:431     ---RRRWIALAIVMTAAFMDLVDVTIVNIAIPSIERDLGASFGAIQWITAGYALAFAAGLITGGRLGDIYGRKRLFLIGITGFTLASALCGFAANEEMLVASRLLQGAAAAMMVPQVLAIVHVTFPAHERGKVFGLFGAIVGLGAVSGPLLGALLTQwlEWRPIFLINLPVGIAGLILGRKYILESRAPKALKLDLVGVVLVTLGLLMLilCMAGSLLVFAAFIafFLVWTLYMQTGLGWSPLKAGVTGVPFSLAVSAAAGMSVQLLVPRFGRKVLQAGAATMAAGLLVYIwyGMAVQPWQMILPLLVMGVGMGLIVAPLTDAVLSEVpeHAGSASGLINTTGQMGTALGLGLVSLVFFGS---------------------------------
     360 UniRef50_C0Q9N6        Drug resistance transporter...   204     4e-51  1  19.3%  5:387    9:391     ----KDKGMFILLAFISAFPPLSTDLYLPALPQMKEILNTTQSQVNLTLSMFFVFYAIGLLFWGPLSEKYGRKPILLIGMVIYTISSIICGFSQYVEQLIVGRIIQAIGGSAATAVSTAMVKDLYSGRKREKVMAMVMSMVIIAPIVAPVIGAFLLEYVSWEIIFFVLAGVGATALMAGAL-LEEtnRYTGSVWRSWGRLAVVLKNPNFSILLAIFSTISMSIMTFLAASSFIYINGFGLNEREFSYFLAFNAVFAMIGPMLYVKLSQHFKSQAIISAGFPIFILCGIAVATV-GHGSVWAFALAAALATLIVDGMRVPGVNLMLEQQQNDTGSASALINFFGMLLGSLGMHLVSLNPNDLILALGCIQIMIGLISGILWFLIRNRP-------
     361 UniRef50_C1P9C5        Drug resistance transporter...   204     4e-51  1  16.9%  1:360    1:414     MKQTNVKAVTIALFVATFLTAIEGTIVSTAMPRIVSDLK-GIGVMNWVFAIYLLTSAVTVPIFGKLADLYGRKKIFTAGTVVFLAGSTLCGLAGSMGQLIVFRAIQGIGAGAIMPVTNTIVADIYPHEKRAKMLGFMGAAWGIAGVIGPLFGGFFVDQLTWHWIFFINLPFGLISVLMVILFLHEQVEKTENAIDVWGAATFswGNPVILGLllVCFLGSAVLMGINVYIPMWIQGLEGHGATLSGLMLAPSPVLWMLGSFAGGRLQLKYGDRLAFLTGMAFILGSTAWLSLFSLGTQEWSFYVFSAISGFGFGIVMTISLVSVQSAVdsLRGAATASNTFFRNLGQSAGSAVFGTYFNA----------------------------------
     362 UniRef50_D2LE41        Drug resistance transporter...   204     5e-51  1  21.8%  9:385   23:405     --------FVTLIALLTALTALSIDIMLPALPKIASALGATTdeQQLVLSVYFAGFAIGQFLFGPLSDSYGRRNPLLFGLALYTIGTVLAVTATSFAMLLFARAFQGFGAAAPRIVAIAVVRDRFAGREMARIMSFVTMVFVVVPILAPTLGEAIVQFSDWHIIFWVLLGMGLLATLWSGLRLPETFHQSDRLPFTARNIwaVATTRQTAGYAVALGFSFGLLFSYIITSQQIFVDVYGLGA-EFPIAFGLIAAFLAAASIINAKLVRRVGMRGVsaILGGLAVCGVMAAFGFPDKPPLWAFGTFMAAVFLCFGLMSANFNSLAMEPMGHIAGTASSLIGFYTTVAAAVLGTIVGQSFDGSVRPLCIGISVMFAATLATVLVTER---------
     363 UniRef50_A9IVI0        Bicyclomycin resistance pro...   204     5e-51  1  21.2%  9:385   23:405     --------FVILIASLMAINAIAVDIMLPAMPNILEGLNvnENDQHYIISSYLISYGIAQIFFGPISDRYGRRKLILIGLAFYSFTAIGCAFVKDFSLLLILRVLQGIGGASMRVLTVSVVRDLYSGRKMAEVMSIVMMVFLVAPMIGPATGQIILLLGHWQFIFIFMAMIGFGLMIWILFRFPETLHEQRPlsSIKHNLWIVVTNRTTLCYTLATSIILGCIFIAVNTSQQTYEGIYNLG-FWFPIAFAIGAAFQAFSSFMNSQLVGRLGMRRIAHTMLLLFCATSCIWflADGVIPFPFYMTLYCILMFTCGGIMANFNTLALESLGEIAGTASSVSGFLQTSIGAGLSFFIAQQFDETTIPNSAGFFFLSLIAIVLVLWAER---------
     364 UniRef50_Q07HC8        Drug resistance transporter...   204     5e-51  1  24.8%  3:393    7:403     --KPSFARNAIVLGLLSAIGPFAIDMYLPALPAIASDFRASAQAVQWSLVVYFFAFGLCQIVYGPASDMLGRKPPLYFGLTLFALGAAGCSLAPDIHWLIAARLVQGIGAAAVTVIPRAVVRDLHTGVEATKLMGLVMLVFSVSPIFAPLFGSALIVPFGWRAAFVAMTIAALIGLLLVATLLPETRPPALraRRALQNFAQLLSERRFVALSLVGGLGMASFFAFLANSSFIYINHFGLTPTQYSLAFALNAIGFIAGSQFAAPLGARFGITRVMLAGVALYaaATLLALTLGGTDSLAVLIALLFVTYGCLGLTLPPIMVMLLENNGPIAGSASSLSGTLQMIVGGLVMASAGRFADGTALPMVSAIALCAVTAAAVAFVTLRARAPASQP-
     365 UniRef50_A6M0S9        Drug resistance transporter...   204     6e-51  1  13.6%  2:360    8:421     -SLASSWLALAVVIIGTFMSILDSSIVNIALPKMMAVFGVSLDDIKWVLTAYTLALGAIIPLTGYLQEILGAKRIYVFALAMFTVGSMLCGLSWSNTSMIAFRVLQAIGGGMIMPVGMSIIYQIFPREKIGLALGFWGIAAMAAPAIGPTLGGYIIEKMDWRLIFNVNVPVGIVGVILALILLKGTERKPFKSFDIIGFllRVFKLFDFTISQIITSVLTLAMMGGVYVLPLFLQNIRGYTPMEAGLIMLPGALVMGIMMPLSGNLLNKVGVKALVIPGLIILAGASylATAINMNSSKDYIILVNCIRSIGIGLSMMPISTTGMNVVPAhiSRASALSNTLRQVAGSVSVTLMSTLIQG----------------------------------
     366 UniRef50_B0SY69        Drug resistance transporter...   204     6e-51  1  17.7%  4:354   12:417     ---ANRVPITVAVMLATIMNSLDTTIANVALPHIQGSVSASAEQITWVLTSYIVAATIMTPLTGFFADRVGRKMVFLVSIAGFTVASMLCGVATSLVEIVLFRLLQGLFGAALIPLSQAVLLDINPPEKHGSAMAIWGAGAVLGPILGPALGGWLTDNLDWRWVFFINLPIGILAFCGVFFFLSEKKSPEKKRFDVlgPSQDWFASSEIWLYLIVgfFIGILLYSVLALLPPMMQNLMGYPVAFTGLVSMPRGIGSFIAMFAVGQLIGRMSIKLILLIGLAVSAVSLWMMTQFTLGMDTRLIIVSGFLSGVGTGLIFVPLSTIAFATvpQHRAEGAGLFTLIRNIGSAAGISIM----------------------------------------
     367 UniRef50_Q13UG3        Major facilitator superfami...   204     6e-51  1  18.2%  3:360   35:448     --PLNRPMITISIMLATLIQTLDSTIANVALPHMQGTLSASQDEITWVLTSYIVAAAIATPLTGWLSDRLSVKRLLIVAIGGFTVSSALCGLSETLTQIVASRLLQGVFGASLVPLSQSILLDINPREKQGQAMAVWGMGVMVGPILGPTLGGWLTDSYNWRWVFFINVPIGAFALFGVATFLPSREPKHDVKFDAFGFATLGLAIGAllLAAISFAFFLavMYATRALLPPMLQNLMNYPVATTGLVTAPSGAGTMVAMLFAGRLLKRIDARILLLAGFLISAFALWQMMHYTIVLSASDIVWPGVIQGFGLGLVFVPLSALTFSTlpELRADGTATYSLMRNIGSSIGISIVQTLMTR----------------------------------
     368 UniRef50_C6WMM8        Major facilitator superfami...   204     7e-51  1  21.1%  7:386   11:443     ------WLALASLCLGFFLLLVDSTIISVALPALMADLGADEGTAIWVNSSYLFAYAVPLLVAGRLGDRYGARAVYLAGLVLFILASLACGLVSDPLALVAWRVVQGLGAALMTPQSMTIIRRLFAFPALGVAMGVWASVGGVASVSGPLLGGVLVGTWGWESIFLVNVPIGLLALAAAWVWLPRAEpaQRGEPDRALVPVPLFRDRGFVMASVGAAMSSFTVGAAMIPVMLHLQGARGLDSMSAALVLIPMGVVCAATAPFAGRSVSARGPRFTALIGSilAVSVLLAAVLVAASAPIWVFAAALTVFGLANAFVWAPMSVAALNSAPDrmGAASGAFNAIKQVGAVVGSAVTAALLAVTSQGAALAALGVAALVCVLASALLGR--------
     369 UniRef50_B8GNI2        Bcr/CflA subfamily drug res...   204     7e-51  1  26.9%  5:390    6:397     ----PRWRVALLVASLAMLAPFTLDTYLPSFPDIAEEFGAGPARMQQTLSIYLLGFAVMTLVYGPLSDAFGRRRVVLVALVGYMIASIGCALAQSMETFLLMRAAQGATAGAGTVIGRALVRDIYAGHEAQRVMGLMMVMFGAAPALAPVIGGLLHDVAGWRSVFVFLSLFGAAVWLFTFRRMPETLPPVArpHFVLASYGRALANARFMALVLVLALAFAGMFLYIAASPELIYGLLGYGVNDFWRLFAPLVCGIVLGGWLSSRLAERIPPVTMVTTGFAVMAVAVSLNLLQAHWLPvfTALAPLPLYSLGLALCMPNVTVLALDCYPHQRGMASALQAFLQLSANALVAALLVTVLSRSLAWLSLGMTGLYLAAAMLWGLWWLIYGRP----
     370 UniRef50_C6DDP2        Drug resistance transporter...   203     8e-51  1  24.0%  3:386   10:395     --KTPGLFFIAILSALMAFTSLSTDIYLPAMPVMAKDL---QGNAELTITGFLIGFCIAQLIWGPLSDHLGRRMPLFIGMVLFIIGSVGCALSTDMSQIVFWRVFQALGACTGPMLARAMIRDLFSRTRAAQMLSTLIIVMAIAPIAGPLLGGQLIKVTSWHAIFWLLAVIG-IAMLMSLRWLPETLPEDRRvpSAFRNYYALLTNTSFMRFTLCLTFYYVAAYAFITGSAFVYITYFGIDPQHYGWLFALNIVGVMGMSVVNRRLVQRYSLEKLLKFAVLIATVASFILAVGahIGGIVLIVVSVFIFFSMNGIIAATSTAAALDAVPNIAGSASALIGSLQYGSGIISSLLLALLSDGTPWTMAWIIALFTAASAVIALTTRER--------
     371 UniRef50_C6QAT4        Drug resistance transporter...   203     8e-51  1  16.7%  2:360   10:421     -STASKVLTASAVLLAVLMVILDMTVVNVALPHMMGALGATPDQITWVLTSYIVAEAIVIPTSGFLAARFGRKRVIFVSVAGFVVASMLCGQAQTLAQMVIFRLLQGAFGASVVPLSQAIMVDTFEARNRGKAMAIWGIGILLGPIMGPTVGGFITDHLGWRWVYYINVPIGLVNLAMILVFLKQT-PKSRAVADWIGALLLAVGVGSLQMLlfIIALIFVSTFCLVAFapLFLEHLLGYPASTAGLVMAPRGIAVAMGMVFVATTINRFEPRWLVLIGLTLAAAGTYATTWYNLDVDVFWIAPG-IVQGLGMGMIFVPLSTLAYQTLPQDAtqAAGIFNLARTIGGSIGIAIAATVLTR----------------------------------
     372 UniRef50_Q3ZW08        Major facilitator family tr...   203     8e-51  1  19.7%  1:360    1:416     MKKGNKLFILLGVILSMMLASLDQTIVATAMPKIATELN-GLSHLSWVFTAYMLSSTVTVPIYGKLSDIFGRRPLYLIGIGIFLLGSVLSGLAQDMTQLILFRGLQGIGGGAMMVNSMALIGDIFSPAERGKWQGVLGGVFGLTAVAGPLLGGWITDAFSWHWIFYINIPVGIAAMVVLAMAIPPIKHKIkrSIDFLGGALLIVGLVPLLLAFVWggIALIALFSflLYITVFAQGVIGVSATSSGLILAPMMLSMVVSSAISGQIISRTgyKKLAVGGVALATVAMFVFSFVGINTTNTQLVMCMILLGLGLGVTMPIFTIAVQNAFShqLGEVTAGTQLFRSIGGTVGGALLGGVMNA----------------------------------
     373 UniRef50_D1R7Z6        Putative uncharacterized pr...   203     9e-51  1  24.1%  4:377    5:390     ---RKKVPSFLLLTLLLGFPQISETIYTPSLPDIAHSLQTTEHLVELTLSVFFIGFAMGVFLWGILADFLGRRTSILCGLGVYLIGTLLCSLAPSIYYLLAFRWIQALGSSVGSVVTQTMIRDTYEGKERNQLFSALGAPLAISPAIGPFLGGYIDQLFGWNANFYALLVLGICILLYAWKALPETRPMHCRVQGwtLVAKKMVNDCKIWGYVLLIGGSNGILFSYYAEAPFLFIDLLKLTPGQYGLMGIAVATPFFLASFVSHHLNKQWQGEGIIFLGCAIVFVglGLIATKWGGTAFMALILPLLFLFFGIGLVISNSLSLALVDYQEARGIAGSLLGLFYYFVIAALTAIMGLIHTGTPYPLPCYFIVMSLLLF-----------------
     374 UniRef50_UPI000023DF63 hypothetical protein FG1137...   203     9e-51  1  14.8%  2:392   46:492     -SSKKKLFIVFVATLLLFNGTLASSLPANVITPMSADYGINNTqlALPISLFLVGYLFGPLVFGPLSELQGRKYVVQAAFAGYTIFTLACALAPNWASMLVFRLMSGIFASAPSVVGGGMMADIYSdtIRGRAFTCFFAVSICGPLIAPTIAGYVSE-VSWRWAFWVGLIVAGVT-VPPLVFLPETFGPTILERrlVRPVQMLFTELIVAATSLYIALAYSIYYMFFQTYPIVFKGIYGMSTKTSGLMYFPIIGGVFLGMIIFFLWDAYYTrrLPLACIGGPLLVISLFWLGWTARPEISWISPMTapFGATQILINMSLTNYLGDCYGVYSASAMAIGSCLRNLAAAGLCLAAAPMYTALNVGWATTILGIVSVFMCAIPFVFIRYGEYIR--
     375 UniRef50_D1A916        Drug resistance transporter...   203     9e-51  1  18.7%  3:371   10:436     --HPRRWPILGVLVFSLLVVVLDNTILNVALRTIarGLGATQSELEWAINSYTLVFAGLLFTFGVIGDRLGRKRVLVAGMAVFGLASLVSAYAQSPEQLIAARALMGLGGAAIMPQTLSIITNVFDPTERARAIGIWSAAVGLAVAIGPITGGLLLNHFWWGSVFLINVPIVTLGLTGMLLLVPESRNPDPGRLDPLGVLLSiwLEPVVLGPIAVgaFCFFATSGVFFFGSFYLQSVRGLSPLEAGAMMLPFAAGQLIFSPYSPTLVRRYGAKAVCTAGMLLVATAMVGYLLCDETSPLWVFGVVAFVQASGMAHVMPPATESVMSALpeRAGAGSALNNTARQVAVAMGVAVLGSLVASVYRGELSGLLA-----------------------
     376 UniRef50_C2BRX3        Possible transporter n=4 Ta...   203     1e-50  1  17.0%  8:365   44:466     -------LILALYLAGIFMGALDMGIVNPARTVIQNSLGVDDQAGVWVFTIYTLAYAIAIPVIGKLADVLGRKPVYVLAIALFGIGSLGCGLaqSFGLLLASRVVQAVGGGGMMPVATAAAGVIAPPAKRGMALGLVGMVYGVASVIGGSAGSLIMDIAgwQWIFYINVPIALAVVVLGAMFLDRERAEAGRHLDIPGTVLIvfQDSNVRVSLLIFAIAggALMMTVMFIPQFAENSMRLSTGDGGYPTIIIGLASGIAAPISGRLTDKLGPRFVLGLGMLISAISGLLLIFWtpYPGFLSTSVSIFVMGFGLGFLmaPLTYLILHLVprDANTGQATLSLTRSLATTLAPAIMVGLLATAMGGL-----------------------------
     377 UniRef50_C7PTJ2        Drug resistance transporter...   203     1e-50  1  24.1%  1:390    1:396     MQNKQHTIIILILGLLIALSPFSIDMYLPAFPAIASALKTDIAHVGYSLTSYYAGLCAGQLIYGILIDRLGRKKPLYAGLLIYLTAAFACAFSLNINMLVAVRLFMALGGCVGMVTARAIVRDLFPPKDTARVLSLLVLVMGIAPIIAPTIGSIVNTIAGWRWLFGVMALIALALLIATYTLLPETKTPDprIKDVLPEYIAVLKNPAFLVYTLAGGISYAGLYAYIAGSPFVFMTRFGFSDTAYSWAFAFNACGLISGSQINRLLLNRYDSIHIsaAILLFITGLLLLISTALGIAGAPMTLCFTFLFLFCLGFLNPNTTALALRPFTAAAGRASAVLGSIQMIAGVIASWTVNFFFNGTANVMAAVMFGCTALTLFLLVFFTGRRRTK----
     378 UniRef50_B3DY96        Permease of the major facil...   203     1e-50  1  18.3%  3:362   14:431     --RHNPWIIALSVMLATFMEVLDTTILNVALPYIAGGLAASNSQATWVLTSYLVSNAVVLPMTDWLGRTFGRKRLLIGCIASFTLSSALCGAAPNLGILILGRIIQGAGGGGLQPISQAILLESFPPEKRGQAMGLFALGVVVAPILGPVFGGWLTDNLNWRWCFFINLPVGILAIIASKITVEDPprNATKKLDILgnWFDALWLRWMGGLSLLgfIVGIVLYATLSGLPLFLQTLISYTAYQSGLAISPRGIGAVAGAIIAGRLLGVLSGRLIVALGFSMLALSSLQIGFFNLEIAKINIVIPNIINGIGAPFVFIPLTTAAVVTLreQIGAATGLFNLFRNIGGSVGTSMVQTFIQRLA--------------------------------
     379 UniRef50_C5E0X2        ZYRO0G16302p n=1 Tax=Zygosa...   202     1e-50  1  11.9%  1:388  100:534     LSWPRKYYVSTLVTLISGIITMISSCWSLVAEDVMSHFHISREVSVLGISLYIFGLGCGPLLLSPISELYGRRITFIFSLSFSVAWQCLVIWSPTIEGVLFGRFLSGFFGSSFLSVASGTISDIFTKDQIGIPMTFYALAPFAGPSLGPVLSGAFNKD-GYKWPFIVMMIVSSVLLGLVTFTVPESYKPVLLIrsVKRPIDLLLRDYMIGVLSFYTGLVLAIIYLYFTVFPYIYPKLWNFTVMETGLAYLGLLIGMIIVCPScaRRVERNgmRFEALFYGAFCTPIGLMIFAWTCYSHVHWilIGSAVFGAGVFFVFVGVFAYTVDAYRRYAASAMACNTFVRCIMAGVFPLFGRQMYKGMGINWAGFLLAMVAVGMIPVPFLFSKYG------
     380 UniRef50_B7VM20        Permease n=26 Tax=Vibrional...   202     1e-50  1  41.4%  9:390   90:474     --------LTFLIAILTAVGQMTQTMYVPSIGHMAGEFLVSASSLQAVMACYLIPYGLSQFAYGPLSDRLGRKPIIVVGLIIYIIGTLVALFAHEYEWFLAGSFIQGLGIGCGGAMSRTLTRDCFEGAELHRANSLISMCVIFSPLMAPVLGGYLTEAFGWRSSYLFLALFGIAVVITMMTSMMETLPKERRKhsVANSYKFVLSDKRFQGFLLVLVATFAGVAVFEAAAGVLLGGVLGLPATTVSLLFVLPIPGYLVGAGLSSYIAQRSSERRALNVGLVAILVGsvLIPGLFSQTTALTLIGGATIYFLGAGILFPAATTGALSPFPYHAGTGGAILGGMQNLGAGIATLLASFFPAQDQLPLGCLMIAMSFIAMLGLRWVNRKPDHS----
     381 UniRef50_Q4KIS8        Multidrug resistance transp...   202     2e-50  1  25.5%  8:391   15:403     -------RTILILGALSAFGPLAIDFYLPAFPSMALAFGTDEKHVQLTLAAYFLGLSIGQLAYGPVADRFGRRLPLLAGVGLFTLASLACAYAPNLEWLIGARFVQALGGCAGMVISRAVVSDKCDAVGSAKVFSQLMLVMGLAPILAPMLGGLLVNLYGWQSIFIMLTVFSALSGLAVALGLPESMPATRPRLPllRQYGLLLSDRVFLGHALTGGIAIAGMFSYIAGSPFVFIKLYGVPAEHFGWFFGINAGGFILVAQINARLLAKRGPAFLLARTVWIYLAAGLTLLGVSALHtlWPLLLPLFVCIASLGCIIPNAAACAMNGQGARAGSASAMLGCLQFSVAAGAAYLVGVLHDGSAMPMAMVISLCGVLAVSMAVMTRRLQNARA---
     382 UniRef50_Q1IAY3        Putative multidrug transpor...   202     2e-50  1  24.7%  1:393    4:397     LRSLTPWGWSCLLLALVCLPRVALDLYLPAWPQMAQALEVPPAQVQFSLTAYMLGYALCMLLAGPLCDLWGRRPLLLAGLGLYGVATLGCLLAVDLPSLCVARFFQALGGCCGPLVARVMVRDRFAADEQARLLGLLSSGMAIAPLLAPAFGSLLLEVLGWRGLFGGLLIIGLLSQVQAVRYLPETRPFDASPAHLCQAWRQVLGSRVFWRSSLVIGCAYCSYFPFISESSLLLQHGLGLSPQVYGLVLGGTVAAYAAGSRCYGLLVRRLGNERVIILGCAilAGSAALLALQLAGVSLWTLPLALLPVMLSVGLIIPACQWAVLQPFAAIAGTASGGFFFVQMLLTALSSALTGAWSDGSAWPMVGMTVVASALLPGVLWLTASRSRARTKH-
     383 UniRef50_C7Z660        Putative uncharacterized pr...   202     2e-50  1  11.9%  6:392   48:483     -----RILSIASITSLAFASCFAGAIYAPAQEAVQEEFHQSRLVAVLPLSMYNLGMACGPIVGAPLSETYGRKTVFVATTPIFLLFMVGSGFSKNVVSLIICRFFAGVFAAPNINNVSATILDYSEPRYRGASLGIYYSIPSLGSTIAPLIGGFIVRSKGWRWTQWV-AIMATVGLYIPVLFTKETYKKVVLRRriLRPLHMLFTEPIVTLVSSYNGFIFGLLYTFVTSVPWIFRHYYDFDETSESLSYLGVTLGTFMasFYQKRLTRWQRsrLVPAMVGSLLLPTSLLIAGWTAQYRIHWFVPIFfmSMVGSLLIYAGVNLFMLDSypLYGASANGAMMLSRYTLGFAFPLFALRMFQALGAGWATTILASCTILMAPIPWCFWVFGEKLR--
     384 UniRef50_B6HRX4        Pc22g12560 protein n=1 Tax=...   202     2e-50  1  15.3%  2:392   83:519     -SVSRKLFMTFLVSLLAFSVTATSAIDACGILQYSEDFNVSEVVGSLATALFLVGFGSGSLLSGPFSETFGRNAVYLITMVLFLIFIMAAGLAPNIHSHLIFRFLAGFFGSTPLSCAGGTVADLWNPVQKTYAFPAYAIPSFLGPMAGQIIGSYIPVNLGWRWLEWIMLIMGGAILVIVLLFQPETYGppRLLASVYRPFALVYSELIIILMSLYLTVVYIVLFTFLEGYTYVFGHTYGLSQQMTSILWVGMLCGILLVSFLVPVVYSWTarLWYAMLGGAPAVPISLFWMGWTSYpsIWSPLIASAVFGYGITAIFVSAYMYIIDSYGVYSASALGFLVFTRYVVAGGMTVAGGPIYRSIGVHYTLTILGAISTAMAAIPYLLYVYGPRIR--
     385 UniRef50_A2QZE2        Contig An12c0130, complete ...   202     2e-50  1  13.1%  3:392   83:514     --TWKKLINLILVAFHACMATFTASII-PAYESISEDLGVSMQRASYLTSLQIAILGGAPLFWKPLANRYGRRPIFLLSTILSLVCNVGCAKSPTYASMAACRALTAFFISPAAAIGSAVVTETFFKKDRGRYLGVWTLMVTLGVPVGPLIYGFITYRVGYRWIFWVLAITNGVQFILYIFFGPETrpTPLTIREFFHPLTMAARPSVMIPACAYAMVFLFGSVMITVEVPQLLQTKFGLNAEQLGLQFIGVIIGTVLGEQIGGSMSDFWMRRryPGVILTIVGAIVFLVCTQQAAPNHWVviIGTAIAAFGNQLVTTVLVTYAVDCYPEDSGSVGVFITFVRQVWGFIGPFWFPDMFDNVGVAASSGVSSALMFAVSLLPVivHMFGRKWR--
     386 UniRef50_O34307        Uncharacterized MFS-type tr...   202     2e-50  1  16.5%  2:382    4:386     -TKSKAVLILYTVCFSAFFASLSQNIYSPILPIIKESFHVSTAMVNLSVSVFMIVTAIMQIILGAIIDFKGARIVLITGILATAAASIGCAVTTDFTLFLIFRMIQAAGSAALPLIAATTIGQLFTGNERGSAMGTYQMLLSVAPAIAPVLGGFIGGAAGYEGIFWILAAISIVLLVTNSITFPKDSPTeqAKGNVFAHYKSIFTNRTGNVILTLSFVLFFIYFAVIVYLPILLTEHYHIDVGIAGLLYLPLALSTIAGTFLFKRIQAKIG-LHTLFIGSNVIAACSIILFAVTHSVSLVLMALTLALFGISMGVIPPLYSTMITNEFEHNRGSAIGMFNFIRYTGMAAGPMVSAYLLTMMPSAMSFSLLGLGFAALSFCLL------------
     387 UniRef50_Q5FSF5        Putative efflux protein n=1...   202     2e-50  1  22.4% 11:390   21:409     ----------VLIGVIFILGPVSTDMYLPAFPALEHDLGHGPGSAQLTLTAWLAGLAIGQFTLGPLCDRYGRKLPLLCGLVVYALASVGLALTTSFHMFCALRFIAALGGAISSVAPRAMVRDVATGAAGVKLMSQLMLIFGLGPLLAPSIGSFLLDLGNWRLIFWANVVFGVVMFLGTLFLLPETLPMERrvSGMAARYRDLLREPLFCSAVMVVSFGTFTMFAYLSNAPALFENILHFSPHLFAIFFGLNGVGFILGSQINARLANRFLFTRVMEIGMlcVLAVAVCLSGLAGPKDPWILCALIWCTTFSLGFIGPNAGILALTHHGHQAGAASALMGTMNWTIAGLAGVMMSFLPTHWVGSTSIGMLVGISCCWLCDLWRRRLDPES----
     388 UniRef50_P96712        Multidrug resistance protei...   202     2e-50  1  18.0%  2:357    7:416     -KQASTKFVVLGLLLGILMSAMDNTIVATAMGNIVADLG-SFDKFAWVTASYMVAVMAGMPIYGKLSDMYGRKRFFLFGLIFFLIGSALCGIAQTMNQLIIFRAIQGIGGGALLPIAFTIIFDLFPPEKRGKMSGMFGAVFGLSSVLGPLLGAIITDSISWHWVFYINVPIGALSLFFIIRYYKESLEHRKQKIDWGGAITLVVSIVCLMFALELGgfLYGGTFIILafIPIFVQAVYGSSATSAGFILTPMMIGSVIGSMIGGIFQTKASFRNLMLISVIAFFIGMLLLSNMTPDTARVWLTVFMMISGFGVGFNFSLLPAASmdLEPRFRGTANSTNSFLRSFGMTLGVTIFGTV-------------------------------------
     389 UniRef50_D0KDX1        Drug resistance transporter...   202     2e-50  1  19.1%  4:359   13:418     ---PHRHWILIACMLAMFTAAIEVTIVATALPTIIADLG-GFSLLGWVFAGYLLTQSISIPIYGRLADLYGRKKVFFFGMIVFLLGSILCGFSTQMGWLIVFRTLQGLGAGAITPIAFTIVADVYSSTERPKIQGYLSSVWGVSAIIGPLLGAFIVQHFNWALVFWVNVPIGLFSIFLLARYLPTINSVRQHKLDWVGAflALWRNRIIIAGNLGGLVVGAAMMGVSAFLPTFIQGVMGKTPLEAGSILAMMSIGWPLASTLSGRLMLWTSYRFTAMCGGIVLLIGSLTLLTVQPDSNLMWARLAAFLIGSGMGLSSTTFLVSIQNSVdsIRGIATASAMFTRMLGSALGTAILGATLN-----------------------------------
     390 UniRef50_D1B0Q6        Drug resistance transporter...   202     2e-50  1  22.0%  7:392    8:391     ------RQIVLILASLSAITPLAIDMYLPAFPAIALDLHSAIPHVEFSLSLYFFGMAMGQLFGGPISDAYGRRPMILIGLSVFALSSFMLSIANSIEMFWILRALQSFGGGVATVNVSAIVRDKFDGKESARIFSMISMIMLMAPLLAPTLGSAILKLLDWEAIFIGLGSYTLITLGVYLFCFPKTK-QIRTKITPIQNYKTVLSHKLAMVFVISQILCTSGMYTFITSSSFIYMEHFQLSAAQFALFFSSNVTMMMFFGWLNASLVKRREPLSLLRFGMSVQALLGILLFTF-QDGSLYLIFPLIGLYIGILGFIFSNSIALTLEFFPTISASANAIIGVLQYSVGALMGFVASSFHDGTLFPITTVMMSVSLCGIILLLTGSRGYAPRHH--
     391 UniRef50_A0JZZ8        Drug resistance transporter...   202     2e-50  1  24.0%  7:368   31:397     ------RPLAVVLGLLTIFGPISMDLYLPVLPALTSELNSTTSVAQLTISACLLGLAIGQVVSGPLSDRFGRRPPLLIGVIAYTVTSVLCALSPTVETLIAARFVQGLAGAVGIVIAQAAGRDVYSGGKLIRYYGRLTVLGGLAAIIGPVIGGQLAAVTDWRGVFLFLAAVGVAILAACLMIFHETLPEGRRSTGGLsdFRRLLADPMFVGAVLITGFTYSAIFAYLSGATYILQGMYGLSPQGYSFAFGLNSLGFVIFGFIAGRLAEHWSERGTLAAGLAMTLAGAllLATAILHLPLIAIILSLFTMVSGVAVTSPPATSLALKGYPDIAGTASSLLGLARFAFGGLAAPLVGIGGASDPVPFGIV--------------------------
     392 UniRef50_Q2GPT8        Putative uncharacterized pr...   202     2e-50  1  14.1%  4:392   61:498     ---WLRWALCIAAGYVTFSVAFISSAFSGGIRNISQDLDATPESATLGVSLFLLGFVLGPLLWAPCSERFGRQVILLSTMAVHVALNIAVCFSPDLAMLLVLRLLSGAFGAATLTNSGAVIADIFPPRQRGLAITVYALVPLFAPVLGPMVGTYVSGIFGWRWSMALMALMSMTALAMAALLIPETYAppSFATTLSRPFFLAANEPIISLLALYQAIVFGTLYFMFTALPMVYTDILGWPREQSGLAFLGVVIGMALSVVFAIWDNTRYSrrLPSCCLGGVCIVGGLLWCAWTAEPGLPWLvaSGVPFGFGIVLITIGSTNYLVDVYTIQAASALTVCICSRAIWGAIFPLFAPGMFNSIGVWWSLSIPAILSLMCLPLPFLFYKFGPLIR--
     393 UniRef50_A8L266        Drug resistance transporter...   202     2e-50  1  21.5%  2:359    8:419     -RPSQRAVVATLFVATMFITIMDTTIVNVALPSIAADLGVSSGSIDEVVIAYLVSLAVSIPASGWLADRFGSRPVFLAALGVFTAASALCGLAGSLTALVVFRVLQGVGGGLLTPVGMAMLYRVYPPAERARAARILIVPTVVAPAVGPILGGVLTDQASWHWVFLVNVPIGIAAFGFGLAFLAGSRVPGAGRFDALGFVlrLLGNDLFRTVSLTLSIAFMAFMGVLFLVPLFMQTVRGVSATTSGLVVFPEALGVLTATQIAGRLYPRIGPRRLMAGGLVFAAASMLALGFLDSAGSLWPLRALLFGVGFGIGFVMMPAQTAAFAtsTQQTAQASALFNAQRQLASAIGVALVSTALS-----------------------------------
     394 UniRef50_A7GX73        Drug resistance transporter...   202     2e-50  1  22.1%  2:385    4:385     -KHNSRLFLLLFLGALSAFGPFVTDLYLPALPSITTWFDTSVSATQLTLSTSMAGLAIGQLIIGPISDKFGRKRPLTISLIIYTISTICIFFAQSIEIFIFMRVIQGLASAGSLVISRAVVSDLYSGHEMTKFFGLMMVINGIAPIISPIGGSFLLEFTDWRGIFVVLSIIGVLLFVANFNflDEPRRIKAPLLETYGVYKQILINKTFMLFVAIQTCALGTMFAYIACSSFIFQDFYGLSSMSYSVCFASNGLALVIGSRTASLLKDKMALR---IGVYGIFASSIVVGLILTAKFHVYAVIVAFFIMLLFIGFILPTASSLAMNSARRYAGSASAVLGFCPFFLGGIVSPLVG--LGDIFYSSSLTMLVCTLLALTAFFKVMR---------
     395 UniRef50_A0B668        Drug resistance transporter...   202     2e-50  1  22.4%  9:387   29:407     --------LIVLISLLSAFVPLSTDLYLPALPGMADYFCVSSDLANLTLTMFFLSFGAGTLLWGPLSDRYGRRPMLLIGLSLYSIASLACAFSTDIHLLIAFRALEGIGGSSGFAVATAMIKDVYDVRSREPILAVVQTMVLISPVSAPVIGAILLKFTTWRGLFEALAFIGLLALAGSI-ALQETLERrgSLLHSLGRLYVVARNPAFASLLLLFSLPSICALAFIASSSYIYIRGFGLSELEYSYFFAFNAIGMISSPTIYLKLSRRMCRRSFVTMCFGVMILSGTLILIL-GTWSPWIFAVALLPSTIAAGAVRTPGTNLMLEQQREDTGSAAALMSCFGIIAGSIGMTLISMTRENMIPALGMMYMLIGTICAILWHYISKKP-------
     396 UniRef50_Q2T8K3        Drug resistance transporter...   202     2e-50  1  19.5%  2:360   71:485     -SAREVRTIYWALMVVIGLGTLDQSIVATALPRIMSDLG-DIAKSSWIVTAYVLSSTTSMPLYGKLSDQFGRKRMILIAVAVFLVGSLLCGLSRSLTELIAARVVQGLGAGAFLPLSQAIIADLIPPAQRGHKQGGIAAVFAATSVMGPLLGGVITDALSWHWIFLLNLPVGGAALYNIVRKLRPGRPGGAQRIDYLGSLLMtwHSPQVYGSAGAGLVLTAAlfGATLFLPLFSQLVSGTGATESGLLMVPLMLGAVISSVMGGRILARIGRYKPTQVAGLSTAIVAFALLAwsARLSYWFIEPCVFMLGIGLGLVMPNMTVAVQNALpaQRGVGTAMLTFFRSLGGLVGIAGSSAIIAS----------------------------------
     397 UniRef50_B7J6B6        Multidrug resistance protei...   202     2e-50  1  14.8%  2:359   55:468     -SPASRLTITVAVMLAVVMQVLDLTIVNVALTYMRGSLHANSDQITWVLTSYMVANVIILPLTGLLVERYGQRTIMLWSVVGFVISSVLCGQSHSLVEIVLWRFLQGIFGASLAPVGQTIMLGAYPSDKRGQAMAILGMGIMLGPILGPTLGGYLTDTLSWRWVFYVNIPFGILAFLLM-RTIPDGGKSTTPRPVDWTGFTLmfSSRTIIILTIciGIFGLALFGTMVILPIMLEGLMRYEAFTAGLVMAPQGIGAMIAMMFAGRMLGrvNPRNIVLVGIVFGAFGTYLTTLYNLDISMAWVIWPSFIRGIGFGLVTIPLFTLAFTTlkAQQAEGSGIFNLMRTLGGSIGIAIVSTVMT-----------------------------------
     398 UniRef50_C5VFP5        Methylenomycin A resistance...   202     3e-50  1  19.6%  1:388   76:521     MRQETKRLATITVLLGFFVIMLDTTIVNVSLAHIGKDLHGTTASLQWVVDAYTLSFAALLLSAGTACDRLGAQRIYLFGLILFALFSIACALSPSMEILISARALQGVGAAMVVPSSLALISEMYSDheRAKIIGLWGAAGGIAAALGPIIGGVLVSTTGWRAAFWVNIPIIGVLAILTISFIPRRVPQASNSFDVLGQtlTLFKTQAFSISSIVGFCLNFSFFGQLFVLSLYFQKYLGWSPWIAGLAMVPQATSAIVASPLGGRFSAKFNPYSAMFVGLSVGALGFSSLVVINESTPYVLVALLTFCAGFGMAFAMPAATSAAINAVpeFAGIAGGIINAARQTGSVFGVAILGIMIAEggFHHAVLMAGGVFALAAVLVMLASRHP------
     399 UniRef50_Q7N4W5        Similar to transporter n=1 ...   202     3e-50  1  18.0%  3:386    2:445     --KRNKRNVLLAANISYILVILDSSIVNVALPTIKESLSLGVTTLQWVVNAYLVLFASLLLSGGALCDRFGSKSVYITGLGLFTLSSALCGISSEAAILLTGRVLQGISAAILVPGSLALITHTYTDkeRTRAIASWASWGGIALVAGPVIGGWLTEYLSWRSIFLVNVPLCLAGIFLTLRVQSPEHEHKSLTMDIKGQllELFRRPNFSAISWIFFSGAFSFFGAMFILTFWFQDIQHLSATQTGMALLPLSISVILGNKVSGWLARRYQTSHMMIVGAMIRLVGFSGLLVTQFNNDYAYLFVPLVLIGFGGGLGSPMSTSLFMQSTpqYTGVASGVSRATGQIGSAFAVAVFGQMVNslNMKYAVITIIIATLSILIINFLFVK--------
     400 UniRef50_C0YUQ3        Bcr/CflA subfamily drug res...   202     3e-50  1  22.3%  3:393    2:400     --KKNLNIVVFILALLNTLESLSIDLYLPAFPNMAKIFNTDIGHIQISISVFFAGFAFGQLLWGPLSDKKGRKPVLYSGLLLFITGATAIYFTSDIYVLWGMRFLQAFGGSAGIVVGRAIIIDLYDKHKAVTIFSQQSQISGIAPIVAPLLGSVFLKFWGWNSSFAFLCIMGLITFFMVYKYVPETNTRINLPDdlKDQLKMIISNRDFISSTMVGSIAFASLIIYISNAPFLFMEIHGFSSSVFSFIFAFNSLALITAAYITPKLIKRISNSTLLFVATVILLVVCTliLIAAKNLSVALEIAMLYLSLLAIGILFPITSAHALSPFKEGRGTAAALLGFMQLMVTFLMSALLGFLEADSIIPMVVTRSAMALIAVWFGYRIFKTQKKESVH-
     401 UniRef50_Q0SF98        Possible antibiotic efflux ...   202     3e-50  1  18.9%  2:361   13:428     -SRTRRFLALAVICLAELLVVLDNTIVNVALPSIGVELRTSVSGLQWVVDAYTLTFAGLLLAFGNLGDRYGRRRVMVIGLIGVAVMSIAGANAESLGQVIAARAAMGVFAAAVFPATLALVINIFTdrERALAIAAWTAMAGFAIAIGPMAGGWLLEHFSWHSVFWINVPIAVVVAAATLLLVPESRASVIGRMDLVGIalRLFRNRRFSLPALAIAIGYFSMFGFLFLITQYFQGVREYTPFEFGVASLPFAVSVAVGAPVATLLAQRVGTTPVIVFGLLLTGVGLYLGGQVAVDSSYLtvLPSMVSMALGLAIVQGPATESIMASLpdEAGAGSAVNDTTREIGGTLGVAVLGSIVASY---------------------------------
     402 UniRef50_C3BVQ4        Permease MDR type n=6 Tax=B...   201     3e-50  1  15.6%  1:347    1:402     MENMRNIFVLIALVSGFFMAILDSNIVNIALPGMAKTFHTSIDAISWIANGYNVAFVTCLLMAARLADQFGRKKLYLIGLLGFSISSFMCGVASSFQMLVIFRVLQGISAAIIVPVAMPLGLELVPKEKQGMIGGVMGAFGGLAAAIGPSLGGVLIDKLSWNWVFFINVPVGIFSLIFIFLFIKESYDHTASSKIDWAglLFVISIISFMLFilALFFVGMGLMNFLFIFAFYLVQVEGMSELKSGMIISTLAIVSIIITAIMTPIAAKRGSSVISSVGVIAFIVVSYLFGHMESSFSAWDYIWRLVIVGFGAGCTLAPLTTTAVLSVpeKSGIASSISNISRTLGS-----------------------------------------------
     403 UniRef50_B2AAQ8        Predicted CDS Pa_1_4860 n=2...   201     3e-50  1  17.7%  2:362   68:489     -TKLETTLVITALASALFLGALDITIVSVAIPTIAEEFG-STAGYTWIGSVYMLASAAGAPMWGKISDIWGRKPIMLIAVGIFWIGSLLSALSKNIGMLIAARAIQGIGGGGIIILVNVCISDLFSMRKRGIYFGVMGIVWAVASAVGPVLGGVFTSQVTWRWCFWINLPVSGVGFAVLAWVLKLHNPRTPMrlAVIGGTLMVlwSSPTVICLIVFGVVTAGIFVLiyYLPLYFQAVLGASPLMSGIYVLPFVLSLSVVSAITGVVIKKTGKYLpiIFGMSIMTLGFGLFIALEPQANWAKIVVFQLIAGIGVGpfQAPLIALQTTVGPRDMASATATFGFIRQLFTAISVVIGGVVFQNGM--------------------------------
     404 UniRef50_A5AB70        Remark: YBR180w is the syst...   201     3e-50  1  17.1%  6:392   51:480     -----KWFLTFIVAAGGLVVPLSSGVLFPCLLEIAADLDTTESVVNLSIAFGSLAVAITPLWWSYFAELYGRRLVYLLSFFFVGIFCILAAISPNIGMFIAMRLLGSASSASLQSVSAGTISDMFETHERGKAMGAFMLGPMLGPMFAPIIGGALTMRWGWRSTQWFMVIYGWTVFMVMVFFLPETahRANASSPVKKAAHFLLKPIEAAKLLQYPPILITVYYTAIVFATYYLiaPYYWSPVTVGVAYIPGGLGLLFGAIIGGRWQDAIMARTArcLMAGILFPGALLWWGWSAEKQIFWLVPLifFYGFSGMILTNVTMTMLTEFTPKKSTVGVAVNNLLRNSLSCVSAVIAQPLFDAIGTGWSFTAACLFCLLSGIPLILLRMKREEWS--
     405 UniRef50_C8WC71        Drug resistance transporter...   201     3e-50  1  18.4%  8:383   22:404     -------AFVLFIAGMMAIPSLAFDSMLPALPEMGKSFSVtpNDQQWIIVVYFLGIGFAQIFYGPLSDRFGRKPVLITGYILFILTSLMVGLSQSYPLLLAARLIQGVAAASSRVLATSIVRDCFSGRRMSKVMSFAVIIFMGVPIFAPSLGSVVLLYASWRTIFFSLTLFTLFFIAMIIWRLPETLHPEDRrkDTIRAAGLFFKSRDTVAYTFALMMIEGGLLGYLNSVVEIFTDNFHASPKVFNLAFAAGGGFMILACLTNSFLVEKVGMHRLGHGSLFMMIAMSiaFLGYCGLETAYTFVIMQGMTMFFFSLCIANFSAISMEPMGHIAGMASSIQGFIWLVGGDFFGAILGQMFNNTIFPMTIGNALYGLFALAIILWA-----------
     406 UniRef50_A0LW52        Drug resistance transporter...   201     3e-50  1  19.1%  1:366   16:440     MSHRQIVIVLSGLMVGMLLAALDQTIVATALPRITGDLG-GQQHLAWVVTAYLLTSTASTPLYGKISDLYGRRKIFQLAIVIFLIGSALAGASQNMAELIVTRAIQGLGAGGLITLALAIVGDIIPPRERGRYQGYFGAVFGLSSVIGPLLGGWFTDTISWRWVFYINLPLGALALVVTSAVLHIPFQRREHKVDYLGAAVLvwGSPQIIGLFALSALLFAAffGAVIFLPVYLQNVKGSSPTVSGLQLLPLMAGVLFTSIGSGRLITATGRYKipIVGMVLVSIAFAMLSFLKAGTSYATLAGEIALLGAGMGLVMQVLVLAIQNAVpaDLGVATSSNAFFRSMGSSLGVAVFGAIATNGLTAYV----------------------------
     407 UniRef50_C9RSF6        Drug resistance transporter...   201     3e-50  1  15.1%  5:362   76:487     ----SRGKVVATVMLGAFVAILNQTLINVALPHMMQDFNVETSTIQWLVTGYMLVNGVLIPISPFLIAKFPAKRLFLSGMSFFAIGAFVCSIAPSFAVMLAGRLTQAVGAGIIMQLMMVIMLSIFPPERRGVAMGTVGIAMMFAPAVGPTLSGWIVEHYTWRLLFYVVLPIAILDIVLASVWLKHTPRKGNPVLDVQGAvfRVFRYPVFTLATVIGSVINMAMFAAMVLLPVYLQNLRGFTPLDAGLLLLPGAIVMAIMSPISGWVFDRIGARMLAIVGLIITAVTTWEFSKLTMDTPYSQLIWLYIFRMFGMSMLGMPIMTEGLNALPRHlsHGTAMSNTIRQVAASLGTAFLVTIMSNRA--------------------------------
     408 UniRef50_C4L8J7        Drug resistance transporter...   201     3e-50  1  27.9%  1:377   28:408     LSRREKWIPVIYACLLIAVGQTGMSLLLPALPAMQQDLHVSSQMTQWLVSAYLLGFGPSQLFYGPLSDMYGRRPVLLAGLMITFSGILLCLFAhsATLIILGRVLQGIGAGCTSVIARVSLRDRYEGAHLRQAMAYFGIVMAFVPTITPLAGGYLTTHFSWISIFFTMAGYLGLLWVLLFYRFEETHAPEphAADFVHQYWLLLKSDHFRCYSGVVSIQYALNIFSISVMPFIMQIMVGMSADTYGRWTLLPAVSLVLGGVLASKTRHYFSKESVLQAAAALQLISGLSMLLL--PHTALLMMLGLSLFAFGNGVAFPNALSSLLEPYKRTAGTATALAGASQMLIASFSSALLVSLGITSILGLGMVILLGSSVLL-----------------
     409 UniRef50_Q1ATX5        Drug resistance transporter...   201     3e-50  1  18.7%  1:359    3:410     LSRRRKILVTLATLIGTFLAALDSTVVGTAMPTVIGDLG-GLGLYPWVFASYLLAATVTGPLFGRLSDAYGRKPVYLAGVSLFLLGSVLCGTAGSMGALIVYRTIQGLGAGAVQPVAVTIVGDIFELETRARIQGLFGAVWGVSAVVGPAAGGLITDYLSWRWVFYVNVPFGLAAGALLALALRESFERRPGRADYPGVFLllFRERLFAVASAGNAALGGVLLGVSVYVPLYVQGALGGTALTAGTVVAPLSIGWPVGSFVGGRMLLRAGYRTTLLVGSAFVVAGSAMCLALDAATPLAYVILSVFVIGLGMGFSSTSYLVSVQNAVphRRGIATSSVVFFRTIGGSLGVAVMGALLD-----------------------------------
     410 UniRef50_B0DBI2        MFS drug/polyamine transpor...   201     3e-50  1  13.9%  2:374   78:498     -STAKKWTAVSIVSFYTFVSPLASSMMAPGLPEVAQKYGITNSSiaLTLSIFLLSFAIGPLIFAPLSEMYGRTWVLHIANIFTMGFSLGCAFAPTTGALIGFRFLSGLAGSAPIAIGAGSIGDMFSERDRASAMAIFSLGPLIGPVVGPIAGGFIAQTIGIKWVFIVIAITCGVASLFGIPLLKETYAPVIRLQRDarPIIMLFSSLVCFMLSLYMAfvLGIYYLMFATFAELFHNTYGFSAGTGGLAYLGLGIGFLVSTIFGAKWADAaeMRIPALSFGSLFVPIGLLWYGWSAAAKIHWIMPIIGSGIYGFGGL--PIQLYLVDAFTFAA-SATSAAAFFRSLFGFVFPLFGQQMFDRLGLGGGNSVCLSLL--------------------
     411 UniRef50_Q5WI75        Major facilitator (MFS) sup...   201     4e-50  1  16.3% 10:377   16:436     ---------LIAVVVGMVMVILDSTIVNVAFPKFQQEFGSTLAVVQWTFTGYTLALSAVIPLAGWMTDKFGAKRIFLTTVALFTLGSVLCGMAQTIEQLIIFRIVQGIGGGMVTPIGMAVIYRLTPSHKIGEVMGVLGIPILIAPALGPVLSGWLLDYVSWQWIFLINLPIGIIAIALGMKWLPAFPQGEVPKLDTLGMilRVFKSSDFTRGILLLWLVQIALFGVMVLFPVYLQTVRGYSPLDTGLIMLAQAVGSILFTPVGGRMYDKVGARPLALIGLTAVSAALFWLSHVSPEAGLTMLLLPLFMIGSGMGLIMMALNTHVLNSAPRdvGRVTSLTTAAQHVITSFAVAGLTGFLAYRMNEMTMNVELQSIAAA-----------------
     412 UniRef50_B2WNM9        Putative uncharacterized pr...   201     4e-50  1  20.1%  5:392   49:483     ----RQRFILIVVTAAGFFGPLCGAIYLPSLKLFQRVFDASESVINGTVSMYMVVFAIAPLFGATASDIGGRKTVYMVGLGSFIIANTLLAVLphLASLYFLRVFQAFGSCIVFSVGAGTIADITEPANRASALSWFLMGPQLGPLLGPFIGGQFATATRWRWIFGFLSLASVPVYLAIIFCVPETLRspKGPRPSLLEFGRLLKYPPQLIVSFNGAVQFAGVYGMYISFPTIWEDGYHWTSAEVGYGYLCPGIAMFVTAIPVGWLSDHmeRRVLIQIPGLLIAAAGKIMFGWFTQKHVHPAAGLffLAGVGASMVSVVTASFQTECDPTQAASAVALGAFLRNFAAAICAAIMASILKGIGWGWTFTGLGLLDIACIPGVVLVMVRGAKFR--
     413 UniRef50_B9DLQ3        TcaB protein n=115 Tax=Stap...   201     4e-50  1  20.1%  2:385    8:396     -KEKPTVFLVIILGALTAIGALSIDMFLPGLPQIRSDFHTTTSAAQLTLTLFMVGLAFGNLFMGPISDALGRKQPLVIVMIVYTLASLGIIFSINITMMVALRLVQGLCAGAVAVISRAIASDMYSGKELTKFLAVLMLVNGIAPVIAPTLGGIILIFSNWHMVFIILTVFGIFMVMSSGLRIPESLSKEAREpsILKQFKSLLQRPKFVLPMLLQGMTFVILFSYISASPFITQRIYSLSPQAFSWMFATIGIGLIISSQLAGKLVDYFEPLTIMRGYTAVQIIGVIMISTVLILHLPIWILFISFLALVgvTGIATISFSVAMDERTGGSGSASSLLGLVQTLIGGISTPLVGLMGENSYIPYLIIISIASVVLIILHLLIAK---------
     414 UniRef50_D2M242        Drug resistance transporter...   201     4e-50  1  14.9%  4:359    5:415     ---PHKWLVVITVLLGTFTIILNNSMLNPAVPHLMNVFGGDAVATGWVITIFMVTMGITMPVTGYLGDKFGKKQLYMAGLFIFILGSILGAFSWDLSSLILFRGLQGIGGGLMMPTSMALIFEVFPRKERGLATGIYGIAAMMAPTIGPTLGGFIIEMGSWQWLFLCNIPTGLLGLIFSYLYLKQTKKVNGLTFDLSGFVAVTLGVGAILLAllNIALIVFGlfAGIFLVPLLVQNVYGYGAIMTGLSLLPGALLSGIFMSIGGRMLDKKGPALVVTTGLILTTIPTFLYGFLSLETALWVIFVLNGVRGIGMGLSTMPSTTAGMNAIPEqiTRGSAMNNVLRQMSSSLGIVFISVYFE-----------------------------------
     415 UniRef50_C5DWW4        ZYRO0D00286p n=1 Tax=Zygosa...   201     4e-50  1  13.8%  2:392   59:498     -SRGKKLWHTAIYGLATFSAQFNSTTTSPSVSHLGEYFNVSREKALLATSLYVLGIAFGPMFFAPLSEMYGRKIAIFGSLLVSMVFTLGSASSKDFASLLATRFFAGFFGGSPVVSSGGVLSDFWSIRVRSIAMVFYAMFVVCGTTVGPVICSLLTFQVgwRWPLWFSCIVQGFIMVVAVFTVSESHsrAKKIRKRTGNWaaMLATPIVFFLALFASYVFGILYLIVTSLPLTFKMTRGWEGTLGNLPMLAVLVGVILGGVANVWGGLRYRrrFPPMMMFAWLMPTGLFIFAWTSWAHVHWIAPCIGlmAFGFFVIFQGCLNYLVDAFTKYAASAIAANTFFRSILAGVFPLFGSALFGNLGVHWGASTIAFVALGMIPIPFVFYAFGSKIR--
     416 UniRef50_UPI00016AE76E drug resistance transporter...   201     5e-50  1  23.1% 10:346    1:338     ---------MVVVSLLCACSVLPLSIFLPSLPNIFSDLHVDYAVMSLSLAGYAGLSAILELFMGSLSDRFGRRPIILLSLALFTIGSLGCALATNAWSFLASRFVQAAVTSS-YPVSIAAVRDVFGKEAAGK-IGYAATAAALAPMLGPALGGFLDEIFGWRANFWVLAGVGALLFVFCWIDLDETKTNISRskAQLEAYPILLRSNRFWGYTVCLACSTGAFYAFLTGVPTTAKISFNLSPAALGAYMGAITLGFMSGSFLSGRYSKRWSLARTMVWglACFGPLISLTIALLGTSEVFWVLAPCMLVGIGNGLSSPCANAGAVSVHPTLAGSAAGLAGCITIGG------------------------------------------------
     417 UniRef50_Q2UL73        Synaptic vesicle transporte...   201     5e-50  1  13.3%  2:393   45:478     -SNAWKRTIIILVAFATFNDAAASSIFTPGVPLVLEEFHETNPTIsfLISVHIIGFATGPLLFSPLSEIYGRYLIMQISNIAFFFSCILCAVSVDVPMLAIARILLGVAGSVPNALAGGFVADLIPLEKRASSLALLAAGVllTFSLGPIVGGYMALKVGWRWTFWLEGIVVGCSTILSFFFLRETYAPTLlrRGISRPMKLCCFSPIMMIISLYNSICYTYLYYMITTFPTLFGEHYGFNAGEVGLTYIAQGVGCLIGQVAVGRFADWyeDRLPPAIVGYVVLAIGMLWFGWSAQVHAHFMVPisGVVGLGLVGGFLVVQVYIVDTFTIYAASALAANNLIRSIVAAVLPLSGPAMYERLGYGWGDTILGFTALALAPTPLLLMKYGERIRT-
     418 UniRef50_A8W034        Arabinose efflux permease-l...   201     5e-50  1  18.3%  4:385    3:438     ---TYQKKIIVALLIATFLAAVEVTVISTAMPSITSDLG-GMDKISWVFAAYLLTYAVMTPIFGKLADLFGRKRVFIGGVSVFLLGSVLCGFSQSMEQLIFFRAIQGIGAGALTPMTFTIVGDVFQYEQRAKAQAIIGSIWGVAGIFGPLVGGFFVDFLTWHWIFFINVPFGLVAMHLVGRHLQEQIEKKKRRIDYKGALTFIIGTGALLYALLSGgfLIAGLFLVLfyLPLWVQGVLGLAAIFSGLTLIPMSLGWPIAAFMSSRLLKQFGAKPVCIGGTGLIMLSTLAMTFVTAATPNWLLVIIMFFVGAGFGLAMTMFTVIVQSSVdtNRGAASSSNAFLRTLGQTLGITILGATLNQYIGGYGGEASAPADVLASGLSTVFL---------
     419 UniRef50_B8MPY4        Florfenicol exporter, putat...   200     5e-50  1  14.8%  2:392   36:457     -TAFQKHVIVSIITLSAFTAPFASSILFPSFTSLVDQFHTTDTQVALTTTVFLIGLAIAPLWWSSLSQQYGRRPILVASFLLSVVAVIVCAVSNSLPLIIVFRLIEALGCSSAQSVGAGVIADIYIPTERGTALGWFYLGTLIGPLIAPIVGGALQVWLGWRANLFFMAIFTFCTAMLTVLLLPETLVKPAAEEAPKLSFLQAVRrpSIVLSISYVSICFASLYCFNTTLPyySAAPYHFSAIEIGLCYISNCLGYAIGSVVGGKLSDAksVRIHTVWYGVGFVPAGLIIYGWLVEEKTFWLAPLvfLFGLGLMLITSTIMPFLVDVVPGAGASVVADLNLVRNLLAAVGTVVSPIAADNIGFGWWMTILAILCSLAVLFVVVVVWKDATWR--
     420 UniRef50_P96709        Uncharacterized MFS-type tr...   200     5e-50  1  23.1%  2:387    6:397     -TGKERLALAFLLGMLAILGPLNIDMYLPSFPEIAKDLSASASLVQLSLTACLVGLTIGQLIVGPVSDAQGRRKPLLICIFLFALSSLFCALSPNITTLVAARFLQGFTASAGLVLSRAIVRDVFTGRELSKFFSLLMVITAVAPMVAPMTGglLLPFATWHTIFHVLMIIGFLLVLLIALRLKETLPLEKRIPSSIgtMGSLLKDRSFMGYALTVGFIHGGSFAYVSGTPFVYQDIYGVSPQVFSILFGINGLAIISGSFIIGRFGGIIHEKSLLRIAVITAMIATAVLLTMTmhGPLATLVISIFIYMITIGMVLTSTFTLAMEKQGHRAGSASALLGMLPLLLGSIVSPLVG-INETTAVPMGAIMFVTAVIGSLAFFGLTKER-------
     421 UniRef50_C7RLZ9        Drug resistance transporter...   200     5e-50  1  26.7%  3:388   13:404     --PPRSRGLAVLLTTLVALGPLSTDLYLPALPTLARVFASDAARVQLTLSVFLAGFACGQIVYGPLSDRFGRRPAMLSGLAIYCAASLGCVFADSIEVLILARFVQALGACAGPVLGRAIVRDVWGATDSARIIAYMGGAMAIAPLLGPTLGGFLTVLFGWQSNFVVLLLIGATQLIAVARLLRESNVHrtHPRQMASTFLRLLADRHYLGNVLTFSFSYSALFAFISGSSFVLAERHGLTPQVYGMCFGVVVAGYLFGSLASGRLVRRLGSVRLLAGglGAIAGAGMWCLVVAGVHSIAALLGPMFLCTVATGLVMPNAIAGALAAYPTLAGSASALMGFVQMTLAALVGIAVGHGLAGGAGALASAVAICTALAPLSYLALIRVRR------
     422 UniRef50_A9HWU1        Putative transmembrane tran...   200     6e-50  1  24.2% 10:389   14:399     ---------LILMGTLTAIGPFSIDMYLPAFPAMADSLQVSRGEVERTLAAYLIGLALAQVVYGPLADRYGRKKPVLAGLALYTVASLGCALAGSVQMLILWRVLQALGGAAGVVIPRAVIRDHYETQDAARAMSLLMLIMGLAPILAPLAGGQLLAVMGWRSLFWLMAAGALALMAATALIMQESLAPERVQpsIARNYAALLCHRGFMAHSLAGGFGQAGMFAYIISSPRLFIELYGVDPQHYGLLFGANAAGLIIGSQVSARLLRTYTPLQLQRGALTALAVASLAALALALAgtLPLLMACLIGYMFSQGFVNPNSAALALSEQGARLGAGSALLGTLQLSCGAAAGFVVSAWQAAGPLPLATVLACCATLSWLAGRVARNLKRP-----
     423 UniRef50_Q21C25        Drug resistance transporter...   200     6e-50  1  17.1%  5:354   15:419     ----RRNMVTICAMTATIMQALDTTIANVALPYMQGSLSASQDQINWVLTSYIVAAAIMTAPVGWVANRFGRKRIFIICSAGFTIASVMCGLAQDITQMVAFRLLQGVFGAALVPLSQSVMLDIYALHERAKAMSIWGMGVMLGPIMGPSLGAWLTETYSWHWVFFVNLPFGIVTVAGLLVFMDETKLNHALRFDWFGFAALAIGIGAMQLAlfIGGCVFMalFSTMALSSPFMQNVIGFPILTAGLLLATRGTGTFVAMMMVGRIMRHIEARTLIAGGLTLTCATLYFMTQWTDQTSVYSIIVVSIAQGFGFGLVFVPLSTValTLPGHLRTDGTAMLTLVRNVASSIGISVV----------------------------------------
     424 UniRef50_B6QZ78        Drug resistance transporter...   200     7e-50  1  20.2%  7:383   20:401     ------WEIVSLVAALMALNAVATSMMLPALPAMSEALSVADNDRQLVITAYMIGLACASLFFGPLSDTIGRRTTLLIGLSLYIIGGVYSTFAMSYEHMLAARALQGVGAAAPRVASISMIRDWYSGRQMGKVMSLVMVAFQIAPVIAPFLGQVVLWFAPWQGVFAALTMFGVLLLVWCLMRLPESLDPMNQrrSILSAYRLALTTRVTVGYMMAMTFVFACLFAFINSAQQVFMERFAL-ADLFPIVFAAISIAMALSSYLNSQMVEKYGLRKMSHMALLGFTATSLLTAAisGTLTIVSFIAIQSLAMFFFGFIGPNFNTMAMEPLGRVAGAGSAMIGFITTLIGALLGAGIGKLYDGTELPLVYGVALFSILGLICVLIT-----------
     425 UniRef50_A6WDT7        Drug resistance transporter...   200     7e-50  1  18.4%  1:375   20:451     MSHKEILEALSGLLLGMFVAILSSTVVSNALPRIVNDLHGTESGYTWVVTAALLATTISTPIWGKLADLFSKKLLVQIALVIFVVASAIAGLSTSMGMLITLRVFQGLGGGGLLALAQVILASMVSPRERGRYSGYLGATFALATVGGPLIGGVLTEHLSWHWCFYVGVPFAVIAFFVLQFKLkpEQPRREVSIDYLGAILLALGISALLiaLVAAGVVFlaMFGATIFLSQYFQLARHESPTMAGVMTIPMIAGLFLASTVAGQAITRTGkkAWLVVGGVLLTAGLALMGTIEYDTNYWVVAPYMALIGLGVGMMMQNLVLAVQNVaaRDMGSASSFVAFARSLGGAIGVSALGAVLGHRVTSHLETGLSTAGI-------------------
     426 UniRef50_Q11T42        Drug resistance transporter...   200     7e-50  1  22.4%  3:386    4:393     --TQNRHLITLILGMLATVSPFAIDFYLPAFSQIANELGTTTARISLSVSSYFIGMALGQLLYGPLLDRFGRKPPLYAGLIIFIIASIGCCFSTGVEMLITLRFIQALGGSVAGVAAMAMVKDFFPPEQNHRIFAMLILTIGLSPLLAPSIGGFVATAFNWKFVFVLLALIALFAITIVFLFLPEGQEPDkqLKPMAKTYLSILSDTQFFTYTISGAFAFASLFIYVAGSPIVFIDLFHVSKQMYGAIFAFLSIGFIGASQLNILLVQKFSSASIFRFAMRLQVAAGMviVAWNGWMDLYTTILMLFVFLSCVGLINPNASALALAPFTKNIGSAAAMMGCSQIGIAAVASIAVGMFDAASVLPMVLSMSATACIALALLMWGEKK--------
     427 UniRef50_A6Q5H8        Multidrug-efflux transporte...   200     7e-50  1  17.0% 10:391    8:387     ---------VLPLSLIVALRFFGLFIVLAVLSQYALQlgGTAFLAGVAVGGYAFTQALLQVPFGVLSDKIGRKKTILIGLLLFAAGSVICAVADNIYVLLLGRFLQG--SGAIGSVVTAMIADYVREDERAHAMAVMGMVIAMSFAAAMIIGPIIGGLYSVKALFWLTAILAILALGILFTAVPEPPKIVHHYSEEEAKIKEVFKDKDLVRMYITFLFHSSTMAIAFFIIPILMKQKFGLGPEHYWKVYLPAVIFGILSMGPAAVFGEKYHKGKEVFIVSILFIAVSFALMGFS--SSFLLFTIGAVFFFIGFNMFEPLLQSFVSKFArhQKGAALGVANTFAYIGIFLGGAIGGLLYQYGHEKAVAIFVLIVSMVWIYWIVGMRNPGVRA---
     428 UniRef50_D1VJD3        Drug resistance transporter...   200     7e-50  1  17.0%  1:364   10:430     VSPRQLRLIFVGLMLSVLLASLDQTVVTTALPTIVGDVG-GLNHLSWIVTAYLLASTVSAPLYGKLGDLYGRKTLFHAAIGIFIVGSLLCGAAQNMPELILFRALQGLGAGGLAVGPQAIVADIIPPAERGRYSGLMGSVYALASVLGPLVGGLFTDRLSWRWVFYINLPVGVFTVIVIALVLPASTPRRRQRVDwwGGSQYAWTSPVVAGLmlGTAAITMAMLGLITFIPLFLQTVQRISPTLSGFETAPIVTTMLVCTIWAGRRVARTGRYriVGAVLLIAGSGAVALFGTRLDAPYWHTAIGMVLFGAGVGLATVVYVLTVQNSVPhdIGAATASMAFFRSMGGAVGVAIFGGIFAHRLGA------------------------------
     429 UniRef50_Q2G4Y0        Drug resistance transporter...   200     7e-50  1  23.8%  7:393   21:418     ------RETIAMMALVMALQALAVDSMLPALGDIARELAVtpNERQLVVGTFLLASGFASLVPGSLADRYGRRPVLLSCIGLYILFSLACALATTFDMLLGMRVLQAVGCGGLAVLPGTIIRDRFAGDQMAKQMSIISVVFLVVPMLAPSIGQVVLLFAGWRWIFVFLAVMALAMGVWVAVRLPETLHPeiRPASIAINMLGAATNRSAIGYVLGGALTFGAMIGYVNCSQQLVGEHFGAG-KMFPVLFGFSALMMAVANFSNSRIVERFGARRvtAVILFICVSALQAWFSSRPDETLWQFMPLMIANMILIGFIGANFGSIALQPFARTAGTANSMHAFLRMVIGSIIGIVVGQAYDGTAHPLGLALLASGILSLALVLflFRRLHPPGTP-
     430 UniRef50_Q6C2G6        YALI0F08063p n=1 Tax=Yarrow...   200     7e-50  1  14.9%  4:392   51:487     ---RRKIQTTVLYAIMTFAAQMNSAIFSPAAPHLINAMGVGHEVATLTTSLYVAGIAFGPLLFAPFSEVYGRKIGVTMPFLISILFTCGTGGSENIQSIILTRFFAGFFASAPIVSSGGVLSDIWAPSVRGNYMVLYGGFVIAGASLAPPIGALLLKHSpwKWVCWFMVALSSLILVLVLILCPETYPPVLlkRHLIRPFAMLLT-PICFFIALYASFVYGIFYLTLTSVNYQFTQYRHWGYVEAFLPTIAVFAGAIvsNLWSGKRYRRleERLVVMMIFGWIFSAGLFITAWTSSPDNHWALpgLLLTGWGFFVIFQACLNYLVDAFQRYAASAVAANTFARSVFGAVFPLFAKQLFDTLGVDWGLSLLAFVAVAMIPIPWVFYRYGNRLR--
     431 UniRef50_A0ST42        MFS transporter n=3 Tax=Leo...   200     8e-50  1  15.9%  4:392   69:503     ---WRKWVITMSLALYALSTTFSSSVFGAATHVLAEEFALPAETVVLgtSLFMVGFATGPIFWGPFSEAFGRTRPLLAGYLGFAVLQLPIADARSLTSICILRFLGGFFGAAPSSILSGILADIWSPRERGFAMPTVGAFLTIGPILGPLIGSVLVqvLGWRWIANVVAIASFLIALSTFPFLPETYTPLLLARrlLRPARMLALEPILLMMTLYVSVSFGLLYNFFLAYPTSFIQERGWDQTTASLPLISILVGAIigALLSFSTNSRweTRLLLMMVGAVSLPAGMFLFAWtaTMNPWPQILSGIPTGFGIHLINMQGMNYIIDSYKIYANSAIAANTFLRSLFAAGFPILATSMYAAIGVKWGTTILALLAVAMIPIPILFYYFGAKIR--
     432 UniRef50_Q03DH0        Permease of the major facil...   200     8e-50  1  21.3%  1:385    5:395     ISTVRKWWLVFFMGVVSATGPLSMDMYLPGLPEMQRAFHSSASTLQLSITFCLIGLAVGQLIVGPISDRIGRRVPLVVGFGLYAVTSLMLIFTTNIYLFIGIRLIQGLAGSTGQVLSRAVARDLFNGHELTKFYAMLMAVNGAFPIIAPIIGGALLSIVQWQGIFVLLFVIGILVMVGVLCTLPETLKVTNNEVLTLggLGAMFGKRQFILIALTQGLIFGALFSYISASSFVFQTYFHMTVGQFSLLYAINGLGIILGNNLPGYLPEQIKDSDILNGGLigMFAGVLLVGSLLLRPMAILVIIPLFIVVFCVGVVNTVATSMAMSLGGrnAGAASAVLGLLMNIIGALASPLAGIMGTQSYAPLAWLIFGFEFLGLILFQLTRF---------
     433 UniRef50_Q0G4T6        Putative transmembrane effl...   200     8e-50  1  18.5%  4:360   40:460     ---PRRWIILAVLLLAGFMNLVDVTIVNVAVPSLTADLGASSAEIEWVVAAYILSFALGLLPFGRLGDIVGRKRMFLIGISGFTVGSALCGLAPTIGLLIASRFVQGLSSAMMMPQVLALVQVTFSREERGFAFSLFGVTAGMAAVTGPLAGGALIAalEWRPIFLVNIPIGLFALVMGWRLIPRTRRGDYEPLDLCGVALAafGWPWWCFAMMAASLPMATAfgFFFVTAIFLQVGFGFTPLESGLATTPFSVGVFIASLVSGRFGSAYAKARLVTGPLILASGMIYLLTVVSgtTDHWAFTAPLVLAGLGMGITVAPLFATILTVVdrDAGSGSGALQTFQQIGGALGVAVLGQIFFG----------------------------------
     434 UniRef50_Q03N75        Permease of the major facil...   200     8e-50  1  24.7%  1:380   27:410     LTRRRRIWLTLLLGTVSATGPLAIDLYLPALPQMKAQFATTASLMQLSITACLIGLALGQLIAGPLSDQYGRRKPLIIGFVIFGLVSLAMAFIHSVTLLIALRFIQGLAGATGQVLARAVARDLFSGKKLTRFYALLNTVNGVFPIIAPIIGGFMIQYVDWEAIFILLALIGLLIALAVTFGLHESLPPEKRQttSLLAMGKLVVQPSFWPLILATGLVYGGLFSYISASTFVFQTGFGMAPQTFSLLYAFNGLGIVVGSNLPGRLASRFSNRQQVTSMLAIAavSALLIISLLFPANVWVVSGLILLLVILIGALLTLTVTIIMDQATSNAGGASAVIGLSQNACGGLASPLVG-LSGKSYAAMAIMLFVCNVGAYGLV--------------
     435 UniRef50_C7R2E6        Drug resistance transporter...   200     9e-50  1  24.7% 10:381   26:403     ---------ILMLGAIAAIPAITTDIYLPSLTDVRDELATTDAMVAMTMSGMLIGGAVGQLMWGPLTDRYGRKAPLLVGLALHIITSLLCAIAPNITILVTLRIMQGFFNAACAVAAISVIRDRFVGATAARLLSQLMLVIGVAPLFAPSVGGAIASFGSWRTVFLALAIIGAIMAVIVARFLPETLAEDHRLtrVAKGYWTLAKDRKFLALAMLPALAMTTIFAYVVGSPFVFQEHYGLSTSQYAVLFAMNGLAMVFSAQLNASLVRKFSPESLLRVGLGLQLVLALALVLwtGWGGFWTFEVTLWLLLGCQGLIGANAQVLALANYGHMVGTAAAVLGSLQSGVAGAVSPMVGVFGGDALAMAAVIAAGLILANLIVVF-------------
     436 UniRef50_Q11I19        Drug resistance transporter...   200     9e-50  1  25.8% 10:392   14:400     ---------ILTLVAVAATASSATNIFLPSLPGMAEQFGADYGIVQMTVSLYLAATAVLQLGIGPASDRFGRRPVMLVSFAVFCIATLAGAYAPTIEALLACRVLQAFSASGL-VLSRAIVRDIVGTDEAASRIGYVTMGMTLGPMVAPLVGGILDEAYGWRSTFLLTFGFGIVALILIYVDLGETNRHRSSSLTafRGYRELVRSHRFWGYVATAGFASGTFFAFLGGGPYVAAEILGLSPFTYGLYFGVVSLGYMLGNFISGRYSRAIGINRMMLSGNAIAALGMGlvLFLGGYDHPLSFFGPTFFVGMGNGIALPSATAGMVSVRPHLAGSASGLGGALQIGVGAALATLAGGLLstGAYPLMVLMLASSSLGIAATLYVIRVARTKGE--
     437 UniRef50_UPI000197687E putative transporter n=1 Ta...   200     9e-50  1  20.6%  2:360   19:433     -RSGNRGLALTALCLAVLLVVMDNTIVNVAIPTMSDALNASSTDLQWVVDAYTLSFAALLLPAGKLSDRWGRRRMLLVGLAGFAVVSAATAFSWALWQLVTLRVVLGVCAALIYPATLSSIIVIFEGSrrSLAVGLWAATSGVGIALGPIIGGVLLEHYAWNSIFWVCSVIGVVALACIAVAVPEVRAYRSERFDFPGTVLslFRRATFTSSTCAICVAFFCLFGFIFITTQWFQALRGYTALQTAVATLPFAVVMAAVAPLATQLAKRFGYRSVVSTGLLFLSASMFVVTRVDAHCSYWFVVVpmALMAAGIALIQGPATDALMSTVPESsgAASAVNDTIREIGGTLGVAVMGSAISS----------------------------------
     438 UniRef50_D1R5H2        Putative uncharacterized pr...   200     1e-49  1  22.4%  1:388    1:393     MKNYPTFKLIGILTPFVFSFAFGLDIYIPIIPQMVQIFDTTPALIQLTLSLFLFITGFGQLFVGPLTDHFGRRKILYASVIFFTLGSLTCASSHHIYGLIFGRIVSAFGACGMLVTAFAIIRDLFSGNENAKMYSFLNGGIGISPLFAPILGGYLSLYFGWKSIFIFLALIGTFAFFINQILIQETLEVDKRtrSIFKRYVQIFSHKQFLVHAVIAGLAESVLFCFFSISPFIIINLLEVPTEEFGYYFAAFGCVIAFGGIASGKMSEKIGAHFTVRLGIHLMFIGGSSMLVwfASLSLAGFLIPMVIACTGAMFLLGSSASKAMEPFGHIAGTASAAFGSLEFGIAALVGSILMIFPVNSTIPYAITILLIAFTAYSLFQVSPRPAK------
     439 UniRef50_C3BKF2        Multidrug resistance protei...   200     1e-49  1  17.6%  3:393   19:410     --KLQVKSMLRILAVIAFFIGLDSLIVSPLLPAISQTIGMPAEKGGLLITAYALCYGITAPFFGPLSDKVGRKQMIVTGLIIFSAATFCTGLTNHFEILLLFRGLTGLSGAMIMPSVFALVGDKVPYQSRGKAMGMIMGAMVGSTVLGVPIGAFLSEVGNWQWTFYIIGLLALLVTLITSRLLQKEISKNQlpKAMIGSCKIVFTNFSVFFALLATFLWTVGLHGMFSYIGVYYGINFGFTIGQIGIVIFFAGLGSVIGNIAGGKLADKIGKKVVVSIASIFASISVILFSVYIGNVKYA--ITAHMIWSICIGFGQASLTALISELNPAIRGTVMALNSSAMYIGMTIASSVASFALSK-GLPFFVLGIICAIASLLILPSIYFLVQEKATT-
     440 UniRef50_C7QAG1        Drug resistance transporter...   199     1e-49  1  16.2%  4:360   31:452     ---PKRWLALAVILIAAFMDLLDATIVNVAIPSMQDNLHARYSDIEWIVAAYALSFAAMLITGGRLGDIFGRKLIFMVGVLGFTASSVLCGLAQTPGELIGARFAQGAMAGLMVPQVLSIIHVTFPPNERGKVFGMFGGIVGSASVFGPILGGLLVQwlHWRPIFLVNLPVGLLALIPAYFVIRESKSPTAPRLDLFGMVLAIAasGYLMMAAAAPVLIVFVLygFFLVWTLYMQIGLGWTPIHSGLTGIIFAFGAAPAAGASVQVLTPKFGRKVLMAGALLNAAGFAVFIYMAAhiTTWEMIPPLLVAGVGFGLVVAPITDLVLSDVpaDAGSASGVFSTVQQVGAALGIALIGVIFFS----------------------------------
     441 UniRef50_B8N7F6        Efflux pump antibiotic resi...   199     1e-49  1  16.0%  2:394   58:496     -SLTRKVSIAIVVSCGQLATLMSTSMMAAALNQIAEDVGLSISVTQICFSIFLLGLAFGPFLVAALSEIYGRKFVWLVSNVWYILWNSLCPVGNNPGLMMAGRFLAGCGASAGVTLTAPMMADLFHAKDRGKSLALATLIPYLGPALGPIMGGLASQHIHWHWLFWILSSFEALVTVLGAIILKESYTPTLLRrnIYRPLRLLLTRPIIQFLAIVYGLDFGIYVLMLSTYANLWIDRYHESETISSLNYLAIAIGTTIGAQAGGHLMDYIFrrIPYMIPSVLLIPIGLVWYGWSAENRISWVviGAAIFTAGCFMVGQGMLAYLLDEFAHAA-SANAATRMLSNILGFAFPIFAPSLYDRLGFGWGNtlALLYLGLGVPIPFVLWFWGPKIRAI
     442 UniRef50_C4KDJ0        Drug resistance transporter...   199     1e-49  1  28.9%  1:380    1:386     MAVMPSAALAVLVVALTSLGPLSTDFYLPALPAIARALHTDSAGVQLTLSVYLLGFGAGQLLVGPLSDRCGRRPVMLWGMLVFLLSTLVCVFAESLAVLVGARLVQALGACAGPVLGRAVVRDLYGPAESARVLSHVSTATALAPLLAPLFGGWLTAAWGWRATFVALAIYAMVLMLAVAALLKETNrhAMRPARMLANYRTLLADPAYRGALLIGCGAFAALFAFISGSPFVFIEHFGMSPQQMGLAFGLNVTGFMIGSTLSARHSRRLGPARLIRYGVWIGAACGVLLAALAFAshPAAVMLPMWGVTAAIGLILPNATALGLAGYPKMAGAAASLMGFVQMGLGAGAGMLVGHGVQHGTAALGLTVAAGMLFALAAW--------------
     443 UniRef50_C8PHE4        Drug resistance transporter...   199     1e-49  1  18.0%  2:389    5:398     -SKFAKFKLVIILAYMSALAPLSTDMYLPALEKVKASFATSEFYAQLSVASFFIAFALGQLVYGPLSDKFGRKKPLYAGILLFICASLACVSFDNIYAFIFFRFLQALGGCAGVVLARAVINDKFELHEAAAMFALMMVVGSLAPMLAPTLGGFVLDFFSWQAIFAILFALGILLFAFIFFGLDESatTTLSVKGVLGEYGIILRNKEFMRYTLGFAVAMSALFAYITGSSFIFLGYYGLGEHAFGVIFGINALGMTLVSALNAKLVQNREPTALLNFGLIAMLVTSLILLACslDLPFICFEVSLFILLSSLGFVAPNATTLAMALYKdnSGAASAVLGTAQFAIAGAISFIVGAVGANKPFLLASVMVICAFCANAVYFLLRKKNQK-----
     444 UniRef50_Q397G2        Drug resistance transporter...   199     1e-49  1  23.4%  5:385   65:449     ----SPRFLLFLICLFASAGQLAIDIYVPALPDMARSFATTPQAIQSSVSGYMAAYALGQLIFGPVADAYGRKRVLAFGLVIYTIGCLLSLGAQNLETFVLARCLQGFGIATTNLLAKAIITDSFSGQALMHAFTYMSIAWGLAPIVAPVIGAHLQEWFGWRACLVFLLVYSLVMWALLWRY-RETLPKPVhpRTLMTNAGKVLASPVFQSCFLAQGLCYSILLVFNIVGPFMVQTTLHKPPTFFGYLALGIGLMYFLGGLSNRIhlPSAEQRLRIGARVMAGASVAMLVLALTVGLRVWTLATPVLVMGFCAGAMYPTLMAKGNSLFPHIAGLTSAILGCALLLVSSAMMGLAGFVSIHVLTPLAVFFVVLSCIVVWMVTKLLR---------
     445 UniRef50_C5BEB9        Drug resistance transporter...   199     1e-49  1  18.3%  4:391   18:408     ---AQQRIAFILIVSISFLMGISIDLYVPSLPAISHYYHSTIASVEISISLYLLGYGLGQTVLGILSDSYGRKKIFIYSSLCFLLSSIFCVLSDSSTMMNGWRFVQGVAVAGLASGMRAIIVDLFSGLTLKKMANYFALSWALGPIIAPWIGSNLSHYCGWQANFYLFAVYGGVIFLICLFLFRESNHNPSrlSSIKNNFIEIIRNKKFTLLSIIYGLSYSSVLVFNTAGPYLIEVVMHHSELFYGYLAMFLGLAYFVGTIINRYLITKFDNEAILKVGGTmlIVAILLWLLLSYVPNIFTLIIPIFLMFVCIGLIVPNAIAITMVIFPEKAGFATSLCGTIVGLVVFLVTYLIGHVKISALELSLCYFALFLLLNVIKLAVYHQKNRPSP---
     446 UniRef50_C7MCT8        Drug resistance transporter...   199     1e-49  1  21.2%  8:385    1:384     -------MVILVLTTLSAIGPLATDMYIPAFPEVAGELSTTASRMQLTITAFFLGTASGQIVAGPLSDRMGRRGPLLFGIVLCLLASIGCALAPTVDFLLVLRVLQGIGGGFGMVLGRAVLIDMTDGPELFRIMNIMQGVGGVAPIVAPLLGGIILIFGQWREIFFVIAAMSLISLLGVLFLIPESLPASRRHSGGFRTFLrlLQRRTFVAYMLVNAFSAFALMAYVSASSFVVQEMLGFTSTEYSVSFAINSMGMMTMSLVSARLTRSIHPRKLIRVGLIvlASFSLLIGSVFLDTPAWVVLPAFFFTVAPQGMIFGNGGALASDQAREIAGTGSAMLGLGFSFSASIAAPLVGIAGTHSSLPMAIAMVVGCLISSTFFVIAGR---------
     447 UniRef50_D2PM93        Drug resistance transporter...   199     1e-49  1  19.6%  3:360   15:425     --HPRRWWILLILCLSLMVLVVDNTVLNLAIPSLMRDLSATPADVQWIIDAYILAFAGLLLTAGSLSDRFGRKRMLVIGLVLFGAASMLATAATDPAQLIACRALMGVGGSLLMPSTLSLLFTVFPPEEQRKAMAGWSTVAMVGVVAGPTIGGVLLDKFWWGSIFLLNVPIAVLAIIGTVVLIPESRGPARDVDPVGAVllALFRDRNFSGTSLSIVLLSFTAGGLLLALTQYLQFVLNYSPLKAGLALIPYAASAMLFNGLGATLGKKLADRTLIATGLAVIAVAFGILTQVGESTGYGLLIVGLLVMGIGGGLAGPAAYTLLMQAVpeHRGVGSAMNDTVQQTGAALSVAVLGSVLAA----------------------------------
     448 UniRef50_Q30CT1        LipEx1 n=1 Tax=Streptomyces...   199     2e-49  1  16.6%  3:357   18:429     --HRNRWYVLAVIATAQLMVMLDGTIVQIALPSVQQSLHMSDTNRQWMVTAYALAFGGLLLIGGRLADRFGRGRTFLVGLVGFAVVSALGGAAPNTETLITARALQGVFAAILSptVSLLTTTFTSTKERAKAFGLFSGVVGSGAAIGLIVGGVLTEYAGWRWCLYVNVPIAVAVTALGIATLPRDRGHRDISLDAIGAvlRVVAERTRAGSFLGAALLNFGMMGISLFATYHLQIVMHYKPLKAGFAFLPmgAVMVTATQVVARVMGRVPTRWLVGPGLAFTAAGVWMFTTLSEDSSYLfvLPAWLLLGVGMGLSYSPTTHASLAGVAErsGAVSAFQTTARQIGGAIGLALSNTL-------------------------------------
     449 UniRef50_UPI0001B4D736 putative drug resistance tr...   199     2e-49  1  28.2%  3:389   21:412     --PPRALRLLIVLGALSAFGPLSLDMYLPALPALARDFAVPDAAVQLTLTSCLIGLAVGQLIAGPLSDRWGRRVPLLIGLAGYLVASVLCAVAPNVTALTGLRAVQGIAGAAGIVISRAIVRDLYEGTAAARFFSLLMLVNGLAPILAPVVGGQLLRFTSWRGVFLVLAVIGALLLAATVVVVGETLPSARRRRGGlrSFGVLLRDPGFLRPALAGGFAFAAMFAYISASSFVLQKTYGLDPQQFSIVFAANALGIALLGQGNARLLRRRSPSALLRAGLALCAagGALLLSVLADLGVAAVLVSLFALVSSIGLIMPNSTALSMSGHPEMAGTASALLGLLQYALGGVAAPLTGLGANGAALPMALAIAACAAGAVVVHLWPVRRAAA-----
     450 UniRef50_A6WG02        Drug resistance transporter...   199     2e-49  1  19.1%  1:366   20:447     LSHRQILAILYGLLLGMFLGALDQTIVSTAIRTIADDLD-GFSLQAWATTAFLITSTISTPLYGKLSDMYGRRPFFIAAIVIFVIGSALCGISTSMYELAAFRALQGLGAGGLMSLALTIIADIVPARERARYQAYFMMVFGTSSVLGPVAGGFlvGLDGWRWIFWINVPLGALALFVVLKNLKLPKRTTKHRIDWPGALtaLLPLRMFRGRTFVVgiLGMGMFGGFAVLPQYLQVVKGSTPTEGGLQMLPVVVGIMSASMFSGKFIARTGKYKVlvVGTGLMVVALFLFSRVNADTPIWQTMIAMLLLGWGLGGNMQPIILAVQNAAAreIGVATSSVTFFRQMGGTLGTAVfsILFSSLGTHVA----------------------------
     451 UniRef50_B6J392        Multidrug resistance protei...   199     2e-49  1  27.9%  3:385   18:405     --HMKKNLIVILTSVFVTVGQFAMALYLPALPALTTYFHTFPGVIQLSLTLFLIAFGFSQLFYGSLSDCYGRKPLLLIGLVIVMIGFLIAVFARHLSLLLIARVVQGLGAGSVSVLARAVIRDRFEGKKLVQALSLLIMAASLAPMIAPFIGGHIQRRLGWHSIFIFLFFYSGLILLGIFFLLPETKKTESVPfaLLNNYKLLLRHPIYIKYVVCIIMAYACQILYLSISPFIFQNGLKLNAAQYGTIITLPAIGYFVGNFLSTRLIRFFDSNHLVFVGALimAGIALALEAAFNGLSAFSVITPIIFCVIGIGLIYPNVISGSLSPFPQMAGTAAALSGAIQMAGTSSIAGVTNALHVVSVLGLGISFLLCGAVVLLMIFRIMR---------
     452 UniRef50_B9QTA8        Drug resistance transporter...   199     2e-49  1  25.8% 11:393   10:398     ----------VVLGLLAVVGPFAIDLYLPAMPQIVADLNTDDAAVQFTFTVYFIAFGLAQLIYGPLADRYGRRLPVFLGLVVYIIGSLMCAWAAEVDALTLGRLVQAIGAGAPMVIVRAVVRDLHTGTEATRLMALVMLVFSISPMLAPLAGSVLITFGSWRLIFLTLGVLAFASMVMIYFQLPETLPRERRSkaLVRSTIYLSGDARFLGLTLIGGFALASFFVFIAAAPLVYMTQYELTPTGFSIVFAINAVGFFASSQFAAPLGERFGMARVAFVGVGGFTAatLFLLVWSGLDGLPILMALLFVANSFLGQVIAPAMVMALEDHGEHAGMASSLGGTLQMVAGGVMIGLCTPFFDRTALPLTGAIAACAIITLALALVTFRPARRGDAP-
     453 UniRef50_B7JH26        Drug resistance transporter...   198     2e-49  1  23.5% 10:379    9:385     ---------LLLMIILVAFPQISETIYTPSLPDISRALHVSNNEVQLTLSVYFAGFALGVFFIGWLSDIIGRRPAMLFGIVVYGIGSFLCFIANSIEVLLVSRFIQAFGASAGSVVTQTILRESVEGHKRHVMFAQISAVIAFTPAIGPLIGGFLDQMFGFKIVFLSLVVMSVGIFLYTFVSLPETKTSstNKINVFSVLKRLITNPKVVTYGLLIGGANGVLFSYYAEAPFIFIEYFRLSPSMYGFLGIVVASASIIGAKVSKRLLATYKPEKIIYIGCLVMVVGAVALSIITSVGsmIGFLVAMFILLLGIGIALPNCLSLALVDFQDVIGTAGALFSLGYYVIVTMTIWGMSQLHTGSLLVMPLYFLAIVVIMMVF---------------
     454 UniRef50_Q9Z9P3        YhcA n=3 Tax=Bacillus RepID...   198     2e-49  1  17.1%  4:372    6:429     ---PKKWMVVCAVLFGSFTMILNNSMLNPAIPQLMNVFEADAVATGWVITIFMVAMGMTMPLTGYLGDKIGKKEAYILGLGIFVLGSLLGALSWNLPSLIVFRGLQGIGGGVMMPLSMTLIFDAFPRNERGLATGVWGVASMMAPTIGPTLGGFIVETSNWKYLFLVNIPFGLLGIIAAVIYLPKIARSGQIKLDRwrAEQPLLDLSLFRIPAYSLSIWVAGifAGIFLVPLLLQQVYDYGPIMTGLVFLPSALFTGLTMSIGGRMLDKRGPSGIMTAGMMIAAVGTFALGYLHLETGLWYIFAWMAIRGVGMGLTTMPATTTGMNAIPelISRGSAMNNVLRQMSSAFGIVFISVFFEVRRGQLALVSTSF----------------------
     455 UniRef50_Q1CVH5        Drug resistance transporter...   198     3e-49  1  23.5% 18:392   25:401     -----------------AFAPLSIDMYLPALPRIAEDLQSTAPAIQLTLASCFAGLALGQLFTGPLIDRFGRTRPLYAGLALYVLGSLGCALAPSASMLVAMRFVQALGGSVALVVPRAVVRDLWSGANAARTMSRLMLVMGVAPILAPLLGGMVLQYSGWRAIFVVLAAVGAVALAFVLKSLPETAPPHVGAQSMRSRMGALMKDPDFVGPALAGGFAQAGMFAYIAGSPFVFISLYGIPEEHFGWFFGVNAMGLIAVAQLNRKLVTHLPLHRLLRLALSLcaAVAVLAVAWTGFMGLWGIAVTLFFFVSAMGLVGPNAAAIALERHATRAGMASAALGALQFTAAAGASWAVSTFNNGTAMPMAGVMTAMALLAWLAAFFGLRARTRQQE--
     456 UniRef50_A7BA35        Putative uncharacterized pr...   198     3e-49  1  22.2%  8:394   20:411     -------ALLITLAVQNAVPPMATDMYSAAFPQITADLATNSTMLGFTLTTFFVGYASGQVLGGAISDQIGRRRPIIAGGIIALVGSMICVFTPNIWVLLVGRVFQGLGGGVASSVARAILVDVAHGKTLARAMSLLQAIVGFAPMLAPVLGAFIITHATWRVVFWALAGFTLLMAALAWFVVPESLPEERRhpRFFSGLVQVVRIRPFVGFMLTNAFSSFCMFGYISNATYVLQGPLGLSPMAFAWVFAFNALLSTGFALVNVRLISHFTPRTLIITGLTIAATGvlAISTFVLDLPLILTCVGFALIMTATAFIFGNSGAQAMSEAREHAGTASSVMGVFQSIANGIAAPLATS-GGDSAVPMVLVMIVGSVGAWFAFWVIARGGKHTPRHL
     457 UniRef50_B6QJG5        Putative uncharacterized pr...   198     3e-49  1  15.3%  2:392   50:476     -SHIEKNTIVGMITLSAFTAPFAAYLLFPSLDALVDHFHTTSTKVSLTTTVFLLGAAVAPLWWSSLSQQYGRRPILVFSFLVSAVAVTICAASNSLPLIIGLRFLEAVGCSSAQSVGAGVISDIYIPTERGVALGWFWIGTLAGSIVAPIIGGGLQEWFGWQANLYCSAILTFSAVMLTIHFVPETltRVMRDARAPLQGLKYFMNPSILFCMSYVSICFSSLYCITSTLPYAYSepYNFSSIQVGLCYISSCLGYAIGTFFGGSLSDHKLrrLTIVWYGAPFMPVGLILYGWlaKTHWAAPLVGVFLFSLGLMLITSTVTPYLVDVVPGAGASIVADLNLMRNILAAVGCVVSPVAAERIGSGWLMTILAILCALGVGFVAIVVWQGENWK--
     458 UniRef50_C0NAS2        Vacuolar basic amino acid t...   198     3e-49  1  17.4%  1:374   86:511     MTKKQIAVVMFALC----------SIIATALPTIARQFNTSESGYSWMASSYLLGNASVIPLWGKLSDIWGRKPIIVVANVLFLLSSLMCALAPNTAILIAGRAIQGVGGGGLVLLGQICVGDLFSQRERPVYYAMFGMTWAIAGSLGPVVGGLFTEKVTWRWCFYINLPFGGLALVTLLIWLKIDTPKTSLIAGlfGGITLPWNSPTVICLLIFGAITLGlfIAGAFFLPLYFQTVLGTSPIMSGVYILPQVVSLSVVSFIVGFAIRKTGTYvfIRLGMFVMTLGTGLYIDFKPYTSWPRLIIYQAIAGSGTGPNFQAPLLALQSRVPqeVSTATSTHSFVRQLSTATSVVLGGVVYQNVLKQSAPRILAALG--------------------
     459 UniRef50_C8WJX2        Drug resistance transporter...   198     4e-49  1  19.0%  8:364   99:511     -------AVFAGLLLAMFASTLSETVTATALPTIVGDLG-GVDHMQWVTTAYILASTVMMPIYGKLGDLFGRKYLFIIALSIFIVGSATCGLAPSMDGLIAGRAVEGLGGGGLIILAQATIADIIPPRQRGKYMGLMGSVFAVSTVVGPLLGGWFVQVTGWRWLFAFNIPLALLAIAAVAFFLTKPVRRDDRPptAWGGTLFPWISPQIFALFALFffIMLGMMGTISYLPTYFQIVEGLAPEQAGLMTVPMMAGVLITAVGTGFLATKTGRYKWMPIacAVTAVGFVLLSQLTVGTPLVVTGVFLFVLGFGIGLGQQILVLIVQNEFPHAigTATAANNFFRQIGSTLGASLVGALFTSRLTA------------------------------
     460 UniRef50_D1RJ70        Bcr/CflA subfamily drug res...   198     4e-49  1  22.5%  5:377    6:380     ----NKHLTLLTIVSSSIITLFASDIFLPSLPNIAEYFAVTNSKAQLSISFFLGGQVLTTLFWGFFSDRLGRQKAFQLGMGIFLIGTIICIDSTTITIFLIGRLIQGIGGVAVPVIGWAIIQDLYPKDKSAGIMSWIGSIIALAPMTAPALGGQLDKLWGWKADFYFIFILTTLILICQFIQSKEKSEAKKSTLNFVNTYTPIIKDKIFLSYIAMFALLACGQWCFLTIAPILYKNTLNLSSDKIGYLMSFSALFFIFGTTIANRLIKTTGIDFLLSLglSFAASLVLLFFHVTNLLNALLISVTFGMYLFGAALLWGSSSSRALQCYETNRGSASAIRSLLMMALFTLGSYLGALINNNNLLQIAALMSIFSLLSI-----------------
     461 UniRef50_Q6C6D0        YALI0E10483p n=1 Tax=Yarrow...   198     4e-49  1  15.6%  2:393   85:508     -TLSQKRIMTAVLAFCFFQPFLVTYAMLPAVPLIAEQFDVSGTIVTVGNAIFFLITGFSSCFFGPFSDAYGRKAALITCCIIFIVSNIGIAASPNLVSYYIFRATTAMGGTAFFSVSGSAIADIWRPEHRGKAVGACLLGSQSGMTIGPIIGGWIVTKTSWRVIFWMQAGVALANLLLVTFVLREPMATTKHQmiWINPFKVLMGLRNMHLLLAGLSIvmYGMDCLLTPLSLVVEPRFDisPVVAALFYLPQGVGFLIGCYFGGMYADKTVQRWTKIRgvGILLPVCMLIYGWSlfGGVAVPVVTMFLVGFGLSMYFPSLNAYCADSSPEltAAAISGNYAIRNCGSAIAAASTLKAVENIGIGWTSTVAAFGFIASTIPVFILLWKGEDMRQ-
     462 UniRef50_C7ZMF5        Putative uncharacterized pr...   198     4e-49  1  16.7%  3:392   44:467     --NAQKRSMTVFLAYCGLVATTSTTSILTAIPEIVDSFHIKATIVSGSNAVCLLFMGFSACFWGPWADTFGRKSAYLGSTALFFLSSLGTALSQSLEAFFFFRALSACQGSAFLVLGSSSISDIYHPTERATSLGWFLTGVMVGPAFGPILGGIIVTFTSWRVIFWLQMAMCGLALLMGLFVLQETLQQPRFLELKGRGFrkLWGHKNLLCVSLASSALVWNMYSLLTPIRIVLNPRLNlsPLESALLYIAPGAGYFVGTLIGGRWADRvdRLRSSLVFMGVILPSSMLLYGLAVDQRIGIvvICMFFHGVAQLAAFPSLNTYILDVMQRRSGQASASHYLMRYMFAGVSTASCLPMIDSIGVGWTSTISSAMLFICAGLVLLTISAGKSWR--
     463 UniRef50_A6VVW1        Drug resistance transporter...   198     4e-49  1  22.1%  9:383   17:397     --------FTLLVALLMSITAISIDALLPALGIIGNELgvTANQPQLLISMLFLGLAMGQLICGPLSDALGRRPILFGGFTLYLIGTVVCYQADSLEMLMLGRFIQGLGVAGPYISAISLVRDLYHGAQMARIMSLVMMIFVLVPAIAPTLGQAIMFVDDWRGIFEMYLVYAVLLIVWIGLRLKETLPKSNrkKGFYEGFKEVITNRITASYTICMGLFFGSFIGYLNSSQQIFQVQFK-TGNLFALYFGLLALVLGFSSLINSRIVEKYGAKYIAFRAICLVVIASIAFFSLHAFvsLWMFLVYATVLFFCFGLLFGNVNSLAMEPMGHVAGIASAVIGSVSSIMSMSIGTVIGQMYNNTLMPISGGFVIMGSLAVCIMYWA-----------
     464 UniRef50_D2L5Z9        Drug resistance transporter...   198     4e-49  1  15.0%  4:362    6:423     ---PNKWLITLAVMVPTLIEILDTSIANVALGHIQGSLSAGQDEVTWVLTSYLVSNAIVIPISGFLSKLFGRRNYLLLSVAVFTIASMLCGLATSLGMLIFFRIVQGIGGGGLQPMSQAILLEAYPPHERGLAMAIFAMGAVLGPILGPLLGGYITDNYSWRWIFNINVPVGIAAIGLIWLYIKDPGYLVRRKAGDTVDYIGlfNSDAILALTVVAAVCLGAFLVwiVLLPLYLQNLMGYTAFLSGVVLGPGGLIMLLVLPVVGKMTQKIDARYLLFVGLLISAYSLFNMAGFTLGIDLGTAITARNIQAVGIAFFFVPLSYLTMAYIpeGMNNASAVFNLLRNLGGSFGVAFITTLLARRA--------------------------------
     465 UniRef50_C9N837        Drug resistance transporter...   198     4e-49  1  21.1%  6:360   37:446     -----KGIALLIIASCQLMVVLDITIVNIALPHIQSSLGFSTESLSWVINAYTLTFGGLLLLGGRLGDILGRRRVFVFGVLLFVLASLLGGLSQESWQLLAARALQGVGGAIASPTALSLITTTfeGPERNRAFGVFAAVSAGGSAIGLLAGGVLVEWLDWRWVFFVNVPIGLLIAFATPRFIKESQRHPgrRSRQPITPLHMFRDRNRAGAYGMMLSLAAAMFGMFFFLTLFVQNILDFSPLRAGLAFLPVSVIIAISAGLASQLLPRWGPKPFMVTGAILAAGGLAWLTQTDVNSTYLgiLGPILVFGSGMGMQFVSLTLMAVSGvpREAGAASGVLNATQQVGGSLGLSILVTVFGT----------------------------------
     466 UniRef50_Q31IV1        Major facilitator superfami...   197     4e-49  1  19.3%  7:389   13:397     ------RRAAFSVAGIFSTRMLGLFMIFPVFALFAHeqGVTATQIGIAMGIYGLTQAVLQIPYGMLSDRFGRKPLIIVGMLVFMLGSIVCAMADSIEMMIVGRAIQGMGA--VAAVLMATVADLVTEQFRLRAMSIVGMTIGLSFTLSLVVGPMLGELFGVRGIFWVIAGLGVLGIVLVLFAVpeNQTFQREAEADPSQFKDVIKNPQLLRLDIGVFVLHAILTAMFIAIPFMIRDNAGLDSLHHWELYLPVMLLSFVLMVPFIIQAESKGRMKPIFVG-AILTIALMQLGFLFEANGFWTMFVLLLIFFTAFNLLEASLPSLVVKLSPAdkGTASGVYSSSQFLGAASGGFIGGWFYEMYGLEGLFFFTASIGFVWFLIAMSMSKPLP-----
     467 UniRef50_C1YSU3        Drug resistance transporter...   197     5e-49  1  16.0%  4:359    9:422     ---RRRWGGLAVLIICLLVIVADNTILNVALRVLsrGLGASQSQLAWAINSYTLVFAGLLFTFGVLGDRWGRRRMIVVGLTVFGAASALSAYSQTPEQLILARAVMGFGASMVTPQTLSIIANVFPPEQRARAIGIWAGAVGLAMAIGPSAGGLLLENFWWGSIFLVNVPFVALGLALVFFLIPESRDADPGRLDVLGVLLSVPGLVLLirFSVSVATIMVLFFSmiFFLSFYWQSVREFSPFVAGLLVLPAALGQMIMAPLSPTLVRWAGPRVVAAVGVLGVCSSFLFFTQLEPDTPLPLIVGFFFLQAGAMAVVLTPATDAIMSSvpGRAGAASAVQNTVRQVATAMGVAILGAVIS-----------------------------------
     468 UniRef50_Q47P50        Drug resistance transporter...   197     5e-49  1  25.4%  2:390   36:433     -RRRSTAFLAVVLGVLVSAGPLATDLYLPAFPAIAEDLATTEARVQLTLTSSMLGLALGQLAVGPMSDAWGRRTPLLVGTALFMVTSLLCMFVTSVEMFIAIRFVQGLAGAAGAVVSHAVVRDLYEGDEAARFFSRLMLVSGMAPILGPLLGGQLLLVGSWPLSFALLALMNGVGFLAVLFFLPETLPRHDRQPMRIRPLlrLLRDPRFVGPMLALGLNFGMMFTYISCFSFVAQNELGASPQMFGMLFSVNAVGMVTGTQVNSLLIGRVsrRLMGGLVLGLGAVAAMVVMEVTGTAGLVTISAALAVMMAGMGLVFPNATTLALSspPSVAGTASALAGSARFVFGGIlvAGIAAGGEASLASMVWVMAVTGALALGIFALSAALERRA----
     469 UniRef50_A2QKV2        Function: CYHR of C. maltos...   197     5e-49  1  17.4%  3:365   52:472     --KSRKWLNVLLISLQGTLSPIASTILTLGVFDIASEFRlsPYTPALPIALYLVGLALGPLGVAPCSEIFGRRPIYTICFAIFTILNVGCALVDNMAGLVVLRFLAGVAGSAGPSLGGSSIGDLFSHEERGKAQAVYGLGPICGPVLGGVIGGFIagTQGWRWMMWVVAIAAGVVTGLAVLFQKETYAPVLLQrsILRPLRLLLFSPICTFMSLYLALVFGLLYLHMVTITLLFASqyHWTHGTTGLAFLGAGLGAFAGVAFcrYFAARyeFRLPFMQVGMLIVPIGLLIFGWTAEYHVHWIvvGTAILGLGMVTAYICVQSYLVDAFEEYAASALAAAVVARFIVAAVFSVVGFQLYRRLGYGW-----------------------------
     470 UniRef50_A6X1K2        Drug resistance transporter...   197     5e-49  1  21.9%  2:385   15:406     -SMRGRGEFIALIAAIMAINALAVDIMLPGLPQIGASLGvsENHVQFVITAYLLGFGVSQLFYGPLSDRFGRRLPLFAGLVIYILAALGAAIVTDFTTLIILRVLQGLGAAATRVIAVSVVRDKFAGRQMAEVMSLVMMVFMILPVVAPATGQLIMLFGEWHLIFLSMAFMAFVIGIWAFLRLPETLPATNRRpsVIGGFGIVLSNRVALFYMLGTSFILGALFGYINSAQQIFVDIYKLGAL-FPLAFAAVAMTLALASFMNSRLVGRYGMRRISQTMLLVFTSFSLLWMVLsgPVPFPILMAIYMTIMFSFSLVTANFNALAMEPLGEVAGTASSVLGFAQTVIGAALGAIIGQAFDGTTTPVATGYCVLGFVALGCVLIAER---------
     471 UniRef50_Q2IPM1        Drug resistance transporter...   197     5e-49  1  23.3%  2:391   22:417     -TARTHGRLAVLLAALSALGPFSTDAYLPSFPEIGRVFGAPAVLVQQTLTAYMVPFSVMTLWQGAISDALGRRRVTLVMLALFALASVGCMLSWRVEALVAFRALQGATAGAGMVIGRAVVRDLLDGAEARRLMSRIALVFAIAPALGPVVGGWLHVWLGWRAVFGFLALFSAALCAWCWRALPETLPPAQRrrSMLRGYREVLSNRAFLALVAGVTCSFSAVFLYIVAAPVFLLRHLGVGETGFLWLFGPISGGMMIGNWASGALAGRMTNQRTVAWGFGAMAVAALalFHALHAPALPWSVLPLVGYVLGTSLAMPSLTLMALDLFPERRGMASSCQAFMQTAGNALVAAALAPLLWGSARTLSLGMAGGLAVGALAFAAYAAIRPREP---
     472 UniRef50_B6J4F7        Multidrug resistance transp...   197     5e-49  1  26.9%  4:379    2:383     ---SSNKLLFFVIALAACLTQFAADIYAPSLPAVALSLNTTIDLAQWSMAIYLFGVALTLLIYGPLSDAVGRKQPMVIGLCIMAAGSVVAMLAPNIKLLILGRFIQGCGAGACAGLWRSIFRDVFTGEELAKYGSYFAILVMFIVPLAPALGGFLQHYFDWRANFVFMTIYTLFALLTVAFGFKETSRHHhrLPYVINTFRRLVKSPIFMGITVSTFLSYGAFFAWITSGSVLLIHVLGMSPLAYGlvFFGGGIAYALAGFLNGRLVSRFSMPTMMRFGWSVMVLSGILMALglAGINVWVIAIPIILFYFGSTFIWPNAFATAFTPFGDIAGYAGALYGFMQLSGGAVIGSLMAYLPHADQLPLALVIIGASLLAWII---------------
     473 UniRef50_B8LVS3        Efflux pump antibiotic resi...   197     6e-49  1  18.4%  1:381  124:565     LRASRIAVIMLSLGASVFVSALDMTIIATASPEIAGHFQ-SASGYTWIGSAYTLANTATMPTWGKISDIWGRKPLLLAGLVVFFVGSMICGLADSIGLLLAGRAIQGVGSAALNILVNICVSDLFALRDRGLYFGLLSLVWAMASGVGPVLGGVFSEKLSWRWCFYINLPIIGAVFVLLLFSLKLNTPRTPMWDGlfGGVTRPWSSATVVCLLVFSVVVGavFMGQGYYMPLYFQAVLGMGPIMSGVYFLPFILAITFSGALTGLFIQKTGRYMPTtlGLALMTLGVGLLINLDEYLNWSKLITFQIVSGIGIGLNfaPLLSLQAIVGKHNAATATSTIGFVRAIACAISIVLGSVVFQNQMVKQGPSLTAALGPSLGGLL-------------
     474 UniRef50_D1CIC9        Drug resistance transporter...   197     6e-49  1  18.1%  1:360   17:432     LPRRQVYLTLAGLLLAMLLSALDQTVVGTAMPRVIAELR-GFNHYAWVFTAYMVTSTTMVPIFGKLSDIYGRKWFYLGGVALFLVASWLCGLSQTMTQLILFRGLQGVGAGVMQAIAFTVVGDLFPPAERGKIQGVFSAVFGLASIVGPTLGGWITDNLNWRWVFYVNVPIGVLALGTLFLFFPNIRPHGHERSIDYWGVLAlwGSSRIIGLLAFSAVmsAGMFGAIMYIPLFVQGVIGTSATSSGTILMPMMFALIFSSIVSGQIISRTGKYKVITigLLVMTGGLYLLSRMDASATNALVVRNMVITGLGLGVTMPVFTMAVQNALpkMLGVGTSSLQFFRAIGGTIGVAIYGSLLNN----------------------------------
     475 UniRef50_C8NJY5        Permease of the major facil...   197     6e-49  1  23.7%  2:389    5:396     -KQRLTTPLLLGLALITATPALSTDMYLPALPMIATDLDTTTPLVQLTLSAFMAGMAVGQLIIGPISDSLGRRRLLLVGAVVSLVASIGCALAPSIGVLIGMRLLQGLGGGACVVIARAIVPDLARGREAAQAFSLLMIIQAIAPVLAPVVGGVISAPFGWRAVFWALALINAAQLLVAVIGIRESRPVAERTggMLSNYLHVLRNPRFLAYAAVLAVTFGAMFSYISASPFVLQNQLGMTPLMFSVVFAVNSLALMISGFLNRRLLNSVHPHRIMAGAMVGFISlvLFLVQVALIRSTPLFLVLLFLIVAHVPLIMANATALGTAVVRERAGSGSAVMGFLQFSMGGLISPVVG-LGADRALSMAVSMVGCALCAGIAVWFAGRHPLP-----
     476 UniRef50_C8WSK8        Drug resistance transporter...   197     6e-49  1  15.4%  2:357    5:414     -RTSNQGLVVLALLLGIFVAAMDNTIVATATGNIVAHLG-GLEQIVWITAAYMLTEMAGMPIFGKLSDMYGRKRFFMFGIAAFLIGSILCGTAQNMTELAIYRAIQGIGGGALMPIAFTIIFDVVPPKEQGKFSGLFGAVFGMASIFGPLLGAYITQHWSWRIVFYINVPIGVVAFLLILFAYRESARHGRQAIDWFGIFTLvlFRKRSFAVSNVAGILSGSAYIvvVWVPIYVQGVRGGSPIDAGLFLLPMMVGSSVTAAMAGRFASRAPYRTVLLPFALVFGAGIALLLGLRADTPTWRVILDMAVVGIGIGPFFSVtmAAMGDLDAQNRGAGSSTNSFVRELGMTVGIVIYGAI-------------------------------------
     477 UniRef50_A1C4N0        MFS transporter, putative n...   197     6e-49  1  16.7%  2:390   20:442     -SAWQKNSIVIIITLSAFTAPFASCILFPSFTTLVDHFHTTEPQVALTTTVFLIGLAIAPLWWSSLSQEYGRRPVLVVSFLFSAIAVIICAASNSLAVIIVFRLIEALGCSSAQSVGAGVISDIYLPTERGSALGWFYLGTLIGPLIAPIIGGALQIWLGWRSNLYFMAIFTFATAMLTLLALPETLVKVSSEGKDLSSLTWllLVPPIALAVSYVSICFASLYCFNTTLPYAYSapYNFSSIEVGLCYISNCLGYAIGSVAGGRLSDAKLrrLKTVWFGVGFVPVGLLCYGWLVEKQVFWFAPLvfLFGLGLMLITSTIMPFLVDVKPGVGASVVADLNLVRNILAAIGTVVSPIAVASIGYGWWMTILAILclGVICMVIVVWRSGRK----
     478 UniRef50_B8MFS9        Putative uncharacterized pr...   197     7e-49  1  14.1%  3:392   28:464     --TWKRAYHSVLPAVFGLVVTVGSSIYTSAVDDVKKAFHISDVAATVPFSLFLLGLGFGPMLAAPLSENFGRTSSYVISLPIYALFTLGAGFSHTFGALVACRFLAGIFASPPLVVGAGTIADIWKPEHRALTTTLFALCPFLGPALGPVMGGFAVAAKGWRWTQWIILFWAVFAYLLVL-GMHETYKKIIVARalIRPIKMLYSEPIVIAWSLYIGFTFAVLYSFFAAFPYVYATVYGFDIQQIGLTFIPVAIGTVLGSITFIWIDQTieQRLYASMIGGCGLPIGLFWFAWTARPDIHWimIATVVIGWGNMCITMSGLLYLLDVYDALTgsAVAAASLLRYVLAAAFPLFVNPMYRNLGVGWATSVFAFISVALTPIPWVFYRWGLRLR--
     479 UniRef50_D1BAI6        Drug resistance transporter...   197     8e-49  1  18.5%  4:360   18:429     ---PRIGWIYASLLLVMFLAALDQTIVGTALPTVVGELD-GVNHMAWVVTAYVLAMTIAMPVYGKVGDLVGRKKLFLFAIAVFLLGSALCGVAQDMVQLIGFRALQGLGGAGLMITSQAILADLVPARERAKYMAPMGAVFGVASVAGPLLGGWLTDSVDWRWIFWVNLPLGVAAFAVAATMIHLPRRTSTARIDYLGIATmaWSSPTILGLGAVGVLagAGMFGALAYMPTFLQMAYGVNATESGLLLIPMTVGMLAGSLFSGAMVSKTGRYRvpVVGTVIAAAAMLLLSRVSDQTGLWSVCGILALMGLGIGLFFQLLVLTVQNAvpREIGTATSSNNFFREIGVTLGTAILGTVFAS----------------------------------
     480 UniRef50_A4J552        Major facilitator superfami...   197     8e-49  1  15.0%  7:385   16:403     ------KYTLAALAGVPLIMVLGNSMLIPVLPQMAKSLNVSQMQISLIITLFSVPAGLVIPFAGFLSDRFGRKKIIIPGLFLYGLGGLLAGAanAFPWILGGRILQGIGAAGTAPIAMAFCGDLWKGKERAKSLGVIEASNGLGKVASPILGALIGLIAWWYIFFFFPVVIAVVIlvWFICKEPETNKQPKKVNEYVGSIKNIfkSPLLLTSFFAGSAALLILFGVLFFLSDYLEKKFGLDGVIKGAALAIPVLFMSTTSYVTGALIK-KKIKLMKWLVVIGHGLIGASLVTLPLFNNVYIFFAGISVAGIGTGLVLPCLNTLITSStkDERGLVTSLYGSVRFLGVAAGPPLFGWLVEKGSDMMFWASASLAVISAVLAFFFIK---------
     481 UniRef50_O94528        Caffeine resistance protein...   197     9e-49  1  12.9%  4:392   80:524     ---WAKLVVTFDICFLTFAVYVGSAIFTPGISEMQETMHVGTVPVVLGLTLFVLGYAIGPLILSPLSEivGRQKIYVLSLLVFVCLQIPTALGSSLGVLLPMRFLAGFFGSPALATGGATLADIWQPWLLPYFMCFWAIGAIGGPVLGPLLGGAMVVAESWRWQFWLLMMISGFALIVIFFFMPETSeaQLAKETIIRPIILSISEPIVLSLNIYIGLIYSILYLWFEAFPILFTSVYHFTIIENGLVYLGILVGALITLACYFVFLYKveGVLVISFPATFFIPICLFWFGWSGRESVHWIVPIvlFYASGAFLMFQSMFQYLAASYPKYVASVFAGNDLFRSAMAASFPLFARAMFNNTgvAWGSTILGIVACLMIPIPFVLHKWGLKLR--
     482 UniRef50_B8DD39        Drug resistance transporter...   197     9e-49  1  22.6%  6:386    8:394     -----KKINLALLVCLVGFPQISETIYTPSLTEIATSYGVSLNLAQMTLSIYFLAFAVGVFFWGVSSDFLGRRKAMNFGIFIYIIGCLVCLMSSSITVLFIGRFIQAFGASTGSVTTQTILRDNYHGTDRHHLFAKISAALAFSPAIGPLVGGFIGQYYGFRVVFLFLVIMGMGLLFWSLKRLPETIIVTSHSFsmVGIGKKMVCDRYTVAFGVLIGIFNGILFSYYSEAPTIFIEKFHFSQSQYGFMGCAVAAATILGAWLSNRRLKQHSPQKIITEGILLALGGTLSLSIVSAFPLIIQVIAYILFVSigIGMALPNCLSLALVKFQEVAGTAGAFLSLGYYVIVSICTFLIGILHSGSLLVFPAFCTVLLLIALTCIKAVTRK--------
     483 UniRef50_Q2RQ29        Drug resistance transporter...   197     9e-49  1  22.0%  9:385   19:401     --------FVGLMAMLMALTALSIDVMLVALADISSdfLADANDRQLVITAYLLGFAVGQPVWGPLSDRIGRKPVLIAGLVIYGLGCLGAMVSPSFETLLAARLVQGLGGASPRVMTMAVVRDRYAGSGMARVMSLLMMIFIIVPILAPTMGSAVMAFAPWHWLFGFMMVFDLIVLVWTLTRLRETHRPQRQLAPSLGGLLETLrnRQTVGYTVAFGFMMGSLMGYVGTAQQVFVEVYH-EVELFPILFGAIASAIAAASIINARFVTRIGSRRMSHAALLGFVAVGlaAFGFPAKPPLALFMAALGIQFFCFGLIGPNFNAMAMEPMGRVAGAASSFVGFYSTAASAFLGWAVGQQFDDSVRPLMMGFAGFGILALVCVLVTER---------
     484 UniRef50_Q6SGC7        Drug resistance transporter...   197     9e-49  1  23.5%  5:392   29:421     ----KERITFATLVALVAYAAIATDLYLPAIPAMVAEFGATASDGQLTLSTFMLGIAVGQLIFGPLSDYYGRLPVVKIGTVLFLGTSIACALASSMEFMWLARLAQGLAAASGPVIARAIVRDRYEGPRAAQIMAILSGAMAVVPLMAPTLGAWLLILVSWRATYIALAIFAGVVLLGLRSfaPHIRKGAIGIVPVLKHFSTCLKNRRFVGYQICGTAAFSAIVAYLSTVSFFMQDVFALPIKYFGYAFAVTVAGFMVGALLCSRIVIHLGINRTLALGTTLSLLGALglGASLNDTPIALLAGCSFVMFLGVGFTSANATMGALSLFPDHAGSASAVFGFTQSSVAALVGVYAGHLYDGSLVSVTNIMLVCAGAGMLGLPLARAQIPVRGS--
     485 UniRef50_D1BPG7        Drug resistance transporter...   196     9e-49  1  22.0%  2:387    6:395     -SAKVSFILVVFLGLLTAITPLATDLYLPALPIMPSELNTSASNIQMTIGVMTFGVALGQLFGGPISDTMGRKLPLITGNLLCVISSIICAYAPSIEILLLGRFLQGLTGSVGVVIAKAIARDFAFGQELTKLFALLMMVNGLAPVIAPLIGGQLLLFTTWRVIFVILAIFSAILLVGSLLflPKEKRVTGGVATATKNYITLIKDKRFLGQTLIQFFAFGGFFAYISGSSFVYQNIFQLSAQEFSYLFGINSCGIILASAISARLSNVITVRQLLTFALwlTIGSLLFLIAMLFEWPLIPVTAILFFTVCTVSLFGSASFSMAMAKYGKMAGSASAVLGFASMFSAGIVSPLVGIGGEYTGIPMGITMLVCAALSLLCLYRLVEKE-------
     486 UniRef50_Q2SB76        Permease of the major facil...   196     1e-48  1  16.9%  5:360   11:422     ----NPWLIAPLVALAAFMEVLDISIANVSLQHIAGSLGAGPEETTWILTSYLVTNAIALPIAGWLSDYFGRTRFFIGSIIGFTLASLACGMAPGLEMLIIFRAVQGLAGGALQPVSQAILADSFPLEKRGMAFAMYGIAVVAAPAIGPTLGGWITDEFSWRWIFLINVPVGIVLIMLVKRYLpePANHDGSKVDYFGFALIAIGLGCLQWMlfAMANVIMFMMGFvaLLPLLMQTLMGYSAFDAGLVLSPGGFAIMFMMPIVGRLVGAVDSRILLTLGLGVSSLALWNLGELTLAVDRDQLAMARVWQTLGLAFLFIPTTSSAYVGLPTSanQAAAMLSFMRNLGGGVGIALLMTFLDR----------------------------------
     487 UniRef50_Q5KKE4        Tetracycline efflux protein...   196     1e-48  1  18.3%  1:360   88:508     LPTKQVIFVFVGLTCALFCSLLDQTIVTTALPTLGQVFG-RADISPWVGTAYLLTSTATQPVYGRLSDIFGRKFTLLGCLFIFLMGSLACALAQTMIQLIIFRAIQGLGGGGILTLAMIIISDVVSLKERGKYQGITGCVVALANSCGPIVGGAFTENASWRWCFYINLPLTSISMIIIVFLLPLRRVrkIKKLDFYGSILTLAWAAPFLIALSWAgsVSACFFTTfyYLPQYFQIVRGASAIRSGVLTLPLMLVQTVTSFTSGIIQSKTGDYWwlVVGYTIWTIGLGLISSITSTTSIAKLSGYQIIVGIGAGQTFQTSLVAIQAGvrKDMATATGLRNFLRQLGGTIALAACNSIVNN----------------------------------
     488 UniRef50_C8NL34        Drug transporter n=7 Tax=Co...   196     1e-48  1  16.2%  1:359   44:459     LPEKEAWPALIALCIGFFMILLDQTIVAVSTPALQEDMGATYNEVIWVTSIYLLTFAVPLLITGRLGDKFGPKNVYAAGMIIFTVSSLACGLAPDMMSLIIARGVQGFGAALLTPQTMATINRIFSIERRGAALGIWGTTAGLATLAGPIVGGVITENWGWQWVFYINVPIGVISVLAVLKYVPAFPPHTRPLDPlvVGWVAWIWVMIIVALVLGYGFvgFTVAGIPLPIMLYFQQIHGMGPMQAGFMMIPQALVAVLLSPSIGRLVDKRNPNTMAALGFGVSSLSILGLSlmILDAPIWVALVSMFFLGVGNSLIWAPNSTSTMRDLPGrmGAGSGVYNTTRQLGSVMGAAAIGAVLQ-----------------------------------
     489 UniRef50_B7VQS3        Multidrug resistance protei...   196     1e-48  1  26.0%  6:394    7:398     -----KKTPLLLAMMIIATGQVGVSIYLPSLPLIASDLSVTQVDVQLLVTLFLVGFGLSQLFYGPMSDAVGRRPIFLLGQGVYLIGTVVCvfSDNMTALEVGRLLQGLGAGSASVLGRSVLRDSYDGLQLTKALSYISVTASIMPIIAPVFGGWISFHLGWQAVFLFVLVYLLAIFTLGYFVLHETLPYGKSRfqVVKNYGRLLTNRQVLTSASYNWMSYMASLVSLSLFPFLMQEQLGLTAAEYGSLMIVPSAGLLIGSVALNLLNRRFSTPQLMSLAILIILASGTWL--LTHELSIFNLVWAFTWLAIAQGISFPLSISMLLEPHKKKAGAVSALSGSIQmlAGLLGGYLVESWVTTHLQLGVFYLIIGACMATVLWSSTRMNKKATATEV
     490 UniRef50_C7RMR7        Drug resistance transporter...   196     1e-48  1  26.9%  6:343   10:353     -----PRGIAFMLAALAALGPFSIDTYLPSFHDIGASLHATPLQVQQTLTAYLLPFALMTLWHGAISDALGRRRVILVTVALFALASAGCMLATRIEHLWLLRALQGMTGGAGIVISRAIVRDLYDGPPAQRLISQITMMFAVAPAVAPVLGGWLQAWFGWRSVFAFLALSSAALWLASWYLLPETLPRHRRQsyLVRSYWQVLTSRPFLLVCGALAFNFAAFFIYVLSAPVFLMHHLGVAATGFLWLFGPAMGGLMIGAWLSGRCAGKLSLPRTIAAGYLVMGLAVVlgLNLAWPPALPWSVLPIFVFTLGMSLAMPCLTLQALDLFPEKRGLAASCQGFLQ---------------------------------------------------
     491 UniRef50_Q633M8        Multidrug resistance protei...   196     1e-48  1  13.3% 13:359  103:503     ------------LILGMFVSILNQTIINVALPPLMNEFNVSTSTAQWLITGFMLVNGILVPISAFLVSRFTYRKLFVAAMLFFTVGSIICATSGNFTMMMTGRVIQAVGAGILMPVGMNIFMTLFPPHKRGAAMGLLGVAMILAPAIGPTVTGWVIENYSWNLMFYAMFIIGLIITFLSLKFFTLAQPVSNTKLDIFGVvlQVFKYPVFTFTLVINAIVTMALFGGMLLLPVYLQNIRGFTPIESGLLLLPGSLIMGIMGPVAGKLFDKYGIRPLAIIGLAITTYATYEFTKLSMDTPYSVIMTDYIIRSIGMSFIMMPIMTAGMNALpkLISHGTATQNTSRQVAGSIGTAILITLMT-----------------------------------
     492 UniRef50_C7YQK8        Putative uncharacterized pr...   196     1e-48  1  14.9%  1:390   45:478     LSSMRKLHIIVAGFTCTFNGNFGSSMPSGALDAIAEQFNVtpVHLILLNSLYMVGYVLGPLLFGPLSEYIGRRPVLIGTYLGYLVFMLASSGAPNYAALLIFRLLCGINAAAPTTVIGGLYSDILdpSVRGNAMALYMGITTLGPLVGPIVSGF-SSPISWRWPFWIAGMMAASGLPLVL-TLPETYAPVLqrKIFLRPMKLLFTEPILASTSAYLTLVYAVFYLMFQAYPRVFQGFYELSPGMAGLAFLPLAVGSILSLVVFYIFtnHIYRRLPLACIASPCMVISLFWLGWTVWPSVNPIIpgGLFFGLGFQLLFMGMINYLTDVFLQYSASALAAASMTRSIGAILLPLAADSMYADLGLHWAPSVLAFIALAMGVIPFVFIRYGDR----
     493 UniRef50_Q5HLN8        TcaB protein n=5 Tax=Staphy...   196     1e-48  1  18.4%  2:382    7:392     -SENQSLLFIVILGSLTAFGPLAIDMFLPGLPNISHDFDISASTTQLTISFFMIGLALGNFLAGPISDITGRKKPLIFSLIIFTIASLGIIFVTNIWIMIILRFIQGLTGGAGAVISRAIASDMYSGNALTKFLSLLMLVNGIAPIIAPALGGIILNYGPWRIVFVILTMFGIVMLIGTLFKVPESLEKSLRESsmLINFKELFKTPRFVLPMLIQGVSFVLLFTYISASPFIVQTIYGLTPLNFSIMFAFIGVTLIISSQLTGKLVDYIDRLLLLRIMSTIQVIGVIIvlTLLNHWTFWILSCGFVILVAPVTGIATLGFSIAMDESKGAKGSSSSLLGLFQTLLGGVISPLVGIKGDSNAIPYIIVIVITAIILMVLQLI------------
     494 UniRef50_C4JIZ6        Putative uncharacterized pr...   196     1e-48  1  17.9%  2:392   50:503     -SPGLRRYIVVCASWAGLFSLLSANIYFPALNAMGRDLKVSAWEMNLSITTYMVMQGLAPMFVGDFADTAGKRPAYMACFAIYIAANIGLALQNNFAALLVLRCLQSAGSGATIALASGVVADIAPSAQRGSYIGYTMAGSSTGPSIGPVIGGLLAHYLSWRAIFWFLVIMASVFIIQYSLFCPETsrPQWRIPNPVNAILIVFR-KDTMLTLLSNAIIICGYYVIAASIPKIFDEKYGYSEFQIGLCFLPFGVGSAVASIITGYIVDWnkARLQLTLPLLFVACCSTLVFGWTLQFNVSVAFPLAALFFAGASlaFNTLGTLIVDLHPNNAATATAANNLVRCLLGAGATAGILPMVDKLGRGWSFTVVAFGMLTTAPMMLATVYYNPGWR--
     495 UniRef50_P39637        Uncharacterized MFS-type tr...   196     1e-48  1  11.6%  6:393   16:404     -----PLLLALALTMGVFAAGSEELVISPLLPDLAKAFSSDVSVLALSISIYGVMIFIGAPLLVPLGDKYSRELSLLAGLMIFIIGTVICALAQNIFFFFLGRALSGLAAGAFVPTAYAVVGDRVPYTYRGKVMGLIVSSWSLALIFGVPLGSFIGGVLHWRWTFWIFALMGVLVVLLILLEMRRHAQHKNSGkePAGTFRDALKVPRVPVYITITFCNMIGFYGMYSFLGTYLQDVFTGGNTAAGLFIMIYGIG-FSMSVITGKIADRIGKMRSLLIALGVISVLLACLPYAPA--SMFLLIASLFIWGLMQSLTVTLLSTILSDCSERHRGKVMVFYSLASNLAVTLGSALMGPVYVAYGYAAVGLICAAITVLGFVLSVFAYKKYGKLEQ-
     496 UniRef50_Q2YNG9        Tetracycline resistance pro...   196     1e-48  1  22.9% 24:385   37:406     -----------------------VDIMLPGLPQIGASLGvsENHVQFVITAYLLGLGVSQLFYGPLSDRFGRRLPLFGGLAIYVVAALGSAFVTDFTTLIILRVLQGLGAAATRVIAVSVVRDKFSGRQMAEVMSLVMMVFMILPVVAPATGQLIMLFGEWHLIFMFMAIMALVVGLWAFLRLPETLPVSHRRpsTLGGFVIVLTNRVALFYMLGTSFILGALFGYINSAQQIFVGIYQLGTL-FPLAFAAVAMTLALASFLNSRLVGRFGMRRISQTMLLVFTSFSLLWMVLsgPIPFAVLMIIYMTIMLSFSLVTANFNALAMEPLGEVAGTASSVLGFAQTVIGAALGAVIGQAFDGTTTPVATGYCVLGFVALACVLIAER---------
     497 UniRef50_C3X9R5        Drug resistance transporter...   196     1e-48  1  19.9%  1:386   11:395     VRMNSRLFLLIAMGMMSAFGPFVTDFYLPGLPALAAWFGTTTSWVQLSLTTSMMGLAGGQLIIGPASDKYGRRGMLLISMALFIVSTVACLFSWNIESFVFFRVFQGIAGAGGVVISKSVAADLYQGKELADFFSLLMVINGLAPIIAPVVGGFVMKYTDWQGIFLILLGIGVILFIVSLVflPKERRIAGSIFNSFGNFIPIMKNGRFMNYVWIQMFAMGVFFTYIASSPFLIQEYFHLDAFMYSLCFAINASGMIVGSRLTPRFDRVFNA--LSTGVYWLAGSSLCFVIVLVLGWSFYLLEALLFLMMVALGMILPTSTSLALTLERAKAGSASAIIGFFLFIFGAVVSPLTG--FADMILSISVMTLVCCGLSLIFLVIAKKR--------
     498 UniRef50_Q3A194        Drug resistance transporter...   196     2e-48  1  24.1%  3:388    8:400     --RTNMRLVVILLGVLTAIGPLTIDTYLPAFTAIAADLHTDVATVSLSMSSYFIGIAVGQLIYGPLLDVFGRKGPLVYGLVLYILASLGCALSYNVEWLIGLRLVLALGGCAGMVAARAVVRDLFPLHETARVFSSLMLVMGLAPIVAPTLGGLIVASLGWRYIFFLMGGSAVVMLAGVWWILphGRREALHPRSALRDYLAVLAVPGFTLRMVTGSFYIAGLFIYLTASPLIFMDMFGMSGPHYGWTMGGNALALVIGSQVNARLLKRFSLGGVLWRslLLAVSALFVLGAILVPVPLWMVLVFAALYLFCLGFLLPDVTALIMEPFgeQAGSASALLGAVQMMAGALAAALVSWGYDGTVAVMAIGMPVCALGSVGLLWRERYPVR------
     499 UniRef50_Q01SW3        Drug resistance transporter...   196     2e-48  1  15.6%  3:362   21:441     --KANPWLIAVVVALAAFMEVLDTSIANVALPHIAGNLGASNDQSTWVLTSYLVSNAIVLPISGWLASLFGRRRFFLLCIVLFTVSSVLCGSAPSLGLLIVFRAIQGVGGGGLQPIAQAILADTFPPQKRGLAFALYGITAVMAPTIGPTLGGWITDNYSWRWIFYINLPIGMMTLFLVHRLVEDPPYLRRLSGAGIrgSRFILTLSIVSAACLISLvlGVVYFSSLVMMPQFLQTLLGYTAELAGLVLSASGILLLVCMPIVGQLTTKFPAKYIIAFGWLSIAAALFYStrIDLEISFRVAMWLRVAQAAGLPFLFVPITLASYTGLPAAKSnaSGLINFMRNIGASVGTSLVTTMLARRA--------------------------------
     500 UniRef50_B1VKV2        Putative permease of the ma...   196     2e-48  1  16.2%  4:391   21:482     ---RWRWLILVVMIVAEIMDLLDASIVNVAGPDLERSLGAGSVGLQWVIGGYALTLGAGLVLGGRLGDRYGRRRMFLIGLASFTAASLLCAIAPNIESLIAFRLLQGTAGAMLLPQGLGLLRENFSGPELTKVFAIFGPVLGLGGIIGPVLGGFLIegLGWRSVFLINLPIGIAALIIAATFVPKKTGDRTVRVDMTGAALVvlWTWLSMAASAIGFALfgGLIGTQLVLTLFLQIGQHFTAGDAGLGNLPLAVGTAIGGAISgfLADKIGRKVLQIGPLVQLAGAAVLWFElsASFSIWDIVPGTTVSGIGAGMVIAALFSFILAAVDDdiGSASGVLSAVQAVGGSIGVAVFGSVFFagGFHRALIVQACLLVVFLAITFLLPKKGRPE---
     501 UniRef50_A5W349        Drug resistance transporter...   195     2e-48  1  25.7%  9:393   26:414     --------VILLLAALAAISNLSTNIILPAFPEMARQFNVSSQKLGLTLSSFFITFAFAQLLVGPLADRYGRKRLVVGGLMIFVVGTFWAANAATFDMLILGRVIQAIGVCAAAVLARAIARDLYEGENLARALSLTMIAAATAPGFSPLIGSMLNTTLGWRALFVVVGMSAILIALFYVRGIGETLPSRRrvPAVLIAYGKLASNRLFILPALATSLLMSGLFASFAAAPSILMEGMGLNSLQVGLYFAATVFVVFAAGLAAPRLAHRWGSRAITLSGLATACLAGALLLIGPSNPSFGWYSLSMVLFLWGMGIANPLGTALTMTPFGKEAGLASALLGFLTMAIGAVSTWMVSTPKFSTVAILGTTQTAVCLLAIMLFAWYAKRKVPHSTQ-
     502 UniRef50_A0NZ16        Putative transport protein ...   195     2e-48  1  22.6%  2:391    6:400     -SIMSARRTSLLGAGLVAIGPISMALYTPAMPALVEAFGTTDSAVKLTLTAYFAGFAVTQLVCGPLTDAFGRKPVTIGFLILYLVSSVLATFSPTVEFMVFARALQGVGAAVGIAVSRAIVRDQFTGQASAKIMNTIAMMLALGPAISPTIGGIVLELFGWQEVFWCMVIYGALLMVAVLVFQVETNPRPGkpRQLAINYTTLLKDPRFLAPSLLIGFGLGNLYALATVLPFILIYEVGLTPSAFGLTMIIQSGSFISGTILTGRLLRFIEARKLvgLGMWVVASSLMCYVTLTHEPTILTVMGPVALFTFALALVLPASFTESMAPFPHIAGSASSMLGFLQFGGGIVASLLIAALGE-PILGLAYILPGMPIVGIIVYLILRSQIPQPA---
     503 UniRef50_D2BS05        Drug resistance transporter...   195     2e-48  1  25.4%  2:387    5:395     -SSRSQLEYALILGSLAALGPLCIDLYLPALPQMANAFATSTSVTQLSLTAGLLGLGAGQLVFGPLSDKLGRRLPLLLSLAMLLLTSIWCALAQDIGQLIVARLLQGIAGAGGAVLSRAIARDLYIGHALTRFFSLLMLINGLAPILSPVFGGLLLSITSWRGIFALLAVIACLLLTMSALRLNETLPAERRITgmLSSLGSLLRERTFMGLCLAQGLCGAGMFAYIGASPFVLQEVYGLSPQAFSVCFAVNGIGLIAAGQLAAHFSLRFGEQRVLRAGLTIAVTAALALTVAglHAPLIGILIPLFFAIAMIGIVGPCASSLAMQSQGDKAGSASALIGLNMFMFGALSVPFTGLGGNTSALSMALVILGCYLLAVTAYLLLSPQP-------
     504 UniRef50_C7JAN7        Multidrug resistance transp...   195     2e-48  1  22.8% 16:393   26:411     ---------------VTAIGPLATDMYLPAFPDVERDLGGGAGSAQFTLGAWFLGLAFGQFSQGPLSDRFGRKVPLVIGLAVFAVASAMCAVVRDYHLFCIMRFMGAFGGSASAVIPRAIVRDVATGKKGAHIMAQLTLVFGVMPVLAPSMGSLVLEFGNWRWIFWSGTLYAVLGMIGIICMLPDTLSPAYrpFEIFTRYRTILREPVFLSNALITTFSTFVMFAYLGSAPVLFEQVLHFSPTAFGMFFGVNAAAFILGTQINGRLVHKFAMPALLQAAILWALIMGGIfsGLAGLAHPWLTCGLITCITGALGFIGPNGTVMAFSRHAHQAGSASALLGTMQFSLGSLSSVLVGVLPGGGAIPTAIGMMT-GVIGMVCANILRRRHTDQAEH-
     505 UniRef50_B6HSX1        Pc22g21580 protein n=1 Tax=...   195     2e-48  1  16.9%  4:393   49:482     ---SYKWGVVALLSFMGFTVTFTCISLAPIAGHVVDDLNGSksATVMLVTIWELGEAVGPLFIAPLSEIFGRYRLYLTMNTMFIVAILFAALSPSTELLIVSRALTGISVAS-NVLSPAIIGDMFVPEQRGTALTLIMFTPLIGGTLGPIISGAVLQTLGWRAIIWISVVMASICQILFLTSFQETYKVQILRrsIMRPAVVLLNSSVLVALLLFGSYMFSHFYIVATTLPEILENIYGLSPTETGLVFIANAIGTIISFIISKVLLDKieYRLPLSIIGALTLPPAVILYGWCAEYRLPllVFSMVWLRASVMLAFSPLTAYIVDACGIYSASAMAGLISMRCLAGAFLPLSVSHLTERLGYRGGFSMLGGLGLVLALIPTLVFHYGAQWRQ-
     506 UniRef50_Q0FFS7        Drug resistance transporter...   195     2e-48  1  24.9% 10:390   18:401     ---------MLTLVLLASISALAMNSFLPSLPNMAEHFGSSTALMGLSVGVYLGTSAVFQILVGPLSDRIGRRTVSLWSLIIFIVVSISCVYAPNTFVFMCLRALQAIAACTF-VVARAIVRDTTETQASGSKIAYISMGTAICPMFGPALGGLMDGWFGWEANFWFIGGLGLLILVIAYFDLGETVPetQGFRQQFSEYPELLLSRRFWGYCLASAFGAGAFFAYLGGGPFVGSIVYNLSPEMLGLYFGAPAIGYFFGNFLSGRFTIRFGIDAMILWGLWIIFSGLSLSMVCsgYGTVETFFGFMIFVGLGNGLTIPNATAGMLSVRPHLAGTASGLGGAMMIAIGAALSTLAGAFLVPGSNEMPLLMLmfSSLSGVAVIIYVRQRNKR----
     507 UniRef50_Q2GHE4        Drug resistance transporter...   195     2e-48  1  20.6% 22:385   21:391     ---------------------ISSDIYLPGLPKISDFFSVDYAIAQLTISLNLAGISISGLLYGPLSDYYGRRPIMLLGVGIFTLASVACCFASNITVLIIMRFIQGFGAGVAGVVGYAIIKDMYSGSDCAKNISIVNMAVAFSPVLGPILGSAIIAhyHWNMLFIAISIMAIIVLICLFVFLKETIVLEksCLSIMRKYKELVLNIRFCGFALIQSFTIMWIWSCIANLPFIFVKDMGVPVGYYGYFVAINVAAYIVGAMLNQRFVERFGINNMLLLGLILTTLssVLILYQIVEITPLLAEIMWLPSGMGIAFILGNNMTAAFSEIRE-PGIGSAFILFLQTIFGALGIYILGCFYDGTLIPVILFPIICSTICIVIYILLRK---------
     508 UniRef50_A4TZ65        Major facilitator superfami...   195     2e-48  1  23.4%  3:383    2:389     --PAPSRLIVIILGIFTALAPLAIDMYLPALPQMQTDFAASSTQVQITLAAFLAGFALGPALYGPISDGWGRKGPLYAGLIIHTLSSLACMMAPSVEIFTLARFFQAIGACAGGVIGRAMVRDLYPPQETHRVYATLMLVMGAAPIIAPLAGAWLINLLGWRSIFATQAIMGGLCLVLLHRWLAESHPPHLRRRsaLVAYGRLLADRSFMAYALAGSFGMAGLFTYISGSPFVLIQYHNLPLEQFSWVFAANAFGFIIAGQINGRVLHGLDRHKVLAVAQWAQLALAAMLAAVAAsaGVIGLSVALFATIACMGFIAPNSSVLVMAPrgAIAGTASALMGMLQFTIGAAASALVGLLHAHSALPMAMVMLGFAVLGPLSLKLL-----------
     509 UniRef50_C0XR05        MFS family major facilitato...   195     2e-48  1  20.7% 20:386   37:408     -------------------GPFGIDMYLPGLPTLQEDLGTTPAMAQLTITGFMLGMAVGNLLFGALSDSTGRKRPIMIASVCFFAASVLCAIAPSIELLVAARVIQGLAGGSMMVVARAVVPDIARGREAARMFSALMAITGFVPAIAPVIGGVLLPAVGWRGIFWALVVLNAVQTLVAFRVVPETLPPQMRSSRALRGlaRCLARPAFVGYMLASGLGFGVLFSYISGSPLVMQRQLGVSPTAFAVIFGSMAMLIPLSNAMNMRVVTRTDPRRALIAALLiaLAGALLVPQALSNPTLVLVVPTLAVLSLMAGFIVANATALGVDSVRDIGAGAGSGAMGFFQYVVAGAIPPLVALGTNPMLAMGISIIACSGIALVALATLTRR--------
     510 UniRef50_A5KY90        Drug resistance transporter...   195     3e-48  1  22.3% 13:389    1:383     ------------MVFIFLGAAMETDIYLPTFPDILNDFNTDAVMVQRILSYNFIGICIGSLLYGPLSDHFGRRKILMFGFSVFLAASIGCIYASSIEQLLAFRLLQGFGSSACVIVGTAMIFDLFDEEPAAKLIADLNTLVVSLMAFAPLIGGWISLHMGYKANFVFIAILVLLSATKCFFFLPESLSKDKrpKRIASDYKTVLSSSAFWYNTLVTSLILAAYMIYVSNMSLLYIEQLEVSPDQFPFFQMATLGTFVLVSLNNARLIDRFGIDKLKSTGLGLIFTTTLIFFLLPSEqsPFILTGTMCLFSIGAGLSIGLFFAKSMQVFPDLTGIAASLVTAIRLFIVSAAIDLGSNAYEGTSESVIHVMTAVVVFLAAISSVNYWRQSR-----
     511 UniRef50_B6VLU6        Mfs family, multidrug tranp...   195     3e-48  1  68.0%  1:394    4:397     MRKLDNFHLLLILIALVAVGQMTQTIYVPVIADIAKDFNMPTGSVQRVMAAYLFSYGLSQLFYGPLSDQIGRRPVILAGMMIFLFSTVCALFSPNLDVLVVASALQGLGTGVAGVMSRTMPRDLYMGTALRYANSLLNMGILVSPLLAPMIGGVIAHFFGWRSCYLFLLILCAGVVYYVFRKLPETRPQQIEKRKMFTSFCHLLSNGPFISYLIMLIGGLSGIAVFEASSGVLMGGVLGLNSIAVSILFILPIPAAFFGAWRAGREGKSFYNLMWHSVICCLLAGVLMWLPGWFGVMNIWTLLVPAALFFFGAGMLFPLATTGAMEPFPYLAGAAGALVGGLQNVGSGVATWLSAMLPQNGQFSVGMLMFLMSVLILLCWLPLAHRMQRQEHAV
     512 UniRef50_Q5LHE8        Putative efflux transporter...   195     3e-48  1  20.4%  2:384    4:385     -RQNSRRFLLLFLGVLSAFGPFIMDMYLPTLPAMADFFHTSSSMVQLGLTTSMIGLAAGQLIFGPLSDKYGRRPPLLLAMILFLLATVGCIFSHTISQFVTSRFLQGIAGAGGVVISRSIATDEYSGQQLAGMLAVIGGINGIATVIAPIGGGILAQITSWQGIFICLFFMGVVLLSGSLHllPAKHRQTVSWQDLYHSFGEVLHNRRYVGYVLQYGFTMGILFVNISSAPFIMQQHYGLSPLSFSLCFGINAIAMVISSAISIKL--PTMERALYIGSRGMLSVSALLMVFLSLRCDFWIYELLIFALLSMIGMTFTASNTLAMECERRNAGIASALLGATGFAFGGIVSPLVS--LGDMMTSTGILFLAGSACAYACTRYVL----------
     513 UniRef50_Q0FEF9        Drug resistance transporter...   195     3e-48  1  23.0%  4:360    6:364     ---AKTNPHLVTLVVITAASIVSLNMFLPSLANMASEFNVSYRVMNISVAGYLAVTAILQIIIGPLSDRYGRRIVLLSSVIIFCLSTIGCIFSSNIWWFLFFRILQGAMISG-TALSRAIVRDMMDSKEAVKVLSIIAMAMAIVPMLAPMIGGFLDELYGWRTSFWVYLIMGLSLLILIWFDLGETNTKKSETlkQLSTYPKLFKSGQFWGYSICMSASVACFYGFLSGAPLVATKVLNLPPTELGLFIGTTSLGFFIGSFLSTKLNIYFNLTQMILFgiAVLGISTGLILVLMGYVSTLTIFGSMVFIGLGNGFSLPSSHVGIMNVRSDLAGSASGLSGAMAVGFGAVVATLMGLILTA----------------------------------
     514 UniRef50_A2QCQ8        Contig An02c0120, complete ...   195     3e-48  1  14.6%  2:392   39:480     -SITRRVWVTSVVAILNLIGTVASSIFETGNETFMQDFKISHEVAVLGTSLFLVGYIFGFLTFGPLSERFGRKWPMLLGITLSSLFDLMPALGHNLPTVLLGRFFGGLFGVAPVAIFSGVISDCWPMAHRGIAMALAVSLVFSGPTFGPVFGGFisSTLDWRWNMWVVIIVGLGASLLCAFVYPETYAPVILRKklIRPSWLFTTQPILALLTLYQSFIYGVLFLFYQTYPVVFGEDRGWPTALKYLPLLAIICGVFAGAFGIIIHNQVyeARLPPMIVGGILVPIGMFWFAGTATppWPSAICASFLIGAGMYLLFIQGFNYIVDNYTSMANSAMGVNGSMRSIFGAAFPLFANQMVDGLGVQRATIVLAAICVALVPVPVCFWYWGDRIR--
     515 UniRef50_B6R5M9        Drug resistance transporter...   195     3e-48  1  23.7% 14:388   23:403     -------------ALLVTIGPLSMALYTPALPTLAEVFGTTEAVAKLTLTVYFAGFTLAQLLCGPLSDAFGRRPIILGFFSCYLLGSLLAWLAPNIEMLLLGRLIQGIGASSGIAVARAIVRDQFSGEAGARIMNLLAVMLGIGPAISPTIGALTLSAFGWQAIFVLMVAYAGFILLLTLTILPETnaRLIRPKQILASYWRLLRSFEFMQPSLILGFTIGVIYTLSTVLPFVLIERIGLTPLQFGMGMVLQSGSFFMGGVVTRLLLRRFSTEALLAPALICCGLGGLALFVVTqyLSFLSIMIPIGVFAFGASMAMPALSMRGMEPFPEIAGAASALMGFIQMAGGFFGSLVTAVVVPDPVTALGVVMPGMAFIALFLLILPVKKRG------
     516 UniRef50_C8XHI6        Drug resistance transporter...   195     3e-48  1  19.3%  4:360   36:455     ---PKRWKALSVLVVGLLVVILDNTILNVALKTIQIDLDATQNELVWAINAYSLAFAALLFTWGVLGDRFGRKRILLIGLVLFGFASALCAFASTPGQLIAFRALMGVGGASVMPISLSIITVIFPPQERGRAIGVWSAAVGAAVAIGPVLGGLLLEhnDWGSVFFINVPVVIVGIIGIVILVPETKNEHPGRLDPVGLvlSLFRIRSFSVPLTGVTLAFAAMQGTLLFLTFYYQIVRGWSPLQAGLLVLPFAVGQLLGAPRSAGMVKRFGARVVIPVGLAFAAAGMVFFSVVTPDTPVWMLVVLGVVFGFGLGNTIAPSTtmTLATPPARSGSGSAVQNTVRQVGAVFGVAILSSIVTT----------------------------------
     517 UniRef50_C9Y408        Multidrug resistance protei...   195     3e-48  1  75.4%  1:394   19:412     MRMFANRHLLMMLILLVAVGQMAQTIYIPAIADIALEMNVREGAVQSVMAAYLLTYGVSQLIYGPISDRIGRRPVILTGLLIFILATLVALAAQSLPVLIAAGCLQGMGTGVGGVMARTLPRDLYEGPALRQANSLLNMGILVSPLVAPLLGGLLDTLWGWRACFAFLLTLAVVVTFCMFRWMPETRPVQAQRPRLLASYKLLFGTASFNCYLIMLVAALAGVAVFEACSGVLMGAGLGLSSLAVSVLFILPIPAAFFGAWFAGRTHKRFTTLMWQAVLSCLCAGVLMWLPGWLGIMNIWTLIIPAALFFFGAGMLFPLATSGAMEPFPFLAGTAGALVGGLQNCGSGLLAWSSALLPQNGQFSLGMLMTAMGVLMLACWLPLAHRERMPEQTI
     518 UniRef50_A4BUQ4        Permease of the major facil...   195     3e-48  1  27.0%  1:392    1:398     MLRLRSTAATLALASFVALGPLATDMYLPALPAMATALNATPAQAQLTLSVYMIAIALAQLVYGPLSDRFGRKPPLLVGLVLFTLASLACALAQSIEAVIAFRFLQALGGSAGPVLGRAAVRDVHGPLEAARILSYLGAATALAPALAPIGGGYLLAAFGWPSVFIFLAAYGLAATALLWLALPEPLAPAQRQssIVRNYRFLLRHREFVGYMLACAFTFAGLFAFLSGAAFVLIEFLGISAQHFGYYFTLAVGGYITGTLFAGRLSRRLGINRLLLIGGVIATLGGALMAALALAqtALAVMLPMMLYMIGVGIVLPQSTAGAIGPFPQIAGSASALLGMVQMSIAAAAGILVGHLHSGTPLAMAAIIALMGTAGLASFFGLVWLPGRALQ--
     519 UniRef50_UPI0001AEDADB membrane transport protein ...   195     3e-48  1  17.6%  1:376   16:449     MNDKQILQAMSGLMAGMFVAILAGTVVANALPRIIADLGASQSSYTWVVTAELLAMTATVPLWGKLSDLYNQKMLLQLSLSLFIVGSLVAGLSHDVGLLIFSRVVQGIGAGGLTALAQVVMAAIIPPRRLGKYAGIFGAVFAVGTVAGPLIGGVLVdwLGWRWCFFIGVPFALLGIILLQRTLKLPTVRREVTIDYLGAFLIVAGVCALLIwtLTTVASLFVGVAMFafLSQYFQIALGKSPTVAGLMSLPMIGGLLVSSTVAGQLISRTGRWkyLVGGGITMTVGLALLSTIGADTHFGLLSLYMAILGIGVGMLMQNLVLAAQNDVpqDLGTATSVLSFFRSLGGTVGVSVLGAILANRVASEMTKGLGAAGIA------------------
     520 UniRef50_Q7X358        Putative major facilitator ...   194     3e-48  1  24.8% 26:392    1:372     -------------------------MYLPSLPDISSRLEATTAQTQLTISTYLIVFALGQLFYGPASDRFGRRPVLMTGLVIYCAASFLCAFAWSVELLMLGRALQAVGACSGIVLARAIVRDLYSGARAGRELSLMGMVMALAPVLAPLIGGVLQTFFGWRANFVVLTAAGLVIVLTIWFLLPETLapALKLAGMLRSFGGFLRDGSFLAHTGLVVFVFAGLFAWISGASFVLQDVYGQSAFDFGVAFAVASGGYMVGTALAAKFVGKYGIDAVSGFGAAAAVSGGLLMVGAVlvPSGFALVLPMALYLAGMGGVLGQAIAGALQPYHDRAGAASSLLGFLQQGVSAVVGIIIGHMLGDSAMPMAAGVAMCGAITFMIWLTTRGVRARGLR--
     521 UniRef50_Q3SQE5        Drug resistance transporter...   194     4e-48  1  22.8%  9:385   33:415     --------FVALVACIMALNPIATDMMLPAMPDVRDAYavHPNHVQAVISVYLAGFGAGQFIMGPLSDRFGRRPILIGGMLLYSAAGLLSVVASSFETMLLARVLQGIGSSAARVIATSIVRDCYSGRRMASVMSLAMMIFISVPVLAPSLGQAILLFSEWRGIFVVLTAYGLLALLWCALRLPETLPPAGRKpnVFDAFRQTVTNRQTIGYALAAGGVQSVLFAYVFCSQQIFTGIYGLG-DYFPLAFAAIATGLAAAGFLNARIVGRFGMRVIsaLTGSVVIAALTLLAAWQGWLSFPVYMVFAIGTMFAFGLMFSNFTALAMEPQGHIAGTASSLFGSITTLIGSGVGAMIGQDFNGTMLRFTASAFLCTIAALVVVIVVER---------
     522 UniRef50_C0Z7Y5        Putative multidrug resistan...   194     4e-48  1  15.5%  7:360   14:421     ------WLSLVAILSGTFVAILNNSLINVALPAMVNIFGSSTETMQWVLTGYMLANAVMIPMSGSLSAKFGAKKIFVLSLSAFTCSSILCALAWSDSSLIAFRVVQGVSGGMIMPIGMSMIYMIVPREKIGMALGIFGIASMTAPALGPTLGGYLIEFLSWQFLFLVGVPFGIFAVIMSIVLLKETPKKPELKFDFLGAflRLLKIPTFTISILTSGFVMMGMMGGIFLMPIFLQNIQGLTAMESGILLMPQSIAMAIMMPISGKLMDKYGVGPIGLVGLTIMSITTYELHNLSADSMHSWIDMILTIRGIGIGLCMMTLSTVGMNAVPRTsgDASPLSNVLRQVMSSFAIAILTVIMQA----------------------------------
     523 UniRef50_UPI00016A85C7 Drug resistance transporter...   194     4e-48  1  22.7% 26:386    1:366     -------------------------MYLPGFPAISIEFGVPHRLVQYTVTAFLTGVIIGQLLHGPVSDRVGRKIPLCTGILLYIVASIGCGLAQNIWMLIAWRFVQGVGGCAGIVIGRAMVRDRFGPNGSARAFSLMVTVVAVAPMIAPLIGGWMAG-AGWRVIFAILALFASLLLIGVFFTINETLPAERRVrsIFGQYRALLSCSQLLAYTVVSGLMQSALFAYVVSAPFVLMEVYGIPAQYFGMVFFANTAGLIFASQVNAAIVERFPPDRILGVALLcvLSIMLITALYFGFSSLFAVLAVLFGFLVGHGFISPNASALGLMKHGKHAGTASAVMGAVQNGLGVATIFMTSLFKITSALPLALVMGSCSILAIACHRLIARP--------
     524 UniRef50_A9BZU5        Drug resistance transporter...   194     4e-48  1  25.9% 17:391   49:429     ----------------SAIGPFAIDMYLPALPQIGSSLGAQVGAVQASLTAFFLSLGVGQLLYGPVSDMVGRKPPLYFGLTVFALASVGCAMATSIETLVVLRFIQGLGAAAGMAVPRAVVRDLHTGHAAARMMSLLMLVFSVSPILAPLAGSGVIAVSSWRGVFWAVAVAAVIGLVAVFMGLKETRGAAArvAGALRAYGVLLRDWHYLGLVFIGGCAMAGFFVYLAGSPFVLINYYGLSSTQYSLAFGLNAIAFIGAAQFTGWLGQRFGLVRVVKVAATGSGLVMLSLLalLGGERLAVLIGLYFVASALMGLVIPTTSVLALEEHGAIAGTASALLGTLQMLSGAAAMQIVGLFSTGKPLPMVVGMATGALIGVALAWITLGGARAHR---
     525 UniRef50_Q6FDN5        Multidrug resistance transm...   194     4e-48  1  14.9%  1:362   17:434     LSGGRLLLAAFVIALSNFMVVLDTTIANVSVPHITGNLAVSASQGTWVVTSYAVAEAICVPLTGWLASRFGTVRVFVMGLIGFTVFSFLCGLSTSLEMLVLCRIGQGLSGGPLMPLSQTLLMRIFPQEKHSQAMGLWAMTTVLGPILGPILGGLISDNLSWHWIFFINIPVGIICVLGTIRLLSVAETETIRVRIDAIGLFLlwFNSSIIVLFAVIAVlfGAFFGSIVLIPQWLQMNLNYTATWAGYLTATMGFGSLMMSPVVAKLAAKYDPRALASFGLLLLGGVTLMRAFWTSDADFMTLAWPQILQGFAVPFFFIPLSNLALSSvpQELASAAGLMNFLRTMAGAIGASIAVTIWDDHA--------------------------------
     526 UniRef50_A8NA75        Putative uncharacterized pr...   194     4e-48  1  14.8%  2:392   56:488     -SRTRKWIVTLVACSFTLLVSAATTSYTMGFTSMMRDLDCTRLEAVLGLSTYVIAFGIFPLLTSAFSEEFGRQPLYFCSLAVFLLMHVAVALSPNYQAIVVFRFIQGAAGSAGATMVAGTIADIWVPQERGLPMSLYSILAFGGNGIGTLMGGWIEMnlGWKWIQWISLIFGGALALVFFLVMQETRSAVITRKRvtRPLILFLTEPIIFAMSLWIGFVWGVFYCMIASVPQVFSELHGFNIGEVGTVNIAMLVAVFIGYFTntKVVKRfeARLYMCCAAAALFPISMIMFAWFCRSDIHWIALAIslYLWAVFTIYLAIFSYLADCYDTYASSALAGQSLIRNVIGGIFPLFTTQMFDALGYSWANTIFAIVGVLMIPIPVTLLFWGSRIR--
     527 UniRef50_UPI0001B565C5 Bcr/CflA subfamily drug res...   194     4e-48  1  25.4%  2:390   18:407     -KRPGALRMAVVLGLLEVFGPISMDLYLPALPRLADDLRAGQSLAQATMSVCMLGLAFGQLVVGPLSDRFGRRRPLLIGIGLFTVLSVVCAFAPSIEVLLAARFLQGLCGSAGIVLSLAVARDLAEGVELVRLLALLTTVGALAPIVAPVLGGQLAAVIGWRGIFGVLAGIGAALLVVAATALPESLPPAARHPRKGRgfRILLKDPLFLGFLLVSTCGGAAFFTYLASISFVLQDGFSLSPQLFSACFAANAVMSVLGAQVNRAAVRRAGPVRMYVLGTTFTAAAAVTMLGawFGAGLAALLIPLALLMFAGGTTQANGNALALANHGQRAGTAAALLGTSSFAIGPIVAPLVS-LGGTTPLSMSLTMTVAYGIATVLLWLAVLPRLRR----
     528 UniRef50_D2SH23        Drug resistance transporter...   194     4e-48  1  19.5%  2:360   23:443     -SHRQVLTVLAGLMAAMFLAALDQTIVATAVRTIADDLD-GFSLQAWATTAFLITSTISTPLYGKLSDLYGRRPLYLFAISVFIGGSVCCGVADSMYQLAAARAVQGVGAGGLMSLALAIIGDMVPPRERSRYQGYTMAVWGSSSVLGPVLGGLLAGQegWRWIFLVNVPLGAVAFTIVFRVLHLPHERRDHRIDWPGALALtwTSPAALVCYALGAAGLGAFVLalLLIPQYLQIVHGSSPTVAGLQMLPLVAGIMAGAGSSGVAISKTGRYRQFPLLGVGLMATALFGfvAGADTPYGLLVPFLAMFGVGVGFTFQPVVVAVQSAvpWEIGVATSSVAFFRQTGATVGTAAFLSLLFA----------------------------------
     529 UniRef50_B5EKD4        Drug resistance transporter...   194     5e-48  1  15.6%  2:360   15:427     -SQEHRWLITIAFMLAMVMVLLDMTVVSVALPYMMGTLAATPNRITWVLTAYLAANAVTIPLTSHLAALFGRRRLFLISVSGFVVASGLCGASQTLAEIVFLRTLQGGFGALMVVLAQSTMVNLFPGKERGRAMAIWGMVLMVAPAMGPVFGGYITQHMGWRWLFYINLPVGIFSLLLGAATMRKSERkaLSILAVFGILTFLLrdRSFATATLITGVFGLGLFGTTAMQPLMLEGLLNYMPETIGWVMFPRGVASAVTMMIVGRFINRYQPRLFIVAGVLLTGISTWIMTSYSLYISPVWVIYPGIIRGIGMGMIFVPLTVIAFDTLpaVSAEASGIFNLARTLGNSIGIAIDGTVLTN----------------------------------
     530 UniRef50_B4VDF7        Transmembrane efflux protei...   194     5e-48  1  16.6%  4:388   43:505     ---RRRWLALAIVMTAAFMDLVDVTIVNIAIPSMRQDLGASTSAIQWITAGYALAFAAGLITGGRLGDIYGRKRLFLIGIAGFTAASLLCGVAANPAMLVTSRILQGGMAALMVPQVLAIVHVTFPPHERGKVFGMFGAIVGLGAVSGPMLGALLTEwlEWRPIFLINLPVGIAGVLLGRKFITESKAPDALRLDLVGVVLATLALVMLiaLMIASPFVFAAFIafFLVWTLYMQMGLGWSALRAGTTGIPFSVasAAAGMSVQKLVPRFGRKVLQA--GALTMAAGLLLYIWESDhaSWQMALPLIVMGVGMGLIVAPLttVLSEVPPRHAGSASGLINTTGQMGNALGLGLTSVVYFGwaFRGALWWVVAVMLVIFAVMFALPRRA------
     531 UniRef50_C7HY03        Major facilitator superfami...   194     6e-48  1  20.1%  3:371   19:436     --PTDRRVILLILCLAVLIAQVDTSVVNLAVHAIGVGLHAPLPALQWVVDGYNLSYAALLMTGGTLADLLGRRRVLMAGAAVFVLGSLLAGLAPNITALIAGRVLAGIGAAMLLPASLALIRVIwdPHERAHAIGVWAGTNGAALAIGPTLGGWLIQTVGWRSVFLLIVPIGLAVLLWAPRAIPESRDAQGRRVDLPGQwlPLLRNTRLAAVNGVAAAMTFGMYGVLFLLPLNWLRGGVLDATGAGLALLPMSLAFVALSHRSGPWSKRYGTHRLIAGGMALIGAGIAVLACSHAGQNLWLAEAGLLLTGVGMAltGPVLASAVAAVEPARAGTASAMINTARMIGATLGVGVLGSVFAAGATMTTGFTVA-----------------------
     532 UniRef50_D0L5Z8        Drug resistance transporter...   194     6e-48  1  17.4%  5:367    8:426     ----NRWWALAALCFAELLVMVDNTIVNVALPTMARDLDAGISGLQWIVDAYTLVFAGLLLTGGYLGDRFGHRRMLITGIVGFTAVSVLAAGSQGLGQLIAARGALGMFAALVFPATLAIVTTVFtpRERAAAVGVWAATSGVAVAVGPVLGGWLLEHFSWTSVFWVNVPLGVIALAAILLVVPGTRPETVSRFDLPGLAlrLFANRRFATAAGMISVAFFALFGFIFLITQFFQGVKGYGPLEAGLRTLPFAIVMAVLSPVAMALSHRFGPRLVAVFGAFVMSAGFGLVEIASRFSGYwlIIWSMSLMAVGLAFISGPCTQMIMDSspEQAGAGSAVNDTTREVGGTLGVAVLGSVLTSAYLAGVG---------------------------
     533 UniRef50_B7VMU9        Multidrug resistance protei...   194     7e-48  1  25.8%  3:393   48:435     --PTPSKLQVALLAMLVLFSPLAIDIYLPALPQISTAFHVEHALAQDTITWFLFAMGVGQLFAGPLADKLGRRTVALGGVSIYALSACLAWAAQSIDMMLMARLLQGLGACATSVAAFATVRDLFGPEKSGRMISYLNGAICFIPALAPILGAWLTHQFGWRSNFSFMAGFAVVVGTILFFQMKESNPATEKVAVflERYWSVLKTPSFLFHATLCLMAMAVILAYVTSAPVVLMENLGLTMKEFTFWFGVNAAINIAAAFTAPKFMDRFGTYKALVVGISTLGLAGVIMLVLAEHASPIAFMLPIFLSSVGFAWILGAAAGKALEPFGDRAGTAAALLGLFQMSGSGL---LVGTM-QRLDLTSQVMIALQMFLIVPALLVLASKAGKSWHT-
     534 UniRef50_Q3B6T7        Drug resistance transporter...   193     8e-48  1  15.1%  5:354   28:435     ----RRTIITLTVIVAAMLELIDTTIVNVAINHISGNLGASIEDVSWVVTSYAIANVIVIPLSGFLGNLLGRRAYFIGSILLFTLASLLCGLADNIWTLVFFRFLQGIGGGALLPTSQAILYETFRPEERGAATGIFSMGLVLGPTIGPLLGGYLVDYFSWEWCFFVNIPVGLLAAWSAFTFIREPKVRHKVQKIDWTGIGLlfDTPYITWFTLitFIVGYGLYGSLFVFPVFVQRLLGFTAVLTGLVLFPSalTGAISLPLGIALQKGASAKLMMAFGMAAFMVFSWELGQQTLQSGAENFFAVLLLRGLALGFIFIPVTMLAvgLHGRDIGQATGLNNMVRQLGGSFGIAIT----------------------------------------
     535 UniRef50_A0NYW9        Drug resistance transporter...   193     8e-48  1  25.1% 11:389   10:394     ----------IVLGLLAAVGPFAIDLYLPAMPEIVQALQTDDAAVHMTFTVYFIAFGFAQLIYGPLADRFGRKIPAFLGLVVFIIGSIMCATAIDVSALTLGRFVQALGAGAPMVIVRAVVRDLHTGPRATRLMALVMLVFSVSPMLAPLTGSLIIQFGSWRLIFVALGVIALLAMLQMAFLLPETLPAERrpTAMLRSAIYLMRDGRFMGLTLIGGFSLASFFVFIAAAPLVYMTQYQLTPMAFSLVFALNAIGFFASSQFAAALGERFGMGRVALMAVSGFAAalLVILVWSGIDDLPVLMALFFIGNTCLGQVIAPVMVMALEEHGEHAGMASSLGGTFQMVAGGVMILVCSPFFDRTALPLVGAVAACALIALVIALLTLRTSRE-----
     536 UniRef50_D1ADS9        Drug resistance transporter...   193     8e-48  1  15.4%  4:360   24:435     ---RSVWVTAGVVVLGAIMSILDATVVNIAIPVLTEEFATTLAKIQWVITGYTLALATVIPVTGWACARYGTKRLYMTSLTLFVLGSALAGLAWSAESLIAFRVLQGLGGGMIMPAGMTILTQKAGPQRVGKVMSVVGIPMLLGPISGPILGGWLVDLDAWRWIFFINVPIGAIALLLSWRVLERDVPKPAERLDVPGLLflWLFKRRSMAAAALTMLLfiAFFGAMLLLPLYFQIVRGETALNTGLLLIPQGIGSMLTMPIGGMLTDRIGPGRVVTVGLPIILAGAFGLTQVTADTSYVTLGVIFFVLGLGMGLTMMPTMSAAMqlVHDEVPRASTAMNIIQQVAGSIGTAAISVILTN----------------------------------
     537 UniRef50_C3KAD7        Probable transporter n=2 Ta...   193     8e-48  1  27.6%  4:390    3:394     ---RSIAHLALLLGLITAVGPFAIDIYLPALPTLGASLQASPALVQMSLTVFFVIIGVCQLFYGPISDVFGRKPPIYAGLVIFAVASVGCALAPTIESLIAFRALQAFGACAGMVIPRAIVRDLYTGHEAAKLMALLMLVMSVSPILAPLAGSLVIALWSWREVFAVLAVVAVACLVMTIVQLPETHPAERRLGKTLgsYGALLRDPVFIGLSVVCGFGLATFFVFIGSAPFVYIEHYGLTPTQFSLGFALNAASFFAMSQLTARLSARFGLAPLIRGSVVAVAAVMAVLATTTLWVDSLALMMTMLFIGFGfgLLLPAAGVLSLEDHGAVAGSASALLGAIQMITAAVSMTLVGVFADHTPAPMLIGIALCGIAAMLTTLWTLRRLPAH----
     538 UniRef50_Q0RV66        Multidrug resistance transp...   193     8e-48  1  23.2%  1:393    1:399     MREAITVPMLLVLALLSATSPVATGVYLPGLPSIASALGTSNIGVQLTLTTFMVGLGLGQLLAGALSDSWGRRRLLLGGSVAFTVASAVCALAPTIGVLTVARLIAGFSGGIGVVLARAVISDRARGIEAARLFSVMMIIGGVAPVIAPVLGGMLLGPIGWRGTFWVLTAIGGIMTFGVATAIPETLPPETRHTglGQNFRQVVGDRRFVGYAAAMAIGAGAMFSYIAASPFVVQKIFGFTPTQFSLVFAFNALSLVTAMTINSRLVSRISVRRLLIFGVGVVWVSGLGLLalFSPTTPWPLLALLLTMMFGMGLTMGNAVALAQDQVPSVAGTGSAVIGAAQFAVAAIVSPLVGLGGESTSVPMAVSIAVCGTIALTALLTLTRDRPETRLP-
     539 UniRef50_A5KS25        Major facilitator superfami...   193     9e-48  1  14.1%  3:392    2:445     --NRRLFFVLLTTIIGSGIVLLDGSVVNLALPALSKELGADFADLQWIADGYLLSLSALILLGGSLGDIFGRKKMYLIGLVGFGITSVLXGFVQTTESLIAMRVLQGIFGALLVPGGLAIINTNFRAEERGIAIGQWAAWSGIATAIGPFLGGYLIDNFSWRAIFFINIPLVIICFLLGLPHIKESKDENPRKVDYWGAglRLFTSRNFTGANITTFAMYGALSGFFFALIIYLQTTVGYSSMAAGLSILPVTLLLLLFSGRMGKLTSTYGPRIFMTLGPILGGIGMLTLLGLGHNANYWlvLPGITLFGVGLVFTVAPLTVTVMTSVSdqSGIASGVNNAISRAAGLIVIALLGLFGASQSYQFTVMLCSALAIIAGIASWLLIKDPPRAK--
     540 UniRef50_B9Z3Z9        Drug resistance transporter...   193     9e-48  1  25.1%  5:391    9:398     ----HPTRLIVLLSALVAFGPLSIDMYLPSLPAIARDLAAPVGLVQFTIGGFLTGFCLGMLLYGPLSDRFGRRPVLLAGIALYLVASLACAFASSAEQLIALRVLQAVGGGAGSVMGRTVVRDVFPLDRAAQVLSLMHLVTMIAPLVAPVLGGWLLLAAGWRSLFLALALFGAVCLALVALRLPETHPAERrlASAFSAYGHLLTDTPTLGYMLALGLTFGAMFAYITGSPFVYIDYFGVAPQHYGWLFGLNIASVIVLTTLNKWLVKRVALDTLLQAQTAVIAAAGLALWLAGAH-SLLAVVLPLLVSVGLTGSIGPNTMARLLQRHSERAGAAMALAVSGQFGLGMLASALVAALHDGTPRAMCQVVALFGVAACLGLQLIRLPAATAR---
     541 UniRef50_Q1GRD0        Drug resistance transporter...   193     9e-48  1  20.5%  4:359   28:437     ---RYRGLLTVAVMGASIMQILDTTIANVAIPHMQSALGATSETVTWVLTSYILASAIAMPITGWLADRIGRRELFLAAIAGFIVASMACGAAQSLEQMVAFRFLQGIFAAFIGPLSQSVMLDINPPERHARAMSIWGMGIMIGPILGPVLGGWLTESANWRWVFYVNLPVGLVTLALMWALLPAMRRTSRkfVHLFTARAPLFSRAMLADRNLVTAMGFmvMFASMALLPPMLQNLFGWPVIDTGLVLAVRGVGILASMWVAGQLLGKVDARWLVGTGLAIAAYSLWQMSHWSLAMGMQPVIVSGLVQGLGMGLIFIPLNTMAFAtaPQHRTDGSSLLNLLRSLGASVGISVVTTLLG-----------------------------------
     542 UniRef50_C6AA50        Multidrug resistance transp...   193     1e-47  1  23.6%  1:381    1:386     MIHKYTLPFIILIVCLSTGGLISTDIFLPALGEMRQYYQVTQSQIQNAVAVFLLALALGQLIYGPLSDNFGRKKTLLLGLFLWLFTTFGAIYTVHIHAFLVLRFLQGLGACAGLVLSRAIINDLLDKKAAGKLYLIVFPFIGMSPALAPFIGGLLIQAFHWQATFIFLSFFIFLTILLCCFVLTETLPPQKrpVGLMKAYLGVFRNKQFIFYALIPCFSYIAYFAYIVESPFLLTT-LGLSPIHISYSYIGVSLPYILGNLLARWFFERESMEKTVCRGYIIFVIGGVLFAvyLSPWPLVTSFMAIAVLTFGNGFLLPLGTALAISSHPKASGAASGVMGSLQLGSAALSAAVIGKISGHSPRAMATLLAVCCVIGFIIYI-------------
     543 UniRef50_D1BK34        Drug resistance transporter...   193     1e-47  1  25.5% 10:389   24:408     ---------VLMLGALAALPAVTTDMYLPSLPTVVQDLGTTDTAVQFTMSGMLIGGAVGQLVIGPFSDRYGRRLPLLIGISLHVLTSLLCAIAPNIGALVALRVLQGFFNAAASVVAIAVIRDRFTGSEAARLLSRLMLVIGVAPLLAPSLGQAIAGAFTWRAVFVALAIIGALLVVIVWFWMPETLPHERRrrGALRSYLELLKDRHFLALAVLPGLGMAVIMSYVVGSPFVFQQEYGLSPTQFSLLFAVNGVALVLSAQLNASLVRRVAPIRILRVAIVVQLMLSLVLLVvtGFGGVVGVLAALWLVLGMQGLIPANASVLALGGYGHMAGTAAALIGSMQAGIAGVVSPMVG-VLGGDSLAMTTVIISVILVSLVVLATATPAYRK-----
     544 UniRef50_C7LPJ1        Drug resistance transporter...   193     1e-47  1  23.7%  6:368    8:369     -----KIRALLILALLAAFPPLSTDMYLPALPSLTTDWGSTETIINLTLVGFFVSFSLALLFYGPLSDRYGRKPVLLGGISLYILACLVCARAESPTALIVGRVLQGMGAASASTLSLAMTKDYFVGAERERALAHMAVIVSLAPMLAPVLGGLMLTFAHWSAIFYAQMLLGALAICGVLRLKEPAPATTRTLGQVMGSYVRLMCNPRFMTLCTLIALGMTPLFCFIGGSSFIFVTYFGLSEQEYSYFFAFNSAALMLGFWICGRLLKRIPGFRIILIGYAG-ILIFATILALCSRLGPWGMALPMAAMTMSLGLTRPPSSNFLLEQVKNDAGSAASLIMFTYFVCGATAMWFIALPWDNKILTMALV--------------------------
     545 UniRef50_D2SGU4        Major facilitator superfami...   193     1e-47  1  20.3%  4:358   27:441     ---PRRWRALSVTLVAGFMSLLDVSIVSVALPTLQRDLGASAAAVQWVVSGYALTFALVLVPAGRLGDALGRRRMFLAGLAGFVLCSTAAGAAPSVGLLIAARLAQGLAAGVLAPQNSGLIQQLFRGGERGRAFGLFGAVVGVSTAVGPIVGGLLLQVADWRWIFYVNVPIGVVAFVLAWRLLPRGGAGGRGHIDvaGGLSRLWWLFPVGVLLVGGFVafVGFSGIWLVFALFFQTGLGLTPLQSGLAVTPFALGSATAAVVAGRLVERFGRLLtlVGVLTGLGATVAVLLLVPADAVPWAVAPALLVGGLGGGFVISPNITMTLRDVprMAGAAGGGLQTAQRFGAVIGTAALPGLF------------------------------------
     546 UniRef50_Q47P56        Drug resistance transporter...   193     1e-47  1  23.3%  3:393   36:437     --QRSAALLVFVLSLLTATSALATDLYLPAFPEIAADLGATESQVQLTLTAIMVGLAVGQLVLGPLSDRWGRRLPLLIGAAVFTLSSLASAVAPSTEVLSALRLLQGFSAAAGAVISRAVVRDIFHGEDSARFFSRLSLLTGVAPMVAPMLGGQLLLAGSWRLLFVVLALIGVANLVLVYVALPETLPRTpqRGSVLGALLRLQLDPRFMGPTLVMSLSFAMTFTYISAFSFVSESEFGTTPQQFSLIFGVNSLGMVLGNQVNTMLINRmpRRLLAGLLGALASVAVLVGLAISEQANVVVVTAALFTMMFFTGLISPNATTLAIASQPSsaGTGSALLGALQFagGLAATTGMGEGGEASLLSMSVVMLVTAAAAGAVFAGWAFLARRVPAP-
     547 UniRef50_A0LYZ9        Bcr/CflA family drug resist...   193     1e-47  1  22.8%  3:392   10:404     --KKQEYIILLVLGTMIALGPFSIDAYLPGFENIAKDFNTSISQIGITLTSYFIGISIGQLAYGPIMDKYGRKKPLLIGLLLYLLSALSCMYSPNLEWLIISRFFLAVGAAAGMVAAKAIVRDIFPVNEVAGAISVLMLIMGGAPIIAPTVGSFIIDSFGWKTIFLFLAVFSALMIISVSRFLPEsrKVDLKPKQVAIKYFGILTHPKFMNFAFAGSFAIGAMFAYISDAPKLFMGNFGLTQKEFGILFGLNAAGLILGSQINRLFLRKYSTFQITLfsVILVVLSLLFLVNSFFEFGFITTVVLLFLMLFLLGFQNPNTTALSLEPFEKKAGRASALIGSLKMILGALTSFIISLFHSSSAIPLAIILSTCLFISSLLLFSFARKEKQSLH--
     548 UniRef50_Q034A5        Permease of the major facil...   193     1e-47  1  19.7%  3:357   11:424     --KRHQWLALTAMSMGVFMGLLDVTVVNVALPTMVNDFNTNFTNLQWVLNAYTLVYAVSLLIMSKLGDMYGRKKVFLGSLILFVLASTVNGMASSLIVLDIGRGIQAIGGAGMNSLSMALVASNFSGNKRGVALGILGSVIGMSTASGPLIGGFLVENFGWPSIFYVNVPVGIVAVIMTLTFVNETPSYGQHERIDFAGMlwSWMDIRIGGWIIAGFilGASLYSFNTFLTALMQNYIGYSALQTGVRQLTISGWSLVLGPISGYLGTRFSKKRMISASLLVGACGFLVMlaMGPRVGFMDLMPGMLMIGFTNGIVSPLINTVGMevAPQQMGMASGLLNIFRQLGIVIGVVGFGLM-------------------------------------
     549 UniRef50_C9LY82        TcaB protein n=2 Tax=Seleno...   193     1e-47  1  21.3%  1:380   13:396     MTKRRRISLTIFLGIMSAMAPLATDMYLPALPELSAEFSASTSATQLTLTMTLFGMAIGQVFLGPLSDMYGRKRPLFAGMVAFAIVSAGCFYASSIEPFLALRFLQGFAGASGIVIARAIARDVAEGVELTRFLSILMLVNGLAPILAPVAGGQLLVFSSWRIVFAVLAAIGVLLAVWTLKT-RETLAEGARQKSmfHAFPTLLRDRYFLGHCLVQCFVFGAFFSYIAGSSFVFQNIYGVSAQGYSLIFGGIGTGLFLAGLLPARLAGRIKDISMLKASLllVSSALLLASLLAGFAPLALTIVLLFITVVPLSVMGTASFSLALSRQGRNAGAASALIGFFSMVLGGVMMPLVGIAGDHTAIPMAVLMLTGYTLGAIVF--------------
     550 UniRef50_Q1ERH8        Citrinin biosynthesis trans...   192     1e-47  1  11.8%  4:394   55:514     ---WKKSLITCIFSTLTIWVTFSSSVFSAAAGITSKEFHVSVEVMTLGTSLTVLGFTVGPLVWGPMSELYGRLKPLYIGYAIFIIFQVPVAVAQNLETLMLARFFLGFFGTSALAIIPGALADFWGPVERAIAISLFSAATFVGPIFGPImgGFIVdsLGWRWTAWITMIPASFFGIIAFLTLPETYHPVLLQRrlFRPIQMLFLEPILVCMTIYISLIYGILYLFFVAYPIAFREVRNwsLGIAALPFLGILVGVLMGCLLVTIATRLweDRLPPMIVAAILLPIGLFWFGWTSSPSISWaaIAGAPIGMGILMIWMQGLNYLIDVYLVVANSAMSANTLIRSAVSAAFPLFATAMYHKLGVDWATSLLGFLSIAMIPIPVIFYFYGAKIRAL
     551 UniRef50_Q0ARP1        Drug resistance transporter...   192     1e-47  1  24.9%  9:385   19:402     --------LVALLVAMTAVVALAIDMMLPALDDIAGDLGvsENDQQFVIGVYLTGFGFAQLFYGPLSDRFGRKIVIQFALAFFIVTSLVCTLTPTFDMLLVARFFQGAAAAACRVIATAIARDLTSGRRMAEVMSMVMTAFMAVPVLAPMMGQAILTFAPWRWIFAFLVLFGLGLMVWLQLRLPETLHPqlRVKPLLAAFRETFSHRLMLGYTLAGAPFFGGLYGFLGSSQQIFVGHFGLSDDAFPFAFAAIAGGIGLSSYANSRLVMRLGQRRLSHWALIAFTVISaaGILWSGIDNFVLFLVLLSAAMAFLGLIAANFSALALEPVGHIAGTASAVYGFVTGVIGAAIGSYVGQLYDGTATPLIVSQALMAGTALAIVFWTER---------
     552 UniRef50_C2C1G8        MFS family major facilitato...   192     1e-47  1  14.0%  2:366    8:426     -SPKQRNGILIVMLMGAFVTILNQTLMNVALPSIMNEFKITASQGQWLSTGFMLVNGVMIPMTAFLIERFTTRQLYLFAMIAFAIGTTIGGFATSYPILIVGRMVQAVGAGVVMPLLTVVILNLFPPNRRGKAMGLIGLAMNFAPAIGPTLSGWIVEQFDWRNLFFIIIPFALLDVIVAAFLLKNVGKRTFPKLDVLGVifKVFKSSTFTFTSIISFFVIMGLFGGMLLLPIFLQSVRGFSPLDSGLVLLPGAVMMAALSPITGIMFDRYGAKYLTIIGLTIMTVATFMFTNLSESTTLTYITIVQAVRSLGMAMVLMPLQTAALNALpqLASHGSAMYNTLRQVAGSIGTAFLITVMSKSASHFG----------------------------
     553 UniRef50_UPI0001788B1A drug resistance transporter...   192     1e-47  1  14.1%  3:392    6:467     --KSSFWLIMSAVFFGNFLAVLSITTINVAFPVVMEQFHATLSTTQWLMAGYLLATGIVAPIVGYMGDQLSYKRLFVLALTGFTLSSLLCVVAWNIETLIAFRITQGVFGGMIIPITMTIIYQVFPRERQAYAMGLWSLASMLAPVIGPTLGGWLVQYFGWKSIFILNVPIGLISIVIVSKFIPFYRLTGKKTFDLLGFllKVFKFPRFRYSLILNCIVTISLYTGTLLVPLYLQTVLKLSPMDTGLIMLPGAIVMAAASPIIGKFYDRIGPFRLVITGVLIIVAATLAFSGIGTNTSVLYISMLQLVRCLGIALCNMPLTNAAMSAvsEYSGHASSITNWARQGLASLSIGIFSALvtTMGIDDVFMIGTMVAVVAIPLTFLLRVKKKKST--
     554 UniRef50_UPI0001B9ED41 drug resistance transporter...   192     1e-47  1  24.7%  9:384   12:392     --------FALILATFSALGPFTVDMYLASLPQIAVFFGTSAAAVQASLTTSLLGLGLGQLIMGPLSDMYGRRPPLLTSMILYILSSIGCAFAPSIEWFICLRFIQGVAASAGLVISRAIVRDRFRGVEMTKFIALLTMISNVAPLISPTLGSAVMSYSSWGSVFLFLGALGIALTAITLGGLKESLPVQQRVPslIKNYNSLFRERSFMGYALVNGILFAGVFAYVAGTPFIYQNMYGVSPQMFSILFALNGLAIIAGSQFVKLFAGRVPESRLFRIGLIIAFisAAVLFVVLVHGALSAMFISIFLFAFSIGIIGPISFTLAMESQGHIAGSASAVLGSLQFALGAVTSPLVGIAGENSAIPFGVVIFSTSVLSIAAYLILI----------
     555 UniRef50_C7Q679        Drug resistance transporter...   192     2e-47  1  18.2%  3:371   40:464     --NPRRWAALVLIAVAQLMIVLDGTIVNIALPTMQRNLHISDVNKQWVITAYALAFGSMLLLGGRVADYTGRKRAFVIGLLGFAAASALGGAATNEAMLFGARAVQGVFGALMAPAALSLLTVTFTEeeRARAFGVYGAIAGGGTAIGLIMGGVLTEYASWRWTLLVNVPIAVVAAFFASRVLTESKAAGNTKYDIPGAlmRVILDRNRGGSFLSSLLMGVGMFGVFIFLTYYLQQILGYSALKSGFAFLPFTFGVIAGAGVATRFLPRIGPRVLMAVGFGLATLGMVLFTGIGVDTSYLtvVPAELVMSFGIGLFFVPLSStlIGVADHDAGVASALVNTTQQIGGALGTAMLVTFATTATTNYLGSHAA-----------------------
     556 UniRef50_D1XR12        Drug resistance transporter...   192     2e-47  1  15.6%  4:393   28:495     ---RRRWFALAIVMTAAFMDLVDVTIVNIAIPSITRDTGASFSSIQWITAGYALAFAAGLITGGRLGDIHGRKRLFLLGIAGFTIASALCGFAVNPEMLVASRILQGATAALMVPQVLSIVHATFPAHERGKVFGLFGAIVGLGAVSGPLLGALLTEwlEWRPIFLINLPVGIAGLVLGRKFITESKAPKALRLDLAGVALVtlGWPVWGHVSMAASLLVFalGIFFLVWTLYLQTGLGWSALKAGTTGIPFSIAVSVAAGLSvkLVPRFG-RKVLQAGALLMIAGLLLYAgyGQAITSWQMVLPLVVMGVGMGLIVAPLTDAVLSGVpeHSGSASGLINTVQQMGTALGLGLVSVVFFGAIDDGAAPQAlcVAGVLAVIFFVMFALPAAPRP-
     557 UniRef50_Q3J6T2        Major facilitator superfami...   192     2e-47  1  16.3%  7:387   19:400     ------RRSLFSLAGIYSLRMLGLFLILPVFSLYAHDlgATPALIGLALGAYGITQALLQIPFGLLSDRIGRKPIITAGLILFALGSIVAAMADTIAGVIIGRALQGTGA--IAAAVMALVADLTREEQRTKAMALIGLSIGMSFAVALAAGPVLNQWIGVPGLFWLTAILAVLGIAVLHLGVPQVTAPRHhvEPAPQQFLRVLGDFQLMRLALGIFFLHLLLTASFVVLPISLRDESGLDPAYHGYVYLPVLVTSIIAMVPFIILAEKKRRMKEVFIG-AVAVLGLAELAWRFFHPSLAGTIVALWLFFTAFNLLEATLPSLVSKQSPasKGTAMGVYSTCQFLGAFVGGWAGGAVYGYFGFEGVFTFCAGIVALWLIFAATMEPP-------
     558 UniRef50_B5GUC1        Integral membrane efflux pr...   192     2e-47  1  20.3%  2:361    5:418     -RHPRRWLILVVLCLSTLVLVIDNMVLTVAIPSIAEDLGATSQDIQWIIDSYILVFAGLLLTAGSLSDKYGRRKVMVVGLVVFGAASVVATCATSPEQLILGRVLMGVGGALVMPSTLSILITVFDEEERPKAIAAWSTVAMVGLVGGPVLGGALLDRFDWGAVFLINVPIALLAIVAALVLMPESKGpeTRGTDSPMVPLSLFRNRTFTGASLSLVLLTFANGGLMLVLTQYLQFVLGYTPTETGLAFTPMALAVIVFNAVGASLLARTGNRALAVIGLLVIAGGFALLASLSAGDGRGLLATAMVLLGAGSGLAMPAAISALMGAVpeHAGVGSALNDTIQQAGAALGVAILGAVLSST---------------------------------
     559 UniRef50_B5ZLT7        Drug resistance transporter...   192     2e-47  1  22.6%  6:385   20:408     -----PAWLVILLGLVTAIGPLATDMYLPAFPAVDRDLGGGPGSAQITLASWFAGLAIGQFSQGPLSDRLGRRVPLLGGLTLFSIASAGCALSYSYHMFCVWRFLAALGGSAGVVVPRAIVRDVATGMQGARIMAQLTLVFGLMPILAPSLGSLVLSVGHWRWIFWFAVVYGALGVVAIAWTLPDTMPRDRriPTVLWRYVTIAREPMFLSAALLLGFSAFVMFGYLASAPTLFEHILSFTPGQFGLFFGVNAALFITGAQVNGRLVHRVALDVLMLRGVTVVTMAAVLFLALSLAghPALVCCLIGLITGSLGFVNPNATVLAFTRHGHHAGSASALLGTLQFTIGSLSGVLLGYLPLDTTVPIAGTMAAGIVGMLFCTVWHRR---------
     560 UniRef50_C4LKD4        Permease of the major facil...   192     2e-47  1  17.8%  1:394  216:608     MGSRRALFALIALSIGGFGIGTTEFVSMGLLKYIGADYGISDGAAGRIVTAYAMGVVVGAPLITALTGKIPRRRLLLLLMGAFTVGNGLSVFAPNYPFLIAARFIAGIPHGAFFGVSSLVAVSLSKPGKRGQAIAIVNLGLPIATLIGVPLAQAIGQAMSWHYAYAMVSLIGLATLVSIWIALP---HMTLMLTTNPLTELSALIKPQVLLTLLMGTVGFGGMFAVYTYISWTMTEVAGLPASLMWIVLMSYGVGMIIGTWFGGKLVDYNPER---GIFFSLIVMMVILTAFFFTSHNPWLGTINFALIGMSGSLLTPNLQSRLMDTAGEAQNLASALNQSALNLANAGGAMVGGWVVSAggGLAGALMALLSMIVWAPTALVRKRSTASVQHV
     561 UniRef50_Q1MYK8        Bicyclomycin resistance pro...   192     2e-47  1  21.0% 13:388    1:384     ------------MAMLMSMVALTIDSMLPALAQIAQDLNADHadAQFIIGAVFLGMALGQMIYGPISDSFGRKPAIYLGVSIFIVGDIISLMASDFHTMLIGRVLQGMGASACRVVSLAMIRDCFSGRHMARVMSLIMLVFIMVPAIAPSIGQLILIFAEWHGIFWVLLGFSLTAVVWLALRQPETLDIEKRVpnIWIGIKETINHNSSRNYTIAGGIMFGALVGYLTSSQQLLQIRYGLGDL-FSVYFGLLALTIGLASFANSRLVMKINMEKLCIYALCLISVASLAFFLMsgLPPFPILFAYLMIAFSGFGILFGNFNALAVHALGHIAGVANSVISTIQTLISVLVGSIIGQLFDDTVFPLVIGFFFCSTLALVIVLRVRHKYG------
     562 UniRef50_Q13MI5        Major facilitator superfami...   192     2e-47  1  17.1%  3:359   26:433     --QSSRPLVIAAVMASMAMVAIEATIVSTAMPQIVAQLG-DLHLYSWVFSSFLLTQTAMTVVFGKLADLYGRKPVMLAGIAIFLIGSVLAGFAWSMPAMIAFRLIQGVGAGAIQPVTLTIVADLYPAHERGKVQGYLASVWAISAVVGPMVGGFIIHNMSWAWIFWMNVPIGLASAAGFIAFLRESERHARPSIDFGGATLflWGRRPIAACNGATLLAGMILMGATTFLPMYVQGVLHRSPVIAGLALTMMMVGWPAGATFAAKSFHRFGLRRILIGGSAFIPIGAVLLLFLSPGGSPLVAAFGSLIMGFGMGTSSVSSLVLIQEIVrdERGSATASNLFSRNLGSTLGATLFGAVLN-----------------------------------
     563 UniRef50_A1S6I3        Drug resistance transporter...   192     2e-47  1  18.3%  1:389    6:391     LTKRRSLVFFPYLALLSMLGFLATDMYLPAFNQIESSLNTSASLVAMTLTCFLGGLAIGQLAYGSLCDKFGKRNTLMAGLGVFAVSSILLGFTENISVFFVLRVIQAFGACSAAVIWQALVMEKFDEGEARKVFSSIMPLVALSPALAPLMGAWVSEQFGWRAIFIILAIVGLLLAAMTPALAKESRTRSQSEPILVKN---ILKNRAFQNNVAIFGACSAAFFCYLTLWPAVMQ-HHGYAAAEIGLSFIPQTLAFMLGGFACKKALHSHSPEAIkmLITGFVVLSLVLFLLTQLGAGILAVLWVFAALAAINGAVYPLLVTDALAPFSNNATKAAGWQNFLQLGMAFIASAAVALIAHWFEKAIGTGILVCAAIVLVAWWRMNWSTWR-----
     564 UniRef50_Q1H0P2        Drug resistance transporter...   192     2e-47  1  27.1%  4:379    2:382     ---RHSIFLVYVLAGLTALAPFAIDTYLPAFPMMERDLGASTVEIQHSLTLYLLPYALMTLFHGAISDAIGRLTTIRWGLVIFIFASIGGMLAPNVETLWAMRILQGLSAGAGNVVARAMVRDLFQGVEAQRAMATVQMLFGIAPAVAPIIGGWLLG-IHWQAIFAFLALYALLIALAAARYLPETMPKERRVsnVCRNYQVVFSHREFSLLVLAIGANFSAFFLYVLASPVFLIQHLGLSSQQFAWMFIPTVCGTVLGSWLAKRAAGKYGAQHILRFAYGWMSTMAVLNLAVSLLPFIHAaiLPVALFNIGLALAMPLLSISALDCHPRIRGTAASGQVFMQMLLSTLSAGLVAPLVWHHPAGLALAMLGYLLLGWLA---------------
     565 UniRef50_D0XKC0        Drug resistance transporter...   192     2e-47  1  23.8% 19:388   27:402     ------------------FGSLSIAMYLPGLPAMAQEFHGSTTGVQDTVAAFSLGLCAGQLIYGPVSDRWGRRAPLLFGIALYLVATLACIVASNLSTLVAFRFVQGLGGCAGVVISRAIVRDRFTPQESAGVYSTLMLILGVAPILSPLAGGWIIAGFGWRAVFWVLLAFGVVLGVVVWLRLRESSSAESRRRapFRSYLAILGDRQVAAFVACGGFGAAGTFIYMTMSAHLLIDGYGVPTTAFGWLYGAGSLAVLIGSQVNRVLLNRFSSHRLLVWSTRLNLAACLLMLATVSRWpiPAFLIPLCLAFSMNGLSSPNAAAEAMGAAGWRAGAVAAVMGFAQFGMGALLATIAVRVLDGTAFEIAAMLCVTSACAVGCLLFAGKSRA------
     566 UniRef50_UPI000169462D hypothetical protein Plarl_...   192     2e-47  1  20.5%  2:353    4:409     -KQTNKTMVTLSIMLITFLSSLEGTIVSTAIPKIVSDLG-GMHLMNWVVSIYLLTTAVATPIVGKLSDLYGRKLMFICGTILFLIGSMLSGMSQSMEQLIVFRAIQGLGAGAILPVTMIIIGDIYSFEERAKIQGWISGIWGISGILGPLTGGLMVDYVSWHWIFYFNVPFGLLSILFIVMYLHEHLDKKKQKVDYLGIALFTvwNSPFMIGILILAVVTLALFLVviYLPLWIQGVAGKGATDSGFTLIPLSVCWPVGAALAGRWFVRMGVRSTTLIGVSCLLAAAAGLYFVGIHTPYLLLVALMGLFGLGFGFAFTSYTITVQSAVgqMRGTAMASYTFLRTLGQTLGISV-----------------------------------------
     567 UniRef50_UPI000187D622 hypothetical protein MPER_1...   192     2e-47  1  15.3%  1:393    1:431     MSSARKWLIVLGISLGALCVACSASAASFAEMGMAEELHVSHIITILTISLFVVGLGVGPLFVGPLSEIYGRNIIYRVSFTLLFVFSWPIVFAPNIAVMLVFRFLSGLCGSTFLSVAGGTVSDLFKDESVANPMALYTLSSFVGPALGPLYSGFVNQNTNWRWTFRALLIWTFFETVALYL-IPETFAPVLRKWKAAkpFELIFCDRMVLLLNTWTSLILGILYLTFQAFPIIFERNHGFNMQETGMAFLGISLGMILAIPTQGYFNHFVNATKTpaEMGGILVPVGLWILAFASRPPVHWIVPIliPFGSGIYLVFTSVFTFLVTAYRPMAATALASNSAMRFGFAAVFPLFAGSMYNALGTVGATALLAGIMTVMIPLPFIFRRIGARLRQ-
     568 UniRef50_A8LBD4        Drug resistance transporter...   192     2e-47  1  17.5%  2:360   23:436     -RRGNPWWTLTSVALGVIMVGLDGTVVSIANPRIAEDLGASLTDLQWITNSYLLALAALLVFGGKLGDRYGRKLIFLIGVVGFGLTSLAIGLVGNIVGIIALRALQGVFGAMLMPNTLAILRGAFPPKELNRAIGIWSGASSISIAGGPIIGGLLVEHVSWESVFYINVPMGAIALAVGLAVLRESRSESTGQRHDIPGIITlwTDPKTLGCVFAGLAvfFALFGVLFFVTLFLQNVQDTSPIETGVRILPLTLAMMIMSPIAGSATERFGPRPPMVIGLVLSGTALLLLTGLEPGSSFNALWPSLLMLGIGMGLVITASAEAIVGNApdDAGVAGGLQTTALQLGGVVGTAVLGSVLSS----------------------------------
     569 UniRef50_D2ELL4        Major facilitator superfami...   192     2e-47  1  15.9%  3:379    7:436     --RTNSAWILTLTSLGFFMSMMDSMIVTTASTAIRNDFGISVDTLQWALNAYNITIAAVLLVGVALGERLGRRKIYNWGLFVFTVGSILCALSGNITVLVIARIIEGVGASVMTPMSMAILSNALPASERGKALGIWSGIGGLVLIVGPSLGGLIVAKLTWQWIFWINVPIGIIAIYLSNRLLPESKGAAEKVNIIDAILIIlfKSVTFTGGNVATFLLYASMYGVVFFLPQFLQVAGHADALQAGLEILPWTGTLVVVAPFAGSAVDRFGEKSIATLGLFLQGLglLIMMLLSNQTAYWKLIIPLIIAGAGLSMAGPALQKAVLGAvpQSVGKASGIYNVFRLLGGAVGTTVSVIVFYAWGGIVGSLAFTAGFKAVML---------------
     570 UniRef50_UPI0001B514C8 major facilitator superfami...   192     2e-47  1  17.3%  2:388    3:444     -SERHSWAPLLAVCAGYFMVILDVTVINVAVPVIGRELSASLTGIQWITDGYTLVFAGFLLTGGALGDRLGNRRVFCAGVVVFTVSSAACALAPDAPFLVVARLVEGLGAALIVPGSLALIQQAYPEraRSRAFGLWGSMAGIAASAGPLLGGLLVSTVGWRWVFLINLPVGAACLALTLRHVAPSPRRADRALDWPAQvlSLLRSRAMSGGAVIGLLFNFGFYGMVFTASLEFQHQRGYSALGTGLALFPAVAMTMFASVLSGRLTRRTGDRPLVVSGMLLAALGLAGWAAAGADPAYGLLVLPMMAAGFGTSFALTGSTATVMGAAPqySGAASALFNTTRQVGSATGVALGGSLLASAATYGTGIRTSMLIGAVAYLAAAGLAWR------
     571 UniRef50_Q8XQ69        Probable transmembrane effl...   192     3e-47  1  17.2%  4:393    8:460     ---RTQKWVLILTSIATLMAMLDAMVVATATSAIRADLGASLSALQWTMNAYNLSLAALLMTGAALGDRFGRRRVFVTGLCVFVAASIACALARSAEWLIAARVVQGAGGALVTPLSMALLSAAFPPERRGKALGLFGGITGLALILGPVLGGVIAGNLPWQWIFWLNVPIGLPLIVLAVRRIPDSKGPAarRAKHPMIPMRLFASRAFSSGIAACFLFYAGMYGVVFFLPQFFQSAQGHDPFAAGLRLLPWTVTLFFIAPLAGSMVDRIGERSVMVTGLLLQAIGFAWIaaASPGTSYLNLVAPLVISGAGISMAGPAAQKAVLGAVtqDIGKASGVFNMFRILGGATGIAIAVVAFSIWGngFAHVMGVCAVLSMAAVLSATWQPTHRAAT-
     572 UniRef50_Q7NNZ0        Glr0268 protein n=1 Tax=Glo...   192     3e-47  1  19.6%  1:358   36:448     LDERTKRLVMGAVLIALFLTSLDQTVVVAALPKIVADLG-DLDLLAWTSASYLLVSTTSLPILGKLSDLYGRKNILLIGIAIFLLGSFLCGLAPSMLMLVVFRGIQGLGAGAITSVALTIPADLYVPAERAQLQGIIAAVFALSSIVGPLLGGVLTDTLGWHWIFFINLPFGLLALAFIVAFMPRLNSGLTRSIDYWGAVLLMLtlSLFRIPIFSLICAMSVMVgaILFLPVFLVNVMGASATEAGVALIPETLGLLVSSFISGLVVQRTGRYkaMLVGLVLMSIGIFLLTQLSLTTTIAQVWFSIAIFGLGAGATFPQANLALQNAVpeYVGVATAGRLFFAQLGQTVSAALYGALL------------------------------------
     573 UniRef50_Q0W4M4        Multidrug resistance transp...   192     3e-47  1  17.4%  4:359   15:425     ---RNRYKIMLVVLPSIFMSVIDGTVTNIALPTITSYFNVDVALSQWVITGYLLTITSLLLVFGKISERTGKIPIFIAGFAIFTVSSLACGLAPNLPVLIGCRVLQAVGGAMVFSISGAILFQAFPVKERGRAMGYIGSTVAIGGIMGPVVGGFLVSTLGWQYIFLINVPIGVVVLllAYLRMPETKYEEAGFDWAGTGALVTAMTSLVLClcLSMLLFFVGSFTVTIVGPFYFEGVMGFTPAQVGMFFLINPIIMMIGAPIGGWLYDKHHSKYYSTAGMLIITAAMFLYAYAAYIASIPAIIAGMVLLGIGGALFQSPNNTELMSALPRQkgIASSVSSTVRNLGFTLGTSFAVLLLT-----------------------------------
     574 UniRef50_Q39BL9        Drug resistance transporter...   192     3e-47  1  18.7%  1:364    1:419     MPRYRRAALVLAACLGTFLATLDISIVNVALPTLQTALDTDIGGLQWVVNAYALALSAFMLSAGPLGDRYGHKRVWLASVILFTAGSVVCACAGSIEPLLIGRAIQGLAGALLIPGAMPILTHAFpaRERARAIGGWSAFSALALILGPLVGGLLVEHGGWQNIFLVNVPIGIVTVLLGAWGIPERRHPQHAAFDPLGQVlwLFRDRRLVRANLASFVLGFSGYSSLFFLSLFLQQAQGRTPAEAGWQLMPQFVMTAITSMLFGRIAARIPLHALMVAGYGLIGAMLAVMAGFGAGTPYLPVGIVLAVLGVGMGLAVPATGMTVMELApeRAGMASATMNALRQTGMSMGIAVLGSMMSVGALH------------------------------
     575 UniRef50_C5P861        Major Facilitator Superfami...   191     3e-47  1  14.3%  2:393   57:482     -SSVRRWMTITIVSVVTFLNAFGSTVFAPSVPEVMHEFNisGALSSFTVSVFAIGWAVGPLVLPPLSELYGRNPLYHASNLFLTLSSMACALSSNLTMLIVFRFFMGLAGCPSLSLSGGTIADLIPLERRGVALSVWGMGPLMPPTLKPCagTLTIISLLLLRETYAPVILgtGNMELTTKYDKGETPGYLFKMAMLRPTKLLLFSPIVFLMALKITISYGYSYFLFTTFTFVFGKQYGFKPSSIGLVYIGIGIGYVVTQIIAALFSDRyeWRLPPLALGAIVLPLGYLFYGWTAMYRLHWLVpgTALIGAGTLCYFFSIMAYLIDTYTIYSASAISANIVLRSIVAATLPLAGTRLYETLGIGWGTSLLAFIALALAPIPFFLLKYGERIRT-
     576 UniRef50_C1XZJ3        Drug resistance transporter...   191     3e-47  1  21.3%  1:361   49:474     LTPQQRLFTLLGTLLGLLLAALDQTIVATAGPAIQRDLEIAASLYVWITTAYLVTSTVFVPIYGKLSDLYGRKPVLIAAISIFLLGSLLCGISQSAVQLILFRALQGLGSAGLFVTAFAIIADIFPPAVRGRYTGLFGAVFGLSSVVGPLVGGFLTDNISWHWVFFVNLPVGAVALAFIFSRMPLLRLSQRRplAAAGLVGFLLTERRVREPILPLSLFANRTFAVGNAASFVLGAGfgLSATNSGLTVTPLTLGIVSGNVISGQLVSRFGRYKPLMLTGllSVAFVIMGFTLTPQSSQLELILKMILMGLGLGPAIPLYTLAVQNAvpLMAGVASSTVLFFRSMGSTIGVAILGSIFANT---------------------------------
     577 UniRef50_A9VKL9        Drug resistance transporter...   191     3e-47  1  20.9%  6:364    2:416     -----RKKVMMSLMLMTFLSAVEGTIVSTAIPRITSDLS-GVELVSWVYAIYMLATAVSTPIYGKLADLFGRKKVLLIGATIFLIGSALCGVVTSMEQLIFFRALQGIGAGAVMPITMTIIGDLYSEAkrAKAQGWMSAVWGVSGVIGPLVGGFLVDSLSWRYIFFLNVPFGIIACLMFATSYKEskSAAKQHIDYLGATVFSLSTIALLYALLTgaAVSFIIFLYivYLPIWSQGVLGKNATEAGLILMPIPVMWTFGAIFSGNLVGKLQTKQIILLGASILSVATFLLFTLSTDSPSFLIYVAVGLFGLGMGLVTPIYMVTIQAAVPAnrGTAVGLNTFINTFSQTLGAAIFGTIFNTMIHA------------------------------
     578 UniRef50_Q5ZSL6        Multidrug resistance protei...   191     3e-47  1  20.2% 10:391   12:399     ---------IIFLGLLSAFSLLTFDLYQPSLPFITNYFNITPSMGQLTLSIYLLVYGITHLLWGPLIDHFGRRRLLPGNLLLALIGSLMCAFAPNITMLICGRALQGFALCCANLIAYSAARDFEDTIVRAKVLSYISMTVSVSPIIAPVIGALIFHHFGWQANFIVMAIVACILLIQTKLSLLEspQERFSVKKILQEYKSILNIPSLWCASFILMFGISAVMLTVINSSYLIIEVLNYSPLAYGLIFILNGLNIIFGNYLGIWLRDRLPIITTIYLGNWFIVLGGTAMLVTSKLFGFSLLALSFSLIalGISVSAAPTISIALTDFKQNAGIVMAFMNTIRLIGPSLLTILTGYLLTRNLDALPLGLIGSGIGALFFSWHFSRLTTESR---
     579 UniRef50_Q39AI2        Drug resistance transporter...   191     3e-47  1  23.6%  4:389    1:390     ---MSHFSLILVVSLLSAFGLIASDVYLPAMPSMAHAFSIGAWQMPQTVSAYLIALACAQLFYGPLSDRWGRKPVLTVGILVYILGSIGCASASGFASFLGWRVLEALGAASGLVIGRAIIADTCDKHASAKVYSIVYPLVSLSPAIAPAIGGYLAAWFGWRSDFIFVAAFGGVALVLVQLLLKETRPPVTprAVPLAGFADVLGDRAFIRYTLVVCAIYCAWFVYLTQSPFIF-SGLGLSEQQSGWLYLPLTAGIISANLLSRRMLDRMSYDAIVAAGVGCFVAGGIAFAlsSQVKGIIAIVMPMFLVSLSNGSSLSLAVSGAIASEHGRAATASGLVGFFQIGSASLAATVSSSLLGTGSHVLATAMPFFAIVAAVAIVPRWYAARR-----
     580 UniRef50_C7Q2J6        Drug resistance transporter...   191     3e-47  1  18.7%  5:362   24:435     ----HPVRTFVITAAAMFMAQLDNLVVSIALPSIRESLHAGLSGLQWTVSAYTLTFAVFLLTGSALGDRFGRRNLFVAGLAVFTAASVASALAPNIAVLIAARTVQGLGGAVIVPLSLTLLSASVRPEKRGAAVGAWGAIGGLAVALGPVIGGAVVEAASWQWIFWVNVPLGIVLLPLAWWGLTESRGPVRrrTDAPMVPMHLFRGRSFPLVNLSALLMSFGMFGAVFFLSQVFQTVFGDSPLASGIRVLPWTGMPMLVAPIAGILSDRIGGKWIVTAGLGLQAVALGWIaaISASVSYTALLPAFVIGGTGMAMFFAPIANLVLGSVSREqgIASGVNNALREFGGVLGIAVMGAVFSANG--------------------------------
     581 UniRef50_D0L4G9        Drug resistance transporter...   191     4e-47  1  20.1%  1:364   15:440     LPHRQILTILGGLMMGMFLAALDQTIVSTAIRTIADDLQ-GYDLQAWVTTAYLVTSTIVTPLYGKLSDLYGRKPFFLVAISIFVVGSLLCSMATSMYELAAFRALQGLGAGGLFTLALTTIGDIVPPRERAKYQGYFLAVFGTSSVLGPVLGGLFAGHagWRWVFLVNVPIGIIALGVVYRVLndQQKGVGGRTDYWGATALAVAVAPLllALLCYGIGVAGifGGISMLPQYFQVLRGSSPMVAGLQMLPMVLGLMLGSITSGQIISRTGRYKipIIGSILITAMTFLLHTVGIDTPVAVVMLYAFGLGVGLGNMMQPIMLAMQnlPPKDMGLSTGTATFFRQIGGTLGVAVFFSLLFSLMGP------------------------------
     582 UniRef50_Q2JDZ4        Major facilitator superfami...   191     4e-47  1  19.4%  4:364   24:449     ---PRRWWALAVLLVATFMDLLDNNIVTVAIPNIQQHLGASPTSIQWMNAGYTLAFAVMLITGGRLGDIFGRKRMFLTGVAGFMAASGMCAIAQSPEFLVGARVVQGGAAAVMVPQVLAIIHVSFAREEVGKVVSLYAGIVGLAIVAGPLVGGLLLQwlEWRSIFAVNLPVGAVALVAVSAWMRESRSPNARRPDGIGMILValGWPMWSIVAMVIAVPVFALfgFFITWTVYLQGGLGWSALHTGLTTIPFSVAVPVAGGLAVRYIFPKYGRRCLMVGVAVMTSGVLSYVwfATTVTAWHAAPSLLLIGSGMGLLVAPLTGMIldVPPHEAGAASGIINATGQLGAAVGVALIGGLFFSQGLG------------------------------
     583 UniRef50_C3X2F7        Drug resistance transporter...   191     4e-47  1  15.8%  7:354   27:430     ------WFAAILLSGANFIAVLDMTIANVSVSSIAGNLGVTTSQGTWVITSYAVAEAITVPLTGWLAARFGAVRVFCCAMACFGVCSAMCGFANSLGFLVAARVLQGLSGGPMLPLTQTLLLRIFPREKAMAANGLWAMTTLTAPVIGPILGGWICDNYSWSWIFFINVPIAIICSWLTWQLLKgeRELVRSPIDVIGLVLLVVWVGAfrGYSICVFTISLAFGGYFAatPLWLQNFMGYTPTWSGETTAWSGVTAFFVAPLAAIWARKTDPRRLIFGGLMWLGLITFGRCFLNTDASYWWIALPIMLMGLGSPFFFVPLIGLamNVEESETASAAGLMTFLRTLSGAFATSLV----------------------------------------
     584 UniRef50_Q2GLG3        Bicyclomycin resistance pro...   191     4e-47  1  19.9% 22:388    8:381     ---------------------ISYDMYAPGLPQIGAFFGVAQTIVQLTVSMNLLGGALSGLIYGPLSDHYGRRSVMLWGIAIFVIASIGCCFAWSIGVLIVLRFLQGLGAGVAGVVGFAIVNDIYVGEAAAKNLSIVNMVVSLSPAVGPIMGSYIVSlyGWRLLFVLVSMISVLLLLALIFGLTEtrREKLSLSSILAEYGALFRNYRFLCFALVQSLTIMWVWASMANLPFVFIEGMHLPVEYYGYLVAMSVVSYIAGTIVNRRLIGKLGMMRMIVLGLLSvvIVIICHYAFPAFLTPLFIEMIWLPSSFGIAFITSNSVAIAFGEV-RDKGAASAFISFGQTIFGACGIYIVGKFYNGTIVPVSVLPIVCCLLGMTIIWLLTKREG------
     585 UniRef50_Q82I69        Putative integral membrane ...   191     4e-47  1  20.4%  4:360   14:424     ---ARRWWALGALVASMLVLGFDMTILNVALPTMARDLGASTGEQQWMADAYVVVFAALMLPAGLLGDRFGRRRMLITGLGVFLAGSLAGALVDDVTPVIVARALMGVGGALVMPLAMAVLPSLFGPEERTRAVGAVSAASALGLPLGPILGGWLLDHFWWGSVFLVNVPMAAIGIAACVFLLPETRDPASPKVDAVSTALtlLAQRGFLLNTLAATLVMFVLSGLMFVLPPYLQAVLGNDTFATGVRMLPMMGGLLIASRGAQPLLAKFGARAVISAGLVTLAFAAILGSRTSVDDGYGFTALWLSIAGLGFGFAVVPAMSAALGALPrrAGSGSGLLMTVRQVGGAIGIALLGSLLAG----------------------------------
     586 UniRef50_A4X8R4        Drug resistance transporter...   191     4e-47  1  19.8%  1:364   31:455     ITGRKRTLALVVVLTGFVLDLLDITIVNVALPSIRDGIDATAATMQWLVAGYALAFASMLIISGRLGDIVGVRRMFLIGVAGFTLTSLLAGLAQTPEQLIVLRFVQGAMGAIMVPQVYTLIQLLYAPKERGRAFAAMSAALAFGTVGGPLVGALLTTalGWRAIFLVNVPIGIAAFIAARVLLPESEANRRERLDLVGAVlsLFRHRSFNAGLVVVFLFQGAVMSFFLVITIYLQIGVGYSILRAGLSGLPWDIAVPLLGWLSARAITPRIGRTGLQLGLVLLIASMFWFMWvtPQVSIWQLLVPMFIGGAGMGMTFPPLMGYSLADVpnQAGSASGVVNANYQIGVTLGIAACGTLFFSLLAA------------------------------
     587 UniRef50_Q0RCM4        Putative Drug resistance tr...   191     4e-47  1  21.8%  9:388   43:426     --------TMVLLGAMTGLGPFSMSVHLPGLPRMADDLATSQSSVQLTMTACVVGIAVGQVVAGPLSDAYGRRRPLLVAMALYCATSAVCAAAWTVPMLAGLRFAQGMFAAFGMTIARAVIRDVADGQRLVRLFARMALVSGLTPIIAPNLGSALLVVTDWRGIFVVLAALGALFAALSVGSLRETLPPARRTrsTARTYAALATDGAFLAPSLVVGLAYGAMFSYVSSSSFVLSDAYGVSQTVFGVLFAANAVGFMAGGQLGAALAGRRGTIRALRITLPAAATAAAGITLAALAGSGPAVVGTLFLTVASIGACMPIASAEAMRTRPDSSGTASGLLGLTQFALGGLIGPIVGAFGSTSALPLGIGMCLCLLAAFALCLRPAAPRP------
     588 UniRef50_B9L0U9        Putative drug transport pro...   191     4e-47  1  19.8%  3:360   21:433     --RSRLALILPGLLLGMLLAALDQTIVGTAMPRVIAELQ-GLEHYAWVFTAYMLTSTVTVPLYGKLSDLYGRRTFFLFGMIVFLIGSALSGMAQSMTQLIFFRALQGIGGGALFPIAIAIVGDLFPPAERGKWQGLFAAVFGFSAIIGPSLGGWITDNWGWRWVFYVNMPVGALALLTTGLTMPKLASGRQHRIDYLGAALLvwSSPPIIGLFGASALFliGMFGTILYLPLFVQAVLGRTATNSGAVLTPMMLGFVFSSIVGGQILSRTGRYKILAIgvAVAVIGMFLLSRMDVTTTSTTVVRNMIILGLGIGTTMSLFTIIVQNAFPAQrgEVTSALTFFRSIGGTVGAAILGTVMTN----------------------------------
     589 UniRef50_B8PI67        Predicted protein (Fragment...   191     4e-47  1  14.6%  3:392    7:434     --KGRKWLNLGIIASQAMITPICSSLLAVSALQIDEEMHVTNSYVslPVAMFLFGLGLGPLFLAPLSEMFGRRVIYVTFFGIFSLLNVGCALVHNMAGLVVLRFLGGLAGSAGPSLGGGTIGDMFKREERGGAQAVYGFGPTFGPAIGGLIGGYISNHIGWRWQMWIMAIAGGVTTTASFFFLRETYAPYLlaRSITRPLRMLFTAPIVTTMSVYMSVIYGILYLHIITIPLLFGptYGWKNGNDGLAYLGAGSGCYLSIVFcrALCKRYGtrMPAMQLGMLIVPGGLFMYGWAAEAQVYWLVPLicVFAFGMMITYISIQTYLVDSFQQYAASALAAIIVLRCTFGAIFTIFGTKLYEKLGYGWGTSLLAFIIIVALPIPSVLWVFGERIR--
     590 UniRef50_Q2RG28        Drug resistance transporter...   191     4e-47  1  18.2% 10:360   33:437     ---------VLVALIGAFMSILDSSIVNVAIPTIMHVFNTDTSTVEWVVTIYMLALGVIVPLSGWLGDKLGFKKLYVIALVIFTFGSLLCTLSWNVDSLIAARVVQALGGGLIMPTTMAMIYRMVPRERIGSAMGVLGIALFVAPAIGPTLGGYLVEYVDWRWIFTINLPIGVLGVLLSLVLLPDFPAAEAGRLDIGGAvlRVFRYPAFTLANLMVVVTTIGLFGGIFYVPLFLQTVRGLGAMETGLLSMPGALASALMMPVTGRLYDRIGPRLMAVTGLVVLAITTYLFHFLDIVTPDRVIITWLILRSVSMSFASMPAQTAALalPPELVGRASAMTNIINRVSGSFGIAILTSILNH----------------------------------
     591 UniRef50_A0JUL5        Drug resistance transporter...   191     5e-47  1  24.0%  1:387   11:401     LSRNRKILYILLLGALTALGPFTIDLYLPAFPALEASLGVSEAEVQLTLTGTTVGFALGQLVVGPLSDKFGRRLPLILATALHITASLGAALSTDLATLGLFRVVMGIGAAGGGVVAMAMVRDLFTGYAMVRMFSRMALVNGLAPILAPVIGSQLLLVMPWPGIFYFLAGYGTLVITAAILLVRETLPRELRGKSGLTayKLLFSDRIFVGLLLLGGMNFAGLFAYLSASPFLFQDVYGFSPQEYGLLFGINSLGIVAGVQTSSRVIRRVPPQWILACSTAWMFLMAVLIVIFdlGLGLWGVMVPLWFYILGTGFTFPCVQVLALSKHGAQAGTAASLLGAATFMMAGIVSPVVGWFGDISATVMGGVQATSILLAAAALWLVVRPR-------
     592 UniRef50_P37597        Inner membrane transport pr...   191     5e-47  1  21.1%  7:386    5:383     ------KRFLVWLAGLSVLGFLATDMYLPAFAAIQADLQTPASAVSASLSLFLAGFAAAQLLWGPLSDRYGRKPVLLIGLTIFALGSLGMLWVENAATLLVLRFVQAVGVCAAAVIWQALVTDYYPSQKVNRIFAAIMPLVGLSPALAPLLGSWLLVHFSWQAIFATLFAITVVLILPIFWLKPTTKARNNSQDGL--TFTDLLRSKTYRGNVLIYAACSASFFAWLTGSPFILSE-MGYSPAVIGLSYVPQTIAFLIGGYGCRAALQKWQGKQLLPWLLVLFAVSViwAAGFISHVSLVEILIPFCVMAIANGAIYPIVVAQALRPFPHATGRAAALQNTLQLGLCFLASLVVSWLISISTPLLTTTSVMLSTVVLVALGYMMQR--------
     593 UniRef50_B9JRB5        MFS permease n=1 Tax=Agroba...   190     5e-47  1  26.4%  3:384    2:389     --NRKTLFLAISIGMICAIGPLATDMYLGAMPLMATSLSTTAATIQLSVMTFFSGFTIGQMFYGPISDRTGRKPIIYVALAIFCLSSFGCLTASTGEQLLVWRFMQGVGGSIGMVIGTAIIRDTHTGPAATKLMSMVMLVIGVAPILAPFAGSLILKIANWQMIFVLLGCYAALCFVVVALWLPETRLPADrpSRALITYGGLLISRNFIPYAGTMALVQGGFFAYIAGSSFMLMTVYGLSAISYSIIFSTNAIGLGIGTQICNRFATRFGVKAAVRGSVLLYTVIALILValTGTDSLTVTCILMFILVMSIGGIMPGCNVLAMEAHGSIAGTAAALAGGLSFGAGALSSFVLGLLENGTALPLVCVMAGCGILAVLVTQVFF----------
     594 UniRef50_C8WT95        Drug resistance transporter...   190     5e-47  1  17.5%  1:366    1:420     MHHTNRRMVSLAMMLAVFLVAIDVTVVSTAMPHIVRQLH-GLNLYSWVFAIYTLTTCVTTPIYGKLADVFGRKTIFCIGVVLFVVGSALSGLSQNMAELVWFRAFQGLGAGAVMPVTFTIIGDIFQGEERARMQGLFSSVWGVAGLLGPLVGGLFVDHVSWRWIFYINVPVGALSLVLVLLFLHERFERRQHRVDVWGALVFTiwTSAVILGLFAASAVFLAVFVWivYLPMWIQTILGHSATNSGLTLMPMSLAWPLASTLSGRYMYRIGAKRTTVIGTLLVAVAAAWLLAIKLGTPYWFFVGVMIVMGLGMGYLNTPTTVMIQSVVsqMRGAATGSNQFARALGQTIGVTVFGSLFNSITSSYV----------------------------
     595 UniRef50_A4X9B2        Drug resistance transporter...   190     5e-47  1  25.4% 16:389   37:414     ---------------ITAIGPLSLDMYLPALPAMARDLDASQAQIQLSLTTCLVGLALGQFVTGPLSDRWGRRRPVLIGLVAYTVLALACAAAPSAPAFTALRFAQGFAGGMAAVVTRAVVRDLHSGRAAAKYFSRLTLVFGLAPIAAPTVGSLVLRFGSWRTLFVLLAVVGALLTAVVATWLPETLPAHRRSRdiVRSLRELLTDRVYLGYTLTQGLAFAGLFAYISGSSFVFQDVFHLSASTFGLLFGLNALAFVAVGQANARLLDRFPPRALLVGTLGVSAVAAAGVLAGAIATSQLLLIGALLTFIGSLGMVMPNGTALALDRHAHHAGTAAALMGALQSVIGSLAAPLVGLGGEGSAVPMAAVLAASAALSLTAALTLARPERP-----
     596 UniRef50_D2AS24        Sugar phosphate permease-li...   190     5e-47  1  18.4%  2:360   19:431     -KQRHPWLTLIAVSLGVIMVMLDGTVVGIANPAIAQDLKASLSDLQWVTSGYLLALAVFLITAGKLGDLFGHRLIFLIGVAGFAITSLAIGLSSSIGMLIGLRVLQGLFGALLQPAALALLRAAFPGERLKMAMGAWGAIIGLSSAAGPIVGGLLVEHVSWQSVFFINVPVGIVALAMGLWVLTESKARTLSKIDWLGVVLllFGNASVSIGTGLMMLVAFSMFGAMFFLTFFFQGVHGLTPLESGLRMLPMSAGMIVASPLAAVLLSKFGTKFTIAGGMLVTATAMFLMSRLSLDASFIDSAIPFVLLAFGLSPVFVGATEIIVGNAPEdsGVAGGVQQSAMQVGGALGTAILGAIVSA----------------------------------
     597 UniRef50_Q1JW92        Drug resistance transporter...   190     5e-47  1  21.3%  5:384    8:387     ----HKALYITYLALLAATPPLSTDMYLAALPEIASSWGVGKDLINLTLVLWFASFSVSILISGSLSDKYGRKPLLLWGLSLFVVTSFLCAGAGSAQMLILFRIFQGLGAGAPAAIVLAIIRDRFTGKERHQAIAYVMTIVAVAPMVAPIIGAMLLEFFNWRFIFVMQGVMVSITLLVTFAFKESLADpnISLKRLMTRYTVHFRNKEFMFASISMGILVLPFYGFIAFSPIYYITIHGLSEKMFSLLFGLNALSSMCGAFSSSFIVKWVSDKTVITVSIYGCVIAGIGLMVL-GSQHFLYFFVFMAFFSFCTGISRPISGNMILGLVKTDVGSASSFLVFYQFISGALCMAFVTLQWSYPVLVYGSLTTIVSILVLILWARIA----------
     598 UniRef50_C6C991        Drug resistance transporter...   190     5e-47  1  25.5%  2:381    6:390     -SNRSRFGYALILGSLAALGPLCTDLYLPALPQLASELSTSTATAQFSLTAGLLGLGFGQLIFGPLSDKRGRRGPLLWSLIMLLLTSAWCALASDIGQLIIARLLQGIAGAGGAVLSRAVARDLYAGHELTRFFTLLMLVNGLAPILSPVLGGALMTLTNWRGIFVTLTLIAILLLLMSALRLPETLPAKRriGAMLASLGSLLQARQFMGLCLTQGFSGAGMFAYIGGSPFVLQEIYGLSPQAFSLCFAVNSIGLIIAGQLAERLCRRWGENGVLRLGLGIAIVASLALALAglHAPLIGILLPLFLAISMIGFIGPCASALAMQSQGGKAGSASALLGLSMFALGALSVPLTGLSGGTSALSMGVVILTCYLLATFCWW-------------
     599 UniRef50_A4XFE0        Drug resistance transporter...   190     6e-47  1  17.6%  4:356   19:425     ---RNRTLMLIGTMAAMIMYTLDTTIANVALPHMTASLGATQDTITWVLTSYVLASAVALPLAGWLVDRVGIRNMMLASVLLFTAASMLCGAAQSLEQMVLFRVLQGLGGAFLSPLAQTVTLDSSTAAERPRMMGIYTQGVMLGPITGPIIGGFLTDNYNWRWVFYVNVPVGVLCFLLLLLYLPKTPTRERKvfHLSGSRNPLFPTALFHDRNFTVGLAFmvMMSVMALLPGLLQQIYGYTPLQSGMLLAPRGVGMLASITLFGRFMAKVDARILLAFGLSLMGASMWMMTGWSTEMPRTPIIMAGLLQGLGLSFTFMPMNLISFalPPQYRTDASSLGNLMRNLGSSIGIAAASV--------------------------------------
     600 UniRef50_A6SDW9        Putative uncharacterized pr...   190     6e-47  1  12.8%  2:392   63:489     -SLGRKIIHTAIPGVFGFSVAFGTSVYAPGIPQVAKEMGVSIEVATL---------ALGPMLGAPISESKGRKAVYILTIPIFILFVMACGLSKNITSLLVCRFFAGAFGAPCLAIGGGTVADLWDMKHGGGLAAVLFvtMFLGPSLGPFIGGYALQTRgwTWLMWVIILVTGPLYLILFWSSETSKKEILRRRalYRPLEMLLTDPIVAFLALYCSFAFGVLFAFFDAYPYVFMGVYGFTIAQSGLAFLGIFIGTLL-SVLTFYIFDRteERLYTAMVGSFGIPVGLFWFAWTARESVHWIVPTliPFGWGMSTIFFSGITYIVDTYGALFgsAIAANGFLRYIFGAVFPLFTLQMYENLGIAWATSTLAFLSLLMLPIPMVLYKWGPKLR--
     601 UniRef50_C8WXP9        Major facilitator superfami...   190     6e-47  1  17.7%  7:373   27:446     ------WFIVGTVCFGAFMAALDASIISIALPKLEQAFHTMMNRIEWVSLIYLLALAGCIVAFGRLSDLIGRRPMYTMGFGVFIIGSALCGASWNLSSLLAFRVVQGIGASLLQANSVSIITAAADAERRGQAIGFQALAQGLGLSLGPLVGGVLTHIASWRLIFYINVPVGILGTISALLFLPRDRREGPRPRFDLVGALVLAFLLIVTMYVllTSILSFSVMYAITlvPYWFVHVEGLSSAKAGLLLTALPVGMALCTPFAGRLADRWSKVKVSAAGMVLAAMGSASLFAFARVTP--AFLAGLFLVGCGIGTFTPANNARVMNATpaHLGVAGGILNMSRSLGMGVGVTAGGVSVELFTAAFGHHGVALA---------------------
     602 UniRef50_C8NPR9        EmrB/QacA family drug resis...   190     6e-47  1  19.7%  1:309   15:377     LDARGRRILLYTCCLSVFIVSMDGYAVSVALPDIGESLGADVSQLQWVISAYALSTAGFLILAGSVADRVGRRRVFQFGLSLFTLGSLLSSLAPTVEILITARVLQGLGGSMLNPVALSIISNTFTDaaRARALGIWSSVIGISMALGPPIGGLLVDLVSWRAVFWLNIPIAVAAIILAARFIPESRAATHRRLDPPGQVLMifRSRTFSVAVISAVLAFISTTGILFSITLFLQNTRGLTPMQAGLMLLPLAVMVAVSSPVSGRLVAAYGPAPSLMIAGSVMATGGLLLTFLGQDTPLWYLGLASCVW-------------------------------------------------------------------------------------
     603 UniRef50_A3VP39        Bicyclomycin resistance pro...   190     6e-47  1  22.7%  9:392   23:412     --------FVSLVAILMAMNALSIDIVLPALGLIGESLDQSDgaIQLIITIYIFSFGCGQLVLGPVSDRFGRRPLLLIALGLFAVANGLAASASDFSHLLAARCAQGLTAAALRVSALAIVRDRYQGRQMAKTMSLVMMVFMAVPLMAPLLGQILIGLGPWPLIFEASAVLSGFVFLWVALRLPESLPPARRRrtLIDGYRLIISHRSAWGYMLASGFVFGVLFSFITASNQILLEVYEIG-NKFPLAFAGVASGLAVSNFFNSRLVEAYGMRALSHTALILFLGvlHAVLAFVGYQPFWLFTVMTALPFVMLGFLGPNFTALALDPLGKVAGLATSVQGFISTGIAGLFGGWVAHLYNGTPEPYAYGVAILSAGAVAMVTWTERGQLRAFR--
     604 UniRef50_D1RKS4        Bcr/CflA subfamily drug res...   190     6e-47  1  23.7%  3:391    5:391     --RWTERQCLLHLFPLIISISFAMDVFVPAIPEMSYFFKADSAVMQASLYVFMITVALVQLFVGPLADRFGRRRTALCSALLFLIGSVLAVFALSIHFLIIARIIQAAGACGTYLLCFIIVRDNYSTTVCARLFSVLCGTNSLIASSAPVIGGLLLDQtdWHSEFYFLIILGLLMSLVAFRYIPDYdkQNLSNFSLVSSTKNIFKHPDFRLYTFIAAVNLLGLYLFCALSSGILMTQLHLSATQYGLWFGLNAMTVFFTNLLAARLTYSFPLEKTVYCGLILMMTSCLLMIVLNFhvSTIRFMMPMLCLTFGIGLGMGAATALALKDYKQQAGIATALLGACQFGLSGLVGILITQ------WTPHPLILAIPVLSLSTLALIKMKKGERA---
     605 UniRef50_O32182        Uncharacterized MFS-type tr...   190     6e-47  1  18.1%  2:365    8:425     -KQSKRTLLITGLIIAMFFSALDGTIVGTAMPKIVGDLG-GLSMMTWLTTAYLLTSTTIVPIAGKLADLLGRRIVYVSGLIIFMAASALCGMANNMTELIIFRGLQGIGGGIMMPMAMIVIGDLFTGKQRAKFQGVFGAIYGLASVIGPQIGGWIVDSLNWKWVFYINLPVGIIAVIFIARGLQGRQQTGPINFDIAGIFTMIVGVVSLLLALSFgfLNLIGFfgAITFVPFFMQGIVGVSASESGTIMTPMMISMIITSIIGGQLVYKIGIKPQIITGMLVMAGGFLLLTTLDLDTSKLVATSFMAIIGLGMGLVMPILTLALQESfkEELGVVTSSSQFFRSIGGTFGITMLGAVMNARSGNL-----------------------------
     606 UniRef50_Q3JFH0        Drug resistance transporter...   190     8e-47  1  17.0% 23:364   53:449     ----------------------DQTIVSTALPTIVGDLG-GLEKLSWVVTAYLLSSTVVLPLYGKLGDLYGRKIVLQAAIVLFVVGSALCGLARDMTQLIVLRALQGLGGGGLMVVTMAAIADLIPPDERGRYQGMFGGVYGIATVIGPLLGGFLVQHLSWRWIFYINLPLGALAFAVIGAAFKPHTAHVRRRIDYAGAAFLawSSPQLwlCCLIGFVVGLALFGSVTFLPLYLQVVKGSTPSEAGMQVLPMMGGLLATSIGSGRLITTLGKYRLFPIAGTFVaaAMLLLATLSLDTPLRAMYLYMALLGGGLGMVMPVIVLAVQNTVerHLGVATSGATLFRSIGGSLGVAAFGALFSNGLHA------------------------------
     607 UniRef50_A9WTP1        Multidrug resistance protei...   190     8e-47  1  18.9%  2:371   22:454     -SHRQIMTILVGLLLGMFLAALDQTIVSISIYTISNDLN-GLSLQAWATTAYLITSTVSKPLYGKLSDIFGRRPLYVIAISIFLAGSIYAGFVHSIGELAVARGIQGLGAGGLMSLGLAIIGDIVPLKDRGKYQGYFMSVFGISSVLGPVVGGFFAGSsgWRWVFLINVPIALAALVVVWMFLHLPKKEGARQkgVLGIIAFILAERmfGVSALLNFIIGIGMFGAIAMLPMYLQLVAGLTPTEAGLLMITFTVGILVGSITSGQVISRTGTYRVFPILGTLILGASALAMGLLLGVDTSLLVPgaIAFGLGLGFCMQPLTLSMqaVPPKDMGVATSTATFFRSMGGTVGTAVFISMLFATAQDKIATLLG-----------------------
     608 UniRef50_A5CMH4        Putative bicyclomycin efflu...   190     9e-47  1  26.4%  2:388   15:405     -SWTARRGPLLTVALIVGISPFATDLYIPGLPAIAADLDASTASVQLTLTAFLVAFAVGQLVIGPISDGAGRRRILLAGTALFTLASIVCAISPDATTLILARVVQGLGGAAAAVSARAMVGDASTGALRSRLFATLAVVNSVGPVVAPLVGGVVLTVWSWRAAFVVLAALGLALTIAAARLLPETLVRTgsPRAVLGRMAELLRIPRFRWYLITGCAATIGFFSYIATSSFVFQEQYGFGEGLYTLVFASNASCMIASTLVFRRLIGRFDEDRLFTIGLLTCAVgaLVLVGAIGGIGPAVVWPALALVTAGWGWVIPGSITLTQALGHRHPGTASALVGGLQFGLGGLATPLAGAL-GGTATAMGALMSGFIAVGLAAQLWASRARS------
     609 UniRef50_A0QWM1        Permease of the major facil...   190     9e-47  1  25.0% 18:385   26:399     -----------------AVTPFSVDMYMSAFPAMAVEFGTSASVVQLTLTTFLIGLATGQLFIGQLSDRLGRRGPLLVGIVACLVASLLCAVSPSIEVLIMLRFVQGFAGAAGIVIARAIISDRSKGSQAAKLYSVMMVIGVLAPILAPVLGGQVVAGFGWRAVFLALAGLNLVMLLGALFMAGESLPPEARRPAGLKAfaSVLTNRRFMGYTLTLSCSGAAMFSYISASPFVLQNIIGLSPRAFSFTFGGCALAVAVSGVISARLVGRFGPRKLLLGGVSAMVVVAALMLltVGGVVPAVTVALMACFMGTVGFTFANATTLAIGEVRHAAGTGSAVIGFLQYGLGAVASPLVGLAGEHSAVPMGVAMFTCAALAATALLVLTR---------
     610 UniRef50_A6SDK7        Putative uncharacterized pr...   190     1e-46  1  15.8%  9:393   61:495     --------VILLLAFMAFTVTFTCIGVVPIARQIILDlqESKSASVLLVTIWELGEAAGPLLIAPLSEVYGRAAVFNVANVLFIIWTVVAACSETSHLFILSRFMTGCAVAS-NVLNPAVIGDMLPPDQRGSAMATLMLAPLLGGAIGPAITGAIAQSIGWRNVLWFAAAMAGVCELCFILLFRETYKSRILQRRIarPAAVFGGSFVLQILSFYGAIVFTFYYIMSTTLPEVLKTVYGFAPATIGSSFISFSVGSTFAVFLCNMLIDRveFRMPLTIVSGCILPISIALFGWTagWPVALLLFLVGLQGFAILTGMVPLMAYVVDAFGLYSASALTAVLITRCLTSTFLPLVVGPLTDQLGYGWGFMIVSGVCLMVAPVPWLVMRYGEKWRQ-
     611 UniRef50_D1VDZ0        Major facilitator superfami...   190     1e-46  1  19.9%  4:360  113:525     ---PRRWLALAVIAVAQLMVVLDGSIVTIALPHAQKALHISTANRQWVMTAYSLAFGSLLLLGGRIADFAGRKRAFVWGLIGFAAASALGGFAPNSGLLFAARALQGLCAAVLAPAALSLITVTFTEeeRARAFGVYGGISGGGAAIGLIAGGLLTEYASWRWCLFVNVPIAVLTAVAAVSVVRESRAEGKPSYDIPGAllRVVLDRTRGGAFGSSLFFGAALLAMFLFMTFYFQNTLGYSALRSGFAFLPFSAGIVFGAGLASQFMPRVGAKIPMIVGSAMAVVGLLLLTQVDLHTGYahVLPAELLISIGMGLAFVPMSSvlIGVAPHDAGVASALVNTTQQVGGSLGIALLNTIYAT----------------------------------
     612 UniRef50_B0K4M3        Drug resistance transporter...   189     1e-46  1  15.9%  2:360    4:414     -KQYNKWLILSAVVIGSIMGPIDGSIVNIAMPEFTKIFHTNITTVSWVSMTYLLVLSSLMMTFGRLGDMLGYKKLYQYGLLTFSISSAILSLSVNIYMLIIMRAFQAIGAGMLMSMTSAIITSVFPPNERGKALGINAMSISIGLAIGPTLGGFLLSNLGWQSIFYINVPIGIIGYIWAHIVVPDNKGVpiSFFGFLASLLLFISEGGTWGWtlLTSVTFLTIFVIitFLTPFLLQHLGFTTEKAGIVMTSFPLVMFVVAPLSGILADRYGAQILSTIGALISATALFLMVTLTEKSTMFSIMTHLALFGVGNAIFQTPNNSAVMGSAPKNrgVASAFLATMRNVGMVMGIAVGSAIFTN----------------------------------
     613 UniRef50_A3EUZ1        Drug resistance transporter...   189     1e-46  1  17.7%  6:360   20:430     -----RVPLTLTAIGATLIETIDSTVVNVGLPKMMGGLDASVDEIAWVITAYSIGNVLMIPMTRFVSDRIGRKKYFTVSILLFTLFSYLCAVSTSLMWVVVFRLLQGVTGAAFFATSQTLLIEAFPKEQIGLANALFAVGISLGPALGPVIGGYLVYHETWPWMFYINVPIGIVLTVMSWRFVPDsyAIEKEETDFWGILLLlfSSPLIRICFLilFLLGTVYFGTLFTVPLMGQSLLGWNPLLTGIVLLPGILGFAFTSMLVGGSMGKLPLFPILLLGVTMVEISLFQLSSISPLVSPDAFFWPLMFRGMGLACLFPPIMTLAMATLPRQmaSGAAIVSMMGQLGGAIGIAVLATLMQR----------------------------------
     614 UniRef50_B2J6X1        Drug resistance transporter...   189     1e-46  1  14.4%  6:360   21:433     -----KWAIALTASLGAILEVIDTSIVNVALTDMQASLGATVSEVGWVVTGYAIANVVLIPLSAWLGDYFGRKTYFIFSLIGFTIASVLCGLAFNLPMLVLSRILQGLCGGGLLAKAQAILFETFPPAEQGLAQAVFGVGVIAGPAIGPTLGGFLVDGLGWRWIFFVNIPFGIVAVAMSFMFLPKDKDKSETQSQSveGEKEDWFSSGFITTLAIASTIGLGLFIwlFAVPIFAQSVLHFTATQTGLLLAPGALASAIVMVLLGKLSSKIDARFLIAMGAVGSSGVMFQLAAITPQTGTDDLFWPLVWRGAFTVLMFLPLSLAVLGPLpqDVSAGSGFYNLTRQLGGSIGIALLTTLLDR----------------------------------
     615 UniRef50_Q0EXF3        Drug resistance transporter...   189     1e-46  1  23.7% 11:382   14:391     ----------LVVAALATVAPFTIDTYLPSFPDIGTELSATHAQMQLTLSLYLFAAATSTLIYGPLSDGFGRRRVIMAALLIYVAASIGCALTATIDQLILLRIGQGLSASAGMVIGRAMVRDVYHGADAQRVMSRVMLLFAIAPAIAPVIGGWLHDMFGWHSVFLFLALVAAALFLMIWLGTGETLAAEKrpLVIARSYARALRHRHFLALVFCFALMFSGFFIYVAGAPVVIYVFLGLGVNDFWMLFVPCVAAIMIGAQLSSWLAGRFSATRTVRIGLGLLLAASmlMQSLWLAATPLSVIAPLALYVLGMALTMPNLNVMALDCFPHNRGMASAMQSFVQMAFTALVVGAVVPLVTVSLTMMTLCMFGLSLIACLFWIL------------
     616 UniRef50_B2W2Z7        Putative uncharacterized pr...   189     1e-46  1  16.8%  2:389   38:481     -TSKEKWLIVAMVALAGFysPLPANIYFPAIPTLARAFHKSLDDINQTVTVYLVFQGISPMLWGPISDRYGRRLVYLVCLSILIASSIGLALCPtfWLLLFLRCFQSGGSASTIALGAGVIGDISTSRERGGYFGMFNLGPMLAPCIAPAIGGALSQGLGWRSIFWSIVIMVSFCLLCILFFLPETLRSIAGNGSLPVPRIqlFTYPDVIVLLSFTGIVYAVNYTITATISSSFAKIydLNETVLGLCYLPVGAGMIIGSTLTGKMLDwhARLRIMPFYLSLFIVCVVAWgaIQAKAHIAVPLILGVLLGWTSIGILNTTMTLNIDILQSRSSGATACTNLVRCSLAAVLVAVIERMTADWGEGWTYTFWGGVCCLLLPLMLLEIKMGP-----
     617 UniRef50_A5FZR0        Drug resistance transporter...   189     1e-46  1  14.3%  1:357   13:425     LSGLPRAIVTVGCMIGTLMQALDATIANVSLPYMQGSLSASYDEITWVLTSYVIAAAIMTAPVGWLAAQYGRKNIFLISLVGFTVSSMMCGVATSLGEMVMDRLLQGVFGAALVPLSQSTMLDIYPVEKRGSAMAIWGVGVMIGPILGPTLGGYLTYFYNWRYVFFVNVPFGIAAVLALGAFMprARRPASGQFDWIGFAVLSLFLGSLQIMltFAVLAVIGLYLFitLMPPFLEKLGNYPVETAGLVMAPRGIGTMGAMMLAGRLSNRIDPRALMAAGFALLVVSFWMMMQWLPSSPQSYMIETLIVQGMGLGFVFTPLQVVAFYTLPQarTQGTSLLSLMRNIGMAVGISVTEAV-------------------------------------
     618 UniRef50_B2S6M5        Drug resistance transporter...   189     1e-46  1  28.0% 11:281   10:284     ----------IVLGLLSAIGPFAIDMYLPALPTIATDLRAETGEVQMSLLAFFLALALAQLFCGPLSDMVGRKLPLYGGLVLFAIGSIGSALAANIDVLVLFRFIQGLGAAAGMVIPRAIVRDLHTGVEAARLMSLLMLVFSISPILAPLTGSIIISFFGWRGVFWAVLLAAGIGIILVATAQKETRSVEAriSSALRGYGRLLKDRHFLGLVFVGGFGLASLFVYLANSAFVLIDHYGLTPIQYAVAFSANAVSFFGVSQLNGWLGARFGLGRVMRFAAC-----------------------------------------------------------------------------------------------------------------
     619 UniRef50_Q67QJ4        Membrane transport protein ...   189     2e-46  1  21.2%  9:385   17:395     --------LIALITVLNMTAPLSTDMYLPSFPTMMDEFGVTAGVLNLTLVGFFFFFAVGMLVFGPFSDRYGRKPVLVAGLGLYLAASLACAGAGSIWQLILFRVLQALGAGCMVSVSTALVKDCFDGRMRGTILATIQSMSVVAPMLAPIIGAFIVQYATWRTTFLMLAGISLCSLTAALLLQEPLPPGARLRGPILGSLGRLfrNPSFTSLLLVVALIPAGFMAYISVSSYIYQDFFGLSETAYSLFFATNAGVSVLGPLTYIAINRKVPPRLIITGALGLALCGGLAVLLL-GRTAPLAFLLSFIPYSFGSSLIRPVSTNTLLSQQDSDTGSASALINFGNTAMGSLGMVLAALPWPDFVTGLGTIAAGCALLALLGWAVLLL---------
     620 UniRef50_C4DV37        Drug resistance transporter...   189     2e-46  1  16.6%  8:393    2:447     -------WVLAALCAAQFMAIVNISVVNVALPAIQKDLDTSLAGLQWVLNAFTICISALTLAGGSLGDRFGRKRVFVTGLAAFIVGTVVCAVSVNLGMLITGRLIQGIAAALLLPGSLSILAQTfdPAERVRRIGIWAAVSAVGLVIGPVVGGVLIQAFGWPSLFWLCVPLGVTALIATLVFVPESANPEHAAIDPLGQIlrLFADRSFAAMNFASASLGFGPYTMYAFLALYLQQERDFSALSAGLAFVPMSIATAIVAPLAGRWVGASGPVPAMLAGYGSSAVGLAGVALFDAHTSWFLMGPVFVLIGVGMGLSMTPTTNGAVDAVpeRSGIASATINTTRQTGLAIGIALLGAMVSatGLRLVAAVTALVSLIAVVYILAGRVATRPRTP-
     621 UniRef50_A6W4M6        Drug resistance transporter...   189     2e-46  1  17.0%  3:378   17:447     --KPRIGWIFTSLMLVMLLASLDQTIVGTALPTIVGELD-GLEHMSWTITAYTLALTIAMPVYGKLGDLVGRKNLFLVAIALFLLGSALCGLSQDMLWLILSRGVQGLGGAGLMIMSQTIIADVVPAKDRAKYMAPIGAVFGVSSVAGPLLGGWLTDSAHWRWVFWINLPLGIVALVVAAVTIKLPQRKNTAKIDYAGMVLLAlwTSATILGLAAGTLVAAVAfgALAYLPTYLQMSYGVDATGSGLLLIPMVVALLVTSIGSGAVVTRTGRYklPVVGTLVAAGGMYAMSTMTLDTPLWQLCLYVAVLGAGLGLFMQIIVLAVQNAvpREIGTATSANNLFREFGVTIGIAVLGTLFSSRLTERLGGALGGDVAAGG----------------
     622 UniRef50_B5FMB8        Multidrug resistance protei...   189     2e-46  1  92.4%  1:394    1:394     MKRQRNVNLMLMLVLLVAVGQMAQTIYIPAIADMAQALNVREGAVQSVMAAYLLTYGVSQLFYGPLSDRVGRRPVILVGMSIFMVATLFAMTTHSLTVLIAASAMQGMGTGVGGVMARTLPRDLYEGTQLRHANSLLNMGILVSPLLAPLIGGLLDTLWNWRACYAFLLVLCAGVTFSMARWMPETRPAGAPRTRLIASYKTLFGNGAFNCYLLMLIGGLAGIAVFEACSGVLMGAVLGLSSMVVSILFILPIPAAFFGAWFAGRPNKRFSTLMWQSVICCLLAGLMMWIPGWFGVMNVWTLLIPAALFFFGAGMLFPLATSGAMEPFPFLAGTAGALVGGLQYIGSGVLAWLSAMLPQTGQGSLGLLMTLMGLLILACWLPLASRISHQGQTV
     623 UniRef50_A1B9W1        Drug resistance transporter...   189     2e-46  1  25.5%  8:388    7:393     -------RMALLLGLLSAVGPFAIDMYLPALPQVASDLHTSEAGAALTLTSYFIVFGIAQMIYGPMSDAVGRKRPLVIGVAIFLVATVAASLAPTIGWLIAARAVQGLGAATLMAVPRAVIRDMATGPAAAKMMAAIMIVISVSPMLAPLTGSAVMAWGGWREIFAVLAAAALLSLALILFVLPETLPAERRRpaMAAGARRLLTDRRFLGLTMIGGFGMASFFVFLASASFVYTRQYGLSPTGFSLAFAVNAVGFFSASQFAGRLAERFGMERVISLAITGFAglVLSLVVLAGFDGLPVVIAGLFLANACLGLVMPTAMVMSLDPHPDIAGLASSLGGTIQMLTGGLMIAVTGPFLNNTAATMVPAIALCAALAWGAAAASLPRLR------
     624 UniRef50_B8FUU9        Major facilitator superfami...   189     2e-46  1  18.0%  5:359    4:411     ----RKTPLILSLMLAMFLAAVEGTIVTMATPTIARDLQ-GFEFISLVFSVYLLTSALSTPAYGKLADLYGRKNILSIGIIIFLAGSFLCGLAQSMVMLIVFRAIQGLGAGAIFTVSFTIIGDVFSLAERAKIQGALSTVWGIASLVGPFFGGFLIDVLSWHWIFFINIPFGLLSVILLQSSLKETFAKKKPSIDYAGTLTLSLAIVVFllVNLISFLIYAVLMGVNVYLPIYLQNILGYRPTAAGLAMLPMSVSWLIVSFILGRLLVRYGGKNVILASNAVLLLSTLLLFTLGIDTPLPIILAYGFIMGIGFGGASAALTIIVQDSAesQRGAAVGTNSLLRTLGQTIGISVFGTIFN-----------------------------------
     625 UniRef50_Q31HA1        Major facilitator superfami...   189     2e-46  1  23.1% 13:346   13:355     ------------LGALVALTPFAVDTYLPAIPEMATDLSSTVNHVSLTVPLFLIGFALGQLIGGPLSDRYGRKRIALLGLLIFFVSSLLIMFSIQIEQLYIMRVLQAVGGGFATVVSAAIVRDLYSGKESARVFSMIALVMLIAPLVAPGVGAFIVNLSGWHQVFAFLAFYAVLLSFLVKKGLPETVTIERKQkqFALNYRQVITHWQGLGFLIAQGFASSVLFVYITESPFIYMEKFAIDSASFPFYFGIVVLGVMFFNRMNLGLLKRFEPRQIVFYALlvILSFSLWGYILLATESVYVVLVFQFFILGLLGAITPNVQSCYMDYFPDFSGTANALMGTSIFAF------------------------------------------------
     626 UniRef50_C2ANS3        Drug resistance transporter...   189     2e-46  1  23.0%  4:381    9:390     ---PPKLRIALILGSLSSFGPITTDLYLPGLPSAAEDLGASQPAMQATLTACLVGLAIGQIVVGPLSDSIGRRRPMIAGMALFIVSSLLCAVAPSVYLLDAARLLQGLAGAAGIVLSLAIVRDLFHGVAAARMIAALMAVSGVAPIVAPLAGAQLLRVLDWRGLFVVLAVLGVALLAVAALLVPETLPTADRRPSGWrgYYSLARDRRFVALTATSGLAFAVMFAYISTSSFVFQDHYGFTATQFSVVFAANAVGLLVTNLIGGRLVGRVSTSVLVWTGLAGMALGSCVAVLALSADLLPLLVGSLFLAVSSLGLVMPTVAALALEDHGALAGTASAALGSARFVFGGLAALVAGIGGNPTVLGVVMVVCAVGALMAFVAA-------------
     627 UniRef50_C6D6S0        Drug resistance transporter...   189     2e-46  1  15.5%  5:359    9:417     ----RFWFVILAIFFGNFSSILNSGTVTVALPFMMKDLHSDLNDTQWVTTGFMLAMGSIAPIVGYLGDKISYKRLYMFSLVGFLICSVLCGCSWNIGSLVLFRILQGLFCGAILPATLTIVYQAVPAEKQALGVSLWSVASMFAPAIGPTLGGLLTEYYGWKAIFFMNIPLALLAIVLASRYLPMQQVNKGSSLDLAGLllRVFRHTTFTFGIVVNCILTIGLYAGAFLLPIYMENALGSSSLTVGLMMLPGALLMIGASLLSGRLHGKIRPEYPLLGGAFLLIIATWAFSRLSLTTSYAFIIGWMICRYVGLGFSSPNIMTLSMSAIPKEsgHASAITNWLRQVIASFAIGIFSSVYS-----------------------------------
     628 UniRef50_Q0W8L4        Predicted permease (Major f...   189     2e-46  1  16.5%  5:373   11:430     ----SPVYVLAVLAIGVFIAQLDATIFVPALNTVVSEFNTSYEWVVWSVTIYMLAFTVTMPLAGKIADLYGRKRLYILGVALFCIGSLACGLAWDIPSLLVFRVIQAIGGGMILPAALSEIGAVVPEKSRGMAMGIMMAINAVAAIIGPNLGGFLVEHFGWRYVFYINPPIGILAILLALRF-TETYGHEKHSIDFPGAAMllLARPEVLAVNFAALAFGFCFFSIVLYVPSYSQMVLGLGIQDSGSILTPLTVSVLVMAILGGRLADKIGIRFVLLAGAIVTCGALFAMAYALSGT--LVLAIILLIMGIGVGFSMGSFQSLTLALvpNMKGSASGIVNTFMNMGGIIGPTIGSYYISGGTKKLEALMASMS---------------------
     629 UniRef50_Q5KG51        Putative uncharacterized pr...   189     2e-46  1  16.1%  2:392   10:453     -TKWQKLSLVVVASLSASFSGFASNIYFPAIPVMATSLGTSIENINLTVTTYMIFQAITPTFWGAISDAYGRRLVLISTLTVFFSACIGLALVKHYYQLVILRCLQSTGSASTIAIGSGIIGDVADRKERGSYMGFFQTGLLLPLAIGPVLGGIFAQTLGWWAIFWFFVIYAGIFLLILALFLPETLRraTPIRPDWIAPLRILFVPDVFLTLSFLSLHYATWQMAITAQSSLFKSIYNLNEIEIGLTFIANGFGCMLGTLSIGRFLdkFsaRLRTVWFWSPFQCAAVLWFGWTLDQKVHMaiVASFVLAWAAMSIQAVISTFIVDIFPKSSASATAALNLARCLMGAGATASVEPSINTLGVGFTFTLWACLMALSLAFVGVQMRFGPAWR--
     630 UniRef50_B1HYF6        Multidrug-efflux transporte...   188     2e-46  1  15.9%  6:352    9:357     -----KSFVLYALSISTFFASLNQNIYTPIIPLIRDSFEVSISWVNFTVSSFIFIIAVIQIVLGTVVDHQNKKRLLLISLVLMGVSAVICAYTNSFILFTLFRMIQAIGAGIIPLVAISMIAQLFEGEARGSAMGTYQILLTLAPAVSPVVGGFIGEFFGYEGIFLFLLFMAVSLLMFIVYLLPSEktEEKQSKGFIHSYKAIFSHYIGTSIMTVSFLVFFIYFAILVYLPVLLHDHYHVSLQLIGLLYLPLTVSMIVGSILFKRLQKKIS-LNTLFILLLIVMPLQVVLFGVLHAQSLVALSIILFGYGIMVGFSAPLFSTLISNEYSEHRGTALGVFNFVRYSGMAIGGM------------------------------------------
     631 UniRef50_B3PEY1        Bicyclomycin resistance pro...   188     2e-46  1  20.3%  2:391   15:410     -SRISAREFIVLIALLMSVVAISIDALLPALGFIANDIpaHPNQAQYLISILFLGMAIGQLVCGPLSDATGRKKILYAGIVLILLGSLICFMAQDINTLLLGRFIQGLGVAGPYVSAISIVRDKYTGNEMARIMSLVMLIFILVPAIAPSLGQAVLLVSSWRYIFVLYIVYALIIGVWIFLRLEETLPRDYRIPFSTrgFKEVISNYTTMCYTLCMGLFFGSFLGYLNSSQQIFQELFN-TGQLFTLYFGILALVFGASSLVNARFVQKWGMDYLcaVLGIVLSSALFLALQLVIEPNLWAFLVYAAVLFFCFGLVFGNVNAMAMEPMGHVAGIAAAIIGAFSSIMSMTIGTVIGQLYNGTLMPITCGFLILGMMAYGILLLAGGYKDKQA---
     632 UniRef50_B1G6M5        Drug resistance transporter...   188     2e-46  1  18.5%  4:360   31:442     ---TRNARVLLCTSGVSFMIMLDSNIVAVSLSTIAKDLNASFTDIEWVVSAYILPFAAFLMPAGALADRFGRRRLLLTGMLLFTAASLVCGLAPNSTILDASRGLQGVGSAIQLSAALAVLGHTFRGAERARAFAFWGTLVGVAVAIGPLIGGFITSTVGWRWAFLVNVPAGAALIAVGFSSVDESRDPHSRKLDLAGITFLGGGLFYLVWGLiaTALLFCFVVamMTYLPLYLQNSFGFNPALAGVTMMPFALPLFLLPRVGASLARSMSGRAILTIGLCIVACGNLsaLVVHFGGSLKLLWMGMLITGCGAGLLNGETTKVSMTvpPERSGMASGIGATLRFVGLLLGITFLGAILAS----------------------------------
     633 UniRef50_A9KG82        Multidrug resistance protei...   188     2e-46  1  16.2%  3:360   23:435     --KNRKWWIFVAMSGALSVVFLDQTAISVILPPIQKDLGLSNVLLQWVINAYLLSLAALVIFGGKLGDVLGHKRTFLAGIIIFVLASISCAAAQTSYWLVTSRIIQGVGGAFMIPVTSVMMAHAFSESERGKVMGLYVAVAPVFLSLGPLLSGLLAHYFNWRWVFWINVPISLLSIFLTIIAVpeNQRDTSKPLDWLGFLTFSLFIATLVVALmlCLLFFTCAFSSSVFWAILLQKVMGYSPAATGLFYLPVTIPVMFMAPLGGMLRDKYGPRLPVMMGSAAVAAGSFWIALSAFKGHYSAMLPGFLLFGLGPALVYSAVMATTISSVpsQMGMASGISNGIRQLGRVLGVAMIGSVISN----------------------------------
     634 UniRef50_C4FBR9        Putative uncharacterized pr...   188     3e-46  1  17.5%  4:358   14:421     ---SNKWAILLTVLIMTFMATLDSSIVNVALPVMQKALGAGLDQIQWISSVYLLTMCAFLLVFGRLGDLYGKVRYFEIGVVIFSIGSLMCGMSTSLPALVASRAVQGIGGASAMANNMGIITEAFPARERGRALGLLASFVALGMMCGPVLGGFIVSMFPWEGIFLINVPVGILSLVIGHFTLPRSTPECAGQSMDVKGalAIFSDRHFAVNVVCLFISFVAIGVYELMTPFYLQDARGFDPGASGLIFCIIPLVNAVAGPISGAVSDRIGCNLLTVLGLGAFSVGLYLTGTLGMTATLPQILFYLGLASFGTSIFQSPNNSLIMGSvtEMLGFAGSVSALARYLGMAVGISGSTSIL------------------------------------
     635 UniRef50_Q1J327        Drug resistance transporter...   188     3e-46  1  19.5%  6:358   19:436     -----KRTTLIGLLVVFLLAALSQTIVSTAMPRIIADLQ-GFNLYSWVTTAYLLASTVMVPIYGKLSDLYGRKPILVFGIVVFLIGSALSGLSggMNQLIAFRAVAGFGGAALFTTAFTILADMFAPAERAKFGGLFGAIFGLASVVGPAVGGFLTDNLSWRWVFYVNLPLGLLALFLILAKMPRLTHRAEGRIDLLGAALILSTTIPLLLALTWGglAAFIMGMAflFLPLYMQMVLGVSPTKSGFSMLPLMGGLILSSIGVGQIVARTGKYKPWMigGVILMLGIFFLTKITTHTTLADLAWRMFVVGLGLGPSQSLFTLAIQNAVpnQLGIATSSSQFFRQIGSTIGAAVFGTLL------------------------------------
     636 UniRef50_B0MYW2        Putative uncharacterized pr...   188     3e-46  1  16.1%  2:392   11:478     -SRGYKWWILSLVMLGTFMAVMDVTVVNVGLPTIMSVFHIPISTAEWVITAYMITMTLMLPSAGWIADRIGNKRMYILGLVLFTFGSWLCGRAGSDMFLISARALQGFGSGIIQSLGLAIVTREFPPQQRGLALGLWSVAAAASISFGPLIGGYLVDDYSWHLIFDVNVPVGLAAILFAIFIQKEWRGARAGSFDWPGFLCVVCFMPLLIFALacFAVAAAALIVFIvlLPLYMQKGLGYTAIMAGSVFLPVGLIQGVLSTCSGFLTRYVKPLFIAVTGILVMTLSFYFASRFTLHTTHAQIMLVLYLRGFGMGLTFAPLNDflMNLSQCDMASAAGISNSIKQLSGSVSIALLTVILTGRTAFhfLFVTFVSLASALPFLWLLRPRRKAAS--
     637 UniRef50_A5F1G7        Multidrug resistance protei...   188     3e-46  1  23.4%  2:394    6:401     -STRFRRTPMLLAMMIIATGQVGVSIYLPSLPLISRDLQVDQASAQMLVTLFLLGFGGSQLFYGALSDAVGRRPTFLLGQGIYLLGTVLcmMSDHFQALEFGRLLQGLGAGSASVLGRSVLRDSYDGFHLTKALSYLSITASIMPIIAPVLGGWLAYHLSWQSVFIFVLLYIGAIFTLGLMILPETLPYPKRRVQWRgnYAKLLTNQQVTSSASYNWLSYLASLVTLSILPFLLQKQLGMTAADYGSTLIIPSSGLLLGSVLVNMLTSRFSVRQLLGCAISLMVFAGLWLLL--TEFSVFNLIWAFTWLSIAQGISFPLATTLLLSPHKSQAGAVSALSGSIQmiAGLLGGYLVEHWVTSQNAMGVFYILVGITMLSVLIATKKAHSQPSAAQV
     638 UniRef50_B2AED7        Predicted CDS Pa_5_2920 n=2...   188     3e-46  1  15.4%  4:392   33:464     ---WKRLYMTSIPALLCVNVSFASSVYTSGTNDISQQFNVSRTESLLGLSLFLWALGLGAIIAAPVSENYGRRIVYLTTVPIFGLFTLGSGLAPNFVTLIVCRTFAGFFGSAVVSVGGGTNADLWRPTLAGVVYPFYFVSPFLGPAFGPVVGGYLIEAKGWRWLQWIILFMIVFNYLYAliLEKRTrsRAILQRILLKPFKMLFVESIVLFMTIYMAFNFAVFYSFFAAFPYIfgGHYNFTPGQQGLTFLSIALGCVVGFVGVVYIDRRteHRLYGAMVGSALNPASLFWFGWSASAGAHWavVAAVPFAVGNIMVYSSGALYIMNSYGshGASALSANSLLRYAFGGAFPLFTVQLFSSLGTGWASSLLGFISVVLVPVPWVLYKYGKRIR--
     639 UniRef50_O31563        Uncharacterized MFS-type tr...   188     3e-46  1  17.5%  3:361    8:426     --QKSQKWAISLFTIGVFMAALDNGIISAALTTINESFSVSPSWGSWGITLYTLGLSVSVPIVGKLSDRYGRKKLFLIEVCLFGLGSLLVALSQSFPLFLISRLIQALGGGGIFIIGSSHILATLPKEKQGKALGLLGAMNGMAAVLGPNIGSFLLDWTgwHWLFLINLPIAVLLVVFGACFIAETKAPEAKRLDAAgnLLHSLGNPEVYGCIIFGILCFAALISyvIFIPSYVEQYLGVPAAKAGYWMTPLALASGIGAWLGGALTDKKGPVKTVILSGIISCAGFALFPLWVTEK--WEFVIASVAAGIGFGFLlaPLNVLVSEAAKTNKGTALGTLSLVRQIGLTLAPTLYAGFITAG---------------------------------
     640 UniRef50_A5DPI4        Putative uncharacterized pr...   188     3e-46  1  14.1%  2:392   76:527     -SKADKFLVSAQVAFLTMTSVMGSSLYSPSIAFLMEDLNTSHTLAELPLALYVIGFAVGPMVLAPMSesIGRAPIFIVSHFIYFILQiwGAGTRSFPALAVLRFFTGVSASPALAVGSATCGDIMKLPYLPMAIVAWSAASIAGPCIGPVIGAALTDAssWEWCFRFQAIVGMVSFVVCSFFLPETYAPTIMHrtLWRPIILSISEPMVLLINLYTSLLYTIMFLWFTAFPLVFENLYHFTLVELGTSYLGVLVGVLSGATIFIVIIYHVYTKrpAAIYGSIWIPTGVFIFAWTSKKSVHWMVPIIGGFIfgTFIVFQTLFNYLATSFPRYVASAFASNALSRSLMAGVAPLFGTFMFdnFPVGWGASILGFLTAAMICIPILFYINGPKLR--
     641 UniRef50_A9B396        Drug resistance transporter...   188     3e-46  1  16.6%  5:359    8:416     ----QKIAVCVVFVAALFMSIMDGTIINVALATIQQDFGASSSAINAIVVIYLICIAVVIPASGWLGDRWNTKWVFLTSLGLFTLASLACGLAQNIEQLMLTRAAQGIAAGALMPVGTTMLFRTFPPHQRIQVSRVLIIPTVIAPAVGPVLGGFLVDHLSWHWVFFVNGPIGLAALIFGVIWLQAPAQEEVGAFDWLGFilRLFSIRLFRVSNLVAIFGSAAFTGILFLMPQFLQNVVGASALESGLTTSPEAIGVVLSSQIVARLYPKVGPRRLTFGGVLGVAVMMGLMSTIDAETNLWLVRALMFGTGVGMAYLFLPIEAAVFAQIPHAsgQASAIFSMQQQLGSALGVAILGSVLA-----------------------------------
     642 UniRef50_C8WFK1        Major facilitator superfami...   188     3e-46  1  18.4%  1:392   19:466     MTRQNRNQAMGAISVSVAMAILDTAIVNTALPSIAKDLGVGHSDSVWIITAYQMSMVAAMLPFAAYGDLKGHRKVFLTGLGVFILASLACGISPSFLGLVAARFVQGIGAAAIMSANTALVRQIYPARILGRGLGLNALVMAFSFAAGPPMASIILSFTSWHWLFLINVPICILAFFLSWQKLPKEDKGKSQKFDVVPAVidLFRISFFSLSAITAFLAFIVQGMIFVAMPFLLQGKLGFDVIMTGFLIAPWPLMGAFLAPIAGRLSDRYPAGILGGIGLAILGLGIGVISVLPPHTKPIIAVIMMALCGGGFGFFLSPNQRALMSSAptRSGAASGVLGISRILGQTTGATLVayLSSDHGAEIALRIGIFIAFAACMVSLSRLLKKPILR--
     643 UniRef50_Q9L210        Putative integral membrane ...   188     3e-46  1  21.2%  3:361    7:417     --HPRRWQILNILCLSLVLIGLDTLILNLALPSIQKDLDATSSQLQWMVDSYALAFGGLLLMAGGLSDRFGRKRLLSVGLGAFALTSLGAAFASNAEMLITFRALMGISAALMMPATLAIIKDVFPREEQGKAIGIWSGAAAVGVPLGPLVSGLLLEHFWWGSMFLINVPLAAIALIGGAKLIPESKAEGHPGLDLVGALLslFLNARYGGGALAIACTSFGLYSGLYLLTQYLQSVLELDPLGAGLRMLAIG-TMMVGAPLSAKLVERTGLKATVVVGLLLCAAGLGVLAGLSVDDE-TQALIGLAVFGLGMGIALPAAvaILVVSAARQAGAGSAVADVGMQVGGALGIAISGSVIATL---------------------------------
     644 UniRef50_A4Y718        Major facilitator superfami...   188     3e-46  1  41.9%  9:380   33:404     --------LIFMLVFMVACGQMAQTIFVPALPQIALSLNVDASQLQAVMACYLIAYGLFQFVYGPLSDRIGRKTPLLIGIGIFILGAFMAARAQHFNQLIFASLIQGLGTASAGALCRSIPRDHYFGDNLVKFNSYVSMAVVFLPLIAPFLGSIMTAYFGWQAVYWVLAGFGVFVWLLLLVGFKESLPSCKREHniIASYRHVLRHRGFRAYLSSLIATFAGIAAFEAIAGVLYGQYLGLPPFMVSCYFVAPIPGYLLGALIAGK-QTKTQRTVYQGVALLGTGALFMLIPGIFLLVSTWSLLVGSVLFFSGAGMLFPTLTSAALEPFPRQAGIAGALLGGLQNFGAGLAALSMSVMPMGGQLSIGLLSTMMVILVIASL--------------
     645 UniRef50_B0T1H4        Drug resistance transporter...   188     4e-46  1  23.8%  6:392   13:405     -----PWRLVLMLGALTAFAPMSIDMYLSSMPEIGRRLHAGADDVQATLAAFFAGMAIGQFLYGPASDRFGRRPPLLLGIGIYVAASVVCALAPSIEVLIAARFVQALGGCAGAVVARAVVRDRFNHADTARVLSLMTLIMGLAPVLAPQLGGVIQFFAGWRGVFWSLVVFGLLIGLWIALGLSESraVQARSENPFKAYGALLSQKRLVGYGLAGALNGATLFTYISTAPDLVMGTYGHTPLVFNLIFAFNAVGIIGASQVNRLLLRRATPDRVLVRaaSIVAAFLLAAAAWTGVGGQFTVLPLLFAALSSYGLMAGNTMAGALSVDPKRAGSISALMGGASFAAGALAAWIGGLLHDGTARPVAAVMFACLIGSSLAIFGLAVPKGLRGK--
     646 UniRef50_A6E925        Major facilitator superfami...   188     4e-46  1  18.8%  8:389   18:455     -------WTILVTSLAFVVAQLDVSIVNIALPQIADSYHANISILQWIIDAYTLAFAVLMLSAGSLSDLFGAKRLFQIGMLIFGISSVACGLAMSSSFLIAARACQGVGAATMIPSSLAILNHTfrPIKRAKAIGLWTAAGSAAIAAGPIVGGVLIKLSDWRFIFFINAPICLAGILLTFRLKEQPKPTVVKKFDLAGQilSLFNSISFNVLLLLGAVLNGFYYGTVFILSLYLQDILKYPPLTAGLAFIPLTAGFVISNLASGNIINRYGIRTPILIGLTLFALGFSGLLVAGMHTSFLQLSAPFLLISLGMGLAVPAMTTGILSSVDKmsGTGSATLNTVRQVAGAVGVAIFGTLAANGGEAVLQTIKISVIAAILCTILIILLSRK-----
     647 UniRef50_B8DHC5        Lincomycin resistance prote...   188     4e-46  1  14.2%  2:366    6:424     -TSVKRNGILIVMLMGAFVTILNQTLMNVALPSIMKDFGITASQGQWLSTGFMLVNGVMIPMTAFLIERFTTRQLYLFAMITFAIGTAIGGFATDYTMLIAGRMVQAIGAGIVMPLLTVVVLNLFPMERRGRAMGLIGLAMNFAPAIGPTLSGWIVQQYDWRNLFFIIIPFAILDIVVAIFLLKNVGKRTFPKLDILGVifRVFKYPTFALTTAISFFVVMGLFGGMLLLPIFLQTVRGFSPLESGLVLLPGALVTAILSPVTGVMFDRFGAKYLSLVGLIIMAGSTFMFTNLDESTTLTFIIIVQTIRSAGMAMVMMPLQTAALNSLpkLASHGSAMFNTMRQVAGSIGTAALITVMSKSAASFA----------------------------
     648 UniRef50_A6FFN7        Bicyclomycin resistance pro...   188     4e-46  1  18.3%  7:389   17:406     ------KTLILTLAAVFALTPFTIDSYLPAMPTMAKAMGVDISLMSVTVSLYIFGLAIGQLIGGPLSDKKGRGYAMIAGLIVFAIASILLTTATEIEVLWLWRVVQAIGGGMAVVGVPATIRDTTSGKEAAKLFSLIALIMMIAPSIAPTVGTIIMSVADWRWIFYTLAIMAVLVAILVMRYMPKPVKKTIaeIKPKLGLLSVFSEKRALGFMVAQAFAYSVMMIFLTNASMMYMEVFDQTAQQFSMLFFANICGLVVVNRANTFLLAKFEPETLLKAFLSLQVLGGIILVTASVMVplYVTVAGFVIAISANGAVISNASACFMKRFGRNAGSASAVLGATQYTVGGTVSALSAFISMGSVQPVVIIMLVSSVTALLGATIAARYSRQ-----
     649 UniRef50_B8G1J2        Major facilitator superfami...   187     4e-46  1  16.9%  3:380    2:376     --QKQYLRPMVILVIIQFLVMVGFGIVIPILPFLIEELGGGAFSLGLFMSAYSIMQFFFAPFWGRLSDRIGRRPVLLIGLSGYGITFFLYGMAGNLPLLIAFRALSGVVSSATLPTAMAYMADITEGADRSKSMGMLGAAMGLGMVFGPALGGFLG-HYSFTLPFYFAGTLALLVLPFAWKLLPETLKEPNLESKPKVRFHPGVIRDPLFPLFIFNFVLSFTMAMFESTFTLFAAERVGFGPQEMGIVFMIIGigVIVQGMLIGKVVRRFGDAKPAKVGALLCAVAFLWLLWA---PNAILLVLGTVVFMIGNSFMVPTGSSLVSKNSHTGQGASLGVFQSFGSLGRIAGPLVGGGIYGLSMNTPYVIGAATLVLCLIFF--------------
     650 UniRef50_C4RMY0        Tetracenomycin C efflux pro...   187     5e-46  1  19.3%  3:360   33:445     --HGHPWLTLLAVALGVMVVGLDATVVAIANPAIARDLGADFAQLQWVTNGYLLALAVSLIVAGRLADRFGRKTVFLVGVAGFAVASIAVGLSGSIEMVIFWRVVQGFAGALLQPASLAILRNTFPAEKLNMAIGIWAGTSGLAIASGPIVAGLLVENASWEWVFFLNGPVATVAILLGLWVVRQSRDPEAAGSFDLPGVGLlfGDVVPLGFFAGAAVLGAAFVvsFFFLTLYLQQVHGMSPVDAGVRLLPMTATFIVASPVAGALTARYGPRPPLVVGMLLTAVALFALSRIGVQADYLSLWPWFIVIGMGFGMVLVSSTEAIVGNAphLAGLAGGIQQTAAQLGGVLGTTLFGTILAT----------------------------------
     651 UniRef50_Q1IZ90        Drug resistance transporter...   187     5e-46  1  21.3%  1:362   20:447     LSLATKREILFGVLLGLFLSALDQTIVATAMPRIAADLN-GLNLYAWVTTAYLLTNTALVPIYGKLSDLYGRKPVLMVGILIFLLGSALCGLSggMMQLVVFRGLQGIGAAALGSVAFAIVADLFEPAERPRYQGLFGAVFGLSSVIGPLLGGFLTDQISWRWVFYVNLPLGLIALSFIASKMPRLASGLQAKVDWLGAFLIILFAVPLLLALTWggLSAAALVAFLffLSLYLVQVKGVSATRAGTATIPLTVGLIIGSVGSGQIASRIGRYklILIGLVVAALGFFSLSTLTADTPYSGVILRMVLLGLGLGPALPLYTTALQLAvpWEIGVATSAGQFFQQMGSTIGTAIFGAMLTAGL--------------------------------
     652 UniRef50_A9M279        Bicyclomycin resistance pro...   187     5e-46  1  18.9%  3:393   15:413     --EMSEKLMAVLMAMLVTLMPFSIDAYLPAIPEMAQSLNADVHRIEQSLSLFMFGTAFGQVVGGSVSDIKGRKPVALTGLIVYCLAVAAIVFVSSAEQLLNLRVVQAFGAGMTVVIVGAMVRDYYSGRKAAQMFALIGIILMVVPLVAPMVGALLQGLGGWQAIFVFLAAYSLVLLGLVQYFLPKPAVGGKIGRDVfgRFKRVLKTRAAMGYLFFQAFSFGSMFAFLTESSFVYQQLYRVTPHQYAWAFALNIITMMFFNRVTAWRLKtvHPQSILLWGIVVQFAaqLAAVLFFGLPPFWLLVACVMFSVGTQGLVGANTQACFMSYFKEEGGSANAVLGVFQSLIGAGVGMAATFLHDGSATVMAATMTASTSCGIALLWLCSHRAWKENEQ-
     653 UniRef50_B9QTF4        Drug resistance transporter...   187     5e-46  1  21.8%  2:391    7:401     -TLMSARRTALLGAGLVAVGPISMALYTPAMPALVEFFGTTDGAVKLTLTSYFAGFAATQLVCGPLTDAFGRKPVTILFLGIYLISSVLATFSPTVEFMVAARALQGVGAAIGISVSRAIVRDQFTGQASARIMNTIAMMLALGPAISPTIGGFVLELFGWREVFWCMVIYGVALMVAVTVFQVETNphHLNPRQLAINYTTLLKDPRFLAPAILIGCGLGNIYALATVLPFVLIYEVGLSPSVFGLTMILQSGSFILGTVITGQLLKVTDAHKLVPFGLAMLVVASVLmmTLTQEPSVASVMAPVGLFVFALAFVLPASFTDSMAPFPHIAGAASSMLGFLQFGGGVAASLIV-AMVGDPVLGLAFVLPAMPVAGVVCYLLLRGQDTQHA---
     654 UniRef50_B5XTA2        Drug resistance transporter...   187     5e-46  1  24.9% 11:356   10:356     ----------LILGLLSGIGPLCTDFYLPALPEITQQLQATSTQTQLSLTAALIGLGLGQLFFGPLSDRIGRLKPLALSLLLFIFASAMCALTRDINMLIVWRFLQGFAGAGGSVLSRSIARDKYQGTLLTQFFALLMTVNGIAPVLSPVLGGYVITAFDWRILFWTMAAIGGVLLVMSLTILRETRPAAATHTARQQRGQPVLKNRRFLRFCLIQAFMMAGLFSYIGSSSFVMQSEYGMSAMQFSLLFGLNGIGLIIAAMIFSRLARRFNAESLLRGGLTLAvcAAIMLLFAWLQLPVLALVGLFFTVSLMSGISTVAGAEAMSAVDAAQSGTASALMGTLMFVFGGIAAPLAGF--------------------------------------
     655 UniRef50_A3L6S8        Putative uncharacterized pr...   187     5e-46  1  22.5%  1:391   12:408     ISPATARLLPILLAGLAMLGPFTINIYMPSFEQMKGVFGVTDVELQITLSLYFAAFAFMSLWHGAFSDSLGRRPVVIAGLLVFALASIGAACATRIEQVYVCRVLQGLSAGAGIVVGRAVIRDLYAGVAAQRLYALVIMLFALAPAIGPVLGGWLQVHAGWRANFALLGAMGMTLLAMVLFCLPETLPSDRRQpaLLAGYRHVLGNLTFMLWAVTFALMFAGFFIYVLSAPVFLSRHLGLEETEFIWLFGPATAGMMSGSYLAGRFALRWSTGRGLVTGFGIMLLASLWNLalWAPTAFGWYLPYLFIYTLGMALVQPTIVLAGLDCVPDRRGLGSSLQLSIQTGFNALLAAFIAPFFWDTPLLLASGAALAMLLSLVGVALAWSQARRAG---
     656 UniRef50_B5HGM0        Export protein n=4 Tax=Stre...   187     5e-46  1  19.0%  3:360   26:438     --RSNPWLTLLAVACGLFMVQLDGSVVAIANPEIGRDLNASTADLQWVTNSYLLALAAALILGGKLGDRFGRRTFYMIGLAGFTAASLAIGLAGSIEGVVVFRAFQGLFGAMLVPNTLGLLRAVFPGNKFAMAVGIWAMVASVATALGPIVGGLLVEHVSWESVFYINLPIGLVTLAFSATVLPQSRNAGGHHRFDirTEHPLLPMRLFRSPAlvTALNFFVMLGVIFFVMLYLQNVRGFTPVEAGVRTLPLSIASLLAAPLGAALTGRFGPRVVMPLGMLLQAGATFGMLTWDADSSYTALWPPFIALGLGVGMVLSASSDAIVGNApkDGGVAGGLQATALQVGGALGTSVLVSLITG----------------------------------
     657 UniRef50_Q2HA17        Putative uncharacterized pr...   187     5e-46  1  14.6%  2:392   81:458     -SRTKKWTITLLQALATLAVAFVSTAYSGGVYEIIRYFHVSTIVAILGVSLFVLGFAIGPLLWAPLSEFHGRQIVFFFTYFGLAAFSAGAAGAQNIHTLIILRFFAGAFGASPLTNSGGVIADMFN----AKAFSPW--------------------PLSWAPPSAPLPAASSWTSPSAA-----PPNPQQIRTTLLRPWALLFTEPIVFLTAIYLAIVYGTLYLLFAAFPIVFQLNRGWSAGVGGLAFIGVAVGMLFAVAYSMFDNRRYGrrLPPAIIGSVLLPVGLFWFAWTNGPEVHWVVPITASAFFAAGlvFLSLLSYMIDSYTVFAASVLAANSVLRSLFGAAFPLFTTYMYQDLGIHWASTVPAFLALACMPFPWLFWKYGARIR--
     658 UniRef50_Q1DG35        Drug resistance transporter...   187     5e-46  1  19.1%  2:362   20:442     -TRSQKVFTLLGAVLGLLLAALDQTIVATAGPAIQADLRIPASLYPWLTTSYFVASTTMVPVWGKLSDLLGRRAVLAAGILIFLAGSFLCGVARSTVALILFRAVQGLGSAALFTAALAVVADLFEPRERGKYQGLFGAMFGLSSVVGPLAGGFITDHLGWHWVFFINLPVGAVALALVLSRMPRLKPQRVSrlDLVGAFtwAWTSWRILGLFALSAVGlgAFLSGIVFLPLFMVNVVGLSATRSGLTVMPLTLGVVAGNVLSGQLVSRVGRYklLGSLVLLMAGFAVMAFTLTPDSTQAEVTAKMVLVGLGLGPSIPLYTMAIQNAvpDQIGVGTAAATFFRQLGMTLGVALLGTVFASTL--------------------------------
     659 UniRef50_D2PLK5        Drug resistance transporter...   187     6e-46  1  23.9%  9:393   30:420     --------LVATVVFVTAIAPLATDMYVPAFPQVAGDLSGTATQVQLTLTTFFVGMALGQLIGGPVSDQRGRRIPLLAALLVMTAASIGCAVAPTIGVMTAARLVQGFAGGWAMVIGRAVIVDLATGNQLVRVLNVVAAVGGIAPIVGPLLGGLILQLSHWRVSFWLVAALGLAMTLAALLAVPESLPRERRHAGGLRNfrIVLANREYVGYLVVAGAAMGALFAYVATSAFVLQSMNGLSPLAYSIDFAVNAVGMTIAALLAARLAGRVSTRKLILTgaALVAGGAMLAGALWLGTPLPLALVCFFVLMTAQGLMIPNGGALASAAVPEHPGTGAAVQGFVQWVAAGTIAPLAGLGGEHTAVPMATLITAGAAVSMVGLLVLAKPEPTVGVP-
     660 UniRef50_C6I0Q5        Drug resistance transporter...   187     6e-46  1  15.9%  2:360   12:427     -SPHYRWWALGVVMLSLFLPVLDTTIVNVALPYMIGSLDTNQDEVRWVITAYSMAFAVSTLASAWLRTVFGIKNLYLGSIVLFVASSFFAGISPNLNLMIVFRVLQAVGGGIMMPLGFTIITEAFPAPERPKAFGFFGIVVVLAPTIGPILGGWLVDNMNWRDVFFINVPFGFLSFFFTMFILKKDRSHTLVPFDYAGFilSIFRDLDFVLIMVANFFRAIGLFGRMFLLPLFVQTFNAFTATDAGLVLLPSSLMAGIAMPVLGAVSAKGskRGLLVAGFLMLAFSQFLYAFLMGVPSMSQIIVAQLVFGLSMGMLNALLSSIPQtvAPRHIGLASSLQSNMLQIGGALGVAVLGNILDH----------------------------------
     661 UniRef50_A0YF58        Permease of the major facil...   187     6e-46  1  15.8%  7:360   36:444     ------WLAMFAVMIAMLATMLTATIVNIAIPQIMGSFGIGQDQAQWLSTANLAASTVGMLTTFWVVQFWGMRKMITVTMTIFMVSCVIGGLSTNFELMVFTRVIQGLATGMVTPLTISIIFQLFPFHKQGLVMGLSSVAAIMGPALGPSVGGVLIDYFNWRYVFFIGVPLSMICLPLAILFLPERDGPKPQQAFDWMGTVSlgWSSDFIVLWSTVSLLAwgLYGSAYLIPLFLQIVQGMKPTDAGLSMMPAGLLMGIASPLFGRLADRLAPRLMIIAGSLLFFLSFYLMIDADADTSFWTFVWWMCIGRVGISCAFPSMSMGAIRSVpeLTGQASGVLNFIRNLGGAYGVNVLSVVLAR----------------------------------
     662 UniRef50_B5JUZ9        Drug resistance transporter...   187     7e-46  1  23.6%  8:371    8:375     -------RLAVILGVLVALGPLAIDTYLPAIPAIAAYYGVPVPLVETSLSTYMIGTGLGQLIGGPLSDQYGRKPVAWMGLTLFAVASVAITFTESVLQLNALRFIQALGGGATVVIAAASVRDHFDGSSAVRVLTSIGLVMLIAPLLAPAIGSALLHIHHWHLIFYVLAGYAVFLMALLYTALPTVKPVNLNrrGVLRGYRAVMGDRRGAGFVIANGLAFACMFSFVTDSAFVYMEHFGVSEATFPIYFGANVFTMITFNRLNVLLIHRYAPLSVLWLGLLlsAALTLFVLVWAGLATLWVSVPLIMLAVGGIALVVPNTLASLMHLFPRNSGSATGLSGATQFFMGGVAGYVISHVHDHSLWPMTSVMAV-----------------------
     663 UniRef50_B0T573        Drug resistance transporter...   187     8e-46  1  22.7%  9:383   21:401     --------FVALIAAMMATNALAIDSMLPAMPQIGDALGvtDNERQWILTAYLLGFGTAQIVYGSLADRFGRKPVLLVGLVIYVVFAAACAFATSFEMLLIARALCGVGAAATRVLSVSIVRDCYSGRQMARVMSLSFIVFLGVPIIAPSVGQAILLVAPWPWVFGILAIFGLAVIVWTWIKLPETLHPEDRVPLAAGPVLAAFknRIAVGYTLAATLVLGGLFGFLNSAQQVFVDVLGAGKL-FTLIFAAIAGGIAVSSLLNSHIVGRLGMRMvvSLFGYIVFAVVHALVALSGHETLWTFSLLQAGMMFCFGLVMSNFGSIAMEPLGHLAGTAASVQGFITTIGGALFGFWIGQLFDGTTVPLTLGFAGFGIAGLVAVLIT-----------
     664 UniRef50_B7KHY2        Drug resistance transporter...   187     8e-46  1  16.9%  2:361   16:430     -SPNDKWWAMLGIGVGVFMLTIDTSIVNIALPTLVKVFKTNFATVQLVVVSYLLVLTALVLGAARLGDMLGKKKLYLIGIIIFTISSLLCGLAPSIWLLIIFRIIQGFGAVFMSGLGPAIITEVFPRSERGRALGIIGAVVSIGIAIGPSIGGLLIGVSGWRTIFLVNVPIGIIATFIVIKFVPFSptSTRQRFDWLGTVVITLTLTCFilSLIAAVIVFIVVGGFVFILPFFLELVLNYTPQQTGLLLAVSPILGGIVAPFSGSLSDRFGQRIISLIGLLLMIVGCLLVSRFNAQLTDLGYILYIAPFGIGFGMFQSPNNSAILGSVSRErgITSGLLSLSRTLGQTTGVPLLGSIFDSL---------------------------------
     665 UniRef50_A8FZA6        Drug resistance transporter...   187     9e-46  1  19.8%  5:393    4:403     ----RAVSFIVITALVFALSPLAIDMYLPALPEMAKHLNATHSQMEMSVAVFLLAFAIAQPLFGLLADRYHKLNLLLTGLVIFTLSTLAIPMVDSATGLYLARIFQAIGGAS-SVVCFAMIQQQYDLQKGARVLTYVMAAVVVAPLLAPMVGGQILKYASWQWIFYTLAGIAIFAFVASLLteKTEQANQSRRAASISDFVQIFKQPLPLAYILVGSFGFAGLFSFVAGSPYVYMNYFSLSPEHYSYLLGLNALGMIIGSLLSVKLLGHISPKVKAVISGTLLGPLSLLFFMLAqeVPLMAIVATVFIFNLLLGLISANAIAAAMSFFPAQGGAISGVFGLSQFALGALFSAAISLSDAQSPVAMLTFMGLACACAAIFSTYIYTKSNADGEQ-
     666 UniRef50_UPI0001905CAE putative multidrug resistan...   187     9e-46  1  23.1%  4:392   34:423     ---SRKQPKLAVLIFLAALSVLPLNMFIPSLPHIADALNSNYAVVNLAIAGYALMSALTHVVAGVLSDRFGRKPVVLVALCVFCGASLICSFAPNVGIFLVFRTLQGVVIA-CYAVSMASIRDTSDEREATSRIAFVSSAWALAPMLGPAIGGTLDTLLGWRANFTAFAVLGLSGVVLVLRGFKETKASDLPATFRLSTYLAPMGSRIFWGYAICMVFSMSTLYIFLSGAPLAAKSFGVGSSIAVGALMGLVPAAFILGSMFAGRFGKKYAPPVLMAVglTLFGLSAGILLFFFDVHHVAAFFLPCAFVGLGNGITMPAANAGVLSLRSELSATALGLANATTVAGGAAIVSISGMFITAADAQWTTIALMSATTFISLVAALIVRSQAAAK--
     667 UniRef50_C5AMF9        Drug resistance transporter...   187     9e-46  1  18.2%  1:362   50:467     MRGARLALLTFALSLATFIEVLDSTVTNVAVPSISGSLGVSNSQGTWVISSYSVAAAIAVPLTGWLARRVGERRLFVTSIVLFTLTSLLCGLAGDLRVLVACRALQGLFSGPMVPLSQTILMRAFPPERRTLALALWAMTVLLAPILGPVAGGWIVDNYSWPWIFLVNLPIGLFSFTVCVTLLKPAREGGHAGPIDVVGIVLlwFDSTLICALAVTalGMMAFSVVGVVFPLWLQTVMGYNAFHSGLAAAPLGILAFVFSILVGLYSSRFDARVLATFGFLVFAGVQWNNAHFTLTMTFTQIITPGLIQGMGLPCFFIPLTAATLSRIPDDkaAASSLSNFLRTLSAAFGTAMSVTLWQNRA--------------------------------
     668 UniRef50_A7HQL1        Drug resistance transporter...   186     1e-45  1  23.5%  3:389    7:399     --RGSRIGFVVILGALIAFAPLSIDMYLPAFPAIAAHFNTTAGAVQMTLAVFFIGLSVGQGVVGPITDRVGRLPPLLIGIGLYVGASIWAALAPDIESLTAARLFQALGGCAGIVVSRAMVRDLFDERGSAQVYSLLMLVMGLAPILAPMIGGFIILHHDWHMIFWVLAAFGLACVPAVIFGLGETLPRERRqrPVLGAYLALFADRPFMGFALANAFISAAMFAYITGSPFVFIELHGLDPSGYAMLFGANAAGLIFASQVNAFLLRRISGRLILKIAMglAAVVALLGFTIFMPGAFYPLAACIFVAVGCLGFVGANATAAAMARADSHIGSASALTGILQFALAAVSGGLVGAFNDGTALPMALIIAGASIAATLARLSARERVPA-----
     669 UniRef50_P39886        Tetracenomycin C resistance...   186     1e-45  1  20.4%  3:360   21:433     --RGRPWPTLLAVAVGVMMVALDSTIVAIANPAIQQDLHASLADVQWITNGYLLALAVSLITAGKLGDRFGHRQTFLVGVAGFAVTSAAIGLSGSVAAIVVFRVLQGLFGALMQPSALGLLRVTFPPGKLNMAIGIWSGVVGASTAAGPIIGGLLVQHVGWEAVFFINVPVGLAALVAGLVILTDARAERAPKSFDVSGIVllMPLAMFRSVPLSAGTVLMVLMAflFFVTFYLQNVHGMSPVESGVHLLPLTGMMIVGAPVSGIVISRFGPGGPLVVGMLLTAASLWGMSTLEADSGMGITSLWFVLLGLGLAPVMVGTTDVIVSNApeLAGVAGGLQQSAMQVGGSLGTAVLGVLMAS----------------------------------
     670 UniRef50_B4UMS7        Drug resistance transporter...   186     1e-45  1  22.8%  4:393    1:394     ---MSRRRLTWILGALAAIGPLSIDTAAVAFPSIARSLGASIPAVQLTLAAYLGGIVAGQLIHGPLSDRLGRRPPLLGGLSLYTAASVAGALAPTLQVLWAARFAQGLGACAVIVVSRAVVRDHCAAREAASVYASRMLVSGVAPVVAPVLGGHLVVAFGWRAVFAVLAAAGLALALLVALALPESLAPAGAprHPLRGAAAALRDGSFVRLSLVGGASEAGLFACISAAPFVFIERFGLSPERFGLVGAANALAVVGGALVNRRLVRRVGVARALRAGTTAATVAYAALAVAVHMGAGAALVAAFMIAGVavGIVLPSATAGAMDLRGERAGSASAVLGLVQSGSGVLASGAVSLLADGTPRPMALVMLACSGVALALSRRGRPRGEADAVP-
     671 UniRef50_C0S5V9        Multidrug resistance protei...   186     1e-45  1  18.6%  3:362   66:426     --QMKLKYIVPAVSIGIFLGAADQTIIVSSYGKIGSDLQA-LNLTSWIATSYFLTLTSFQPLYGRLSDIFGRKSCLLFAYAVFGIGCICCGLARNIEELIAARVFQGIGGGGMTTVVSILMSDIVPLRDRGVWQGIINIIWATGSAVGAPVGGILADYIGWRWAFLLQGPICLLAFISVAFILHLPVQEEAH-------WLQKLRRIDFLGALILVGAVFAFLIGavSWSIPITIATEGVSATGAGIRLLPSILAGVSGSLFGGVVMKMTGKYFWITIMGYCLLTIGVTVTFLWSGvsTAGIIAGMCVASFGNGiiTTTLISLIACATPQDQAVATACSYLFRSLGSVMGLALSSTVVQQSL--------------------------------
     672 UniRef50_Q3A6G5        Major facilitator superfami...   186     1e-45  1  20.4%  7:393   11:397     ------RSIIVMLALLSAFPPLSTDLYLPALPHVVKTLQSNQTLVNLSLSLFLISFALGILVWGPVSEKYGRKPILLIGLTLYTLGSAGCALSGNVTMLIIARVVQGFGGGAAEAVVTAMVKDLYSGRKRESVLAIVMAMVVVAPVVAPVAGAIILKVMSWYAIFWVLTGVG-VLSLCLSLLLDETLETrgSLTHSLARLGVVLKNPGFAVPLILFSLVPLPLLAFIGASAYVYIQGFEMSEQMYSYYFGLNALGSLVGPLLYIKLSRRISSAHIISGCLALLTVSGICI-EATGDSSPVMFALPMLTATVAISMMRPPTANLLLSQQDKDTGSAASLINFMALFMGSVGMFLISFETQSELIPSLGLMQLTVGIVCGSLWLLLRERSFIRQP-
     673 UniRef50_D2PYB1        Drug resistance transporter...   186     1e-45  1  15.6%  1:360   32:448     LTPRQTVQAISGLMMGMFVAILAGTVVSTALPRIIHDLEASQSSYTWVVTLELLAMTATVPLWGKLADLYNNKLLVQLSLGFFVIGSLVAGLAPNIEVLLGSRVLQGLGAGGLTALVQIVMAAIIPPRELGRYSGIFGAIFASATVGGPLLGGFLVDslGWRACFLVGVPFVLAAIVLLQRTLKLPTVRRDVQIDWWGAFLITAGVCTLLVwtVTLSIVASALVGVAMflAQYFQIAQGYSPTKAGLMSLPMILGMMVASTIAGGLITKYGKWKIYLVIGSVLLPIGLALFgiDAHTSKYLLWVFMIVLGVGIGLVMQNLVLAAQNDVPArlGAATSAVSFFRSMGGTIGVSVLGAILAN----------------------------------
     674 UniRef50_A0NYI6        Drug resistance transporter...   186     1e-45  1  24.7%  9:385   39:421     --------FVAIIAMIMALNAMAIDVMLPALPAIGDALnvEENNRQLVLLSYLIGFGGAQLFFGPVTDALGRRGVLVGGLALYSLASIGAIFAMDLDTLLIARVLQGIGCAAARVTVLSVVRDCYTGRRMGKVMSLVMMVFMAVPVVAPSIGQAVLLIAGWHWIFALLLISGVTMMIWSALRMPETLAVENRRptIVSAYMTALTTRVSLGYTVGTAFIFGGLFSFLAMSQQIFVDIFDLGTL-FPIVFAAIAITMAGASFTNAQLVEAIGMRRLSHGAAVvaLGFAVWLLAALGLENFWAFMILATLIMTSFGFLGANFNAMAMEPLGAIAGTASSVIGTISTLGGAILGYIMGQLFDGTTQPLGLAYTIYGLCAIGCILYAER---------
     675 UniRef50_B1ZZC0        Drug resistance transporter...   186     1e-45  1  17.4%  1:362   11:426     VTAETRKYLPWLVAVALFMENLDATIVNTAVPTMALNLEVAPLSLKAVLTSYTLSLAVFIPISGWLADRFGTCRIFRLAVVLFLLGSLACGLAPNVPALVGARILQGLGGAMMTPVGRLALVRAFPRSEMLRTMNYVVIPALLGPLLGPFVGGLIVHWMSWRVIFFLNIPLALGGLWMIKRYMPDFRDEQVAPLDRTGFVLflFKVRTFRLSVAGGFATRLGVGGMPFLLPLLYQIGLGYAPWQAGLLVMPQALAAMGMKLISRPILGRFGHRTILLTNTVLLGLTIMIFTQVGPGTPWWAIIALSFLQGFFSSLQFTSMNSLVYADVHDRKAsaSSIASTAQQLSLSFGVAFGSLLAAWFL--------------------------------
     676 UniRef50_Q5GSS7        Permease of the major facil...   185     2e-45  1  19.7% 21:385   15:382     --------------------FIEIDISVPGFPDIARYFNILEGTIQLTIAYNFLGLCIGGLFFGPLSECYGRRKIMIIGNTLLLIGAIGCVFAPSVFWLLTSRFIQGIGVS-TSVVVFTIIADSYQGNKAIKFIGIMNSVLTVVMAIAPVLGSFINGIIGWRGNYASVAIICLISWILLLLALPETKKDRdnLKKMMKDYRKLLSSSKFMALSLVPSFFSAAYMSFITCGPFLYMKTFGLSSTIYALHQGAIVGCFSLVSLFTGKILQKLGAIRCVISGTGMIIIGSLSLVIFSLTMPHllVTLSMIIFVVGCAICQPVIFNASLNIFPDIKGTASSAVSFIRSFIIAIFIGLTSYVYNGQAISVSLLVLSAVVLELIFTIYLLL---------
     677 UniRef50_C6D3D1        Drug resistance transporter...   185     2e-45  1  14.5%  5:363   10:422     ----RFWPIMIAIFFGAFLSILGISTINVALTIFMQDFHSDLSTVQWTLTGFMLSLGTIAPLSGYLGEKFGYKNVYLYAMIGFVIFSLLCGFSWNAGSLIAFRIIQGIFTGLVMPATMTIIFQIIPKEKQPFAVSIWGLSGMLAPAFGPTLSGWLIQQFDWRWIFFMNVPIGIVAILFIIAMIPDVRIGTAKVLDKLGLtrQWGWDSAKVLGLFGLGAVMLVLFIwtLLVPLFLQNVQQITPMDTGLILLPSSLVMALAMPIAGKLYPRVGAKWMTIGGLVLIIFGSYEMTHLHTDSSHFYVIFWMAVRNLGVSFAAAATSTAGmeIPPQMVGHASSVTNWVRNVGGSFAIALFTSLLASHTI-------------------------------
     678 UniRef50_C6CS78        Drug resistance transporter...   185     2e-45  1  16.4%  1:390    2:460     VSTASRVRLLVVTCIALFMAMLDNLVIGVALPSIQEEFHASMSDLQWFLNAYTLAFAVLLIPFSAIGDRFGRKKIFLLGIVLFTLGSLASALSTSSIELSLSRALQGIGSAAIIPLSLTLVNAAFPPEKRAAAIGLWSGISGLGLSIGPLVGGIIINGAPWEMVFWINVPVGIIAVILGALWLTESKGERKPLDLPGIVLLGvfKSRTYSAYLSAGFWMNAGIFGAIFLLTLFLQQAQGYSALGAGVREMVWTVCTMICAPLAGLLVGKYGSKKILLFGLFLQTAAMIYFALmgAIFPFGYIAPAMVAAGAGMGFSFTPLSHGILTSVPEhaGEASGLSNASRELGGVFGVAISGLIFESGgvPALFVLAAMLAIGFLSVTFLVRRGKPA----
     679 UniRef50_UPI0001B54FA8 EmrB/QacA family drug resis...   185     2e-45  1  18.4%  2:375    4:437     -RPVNPWAALSALCIGFFMILLDTTIVSIAVPAMLQHLGAGLNSVVWVISVYLLTYAVPMLFTSRLGDRFGPKRVFVAGLVVFTASSLWCGLSGNVEMLIAARAVQGLGAALMTPQTLAFISHLFPPAKRGAAMGAWGGVAGLATITGPLLGGVLVQHLGWEWIFYVNVPIGVIAIALTLWLVPDWQPKHSHSFDLLGILLSAAGLFCVVfvFGGITVFEIIGAGVVLLIAFVLWQRRnlTATTVGFTMTGMFLPLivIAPFVGRASDKINGKYLVMGGLALLAAGVGIIAlaRPDTSPWALIPALLVCGLGVGCIFSPMSNLTMASvpRLTGTASGIFNTARQVGGVLGSAAIGVLLQARISASITSEAATAAA-------------------
     680 UniRef50_C5V8U8        Permease, major facilitator...   185     2e-45  1  21.1% 21:385   24:387     --------------------PFSIDMYLPGLPQLGRDLATTN--AQLTLSGFMIGMATGQLIIGVLSDTFGRKRFIVGGAALALITSLLCAIAPNIGVLIAARFLQGLGSGACVVLARSIIPDITSGVAAAKAFSWMGIISGIAPAAAPVLGSLLVSSLGWRGIFYVLAGIAAAQLLVALFVIPETRPPANRTPLSFGSFTAVIKEPVFVRYALVVGFGFASMFAYISASSFVMQEIMGLSPQIFALVFGTNALGLMVGGALNTRLLDRFPAAAILKIALIImvAATIVLVCALTGLPRIPFFLALFFAVMPLSLVMGNATALAVAAVRTRAGSASSVMGFGQFLLAGLVSPLVGMVGGSQAVGMGVCMVGAAVVAVMMFVLARR---------
     681 UniRef50_C4V361        Major facilitator transport...   185     2e-45  1  17.9%  8:365   28:393     -------YILPFILVGSFLSIFDQFVINVAAPAIISSLHPSAAEFEGIMSGYALVYGAGLMVGGRLGDRFGRRRIYRLGLFLFAVTSLLCGAAQTAPQLVVARLLQGLSGAVMVPQVLALIRVSYEDNARVQALSAFGVSIGLGQIMGQILGGWIPAwlGWRMIFLANMPICLIAGIGCRSLPTGQNAAHGAHQKQLGSPLRLFRYRGYTVGIFLNVCLYAAIVPFFVVLGLYLQNICDLTPQTAGLVFMAVGTGFVLASSAGPALMRKFAPPRVLICGTICTSAGIFAVLltGLSTAIPFVLLSLFLLGIGNGTVIPIATGIVLRYLpaDAGVGGAILTTGQQLAGALGIVLTGEFLMGDGASL-----------------------------
     682 UniRef50_Q1RI77        Uncharacterized transporter...   185     2e-45  1  19.2%  7:392    6:404     ------KIPAWMLLCLFTLSPITETIYTSGLPSITEYFNTDGSTTQITSSLYYLGFALGILTLGRLSDIYGRRPVVLFGLCIYAISSIISIFAPNIETLMLARFVQAFGVSVGSVIGQAMARDSYQGSELSYVYASLSPWLLFIPSLGSSIGGYIIEYSSWHYTFVFFSLTGTVLLTLYCKILPETNPYisQTSKYFEVLKVVIRDKSLWLYAFIIGAFNGIYYGFYIEAPFIFIDKMKVAPSFYGKLAFLLSFAGIFGGFLGGYLIKkiHDQKVMILGLVFSVIGCSLLAivGQNIAVIMMFAPMMLHMVGHNLLIPMTLRYALEDYAKVTGTAGSVFGAIYYVLIAAVTFLVSKLHSDTIGNFALLFLVLSVSSAAAFYYILILYKKKLT--
     683 UniRef50_A6W7T8        Drug resistance transporter...   185     2e-45  1  25.7% 11:391    1:387     ----------MTIALLCAIGPFGIDTYLPTFPDLARDLSTSAARVQLTLTTFMLGMAVGQLVLGPLSDRLGRRRLLLAGTAVTFLAGVVCALSPSIGVLVAARLVQGLAGAAGMVIGRAVIADLATGRTAARAFSTLGVIGGVAPVLAPVLGGLIAGHGGWRGIFGVTALLAAAMLVAAWFVLPETLPRERRHAGGLrtARAVLSRRRYVGYVGCLVLVFATVFAYVSASPFVLQNVVGLSPRTYSVVFATNALGIVAAGAVSNRLLRRRTPAQVLTAGVALQVVCAAGLFTTVVALDAWAPAVLVLLWffSIGLVFGNATALAADEVRFASGTGSALQGALQFTVGALVSSLVGLAGEHSAVPMVAVMLGCSGAAALVLVLVARPRRTHP---
     684 UniRef50_C7LZ16        Drug resistance transporter...   185     2e-45  1  17.3% 19:360   32:428     ------------------VAALDQTIVATALPTIANDLH-GFSHLSWVVTAYLIASTASTPLWGKLGDLYGRKRFFQLAILIFLVGSALSGLSQNMLELILFRGLQGLGGGGLIVGAQAIIGDVVSPRDRGKYQGLFGAIFGVASVVGPLLGGFFVDSLSWRWVFYINLPIGIIAIAVISSALPQLSTRVQHRVDYLGTLLVALAATGYILVTTLGGlgFVVGFAMFGAITffLQIVRGASPTVSGIQLLPLMAGLLVMSIGAGLLISRFGRYKvpIVGTALMTVGLWLLSRLSVHTSYGVIAFDMIVLGVGIGGVMQVLVIAVQNAVgeDLGVATSGATFFRSIGASFGVAIFGSIFTN----------------------------------
     685 UniRef50_B5ZHM1        Drug resistance transporter...   185     2e-45  1  21.9%  2:390   12:455     -SDLRPGLVLATCCLSLLLVMMDVTIVNVALPSIRAALGGRFSTLQWVVDAYTLVVATLLVLAGSTADRIGRRRVFVTGIAIFCLGSALCGLAPSARALVMARAFQGLGGAMLNPVALSIIANVftPVARARAIGMWGGMSGLALALGPLAGGVLTTLAGWRAVFWVNLPIGLVAMVLSLRFIPESRAARVRPIDVPAQvlRFFRALPFTGAILIAICAFAIFSSFLFLNTLYLQDVRGLSALRAGLYTLPFAMGVMACAPLSGRIVGAHGARLPLLLSALGLGGGAILLTGLTATTPPAVLLAAYGLCGCGFGLCNAPITNAAVSGMPrqAGLAAALASTSRQIGALLGIAASGAMTASVMSAPVQPAPLSSAGAVVAYMALLPAASHR----
     686 UniRef50_C2BTS3        MFS family major facilitato...   185     2e-45  1  20.3%  1:364   52:469     LTPAQRQRVLLVCSMTVVCTQLYLNAMNVTLPAIRADLHASTGELQWSLNIYALALAAMLMVTGALGDRFGRRRTMIVGMATFTVGTVLAAVAWMPLVLIVGRGLQGLGACMLPVISLAVINEVfdPVERAKAIGFWNALLGVGLAAGPVLAGALVTWVDWRAVFWAPLPLLALTLVGIIREVPESRDETGRRLDIPGQILTafRSVPFVGSLAVMEFVFITHGGFMFVFALYLQLDLGFTPMHAGLMMLPLALANTIAAVAAGRIVATGHYRAAFLVAGIGTLLLGVCLLPLNSTGPVALLFVATTLAGVVLAFTNMPVTNRVLAAMPeqAGVASATTSTARQIGMSLGIAGFGAFMNLGVAR------------------------------
     687 UniRef50_D1CFG2        Drug resistance transporter...   185     2e-45  1  16.7%  1:360    6:419     LARNSRKLIVVGLMLATFLSAMDSSVVSTAMPTITGILG-GFSLYSWVFSIYLLTSTVTVPIYGKLADLYGRKRVLLFGILVFLLGSGLCGLAQSMLQLVIFRGIQGIGAGAILPITMTIFGDIFSIEERARVQGLTGSVWGISAIVGPALGGLIVDNTSWRWVFLINLPAGLLSLLVLIFFFHEKTQVHQHSVDYVGAIALmiSVFLFAVLSIIAFlaGGVMIGATTYVPLFAQGSLGTSATVAGAVLATMSIGWPIASSLSGRLILRVGYRITAVVGGVFLVLGSGLLFYFSHLSSPLLIAVASFVIGAGMGFSTTAFIVGIQNAVdsRRGVATSSNLFLRSMGASIWVALLGAIANN----------------------------------
     688 UniRef50_A9AR49        2-module integral membrane ...   185     2e-45  1  24.1%  5:385   13:397     ----SPRFLLFLICLFASAGQLAIDIYVPALPDMARSFATTPQAIQSSVSGYMAAYALGQLIFGPIADAYGRKRVLAFGLVIYTIGCLLSLGAPNLETFVLARCLQGFGIATTNLLAKAIITDSFSGQALMHAFTYMSIAWGLAPIIAPVIGAHLQTWFGWRACLVFLLVYSLVMWALLWRY-RETLPKPVhpRTLIANAGKVLASPVFQSCFLAQGLCYSILLVFNIVGPFMVQNTLHQPPTFFGYLALGIGLMYFLGGLSngRGLPSAEQRLRIGARVMACAAVAMLVLALTVGLRVWTLATPVLVMGFCAGAMYPTLMAKGNSLFPHIAGLTSAILGCALLLVSSAMMGLAGFVSVQVLTPLALFFVALSFVVVWMVTKLLR---------
     689 UniRef50_D2AUZ4        EmrB/QacA family drug resis...   185     2e-45  1  18.1%  2:360   10:432     -RRREVMVVLPGLMLAMVLAMLDNMIVGTAMPRIVGELG-GLTHLSWVVTAYVLGTTVSTPIWGKIGDLYGRKNIFLWSIVIFMIGSVLCGMAGsmAQLIAFRALQGLGAGGLMVNAMAIIGDLVPPRERGQYQGIMAGVMSLAMIAGPLVGGFITDHLDWRWAFYVNLPVGFVALALLAAKLKLPKYRTEHRIDWLGAILLswGSPQILGLAavGFLLGFAMFGAINFLPLFQQTVQGASATNSGLLLLPMMGSAMVISLFVGQAITKTGKYKlpVLGGVIMAVAMWLLSLMDVNTPSWQTGVFIAVLGLGMGFLMQTTMLIAQNSVEqdLGVSSSTSTFFRSIGGSFGVSLFGAVFNN----------------------------------
     690 UniRef50_A4VH19        Major facilitator family tr...   185     3e-45  1  17.6%  3:393   92:481     --TPRFTRTALALFAGGFATFALLYCVQPMMPMLSQAFGINAAQSSLILSLSTLTLAVGLLITGPISDAIGRKQVLVASLLAAAVFTVGSALAPSWHGVLLMRALVGLALSGVAAVAMTYLSEEIHPHHLGLAMGLYIGGNAIGGMSGRLLSGVLVDYLSWHSVLGLMGGLALLAALLLWRFLPEsrPRPLRPQGLLQGYRLHFRDAGLPWLFLQGFLLMGSFVTLYNYIGYRLiePFHLSQTMIGLLAVLY-LSGIYSSAQVGALADRFGRRRVFWLVIALMLAGV----GLTLFDRLPLVLLGMLLFTFGFFGAHSVASSWIGRRARQARGQASSLYLFSYYLGSSIAGTLGGVFWHAAGWDGVGLFIASLLLIAFAVALHLARLRPLPEP-
     691 UniRef50_A8LYI3        Drug resistance transporter...   185     3e-45  1  18.8%  1:393    8:482     LRTPAGVGTLLAAVLASGMVFLDATVVNVALPRLGDDLDATVSDLQWTVNGYLLMLAAFVLLGGALGDRFGRRRVFLLGVVWFTVASVLCGLAQDTGQLIAARLLQGAGAALLTPGSLSVLQASFHPDDRGRAIGAWAGFSGVSTALGPFVGGWLIDELSWRWIFFLNVplGAVALAGVTFALIDAPARGVASRSVLLAIAalFSSRLFSVLNIFTVVIYAALGGFTFFVAVYLQNVAGWSALGTGLALLPVTVLLLVGSPLAGDLATRIGPRLPLVVGPVVSAAGLILLRQVGADASYwdVLPGVVLFGVGLTLVVAPLTASVLAAVADraGVASGFNNAASRAGGLLAVAALPLLVgrGALAWCAGLLLVGAVLAAVFVHRPRRVPPPSQP-
     692 UniRef50_A1T6H1        Major facilitator superfami...   185     3e-45  1  15.6% 10:393   39:423     ---------VWVLVAANFVVALGYGVVAPVLPQYARHFGVSISAATFVITAFAVMRLVGAPPAGMLVQRLGERRVYISGLIIVALSTAACAFAETYWQLLLFRSLGGIGSAMFTVSSLGLMIRISPPDARGRVAGLFSSGFMVGSVGGPILG-ALTAGFGLSAPFLIYGAALLVAATVVFVSLRHSTVVGQQDEDppVPFRTVFRHRAYRAALFSNFATGWASFGliALVPLFIVEVLGQSPGAAGLALTAFAVGNISVVIPSGHLSDRLGRRKLMIFGLTLAAASTALVGFTT---SLPVFLVAAYIAGAATGIFVSPQQAAVADVVGNKsgTAVATFQMMADFGSIGGSLLVGLIAQYTSFGWAFLISGVILAVAAVGWIFAPETRPRAST-
     693 UniRef50_O50465        Uncharacterized MFS-type tr...   185     3e-45  1  19.7%  4:364   15:429     ---RNPWPALWAMMVGFFMIMLDSTVVAIANPTIMAQLRIGYATVVWVTSAYLLAYAVPMLVAGRLGDRFGPKNLYLIGLGVFTVASLGCGLSSGAGMLIAARVVQGVGAGLLTPQTLSTITRIFPAHRRGVALGAWGTVASVASLVGPLAGGALVDSMGWEWIFFVNVPVGVIGLILAAYLIPA-LPHHPHRFDWFGVGLSGAgwQPWIWAVIVGGIGFMSLfgMMLPVTFYAQAVCGLSPTHTAVLFAPTAIVGGVLAPFVGMIIDRSHPLCVLGFGFSVLAIAMTWLLcmAPGTPIWRLVLPFIALGVAGAFVWSPLTVTAtnLRPHLAGASSGVFNAVRQLGAVLGSASMAAFMTSRIAA------------------------------
     694 UniRef50_D1BKW4        Drug resistance transporter...   185     3e-45  1  21.0%  4:360   18:433     ---RSPWSVLPPLLLGFFMIMVDTTIVNIAVPTLVETFDVGLSAVGWVTSAYLLSYAVLLLVTGRLGDRFGPKNIFVAGLVVFTLASLWCGLSGSIGMLITARAVQGVGAALMTPQTMAIITRVFPPQKRGAAMGVWGSVAGIATITGPVLGGLFVETLGWEWIFFVNVPVGVVALFLSFRSLPALATNKKseTFDWGQVWGPVSIPLIIGFGAVVIAAFlgMAVSFAMIGIFfqTTLGLSPLHAALVSLPSSVVSGVVAPFAGRLSDRVPAKWVMVTGFASLAVATVWllVIAPGISPWTIVVPMLFFGLGTGCVFSPMASLATAGLDQsaGAGAGAFNTTRQVGGVIGSAAIIAMLQT----------------------------------
     695 UniRef50_B4F2U2        MFS-family transporter n=4 ...   185     3e-45  1  20.5% 10:390    5:389     ---------VIFSFFLVLIYPLGVDLYLTGLTAIASDLNASEVTLHHAFSIYLMGMVSSMLIAGWCSDNLGRKPVILFGTLIFFLASLSAGLSITEKQFLISRFFQGSGSGFCYVVTFAILRDTLTEQQRAKVLSMINGITCIIPVLAPVLGFIILLYCEWSMMFYLMGAYSLLVFIFCFLGIKETYHKKEIKisVIKPTTESFLTHYFLSRLLISCLGMAVILTYVNISPIVVMQQMNYSTGEYSILMTSLAMISMTISFLMPKILMKYRYKHILSVGLICFGIGIIFLF-IGKKSDMRWFFITFALCGSGFALLFGIIMSQALSPFSQRAGVASSVLGISQLSFSSLYIWVMGWIEVSSINMLVVILFISCIVGTLFLCFPRFTEQKK----
     696 UniRef50_D1AA13        Drug resistance transporter...   185     3e-45  1  23.9% 19:390   27:402     ------------------VAPFATDMYLPAFTDMADDLGAGASSVQLTLTAFLIGLAVGQLTIGPLSDRFGRRVPLLIATCAATAAAVVCALSPNVWVLVAARFVQGFAGAAGIVIGRAVAADRTGGQAAAKVFSLLTSISGIAPVVAPLAGGLLVPA-GWRMEFWALTGISALMLLGALLVVPESLPPERRHRGGlrTMRHLLADRGYLGYILTFGLGFTGLMGYISASPFVIKNVLGLSTSAYSADFAVNALGMVTAGLINARLIGRFTPQGLLGFggAVLTGSAVLLAMLAAGAPAAAVLPVLFLTVSCVAFVMGNSAALALGRARHASGTGAAMMGALQFACGALVSPLVGLGGEETGVPMGIALVTAAVLGIGAHLLARTVPASR----
     697 UniRef50_B6R2L9        Drug resistance transporter...   185     3e-45  1  19.4%  9:385   17:401     --------FVALMATLTSLTALSIDAVLPAFTVIGEDLQlnSNNVQFIISALFLGLSVGQFFFGPVSDRFGRKPAVYAGSVVFALGAVLAATATSLPMMLFGRLLQGIGASAHRTVVMAIIRDKYVGAEMARILSFVTAVFIIVPTLAPLIGQGILFAAGWRAIFVIMLIMASVGCIWLAVRQPETLKPENRrkVLWQGLEEVVSHKATLLYTAASGFVFGTMMTYLSTAQPMFADIYDVHET-FPLYFSGIAVVFGMASIVNGRIVRRIGLQNMCRAALGIQIVASLalLFVDSTPALWLFMTYLSFAFFCQPMLNGNLNAMSMEPLGHIAGLAATLIGASTTFIALILSVLVGRFYDQTLLPLSFAFCVFGGIALVLVVLGAR---------
     698 UniRef50_A9IAC6        Putative drug resistance tr...   185     3e-45  1  24.0% 26:383   36:397     -------------------------LYLPGLPSMAAALHASPAEAQWTLSSFLVGFGIGQLFWGPVGDSFGRRIPLLVAISVYIVASLGCILSSSIHEVIAWRLLQAFGACAGPVLARAVVRDVY-GHHRSADILSLLLLAASFAPLLLPLAGGGLLWFGWRAIFWGQVAFGAVAMVGMLltLPQARRVSLKLSQVVLGYAQMLRTRRVLGATLVSAFFYGGIYAFAAGSPFSYVTHYGVPPSMYGFLYGLNVVGMMAMFAVNRRLVVRLGPERLLLWGTSiaAGVVQAVAGWTGYGGLFGLVVPNVIFFSMVGFVTGNSIAVAMSAFPHRAGSASALGGAMQFGGGASASAVLGLLADGTPWPMTLVMAVCGFGAFGAAIML-----------
     699 UniRef50_A8M3B7        Drug resistance transporter...   185     3e-45  1  16.2%  3:360   10:431     --RPKIRIVLFGLMIAMMLAMLDNMIVSTALPRIVGEFG-GLDHFTWVVTAYVLGTTVSTPIWGKLGDLFGRKSIFLTSVVIFLVGSALCGMAGsmAELIAFRAVQGLGAGGLLVGVLAIIGDLVPPRERGRYQGMIAGIMAIALVAGPLVGGFITDHLSWRWAFYVNLPLGGVALVLLVATLRLPRYRTEHRIDWLGAALlaWRSPQIVGLvaIGFLLGFAMFGAMSFLPLYQQTVQGASATESGLLLLPLMFGMLVVSLAVGRTITRTGRYRvpIVGGVVMSAGMALLTYLDAQTGRTESSLYLFVLGVGMGFLMQTTMLIAQNSVDQrlGAASGAATFFRSIGGSFGISLFGAVFAS----------------------------------
     700 UniRef50_D0W3E0        Drug resistance transporter...   185     3e-45  1  18.1%  4:390    1:395     ---MNEKLMAVLMAMLVALMPFSIDAYLPAIPEMAQSLGADVHRIEQSLSVFMFGTAFGQVVGGSVSDIKGRKPVALTGLAVYCLAVAAIAFASNAEQLLNLRVVQAFGAGMTVVIVGAMVRDYYSGRKAAQMFALIGIILMIVPLVAPMVGAVLQGLGGWQAIFVFLAAYSLVLFGLVQYFLPKPAVGGKIGRDVfgRFKRVLKTRAAMGYLFFQAFSFGSMFAFLTESSFVYQQLYRVTPHQYAWAFALNIITMMFFNRITAWRLKTGAHPQSILLWGIVVQFAalAAVLLFGLPPFWLLVACVMFSVGTQGLVGANTQACFMSYFKEEGGSANAVLGVFQSLIGAGVGMAATFLHDGSATVMAATMTASTSCGIALLWLCSHRAWKE----
     701 UniRef50_Q7MK22        Permease n=41 Tax=Gammaprot...   185     4e-45  1  41.4%  9:387   24:405     --------LTFLIAILTAVGQMTQTMYVPSIGHMASEFLVSPAALQAVMACYLIPYGLSQFVYGPLSDRLGRKPIIIAGLLIYIAGTMLSLFAHEYTWFLVGSFVQGLGIGCGGAMSRTLTRDCFEGAELHRANSLISMCVIFSPLMAPVLGGLLTETFGWRSSYLFLALFAIAVIITMMTSMIETLPKEKRKhsVARSYHYVLSNKRFQGYLLCLVATFAGVAVFEAAAGVLLGGVLGLPATIVSILFVLPIPGYLIGAGLSSYIAQRRSQKRALNVGLvlIGAAVVLIPGLFGQTTALTLVGGATIYFLGAGILFPAATTGALAPFPYHAGTGGAILGGMQNLGAGIATLIASLFPAQDQLPLGCLMLAMSILAMLGLRLVYRKP-------
     702 UniRef50_A8TT91        Drug resistance transporter...   185     4e-45  1  24.2%  7:390   12:401     ------RSLIVLLGSLVMVGPLAVDMYLPSLPDIAVGLSAHPAEVQQTITVFLLGFAVGMLVYGPISDRYGRRPIIAAGLALFMLASILCAVADGIGMLTLGRVLQAIGGGAASALARAVAKDMFSTEGAARVLSLMAMVMAVAPLAAPTVGGQILLVADWRAIFYVLAAFGAAGLFATVTLLPESLPPSARvlGAFAAYGRILADRRALADLSSGSFNSAAMFAYITGTPFVYIEYYSVPAQWYGALFGINVVALVIASFLNARYVGRFGVLPLTRLSIAIGAVggLLFAGLTGIGGLWGVALPLLLVIGVQAPVGANCTARLMGLFPASAGAASALFGAIRFGAGAVASALVGLLHDATPLAMCAVVAACCFLALVCRFGFDRLEAPA----
     703 UniRef50_D0LCA9        Drug resistance transporter...   184     4e-45  1  23.9% 21:392   23:396     --------------------PIATDLYLPSFLEVKDALHTDATQVQLTLTAFLVGVAVGQVVWGPVSDRFGRRSPLLVGSVAAVLAGIVVVAAPTIEVLIAARFVQAFAAAAGMVIARAIIADLLRGFAGARSMTLMMTIQSLAPVIAPIIGGVLAGHVSWRGVLGVILGATVLQLVFAVTSVPDTLPVERRTRRvfGDLLGRFGRPAFLAYVLTQAFAFGALMAYVSSSSFVYQRVLGASTVIYGLAFAVNALGMTAAGLVAARLSRrvHPATTIGVALPVLVVASAGVLVAAVSSTKILLVVPLFIATTSVGFVMGNSAALAMEHTRDAAGAGSAVLGGLMFLIGGALSPLGGLAGDDTAVPMGIVMCSSAVLALACFVVARRSVARNPE--
     704 UniRef50_B2GJL0        Drug resistance efflux prot...   184     4e-45  1  18.2%  2:358   17:430     -KPPHLGLLFASLMVVMLLASLGQTILSTALPTIVGDLG-GVDHMSWVITGFILASTVMMPVYGRISDLFGRKPVLIAAIVLFIAGSALGAAAGTMSSLITARVVQGLGGGGLMILAQTSIADVVPARERGKYMGVMGAVFAVSSVAGPLLGGWIMEGPGWRWAFSFNIPLGILAIIAVAVFLKLPRRPREERERiwGGTQYDWNSPQILLLCATTLavGVAMFGAIGYMPTYIQMVKGVDATQAGLLMTPMMASLLITSIVSGQIVSRTGRYKlpLVGMVIMGIGLWLLSTLEVSDSTVRMCVFLAVFGAGIGLSMQILVLIVQNSVPNRigTATASSNFFRQVGATVGSAVVGSLF------------------------------------
     705 UniRef50_C0ZEL8        Conserved hypothetical memb...   184     4e-45  1  19.3%  4:381    1:379     ---MNPKKVLYLLGITLMLGMFAQNLFMPILPAMQKEFQTSAAMINWTVSIFTVMLAIMQIIYGPFIDRFGRKRVMIPALILFTIASIGCYLVDSIYGLLFFRALQGAGFAAIPIVAATIIGDIFTGVQRASAMGTYQMLLALSPALGPLLGGWIGGIGGHSAVFLFLAICAVFLVGINAIWLPETKKAQATSSGGfgSFRNILLHPVGASVILIGFSQMYAYYCFLLFLPVQLTNHYAVSVEIIGLVFLLVSVVFIISSKLSAVLQNRWGARKTLLVTTGSNALAMFLFMTA-ADVSFLLLVLTSTLFALTLGVGMPAHTILLSEEFEAERATSIGVYNFIRYTGMAAGPVVGAMLLEWGGVWLDFGMAGILIALATLFA-------------
     706 UniRef50_Q63BE3        Multidrug resistance protei...   184     4e-45  1  16.4%  7:391    6:391     ------KSMIRILAIVAFFVGLDSLLVAPLLPVITETISIPDGSGGLLITIYALCYGITAPVFGMMSDRVGRKRMIIIGFIIFSISTFCTGLAKNFEILLLFRGLTGLSGAMIMPSIFALVGDKVTYESRGKAMGTIMGAMIGSTVIGVPIGAFLSEIGNWQWTFYSIGLLTLFLTLLINHILRNEKERDDVHVSLtaPLKMTVVNISVLFALLATFLWTIGLHGMFSYIGVYYENNFGISVGKIGIVIFLAGVGSVAGNILGGKLADKIGKKNVIVIASIVSSISVMLFSLSTG--NLVIAIIVHIIWSLFIGFGQASLTALISELKPAVRGTVMALNSSAMYIGMTIASGVASLAISN-GFPFSSLGTICAIASLLVLPIIFVLVKEKA---
     707 UniRef50_B8FIL7        Drug resistance transporter...   184     4e-45  1  17.5%  6:360   15:424     -----KWFVFGIVGVGIFMSTLDGSIVNIALPSILKSYGVSLSTIRWVPLVYLLTISCLLLSFGRFSDMIGRRRVYTRGLFVFSLGSLLCGLAGSAGVLITARSLQGMGAAMIMSCTPALIADNFPPEERGMAMGMIGAVVASGLTVGPALGGLILEHFSWHWIFFINLPVGLGAIIAANRVLKESQASGPRESFDWIGALLllFRIRLFACALCAAVTLFilFCLIFLMPFYLKYPGGFSDAGAGGMLVVPFLFMLVGAPLFGAMSDRLGSRLLCTLGMLMLSASFFSFMFMEPTTDIFPIFWRLALAGFGTSLFTSPNNAAAITAVpnRRGIASALIATARNMGMVMGIAMASTVFTA----------------------------------
     708 UniRef50_A3JVE8        Drug resistance transporter...   184     4e-45  1  24.7% 10:329   46:367     ---------LITLVLTAGLAALSLAIFVPSLPKMAEHFGTDYAVMQLSIAGYFLVTGTLQLIIGPLSDRYGRRPVLLWGILIFVIATIGAIYAPNVETFLAFRMAQG-GIATGMVLSRAVVRDLVPGPSAASMIAYVTMGMAIFPMIGPIVGGYLGETFGWQTTFWFLATFGAVMLGLVFFDLGESNSNRSESFsqFAECPELFGARRYWGFTLTSMFCSGTFFSYLGGAPQVANQVYALSETQTGAYLGLISLGYFFGNYYSGRNAERLGIFKMMIIGCWFagIGISIILVALGAASPLAFFGCVVAVGFGNGLALPSATVGLMSVRP-----------------------------------------------------------------
     709 UniRef50_UPI0001B4B8B8 integral membrane transport...   184     4e-45  1  19.7%  6:361   26:436     -----RWPILAVLCLSLLIVGLDVTVLNVALPTLVSELGATTSELQWLVDIYSLMAAGLMLVAGSVADRFGRKPVFLIGLVLFSGASAVAAFSDSTTSLMAARAVMGVGEALIMPATLSIIGSVfdPAERMKAIGLWSAMIGVGLAMGPLVGGWLLGEFWWGSVFLINVPIGIVALAVALRVVPNSRAAIARRLDLPGAALSVLGVGTLLWavLIGFAVSAVLLAAffVLVQYLQFVLGYDAGETGMRIAPTALVILVAAPLASFLGQHVGTRWLAAAGLTFATVSLLLLATTGNGDGYGRVLAAMLFLGFGAGFIIGPTSDAIVGSLPedLGVGSATNSAAVQLGSALGVAVLGSLLAGT---------------------------------
     710 UniRef50_D1XTP8        Major facilitator superfami...   184     4e-45  1  17.0%  4:391   16:477     ---RWRWLILVVMLVAEIMDLLDASIVNVAGPALEESLGAGPVGLQWVIGGYALTLGAGLVLGGRLGDRYGRRRMFLLGLSAFTASSLLCALAPDIGSLIAFRLVQGTAGAMLLPQGLGLLRENFSGPELTKVFGIFGPVLGLGGIIGPVLGGGLIqgLGWRSVFLVNLPIGIAALAVAARFVPKKSGDRTVRVDMTGAALVAVSCALlwLSMAASALGFAGfvGTQLVLTLYLQIGRQFTAGEAGLGNLPLALGTAIGGAVSGalADRIGRKVLQIGPLVQLAGAVLLWflATASFSVRDIAPGVTVAGIGAGMVIAALFSFVLAAVDDdiGSASGVLSAVQSVGGSIGVAVFGSVFFagGFHRALVVQACLLVAFLAITLLLPKRGRPE---
     711 UniRef50_D1YY72        MFS transporter n=1 Tax=Met...   184     4e-45  1  15.9%  4:375   16:442     ---KNRYIILAIVLSGVFMGVLDTNVVNVALPTITQAFGVELSQSQWVVTAYLVVNTALLLIFGRLSEYTGKVRLFFAGIGIFTISSLACGLSTDLNQLILFRIVQGLGASIVFSINTAILVQAFPRKERGRTLGMIGTIVAIGSIAGPILGGFITGTVGWQYIFFINVPVGIVLLAAASKYLKLTEKsrITGMDWTGAVALMLTMVSLMLMllSTLINFTAFSMFILCIPFLLQYVWGYSPQQVGTMLLAVPLLTGIVAPLSGYTYDKLQSTYHSSFGMLVMALALFLLGYVVNLSSPVLLLICLGLFGLGTGLFTSPNNTEIMSapPQKSSTASSVLATVRNFGNSIGVSLASILLYILLEAAGFTGVVSASL-------------------
     712 UniRef50_C3PFC8        Permease of the major facil...   184     4e-45  1  17.6%  8:360   23:431     -------LVFSALVLTMLMSSLGQMIFASALPTIVGELG-GVDHMSWVISAFLVTMTIAMPISGKLGDMMGRKWLYIGGIATFVIGSTVGGFANSMNLLIIGRAIQGFGAGFMMISSQSIIAEVTTARERGKFMGIMGGVIGLSSVLGPVLGGWFTDGPGWRWGLWMNIPLGLLAMTVCVLVLHLRVGDTDLRKFDALGATFiwSDPVILTLAVigMVLGLAMFGVLGYMPTYLQMVHTLTPTKAGLMMIPMMLGMIGTSTTVGFVIARTGhkRYPIIGLAITAGALFWMSKLTVDTSLTQLGAEFLVFGIGLGFVMQVLVLIVQNSFpaLVGTATAANNFFRQIGSAMGASLVGSLFIH----------------------------------
     713 UniRef50_B4AVF7        Drug resistance transporter...   184     5e-45  1  14.0%  4:359   30:443     ---PRKWAIAVTASLGAILEVIDTSIINVALTDIQTTLGATITEIAWVATGYAIANVILIPLSAWLGDFFGKKTYFVFSMVGFTFASVLCGLSPNLAILVIARILQGLFGGGLLAKAQAILFESFPPAEQGVAQSVFGVGVIAGPAIGPTLGGYLTDNLGWRWIFFINLPIGLVAIAMSMIFLRPDPpkTQQPVDWWGIALLawFESSFITTLAITGVvgMGLYGALFAVPLFAQGVLGFSATQTGDLLAPGALASAIVMIILGKMSGKVDARILIGLGAVGTSAVMFNLATITPQTGTDDLFWPLVWRGATTVLMFLPLSLACLGPIpqDISAASGFYNLSRQLGGSIGIAILTTLLQ-----------------------------------
     714 UniRef50_C7Q642        Drug resistance transporter...   184     5e-45  1  16.9%  3:362    2:422     --TAAQRWVLTLTSLAAFMIALDGTIVTTALTTIRKSLNTSVEALEWTVSAYILTFAVLMLTGSALGDRFGRRKVFVGGLTLFTAASAACGLSSTVAELIAARAVQGVGAAVIMPLAIAQLGAAFPPQERGRAMGVSAGIIGLATAGGPFVGGVVAQGLAWQWLFWVNVPVGVLVIAGVLLKMSETHQHPGQPQGPRARLDLvwLSPETLGAAAIGVVLTVAfyAQLYFLAQYYQTVLHYGPFGAGVRMMPFSATLLVFGPLSGRLADRLGERRLVSTGLAVQSLGLVAIALLahHAAYLAMVPALVLSGAGVSTGIPPTQKAVVSAvpHQIGQASGVFSMLRQFGALFGTAVSVAVFAASG--------------------------------
     715 UniRef50_D2SAZ8        Drug resistance transporter...   184     5e-45  1  22.9%  3:387   34:423     --PPSRALLALLLGAFVAIGPLTIDMYLPALPTITAELGTTSAMVQLTLTGTLIGLALGQLVLGPLSDAFGRRGPLLAGTALYVVASALVLVAPTIEVLGALRVLQGVGTAAGAVVAMAIVRDLYTGRAAATMLSRLFLVLGAAPVLAPTLGGELLRFTSWRGIFAVLAVYGLLLLAIGALGLRETLPPSRRSSrtLHTYRGLLRDRTLVGLVLVAGLTMAGLFSYVSGSSFVFQRQYGLDEQQFGLLFGAGAVWLIAATQLNPVVLKRWAPAQVLVAGVVAGALSglLALALTGTGGLPGVVVPLWAMLFASGLALPNAPALALSRHGEAAGSAAALLGAVQFGVGAAVSPVVG-LLGNDAAAMGTVILAALVLAIVVLATVVRPW-------
     716 UniRef50_Q0CQ50        Predicted protein n=2 Tax=m...   184     5e-45  1  16.2% 33:389   57:462     --------------------------------AMAEDFNIPSDDLRMVlsLYMAGFAIGPLIFGPLSESVGRKPVLITTFALYLIFTMACALAPNFPALVVFRFLCGLGGSAPNAVLGGLFSDIydPHHRGLVMSWFMFATTFPPLLGPIISGF-VSTVSWRWAFWSGLIIGGAGFPLIL-TIPETFYPVLLRKalSRPFVMIIREPIVACCSLYLALIYSLLYLFFQAYPLVFQGLYGMSAGVGALAFLPILPGSVIAFLiaGLAWSRVerRLPLACIGAPFIPIALFWLGWSSKLSISPAMPMMSGIFFGIglIFMALLNYLTDAYKQFSASANAAASTLRSIFAVCLPLATTPMYTNLGINWASSLLGFFSIAVAVIPFVFIRYGA-----
     717 UniRef50_B7DQN8        Drug resistance transporter...   184     5e-45  1  15.3%  4:356   25:432     ---RKMWWIFTSVVLGTLMVNIDSSVVNVLIPTLERAFHRPPSLLQWAVSAYLLVVTTLLPLLGALSDRGSRKKYYLMGVALFTISSALCAMATNLIELIIFRMIQGLGGALIMANVMSIITFTFPPERRGKPLGYVNSIVALGTIIGPGLGSVLLSLFGWRSVFWINIPIGMISLALSIVHLPPLRTSKEEQPLDLVGAIWigWTSAPSIVLLVTGVICFLLFLvqFLLPIFLRDVQGESATRVGLVLMTQSLSMFVFSPVAGWLSDRYGPRAWPVIGMVMVGISVAVFSSLSAHTPLAYTTIDLFLFGLGLSLFTAPNNALVLAAvpQHSGEVGSLLALVRNLGRLVGIAVSSA--------------------------------------
     718 UniRef50_Q13P00        Major facilitator superfami...   184     5e-45  1  15.7%  3:364   35:451     --HPPIRLLFPALLLVMLLAALDQTIVSTALPTIVGELG-GLNNLSWVVTAYLLSSTIVVPLYGKFGDLFGRKIVLQTAIIVFLVGSALCGVAQDMTQLIVLRALQGLGGGGLLVVTMAAIADVIPPAERGRYQGVFGGVFGLATVVGPLLGGFLVEHLTWRWIFYINLPLGIVSLVVIGAVFKPHVRHVKHTIDYMGAAFLawSSAQLWFTLGMGLVAIWGffGSVTFLPLYLQVVKGSTPSQAGMQMLPMMGGLFVMSMVTGRVISKIGKYRmpIAGTLLVAVAMLMLARLQISTPIHVMYIDMGILGCGLGMVMQVLILAVQNTVerHMGVATSGATLFRSIGGSIGVAGFGAVFSNGLAA------------------------------
     719 UniRef50_B6ZK58        Putative resistance protein...   184     6e-45  1  19.1%  1:361    7:426     VSDARRWWAVGALALSALVVGLDTTVLNVALPTLATDLEASTSELQWFANAYNLVFAAVLLPAGLSGDRYGRKKLLVVALVLFGAASVGCAYSGSTDALIWWRALLGLGAGFIFPLSLSVLPVMFSDEERPKAIGMVVTASALGLPLGPIVGGWLLDNFWWGSVFLINVPMVALAIVAVLLLLPDSRSPEPPGLDLVGVLLSSAGLAGItlTMLIGGVVLMLLfgLLFTVPQYYQAVLGADALGTGLRLLPIIGGIIVGARVGGKVTAKAGPKRLVSVGFLLMAVGLFMGAVTDTDTSYGYAATWIAVVGLGTGLALPLAvsALGALSTERSGVGSAVIQTVRQVGGTIGVALLGTILTSS---------------------------------
     720 UniRef50_Q07GL6        Drug resistance transporter...   184     6e-45  1  23.7%  1:392    1:396     MYRPKTPPHLITLILLTGFSPMSLNMFLPSLANIAVDLETDYGTVSWAVSGYLAITAIIQLIIGPLSDRIGRRPVLLGALLVFAFASVGCALAQSVEVFLFSRILQG-GIIGGYALSLAIVRDTRSEREAVSLIGYIGMTMAIAPLVGPMLGGVLDTFLGWRSIFAFYAVSGFGLFALCWLDLGETKTRSNSDTGMPVptTTLMREPLFWAYALCGTFSVGAFYIFLTGAPLVAQSVFDITTAELGFYIGTITVGFMLGGFIAGRFGKGFEPTTMMIAgiACIGLVGGLIVLAYGITSPQIFFASTIFVGLGNGITMPGSNAGAMSVRPDLAGSAAGLSGALIVAGGATLTAATGTAvtNGAQTLLTLMLVASGLGLGFAIWASWLRQRAAQ--
     721 UniRef50_UPI0001B4CE2E EmrB/QacA family drug resis...   184     6e-45  1  19.4%  7:362   18:425     ------WKAATVVIVGATMSFLDSTIVNVALSALGTDFRAPLNTVQWVVTAYLLAVAAVIPVSGWAARRFGARRTYVAAVVLFTLGSALCAAAQDAGQLIAFRAVQGLGGGLIMPVGQMILARTAGPANMSRVMATVGVPIVLAPVFGPFIGGLLLHYADWRWIFLVNLPVGAAAVLCAVCLLPADRPEAAPPLDVPGLAarLYRDRVFRAASLTTFLLSMGMYAGMVLMPLYFQDVRHEDPVATGMLLVPSSIGAAAATWLSGRAAERLGTGRTALAGAGLSLAAAVPFVFVGTDTSYALIGTAMTVSGFGAGLSVMPAMTTAFRSlpQKISDASPQLSILQRLGGSLATAVLVTVLQRGL--------------------------------
     722 UniRef50_C9STT3        Chloramphenicol resistance ...   184     6e-45  1  16.7% 22:392    1:433     ---------------------MTANIYYPVLEPIARDLDVTIALINLTVTSYMILQAISPTIFGDFGDMAGRRPAYLIAFAIYLCANIGLALQRNYVALLVLRMVQSGGSSGAIALGFAMVADITTSSERGKYMGLVGAGINIGPTLGPILGGVLTEFLGWSAIFWFCAILSVVWLVPFALAVPEtpPRPRLRFPNPLRAVRIIFDREMALILFYNSILYVAFIDVSATLGTLFKLIYGFSDLELGLCYLPYGAGCCIASVAQGYILDWNYRRTARRVGFAicGLVVLAVYGWVLhtSVAVPLVLQFLIGLTITGSFGVMNTLIVDLNPKAPATATAANNLVRCLMGAAGTASIEYMIMGMGRGWSFTFLALLCAVLSPALWVIVRYGPEWR--
     723 UniRef50_A0NTY9        MFS permease (Drug) n=1 Tax...   184     6e-45  1  27.1% 26:386    3:370     -------------------------IYLPSLAGMMLVFSATAGEIQLSMSAFFIAVAVFQLFWGPLSDQFGRRPVIILGSVLFVIGTVFCLFAQSIEALIAARVIQAAGGCTGLVLGRAILRDLYSPKQAASMIGYVTMGMAVMPTVGPAIGGLLDHYYGWQGGFMLLLVFGVATLWASVFLLPEThrNEVGGRQILRAYATLCREPLYWCYTLTAAFSALAYFAYLGGAPFIAADLLSLSAGEMGFYFMFVALGYIAGNFISGRYSERVGLFRMMLAGTLIAIVCVAVIAGFTyaLSAPSLFLPMFLLGLGNGICLPSALSGAASVRPELTGAASGMTASFQVSMGAIAGSLVASLYAHggSPWGMILVMGVGVGFSLIAALTIR--------
     724 UniRef50_B5ZDH9        Drug resistance transporter...   183     7e-45  1  23.9%  8:392   25:426     -------WIAILLGFLTAVGPVSTDIYLPAFPALEASLHAPAGSAEMTLAVWFVGLAVGQITMGPVSDRFGRRMPMLVGTLVYTLASVGCAVAPDIWTFSSFRLLASLGASASLVIPSACVRDLSHGNEAARLMSRLVLVMGVVPILAPTLGGFVLSFTTWRSIFWASAVYGLICTFLIARVLPETLAPDDrpVALAGRYLTLVRDRGFITNALVAGFGAFMSFTYLSAAPSVFIHLFGFSPAQFGMLFGVFAVCMIGASQLNGVLVGRIDATRILGISVGTAVLGTVAMTVVshGLALVPLVLTMMVALGTTGIIGPNATVGAMADHPRLAGSASAFVGTLQYVLGAVAGAIVGMLPATTPVPMSGVMLTGAVIMLLMVLLRPARRPGEAT--
     725 UniRef50_UPI000023D60C hypothetical protein FG0305...   183     7e-45  1  12.8%  2:392   85:516     -SMWKKVIHTAIPAIYTFGLTTGISTLVAGLPGIMQQFgtSRNVALLPITLYTMGFIFGPCIAAPISDLYGRLVVYKVNIIILIICNAIAVSSDNFAALVIFRFFASLGGSGVMAVGAGTMSDLWLPSQISRVGIAYLLAPFLGPSMGPLIGSyiEQYGDWKWGIWVVLCILTPVAIAIFfiLAERAKRLGRHpaMLKPWHMCIFEPVSLVLGLYTGFSFAMIFSFFGSYSYVYSTVYQFDARQIGLCygLVTFGVFDATIyvARTGDRveHRLYAALVGSLLVPIGLFWYAWAPDPSVHWIVPVMAGVPFAWGTmfLSCLAYLSSAfpSDMSSAVAANGIFRFLLGAAFPNFVFQMYQEMGINWAGSVFAFISLAFIPVPWLLFWKGKVLR--
     726 UniRef50_A6W061        Drug resistance transporter...   183     7e-45  1  22.8%  1:381    1:387     MSSALSKLTIPLLGFLVAFGPLSIDMYLPSLPTIAKSLNSSDQLIQTTITVFLLGMAIGMLIFGPLSDMMGRKRLLLIGIGFYFISSIGCALASTGESLILFRFLQSLGGAAAAVLARALVRDLYELKRAANILSHMHVISMMVMLISPILGAYIVSYFEWRWIFYFLALFSTLAFIGSALLLPnsPTVKPSFSHYAKNYIDCLGAPLLVQYVLANAFSFAGMFAFIATSAFVYIEYFQLSETYYALLFSANIFAIIIATLLNSYLSKRygLALNVAIGVSFTATLLIWGMVGLGSTSMVLFVITTMMYISVTGAIGANSLATLFEQLPEKAGTVSGLLVATQFAVGGFISYLASLIFDGSPNSLLIMMACCGTLCTIFYL-------------
     727 UniRef50_C8UTR4        Transporter protein n=43 Ta...   183     7e-45  1  17.5%  3:367   23:441     --QKNRWWIITAIGMFTIMSTLDGSIVNIALPVMSRDLNIPMNQAEWVVSIYLMMICGLLLFFGKLGDSIGKIKVFRIGMVLFLIGSLFAGFNNSLALLLAARIVQATGASMTMANNNGIVTEIFPMNERGKALGLIGSFVSIGAIAGPGIGGLILGQLPWGYIFWINIPIGIVALILGTVVLPKDLPSKRVPIDWSGFISFlfTDPLILGLFVIAVIALAAFvfFNVISPFYLQNARGLSPEKAGYLLMIFPIVQVIVAPVAGSIADRIGPYRITMVGLLFIVGSQIGYALFNLQTSFVFVALMIGLVGFGNGLFQAPNNTVVMSSvpRDLGIAGGMNALARNLGMVVGISSATTVLFSSMSHTAG---------------------------
     728 UniRef50_B1YLV6        Major facilitator superfami...   183     7e-45  1  20.2%  6:366    2:416     -----RKNVTIALLLATFLAAIEGTIVATATPVMASELN-GAKLVSWIFAGFLLFMAVSTPIYGKMADLYGRKRVLLFGIGVFTVASLACGLAQSMEMLILFRAAQGIGAGAVLPIAMTIIGDLYTYEERGKIQGVLSAVWGISGVAGPLVGGFLVETLSWRYIFLLNVPFALISFIMIVLFYKENVTETSRKIDYRGAILFafAETLILISFAVSVILLFWFysMSAYIPIFAQGVLGKSPTEAGFMLMPLSLFWTLTAIVGGRTIGIASPRYRTMTGMGLLVIGMAILIGIGRESSDVFIYLAVSLIGIGFGLAQPVFMVVLQTSVdsLRGSATAVNSFLSTTGQTLGVAIFGTLFNVSIIQAF----------------------------
     729 UniRef50_C1A5R1        Multidrug resistance protei...   183     7e-45  1  15.9%  4:361   29:442     ---KNKYLIAIAVTLAAVLELVDTSIVNVAIPHMMGTLGATLDEIAWVSTSYIIANVIVIPMSSWLSGFFGRQRYLTGSIFIFVIASFFCGAATSLWGLVFWRVLQGLGGGALLSTAQTTLFEAFPPHERGIGQAIFGVGVMVGPTIGPTLGGFIVDAYAWPWIFYINVPLGLIAALMVWTYVKDAAHQVRTRTIDGTGILLlwFESRFVLTLAIvsFMGVALFGSVFVLPVFLQSLHGYSAQQTGLVILPGAIASAFTMAIMGRFGGKIDARILVTIGAFLFLASMTKMSQLTLDAGQDDMFWPLILRGVGLGCLFVPLTGASMAGIpeRLGQATGMFNLMRQLGGSLGIAIMATMLSRL---------------------------------
     730 UniRef50_A9WHK7        Drug resistance transporter...   183     7e-45  1  20.6%  1:360    1:410     MSRQHTILITMGVMMSLFMASMESTVIATAMPGIVRDLG-DIESFSWVFAIYMLTSTTAGPIFGRLSDLFGRRPVYMVAIAIFSLGSLLCGLATTMPMLIAARALQGLGAGGLLPLAFIIVGDIFTLDQRAKVQGLFSGVWGISSVIGPLIGGFLVDQISWHWVFWINLPPAAIAAALVWIAWRDPVRANAKRpdIAGALLllLRDRTFAIACLHGILAGGVLFGSMNYVPLFAQGVLGTSATEAGTTLTPLMLGWVFTSIIGGRLLLRMSYRTLTIGGMVMFVAGAILMARLRPDMSRLELAIALGLMGIGMGASIPSFLIAVQSTVARNvgAATASLQFSRTIGGTIGVAVLGTLLTN----------------------------------
     731 UniRef50_B4B3L9        Drug resistance transporter...   183     8e-45  1  15.6%  2:361   16:430     -SHNNKWWAMLGVGVGVFMLTIDTSIVNIALPTLVKVFQTNFATVQLVVVSYLLVLTALVLGAARLGDMLGKKQLYLIGLILFTISSLLCGFSPSILFLIGFRVLQGFGAVFMSGLGPAIITEVFPSSERGRALGIIGAIVAIGIALGPTVGGLLIGLSGWRTIFLVNVPIGIVASFVVWRFVPLSPVSSTKQRFDWLGTIFifNSATSSLLFLIAAISLIIFigIIFILPFFLELVLKYSPQQSGLLLAVSPILGGIVAPISGTLSDRFGQRIISLIGLLLMVIGCGLVSTFNQQLTDLVYILCIAPYGIGFGMFQSPNNSAILGSVPRErgITSGLLSLSRTLGQTTGVPLLGSIFDSL---------------------------------
     732 UniRef50_A0SYY3        Putative drug resistance tr...   183     8e-45  1  22.2%  4:391    1:394     ---MKARKLTLVLAGLAMLGPFATDTFLPSFPAIGTHFDVSSVLVQQTLSVYLAAYAFMTLFYGTLSDSFGRRPVILASLLIFAVGSIGAAFAPSFGWLLFFRGMQGASAGAGRVIGQAIVRDSLSGAAAQKMLANIMMVFGIAPAIAPIIGGWLHVAYGWQSTFVFTFSVTVLLLLACLKGLPESLAVEQRQpsIARNYWLALRHRAFLLRSLAVAFAFGGFALYIASAPHFILELLRLPETAFGWMFIPMVAGLVLGSALSGKLAHAVKSAVLVRWGLLAMAATGaiAYNHWFAASIPFAVVPVMLYAFGMSLALPGMTMSTLDIFPQMRGLAASLQNFVQMLVFALVSGFVAPLLFDSAFKLALGQASAVALAAVFWWMGSRQPAGQG---
     733 UniRef50_C6AZT7        Major facilitator superfami...   183     8e-45  1  17.2%  6:359   58:465     -----PRLTPMILAVALFMEQMDSTVIATSLPAIAADIGTSPIALKLAVTSYLVALAIFIPISGWMSDRFGARNIFRMAIFVFMIGSIACAFSNSITAFVISRLIQGAGGSMMTPVSRLLLVRGTPRHELVDAMAWLTIPALIGPIMGPPIGGFLTTYLTWHWIFWINVPIGVLGIILVTRFLPAVEPRSPRPMDFPGFFlkMFRYPMFRAAILGASNFRMGLGALPFLMPLMLQLGFGLTPLQSGSVTFVSALGSMGSKFAASRTFNAFGFRTVISLTTLLAAIFLGINGLFTAETPLFLIMACLLIGGLFRSMAFSGVNAMAFGDVDddSSQATAINAVAQRISMAMGVAIAGGILE-----------------------------------
     734 UniRef50_B4U960        Drug resistance transporter...   183     9e-45  1  17.1%  6:355    2:410     -----KWLYTFIVLSGTFVAVLGITSVNVAMPKMIAPLSTDIYGIQWVSISYLVATAITILVFNHFTNLYGLKRVYLAGIVFFAIGSALSGAVDNIGTMIMARSIQGIGEGFLIPAAQAIIFRIFPPEQRGMAMGMYAMGVAFAPGLGPTVGGYLVEYMSWRWVFYMNLPFIIPIFFASLILLPDFHNQQKHEKpwFSSIKTIVFLSIAILCFLavLVYGLAFFQILYIMPVYFERVRGLGSFDTGLYIFPFAIGIVLFSPIGGRLSDRLDPKILLLACQSIIFiiHFFLSHVDFFTPKLNISFYMFFVGIGMGLFFAPLTALALRHLRHdvPLGSALYNYARLIGAAAGTSIAT---------------------------------------
     735 UniRef50_C0WM86        MFS family major facilitato...   183     1e-44  1  21.8%  9:385   15:392     --------FIIFLALLSAFVPLSTDLYLPALPTMTTFFNVSEITMNLTLILFFVFYSVATLIWGPLSDRYGRRPILLIGLTIYMLAGILCGVATSAFEIILFRVLQAIGGGVATTIATAVIKDVYTGRKQETTLAIVQSMVVISPALAPVLGSLLLTFISWRGIFFTQALLGLIVVLGAVIFqhDTSKESISVLHSLGRLGALMKNPPFSAMLINFSAVSIISLSFISSSSYIFQVHFGLSSQAFSYFFAFNAIGMLVGPLLYIRLSKYID-RMVILYACFFLGIIGGILILGFGLNNPYLFAITELPATLASSASRPPATYLILKQQENDNGSASSLYSAGGTIMGSIGMVVVSFANHWPVLIIAIIDIVINVLCAIGLYVTLR---------
     736 UniRef50_Q1AYE3        Drug resistance transporter...   183     1e-44  1  19.1%  5:360    6:416     ----HKNIIFIGVALGMLSAAAAQTIVSPAMPRIVAELG-GMNHYSWVATAALLASAVTVPVVGKLSDMYGRRGFFIWGLVVFMAGSALSGAAQGFWWLVAARAVQGLGMGTIMPLAQTIIGDIISPRERGRYVGYLGAVFGVASITGPLVGGWITDNFSWRWLFYVNLPLGVAALAFVVAYLHLPHTPRRHAVDYAGFATLAVGLSAVLLATSWggLGAAVLAVFLvyIPVFAQGVLGVSVTNSGAITLPLMLAALPVSVLVGRMITRTGRYKllLAGVAVMWLGYLILSNLDYGSTQAELTLAMVVVGLGLGAVMQTFTLVVQNAvrEDLGVATAATQFTRSTGATVGIAVFGTIMTN----------------------------------
     737 UniRef50_B6J766        Multidrug resistance transp...   183     1e-44  1  19.6%  1:392   13:407     ISESQRYWYAAIALFIVPLSGLSIDIFVPSLPVISHYFGATKSLAQLSITMYMLGMGVMQLFSGSISDSFGRKKPFLIAMLINIVVTLLIPLSHTIYELLFLRLMQGILVAILIVPIRAIFADLFSGVEFHKMTTYSTVIWSIGPVVAPAIGGYLQHYFGWQSNVYFIGVYNIIAFLLILFFMPEtyRHPFQTASLLQRYKEILSHSEYIRMLIVNCALYSIVILFSIVGSFLIQKVLHYSPVDFGHMEFLTGLAWFFGAMTNRAFIHayNLKVKIGLWSLLIVSLISIFAASILPLTIYAVMIPTFILIYLGGTVFPNNFAKALSLFPKINGSANSLFGAFIFLLPGLSSALGTLLKTNSVIPLLTSYLGLIAFSLIIFYARLVGVTVRKR--
     738 UniRef50_Q2T382        Drug resistance transporter...   183     1e-44  1  17.1%  3:365   73:490     --RSAARHALATASAVCSLIVLDTNVVAVSLPSIARTFHASFADIEWVVSAYMTAFAACLLPAGGLADRAGRKRVLLAGLAVFFVASLGCGLAPSAASLNVARAVKGVGAAMLLTSALAVIANRFpgRDRARAWAVWGMCMGIATTIAPLAGGAIAQWIGWRWIFLLNLPVCIALAAAVCATIDDSRDPHAKRIDAPGSVLflFREPRFVGALLAMFGYAACAQVMMTFLPLYLQIGFGMSAIAAGLGMLPFALAMIVGPSLGAALSARAPAATVLGCGLALIGIGDFVTAALAGASHDGLVALGMLVTGCGAGILNGDTQKAIMACvpERTGMASGISTTTRFSAIVTSVGVLGAVLAARTHAA-----------------------------
     739 UniRef50_Q1ASB8        Drug resistance transporter...   183     1e-44  1  18.3%  5:360   21:430     ----RGWVVLSAVSVGTFMATLNTSIVNISLPVIAGDFGVGVSEVEWVVISYLLATGTLLLTFGRLGEVAGYRRVYLAGLAVFAAAGALCGLSGGLGSMVLLRALQGVGAAAVQAVGPAIVTAAFPPSRLGRALGVNAMSVSFGLALGPTLGGLVAEWLSWRWIFFLNLPLGLVGLPWSWRVLPRCGRGEGQRFDPAGAllRLFAIRAFSAGNASLLVTFVALLSATFLMPFFLQRGQGLSALQAGLLMTPLSLTTLVVSPFSGALSDRIGSRLLASSGLACAALGLLLLTRLDAGSGGLDVVWRLVVIGFGMGLFNSPNQSSILGSVPRLrgTASGMIAQMRITGQMLGVAASSAILAS----------------------------------
     740 UniRef50_C6D7L0        Drug resistance transporter...   183     1e-44  1  16.0%  8:364    7:417     -------AIIGGLLLAILMASMDNTVVSTAIGTIVGEMG-GLDKFVWVTTAYMVAEMACMPIFGKLSDMYGRKRFFIFGIIVFMIGSALCGMAHSIIELSIYRAVQGVGAGAMVSIAFTILFDVVSPKDRGKMMGAFGAVFGLSSVVGPLLGGYITDHLNWSWIFYINLPLGFIALLMIALFYKESAAHSRQRIDWAGSILLvwDSPQIIGLFAGFAVLAfaYMTAAIFIPIYVQGVIGGSASNSGLTLLPMMVGSVVTATLGGFLMTKLQYRTIMIGTLSILFIGLALLSQITVESSRLFITGIMILIGLGIGASFSVLSSSVLHSFpaQRGAASSTLNFNRSLGMSLGITIFGIIQSHSMLS------------------------------
     741 UniRef50_Q3IES9        Putative transporter n=3 Ta...   183     1e-44  1  24.8% 17:367   20:372     ----------------VIFCPMAIDIYLPAFPTIAEQFAVSEQQVQQSVAIFMLTVGLGQLIAGPLADKFGRKPVAVIGISLYAGSALLAYYAPSFNILLLARALQGLGACATFVVAFAIVRDKYGAQRSGQMITYLNGIICFIPALAPILGAWLTVQFGWRMNFLFLTFFAIFGLVITLLFFKETRPAdqGHILDLRRFMPIISTPIFLFNSLLCMVAMSAILVYVTLAPGWLITHLGGTVADFTFWFTLNAVCSIVASFIAPMYI-KNNSQRALRLGVGLLIFSGLLMLALSTIQTALALMLPMLIAALGFALSLGSAAGMALSRFAKQAGTASALLGAMQMSGASILVFATQFLGLTTPWLIAF---------------------------
     742 UniRef50_Q93CW7        Putative transmembrane prot...   183     1e-44  1  21.1%  2:385   21:408     -SKSRIIWLSVLLGSLSAYGPLLVDMYLPAFPIMESDFHTSASMIQISLTMCLAGLAIGPIFMGAWSDRVGRKTPLVIGTSLAIIACFLSLVTHNIWLFFLLRFIQGLASSAGQVVTRAVAKDLFNGKQLTKFIALLMAINGIFPIISPLIGSLLLRYTSWQGIFGFIGCTGLLLLLGLIFGFKEThpADQKATSTRLNVQTVFKDRPFICFVLIQGLVYGAMFCYISGSSFMLQNVFSLSKSTFSLIYGINGIGIILMAELSTVLINWFTELEQLKLGLIGGLIGGFCILISGLGPnlWLALIGLFLVVSTLGLINAVVTSLALQRQGKQAGIASSVLGLGMYVFGIFLSPLVGIMGSYTYLPLAVLILLCEFSALLLYRYVRR---------
     743 UniRef50_B2GJA6        Drug resistance efflux prot...   183     1e-44  1  18.9%  2:371   46:489     -TDPRRWRILAVLLVAIFMSLVAVSIINVGLPSIQEGLGASESQLQWILSGYALTFGVVLVAGGRAGDVFGRGFLWMLGVAIFTLSSIAAGLAPDPTMLIVARFVQGVGSGLLNPQGVAMIQQYFKGAERGKAFGMLGSAVGVSVAIGPVLGGLLIQTggWRWLFVVNVPVGVVALVLAFLWFPrtIRHALREMDPTGAVLLGitSPWVWALLAVAAMFLALWIAwwVLVTLYMQKGLGHTALAAGCVGLLNALASAVASNLAGSRVNRMGRKIVVLGMLSVVVGLLLSMAVILLHDSwwWLVLTLGFVGFGQGAVVSPNQTLTLAEVpeYAGSAGGVMQTGQRVGTAVGIAMITAVAYGVIADQGWSVGI-----------------------
     744 UniRef50_B7RQJ1        Multidrug resistance protei...   183     1e-44  1  17.7%  6:373   19:441     -----RWTIVLAVVLTAVLEVLDSTIVNVALPQIQAAFGITNDQTVWILTSYIVASVVVMPLTGFFVRMVGRRRLITTAIIGFATFSALCGLSWSVEVMVACRLGQGIFGAFLIPLSQSILFESFPKEKRGQAMALFGLGVVVAPVLGPTLGALLTEYFSWRAVFYVNLPLAAFALMmlMLDLGESRDWFASKLIQIAALTLIACGAVFVwaNVAIMGFGVAMFGSIAILPLFVQGLLGYPVLDAGFLFIPRGIAAGASMILTGalVNRFDPRKLLMLGLILTGTGNILLAFLNLNADFWQLALPGMVSGLGMGLFFVPMSTLaqNIGPERQDEASGIYGVTRSLGSSLGIALVGWQLASRMQYHYATLAAGI---------------------
     745 UniRef50_D0KY58        Drug resistance transporter...   182     1e-44  1  23.1%  4:389   10:409     ---PKAFLIVPLVASLLMIAPFTVDAYLPSFPAIGHEFGVDQATMQLTLSLYLWFFGGMMLVHGPLSDTFGRRRMVLISLTVYALASVGAAMAGNINELIAARVIQGIAAGAGVVIGRALVRDLFEGATAQRVMSNITLVFAIAPAIAPIIGGVLDTWLGWRSVFWFLALFAALSMAGVFAFMPETVGAHNrpLFILKSYGRALSHAPFMGLTLVFALLFSGMFLYIAAAPMVLVGHLQQTPTDFWKFFVPLVTGLILGSRISNVLASRFAPMTTVSIGIGIVTLAVIfqSFWFAHHSfwLTVSPIMIYAMGMATAMPSLNLMGLDYIPAQRGLASALQGFTQMILAGIVSGLAVAHLAQNLLWLAWGMAALWLLAALIWIAWYRRAPR-----
     746 UniRef50_B0TZ80        Drug:H+ antiporter-1 (DHA1)...   182     1e-44  1  18.7%  1:385    2:391     MIKKDSKLFILTLGLLAMLPPFAVNTYAPAIPNIAEHFGIHANDVIFTFTTYFIGFSIGMIFWGSFSDKFGRKLSLILGMFLYAASTLLCAHSQNFSQLAIFRLIQGLTDSSGTVIALAIARDCYSGKKLTNIISTLAIIMLISPIISPMIggLIVSTQSWKSSFYFLFGFGIVLLILCSK-LPETHAKEQREKslFIAYFYHLRNLPFTIYTICSGLLFAAFFSYIGASSIIYLNVYDTGYTLYMLYFALTIIGVILANLTLKQFSESVELKIfiGLGVSLFSVFIMVIYSHTQFKHGYIFMSLMLVTCYGLSLSSTSLLSQSLQLISNHFGAATAVNNFFKFSLAGFANFVMSFSVGSMLVSNLPLQQLTIILITIVLLYTTK---------
     747 UniRef50_B1VHN6        Putative permease of the ma...   182     1e-44  1  26.1%  8:383   11:395     -------LTLAGFALLSAGGPLGTDMYLPALPLIGRDLGASPAVVQLSITAYMVGMAMGQLLIGPLSDGRGRRGLLCFGMVLGLIASVVCAIAPTAAVLIAARFFQGVAGGTGVVLTRAMIADKLRGSAAAQALSVMMLIIGVAPILAPLLGGVINQAAGWRAIFFTLALIALTQILVASrtLPVERRHGGGPVRMYRNMLGLFRRPAFVGYAMAFAFGFGTMFAFISGSSFVYQEVFGLSSVGFSVMFALNAVALLSANSLNIRLVGRIGARRLQRVAVCVIAAGAVAVLLCALVLpmYALAAAVFVATFGVGLNMSNSTALAQGLAADRAGAGSAVLGAGQFVVAGVMSPLVGLGSDRMLALGLCMVASVAVAIAGTLLAA-----------
     748 UniRef50_Q2SEJ5        Permease of the major facil...   182     2e-44  1  21.9%  2:394    3:398     -SSTTHSRLAFILAMAVALGPFAIDTYLPAFPDIAKAIGADIHDVSLSISVYILGLAIGQLIGGPLSDRLGRSRIMLIGLGVFLFSCLMLSQSESLASLLVWRFTQAFGGGWCAVSVPAIIRDRTEGQETAKLFSLIGLIMIAAPAIAPTLGSAILAFADWRWIFLFLALYTGVVIVTLWFSLFADAPPhpPKRNVLADYLEILKNTAALRFIFIQSLGFSVMLTFLTHASFIYQEWFGLSEFAFSLLFAGNIAVMALMSMANRALLTWVESAQLLRLAVWLQTCGVIALVSItlHPSLYLFAPALMLSVGSLGAAMPNGSACFIQFFKSNSGTASALMGALQFTISGAISALSSALSDGTLIPIVAVMLLCALLNAAFAWGAPSAAQKAPAGV
     749 UniRef50_A9FCA0        Permease of the major facil...   182     2e-44  1  17.0%  2:360    5:411     -RKTHRALTVAGLILALAMAALESTVVATAMPTVIGDLG-GIHQYAWVTTAYLLTSSVLVPICGKLSDIYGRKPIMLFGIAVFLLGSIASGAAQTMPQLIAFRALQGAGAGAMQPMAMTISGDIFDLEERARIQGVFGAAWGLFGIIGPMVGGLIVHYFSWRWVFYVNVPFGVASVALVASSFHERIDRRPHELDFLGAALllFRRPVMLISNVAGAILGGAMVGTITFVPLFVQGVLRGTPTDAGSAIAPMLIGWPVASAIGGRLIPRVGFRPLIWIGLGVTAAAGLALALGGAHDTPLMLRATTLFFGVGMGLSNVALLIAVQSSVadQRGIATASTMFSRLLGGVVAVGIMGGVLTA----------------------------------
     750 UniRef50_A0Q4Q3        Drug:H+ antiporter-1 (DHA1)...   182     2e-44  1  19.8%  7:379   13:387     ------KTVIFIICLFGLMSQFATDSFTPSLPHIAEYFHAAAKDIKLTVGVYFFGMTCSMLGFGYLSDKYGRKPALLAGYLIFCVASILCMIAESETQLLFFRFLQGIGMGSSFVSFRAIMKDVFSDSqlAKASLVITSIVSLTPPLAPITGGIIQETIGWRGNFTLHSIMAIIITVLIIKYL-HLKAIPKSNYNVLDSYKRILTHKVFVLNAICSGLALSLVFVFATLSPFFFQIKLGFSAVEYSFISAGVIIPSAIFLILFKNIISRLDMNKVILYCGSFSTLSGLLLAffIFGLDAKVIVILCALAFCGNVFQYTATYVCAYRDIHTEIGVASAIFGFIQIAVTTISSSLVSSITLHNQLVFGLLMAIPPFLIVIL---------------
     751 UniRef50_A3TIV6        Putative transmembrane effl...   182     2e-44  1  17.2%  4:392   13:473     ---TRGRLTLTAVTLGSGIAILDGSVVNVALRTIGTELDASLEQLQWVINGYMLALASLVLVGGALGDRFGRRRIYLGGMGWFLIASALCAVAQTPGQLIAMRVLQGVGAALLTPGGLAIIQSVFRREDRAAAIGTWAGLSGIAAAIGPFVGGWLVDNGGWRWIFGINVPLCIAVIALTLWATPESRDETPRtfDIPGGALTVLSLGALTYALTSSavVYGALGVVFFILVLQLQVSAGWSALSAGLTGLPATVALMFLSSRASQLSERIGPRIPMAVGPIICAVGVLLLLPAGRDATWWTVLPGLVIFALGLALLVSPLTSTVLAAAprYAGVASGVNNAVARAGSLIAVAALPALVgtSGFRAAMVICAALLTAGGVVSWFGLANSPPPS--
     752 UniRef50_C5F257        Multidrug-efflux transporte...   182     2e-44  1  16.5% 10:384   11:382     ---------TIPLSLILAGRFFGLFVVMPVLSLYALSmgMSPILVGIAIGGYALTQVLFQIPFGFLSDKFGRKSIIALGLIIFIIGSAVCAMSDDIYMLILGRFLQG--AGAIGGVVSAMIADLVKEEKRTKAMALMGATISLSFTTALIVGPILSAYFGVASLFWITCFLGVLSLGILLLFVPEAPKIQYSFISSSDKYSFILKNKNLQIMNLTNFLQKGFMTLAFLIIPIALVKGFEMPKENLYQVYVPASLLGLIAIAPAAIFAEKKGKFKSVLVVGILFFVVAYLLML---SQNLWVFVAGILVFFVGFSVHEPIMQSLASrcKAHQKGSALGVFTAFGYFGSFVGALVGGHLYEYFGMLSISLFVVVVSFLWILALGFL----------
     753 UniRef50_B8DRU1        Major facilitator superfami...   182     2e-44  1  18.2%  3:392   24:479     --PVSRGAVLFVVSTSMVLMPLMMSAVGVSLPAIGRDLAATAMQVGLVETTYVMALSVFLLIMGRLGDIFGRRRLFLAGLVLFTTITAVLSLSQSIRMVIGLRFLQGMGAAMIVANSFAIMLEVFPREERGRAIGIVSAAAYAGISCGPLIGGFLTTHFGWRWVFLMVLPFGISALLLVFTRLRGEWRSARGEPFDLRgvTLLSRNRLFTLSCLSALINYASTFGVLFFLGLYLQYVRGLTPSDAGLLMIIQPVIQMVLSPVGGRLADRFPAERVATVGMVLCAVGLGVAAFIGQDTSTatVVVLVLLGVGYGLFASPNASAIVGSVEPRHLGVASGMTSTMRTLGMMASMIVVTIVFsgFLSSMRTALWTFCALCAVGVLLSVGRVRSKGR--
     754 UniRef50_B8FIG1        Drug resistance transporter...   182     2e-44  1  18.6%  3:389    7:400     --KPQSLLYTGMLAGLASLPPLSIDMNLPAIPAIEASLGVASGQGALTFSLFLLGFAIAPIAGGPAADRFGRRPTLLLSLLFTSIAAFSCMIAPSFQALLIFRLIQGIASGICILLPLAIVRDTLSESEAPKLLSRIMLVVAVAPLIAPIIGAWVLSWSDWRTIHAVQGGLSTLLLLLTAMGFEETLEEDRRTPLSMraYAEIATSKTFLGFSFLMAFTFGCMFSYISGSPGLLQVQLGLSENLYSLVFAFTSFGIMCGSYISYRLGRrvPARSIINRGLTCMVVAVAAALVLVLNGFVHlmAPALFLIMMCAGTIQPNCMAEAVAPLPHIAGTASGALNSLQMFIGSAASAFVTFLTGYFTPALAMMISMACSIALAFAIYHGLRTGR-----
     755 UniRef50_A1RPU2        Drug resistance transporter...   182     2e-44  1  27.9%  6:392    2:397     -----RRNLLPILMSMVLLSPLAIDIYLPSMPTMAAEFAVSASEVQSTLVLFLFAMGLGQVLIGPLADRYGRRPVALFGVLLYGASSLLAAAAIEFHWLQIARVLQGLAACSTSIVVFSAVRDCYTQKEGAKIYSYLNGAICVIPALAPTLGGLLAMQFGWRSTFVFMTLYAMLMMLVVGYRLPETRPANTVTTGpwGRYKPVLSNTHFLFYAFACMSAMAAILSYVSYSPVWLIGHLGVSELAFSGLFGLNALVNIVACFAAPVVIRKLGNRPTVILALSLLVLSAVFILGaaGMAGAFAFMLPMMLLCIGFALLLGPATSMALSAFGERAGTAAAMLGFIQMSGASVLTGLVQQTNLTAPYAVALVMGVFSIGLLLMMALSRFDHWHQEQ--
     756 UniRef50_A0KXB4        Drug resistance transporter...   182     2e-44  1  21.3% 20:385   31:398     -------------------ASLGMDLYLPAINDIRQSFSVSQGQMQLTLTLYMAILGLGQLLFGPLSDAIGRRRVVIAGALVYAGSSLAMALTDSFSVFLLLRIVQALSASAVLVAAFATVRDVFADREEGVViaIMGSVLAAVPVVAPFIGSLIDGLWHWRGIFYTLAIFAALVGLHALLKWPETRPAQTHPFEWSRCF-NIIRAKAFLGYTLAYATAMGAFFVYFSASPSILMDKLGLDKVTFSLWFGSVAIVMIITTRFVKHLVKRWGTQGTVLRGLIGMMLSSGLLYgwLNGLSLLGFMLPMYFIGVHIALTCAVTANGALAAFSHSAGLATALYYAIESLFLSALVSLLIWLLPSGTTLVICSYILISASLSLLFILSIR---------
     757 UniRef50_B7VRB1        Multidrug resistance protei...   182     2e-44  1  23.9%  1:394    1:396     MSRRFDFKSILLACLVISIGQLSMGLVFPSLPWIAKDFDVSLEQAQLLVSVYLLGFGPSQFIYGPISDALGRKKVLLSGLLIAMLGLLMIIfsHSFTSMVMGRFLQGLGTGCCAVLARASTRDRFSGADLPLAMSYIAMVASITPLIAPVIGGFINFHFGWSMVFISLLGYVSLAWVVLAFKFKETVTQvpSPKKMVSQYKELLTSRYFMSFASIGWLNFSLMITTVSVMPFIMQNQIGMTSDEYAMWAVIPALGMLGGTSLCNRIRPMLGNKKTLLCTPVLHIFAALWLFFCPLEP--LYLMLGQFLMILGNGIALPCAQALVMLPYKKNAGAAAAMSGGGQMVVSSMVSMGLVQLGLGEAWHLSLVIMLFTIITLINILRGFSSQEARESQL
     758 UniRef50_D1S758        Drug resistance transporter...   182     2e-44  1  18.9%  4:384   13:449     ---RRRWWALTLLCFVQFMLVVDDTVVNVALPSIREDLGYSATGLAWVVNGYLLAFGGLILLGGRAGDLVGHRRVFLAGVAVFAVASLACGVAQEPWQLVAARFLQGVGGALASPTALALITLIfeGAERAKAIGLWGGIAALGGIVGYVLSGLLTDLVSWRLVFLInaVTATVGLAALVFALLEAPGaqERRVAYPLVPLRFFANRTRSAANGTMMLFTTGLFAMFFLLTLHVQERLGWSPLQTGLAYVPMAVCLLIGISLSQRLVGRLGPRPVLLVGPLLTAAGLLYLSWIDGTERYLpiLPGMVLVALGAGLAVPVltAAMSATTAEDAGLGSGMLTVAQQIGGAVGLALLVSLAGLRSRQMVSDGAGEDAAAIGGTVLAF----------
     759 UniRef50_Q1BU78        Drug resistance transporter...   182     2e-44  1  19.5%  9:392   89:537     --------MLWLVATGFFMQTLDATIVNTALPSMAASLGESPLRMQSVVIAYSLTMAVMIPVSGWLADTFGTRRVFFSAILVFSLGSLLCANAHTLTQLVAFRVVQGVGGAMLLPVGRLAVLRTFPAERYLPALSFVAIPGLIGPLIGPTLGGWLVKIASWHWIFLINVPVGVAGCIATFYSMPDSRNPAAGRFDLKGYLLllFKIHTFSVGLLGNLFARIGSGAMPYLIPLLLQVSLGYSAFEAGLMMLPVAAAGMFSKRIITRLITQHGYRKVLLANTIMVGVMMASFALMRDTVPVWVKVVHLALFGGFNSMQFTAMNTLTldLGTGGASSGNSLFSLVQMLSMSLGVTVAGALLATftLPAFHATFICVGIITAASAWIFAQLAPEIR--
     760 UniRef50_C4RIC5        Transmembrane efflux protei...   182     2e-44  1  18.0%  2:362   80:494     -SHRLFTAPFLLSAVAAFMVAVDNLVVVTALPSIRHTFGTGIEGLQWVVSAYTLTYAVFQLSGAALGDRFGRRRVFLAGLTLFVLASAGAALAPTVWALVAARAVQGLGASMVSPLALTIVAHATPRARRAAVLGAWSGISGIGSAIGPVLGGLVVTYAPWQWIFLVNLPIAAVLLPLARLRIDESHGPRDrvFALINGNDLGWAHPTVWGMLVAAalMTFGLFGAMFLATQYFQDRLGYSPLQAGLAIAPAAALPVFIAPLTGKLSRRigARVLAAGLALQAAGLLALALAVTPDTAYPRMLPGLLLMGVAASLFFGQISRVILGSVAERygIASGAGTTFRQIGTTLGVAVLGAVFAAAG--------------------------------
     761 UniRef50_B2HK01        Conserved hypothetical memb...   182     2e-44  1  20.9%  4:386    5:393     ---APSRRIVAVLLCVVPLNQIPMDAYTPALPQMETSIGTTATALQSTVTVFMIGMALSYLAVGIMSDSWGRKPVLMGCAAALTVTSLACAAANNVAMLLVLRFLQGGACSAFIVVAIAIAADCFEGARLRSVNGLLGAAWSAAPILAPAVGGFIVEYASWRYVFVLIAALSVVVGLAVTWALPETLDQESRTRFELGQTWQVlrNRVFLALAAIFGLLAGPQLSFGVAAPFLYQDEMGFSPSAYGLIALVVGVAVLLGSFSTGMLATRMAFRRLAFADWTLYMVGAALLLGSApgVNPWAITLAVSLAVAGCGALVPQAQAAALGAFSRNLGLVSGLFGTLTYLIIAAIMAIVGVSPERTQAPLGWLYVLCGALVFAALAWVTPR--------
     762 UniRef50_UPI0001B4E538 major facilitator superfami...   182     2e-44  1  19.9%  1:362   22:445     LTHRQITTVMSGLVLGMFLGALDGTVVSSALRTIADDLH-GLTAQAWVTTAYLITATIATPLYGKLSDIHGRRPVYLAAIVLFTLGSLLCGIATSMYELAAFRAVQGLGGGGLMSLAMTIVADITSPRERGRYQGYFMAVFGGSSIVGPLIggVLLGIDGWRWIFLINVPLAILAITVILRVLHLVPHRPVRHRLDYGGAAAlwGAPLSLAMYAIGVLGLagMFGAMTTLPLYLQLVKGMSPIGAGLATLPTVAANLTVTLVVGRLIAKTGRFKvlVTGVGSFAAAMVVYATLGVDSPMWHVSLGMVFMGAGLGAAMQTLTTLAQSEVPrdMGAATAGVNFFRSNGGTVGAAAFVSILFSFA--------------------------------
     763 UniRef50_A3UQ96        Putative multidrug resistan...   182     2e-44  1  24.9%  5:381    4:384     ----NKFLPLLVIFSLIPLGPLAIDIYLPSFPQMIEAFAVSDSEIRQTISIYVLALGVSQLIAGPVSDRKGRKFSAMLGLFMYAAGSLLVVASSSLEMLYAARALQGVGASFTMITAMAWVRDNYEGDVAGKWLSYMGGVTSAVPTIAPLIGSGLALLWGWTGGFYLMAGLALLLFVISAVALqkTTVDVKNTQALKCNVRDILSNRTFLVYSLTNMLSFGALLTYISVAPIVAISEGDFSQVQFSLMFGVIGGFQILASLIAPRLIKSFGRRNTVRLGATVITVGGMGLLFIGFDATY-LFFALSALGAAGFSLLSGSATSLALEPFKYCAGLATSIDGFFRMIGGALLVATSGLLGVSSISTLAVVMLLSLLPVLLITL-------------
     764 UniRef50_C6PTG8        Major facilitator superfami...   182     2e-44  1  17.8%  6:381    7:384     -----KKLPLFILMINLFIALLGQGMVIPILPEYLKQFNAAGSAAGYLVAAFGAAQFLFSPIGGRLSDRYGRKIMIFSGMILTVISDFIFAVSPYLMLLYIARFIGGIGLGIMIPSVLAYVSDVTSKDTRAKGMGYLSAAMNLGMVLGPGIGGMIA-NFGIRVPYFFAAALGIASTLLTLI-LPETLPIEKRTASKGSEQQESiaHTSYFRYLILIFIMTFGLVNYETVYSLFVEHKYGFTTQQVslITLGAAIGIIVQVWLIDKVIKRYGEYKTIRFSLVMAAIALVLMLL---KVNFIYLILVSSVFFTFNSLLRPTVNTMLSKEAGDQQGFVSGLNNMYTSLGNIIGPILAGNLFDK-QINLPYILGAFILLITTCLV-------------
     765 UniRef50_B5ZNV1        Major facilitator superfami...   182     2e-44  1  16.7%  3:374    7:428     --RSNRVLVVATIMFATFMVAIEATIVATAMPRIVGQLG-GFSYYSWVFSAFLLAQSTTTVIYGKLSDIFGRKPVLIGGILIFLLGSLLCGLAWSMMSLVLFRLLQGLGAGAIQPVTMTIIGDLFKLEERGRVQGAMATVWATSAVVGPLAGGIIVDNISWAWIFWINLPIGILSIIAFMIFLKEEVAHKQAKIDYLGSVLflWSRRLIATSNAATLLAGMALIGLSTILPIYVQGVLGRSPIVAGFTLTMLVVGWPLAVMLSSRFYKAFGIRRTLRVGSLLFPFGACFLLFLTPESSPALAGAGSFFMGFGMGLISLTSIVLVQDSVesMRGSATASIIFARSLGNTLGATVLGAILNAGINHYAGGEAAAGL--------------------
     766 UniRef50_Q2RW36        Drug resistance transporter...   182     2e-44  1  15.9%  1:364    9:428     LTGNRLVLATIALSLATFMNVLDTTIANVALTTIAGDLGVSVSQGTWIITSFGVSNAIAVPLTGWLVGRIGQLRLFLSAVVLFVVLSLLCGLSTNLESLLAFRCLQGLVAGPMVPLSQALLLQCYPKAKAGMAIALWSMTTTVAPVMGPVLGGWLTDNVSWPWIFYINGPIGLIAAWLTFVTlrESATRTLPIDTIGLALLVlfKGRNFTTGTIAITLGYAVFFGNLVVIPMWLQSVMGYTATWAGLVTAPIGFFSLLLSPLIGRTIHKVDPRLFASFAFFIFAVCSFWRSTFSPDVALWDIAASHLLQGFAMATFFIALTTVILSGLDQQrpAASGLYNFMRIMAGSFAASVWTTLWENGATR------------------------------
     767 UniRef50_A6U9M4        Major facilitator superfami...   182     2e-44  1  21.6%  9:383   34:414     --------FIVTIAVMTASIALAIDSMLPALPAIGRTLNvnANDTQLVIGVFFLGFGLSQIFFGSLSDTLGRRSVLLAGLALFSLSMFAASWVESIEALLLLRFVQGIGGAAVRITTMAIVRDCFGGREMARVMSYVMIVFMIVPIVAPTLGQLVIAYADWHWIFILIGVVGAALFVWALTRMKESLPREERLpaVLSGFRTVLTNRITCGYMIGMTLFTAVICAYVVSVQQVFGEVYNLS-DWLPIAFAGTAGGIAVANFANGYFVRSFGMRRISHTAMILFTVVAAIGYVLSLAGTPAFTilLFSLLLMFFAVIATNFTAISLEPMGHLAGTATAITGFVSTTGGALIGGAVGQLFNGTLQPLFGGYALFGVLTILATLWA-----------
     768 UniRef50_B5EVT0        Inner membrane transport pr...   182     2e-44  1  18.0%  1:394    1:394     MDNKKQSIPYIWLAGLSMLGFLATDMYLPAFDIIRGDLGTTENMIGLTLSIFLLGMAIGQLFYGRLTQKLGTKKSLIVGLSIFAISSLAASFSTSVEMLLVARFFQALGACSANVIWQAMVIQRYDAKTSQRVFATIMPLVALSPALAPLLGAAIEKFYGWSMIFVTLTVIGV--GLALRTFVDKEPKQEKMTSEKSITFRDVIKSKKFTGNMLIYAASSAIFFAWLTGSPFVMTQ-MGYSGADIGLSYVPQTIAFIVGGYGCRWALERFDAQQVLPWilSIASVATVFLVSWRMdsSIIPMLIPFCFLAAANGAIYPIVVNNALVDFKEGSAVASGLLNFLQMLFCVAASAMVSSISYLGAISMGSIMLLQLVFLFIGAVMVFKVNKEERAAL
     769 UniRef50_Q5P697        Possible transporter n=1 Ta...   182     3e-44  1  24.7%  3:379   29:411     --RTRPAHLLWLITGFWMLQPLSTDLYLASLPELASYFHASPALVQQTLSMFALGVAVSQLVSGPLSDRFGRRPILLAGVLVYAAASLACTLATRIDALLIGRFMQAAGSCTVAVIARAVVRDTYPIGEGAHVIARSTSILAVALLLAPVVGAQLQASFGWRANFALLTLGGAALGLASVLRFAEtnPAAMRPATLLGNYGALLRSPAFWAYALPGSLSFGMVFVYISGASFALIDVLHVPTRYFGYCFALGVLGYLFGTQACRRLLRHYGLSRTLRVglGLAAGTTFAAGLALDLQHWATVVVAHFLVTLAHGINSPCAQSGAVAPFPEKAGAAAALLGSLTMLCAFSVATLLGATYDGTLQPLATLSALLAIALFVA---------------
     770 UniRef50_A3Y7F4        Chloramphenicol resistance ...   182     3e-44  1  27.1% 25:374   23:375     ------------------------DVYLPAIPAIAESLNTHVDGVQASVAIYLSAMGIGQLIAGPLADRYGRKPLGLFGIALYFSGALLASLATVVEVLWLSRVLQGFGACAISVCVISGVRDSYSLEKASRIYSYLNGVICVIPALAPMLGGILLTWWGWQSGFILMYAYAILMALLVILKLPETLpvKQKKLISLARYKPILESSKFRFHAGMVMLFMAIIIAYISMVSVQLMVVMQQSTFAFSLWFGANALVNITASFSAPKLVDRIGRKLAIQASVGLALVAGIWLFVAQDSLAPLALMIPVFISSVGISLVFAVSNAGALAPFAERAGTASALLGFFQMTGAAVLVGLVNLLPFGPMVNFALVMCLPLI--------------------
     771 UniRef50_A7IE08        Major facilitator superfami...   182     3e-44  1  18.7% 23:359   40:431     ----------------------DANIVGPALPLISSEFGA-LDSLTWVLTIFLLTSTAATPLYGKLSDMYGRRPLLTIAVLLFLAGSAFSGLAQSMNQLILGRAIQGVGAGGLMTLTQITMSDLVSPRRRGSYQGLFGAVFTIASLAGPPLGGVIAEFWSWRWIFYVNLPLGAAALTLLWMGLPPGVRTTSHRIDVLGFVVImvGNSVWLIATGVATLVTIAVFGALAFMPLYLQLAGGLSPTASGIAMVPSAAGLMLSLLYGGRAITRTGRYKVFAvvGVATLALFALALAAYALPSPYLLGALLFPLGAGLGLLMPGLTVAYQNAVAhdIGTATSTAGFFRSLGGAFGIAVAGAILA-----------------------------------
     772 UniRef50_D2NPW5        Permease of the major facil...   182     3e-44  1  23.8%  4:390   17:406     ---KRTLLRYITLSALMACTALATDIFLPGVPEITAELGSGEE---LVITGFLLGFALAQLILGPVSDRVGRKIPLAAGMIVFALGSAWCAVAGTMPELVIARVLQAVGACTGPMLARAIVRDLYEGTRAAQVLSTLMLIMALAPILGPLMGGFLVVAGGWRWTFWAIAAVALIIFGLILF-LPESLPPAKriLSAFVNYPVLFKNGPFMRYVLCVCFYYISIYAFITNSSTVYITHFGVDPRYYGLLFGMNMIGVMSLTALNKRMVKNYSLRGILKVATLVATVAGAALATTGVTGVGGLLGVVVTVFFvmNGVVAACTNAAALNSvpAVAGTAAALLGSFQYGSGIISSLLLALSPLNAVESMTVMMLAGTALSALMVWLPSRSRNAR----
     773 UniRef50_A8LGG3        Drug resistance transporter...   182     3e-44  1  25.5%  7:391    5:390     ------RRTLLVLGFLVALGPFTVDFYIPAFPLVQADFGTSAAAVQLTLTATTIGFALGQLAIGPWSDSIGRRRPLLVATALHVAGSLGVAAAPTVEVMLVFRLLQGAGAAGSGVVALAMVRDLFDGALFVRMAARLAVVTGLAPVVAPFAGSLMLSHMSWRGLFVCIALYGLAVLAVAAFLVRETAPLVRRAGAPLGRYRVLVTDRGFVGAALAGGLLVSSVFTYMSSSSFLFQETYGLSAQRYSLVFAANAVGFVIGAQTSARLVTRIGPRRLLRYVlsLGFLGFTLLLAAFAGENVVVVTFVTALYFLLAGAVGPCLQVIGMAPHGERAGTAAALMGAANFGLAGATAPVAGLLGVGSIGPIGLVMGLTMTVAVVVFRVLARDRREAR---
     774 UniRef50_A4CL50        Bicyclomycin resistance pro...   182     3e-44  1  21.8% 39:382   64:413     --------------------------------------NSDPAANQLLITLFFLGMGTGPLLFGPISDSVGRKPVVYIGFAVFIGASALCVFARSLEWMIVGRILQGMSLSAPRTISIAMIRDRFSGDYMARIMSFVTVVFILVPVVAPAFGKLVLDTLGWEAIFYLQVVFSLLVSLWFWRRQPETLPRENRNtrIFSGFREVLAYRRTMLFTLIWGFITGSFLVYLSTSQQIFEVQYRM-PEMFPYLFAGLAITIGTATLINGWLVVRFGMRRLITVSLVGFTLNSLCYALLFanPHMAFLMVFLALQFFTVGFLFGNLRSMAMEPLGHIAGIGAAITGFIATLMSVPISAWIGSFVVTSALPLFQGFFICGALSLVLLTY------------
     775 UniRef50_A5IBG6        Drug resistance transporter...   181     3e-44  1  22.2%  6:388    2:385     -----KKNALLIVLLTWFLGNMDIHFLTPALPSLVDYFSVTPNTAQLTISLFLLGKALSMILWGLLSERYGRKPIFIGGLLLFILSNFLIALNHSILLFLVCRFLQGISVGATLLMGRAMINDTHNEQNATKYFAWLFTLAGLFICFLPFFGGLINSYWNWQIASLIIAAYGLLLLPLC-RGLKETKPHYVKFPRLGHSIMVVFNHPLFVSYLLISALMMAGESAFNTSASFILIKGENFTSAQYGTIKTTMAIMHLLGTACCGLIAKYYHSIQLTKLgfFIFAAFLMWLFVFSAENIYLTFIVPMVIYYFGTGFIVASATASAVRPFPQQMALALAITLFCQFNCSAFFSFITSMIGIQQVETFMFLLSLVSILSFLALLKLQRMEP------
     776 UniRef50_UPI0001692C61 multidrug-efflux transporte...   181     3e-44  1  16.0%  5:360   11:423     ----NKRLVLAGLIIGMFFSSLEQTVVGTAMPTIIKDLD-GFSIFAWVTTAYMITSTTIIPIVGKLSDLFGRRMMYLIGTVIFVVGSMLCATATSMEQLVIYRGIQGLGGGMIMPLSQTIIGDIFTAEQRARWQGVFGAIFGLSSVFGPFVGGFIVDHVSWHWIFSINAPFGLLSALLILFGMKHEITAKSQGkdYLGILTLVTGLVLFLLGITFAglGFVLGLGMFGAIMFvmQGILGVSPTAAGSTMTPMMIALILASVIGGQLLLRFTYRTILFIGMLIASLGFFLMSTLGIDTASLTVYSFMIVMGLGMGLVMPTLTIAVQNEFPRNqgAVTSATTFFRSIGGTIGVTVLNVVMNH----------------------------------
     777 UniRef50_Q8CN60        Bicyclomycin resistance pro...   181     3e-44  1  17.7%  2:385    7:394     -SKHLSKILIVILGVMTAFGPLTIDMYGPSLPKVQHAFGSSISEIQLTLSFAMIGLAIGQFVFGPLSDVLGRKKMALILLIGYLIASLLSVFTVHLTIFLIIRLIQGLAGGGAIVIAKASIGDNYDGDELAKFLTSLMVINGIITIIAPLLGGLALSIASWRMIFIFLTIITLIVILGILLKMPVGPHQEQSqkAIFKDFGLLLTKPTFVIPMLLQGLTYVMLFSYSSAAPFISQKMYHMTPLQYSAMFAINGVGLIVVSQITAIIVEKVSRYAMLIYLTIimLGVVILIFTLTLHLPLYVLLIGFFINICPVTSIAPLCFSMAMAERTGGSGNASSLLGLFQFILGGLISPLVGLNGQHDMSPYLIIISATAVLLIALQIIYFK---------
     778 UniRef50_C6BU56        Major facilitator superfami...   181     3e-44  1  16.4%  1:360    1:411     MDDAKKKAVIFTVAVTQFTMPFMFSAVGITLPVMGREFGASGLDLSLVESVYIGSVAALLLPFGRLADMHGRQPMFRLGVLLFAIFTLLIGFAQNIETVICLRMIQGMVGGMGIATNMALLTNSVPKDERGKAMGLAVAAVYVGLSAGPYVGGLVTSHMGWRWIYYLSMIPLGISYYVAHRNLNGKFRPSDEKFDYPGSFVVALsrRDFSDAALVQFINYAGTFGIVFLFSLYMQSVKGFSPHDAGLVLVIQPIVQAVLSPLCGRLADKFSPRVLALLGMLACTAGTIMGAMVTADTSLPYLYSMFVVLGIGFALFSSPNMIILMSSVPPSrgFASAISGGLRTIGMVFSMVIIAIFLST----------------------------------
     779 UniRef50_B4S6I0        Drug resistance transporter...   181     3e-44  1  20.8%  9:379   15:393     --------FIVLIAMMMSLVALSIDTMLPALPAIINDLNVtpNSGQLVLSTLFLGMSAGQIVYGPISDTIGRKPAISIGFGIFIAGTLLCLNATTFSAMLGGRFLQGLGAAAPRIITLALVRDKYEGAEMARIMSFVMTIFILVPILAPFTGQVIMSIAGWRGIFAGFLFMATGILCWFLWRQPETLISEKRHPFSLgsLREIISNPQSMVYTLTSGLIFGAFLGYLNTAQQIFQDQY-ATGEMFPVYFGMLALPFGMATLLNSKLVRHVSLQRIVALAMTGIALllLPLLFSHGQPPFWAILAYLAPIFFAIGILFGNLNALAMEPLGHIAGTGAATVGSLSTLIGMITGTTIGQFYNGTLFPLVYGFLACTLLSLLI---------------
     780 UniRef50_UPI0001B54ABC major facilitator transport...   181     3e-44  1  20.3%  1:389    5:443     ISARRQRLALIALCLPFFIVQLDATVVNVAVEAIRRDLGGGLGGEQWVIASYTIALAAGMLTAGSLGDRYGSRRVCVLGTVVFGVGSALCSLAPTLPVLIVARTLQGVGAAALLPCSLALIIRQFppRARAHALGLWGGIAAIGLATGPVAGGVLIALADWRAIFWINIPFAALAIVLTCRYVVESPQRRDRRLDPYGLvlAIFSSRPFSAASTAGLLFNFCLYGALLCLSLFLQGPLHQSAYATGMLTLPLTIAIGIGATASGRLTARFGARVPMLAGFSLAGLGAVLLAAAGSLP----LLVAGGIVLCCCSIAMPAMTSVAMSTPpeHTGLASGVLNTARQTGGALGTAVLGTLLTAgsLSLPMTVVALGYAAAVGCTLLATRRRP-----
     781 UniRef50_B2I132        Permease of the major facil...   181     3e-44  1  19.1%  7:394   15:463     ------RLLVLLVSIGFFMQALDTTIVNTAIPAMAHHLNEDPLRMHSVVVAYVLSVAACIPLSGWLADRFGVRNTFLSAIIIFTLASLGCGLSQSLNQLLFFRVIQGVGGALLLPVGRLSLLKIIPRTQFLAAMSLMSLAGLLGPLAGPTLGGWLVEVATWHWIFLINIPMGVLGILMTLKVMPNVKEPTVKTFDLIGFVlrLFRNKIYAIGILGNFFARFGGNALPFVLPLMLQVAFGFEPFIAGLMMIPLVLGSLFSKPIVRPIIQKMGYRRFLLINTTLVGLCIASFAIMTVDTPTWFRALHFFLFGTLNSLQFVGMNTLTLKDLPQqaSSGNSFLSMIMMLSMSIGVALAGTlyGTAHVTTAFHVTLICLGCINIITALIFWQIPKNTPV
     782 UniRef50_C0QKD8        Multidrug resistance protei...   181     3e-44  1  17.8%  3:361    5:419     --EKNKWLIFACVALGVFMSTLDSSIVNIALPYIMQDMGTGVETIQWVVVGYLLTISSLLLTFGRLSDIRGKRMVYTGGFLIFTAGSGLCAMAQTPLFLIISRVVQACGAAMLMACSPALIVDTFPVRERGKALGMVGAVVAAGLTAGPVAGGILLDLFSWRFIFYINIPIGIGAALAGSLIlpGSLEPMDKTGSLLQAVSLvfFSAKTMGFLLTFaiLFGTLFVIVFMMPFFLVHPCGLSASATGLIMITPFILLFFISPVSGALYNRTGSRGPCSLGMTILALALFAFARIEPSSGMTAIVSYLALAGTGTALFVSPNNTAAMGAVParRGIASATVATARNLGMVIGVATAGLIFTGT---------------------------------
     783 UniRef50_C7QA77        Drug resistance transporter...   181     4e-44  1  21.0%  7:340   20:408     ------RGVLATTILGSAMAFLDGTVVNIALPRIGSQFGATLAGLQWTVTGYTLTLAAFVLVGGSLGDRFGRRRVFLIGVVWFALASLACGLAPSLGFLIAFRAIQGIGSALLTPGALALIQSVFHPDDRAKAVGAWSGLASIAGAAGPLVGGYLIEYASWRWIFLVNLPLAAAVVAIALRYVPESKELVAGHFDLPGAvlSLFSSREFSAANALTLTAYGALGALFFFFATYLQVVGGYSPLEAGLASLPTTVVLMTLSSRVGGLTTKVGARRLITAGGALTAIGTLILATSGHHPDYLtiLPGLLVFSLGMVMIAVPVTVTVLNstTDRAGIASGVNN------------------------------------------------------
     784 UniRef50_UPI0001C31FA4 drug resistance transporter...   181     4e-44  1  18.9%  2:360   15:430     -TETNRWVVLVLVCLAQFMVVLDATIVNVALPSIQTDLDITAGNLAWIINSYTLLFGGFLLLGGRAADLFGRKRVFLAGVVLFSVASLLCGLATSQETLIAFRGLQGLGAALVSPAALSIIMTTfdGAERTKALAVWGAIAAGGSAFGLLLGGVLTEALSWPWIFIVNVPVGIAAFVLSLRLIPESkpDAGRGFDALGAVLviFSTRSLSTANGVMLVVAGGMFAMFFFATIYVQVVLGYSPIEAGLAFLPFTVGIIAGSVAAQQLIPRIGVRAQILFGLTLAAIGLLLMMRITADGDYVtlLPAVLVMSIGMGNTFVPLTLltTNVEERDAGLASGLFNTSQQIGGALGLSILSTLAAS----------------------------------
     785 UniRef50_C3XB23        Drug resistance transporter...   181     4e-44  1  20.9%  9:386   20:397     --------LIAFLAFLNAFVPLSIDLYLPAMPTMAEYFSATPELTNFTLSFFMLFFAISMLLWGPFTDKFGRKPILYIGIVLYILGSLTCVLSQSIYHLIAGRAIQAIGSGAIQAVSMAIVKDNFKGLVMERVLVWIQTLTILCPMLAPIIGAFLLEFISWRGLFVVLILCGILGLILC-FFLKETlaTEGSALRSLTRIGFVLKNKGILILLFTFSLIIMPVMSFLSTSSFIYMDLFKLSAQEYSYFFALNGCFAMLAPILYLRVLRKIPRVLFLTICFASVAASGAMILIFGTLSPYAFAFLYIPVTFFG-SASRPAGTMLIMNQIDTDNGTVGSLWGCIALLFGSLSMMLCSLDWPNLTMAVGTISLVSGSLCALLWLFAWSR--------
     786 UniRef50_Q2T7X3        Major facilitator family tr...   181     4e-44  1  21.4%  1:393  104:498     VSRMHPLRSILPLALLTAVGLLATDLYLPAVPSLPQQLGGSIESAQATLAAFSAALAVSQLVWGAAADRFGHRRTLAFAVLLQLAAGAACALAPSMGALIGARVAQGFGAGAATVIVPALVRQSFGDGGAVRALAWLGIVESAVPGLAPVAGAALLVVADWRMSFWIIVALSVVTAPLAFRVIPAARAMRPRTPARAGGYRRLLRSPGYLGYALGHALCFAALLAFVASAPQVVEIWLGAGPSTFSLMQACGVAAFMLTAARSGKWSDALGLDRIISLGALLQFAASAAFLLLAYAdsTALVVATWMLFCGSLGLRGPASMARALAAEPAVAGRAAGLLMFFGLGGAALATQAVAPFLHLGLAPVAWMCAGFTLASGAVVLWAIAMRDRHRAP-
     787 UniRef50_A8GE47        Drug resistance transporter...   181     4e-44  1  18.3%  4:359   11:416     ---AHRPLILIACMLAMFMSAIEATIVATAMPTIIGDLG-GFSLLGWVFAVYLLAQAITIPIYGRLADLLGRKRVFFFGASLFLLGSVLCGFSPNMYWLIGFRLLQGLGAGAIMPTATTIIGDIYSPTERPKVMGYISSVWGVSAIIGPLLGAFIVQHLPWALVFWVNLPIGLLAMFFLARYLPSRQQVREHALDLAGTAWllWQSRVIVAGNIGGLVIGAAMMGISAFLPTFIQGVMGGTPLEAGTTLALMSIGWPLASTFSGRLMLMTSYRTTALLGALLLLAGGLILLLLQPTGGLLWGRVAAFMVGAGMGLCNTTFLVSVQNAAHhiRGIATACTVFTRMMGSAIGTAILGATLN-----------------------------------
     788 UniRef50_Q03P09        Permease of the major facil...   181     4e-44  1  19.4% 10:386   11:389     ---------LGLVIVLVGFPQISESIFTPVLPQLQHVLAVSANQIQLTMSTYFVAFAIGVLVWGQLADYWGRRPAMLAGIGVYLVGNVGLLVSTQFTTLLIWRLVQAFGASTGSVVTQTIMRESFTGVRGAKVFAKTSAAMALAPALGPLIGGIMQTISGYRGVFATLVTMAIVVGLLAQAGLPETRQLTTHAPIVKQRLvrLLTDSVVWGYGLLIGGINGALFSYYAEAPFIFMTHFGYSAVAYGWLGLVLAAASLLGALIVGRLLNRWTPEQVTGGGLIVSMVMSAGLVGAAALHQATLMIIGIFLTFFGFNITLPNALNRALVGYEQVMGSASGWFSLGYYLLVSAVTYGMSWWHNGAINRLPLYLLVLSLGMGLAFWWLIRR--------
     789 UniRef50_B8IR51        Drug resistance transporter...   181     4e-44  1  28.5%  1:368   20:392     LKNAPVRAPLPLLVAVTMTGTVALHIFVPVLPAAAADLGTSPVAAQLTITLYLVGLACGQLVYGPLSDRYGRRPVLIAGLSLYLAGLLLAIPARSIGVLVAARVLQSLGACGSLVLGRAMVRDVSTAADATRKLAILTMAMTLTPALAPAIGGVVGGAFGWRAVFVLLAAVVAALGLLVVATLPETNRRPVALPGlgAAYLRLLGAPVYRAYVVAGACAGTSLYAFLAVAPFLLGERLGRSPQEVGLDCLLVVAGMVAGAWIAGRLAGRVPTRRAARQGNALCFAGALALLAisGSLSVSTLILPLVLYAVGIGILGPNAVAGLMNVDPHAAGAASSLYGFLQMAFGALFTLSVAAWHDGSATPVAVT--------------------------
     790 UniRef50_C6XGD7        Probable multidrug resistan...   181     4e-44  1  21.1%  9:383    3:386     --------FVIVIAMLMAINSLGIDIILPCLPKISDSLHLSNENYGqlISFYLIGYGIAQIFYGPLSDRFGRKIVMMFGLVIHIISTFIMVTINSFTGMLCMRLIQGIGGAAPRIITISIIRDIYDGRDMAKVLSIAMMIFMIMPILAPSIGQavALSGGWIGIFVCMGVITTFITLWYYIRFPETLDPRDVRpaILHSFSLIFKHRASTLYNIANSLTMGAILGFVNSSQQIYVGIYQLGNL-FPIAFAVGGFAMSIASFINSRLVEKFGIRRVSHYSLLimITGSWLLVQITSNHPIHlfIAFFFLASFQFGLINSNFSSISMEPFSHLAGTASSIFGFINTVISTILGIIIGQSFNGTTYPITIGFFGIAVSSFICILIV-----------
     791 UniRef50_Q73I02        Bicyclomycin resistance pro...   181     5e-44  1  21.5%  2:391    3:400     -TALSQNIISLIMILSVAIVDMATDLYSVALPSIANYFKVEGSVVQLTISLNLVGFAVSGLIYGPLSDHYGRRPMMLIGMTIFTLASVMCYIADSIMLLILIRFIQGAGAGVAGVVGYAAIRDMYSGSEYSRVISKLNMVVALSPGIAPVVGSYIIShyHWKFLFFIMSLAAIAILIFIYFKLQETLTVNKntTNIFKQYISIFRNYRFLGFSAIHGLTFMWLWAYIANYPFIFES-MGIEVQYFGYLISIIVIFYIIGTLINRRYVPKVGVSKMLIIGLVLPIisLLVYFYFADKLNIFILQTAWIPANIGLALIISNNVTSALETIKGI-GLGSAVLSFCNMMFGAIGIYIVGKFFRYGILPNLLLTIACSTIAILMYSQLKCTEKHRE---
     792 UniRef50_C6HFX1        MFS multidrug transporter n...   181     5e-44  1  16.5%  3:360   40:424     --QRREWLIVFSIFLLYLMIALDSTIIVPVLPTIASDLNGTAVEAFWAGTSFLLTYAIFQPFIAAVSDIFGRREVMLASVSLFTAGSLIACLAQNFSMLLTGRSIQGVGAGGVFVLGYVILTDIVPLRQRPKFTAIIQIAWAIGTILGPLFGGIFAEHSTWRWTFYINFPFCAIGFVMVPIAVrsTLIYKIKQVDWIGGSLFIISITLLMIAISWGGTQfmILGIFGTLYTIWYeqIANVPFLRKGLFYCRSAIAAYICSLIQgiALYYIPLYFQAVKGLSPVLTGISALPITSSLVPASVFVAglILLGFGHGLVLSALNLGVQAIStnNVAHAVAMYSFLRAVGAALGVGMGGTVFQN----------------------------------
     793 UniRef50_C4V2K6        MFS family major facilitato...   181     5e-44  1  19.5%  1:384    3:389     MNARTRLWLTIFLGVMTAIAPVSTDMYLPALPEVQEAFSVPTSLVQMTLTMTTLGMALGQILAGPWSDLWGRRRPLLIGMLVFVGATLGCVLAQNIYLFLFFRFFAGFAGASGIVISRAIARDVCEGSELTRFFSVLMMVNGFAPIIAPVIGGQILLFAKWRATFILLTLIGVVLAGATLAY-QETLPKEQRSKNVMDSLKklLHDRYFLGHCLLQCFVFGAFFSYLSGSSFVFQNIYGVSPQGFSMIFAVIGAGLLLAGILPARFAGRVPDIVMLKYAVLvlIGSSLLLIGFFVSAPLPVIFILLFITIIPLSVMGAASFSLALSRQGKNAGSASALIGCFSMLLGACMMPVVGIAGDYTAIPMGVIMLTCYGLGIFVFYRMI----------
     794 UniRef50_UPI0001C311F1 drug resistance transporter...   180     5e-44  1  18.0%  4:380    7:437     ---SRARWTLGITGAALFMTALDSLVVGVALHSIRMDLGGSLEALEWTVNAYTLAFAVLLVTGAALGDRFGRKRMFIVGVGLFTVASAGAALAPSVGALIAARALQGLGAAILTPLTLTLVSEAFPAEKRAAALGIWGGISGLGVAIGPFVGGAVVEGISWHWIFWANVPIGLALIPLASAKLTESHGPDrrRAPSPMLPLRLFRSRAFSAANGLSFAMFFGAFGAIFLMSQYFQMAQGVGPFEAGARTLPWTAMPMLVAPLAGVLATRFGTRPVMAVGLALQAVGMAWMAtvGVDTPYAELIGPFAITGVGMALVFPTAPEAVLASvpSEEGKASGATNAIRELGAVLGVAVLASVFAANGGYASAQAFVDGLVPALPI--------------
     795 UniRef50_A8FV74        Drug resistance transporter...   180     6e-44  1  18.1%  1:392   31:425     VNNTKYFFFLGYLALLSMLGFIATDMYLPAFKAIEDSMQATPAQVAGSLTCFLAGLAIGQLLYGPLVQRIGKRNSLLLGLMIFAAASFSLASSETVLSFNIARFFQALGACSAGVIWQAIVIEKYDATKAQSVFSNIMPLVALSPALAPLLGAFVLEISGWPTIFLILTCLAIFLMLLTVLFVpeKVTSTAQEGTKKLTYWNLLNNPKYLGNVIIFGACSGAFFAYLTVWPIVMEQH-GYQAKEIGLSFIPQTIMFIVGGYASKILIRKVGTEkvLLTCFGLCVVAIVACSLLVKMDSILPLLISFSILAGANGAIYPIVVNSALQEFTKHAAKAAGLQNFLQISIAFGASSLVAIWASYGEVAIGFGILICSFGVIAGYKLRNSKSWEKVR--
     796 UniRef50_UPI0001C3150A drug resistance transporter...   180     6e-44  1  17.1%  5:360   24:433     ----RRWWILATMTGSLSMILIDQTVVSVALPTMQRDLDLSTVGLQWVVNAYLLAIAAFVALGGKLGDLLGNARIFRLGAAVFVLASAACGFAQGEEWIIVARSIEGLGAAMMTPATGAIVMNAFRPSERGRAMGIYAGVSMVFLALGPLIGGVLTEWISWRAVFFVNLPVGIAMLVLARVTLKGREQPAGGRMDWGGVPLIvfANRNFTADNVVLAAVQFALMGVSVFGAIWVQDVLGFGPIEAGLSLLPLTLSLLVLAPRVGVLYDKIGPRMPVALGALAVAAALAWNAIWLHELSYAWIVPGYLLMGVGLAFVMTPANTDGMNAapELRGQASGVIQTMRQVGGTIGIAVMGTVIAN----------------------------------
     797 UniRef50_C7PKR0        Drug resistance transporter...   180     7e-44  1  15.1%  1:357    6:421     LSSAAGRWIMISAIMASAMAFIDGTALNVVLPSIQKSMHASGTDLFWILNAYLLMLAALMLIGGSLGDRLGRKRVFIAGILIFIAGSAACGIAGDVTLLILFRMLQGIGGALMIPGSLSLISSSIHEKERGKAIGTWSAFTTVVTIGGPVLGGALADAGYWRYIFFINVPIGIVAVLILWRKVKESVDDTQDKTLDFAGAFSIAAGLAAVTFGffSGANLLTFFLymLFLSLNLVQVQGYDQLQSGLTFLPFTILMVLVARFAGTLADRYGPRLLLTIGPAIAGAGLLILSFIKQTPgfTTFFPGIVVFGLGMSFTVAPLTATVMGAvdHYSGTASGINNALSRIAGVFANAIFGAM-------------------------------------
     798 UniRef50_C7MFV1        Arabinose efflux permease f...   180     7e-44  1  22.2%  3:394   30:433     --RRAGARLTLTLASLAMIGPFSIDSIFPAFTRIGAEFGADEVGLQQLVSAYLAAFAVMSVFHGPLSDALGRKKVMIGGLVIYLIGMFGSIIAPSLGSLVLLRMLQGMSAGAATIVSRVVIRDLFDGAEAQRLMARVMMIFALAPAIAPIVGGWLLLLGDWRWAFAGVGLYGMVVLALTL-TLPETLPPEDRtrSLLGSLLHVGRSPVMLRIAAATAFGFAAQFLFIAGASIFVVRLLGLGEQDFWVLFVPLIAGLMSGSWVVGRAAERMPRSRLITVGFLGVVATTALNLLLVSLLplLPAVIGPMLIAFTVALVFAPIQLEVLDLFPHQRGAAASLGTFFSLVLNALLAGMIAPLVSGTLVSFALTALGFALLGLGFWTWHLRTHARAVQQV
     799 UniRef50_P76269        Uncharacterized transporter...   180     7e-44  1  18.1%  4:362   12:424     ---PQRYGAILTIVIGISMAVLDGAIANVALPTIATDLHATPASSIWVVNAYQIAIVISLLSFSFLGDMFGYRRIYKCGLVVFLLSSLFCALSDSLQMLTLARVIQGFGGAALMSVNTALIRLIYPQRFLGRGMGINSFIVAVSSAAGPTIAAAILSIASWKWLFLINVPLGIIALLLAMRFLPPNGSRASKPRFDLPSAVmlLRIPLFSLSICTSVCSFCAQMLAMVSLPFYLQTVLGRSEVETGLLLTPWPLATMVMAPLAGYLIERVHAGLLGALGLFIMAAGLFSLVLLPASPADINIIWPMILCGAGFGLFQSPNntIITSAPRERSGGASGMLGTARLLGQSSGAALVALMLNQFG--------------------------------
     800 UniRef50_Q0BXK4        Drug resistance transporter...   180     8e-44  1  22.6%  4:383    1:390     ---MRKVEFVAIVAGLMALNAIAIDIMLPALSAIARDTGLTAEGgqLIIFAYVLGFGAPQLIWGPITDRFGRRAPLFIGLIGYVLTALLCIMAHSFWALLAARFLQGVFSSGARTVASAVVRDLFAGRSMASFMSLVMTIFMIVPIIAPTIGQIILYVAPWEGIFVVLAVWGALMLGWTWFRLPESLPKEARRssVMTAYLQVIRTRVSFGYMLASGLVFGSLFAFIASSEQVFRDVFDQGDT-FAYWFAGIAAALAVSNFANSRLVEKVGMRRISHIALLTFMLSSLVLTLATLAwnLAVFFPLFALGFACFGMMGSNFSALAMEPLGKIAGTASAAYGFATTMISSIIGMIIGSQFNGTTVPLTLGFVILGAASLVVILVT-----------
     801 UniRef50_Q03HT6        Permease of the major facil...   180     1e-43  1  17.3%  5:356   12:418     ----NKTLILIALGMFTFMSTLDGSIVNIAMPIMSKELSVTASQIEWVVSIYLIIISSLLMFFGRLGDVVGKTRIFKIGTAIFIIGSLIAGINLGLPFLLFARGVQAVGAAMTMSNSFGITTSSFPINQRGRAMGFIGTFVALGSVAGPAVGGLILNYLPWNYIFWINVPIGIIAILLGLKSLPKDVPVSANApaILRGQAIGYTHPIILGALLIAvlVFINGFFYNVLMPYYLVNARGLSSGLSGILLSIIPLTMVIFGPIGGVLADKFNSTKITIIGVTLVLLAQFLIMGFQLDTPFWYFIFTSIVTGIGIGMFQSPNNASVMSAVPSNrgIAGSVNALARNLGMILGVSISTS--------------------------------------
     802 UniRef50_A4QD12        Putative uncharacterized pr...   180     1e-43  1  22.6%  2:382   24:409     -SNTIGLATLFTLAILSAVAPFSIDLYLPAFPAMTEDLHTTATGVQLSLTAFLIGAGVGQVVFGPLSDRIGRLIPLYIGLVLFLVASIVTVFASNVEILVAARLAQGLGGASGMVIGRAMVLDKEKGAAAAKALSIMMVIGGIAPVVAPLAGSLLADLIGWRGLLAIVAGIGVVGIASTVFFIRETLPKSQRSHSAQASTSKPIKALAFRGyvVAFAFAMAILMSYISASPFVYQNMIGLDAVGYGFAFAVNAIGITVLTGISARLTGRVTTFALTLIGLSTSFIAIVVISILTFSSAPawLMVPLFCAIAPLGLVLGNATALALSAVPQTagTGSAILGLIQFLLAGIVAGLVGIAGEDTTVPLALTMVAAVLIALSGLAL------------
     803 UniRef50_A8KZ35        Drug resistance transporter...   180     1e-43  1  20.2%  4:364    1:415     ---MRKWLTLITVSLSTFMLLLDVTIVSVAVPAMARALDSSFTDLQWTVDIYVLVLAALLMAIGSASDLLGRRKVFLLGLVVFAAASLACGLAPNTGFLIAARGVQGLGAAAMFATNAALLSATYRGRDVGVAFGVWGAVNGAAAALGPIVGGLLTEHVSWRAIFLVNLPVALIAIVIALRSVAESRDRMSGRIDIPGTVtrLFRGPSFSALMVGGFVLTGAAFANLVFVSVWAQTVLDFDPVKAGLVLTPLAGVSFVVAGAGGRLLHGVPPRYSIGAGLLLVGVGTFLDMIIAPSSGWTALLAGLIVTGVGVgaSPALASAALTTVPPERAGMANGAMNTFRQLGFAVGIPVFGTALAGQARA------------------------------
     804 UniRef50_Q03AB2        Permease of the major facil...   179     1e-43  1  18.4%  1:358    4:413     MSASRRWLILIATSIVSFMATLDASIVNIALPYIARELKVPMSTVELVTSVYMIAICVLLIFWGKLSDSVGRIWLFQLGTILFALGSLFCGLSMTLPWLLTARLIQATGAAMTMATNFGIITAIFPMNQHGRALGVNSALLQLGNIAGPGIGGGVLAVLSWHWIFLINVPVALVAFLIGVLVFPRQRPSLAGAHMDWPGyfAIFKNPGFTIGILTAMIVYMLGYFNSVIMPFYLEETLGLSALTAGFCMMAIPAANVISAPIGGNLGDHSGAERVSFFALFLWCVPMGLFAAVTPNWPLGWIVFGLAWSGLANG-AFQNNPMMMDNVAPRFQGLAGSMAALGRNLGMTIGVALVTSLL------------------------------------
     805 UniRef50_Q0B8M3        Major facilitator superfami...   179     1e-43  1  22.8% 11:370   42:403     ----------ATLILLCAFSVLPLSMLLPSLPAIARDLHADYGLVALALGGYAAVAASLEFVMGPLSDRFGRRPIMLASLGVFTLGSLGCAMATDIRMFLACRLMQA-AITSVYPVSMATLRDTAGGERAASRIGYAAMAAAFAPMIGPTLGGALDQTVGWRSSFWLLGAAGIALLGWCGFDLAETHTKRATTLaqLRAYPALLRARRFWAYALCMAFSTGAFYAFLAGAPLAAQAKFGIPPAEIGLYMGTITAGFVCGSFLAARHAHRYPLAATILCavACMGPVIALALLFGGATHAIAWFGPCVLIGVGNGLSNPGAHAGAMSVRPDLAGSASGLVGAMTIAGGAALSSLTGAVLTVRNAGYAPLVV------------------------
     806 UniRef50_C6BBI6        Major facilitator superfami...   179     1e-43  1  18.7%  1:391   29:480     LSRWRRNATLGILTSGVFMAVLDTTVVNVALIAMRDSLHGSVAELAWIVDAYTLAFAAFILTGGLLSDRIGARTVFMAGMAVFIVASAGCGVAPSVATLIAARILQGVGAAMFLPSSLSLIRSTfdPRERAWAIGLWGAIVATAAAVGPAVGGVLVDTYGWRSAFLINVPLGVVGMLGTWMIVRNDQPARAKPFDWAGQvlAWLGHRTLGAVNGVGFLLNFGYYGALFVLSLHLQNVEHLSARQTGLVMLPMAISLSAGNIFAGKLMAHFSMPTMMLSGLVIGASGLLAtaALTGQVHPWVVSAAMVAYGGGTALAIAPMTSTILSAApeLAGTASGLLNAARQTGSLLGVAAAGAVVtaHASPMVFGLMTLSYAGAMAMAWISRRPAATA---
     807 UniRef50_C4TYD0        Major facilitator superfami...   179     1e-43  1  19.6%  4:386   18:455     ---PRRIRMLIGISIASFLGCIDFTVVNTAIPAIAQDMNASIPRVQWVVSLFLMALCAFMVTAGRLADLYGRRRVLYVGMMVFGVSSLGAGLTESIGVLNGWRFIQGAACAVLYTVTVTIVADAFPDHQRGRAVGTLLGVNGLGLALGPVLGGIVVSTLGWRWVFLLNIPLILLSFAFCLGNIRESRLSEGRPLLDirVAAPLVKLSLFRIPAFSIACLASALLAffFLMPLYLEGTRHYSGLILGLLLLPTTAVMALISPLIGRWMDAAGARPPLIMGFIALALSAGLQATFTPSSALWIIIAAFTLMGIGWGAILSPAAVSALNAvaEQGGSAMGVAWTLHNLGGAMGLAVSSLIYTTFSQGYQSAMLLLVAISVVGLLAVSWR--------
     808 UniRef50_A7I9I4        Drug resistance transporter...   179     1e-43  1  18.1%  8:366   21:438     -------LLVFSISLATFMAGLDGTIVNIALPTISEAFHVSSTTVSWVATAYLLVMAGCVLIFGKISDIIGFKKIFLTGFVIFTLGSLACglFHSLPVLVGSRMVQAIGGAMITAIAPAMVTAYIPLDQRGKAMGIVMTLAGLGTALGPTIGGFLTQYLSWHWIFFINVPVGIGAVILGTREIPASTARGSLAGFDRSGAVLIfwTSPAILGIAALAIVTLAWfgINYLLPFYLKYIGAYDTSTAGLIMTALSFAMMVAGILAGMLFNRTGPKLLCIAAGILLTAGYFLIMQLHPDTPVGYIVLCLALIGFGLGLIITPASNLVMNSVAKaqGMVSSLTSLERFVPLTLGIAMFNLIFLWGILSIA----------------------------
     809 UniRef50_C6IZB1        Major facilitator superfami...   179     1e-43  1  17.9%  1:392    3:450     MNGKYRTLVQYIICTGAFLSNCSAGMFNIALVDIARDYQIGLASAQWVVTAYLLVISVLLPVMGKLGDIRGRRSVHNLGYLGFALGALGCALAPSLGWLIAFRIVQGLGASMYQATNMALIVSLFPPEKRGRALGMISTFVAAGSMIGPSLGGVLIQWISWEACFWLLAGTALVAWMMAQRFIPKDQPEEQGHIDVTGALLFGTSLTGLVTAicAAGFVMWSlfSAQLVLPVFLRHELSTPPAMAGLMMMGYPLALIVASPLFGSLSDKHGSLPLLTAGLLAMSGTLVALGFLSSSYPMFLLITLIVLLGASMGMITSPNTSLVMGRvpGHLGLISSLLALSRNLGMIftAAGGAFIAGADGYRMVFVLCLALVLGSVVLLLVTVRQARHRR--
     810 UniRef50_Q28PX7        Drug resistance transporter...   179     1e-43  1  21.2%  2:388   10:405     -TRLSTGEFIALIGMMFGTIAFSIDAMLPALPQIAEELTPDdtLAQLVLTSFILGMGVGTLFTGPLSDAFGRKPVIFAGAILYIAGSILAWAAPTLELLLAARVLQGLGAAGPRVVAMALVRDLYTGRAMARIMSYAMLVFTITPAIAPLIGEGIITLFDWRAIFLTYVLFSCLTVGWLMLRQPETLPRGLRKrsLWAATREAMALRQMQLSILVQSLIYGALFGTLSSVQQIFDLTYDMG-DAFPWLFGAVALLAAPGAPINGRLVVRLGMRPLVRRALFLQVAAaaLMLGLPPGTEVWIYFAWTVTVFMMMGFTIGNLNALALEPLGHIAGISASLMGSISTIGGAAIGALIGQLYDGTALPLAVATALLAGIGGLIMRRMPREGR------
     811 UniRef50_D1C8Q7        Major facilitator superfami...   179     1e-43  1  18.1%  3:362   25:437     --RAHERWVVAIVGLASFMTVTSGTMVNVALPPIGDHFGVDAGALGWLVSIYLLTFGVAMPFHGRLGDRFGERRIYLGGMVLFVIGAALAGLAFAFPMLVIARCIQGLGAGAITSLGMAMVARIVPPERRGRTMGIIATAVSAGTAIGPTLGGIITQLIAWRMVFLFAAMLAAV-IPLAARYLPPPLLHQQVRIDWLGGirALLANRRYVLLALVGFLTMNGGMGVIVIAPFLYTNVNGLPSGQVGLALLPQALVVVLLAGTAGRLADRWNPFILIIPGLLISCATVLFLSSVAIGWPAAAFSAVTMFLGLGQALVNAPLMTVLTRTIPARigVGLGIFNMLFFVGTSLGAAVATALLESRA--------------------------------
     812 UniRef50_A5VC62        Drug resistance transporter...   179     1e-43  1  18.4%  8:360    2:408     -------IVTTAIMAATILVVLDQTIATVALPHMQAALGATPDTVTWVLTSYIMATAVGTPLTAWLTGRFGRRQVFLVCVLGFTISSMLCGAATSLPMMVACRLAQGFFGAFLMPMSQAFLYDMNPPSLQVRAITMWGIGAMVGPIVGPVLGGYLTDAFDWRWVFFVNVPVGIVALAGVFFGLPEFPSARRSFDHviAAFWMLIFhpSFSGAMVLAFVLMPTIIASNALLPQLFVQLLGYPVATAGEMMLPRGIAMTIGIFLGGQFTRWMDGRLQVALGVCIVIASLYVQTGFNMEMDQHLIIWAGVLQGFGTGLSMTVLNFTAMSSApsHRTEAAALYSLSRNTGSSIMLAIFSGLLAH----------------------------------
     813 UniRef50_A0Q5Z6        Drug:H+ antiporter-1 (DHA1)...   179     1e-43  1  21.1%  3:386    5:393     --RKGSKYLIFFVVIFVALPPFAIDAYIPAFGNIADFFNVNVNKVAITVSTYVVGFGIGMLFWGALSDRFGRKKILTIGMLIYIVSSILCSLTHSFDTLILMRFLQGLGDSPAGVAAMAVLKDCYRGQKLMKMMATMVMVFMLAPIVAPIIGSLIitTGSWQDIFHFLTIYGVILLILTLI-MPETHPSYKRSKNlfKTYLNHFMNIPFIFGGLTGGLCFGALFSFITASSNLIIGYFHLGYTQYCILFGLNICGVVFASNYIRRKVTAHNQRKLILNGYYFAIIITIINILSSyfDNIYIFIFLNALLTIGLAFVNITTTSKVIDLLKEGFAAGNAVIRLVKFTVAGTAGFFLSFliSKLMIGIPAQQLGFIVASLCLFLLIKHR--------
     814 UniRef50_C4XGX8        Putative drug resistance tr...   179     1e-43  1  18.0%  3:369   13:433     --TPRPALAMIGVNLMVFMATLDMSIVNVALPTLTESLATDFATIQWVILSYVLVIASLLLLVSRLGDMYDKKRIFGSGLVLFLLASLCCGLAPSVSWLIGFRAMQGIGAAMSQALGMAIVTQLAPPSSRGRALGFIGATVAMGLMLGPPLGGVLIGLLGWRALFLLNIPLGLLALFAVVRFMPALPPQRRGERFDLPGAAIalFANPLISLPLAMATLVFVTGASGFIMPFFLQAGQGYSVTQVGLLLMILPASMAVTAPVSGSLADRYGARGMSLLGMVVLTGGCLALGTLTEHTPWWGYLLRTMPVGLGIGIFQAPNNTTIMGQMPPHrgVGSGLANYARVFGQSTGLPLVATIFSGIVHATGSIA-------------------------
     815 UniRef50_D1RIY4        Major facilitator family tr...   179     1e-43  1  17.3% 22:385    1:368     ---------------------MEIDISLPSFPSIMSYFGSTEAQVQSTLSLNFLAFCLSGLLYGPLSESWGRRGLMLFGATCFLIGAVGCVFSFSIYQLMFWRFIQGLGASSTLVMGFAMISDRYSGEVAANYIGKINAYVTIFMAAAPILGSAIINYFTWRANFTFVAMIALISWLFLIWQLPETKTKKQpiLTLFKDYWTVFSHGKFVIYASMPNMLVTAYLTFVGSASFYYINTCKLSYFQFAMQQGMIVLIFSLTSFYAEKVIARIGSRKAVNFGMVCCTISIVLFTYFAFDysPHLITFAMCWMAVGCAFPMSVTFAQSLEILPNLKGTCSSFIMSTRLFVSSGAVALTGLLFDGSMRPVALVIDGAIIIGISLYFLIER---------
     816 UniRef50_D2EJP8        Major facilitator superfami...   179     1e-43  1  17.4%  3:358   10:420     --KNKKTLILIALGIFTFMSTLDGSIVNIAMPIMSKEMNISLSRIEWVVSIYLIVISALLMFFGRLGDVIGKSKVFRIGTAIFILGSLLAGINLGLAFLLFARAVQAIGAAMTMSNSFGITTSTFPIEQRGRAMGVIGTFVALGAVAGPAIGGLILNYLTWNYIFWINVPIGIIAVLIGVKSLPHDQPLAANApaILRGQERGYLNPLILGALLIAIISFILffFYNVLMPYYLVNARGLSSGVAGTLLSIIPLTMVIFGPVGGFLSDKFGGAKITVIGVTLLLISQFLIMGFNLQTPYWFFIFASIVTGMGTGLFQSPNNASVMSAVPHNrgIAGSVNALARNLGMILGVTISTSAL------------------------------------
     817 UniRef50_A6WGF0        Drug resistance transporter...   179     1e-43  1  27.7%  2:344   41:406     -RTPSTAGLVVLLGAMAALGAVTIDLYLPSLPEVAVDLGTTEARTQLTITGVLVGAGLGQLVVGPLSDAYGRRRPAAVGFVVYVVATLLCAVAPNLPALVAFRVLSGVGASAGAVIGMAVIRDLFVGPAAARLQSRLVLVIGVAPLFAPTVGGAIAAHTGWRPVLALLAVAGLGVLIAVWRRLPETrpRGARVLRTFTGYGALLRDRRFLALAAMPGLALATIMAYVSTSVFVLQDGFGLSGTGFAVYFAVNGTALVGGSQLNAALVGRFGSARLLRVGVAAAFVFGLALAGVLMARtlLLFAVPLYLLLLVLGLIMPNAVTLALEPYGDSAGAAAALVTALQS--------------------------------------------------
     818 UniRef50_C6IZA1        Drug resistance transporter...   179     1e-43  1  17.8%  1:360    4:415     LSLKRKVSIMIAIMAAMFFAAINQTIVSTAMPRIISILD-GMDYYTWTINIYLLTSTIATVLVGKLSDMYGRKPFLLIGILLFMMGAFMTGTSSDVFQFIAYRGIQGIGAGIIQSTAFTAVGDLFPPRERGKWMGLMTAIFGFSSVLGPTLGGYLVDHMDWHWLFWIFLPLGIVAFIMILSLFPKMERGSSQSIDYVGSLFMTTTIVPLLLalLVATVVSGLIFVflIYLSFFVQGVLGISPTYAGYVTMPMSIVMVVASAITGQLIAKKGKYKQFALFGIPIMIAGMVIMIF--MNSVPVAILSMIVFGLGLGVGMPVFSLATQNAVPheLGVVTASTQLFRNLGGTIGIAVMGTVMSN----------------------------------
     819 UniRef50_A3UGC7        Drug resistance transporter...   179     2e-43  1  24.1%  7:383   17:398     ------RELIAMVGCLMALNALSIDILLPALAEIGHALGAPGNDRQLVITSYVFGFGLAQLGFGPLSDAMGRRKTLLIALVAYLAATVLCLVSQGLWALVAARALQGVAAAATRVIAVAIVRDLVSGRRMAEIMSFAMTVFTVAPILAPSIGQLILFGGDWRVIFIFLFVMASALALWMMTRLPETLHPEKRIELRLGsyALAASNRITLGYLTASCFIMGALFAFIATSEQVLAELYELGA-MFPIAFAVIALGLAGANIVNAKIVRRLGMRRisALIAYLLVNGANMTLAFFGKPPFLAYFLLLMTALMLFSMIGANFSALAMEPAGDRAGTTAALYGSSTAMAGAVLGSVIGQGYDGTVLPITLGFTVLGAIAFLIVLWT-----------
     820 UniRef50_Q0BW46        Multidrug resistance transp...   179     2e-43  1  22.0%  2:378    3:386     -SARLSVPLIILLGLVTSVGPMSTDMYLPAFPQLQADIGGhqGAAQITLAAWFVGLAIGHLTNGTLSDRFGRRIPLIAGMLIYTLASTGCALATDLWSFTLFRLIAALGGSAGMVTPRAIVRDMSDGHEAARLISRLMLIMGVVPLLAPTLGGMMLSVMSWRAIFWLGSLYGAVCVVLVIMFLPDTLAPEKrpGSIVIRYGTILRERVFITHAMLSGFCVAALFTYLAGSPAAFIQYYHISPTVYGMIFGMNAVGYIGCSQLNNLALPRLGMHRVLRIGTtlWLVSLLIVNVYTGLGGLIGMMILLFLAQSIQGFLTPTAAVGALSPHAAHAGSASALMGTLQYVLGALFGTGVAVLADGTPRPMVVFMMLGGICSLI----------------
     821 UniRef50_A7IGU1        Drug resistance transporter...   179     2e-43  1  23.1%  4:389   22:413     ---MSEREVSVIGALMVMLGPISLAMYTPALPTLVEAFGTSIATVKLTLTVFFMGFAFSQLVCGPLSDGYGRRPVALGFFGIYLAGSVVAMLAPTIGWLIAGRALQGIGCAAGIALSRALVRDQYTGQASARVMNLIGTMLAIGPAVSPTLGGFILGTAGWHVIFIAMAAYGLLLVAVLALRVPETNRSPDrpRGVTTSYRRLLTDRVFMRAALTAGLSLGGIYTLSALLPFILIQRVGLSPTGFGLAMLLQTGAFMSGTLIARPLLKRYSAHALILPGLLLVLTGAVGLGlfVLPLSVASVMLPISFWACGVALLLPGCTTAGLAGFAPIAGAASALMGFLQIGSGFLGTSFAVLFPSPLVAMMTLLPALAVTAAGAHVLLAPRREPA-----
     822 UniRef50_A8H6A1        Major facilitator superfami...   179     2e-43  1  25.1%  1:378    1:380     MSRVMNFKAILLACLIISVGQLSMGLVFPSLPWIAKDFSVSHEQVQILVSIYLLGFGPSQFFYGPISDALGRKKVLLIGLMIAMLGLLMIIfsHSFTGMVLGRFLQGLGTGCCAVLARASTRDNFSGAELPVAMSYIAMVASITPLFAPVLGGFINFHFGWTMVFISLLGYLTLVWAVAALRFQEtpSPLPSPKKVLLQYRELLSSRYFMSFASIGWLNFSLMITTISVMPFIMQNQIGMTSDKYAMWAIIPALGMLIGASICNRIRPLIGSKKLLLYTPVLHLAAAVWLFFCPVEP--LYLMLGQLLMILGNSIALPCVQAMVMQPYKKQAGAAAAMSGGGQMVVSSIVSMVLINLGLSQAWQLSLIIVVFAIITLI----------------
     823 UniRef50_C0N4Z2        Drug resistance transporter...   178     2e-43  1  23.6% 24:383   16:378     -----------------------IDAYLPAMPQMADFFTVSIHDIELSLSLFLAGFAIGQIIGGPFSDHFGRRAATGIGISLFCLGTLGIILSPSIAWLWGFRIIEAIGGGLAVVNSAAIIRDFSKGQESARHLSNMAIIMMLAPLLAPVIGMLLLHISGWRLVFDFLLLYGLLIGATLFFKLPETRIKTEDRPNAFRRYWMVLSNRYAVGFLFSQCFALGGMFAFITGSPSVYMGFFGVSETVYPFLFGTNVVAMMLFNRLNVRLLKQHQPRVILSVGQaiTASLLLAYVSLSSTPSLYIVTPLIIIFIGIMGLIVSNATSSTVEFFPTNSATATALLGAAGFTTGAIAGAIVGILGDGTAFPMALVMFTCAATAPLLRFLV-----------
     824 UniRef50_D1VGI9        Drug resistance transporter...   178     2e-43  1  18.6%  1:360    1:415     MSPRRRLAVLVTVCLAVFAINLDTTIVNVALPDLARQLGATTRDLQWIVDGYNLAFAALVLTAGSIGDRFGRRPVLLGGLVGFALMSGIGALCDGAGALVAVRFVMGAFAALIFPTTLSIITNAYPDreRAKAIGVWGAVTGLGVAIGPVTGGLLLAHFWWGSVFVALVPVALVAAVLAFVLVPESSDPAAARLDLPGLvvSLFRTPAFSAASGAVTVAFFALFGFIFLITQYFQFIRGFGTVSTGVRILPVALTIALGSVTGTLLAGRLGTRTIVVTGLVLFGGSFAWIAVSSTYQPYLQIAAQMVLMGTGLGLTTAPATESILSVLPAaaGVGSAVNDATREAGGTLGVAVIGSVFTS----------------------------------
     825 UniRef50_Q4K4A0        Multidrug resistance transp...   178     2e-43  1  21.7%  2:388   10:398     -STTRKVGAIVLLMAMVMLGVFPIDVLLPSFPALSQHFATSAADIALSVSLFAIGISMSQLLIGPLSDALGRKTLLLAGMAVSVGGALGCVWARDYNWFLVFRVVQALG-CGCFVLSQALVQDLFVGQERDRLRILMVTASGLCISLSPLAGTLLQSLMGWPGSFYVFSAIAVLVFLKALATLENPpvRSGPRTGILQAYRRVCSNFSFVAYWLISAIVFACHFSFIVVSPLIFLEQLQLSSYEFSLTLLLYGAAYVIGGVVAGVLNKYLEPGTQIITGLCLIFLAGLVMLLLAsgLSISTVLVPMIICTAGTTITRPAATSRAMELFPDNAGASASAGNTLIFVMGGLISAVINLSASDLQTTLALSFIALSSVGLLVNQRISRRAR------
     826 UniRef50_B0TJE8        Drug resistance transporter...   178     2e-43  1  19.9%  8:388   21:404     -------LLIPMLSAIVAITPLAIDMYLPAMATLASSFDTDITLVQQSLSLYLGGYSLGMLCFGPLADRFGRKRLVILGLTGFMLTSLSLAFVTTIENFLALRFLQAFIGAAATVVVPGYIKELY-GKNTAKGMSYVSLIMMLAPLIAPSIGSLILEFGEWQLIFFILaaFILLLLISLKLKMPSDKdsTRSTQSFFGAYATVFTKKGVKLNIASGVLTSFAFFCYLTASPFVYMEVFGLDKSLFAVLFSTNVGALMLANVVNSRIVGRYGSKRMLKVSTFFGTISGIALLSvlLGLSYHFSVMMLLPLMACLGVMSVNADAIVLMKFQKETGTATAVIGTLRFGFGALAGPLLALFYTGTAVPFSALMLSAVILVGLCQFLSRHEPA------
     827 UniRef50_B8GBJ6        Drug resistance transporter...   178     2e-43  1  20.1%  2:389   19:414     -SSPRMGEFIAMMALMTSLVAMSIDLMLPALSSIGHELGAPHANaqLVVTMVFVGLAIGQLLYGPLSDSIGRKAAIYLGFTVFIIGSVLTIIAINFPMMLAGRLLQGLGVAGPRGVSMALIRDRFSGRAMARVMSFIMVVFIIVPIIAPAVGQAILLVAAWRMLFVTLLVLGIVSLLWFGLRQPETLPAAQRTprIGRAFREVVSHPIALGYTLMAGVISAILQSYLSSAQQIFQEQYALGTL-FPLFFAGNALAIGLASFVNGRLVMRYGMRSLIGNALLVLIGLTITLAGIagQPSLWVLMAALMPSFFCLGILFGNMNAMAMEPLGHVAGTGAAVVGSLSTFVAIPIATIIGQAYNGTITPLALGFAVLALSAFGLMRWADGRQHR-----
     828 UniRef50_C5SHD3        Drug resistance transporter...   178     2e-43  1  20.0%  2:366    8:446     -TPAERRVTVIALMIVFLLSALDQTIVSTAMPRIVAHLS-GLDLYAWVTTAYLLASTVMVPIYGKLSDIYGRKPILVIGVIIFIIGSGLCGMAGEFgqLIVFRAIQGLGGAALMTSAFAVIADLYPPRERAKLGGLFGATFGVASVVGPLIGGFFTdiAGWRWVFYINLPLAGLALFMILVKTPKLLHRTGGKIDFAGAILllFRNRTFASANLASVLIFMAFMGLVSFLPLLMQLALGLSATTSGLALMPLTVGLIASATLSGLLVHKFGKYRLIMLGgaLTALGALCLATMPNTAGVWDVVWRVALVGIGLGPAQSLFNLAVQNAvrRDLGVATSAGQFFRQIGSTIGVAVFGAVLTHNLMVMA----------------------------
     829 UniRef50_B8LU96        Efflux pump antibiotic resi...   178     2e-43  1  13.6%  1:360   49:470     LTKAEAFLLIVSICIPTFIAALEQTIVSTAVPTIAKSFDATPVEYAWIGTAYLLPVAASAPPWGALSDIFGRKPALLGAIFVFFIGSLIGAVAPNIHAVLAGRVIQGTGGGGILGLSATVVGDAFSPRERSKYYGVIGVIWGLACGIGPIIGGAFAQFVSWRWCFWINLPVAGVAAVCVFFFLKVHTPRTplAMDWLGTLLLVcwDSAIVICLIVFgfGIAYLHGAIFIANLYYLPLygATPILSGVYLLPVAITLCVLSSLSGYYISKSGRYRPPiiGLIVMLLGTGLYIDLKPSPSWSRIIIYQIVSGLGLGPVfaPIMAIFTLTKPADIAAATTTLLFIRDIATAMSIVFGGVIFQN----------------------------------
     830 UniRef50_A8LFX3        Major facilitator superfami...   178     2e-43  1  17.5%  4:391   79:534     ---PRRWRALPVILIASFMSLFDVFVVNVAAPSIESDLHASNAGLELVVGGYSFTYAAALVTGGRLGDRFGRRRIYLLGMAVFTAASALCGLAPNEAVLIGGRLLQGAGAAAMVPQVLALISVTFPPAERPRAFAFFGVTIGLGGVCGQVLGGVLLDllDWRPIFLVNVPIGLAALVGARRLVRESRAARAERLDPVGLGTLTlgWPLWTWLALAAGIVVLGGFgfLLALTIFLQVGQHRSPLNAGLMFAPLGVVFAFSSLAARRLVTVYGPRVLTAGALTTALSLVGVAVAVstGMTAYELTPLLMLAGIGNGLVIplAASVMAAAPPDISGTVSGVLTTTQQFASALGVSGVGALfaRSGADAGLFAAVICGLISVGAAFLGSLVLRRP---
     831 UniRef50_C4RFW2        Transmembrane efflux protei...   178     2e-43  1  19.5%  2:360   69:483     -STGHRGVILTLILAVQLMIGIDITVMNMALPQIQEELNFSPTGLSWVLNAYTLAYGGLLLLGGRMGDILGYRRALIIGIGLFTIASLLGGLAPNAWLLLVARVAQGVGGALAAPATLALVVSTFqeEERNRALGIFVMASGLGSAGGLLLGGLLTDAVSWRWVLLINVPFGLVVCLLAPKFLPIT-PVQSGRFDAGGAFTATLGTAALvgGFLVFVCSGAAMFGSFFLLTQYVQEVLGLSPFRAGVAFLPMALLMLAVPpiTPWLVNRLGAKPTMLIGLTLILLGMVWLTQVTADTAYlgVLGPMMLFGAGVGLLNPPLttILASVAPEDSGAASGAVQAVGMIGGSVGTAILVTIFGT----------------------------------
     832 UniRef50_C5SLF2        Drug resistance transporter...   178     2e-43  1  21.9%  9:383   15:395     --------FVAIIAACMAATALSVDTMLPALPAMAADFGIDNarMQLIISVFFMGIGVGQFICGTLSDWLGRRRVLLGGLIVYVLLSLTVSLVTDLEHMILLRFFQGVAAASANVIPRSAIRDLYTGARMAKVLSTSHVIFMAVPIMAPSLGQLIMLAFPWRGIFFALTIAGLLVFVWVWLRLPETLSVEQrpGKFLRVARYIASEPMSLGYGLAVMVMTAMILCYLSMMPQIFEEVFHQ-PGYLGLVFALCAGAMAVGAFTNIRLVERLGTRVMssLTALIILSTVHVIWALLGYETLISFTILQGLTMMCMAMCTSNFTAIAMEKVGHVAGTAASLQGVLSMVGGGLIGAWIGQFWSGGVWLLPLAAMGLGLTAICIILVV-----------
     833 UniRef50_A7NEP7        Multidrug resistance transp...   178     3e-43  1  24.7%  1:389    4:396     MWKYSPLKTILILGPMVFAFALAMDVYMPVLPDMREALHTTQQMVQVTLSLFLVVTGVGQLFLGPLSDQLGRFRVILLSAVLFVIGSVLCALSSNIEFLIASRVVQGLGCCGLSVCAFAIIRDAFSGKTSSMIYSFINAIISVSPIIGPLIGVQLAIHFHWQSAFVFLTGLAVVAFLIVVIFVKESLPVERRKknVFARYLYVAKSLQFWAFSLAAVSGMASFFILFSMTP-YIINYLGYPISEIYVVFGSAGLAFLIGSLFAGVIVNALGVYKTALLGVACVFAAGILSLSiiWGLSLWGFFAPCFLATFGCALTVGTGASGSMEPFYEIAGVAAALFGTMEFAISGIIGSIAMLFPATSSLPIAITMIIMSILCFVLLFLIKGKTKH-----
     834 UniRef50_Q4MIT7        MW2376, putative n=9 Tax=Ba...   178     3e-43  1  16.6% 10:389    5:382     ---------VFILALATIAVGLVELIVGGILPDIAKDFNVSLSSAGQLITIFAFTYAIAGPVLLIFTNKVERKKLYIISLYIFLIGNILTYFSPNFTFMMIARILTAMSTALVVVLSLTIAAKIVNPSYRAKALGLIYMGISSSLVLGVPLGILISNTFGWRVIFLCIAILSLGSIILISVFLEKIPGEENRIP--LSIQLKAVCSPKLGAAHLATMFMLAGHYTLYAYFTPFLEDKFHLSPYWISIFYLVFGIAAVSGGAFGGVLSDKIGAPKSIVIVITLFALILFILPFTTV--SIILFVPVMIVWAALSWGLAPPQQSYLIQTAPDTSDIQQSFNNSALQIGISLGSAVGGIALkhNVANMAWVGGSLVLLSLGLAIFSLTRHTP-----
     835 UniRef50_A1C187        Transmembrane efflux protei...   178     3e-43  1  18.0%  5:366   24:440     ----RTGIALTIIVVCQLMIVLDMMIVQIALPDMKSSLGLSTASMSWVINAYTLAFGGLLLLGGRAGDILGRRRVFLIGVAVFTLASFAGGLATEDWQLLAARAVQGAGGAMAAPNTLALIMSIfeGPKRARAIAMYSVVGGSGAAIGLILGGVLTDVASWRWVMFVNVPIGVAVFLLTPLFISETEKHSGrtSTLVAFALAVVLLPSFVasYIAMLLIQGSMIGMLFFLSQFVQQIFDYSPLTAGLCFLPVAAVLVPVAGMVTKLVAQVGSKVLVIAGAVLLTGANWWLSRLDEGSSYWalLPPMLIFGVGMALaiPPTMLALSGVAPEESGSASSVLNALQQVGGSLGLAVLVTVFTEGGHRAA----------------------------
     836 UniRef50_A6LUR3        Major facilitator superfami...   178     3e-43  1  14.7%  3:384    8:388     --TREFRHASIALFAGGFNTFAILYCTQPLMPYLSKEFGISPTMASLSLSVTTCTLAVSMLIFGSLSEVLGRKPIMCFSLFASSILAVLTAIVPNFNSMLVIRCLQGFVLAGLPAIAMAYISEEIDKSSLGLVMGLYISGNSIGGMSGRIIIGVINDFFNWRLALAVIGILGLISSFLFWRKLPLSKHFEARskNLIKSSFNHLKNPNLLCLYCIGFLIMGSFVSLYNFIGFQLIEryNLSQTLVSFIFVIYIVGTF-SSTFMGRLADKHGQYIM----LCISIFIMLFGISITLNVSLLLKIIGIALLTFGFFAGHSIISSWIGKIATHDKAQASSLYLLFYYVGSSVGGTAGGTFWSLYGWEGVVIMISCFLAVAFFILIGL----------
     837 UniRef50_UPI0001AF64BB drug resistance efflux prot...   178     3e-43  1  18.3%  6:361    5:414     -----PRGVVLACCGALVVVMSAVAGVNVALPDIALDQGASATDLTWIADAYTVALAALVLPAGAIGDDFGRRRTLIGGTLLFGLANVLAAAAGSPHTIIIARVIMGIGAALIMPSTLSTITAVVHPDHKGRAVGIWAGFASAGSIMGLLISGLLLEHYSWRSTFIGTAAMAAVSLLVTVALVPDTKSAEEPAPDFPGAGlrLFADGGFSSGTAALIIQFLGTFGFFYVGLQYIQLMLGYGPLKSSLAMLPMAAVVLPVSAIAPKLGERLGNRLVIAAGLACMVAGFALLARLGTASTYTDLLIGMLVFSGGLALSATPATNTIVDspPDKQGVASAMNDVTRELGAALGIALLGSLFSAG---------------------------------
     838 UniRef50_B1LVU0        Drug resistance transporter...   178     3e-43  1  16.9%  5:359   37:456     ----NPWLIAGVVALATFMEVLDTTIANVALRYISGGLAVGPDEAAWVVTSYLVANAITLTASSFLAKRYGRKAFFMWSVALFTASSILCGFAWSLESLLLFRVMQGLGGGGMAPLAQSILADSFPPAKRGQAFALYGVAIVVAPVIGPTLGGWLSDNASWHWCFLINGPVGVIALGLMYWLIEDSDAAKKERRALVRKGIRFDIVGFVLVALFLGSlgVLMVVSFIAMIPWLLtdLRLIGNRQFGSCFLVMMfvTVVMMFLTGRISSYVQPKWLIATGMTIVALGMYDLTRIDGSTTFAFFAWSRVYIGIGLPMVFLSITSASYEGIRKDQtqASALINVARNVGGSMGVSLAQNILA-----------------------------------
     839 UniRef50_A5EVP1        Drug resistance transporter...   178     3e-43  1  21.1%  2:361    6:418     -TQQPSRYLPCLLTLAIFMQMLDTTILNTALPSIARSLHESPLSMQSAIVAYALTVALLMPLSGYLCDRYGTRKVFANAMLLFVVGSVLCAAAPSLTFLVLGRMIQGMGGAMLSPVPRVVVMRAYPRNQIVSMLNLIVMPALIGPIIGPLLGGYLVEYAHWSWIFLINLPIGILAILATHRVMPDFTGAANPRLDIVGFLLflFKVRTYRVGLSGNLVSRLGMSSVPFLLPLLLQVVFGYSASAAGWMLMPIAFAAMFGKMVTLPLISYFGYRRLLIINTRLIGILIMSLALPQPHTSPWLLMPLLAGIGLSNSVQFTSMNTISLADLRIYqgSGNSLLAVDQQLSISMGITLGAAVLTGF---------------------------------
     840 UniRef50_Q1GI27        Drug resistance transporter...   178     3e-43  1  22.5%  1:383    2:386     LRPAQTPPMLMTLVFGTALSVLSLNMFLPSLPGIAQEFGVDYGLANLAIAGYLTISAGLQLIMGPMSDLYGRRRVMLLCCALFVLASVGCALASNIWVFLGFRLLQGAIISG-QVIARAVIRDMYPPSEAASKLGYMSMIMALAPMTGPMIGGALDMAFGWRAGFWLYSGLGLLVLWLTWGDMGETNTKRAAtrAQMRLYPRLFSSRRFWGYSACVAFSIGGFYSFVTGAPMVAAAWFDLSPAMVGLGIGIITCGFMVGNFVTGQLAQRLRLLTLILigVACLGPAVGLALFFMGQGSELVFFGSAICVGFGNGLTIANASAGLMSVRPELAGSAAGLSGALSVALGALLTAVTGVAVEPETAPFAVLGIMLSASVLALVSAL-----------
     841 UniRef50_UPI000185C2FB drug resistance transporter...   178     3e-43  1  20.9%  3:360   11:422     --PKKAWPALWTVLLGFFMILVDATIVTVGINTIQHELGGELNQVMWVTSGYLLAYAVPLLITGRLGDLWGVKHTYVAGLVIFVLASLACGLAPSLSMLIIARVVQGLGAALLTPQTMALITQMFPPAHRGAAMGLWGAAAGIASLTGPLAGGILIQLLSWRWIFLINVPIGLVGLVFAFRYLpeTHRNKIDYLGVVLSAIGMfkDRNFTISSLAIAVMGALVVAVGFPIILFAQNARDLSTIQASLLLVPQALISGVMAPWTGRMLDRLKFREFALIGFGSSLVGMLGfyLIHEDLSVLWLLLPGAAFGVANAFIWGTLSTAAtnIDPTLAGAASGVYNTIRQIGSVLGSALIATVMAA----------------------------------
     842 UniRef50_Q67MP2        Efflux transporter n=1 Tax=...   178     3e-43  1  17.6%  3:359    2:415     --RDRRMLTVFALMLASFLTAVDVTIVDTAMPRIVGSLG-GFSMLTWLVSAYMLTSTATMPVYGKLADIIGRKRTFTIGAVIFVIGSALCGAAPSMEALILFRALQGLGAGAMQPTVQTILGDIFTPAERAKVQGWFSAVWGFSALAGPLVGGLMVDYLSWRYLFYINLPLGALALYMVWRHFDERVQRRKARVDYLGAVTLtwGSPQILGMAGGAAvvGGVMYGTSVYLPIWAQGVQGYSATRSGASLLWLSIGWPLAAVLGSRLIVRMGVRPSALLGLGLNVAGSAALVALaaEIPEVLLALVTFVIGAGMGFSTLAFILGIQSSVdaQRGVATASFQFIRTLGGMIWVSAMGGVMN-----------------------------------
     843 UniRef50_C5CMZ9        Drug resistance transporter...   178     3e-43  1  18.5%  4:360   28:440     ---ASKPWVLAAAIVGSSMAFIDGTVVNVALPAIQADLRATAFQAQWVVESYALLLAALLLVGGALGDHFGRRRIFAIGVGIFALASVACGLSGSVQQLIAARAVQGIGAALLVPGSLALISAAFPEKERGKAIGVWSGFSGITAAAGPVLGGFLVDHFSWAWAFLINVPMALLVLWIAWRHVPESRGSSASGGLDLVGALlhWRSPAVLTALGIGIAASAGFIAvlYFFPLNLIQVQGYSATVAGAALLPFILIMFALSGWAGQLVDRFGPRLPLVIGPAIAAAGFALFAVPGVEASYwgFFPAVVVLGFGMTVTVAPLTTTVMNAvpEQAGVASGVNNAVSRAAAVLAIAVFGVVMAW----------------------------------
     844 UniRef50_A2QM00        Contig An07c0010, complete ...   178     3e-43  1  13.4% 21:392  105:525     --------------------AFSGAVYAPAQNAVMESMNCSYEVAMLPLALYNLGLAFGPIVGAPLSETYGRKAVYLVTTPIFMVSMIGGTLCNTISGLILCRFLAAVFGSSNISNASATILDYTSDNERGTVLAIYYAVPTVAAALAPLVGGFILIRIgwRWTQWVPVILAA-AFYCLLIFTKETYKAVILRRRAmrPIHMLLTEPIVTCISLYNGFLFGLLYAFVISIPWVFQKYYGFGPQAQALSYLGVTVGNIAACIP-HALIDKyeARLVSALGGGLLLPPSLLILSWTANFQVHWIVPIIffSMFSCLLVYSGTNLFMLDTypLYGASASGAMMFSRYILSCAFPLFTLQMFDGLGVGWATTLLAALSLLMAPIPWIFWIYGPRIR--
     845 UniRef50_Q7MZM7        Similar to bicyclomycin res...   178     4e-43  1  19.2% 20:384   20:387     -------------------SFIEVDITLPAFPQMLNFFSAAESAVQFTLIVNFLGLCIFTPIFGPLSESYGRRKIILIGATLFFIGSIGCSTVVDLNQLYLFRFIQGAGCSAIWIVGFIICSDIYKDEESVQVFGILNAAISMALIIAPIAGSLIVAHYNWRFTYHLVALLSFLSL-MAVFIVPETNrvKLSVNKVIKNYCQLIFNTRFLIYSFTPGLLVSACIAYVSVVPFLYIDKMGMSYYIFAVHQAILGICLSVAGFYSGALNRKIGSaiYLSIIICLIGCGSLMIFSHIYPESAILFTLSMAVICIGSAFQYSMVFSRSLALHPELVGSASSLLTFFRLIFFSFSVLISGWAFTGKLFNSAIVVSSIIAMGLLFSLFVL----------
     846 UniRef50_C5VFB9        Permease, major facilitator...   178     4e-43  1  15.4%  3:360   27:439     --KRTIFMVFAGLIVSMLLSALDQTVFSTALPTIVGELD-GVNHMLWVTTGYLVAVTIMMPIYGKLGDMMGRKTLFLGALTVFLIGSVIGGFATNMTWLIIARVVQGLGGGGLMILSQAIIADIVPVRDRGKYMGVMGAVFGLSSVVGPVLGGWFAESIGWRWVFWMNLPIGIIAIIIAATVLKLPKHDTKFTFDVWGTLTMAvwGSATIINLIITAIVFSamFGVLAYMPTYLQMVTGVNATGSGLMMFPMVVGLMGMAMTTGALASKTGKYKWMPIamVVLAISLWLLSTLTVETPLWVLLSYMFLLGAGIGLGMQILVLVVQNSfdHEVGMATASNNFFREIGASLGGAFVGAQFTT----------------------------------
     847 UniRef50_B7HW39        Major facilitator family tr...   178     4e-43  1  18.6%  1:345   12:411     LSLFSEKLVILIAGIGMFLSTLDTGIINIALPYLEKEFHSTVTITAWSVTIYVMALSATILLFGKISDRVGRFRICLYGFFIFLISSILCGLAQEMWQLIVFRAIQGVGAAALQATSAALITTLVSPENRNHALGTLGVMIGLGPILGPTAGGLFISLGSWRWIFWINIPLCLIGLWACyrFIKEEKHPApfLFSLSHGANKVMGSIPNWGYIIASIILLGIFiiIFIVPPYFLQNFTSLTPLQTGFVLLSAPLGLVIFSRIAGKFMGRFGTTLFMSIGLGIMFIAFVGLSFIEPQWSPYLLASVLFLYGIGGGIFQPANIASIMASVteKQGSIGAVQRMLQNV-------------------------------------------------
     848 UniRef50_C7I2K9        Drug resistance transporter...   178     4e-43  1  24.0%  1:379    4:390     MARSGALQRILTLGALTAFAPMSIDMYLPAFTALQHDLHTTPEAVQRTLVVFFVGLALGQAFWGPVSDRYGRKRPLLIGIALYVLASLGCAMAASMDALMLWRLLQALGGCAGIVIARSMVRDLYAPVDAARVFSRLTLVLGAAPILAPLAGAALVQAWGWRAIFLVLSAFGVACLLAALALPerSSAQQHPVRNALRIYFALLRDRRFIGFALSGALGQSAMFAYIAAAPFVFMQVFGLSSAQFAWVFGANALGLIAASQINHALLAHVGSGVLLRWALLSLaaSVMLALAVLKVGGLWGVVIPLFIALSSLGFSFPNATALALAHQTGRVGSAAALMGSLQFTLAAASGSAVGVIAAHSALPMAAVFCAFAGLALWA---------------
     849 UniRef50_A5G198        Major facilitator superfami...   178     4e-43  1  18.2%  2:358    4:416     -THRQRLQVISGIILCILLAAIDQTVVIPAVPAMAAGLH-GFSHLSWVVTAYLLTSTATTPLYGRLSDQFGRRQTLIPSIALFVLASCVCATAETLPWLIAGRALQGVGGGGLMAIAQAAIADVVSPRERGKYQAYMAGTWGVASTAGPVVGGWVTDHLSWQWIFWFNVPLGLAALVLSQIGLRQLRTVARGGRIdaRAAVPLLPMRLFGSASFvgFLTALAMFSAIFLLPLFFQLVYRANAAQSGWDIMPFMIASTIGAYAAGQVARRTGrrKLLIGGLVVGTAGFVLLGLLPRATPLGLVVFNCFVMGLGIGFVLPSNLVAVQNAarHDVGAATATLLLLRAMGGAFGATIAGAVL------------------------------------
     850 UniRef50_C8Q759        Major facilitator superfami...   178     4e-43  1  20.0%  5:394   13:407     ----RVLLFPLALVLFEFATYIAHDMIQPGMLVVTGEFNVGPEWVSTSLTAYLMGGVVLQWLLGPLSDKYGRRPVLLFGILFFAAACLLTTLVENIEQFVALRFIQGISLCFIGAVSYAAVQEAFAEALAVRMMALMANVALLAPLAGPLAGAAWLSVSDWRSMFWLFAACSIVAFVVLWRIMPEtrSHSIALPTLARGYGRLARDRQVMYGSFAIGLVFIPILTWVALSPVILMHDEGLSRLQYALLQLPVFLAMIGGNLTLGKLAGRVPIEQPVKFAaiLLGLSIALLANLFNSHSYLLLTAGLSLYAFGAGMVNAGLYRLTLYASNEGKGSIAAMLGMISILTLAIGIELAKSGYFSGGTPWFSTINFISGVMWFGLVTLFLRERKRRSHI
     851 UniRef50_P77726        Inner membrane transport pr...   178     4e-43  1  17.0%  7:388   11:392     ------RRATWGLGTVFSLRMLGMFMVLPVLTTYGMAlgASEALIGIAIGIYGLTQAVFQIPFGLLSDRIGRKPLIVGGLAVFAAGSVIAALSDSIWGIILGRALQG--SGAIAAAVMALLSDLTREQNRTKAMAFIGVSFGITFAIAMVLGPIITHKLGLHALFWMIAILATTGIALTIWVVPNSSTHVLNREsvKGSFSKVLAEPRLLKLNFGIMCLHILLMSTFVALPGQLADA-GFPAAEHWKVYLATML-IAFGSVVPFIIYAEVKRKMKQVFVFCVGLIVVAEIVLWNAQTQFWQLVVGVQLFFVAFNLMEALLPSLISKESPayKGTAMGVYSTSQFLGVAIGGSLGGWINGMFDGQGVFLAGAMLAAVWLTVASTMKEPP------
     852 UniRef50_Q2T426        Drug resistance transporter...   178     4e-43  1  15.7%  1:362   21:438     LRGAKLALLTFALSLATFIEVLDSTVANVAVPAISGSLGVSNSQGTWVISSYSVAAAIAVPLTGWLARRVGELRLFVASVILFTLTSLLCGLARDLEVLVACRALQGLFSGPMVPLSQTILMRAFPPARRTLALALWGMTVLLAPIFGPVVGGWLIDNFSWPWIFLINLPIGLFSFAVCTLMLRPQAQRGEASPIDAPGIVLlfDSPLITALAIAAglGMMSFSVVGVVFPLWLQAVMGYTAYQAGLATASMGVLALVFSILVGLYASRVDARVLVTFGFGVFAAVMWWSTHFTLSMTFAQVVTPRLIQGMGLPCFFIPLTAATLSRVPDEkaAASSLSNFLRTLSAAFGTALSVTWWDNRA--------------------------------
     853 UniRef50_B9ZKH2        Drug resistance transporter...   178     4e-43  1  22.8%  3:392    5:400     --RRTRLRFALLVAPLALLAPFSLDTYLPSFPAMADDLAVDGAAMQATLSAYLVAFALATLVAGPLSDAFGRRPVVLWALVAYVATSALLVVAVEYWQVIGLRIGQGFAAAAGVVVSRALVRDRFDPIDARRVFALVTIMFAMGPAIAPILGGYLQSAFGWRSVFAFLVLYGVVLLVAARLWLPETLPPVGrpRLVLRRYAGTLRNVQFLQPVLVHTTLFGAKFLFVAASPALIYVHLGGGERDFWWLFAPMVVGLMLGGMASGWSAGRVAPEVTVRIGLLLTGIALAlwAALAPETSVAAVTLPFALYSFALALGMPSLTLLALDCYPGARGMASAMQAFVQLGLAALLTLFVVDWLDDVLWHLVAGAAVIWLFAVFVWFAGGGLVRAARE--
     854 UniRef50_C0ZI14        Probable multidrug resistan...   178     4e-43  1  17.4% 10:393    6:388     ---------LALLFFIAFFIMLGFGIIIPILPFFAEKLGATSLQIGVLFASYNIMQLVFAPIWGALSDKIGRKPLLSFGLFGFSITFILFGLADSYTEMLLYRILGGIVSAAALPTVTAMVADLFPSEERAKGMGVIGAGIGLSFVFGPVIGGLL-SKFGFAVPFYASGIVALLTFFLILFSLPESLPKEKrkEQRQNPLVSLFGSMSLLYGILFT--VSFAFSGLETTFALYISDLYGFTSIDLGYMFLVMgiAAAVQGGLIGRMVKQLGEASVLVIGMILYGIG---FFAIPLSGNFWVLALILSLFGAGQGMIRATATAMITQRTTQGQGVTSGAISSMDSLGRILGPLAGGAVYQVSHGGPFFLGGVLMVLLLLWFVSSYRRLPEPSTH-
     855 UniRef50_D2EKV6        Major facilitator superfami...   178     4e-43  1  21.4%  1:384    1:432     MKKERFGIVLPIVLISYFMILLDNSVVFTSTVKISQDLQMTSRTLSWISTAYVLTFGGFQLLGGRLGDIFGRKRLFLIGTYIFTFSSLLVGLSVSAPMMIVMRAIQGAGAAILAPTTLALLMDNYQGKMLQRGINYYGMTAGLGASLGLLIGGLIASFTSWRIGFLINVPVGVGIILLTIKNVKKDQQVKSQSMDILGSllELFKDSTRVGAYIARFFIIGMAFSFLYLAPQVMQNLYHFSPFLASIAFLLMSLPQFVAATQVGRLNTKISPARLAVLASIISIVALAWIVIVGAQNGFWllAVPLILVGIGQGLAMSPLTSlvAHTTADISGSASGVLNTFHQTGQSIGLALVTALTSGIHSYTGSFNAAMLVLLFYATIALL----------
     856 UniRef50_Q477L0        Drug resistance transporter...   177     5e-43  1  19.0%  8:380   36:464     -------RVIGGIVLCILLAALDQTVVIPAVPAIANDLN-GFGHLSWIVTAYLITSTVATPLYGKLSDSFGRRRLLMVAITLFILASVACAMAQSLGQLILFRALQGIGGGGLMSLAQAAIADVVAPRQRGRYQGYLATVWAVASIAGPLVGGWVSDNLSWRWLFWINLPLGGLAMLLCYRGLAMLPVRGGRARVDwrAADPMLPPRLFANRAYVMGVAASAlfLCIFALPLHFQLVRGADASMSGLLVMPFLLATVAGNFIVAWVAPRVGrrGILTAGFIAGAIGLAVLALATPAVPLAVVLLAMSIGGTGLGMVMVGTLMSVQNVlrRDTGAGTGALLVLRSLGSALGGALAGTLLTLEFRHATAAAGVSQALDLGAL--------------
     857 UniRef50_P32482        Chloramphenicol resistance ...   177     5e-43  1  22.8%  8:389   14:398     -------ATVLLLSPFDLLASLGMDMYLPAVPFMPNALGTTASTIQLTLTTYLVMIGAGQLLFGPLSDRLGRRPVLLGGGLAYVVASMGLALTSSAEVFLGLRILQACGASACLVSTFATVRDIYAGREESNVigILGSMLAMVPAVGPLLGALVDMWLGWRAIFAFLGLGMIAASAAAWRFWPETRVQRVAGLQ-WSQLLLPVKCLNFWLYTLCYAAGMGSFFVFFSIAPGLMMGRQGVSQLGFSLLFATVAIAMVFTARFMGRVIPKWGSPSVLRMGMGCLIAGAVLLAiiWALQSVLGFIAPMWLVGIGVATAVSVAPNGALRGFDHVAGTVTAVYFClgVLLGSIGTLIISLLPRNTAWPVVVYCLTLATVVLGLSCVSRVKGSR-----
     858 UniRef50_C0Z5S7        Conserved hypothetical memb...   177     5e-43  1  17.5%  7:384    3:381     ------RLFLMIFFFTMFLIGTNTFIISPLLPTLRELYHVSTNQAAWLIGTYALGFALAALIAGPLSDNRNRKHVMAVGMLGFALSTLACAFAPSFTAMLFFRFLAGICSAFIGPQVWAAIPVLFPPARIGKAMGVVMAGLSVSQVIGVPIGSFLSAY-HWSFPFLAVGIASLGAFVLIIRKLPDLLPPTSIPgaIFARYKDLLRLPQASRSFIGYFVFMTGVYAVFSFYGVWLSDQYQQSVTEIGLITLVIGLGNTVGSLLSGWLLERWKRSTILTVG---FLGSALLYLVLPYIPGIGLLQVVLFFMYCFGGVLVPVLMGYLQSLSDTSRGTISSLANACMYIGTFIASSFAGSLYSIFGFVGVSTFATFTFLIAYFLFVWR----------
     859 UniRef50_A0RMF6        Multidrug-efflux transporte...   177     5e-43  1  15.4%  9:384    4:375     --------TVLPLSFIVASRFFGLFVVLPVLSLYALNlgANELLVGLLVGGYALTQMALQVPFGSLSDKFGRKNTMTFGLIVFIIGSLICAQATDIYTMLIGRLVQG--SGAVGAVATAMISDFTTEEKRGHAMAIMGGMIGVAFAISMVVSPILSSKFGLASLFYLSAALTFACIVLLYTVVP--KESKIHHHDAKAPFLNLITQKNLFIMNITNLMQKMLMSAAFVAIPIVLVNHLGYDSSRLWIVYLAAMVFGFISMGLAGFLGDAKGHSKKLLLIGVVLFIISYLDFAFSENS--LAFIIGVTLFFIGFNLHEPIMQSCASkaLASQKGAALGVFNAFGYAGSFLGGAVGGYFLHKFNITYLAIFYSILSVFWLVLLFML----------
     860 UniRef50_B1JF31        Drug resistance transporter...   177     5e-43  1  22.4%  2:390    4:394     -TKRYENFIVFLAPLINSVGGIAIDLYAPSIPSIGRELSASPVLMQNTITITLLFYAIGQLFFGVMADARGRKPAVQLGLAVFLGGSLLATVATSIEMLLLARALQGFAIGACQVVARALLVDVVKGPRFYVAIIYLSLAFGLGPVIAPYVGGLIEVHLGWRYNFVLYAVYAVIVLAFVLAGLKESLAVTGRRSAliAGYRCILADSRFRSSVVVLGSSFSAFLLWNVFGPHIVQERLGHSAQYFGTTALAVGSCYLVGTLVNRVLIRYVNAHALMWAGMALFLLGVAVIAAMPGGLNLVTILGGIMLVAFGQGFIFSNAMARSMSLFPDRAGVAASLQGCLMLVFGAVASGIVSALPLTSNLAIAGVFLMLWLVSLSGMLSVRMQRQAS----
     861 UniRef50_C5SGU6        Major facilitator superfami...   177     5e-43  1  15.4%  9:390   44:428     --------ALSVMFAVVFINLVGFGLLVPLMPFFAQTLNAGPWQVTLMFAAYSLGQFFAEPLWGSLSDKWGRKPVLLITTASNILFYVLLAFAPNVWWAIAIRFLNGIG-SGNVSCIQSYVSDMSEPHQRAGRMSLIGAAFSLGFVIGPVMGGFLAhaAGFRLPLFLAAGLSAVATLGILFYVRESRVRTHAAPQNFRafAEARRHPIISRLILSTLFYMAALAGLEATFGLWAKARYDWGPREVSLVFLFIGVTAALmmVFTRPLVRRYGEARILVLGLTVFGLGFFLQGI---NQVPWLVTPLVMVAALGQAVIFASISAIIssTATDRQGAMLGLNQSTGAIARIAGPVVAGFLFSQLGADGPLWFCALMCFTAALLALRVSQVERR----
     862 UniRef50_B0TYF8        Drug:H+ antiporter-1 (DHA2)...   177     5e-43  1  17.7%  5:360   15:424     ----KRTIVALAISLLALAEIVDLTIVAVAIPQIMGAIGANVETIADVTTVYIVTAAIFILLSGLIIEKYGIKRVALVSSVIFGISSVMCGLSTSLAEMIVFRAFQGMGGAFLPSVAQTYISTNFRNEEYNKMMTVYSMVIVMGPIIGPVLGGAICENMSWEWIFYVNVPLCIVAFVIIFFMMDATKIkvSLGFFIWRgySSVVKFRIFKNFNFILACFLCFMfaAMAYLPTMLQQVYGYPVDLAGYITAPRGVAAIFGAVItnFLVKKLGVRTTISLGMLTFGASCLMQASFSPTASEFDIVLTTAIQGLGMMMFFVPFMslVVGVADEDMGDMSGSFNFFRNFGSSVGTAFVATFISR----------------------------------
     863 UniRef50_Q11DD1        Drug resistance transporter...   177     5e-43  1  24.5%  4:390   14:404     ---MSERRVSVLGAMLVAIGPTSMALYTPAMPEIVSAFGTTEAAVKMTLSLYFAGFAFAQLFCGPLSDGLGRKPVTTCFIAIYALASLIALSAPSVEMLMAARFLQGVGAAAGIAISRAVVRDLFTHEQSARIMNLIGLILAAAPALAPTIGGLIMEFFGWHAIFLAMFALGAAIVVVVHFFLRETVTRDLSrrGLASAYTTLLRSPYFLSSSLIIAGSIGAVYSQATILPFVLMGRVGLTPSQFGVGMLMQSGMFFAGSLCVRFLLGRFRAPQLVPAGLCFIAIGSTLLAVsaASPTFLRVMVPVGFFSYGIAFIMPAMMTASLAPFPHIAGAASSLAGFMQMGAGLLGGSVAALIGD-PVLAMGLVIPSMGAIAILAWLFWRRLPEPA----
     864 UniRef50_C7PZI4        Drug resistance transporter...   177     6e-43  1  18.4%  4:362   18:436     ---PNRWRALTVCLVAGFMTLLDVSIVNVGLPQMEAGLRASPADVSWVRAGYTLTFGLVLVPSGKLGDALGRKRVFLLGLFLFTGVSLMCALSPTAQWLVVARLLQGVAGGLLNPQIIAMIQQLFRGSERGKAFGLYGGTVAVATAIGPLAGGLLIEAGGWRWMFLINLPIGVVGLVLGVLLVPKIPPRRRGRGMDLVGVALlfWERWWKGRGlaSSLVGLAYFavLFILSLYLQQGRAYSALAAGATSMPFAVGSAISAAVSGRAVYRIGrvAGLVAVLAGLIPAAVIIQHDTGGAVWARLFLPLLVAGLGSGLVIGPNQTLALqvPPASSGTAAAMVQTGQRIGMSVGTAMAATMFFGHL--------------------------------
     865 UniRef50_C7N8A6        Drug resistance transporter...   177     6e-43  1  20.4%  3:389   15:403     --PMGKVMLIVFITLLSVFPPLATDMYMPSLPELREDLGTSSAVASASIIAFFFMFGVGQLLFGTISDKFGRKPILLAGLGVFVASSIGCALAPNIAVLLALRALQGLGGGAGGAIAMAITKDCFPEERRARVLIVTQAAGALGPVVAPVIGGWISTFATWRVVFWVLAGTGLAAFALAIVY-RESNPPEMRYTGSlgRLAVVARNKGFTLLLVTLALVSAPFMGYVTTSSYVYMDFFGLSSGAYSLFFAGTAL-IMVAAPFVYLIVSRYFKTKTLIEATMVGAFVFAGLMLLFAKRSPWMFVLTIAPFLMMSSAIRPGTTNVLLMQHETDTGSASSLINFTFTAFGSLGSVVAALSWPDFVTADAGTILVFFTAAVALWVVLLKSPYP-----
     866 UniRef50_C7PUK1        Major facilitator superfami...   177     6e-43  1  18.3%  2:394    6:400     -SEKRKRIATTLAFISIPLSGFVTDIYLPSFPSMAKGLQVEESSIQLTLTCFFISYGISQLLVGSLLDSIGRFKPAMYALVAVIITSMLIGFTSNVQLICLLRVIQGIAVSFVVVSKRAFFVDMYSGDKLKNYLSYFTIIWSCGPIIAPFLGGYLQKYFHWQANFWFLAAYALVMLIFELIYSGETIKARKqiARVKKDYSMALGNLNFVLGIVTLGLAYSVVMVFNIGGPFVIENGYHFNSIVTGYCTLILGFSWLVGGVIGKRLVAVDFVRKITVASATQLLLIVILMFIGFGYPALWCFMLFAFVIHICSGFLYNVHFTQSMLYFPEHAAMASGLLGGSVYVITSFSSFILSKAGKMGHQQDITLRYLVVSAILSAVVWYAVKRRRTLRKV
     867 UniRef50_B1VTL7        Putative permease of the ma...   177     6e-43  1  18.2%  4:360   14:435     ---RRRWFALAIVMTAAFMDLVDVTIVNIAIPSIQRETGASVSAIQWITAGYALAFAAGLITGGRLGDIYGRKRLFLIGIGGFTLASALCGFAGSPEMLVAARILQGATAALMVPQVLSIVHATFPAHERGKVFGLFGAIVGLGAVSGPLLGALLTEwlGWRPIFLINLPVGIAGLLLGAKFITESKAPRAVRLDLPGVALITLAMLMLilSMVGSLFVFGALVafFLVWTMYMQMGLGWSVLRAGTTGIPFSVAVSVAAGISvkLVPRFG-RKVLQAGALLMIAGLLIYLwyGLGITSWQMAVPLVVMGVGMGLIVAPLTDAVLSEVpeHAGSASGLINTVQQMGTALGLGLVSVVFFG----------------------------------
     868 UniRef50_Q6ML57        Sugar transport protein n=2...   177     6e-43  1  14.9%  1:389    1:392     MFSKQEKFLLAILASIQFSSIVDFMIMMPLGPQLMRMFAINPHQFGLLVSSYTFFAGLSGFAASFFLDKFDRKACLLFFFVGFSVGTVACGLAPNYEMLLLARGLTGVFGGVLGSLVLSIVSDAISYERRGSAMGVIMTSFSMASILGVPFSLFLANQFNWHAPFIFLGCTSLLLCVVIWFKVpkHLEGGVNKEPMWNTISRIANNKNQRRGLYFMSSVMFGHFAIIPFLSPSLVANAGLSESQLPLMYMIGGAFTIFSSPFIGRMADRYGKHKVFLWGALVTLIPYWVITNLGPSPLWVVLAICAFFFVVSGGRMIPATALVSGTAKPQNRGSFMSIVSCVQQLSSAVSSYIGGLIVTTGANGRLEHYPVVGYIAIAFTFVAIFLSRR-----
     869 UniRef50_B3QY61        Major facilitator superfami...   177     7e-43  1  15.0%  6:384    2:385     -----KKSPLVVLFFTVFIDLVGFGIVLPLLPTYAKDIGATPLEIGLIAASFSVMQFFFSPIWGSKSDQIGRRPIILISVAASAISYLIFSQSDTVALLLISRVLAGIG-SANISATQAYITDVTDSANRSKAMGMIGAAFGLGFVLGPPLGGFLKTFYGISMVGYVATALTLLDLILAFIFLPEskPKTKIQLFSFDKMLDAFKRPAVSRIMITNFLFLFAFVNMQVSAALLWKEYFSVTDQSIGYLFAFVGVVSVIvgFLIGKLTKKYGERKVFLLGNIIMALGLIFIPYIPTDSLFSLGLIFLAMLAIGNGLAVPVSTSLISLYTPHhqGEILGISQSVGSFARILGPFSGSLLYGVEIHAPYLVGGALVLVGSLVASTLF----------
     870 UniRef50_C6QEQ1        Drug resistance transporter...   177     7e-43  1  22.4%  9:388   28:412     --------FVVLTAAMMALTAISIDIMLPALPEIGEALGvsANDRQLVVILYMVGFAAGQLFFGPLSDHIGRKPALMAGLAIFIVGTIAALVSNGFSMLLAARFVQGIGAASPRVIAIAVVRDLYGGRQMARVMSFAMMVFIVIPVLAPSIGQALIHLGNWHWTFYALLAMAILIAVWAGFRLPETAAPAlrAMTLRASLKAAIFDPQTMAYGAAGGFMFGCLLAYVASSQQVFVEVFGIGE-AFPVVFGAIASVMALASFVNAQLVGRLGMRRLSHASLLGFVGLSLCLAGAAAAGIAGIAviLLAGAFFLFGLIAPNFNAIAMEPQGHNAGMASSVTGSLSTAIGAMAGGLVAHAFDGTVFPIAAGFVACSLIATLIVFAVEGKRS------
     871 UniRef50_B2GKF0        Drug resistance efflux prot...   177     8e-43  1  17.9%  2:364   12:433     -TDPRAWHALWAMVLGFFMILVDATIVSTAIPAITAGLHTDISGVLWVTSGYLLAYAVPLLITGRLGDRLGPRTVYLWGLAVFTGASLWCGFAQDITALVVARVVQGLGAALMSPQTMTVITRMFPVATRGTALGIWGATAGIATLVGPLLGGILVDLAGWRWIFWVNVPVGIFALWRAAVHLPRLPVRSHsqSHDWSTVVGPVTIPMVIGAGVLILVAFLAWQamIIPAMLYLQVVRGLNPTVAALSYAPMSLLSAVLAPLVGRALGKVAPRSIALPGMLIMAAGLAAYAllRPGTSVWLLAALTLVIGLGSAMIWSPVstATSDLAPDVVGAGSGVFNATRQVSAAVGSAMMAVLMQAQLAA------------------------------
     872 UniRef50_B9XJZ1        Major facilitator superfami...   177     8e-43  1  17.9%  2:359   13:372     -TLARERLLLLTLAAIQFTTILDFLIIMPLGPQYMRVFSIDPKQFGLIVSSYGISAGVAGLAAGFFLDRFDRKRALLWLYLGFGVGTLFCAMAYNYQLLVASRFFAGAFGGVVGAVILAIVGDVIPMERRGAAMGMVMSAFSVSSIVGVPLGLLLASHYNWHVPFYALTVLSFIILIIAAWITPPLRGHLAHHQdpFARTLTVMMHPDHQKAFLFMAALTCAGFAVFPYISTYMVSNVGLTETQLPLIYLCGGLCTLYSMNWVGRWADRAGKLRVFTITSLTTAVPILLVTNLPRVPVVAAVATSTLLMVCMSARMVPAMAMMTGAVEARYRGGFMSINSAVQQLSMGVTAFLGGYIVQ-----------------------------------
     873 UniRef50_Q829Q8        Putative transmembrane effl...   177     8e-43  1  21.0%  3:373   21:446     --PARLGAVLFVIVTAYLMVGVDSTVVNVALPDIQRDLRFSPTGLSWVLNAYTLAFGGLLLLGGRIGDIAGRRRTLTCGVLLFALSSLLGGLAGESGWLLAARALQGIGAALTAPSTLALITTNFpgPRRHHALGVYTSMASIGASIGLILGGMLTSWASWRWALLINVPIGIGVALALPRFVAETPRHAGraAALLAGFARvfRDRNRAGGYAGVLLLPAGMFGAFYFLTLFTQQVLGYGPLRAGFAFLPMTLALFATVRFVPRLLQRHGAKPLLLIGTTLLVAAAGWLWRLEPGDGYVtlLGPLILMGMGVGMSFMPLNATILAGipRDAGAASGLLQTLQWLGGTLGLSVLVTVYGTATRHATGSPSAIL---------------------
     874 UniRef50_B4S1X5        Bicyclomycin resistance pro...   177     9e-43  1  19.5%  9:387   25:411     --------FVALMATMTSLVALSIDAMLPALIQIGESLNVEEAhtHLIVTVFFLGMAFGQMFFGPFSDSRGRRLTILVGLCIFALGTFVCMLATNLETMLVGRVIQAFGVSGPRIASMAIIRDLYVGDAMAKVMSFIMMVFILVPMLAPIIGQTVMELTSWFHIFTLFLLVATMAGIWFFSRQGETLPRAKRRkhFFKSSKFILTHPEVMGYTFAMGCIFGAFLAYLSASQTIFTVFYNVGE-WFPYIFATLAFSIGLASYFNGKMVMRFGMRKLCRFAlgFAVVYLALLFAYDGLPPLVLTIAVMFVGFFFVGILFGNLNAMAMQPLGDMAGLGAAIIGCFSSLFSVPVALIVDSFLNGNLMPIGWGFLIFFALAYASVRFAERVR-------
     875 UniRef50_UPI0001C314E7 drug resistance transporter...   177     9e-43  1  18.9%  3:368   16:436     --RDNPWLTLVAVALGVMMVGLDGTVVGVANPTIAADLDASLAGLQWVTNGYLLALAVLLIVGGKLGDRFGRKKVFVIGIAGFALTSLLCALSTSTGMLVGARVLQGVAGALLMPNTLALLRAAFPPAELNRAVGIWGGASALAVASGPIVGGLLVEHVSWESIFLLNLPLGLLAAVVTLRWVRESKDETHVGGFDVPGVALliGFGIAALVTLAGFVvfFALFGILFFIGLYLQNVHGYSPIQTGVRLLPLTATFTISAPLGGLLTEKFGPRVPLCLGMLILAGCFFGLTGLEVDTGYGGQWPFYLLIGLAMGFVIVASTEAIVGNApeRGGLAGGLQSTANQLGGVLGTAVLGSVIVSGVGSALAG--------------------------
     876 UniRef50_A3SLF1        Sugar permease, MFS-like pr...   177     9e-43  1  23.6%  1:365    6:374     LSPKHAAALTAVLGLLSLFPPLATDMYLAAMGDLAEAMNASHAATELSLSLFFLGLCLGQLLIGPLIDGVGRRLPLLAGTALFILTTIGLLLVEDIATFNALRVLQAIGASAGMVVGRAIVNDLYEGRDAAKVMTVLVMLLTIGPIISPTLGSLLLEGFGWRAIFVTMLGVSVIALGLSLAIIPETLPPSARSRRPFRsaATLLRQRRFLLPALIAGLVQGGMFAFITGSSGVFQGAFGLGAIQYGLLFAVIATALMLFGQVNRRLLDRASPARLLRLGLPVYAAISLLLTLSSGTGTLWVYVLPLWFAIGMVGLLSANVMSLAMEAARQGAGIGSALLGAVQFGIAFTVSACVALGGTGSALPM-----------------------------
     877 UniRef50_A7ZBP2        Multidrug-efflux transporte...   177     9e-43  1  17.9% 10:388    5:379     ---------VLPLSFIVASRFFGLFIVLPVLSLYALNlgANEFLVGLIVGVYAISQMIFQVPFGALSDKIGRKKALTIGLLIFVAGSIVCALASEIYTMLFGRFLQGVGA--VGAVATAMISDFVAEENRSKAMAIMGAFIGLSFTLSMVLGPLLVKDYGLSSLFYLSAALSLLCVVLLYTVVPKEIKVSAKAEKV--PFGKLFLQKDYMIINFTSFMQKMLTSIAFLVIPIVLVKEYGYESSELYKVYTLGAVLGFLAMGLAGALGDGKGLSKVILIAGTLLFALTYVIFALSFTK--FIFVVGIAIFFIGFNLHEPIMQSTATKFVksQKGTALGIFNSFGYFGSFVGGAFGGYIMHAFGFKVLAIICVVLCVIWLVLLFSLSDPR------
     878 UniRef50_C7NFY0        Drug resistance transporter...   177     1e-42  1  19.0%  3:350    5:411     --PVRPWPALWALCLGFFMVLVDSTIVSIATPALMREFDASVSHVVWVTSAYLLAYAVPLLVTGRLGDRLGPKRLYLAGLGVFTAASAWCGLADSIEALIAARVLQGLGAAMLSPQTMAVITRLFPGNQRGRAMAAWGATAGAATLVGPLMGGVLLDSAGWEWIFFVNVPVGILAMVLAARLVPA-LGTRAHSMDWWGVALSAVGMFLLVflLIAVGLVVLTVFVVwfPFILYLQSVRGMTPTEAALVMAPSSVMTLLLARWAGGLVDRVHPRTLASIGMVGLALTYLFVAlvRPGTPLPVLLVPWFMLGITSSFVWSPLSVSATRTLPPHagAGSGVYNTTRQVGSVLG--------------------------------------------
     879 UniRef50_B0LJ21        Lct38 n=3 Tax=Streptomyces ...   177     1e-42  1  19.6%  4:360    1:411     ---MRKWLPLVAVCLGSFMLIVDTTVVTVALPEIGTGLDASLSSLQWVMNIYTLVLAALTLSAGSVGDLLGRRRVYLLSLAVFAGASLLCALSPNPEMLIAARGLQGIGGAAMFVTSMALLGTTYEGKDRGAAMGVWSAVIGVAAAVGPIFGGLLTQSMSWRAIFYVNIPISLVTMLLTKVCFTESRQPGGARIDFPGIITFAlwTSPFTLGLFALAILSAVLFVvlVFTSLWLQSVVGLTPIKAGLALLPLAAATFAASTLTGKRLHDVSPRVTITAALVLIGAGCAVNGFVIDGDSSWVAALPGLLVIGVGVGVGMPATGSAvsVPPQRAGMGSGAMATFRQLGQALGVAVLGLVFAN----------------------------------
     880 UniRef50_Q2BKB7        Bicyclomycin resistance pro...   176     1e-42  1  21.3%  9:384   16:399     --------FVALMAFVTCFVAMAIDLMLPALSYIGNDLGVapNDTQLIISVIFLGVAFGQVLYGPLSDVVGRKPAIYLGFSVFIIGTLMSILAQSMEMMLLGRLFQGLGAAGPRIVTVAIVRDKHKGPQMARVMSLIMTVFILVPVVAPIIGQGILMIADWRMIFVFLLLMALLILGWFGVRLPETLEQEKRQSFSVtsFKEVIANKTAMAYVISLGLVFGAFLAFLSSVQQVLQDLYELGA-AFPFYFAVLAMGIGASNFLNAKLVMRFGMKRLVMFasVLSALALLAMVWLGAVPPLWFLMSYFMLLLMGVGLLFGNLNALSMEPFGHIAGLASSFVGVVSTLMAVILGMIVGQAFNGTVVPLMLGFVVLPGIAFFVTRWAV----------
     881 UniRef50_C6VMY6        Transport protein n=3 Tax=L...   176     1e-42  1  17.7%  3:381   48:424     --QHTENWLIIGLFCGAFVTGADAFIISALLPAIATSLHVPTNTAAYGVTVYALCYAIGAPLFGPLGDRFNKRFLLINGCGIFLLGTLLCGLANSLLTFYLYRAIAGIGAALFVPNIWAFIGTYFNGQRLNQVMGIVMSALSLSIATGVPLGALLAQLSSWHMAFWGSAMLTLIALSILTIAIPSLPSQNAQPDGYFTSFKTLVHTPHAIAALLITLTWMTGFYGVYTFLGVFATATFHFNTMQTGLIFITYGSANFVASFFAGKLISLLGKKQSVTINGLVSATLVLSLGIWGQHLAVLLIILVVLALSQGWGVT--ALTATIVNIVPSNRSTIMSFNSAFLYYGLTLGSAAGGLLLTKIGFYAVTIAAATALLVAVLIA-------------
     882 UniRef50_C8VXL2        Major facilitator superfami...   176     1e-42  1  18.5% 15:370    1:408     --------------MAIVLAAIEVTIVSTAMPTIVRDLG-NIHLMSWVFAIYLLATAITTPIYGKLADLFGRKKVFTIGIVIFLIGSSLCSLAHSMAHLIFFRAIQGIGAGALFPVSLTIIGDIFNIEERAKIQGLISAIWFISGILGPLVGGFIVDLLSWHWIFLINIPFGLLSISLIKLFFHEQFTKKKRYIDYPGAITFTiwISPITLSLLINAVGFLSLFYFivYLPIWVQGVLSYKATGSGIALIPMSVGWTLGAFYCGKLLMKFSVRNTTSLGAGAILAGCSLLVAMGF--SIFELIFGMFIIGLGFGLALTSSGIVIQSSVenLRGSATALFTFTQALGQTVGVAMLGVLFYHTVSTGSATLN------------------------
     883 UniRef50_Q1AX54        Major facilitator superfami...   176     1e-42  1  17.3%  3:367    9:427     --ERQHRLLLAVVTAAVFVSVLNSSMVNVVVPVIARDFRASEAQIGWVITGFLLSYAVAIPLYGRVSDAFSLRKVFAVGLWVFAAGSFVCALAPSLPVLVLGRILQAAGGAAVPALGSVAVTRVLPPGERGGALGLIISSVGVGAAVGPIVGGLVEELAGWHLLFYGSLLLSLLLIPGALRVLPDGGQKTPRSFDLPGGILllFANRPYVAAVAVGFFSMFANVSTLVTVPLLVTEANGLSPGQAGLVLTPGAAALAALSPFTGRLSDRIGVKLPIRAGLSLMLASTLFLSTLGAGGPAPLVAAGMLGVGTGFAFANPPTNNAAANALpkEVGAGLGIFNGAFFLGGGTGPAVIGALIAARSEGPAL---------------------------
     884 UniRef50_C5BX54        Drug resistance transporter...   176     1e-42  1  15.8%  3:368   20:446     --HKQILRVLVGLLLALFVAMLSGTIVANALPVIIAELDGTQQQYTWVVTATLLASTAVTPLFGKLADLYDKKKLLLIGIGIFAVGSLLSGLSTSAGMLIGFRVIQGVGLGALQALVQITIATIISPRQRGRYAGYMGAVMAFATVSGPLLGGLIVdwLGWRWCYWSAIPLALIAMVVLARRLHVPPPSRTEVKVDWLGATLISAAVTLLLlmVPGALALFGLFIWvvFLGQYFQIARGYSPTEAGLLTIPMMLGLLVSSTVSGRFVTQIGRWKpvVWGLVTFTAGMGLLGSIQYGTSLWLIGVFMLVAGIGLGASMQNLVLAVQNTVpsDMGAATSSITFFRSLGGAMGVQVLGAVFASHVSSLTAT--------------------------
     885 UniRef50_C9YU28        Putative transmembrane effl...   176     1e-42  1  22.1%  8:360    1:408     -------MALFVIASCQLMVVLDITIVNIALPDIQRSLDFSTTSLAWVVNAYTLTFGGLLLLGGRAGDILGRRRVFVFGVLLFVLASLLGGLAQNETQLLAARALQGVGGAIASPTSLALISTTfeGPERNRAFGVFAAVSAGGGAIGLLAGGILVEWLNWRWVLFVNVPIGLLIVLATPRWIRESERTPGhrSRQPITPLHMFADRNRAGTYGIMLCLAAAIFGMFFFLTLFTQNVLDFSPLATGLAFLPVSAVIAVGAGLASRFLPVYGPKPFMVGGAILAAAGLGWLTLTDVHSTYAgvLGPMLVFSLGMGMEFVSLTLMALSDVPteTGAASGLLNATQQVGGSLGLSILVTMYGT----------------------------------
     886 UniRef50_C0ZVM1        Putative drug resistance ef...   176     1e-42  1  16.1%  8:387   19:453     -------LALTAVCLGFFMILLDGSALNIALPAIERDIGGSIAALQWLVNIYTIPLASLLLTAGVLADRVGSRSVFLWSLGGFTAASLLCAISPNLLSLAAFRCLQGIAAAGLLPTTLAIIARTYppIARAKAITIWGATGGIALVAGPIGGGVLTEFIGWRSIFFVNVPIGVIALWLCWRHVRETATRDAESYDVPGQvlSIFRKPAFSASIANGFAFQFGAYGMQLMLAIFIQSYWGSSALRTGLFFLPFAVLWTFGTLVLNRVWAGRGMCWLLTVGASTAAIGALLCTAIGDSDTWPVVMAGTALVGLGCGVFGPSCNGAAMAVIDKsaGLASGVLNTSRQTGMAIGVAALGIALSASNSVGGARIGMIFVAACFVAIVALSRR-------
     887 UniRef50_A1TQB2        Major facilitator superfami...   176     1e-42  1  22.8%  7:365   23:378     ------RGATASLALSMLLASLGTSIANIALPALAGAFARPFPQVQAVVVAYLAGLTVSVLIAGHLGDRHGLKPTLLAGLALFATGALLCGIAPSLGLLTAARVLQGVGAAFLMTLSMALMRETADPERLGRAMGMLGTVSAIGTALGPSLGGMLVSTAGWRSIFLVQVPLTLLAGALTFSWLP----HGGPGRAGPKPSWMHALDRRMVSPLLVNGSVAAVMMATLVVGPFYLGTGLGLKETQVGLVMAVGPVISIFGGIPAGRRVDAWGSRKVLAIGLGLLACGAFLLSLLPGWIGVAGYLLAIAALTPGYQLFQAANNTAMLADVPqrRGTVSGLLGLSRNLGLIAGASLMGSVFAFGAGTA-----------------------------
     888 UniRef50_UPI0001745101 tetracycline resistance pro...   176     1e-42  1  13.7%  1:393    1:399     MSAASRKTQFTVIFITILLSTIGFGVCIPVLPLYAKTFGASEFLNGLLIGVFPMMVFLASPLWGKLSDRVGRRPVLIFSVLGSAAGYFLMGFAHTLPLLFLARIVDGASGG-NVAAAQAYIADITSPQERSRAMGMIGAAFGIGFIIGPALGG-IAAQISPNAPFFLVGILCLINAVLIWTSLPESLTQERRhpQPLTALPRHADGPVYFTVAASYLVCLAAFSIMTTVFSLFAQERFGMDEQHVGYVMAAIgvGVIMQGGVMRKLLPAYGDIRLALSGMSILLVSFVLL---PLDTGLYGLYAVSCLIAVGNSLVQPTLNGLASRCVTNaqGRAMGLLQSSASLGRTVGPVLGGWLldAHYGRTPFWVAAALMAVTLAIASRLRDPQCPPEP-
     889 UniRef50_A0LVI5        Drug resistance transporter...   176     1e-42  1  21.3%  5:370   19:440     ----RRGLGLAAVCTLLFLTFLDNTIVSVALGDIQQRLSAGVQSLQWVVNAYALTFASAMLLAGALGDRVGERKVMFSGAAVFCIGSVICAVAPDTSVLIAGRGVMGIGAAASEPGTLAMIRYLFPgrERARATGVWAGVSGLALALGPVIGGIIVGLSSWRWIFWFNLAFGVAALAIAAIVVPETPRVPSRRIdvLRGELDGFGAAHVISLliVAFATYFGTFAVFFFAALYLNIVVGFSGLRIALQFIPMMVIMIAASVLTGRWIGRTGARRPVVLGCGVFTLGLLLtgALTRHPHYLPLAASLALAGLGIGITVVPTAFAAMSAVpdRAGVASSAVNTSREIGAVVGTAVLGAIVNSALISHATSTL------------------------
     890 UniRef50_C6WMK4        Drug resistance transporter...   176     1e-42  1  18.9%  4:384   53:503     ---PQRWRALAVCLLAGFMTLLDVTIVNVALPSIQRDIGATTAELSWVVTGYALAFGLVLVSAGRLGDDLGRRRMFLIALALFTLTSALAGLAPDGTWLVVARLLQGVAAGLLNPQVAGFIQQLFPGRERGKAFGLFGAVVGLSTAVGPLLGGLLLQWGgwRWVFyaVLLGGAVVSLMLPLVLSEHDPATAPWWLIGVAvfALLRTRGYSTGVALGLVYFAGFTSIFFVLTLFLQQGHGYTPLQAGLALTTYSVGGATAAAIGGRLVGRHGRVVVVVGLALEAAGLVVVDLVLRGAPegLAIALPMLVAGIGNGLVIAPNQTLAldVPPRQSGTAAGVLQTGQRIGSAIGISAAGAVfgGGGWDHAITTSLLVTIGLILLALVV----------
     891 UniRef50_Q168G3        MFS protein, putative n=37 ...   176     1e-42  1  26.7%  4:393   24:417     ---RTTPPHISTLILLAGMSAIVMNMFLPSLPRMTAHFETDYGIMQLSVALYLGISGVLQLFLGPISDNFGRRPVILVGLAGFLLATLGCIYAPSVEVFLFFRMCQAV-VAVAMVLSRAAVRDMFEQDKAASMIGYVTMGMAVVPMVSPMFGGILDQMFGWEANFWALFILGALMLWVAWADMGETAVKSGKTLTafAEYPELLTSPRFWGYSLAAGFCSGAFFAYLGGGPFVGSVVFGMTPFWVGIFFGAPAIGYFFGNMFTGMFAQRVGINTLILIGALINAAGValLIFLLGAGSPISFFGLMTFVGLGNGLVIPNATAGMLSVRPHLAGTASGLGGAIMIGGGAALSALAGATlaTGAFPLLYIMLATALAAVASIMAVYARERRLTRQ-
     892 UniRef50_Q5ZRN9        Major facilitator superfami...   176     1e-42  1  19.7%  6:380    4:383     -----RNLQLFIVVASCILVLIGTDILLPSLPNIAHALSVSSNEAKMLISIFMIGQFSTVLIWGVIADRLGRRKTLFLGMLIFFIGSIFSLKADSIQLLLACRFLQGTGAVVVPVAGWALVQDLFPKDEGARIMTWIGTLTAVIPLFAPALGGQLDVLYGWRSNLYCIAFYSFILCVIMLF-LPRTIPVQKTTTADLKeyIRIIKNKTFISYIALFGLLNCGEWCFLTVAPFYY-SHAHIAADTMGILLMITSMGFVCGSLLASRLFNRLGIDKIIALglAVMSSLMLLIGEYFHWSKYQLyaITIGVYILSSALLWGATTSRALQCFDDCRGSASAIRSLILLCFAAFGTYSGRLVNHNSLFPVGLFLLFMAFIAFIVF--------------
     893 UniRef50_C8WKQ5        Major facilitator superfami...   176     1e-42  1  18.8%  2:385   12:397     -RRLGPLGLIVLLVITSLVTPLSLDMYTPAVPHMTEHFNTSESMVNLTLVGYFLFFAVGLLAFGPASDRYGRKPVLLAGILTYALASALCALSVDIVMLIATRILQALGAGAVSAVSTAVVKDAVVPERREALLSVVQVMFVVGPVLAPVAGALILQVADWRMTFWVLAGIGLLCAGLALLflPVSERYEGTVLGSVKQLGAVARNKGFSAFLGIVGLYNLPFMAYIAVGSYVYITFFGLTELEYSMYFAFAALLTAAGPFIWLAASRFMSARRFTSILLGIALASGAAMLAV-GQASPQLFCITFLAFALTEAAVRPYSTNVLLSQQEGDTGAASSLINFAHTAIGCVGMLAAVLPWPNYVVGVGVIIVGSMGVAIAGWVALLR---------
     894 UniRef50_UPI0001C31104 major facilitator superfami...   176     2e-42  1  16.2%  4:360   17:429     ---PRRWWLLTLVAIAELMIILDIYIVNIALPSAQSALEIPDASRHWVVTAYAITFGGLLLLGGRVGDYWGRKRTFTLSLVGFGVASALGGAAWSPELLFAARALQGVFAALMAPAILSLLFVTfdPRERAKAFGVWGAVAGTGSAIGLLLGGVFTEYASWRWTLLVNVPVAVALAVAAWWIVRESRTDGETRYDIPGAllRVLTDRNRAGSFAANALFAGAIFSYGVFLVYYLQGSRGYSAIESGLAILPLTLAAIAFVSIGARLLPRVGPRPLTVGGFAIGAVGLGWLALIGEDTSyaVVFPGLVLLGIAAGLVWPVlnTALVGVQPRDAGAASGMVSVAQQLGGALTVAFLNTLAAS----------------------------------
     895 UniRef50_C2QNT4        Major facilitator superfami...   176     2e-42  1  13.5%  2:394    6:396     -SDVNPRLALISLMISTFAIGTTEFIIMGILPDVAKDLNVSISSTGLLVTGYAIGVAIGAPLLTALTGKMQRKKLLLMLMLLFVIGNTLCAVAPTYEFLLVSRVLAAFAHGTFFGVGSVVASKLVPPEKQSSAVAMIFTGVSVANIVGVPLGTFVGQALGWRASFWIISALGVVAILCITKFIP---QMALTSVPSFRQEIRVLKKPQVQLTLLMTILSFVGVFAAFTYIAPTLTDITKFSASAITPILLLYGLGLTIGNTVAGRLSDW---KPMPTIIGMLALLTLVMGSFYITSEYKILAVITVFLWGFTSFGHVPGLQMRVIAKAKGAPNIAASLNISAFNLGIALGSFVGGVVINTsaIPLVAALLTVLCIGVVLVGWLFDSKEEKQVQV
     896 UniRef50_UPI0001B540EC transporter n=1 Tax=Strepto...   176     2e-42  1  18.9%  8:362    1:401     -------MLATAVFLGSFMALLDASVVSIALPTIQRDLHAEFADLQWIVDGYTVGLAALMLTGGTLGDRYGRRRIYLGGLAVFTLASLGCGLAPTLGLLIAARVLQGIAAAAVIPGGLALLAHAYppRERARMLGAWGGVAGCALVIGPLIGGPITDALGWPTIFLINLPIGIFAVLAGRRGLEESSDPAHGALDLPGQLLGALWIGSFTYAVIasFVLGFACYPLPMLLAVYLQQAWGSTASATGVQMLPYVVANAVLAFFSGRLAGRFTAERVLPVGLAITAAGSLAFLLVDAASPYWLLSVPLTLSGVGLGLSITPTNVVGLAGLprRTGTAAGTVNAARQVGMALGVAALGALLDQGS--------------------------------
     897 UniRef50_A9KFD7        Multidrug resistance transp...   176     2e-42  1  19.1%  2:389   10:401     -RPQKIALIVATILSLYPFVGMGIDLIAPSLPAISQSLDVSDIVSKNLIAIFLFGYAIGNFLIGFLSDTLGRRKLMVGALLIFTIASLLPIAVANTKGLLLARLFQGLAMGAFTVIGRAILIDILTPEKLMRIAPLFATMWGIGPIAGPVIGGYLQHYFGWEACFYFFATFGFLALIAVFFIIPEThlQTFSISTARANFITITKNRLFLGLTILMGLLYSLLIVFNTLGPFLIQTELGRSSIYFGHVALWMGIVFLAGTIICRLLIKHYGPERLTSIASLLFLLIALVALILAYLnnLIIILFSTLVAYFACGIMYPAAMSKGLSLFRHLAGSSAAVMNLINVLITSLTASLMAFITASSAIPLAWLYLGLLSLSVFTYFFICKPKVH-----
     898 UniRef50_B0T3E3        Drug resistance transporter...   176     2e-42  1  19.2%  2:360    7:439     -TDTERRLTLGALMIVFLLSALDQTVVSTAMPRIIAELN-GLTLYAWVTTAYLLTSTVMVPIWGKLGDIYGRKPVLLAGIGIFLAGSWLAGLSGEFgqLIVFRALQGIGGGALFTTAFAIIADLYPPRERGKFAGIFGSVFGLASVLGPLIGGYFTDhaGWRWVFYVNLPLSLLSLFMILVKMPPLEHRRSGAVDYVGAILLvwSSPQSLGLLAFAAVAlmAFLGVVTFLPLYMQLGLGVDATTSGLAILPLMGGLIVASTAAGQMVSKTGRYKPLMigAVLLMTGVWLLSRVTVHTTLPDLCWRMAIVGLGLGPGQSLFNIATQNAVerDIGVATSSNQFFRQIGSTIGVAVFGALLTH----------------------------------
     899 UniRef50_A4XDY5        Drug resistance transporter...   176     2e-42  1  17.6%  3:354   13:420     --PSRQLVAGLVLALANFMVILDLSIANVSIPHIAGNLGITLEQGAWVITSYAVAEAICVPLTGWVAGRFGSVRTFLFSMVGFGICSFLCGISVTMGMLVASRIGQGIFGAFLMPMSQTLLLSVFPPEKRNMAMGLWAVTLLMGPALGPMIGGYLTENYSWHWIFLINVPVAILCIVVGFALLreTERQILPIDYVGLALLVLwrHRGFSVSLTVLSLAFAGYFAAFVVVPQWQQAWLGFPATAAGLSSSFSAMGGLITVPLVAFLMSRLDLRFLVSCGVTWIAAMTLVRTTWTTDSDFWTLSIPQFVQGLGTPFMMLPLMTLTLNTVKEnvASAAGLQSFMRTIATAVATSIT----------------------------------------
     900 UniRef50_Q0FYE8        Drug resistance transporter...   176     2e-42  1  25.3%  9:387    1:381     --------MLVTLMIASAISPLAINIFIPSMATIAEALGTDGPTVGLGLSLYLVAVAVLQVIAGPLSDRYGRRPVIIGGMVLFLVGTAICLFSETIGWFLIGRIVQA-ASATGIALSRAIVRDVYSRRRSAAMIGYVTMGLAVAPMIGPAVGGVMDTWLGWRSVFWLLMALGVLSLVLVHFDLNETNPngTPVTRQLSNYGKLISEPSFWIFAGASSFITAAFFGFLGGATFVSVEVLRLTPAEYGVWFILCPLGYAIGNFLTGRMSERVGIKRMMVIGSVLTLASVLVILvlLDRLSPLSLFGPMILLGIGNGMTLPSATAGGVSVRTDAAGAAAGLLGSAQIGLGAIASSITATFAVGPAAATSLVLVMLGAAVLALLLSLIAPR-------
     901 UniRef50_A5VHZ1        Major facilitator superfami...   175     2e-42  1  13.5%  7:391    6:396     ------KRIIFVVLFCEFLICLGMSLIFPVEPFIKNEYHFTAFDMGVMSSLFAFVQFIASPIVGRISDKVGRKPMLVWGLLIFAIAEFVFALAQHLWLFDLSRAVDGLSAAMFVPTSMALAADITSEKDRAKVIGWLSAAFSGGLILGPGL-GGMLAHVNYKFPFWVAGILGLISTVVAWRFLpeTKNPENELLTGGWSQLKQIMTPILITLFGMIFVASFGLAGFESIYSLYVNEVHNFDLNAIALVLTLNgiSLILQVFFFDRLVRWLGEVRLMRYSFFLSLVGTIMVI---YDHNHWHIIIATLFVFEAFDLLRPTITTLLTKMSKTNQGLLNGVNMSLTSVGNIIGPLISGYLLDVNYQYPYWFVSIFLIISWVITLILGRERKAAA---
     902 UniRef50_C6IVP9        Major facilitator superfami...   175     2e-42  1  17.0% 10:391    8:400     ---------LIALASIPLIMTLGNSMLIPILPQIARELHVNSFQVSMLITVYAVVAILLIPIAGYLSDKFGRKAIIVPSLIIAGVGGCISGVAdvYWLILGGRFLQGIGAAGAFPIVLPLVGDLysEEEVSHNLGLIETSNTFGKVLSPILGALLGAWI-WYVPLLSIPVLCLISLLLVLFLVREprEKAKPLREFISAVKAVLKQKGRWLYAiiGCISMFLLFGVLFYLSEQLEAKHGLDGVIKGLVLAIPLAALCLASYVTGKKIGK-DKKLMKWSGVAGLILSTGALFGIGFFNNIYFVIVCLIVCGAGIGIVLPSSDALITEGvkEMRGTITSLYSSMRFIGVSAGPPVMSLLMKAGHMTMFFVIAGVSLVAVILLLTMVKPESGHG---
     903 UniRef50_C0XQQ4        MFS family major facilitato...   175     2e-42  1  16.6% 13:385    1:424     ------------MMIGFFMILVDSTIVSVAIPAITDAFGAGYNQVIWVNSAYLLAYAVPLLITGRLGDRFGPRRLYIGGLALFTISSFACALAGSIEALIVARAFQGLGGAIATPQTMSVMIRTFSPRERGGAMGVWGATAGVATITGPLVGGLLVDAAGWPWIFFVNVPVGVVGLALAWRFVprSLDWTGVIISAVGMFCLIFgdRNYAISILAIFAVGATVATYAIPWMIHVQQGVGYSPTQAALLVLPAGVISGALSPYVGKLTNTLPPKPFAISGMALIGISVVLMALLTTttDPRWMLAISVVTGLGNAMMWGPLSMIAtnLDPQLAGAGSSVYNTMRQVGAVIGSAAVAALMGAQVARHDSLSAAMGTSLLLPAAVILL---------
     904 UniRef50_Q9KDN7        Multidrug-efflux transporte...   175     2e-42  1  18.4%  3:393    2:393     --TRSERKPLLMLMVNMFVVMMGIGLVIPILPYYIEAFGASSVELGLLIAIFSFMQFLLAPFWGRLSDKVGRKPLIAVGMFGFAVAEFIFAFATQFWMLFVSRILAGAFGSAVMPAAMAYVSDRTSEEKRGHGMGLLGASMALGIVVGPGIGGWLAE-FSLATPFLFAGFAASFAAIFSLLWLPESLPLEKRKTEvfVQMWQAVRSPIGFLLFLVFGLSFG-LANFQTIFGIFALHRFHYNPSEVGFIMVLTGigAIAQGSLVGRLTERYGEEKVVLGSLSLSGIGFLIMMLAF---NYWTVIATTCLFFLGNSILRPAVQSFLSKMAGDQQGMIMGLNNSILSLGNVVGALLAGLLFEWNMFLPYTVGAFVMFASLGATFRWLSKRASQGKH-
     905 UniRef50_C7Q6G3        Drug resistance transporter...   175     2e-42  1  22.1% 23:361   38:430     ----------------------DQTIVSTALPRIAEDLN-GFDDIAWVSAAYLLASTAVTPLWGKLGDMFGRKRLYLAATSTFLIASVACGVAQNLAELIGARVLQGVGGGGMIVLTFALVGDIVPPADRGRYQGMFGSVYGVASIVGPLLGGIFTDHLSWRWAFLINLPVGLVALVIAARALPKATRGAKARIDYLGSLIlmLGSRTVVFSSLIAFFANAAMFSVLVYLPTYLQIVHGVSATLSGISMLPLVAGLVVSQSLAGRWAAHVERLRVilAGLAANLAGLLLLGTIGGATSTVLLSVYFLITGIGIGMVPMVVLTTVQNSVPadLGAASAVVTFARSIGAAFGVAVFGTLLNTG---------------------------------
     906 UniRef50_A8EWW6        Major facilitator superfami...   175     2e-42  1  18.9%  9:384   10:391     --------FILTIALIEVLCYMAVDMYLASMPNIASYFGTSYSKVQLTLTFYLFSMGIGQLFFGPIIDYFGRKIPLILGVLLYSLCSILITLSTNIELFLLFRIIQGLSVALIYVCIISMVRDVSKGRVAANIFAILITIGAITPILAPTFGGYIEQEFGWKTVFYTLFSLAILLSIMSFFTLQETLKEEKKVKINFKnyFKIIKDRKFLTPAITACLMYMFVFAYIAGASFAYQEIYKLDSKTFGLIFGLTGSALLFGALLSTKLLKVFNMKQLSISGAFILVIGSIISFFSANItgFDGIVAGFFISFFGLGLCEASLFSMAMSSQEKSVGATAALLGSLQLLLPASATLVAGYLVEISIIYWLGIILFLGILSFLFTYIVF----------
     907 UniRef50_A5FWT5        Drug resistance transporter...   175     2e-42  1  19.5%  7:386   19:402     ------RRLPLLLGFLIAIGPVSVDMYLPAFPTIARQFH-DPAGPGLTLAAYFAGLAAGQMTQGPFSDRAGRRLPILLGLALYTLASIGCALAWNTASLSAFRLVAAFGGSAAVVVPRAMVRDIADGPAAALLFSRLMLVMGVAPIIAPILGSAVIAFGSWRWIFALATLYGIVAIGLVWFRLPDTLPLARRsrTIIIRYGQISAERGFLTHALTGTFAIGALFAYLAGTPAVFIGEFHWDPISYALLFGLNAAIYIGFNQWNPHLVARAGLRPVISAAVAALVCGTIVLVAAAlgGGPLPIIAGLFICQASYGLSLPSSLVAALSRHQAHAGSASALLGTWQYLGGAITGALVGAFADGTARPMAFAMFACAVLAALAAAFRPQR--------
     908 UniRef50_D1V7V1        Drug resistance transporter...   175     2e-42  1  20.0% 23:362   49:444     ----------------------DQTIVATALPTIVGDLG-DAQHLSWIVTAYLLASTVSTPLWGKLGDLYGRKIFFQAAIIIFLVASAVAGLSQSMGELIAFRALQGLGGGGLIIGAQTIIGDVLSPRERGRYQGVFSGLFGFASVVGPLLGGLFVDHLNWRWVFYVNLPLGAIALVIVASALPSTRNRVKRTIDYLGTALLAGATTCLVLFTSFGgmGFVSGFAMftFLPLFLQVVKGVEPTMSGLRLVPVMGGMLVSSTLTGRLVSRTGRYRVYPIVGSVLVTASLLMLAWRLTPEIGtmVIYLALLGFGLGGVMPVLVVSVQNAVerDLGAATSGSAFFRSIGGSFGTAILGAIFASHL--------------------------------
     909 UniRef50_D1VJX0        Drug resistance transporter...   175     2e-42  1  19.1%  2:368   21:444     -STKAQWWILVIIACAQLMVVLDSTIMIIALPSAQKALGFSDTERQWVITGYTLAFGGFLLLGGRISDMLGPRRTLMVGVIGFALASALGGAAPDTVVLIAARGLQGLCGALLAPSVLSLLSATFtpRERARAFGIYASIAIGGSAFGLILGGLLTQYADWRWCLYVNLPIAALVIFGIVTMIPKSVGRSGVRLDVAGVilRVLRDRNRSGAYLTILLAMTAMFGTFVSLTYLFQAVDGYSPLRSGIAFLPLMVLNGLAsqLASRLMPYVPTRLLIVPGLLAAAVGVALLTRLTPESAFLTHVLPtiLLGVGLGIAmpVISTATSNADPGDVGVISAMSTTSQQIGASIGTALLNTIAASAVTSYLAS--------------------------
     910 UniRef50_B9JAZ9        Efflux transporter n=2 Tax=...   175     2e-42  1  19.0%  6:394    2:452     -----RYIIPAVVAVAFLMEQLDSTILITAVPDIARSLGTTPVRMNLAVTTYILTLAMFIPVSGWFADRFGARRIFALSLFIFTIGSILCGLATSLPMLIATRALQGLGGAMMTPVGRLILIRSFPRSQLVTAMTYMTLPAIIGPVIGPLLGGFLTTYLSWRWIFWVNLPFGIIGMAMALKYIEDTVRDTSLKFDFPGFilTLFKLRTFRVGTLAGGICRVGLNGVPFLLPLMLQVGFGLSPIVSGTLTFVSALSSLAVRPVSSKMLRLFGFDRVLTASAIFGAAIVAGFALIGPDTPHWVIIVYVFIFGLARASQFMTSNTLssDTPAAQLSRATSLGGVLQQLSVSFGVSIAAMLLGLVTLDGSAlfLLMAVIPLLGLPGFLKLRPEDGRQV
     911 UniRef50_Q9ZBW5        Putative integral membrane ...   175     3e-42  1  21.3%  4:360    1:411     ---MRTWGPLTAVCLGTFMLLLDVTIAVVALPDMARGLHASLSDLQWVMDGYALALAALLLGLGAAADVLGRRRVHVAGVVLFAVASLLCGLATGPGMLVAARGLQGLGAAAMFATTLPLLGSVYQGRRRSMALGVWGAVSGAAAAVGPVLGGLLTDGPGWRWIFWVNLPVSVAAVWLTLRVVPESRGAAGRRVDWAGTAtrLFLRPAFSGVMLGGLAFNAAAFGVMAYTSIWLQTMLGMSPVRGGLVFVWLSLASFVVAAAGGRLLHGVPARLTIGGGLLLIAAGQFCMAFLDAGSTASALVPGLLLVGVGTGLVSPGigAALAAVPAERSGMAGGAVNTFRQLGYALGIAVFGTVLTS----------------------------------
     912 UniRef50_Q67R18        Multidrug efflux protein n=...   175     3e-42  1  19.2%  4:383   23:456     ---SYRWLVLIVAGTSAFMGALDGSIINIIIPQIQAQYQATLGDISWVSTAYLVTISSLLLSAGRLGDMWGYRPVFGAGFIVFGLGSLLCGLAPTLPTLIGGRLVQGVGAAVMMALSPALITTTFPGRERGRALGMQATLTFTGLTLGPSLGGFIAGRWGWHWVFLINLPVAAVGAVLAYTQLRPTERRSGQAFDFAGAllWMFRVPAFTGGVAAALLQFSATFVLTFLLPFYLQQFRGLSPSAAGAVMTAQPAAMVAVAGLAGWLSDRIGTRIPATAGMAAIACGLWLVSRAGAATPVTQVALCLALIGLGAGFFNPPNNSSIMSAApdRQGVAAALLAAARNVGMVTGITIASTLFAHLSQRMDFLAAFRTTLAVPVGLAV-----------
     913 UniRef50_A3YHL5        Drug resistance transporter...   175     3e-42  1  21.2%  5:382   14:397     ----QKNQILALLILIGALAPLAADAYLPALSLMSDYFETSDSMLKFSVTAYFIGFALAQIVFGPLSDAKGRRKVILLGLLIGILGALICFVSQSIWQFLIGRCILGIGMASGIPVARAVLKDLFNGVELSKAASSINMVLALMPLIAPLFGAYLASYYQWQQIFQLVFALSLVVLVLTYYLLPETNPkiLQVKPLLQTFIRVLKDRAVFTYSMTTLCAFGCAVAYMVSAPFVFLDVFGFSMIEFGWLAGLITLSYILGGFLNNYLLKKLSPDHIIFAALIGLLVTGLNIYliLFGPNLIIITLNVFLLTLSSRMVFPNALAGAFSSPIKEVGVISSVYGIYHTLGAIIASGIMSLLNINPISAMASTMIGFACFGIGVFYL------------
     914 UniRef50_Q70DW1        RemN protein n=1 Tax=Strept...   175     3e-42  1  20.2%  4:359    3:413     ---PNRWWTLTVVSVGSFMLLLDVTIVNIALPDIEEALDATLTDLQWVVAAYAVALSAVLLTAGSLADRFGRRAVFSWGMAVFTLASLLCGIAQDPLTLIAARVLQGVGGAALLATSLALLAAAYPDHrrHVALAVWGAVSGAALAVGPLAGGVLVEAAGWRWIFLVNLPVGVLALIATALRVAESRAESAGRIDWPGFlgALFRKITTTGAAIGVLAMSSTAFALLLYLTLYLQTVLGHEPLAAGLRLLPLTLSIFVASAIAARVGTVLPARWLVSAGLACVGLGLLLMGDLSASDDWTALLAGQLVTGLGVGLVNPNVVAAAMGAvpARVGVASGLSNTCRSLGIAVGIAALGAVFA-----------------------------------
     915 UniRef50_A0LD05        Drug resistance transporter...   175     3e-42  1  20.9% 23:390   30:405     ----------------------SIDAMMPALDQIGTALQSspKENQLIISVMFAGFTCGQVIFSPISDTTGRKPMIILGLAIFMLGTLICIFAETSTTLLLGRFLEGLGISSPRTVSMALVRDLYAGRHMARIMSMVMALFILVPVIAPTLGQLILNLSHWRMIFILLLLTAVLVMVWFGLRQPETLSPNHRHPFSLSRLKSLFthPITRTYTVANGLIFGAFLGYLVSAQTIFQHLYHLG-SAFPFYFGLMALSVGFASISNAKLVMRFGMRlvALIGTVVTATVCLLVISWSANpsLTGFILWGFLSFFCIGILMGNVTALALEPMGHLAGVASSVVGGLSSLMAVSLGTAIGQAFNGSVVPLISSFAVLNSVALITVLWCQARTAES----
     916 UniRef50_Q11IV7        Drug resistance transporter...   175     3e-42  1  22.4% 24:385   37:404     -----------------------IDIMLPGLQQIGSALGvdENSRQLIISAYVLGLGGAQLFYGPITDRFGRRTPLLIGLVIYVATGFACAFAPSFAAMLVLRLLQGIGAAATRVVAISAIRDVYGGRRMAEVMSMVMMVFMIIPVVAPSLGQVAMLFDDWPSIFLLMGFMSLIITVWTLLRLPETLAPEMKRSLSLggFRLVLTNRVALCYTLASTAIFGALFGFINSAQQIYVEIYDMGTL-FPLMFAIGAGLMAVSSFTSARLVGRYGMRRlaALLGFVAVSGIWLIMALFDYEPFWLFFILFSLAMFQFGWVAPNFNSIAMEPLGRVAGTAAAVQGFITTLGGGVLGALIGLSFDGTLVPLAAGYFISGGVGLILVLIGER---------
     917 UniRef50_C2YTE4        Permease (Major facilitator...   175     3e-42  1  15.9%  3:393    8:396     --KKNPLTGLLVIAMAVFIDMLLYSLVVPIVPLYVSKFGASQTTVGILISCYAFTFIFFTPILGVVSDKFGRRGSMLWGMVVLIASTLMFAFANNMYILILARLLQGIAAAATWTAGLALITDLYPANKRGKALGTVITFMSAGTLLGAPVGGLLYEWGGYQLPFLLAAGIALLDGLARMFLLED---PPKDKETSSVDIAKIFKDFEVLKIFGVVLLGSSAISILEPTLPIYLMENLGASTVHIGFLFGITTLAYGLASPIAGWLSDKSGTFHIMMIGLLILAVC---LPFVTIPNTLVLEGVVLFFLGAAAGLVLTPTLPELANSVDRLGgtAFAVFNVAYSVGMMIGPIFGGFFADMFNVSIALYILSAFLVCYSISLRIMKSKPKKTEH-
     918 UniRef50_B7X2W6        Drug resistance transporter...   175     3e-42  1  23.5% 21:386   27:394     --------------------SLATNIILPAFPSMGVELGTSVKDLSATLSTFFVAFALGQLFVGPLSDRFGRTPLVVCGLCVFVVGSAVCAFATSLPQLIVGRVIQALGVCATSVLSRAIARDLFEGDALARALSLVMVAMAAAPGFSPLLGGVFNSVLGWRATFGVVGVLAILLGIHYVSRLGETHSSDLRRPLALSayKALLTDRRFIAPAMSVSLVLGSLYLFFAMAPAILMEGFGFSPLQLALFFASTVFVVFGAGLLAPRLAHRFGAMRAARAGIAVAFAGGA--TLLAAPEQVYYFSAALTVFLIGMGLINPLGTAVTLQPFGQNAGAASALLGFLQMGCAAISIAITSALPLSPYLAFSAVIATSLLMAMVTFGVAVKR--------
     919 UniRef50_C7JI57        Multidrug resistance transp...   175     3e-42  1  19.7%  3:362   15:430     --PTTRILVFIGLIMTMIMGALDQSIVSTALPTIVSDLG-GLARMSWVVTAFMLTSTIATPMYGKLSDMFGRRPLLAFSIGAFLFASLLCGIAQNMWQLILFRGLQGVGAGGLMTLSQTVIGDMVTPQQRGRYQGLFTGAFAVSSVTGPFLGGVLTSALSWRWVFLVNLPIGLLAFALIMFSLPAGRSEAKPQIDYLGAGLLSIATAGFLLlfLLFGLSLAVFYLFivFLPLYYQLVLGQTPATSGLMMLPQVGTMLVSSILGGIVSSKTQRYELLLAIGVgfSALSLIAYCAHHGAPPLFFLISLGCLGVGMGIGMPNATVIIQNSVPSNagIATAMMSFIRSLGGSLGVALSGGVMALTL--------------------------------
     920 UniRef50_A8LDP4        Drug resistance transporter...   175     3e-42  1  17.7%  8:362   27:435     -------LALFVIAAAQLVVVLDATITNIALPSIQTDLDVSDANLAWIVNSYALAFGGLLLLGGRTGDLFGRRRMFQTGIAIFTLASLLGGLAPNEALLISARVLQGIGAALAAPNALALITTTFPPGkrNTAMGVYAAMGGVGATVGLLLGGTLTDVLSWRWVFFINVPIGLVVLVGTRSLVEAERDPGrlVYGITHGGEHGWSDSATLTAFAVAalIGAGMFATFYFLTLYMQLILGYSPVRTGFAYLPFSFGIAIAAGVSSKLVTHVAPRVIAGPGLLAAAAGMLWFAALDPDSPYAglMPAMFLTGLGLGLSFVPMtgAVSDVAHEDSGIASALLNTAQQIGGALGLAVLSTIATSTA--------------------------------
     921 UniRef50_Q13FE7        Major facilitator superfami...   175     4e-42  1  16.7%  4:392    7:457     ---RDQRGTLAAAGLGFVVVLLDVSVVNVALDALRARFATDVTGLQWVVNAYTLAFASLLLTTGALGDRFGAKRIFTAGFAVFTLASIGCGIADSLPLLVAARVVQGIGAALLVPNSLAMLRQAFPdqQRSRAVGWWGAAGGIALAAGPVLGGLLVTHVGWRSIFLINLPIGVAGVALTLRHAAAAVSTHNRSIDLPGQllSLFRTATFSVASVAGVIVNFAYYGLIFVFSLFFQIEQNLSAQWTGLAFLPMTAVLMGVNILAGRLLNRIGAKKLMIAGMVIAASGYLLLLPVSTNGSYWMLVLPMLVAASGIALMVPTMTNVTLSSVDarSGVASGILNSARQVGGMLGVAVFGFFVRDtgMHLSIMTAAVLLLCGSVICLYGIRTPRPAH--
     922 UniRef50_A6W9A1        Drug resistance transporter...   175     4e-42  1  26.0%  2:359   20:383     -SRPSMGRTALVLGAFVAIGPLTIDMYLPALPTIVTQLQTTEAAVQLTLTGTLVGLALGQLVIGPLSDALGRRRPLLAGTALHVVASLLVLLAPNIAVLGVLRVLQGVGTAAGAVIALAIVRDLYEGRAAATMLSRLFLVIGAAPVLAPTIGGELLRFTSWRGIFVLLAVYGLALLAVGARALRETLPPEARRpaTVRTYRGLLRDRTYLGLVLVAGLTMAALFSYVAGASFVYQGQFGLDQQQFGLLFGAGAFWLIAATQLNPLVLRWAAPSQVLLAgaGLLAGVVLLVLAATGTGGLAGVVAPLWVVLFAIGLALPNAPALALSRHGEAAGAAAALLGAVQFGVGALVSPLVGLLGN-----------------------------------
     923 UniRef50_C3PFV4        Permease of the major facil...   174     4e-42  1  17.4%  1:385   15:453     ISEKQAWLAMAALSLGFFMSLLDQSMIAVALSDVRREFNADVNQVLWVSAIYLLAVVVPLLFTGRLGDIYGQKRMFQLGNGLFGLGALLCALSPSVEFLIAARALQGLGASIQMPQTMAVINRIFPRERRGRALGAWGVVGSLATLAGPLLGGLVVAAFGWQAVFWIHIPFVIAAIALSGLWVppTTPGRVDFVSVWASFIAltGWPWWIWAFLAVGVLGMVIfsMMIPIMMWLQVEQGMSARDAGLIVTPMALVSLCVSPLAGILADKLHPRRLAVVGFGILISTflLWFLMHAGVSAWWLSLPCAALGAGQSFIWGSNAATTmdIDAHLMGAASGVYNTSRQVGSVIGVAGVSAVMQVAGAANSLVLIVAILAVGCVSSLFFR---------
     924 UniRef50_C2HEP2        MFS family major facilitato...   174     4e-42  1  17.2% 11:387   34:402     ----------LVVAATCMIAFMGVGLVDPILKTIAAQLNATPAETTLLFTSYMLVTGVVMLFTGFLSSRIGLKKTLMTGLFIIVVFAGLGGLSGNIGMLIGLRAGWGVGNALFVSTALATIVSILVGNTE-KAIMMYEAALGCGMAVGPLVGGVLGS-GSWRYPFFGVAFLMFCGFIALAVLLPETEKPKRKVGLWEG--VKALSNHKLRSVGLIALLYNFGFFTLLAYAPFLLI---GYSELEVGFVFFGWGVLLAIAsfVAPALERKFTTYRTILAAFVLFIICLLLLGAGTSMPVLVPI--SIVLAGFFQGIINTLLTTIAMEIPGLQRNVASSSYSFVRFFGGALAPFIAGVVGEHIGESYAFYFAGAIVLISVCCIIYHRNY-------
     925 UniRef50_A0B1K1        Major facilitator superfami...   174     4e-42  1  17.2%  3:368   49:476     --RSHHSWALVVLLVGAILPPLDYFIVNLALPAIRDGIGAHQAELQLVVSAYACANAVVQITGGRLGDLYGRKRMFMIGMAGFVLASTLCGLADNGTVLVGGRVLQGLFAAILAPQVLATIRSVFSPQEQVRVMGFYGFAFGLAAVIGQLGGGALISllGWRAIFLVNLPIGILALIGSWRFIPENRAPRGQRIDVPGTVLMSlgWPLWMIACGVGALPMLglSAFFLSYGIYLQGCLNWSPLASGFAILPLGLGFLASPLLTTRLVARFGGYRVLTLGFAMLAAGVAIAAALARDGAppGFYAGIAAIGIGQGLVLPSVVRIVLAEvaARAGVASGMVSAMLQIGAAVGAaiGGVFFARLGVHPAAL--------------------------
     926 UniRef50_B5L6M5        Putative multidrug export p...   174     4e-42  1  16.9% 20:386   36:472     -------------------MQLDGTMVGIALNTLSGELSVSVSTLQWVVTGYLLALMVGMPIAGWAADRFGTRRMWTVSLVVFLVGSVLCGIAVNIETLIFARVVQGLGGGMMVPVGQAMLMRVAGAEHRARLVGLMAIPGVIGPTLGPVVGGVIVDDFSWRWMFLINIPIGLIAFFLAGRNLPNFKEEARavFGLSRAAAGGLGDPLVVAPLVTGVVLIAGfmGAGIVQPLFLQQVHGESPMGAGLLLVGFGVGSALTSVVLSRVFNRLGARLVGTVGLALTFTGTVAFTQFYASTGRVFIVLAMLLSGVGLAMVTLTMSTAlvGLPPQQIARATGASRIVQQLGLSTGTAVISLvlANAYHHAFWWSAGFLALAIVPALLLPGR--------
     927 UniRef50_B6WWS3        Putative uncharacterized pr...   174     4e-42  1  21.7%  7:384   11:388     ------RWLVAYLAFLSAFAPLSTDMYLPALPHMTQALQTTDALSSLSISCFLLLFGASMLFWGPLSDKYGRKPVLYAGALLYVLSSLFLALAQSIWPLLFWRAVQAIGSGGISAMALAIVKDVLRGRAMEKVITWIQTITILAPMLAPVIGGALLAVTDWRGIFACLLLCGLLAGAGTLLLRETMhpVQGNAFRTLGRLLVVLRHRGFRCLLLLFSATSMPFMAYLALSSYIFQGLFGLSPQAYSLFFAFNAGMSMLGPLAHERFFRTAPRRLFFSAYLGIVVVAGLGLLLV-GDQGPFIFALLCAPISFCGSALRPPATVLMLNQMRNDTGSLTALINSGGLLFGSLSMLLCALPVWPGPVAAQALMAILVGTACLLGWLWL----------
     928 UniRef50_C7PVF0        Drug resistance transporter...   174     5e-42  1  22.8%  4:372    1:424     ---MRKWLPLVAVCLGTFMLLVDVTIVTVALPDMARSLDTTFADLQWVMDVYALVLAALLLAAGSLGDRAGHRRLYVAGLVVFAAASLACGLATSPGVLIAFRAVQGVGGAAMLATTVALISHLYSGRDLGTAFGVWGAVSGAAAAAGPIMGGLLTQHLDWRWIFFVNLPISVAAVAMTLRYVGESRGERRRGLDLPGLllSLFRRGTFTGVMIGALLLSGAAFSYFAYESLWLQSALGMSPVTAGLCFVPMSGAAFVTAGLGGRLldRLSPRVMIGGGLLLIAAGSAAQMLVSAGSSWTVLVPGLVVSGVGVGLATPTLVSTAVAAVgqRAGMASGAVNTARQLGNALGIAVLGVVFHAGLASSVRGAGVP----------------------
     929 UniRef50_B2JRB9        Major facilitator superfami...   174     5e-42  1  16.5%  5:391   33:480     ----KAFIAPVIVACAMFMESVDANVIVTALPEMARAFGRDPVTLKIAVTSYVLGLGVFIPVCGWLADRFGARSVFRTAIGIFVVGSLLCAASTSLATFTVARFIQGVGGAMMVPVGRIIIFRVVERSDYVRAMNYLSVPAMLGPAAGPLLGGFITTYLHWRLIFFINIPVGILGIWLTNKYIKNTREPHPGPLDWAGFilRFFRVPTFQASVLGGSLFRIGLGAVPFLLPLVLQEGLGMSAFKSGLITCASAFGGMFMRTLAATVLRRWGFRTVLMYNAAFSGIAIAACGAFFPGTPTWLIWVIVLLGGFFPALQFTSLNSMtaEIESRDVGRATSLGSVVQQISLGLGVTVAGIVLshGALQWSDFWPAFVVVGLCSVASISVTRRLAA---
     930 UniRef50_Q47HB0        Major facilitator superfami...   174     5e-42  1  16.9%  3:393   65:522     --ERYKWMVLFILALGTVAGVLCTSSFNVAVPALSRHFRLGQDQVQWAMTGFLAAMTVGMLPTSWLLDRLGFRIIFLLSLAVLTLASVGGYFAPSFTLVVAARILQGLAAGVLQPMGALALMRLFPPEIQGRASGILIFSIALTPAIAPSLGGALLDRFGWESIFLLGTPFAVIAALCAIYLLPAPREIKRKPFDWLGLGWLTlrQRTFAMGTLVSFAYGFGLYASTYLIPVFLQNALSFKAGAAGMALLPSGIALVVMLPLAGRMADHYSPKWITLIGLVAFGASFLIFSIRGGAIQYAEIIAATIIGRIGLGMILPALNLATLRHmpHQLGQSSVVTSYARQLGGVMGVAVLAVFVEwsAYSQGFLLLTAVFSLAVLAACFMRTEGSRPSP-
     931 UniRef50_C7QKL5        Major facilitator superfami...   174     5e-42  1  19.0%  2:358   20:440     -TARAQNLTLLVLLAGIFMTTLDIFIVNVAIPATQRDLHASPAAIQWIVAGYGLTVAAGVITAGRLGDMFGRRRMYALGMALFTAASAACGMAPTANVLIASRIVQGIGAALLSPQTLAIIGTAFEGAKRVRAFTAYALAMGLAAVFGQLIGGVLIDmlGWRSCFLINVPVGAVALTLVPRAVPESRAEVRTRLDVPGVALVSagWPLWTWLSFGAALVLFGVFgfFLVFALYVQLGRGLDALHAGLIFTPIGVGYLLTSMVAQKVTERLGRQTAAVGTLLMAVSLLDLIVTlgTHGSLLWTIPALVGDGAGMGLAIGPLAAGAMgvAPHHTGAASGVVSTVMQVGGAVGVAVIGIVF------------------------------------
     932 UniRef50_C6WIV6        Drug resistance transporter...   174     5e-42  1  25.0%  1:384   16:404     LSRGRRAWLALVLGSLSAFGPLTIDMYLPAMPDMARELATSASAVQLTLTVFVIGLAVGQVLVGPVSDAWGRRRPLLAGLALYAAGSLLCALAPDITWLLTGRVVQSLGAAAGVVLSRAIVRDLFDGVAMTRFFSTLMLVNGVAPIVAPVIGGQLLVVARWQAVFHVLTGLGVLLLVAVLLALPESLPAErrPRDTLRSLGALIADWSYLRHVLAAALVFAAVFAYISGSSFVLQDGYGLSAQQYSLVFGLNGVGTVLLGAGNGLVVGKleRTLLLAGTAVTAVAALGALVGALAGWPLPWLLVCLFLVVAMMGVVLANATSLALAGHGSAAGAASSLQGLLQFLVAGIAASAMSWGGQATAVSMGATMVACSVGALALLVVRR----------
     933 UniRef50_B0KKV2        Drug resistance transporter...   174     5e-42  1  24.2%  2:385    6:394     -SPPIRFSFALGLGLIGALGPSAVDMYLSSLPEIASHYQASFTRVQLTLTFFLLAMGAGQLIFGPIVDAYGRRKPLLAGLLLFILCSLGAAAAPSLDTLIMLRFFQGLGSALTLVVIMSMVRDVSQGVAATKLFALLMTIEGVAPILAPALGGVIDAHFGWRAVMLVLAGMGLAVLLNSLLNLPETLPPGKREPLRlrTYLAILADRRFLRPTLAVAAVFFFLFAYIGGATLVYQAHYDLSAQAFGLLFGATGVSILFGAMAASRLISHLGLNTLTRLGVLCMAGGACilLGALTGLGLPGVAGGMVVALFGLGIAESTLMSLVMASQDKALGSTAALLGAIQLSASAGAAPLAAVVLDHGPTAWAALLALCTLVVCLLTALSLR---------
     934 UniRef50_A4BGW6        Drug resistance transporter...   174     5e-42  1  23.3%  3:380   17:403     --HSKSATFYITLILTISLSVIAIDSIIPAIPSMTLAFQTDPGLSQLTIGLYLAGYALGQIPMGLLSDRFGRRPVFLIGMTGFTLLSVATVFADTISQLLVIRFVQGVAGTVGPVVARAVARDTHHGKDLDKLMAILVTSLAAGAMIAPILGTLIVSLFGWKAPLILNAVIGGLCLILLLTSLPESHRPNRDLHPWvqSALAFFTNRQALVASFVVSFTFFAYFSIATGLGSILVDYYHYPAHVVGWGFALAVTFYMVSAQVCRFRIHRQSAEKLMHQGSLfvAALLIVTLLLGAQLSVVALYGLLLLFLVGMGHVFAPASAVTMQPLGHIAGFAASMLGTLQMGLGTLGASLTAVFYDQTPISLIGVLMLGALFSAILI--------------
     935 UniRef50_Q02YV3        Arabinose efflux permease n...   174     5e-42  1  15.4%  5:381    4:377     ----KNFSTVTGLFLGVFVVGVDSFIITPLLPQIAQDFHATISQTTLGVTTYALCEMIGAPLFGPLGDRFSKRKLLITGMSLFLGANLLCAIATNLATFYIYRAAAGLGAALFLPNVWAFIGSYFNGQLMNKIMGISMAGLSLSVAVGVPLGSFLSQLSNWHSAFWASAVLTVFSLILIIAIIPNT-TAQNQKISYLVNFRNVFKAKNVIHTLLLDFFWMFGFYLVYTFLGSFLAEHFHFSSGKAGLVFLIYGTANFIAASTGGVIMNKLGRVKSILFNACASLSFTLALGLFSNSILGLIIFLILLAFSMGWGVT--AISAYLVTLSTQNRSTLMSFNSSALYLGLTLASIVGGLIYQGLGFWILGIISSFSYAIVILLI-------------
     936 UniRef50_C7PWN9        Drug resistance transporter...   174     5e-42  1  17.6%  9:361   22:428     --------VLFAMCLSLVLVVASVSALNLALPNLAVELGATNSALTWIADGYTVALAALVLPLGALGDRIGRRKVLIAGNLVFGTAAVFAAYSPTTSDLIVSRVVMGIGAAMIMPGTLSTITAVFPPEKKDRGVAIWSGFAAAGAIIGMLVAGGLLERFSWTSIFWASSATAVVCAVAAWALAPETRSSERQRFDYGGSVtrLFKLRGFRAGTLAILTQFMAVFGFFFVGLQFLQLILSYSPLKSAIALVPVAAVVLPTSVLTPRLAERLGVRTVMPAGLLCLAGGMFWLTMLHVDSGYLVFLGALVLAGVGIGLTSSTGTSAIVESlpDSQGVASAMNDTTREVGSAVGIALMGSVFSSH---------------------------------
     937 UniRef50_Q47VB4        Multidrug resistance transp...   174     5e-42  1  19.9% 14:389   39:422     -------------ASILAVSPLAVDMYLPAMPTLAEHLNTPMSMVQNSLSIYLLGYALGLILFGPMADKHPRRNLVLLGIGGFFIASLLLPFVSNIEQFLTVRFFQAFVSSAATVVVPGAVREYY-GKDTAKGLSYVSMIMMLAPMIAPSIGSVLLLAHSWQLIFYVLAAYSLIVLVLVSYylPEGPVVKKVEMSFIQRYKIVLSNAEARLDIISSMMIALAFFAYITAIPFVYLTIFEVSEYTFSLLFALNILALMTAHFTNTRFVVRKGSRTMLRFGLTLamAATALMLVNVLALPLIYTVVAIFPLMGSISMIAVNSDALILTKFPAHSGTVTAVIGTLRWGIGALAGPILAFFYDGSAKPFALLMFFAVLVVLSCQLMIWFNNKK-----
     938 UniRef50_A9AXN0        Major facilitator superfami...   174     6e-42  1  18.0%  6:393    2:389     -----KRSPLLTIFLIAFVGTMSYGVVIPITPFYAQEFGASEVQVGMIVGSYALMQFIFAPILGQLSDRYGRRPLLILSLIGTVCSLLLFGFANSLIWLFVGRMFDGATGG-NISIAQAYVSDITTDKDRARGMGMVGAALGLGFIAGPAIGALLSKDGNYQLPIFVAAGIAVLSLILTIVVLPEPERHAPQQGRTFNPMKLlvRKPNVGRLLSITLLINLAFVAFETTFALFAARRLEFGSHQTGYTLAGVGIVVAIvgGLIRRLAARFGEATLIVSGSLLLALSLAGLGFI---QNVWHLVAICIVLAVGEGLLTPSLSSLVSRNSPaeRGENMGLYQSMSSLARIFAPLYATWMLSNVGEASPYLMGSVLVVAGALIAVGLPSPEPQAQP-
     939 UniRef50_C7Q3U9        Drug resistance transporter...   174     6e-42  1  21.7%  1:360    6:418     MGGRRRWLILIVLCLATLVLVVDNMVLTVAVPALTESLHASAQNIQWVLDSYILVFAGLLLTTGSLSDRFGRRRVLIIGLAVFGVASAVATMAHNPGELIAARVAMGIGGALLMPSTLSILITVFTDeeRRKAMAAWTVVAMVGLVGGPVLGGVMISHFWWGSVFLLNIPIAVLAIISAVVLMPESKGPWRKPDPLGTVllQLFKQRNFSGGSFSLTLVQIGNGGLLLVMTQYLQFVLGFSALKASLCFIPLAIAALIFNTLGAGLGMKFGNRPLMVVGLLICAVAFGILADLGVNDGLTKLFVGLFLLGAGSGLAMPAAITAIMGAvpEHAGVSSALNDTVQQTGAALGVAIMGTVVAS----------------------------------
     940 UniRef50_A8EWP8        Major facilitator superfami...   174     6e-42  1  19.5% 22:380    1:357     ---------------------MGVDTYIPSIPEIAKYFEVDIHKIELSLSIFLIGFSIGQIFGGPISDRYGRRFGSILGLLGYAFFSFLIIFSSTVYELWLYRFFEAFFGGITVVNASASVRDRFKGQEAAKVFSLIGMVRSLAPLLAPVFGAAIIHFFPWEGVFIFLTIYALIVTFFVYKDLPESF--TYIKQSVFESYKIVLTHKLAMKAMIVLALSFGGFFIIISKTSFIYIEYFKISTDYFPIFFGINFVILIFMIKVNVNLLKKYYALTIIKTAILIQVLVGLIFIFVHKDLTLIMTMFILASYMSMMAFIFGNCMALAIEHFSKNAGVASGVIGVLQFGLGALISSIALNFSDNGFLVISVSITLISIISYFII--------------
     941 UniRef50_C3PJI5        Bicyclomycin, sulfonamide r...   174     6e-42  1  20.8% 21:391   18:391     --------------------PFATDMYLPVMPEIVAELGTTRSMVQLTISGFFIGMGVGQLVMGPLSDAIGRKRLLVAGAALALAASVLAAMAPTATVLVAARVLQGLGGGACTVLARAVVPDLVHGSAAAKAYSLLMALQGIAPAVAPVLGGVLAEPLGWRGIFWVLAGLHAVQLVLAVAIVPEtrSRAGLFRTVAGNYWAVLTNARVWGYLVTMAFGFCSMFCYISASAFVVQDQWGFSPLGYSLIFGVNSVGLFAATLVNSRAMDSVSPAVMLRIGvgVFVCGVLLLLSVLFGAPVWVCLTVLFACVAPTGFIMGNATALATGLMRPRAGSVSAIMGFGQSMLASAISPLMGW-DSNAALTMAIGMVCCSFISLYGLVVSTRLARGAA---
     942 UniRef50_A8KQU7        Elloramycin permease n=2 Ta...   174     6e-42  1  15.2%  9:364   30:440     --------VAAAVIAGSIMAILDTTVVTIALQSLIVEFHTSFDTVQWVTTAYMLALAAVIPVTGWAADRFGTKRLYALALTLFLVGSVLAGFAWNIGSMIAFRVLQGLGGGILTPAGMTVLAKAAGPARVGRVMSLLGVPMLLGPLAGPIVGGWLVDSGGWRWIFYLNVPIGLLALALTLRYLPKDTETTGGALDTVGTLLllFRNRRFSLAVVTMALFAVAFFGVSILLPTEFLMVRQLSALETGMQLLPLGIGAVVTMPLSGRLADRVGPGKVVVPGLLLIAAGITVFTQAGPDSGYavLAPGLFVIGLGVGATMMPIISAALQVlgPAVARGSTMANIIQQGFGAIGSAVMSIVLAAGLAG------------------------------
     943 UniRef50_B8GK17        Drug resistance transporter...   173     6e-42  1  16.3%  4:383   15:447     ---TNRYIILIIVLTGILMAVIDGIVVSIALPTMTSYFGVDVAQSQWTITAYLITMTSLLLVFGKVSEYTGKVVLFIGGMAVFTVSSLACGLSTSLMMLIGFRVVQAIGAAMVFSISGAILFTAFPVTERGRAMGYLGATVAVGSIAGPVVGGFLAGTLGWEYIFFINVPIGVVLLLAAARYLrgDLADGASLTTLPLALVFLLATGFFilPMISMVLYFIANFMLGVIGPFYFEGVMGMEPTQVGLVYLVMPTIMVFLSPLTGWLYDRHHSPHYATIGMAVVAGALFVAGYASVRQDLTLILLAFAGVGIGSAFFQSPNNTDLMSapPQKMGLASSVTATGRNLGMALGVSIATILISVFLRVFGNEDAVMGAPVSVLAAAV-----------
     944 UniRef50_D1VLQ4        Drug resistance transporter...   173     6e-42  1  19.0%  4:392   37:488     ---PRRAWTLVLASLGVFMTALDTLVVANALPALRASLHADLGDLEWTVNAYNLAFAVALLTGAALGDRYGRKRTYWIGLLGFTVASAAAALSPSVGVLIAARGVQGVAAAAVMPMTLTLISEAFPADRRGAAIGLWGGITGLAVALGPVVGGAIVGGISWHWIFWLNVPVGLALVPLSIARLRESFGPRsrRTATPMLSVQLFRSRAFNAANGVSFFMYASLFGVLFLMMQFLQTGLGYSPLAAGLRTLPWTGAPMVVAPLAGALADRFGNRPFLIAGLALQAVGLGWIAAIapGMSYRWLAVALAVAGVGISLCFPTVANAVVGSvpAEMGVASGTNSAVREIGGVFGVAILASVFAGSGvhFATALWIGAAFSAVGILAAAAVPGRPAT--
     945 UniRef50_C4DMC4        Arabinose efflux permease f...   173     6e-42  1  16.4% 21:393   31:466     --------------------SLDLNIVFVALPEIGAELGFPGQTQQWVVSAYTVFAGGFLLLGGRLADLLGRRRTFVTALSLYAAASLAGGLATDPGLIIVSRAVQGIGGALLLPSTLAIINNLfeGRPRTRALAVWGGFGASGLTVGALLGGVLTQAFGWPAVFFVNVPLAAAVVLGALLVIPADGPRASGNFDLPGALTAtwTSPSVLAAAVLGVALLAafMGTFGALPYFLTTvyDYSALATGLAFLLPSAAIFAGTQLGASLTVRFGARAALLTGFGIGVVGTVALAVAfaDAGFLAAAPGLVVSGLGQGIVWTAMFAAASTGvpARAGVANGLATTTLNVGNALgvAVAGAvaQRGGFVAVLVAAAAMVIGLGLAAALPRRSRLPHRH-
     946 UniRef50_D0XJ52        Drug resistance transporter...   173     7e-42  1  21.4%  1:360    8:422     LSAGRKRWILAATVLGSALTFIDGSALGVALPAIQRDLGAGPAAAQWISNAYLLTLGALVLIGGAAGDRFGRKRVFLIGVVVFALASIACGLAPTASLLIAGRALQGIGAALLTPGALALIGANFPERERGAAFGTWAGAGALFGMVGPLVGGWLADHADWRFIFWINVPLAALTVVVALKAVPESRDEQATGLDWPGAvlTLFRSRVFSGINALTLLLYFALSGAMFFLPFELIRVHGWSATGAGSAMLPFAVVMGLFSGVAGRLADRFGAKLSLSVGPMLAGVGLALLALMSPDAGYVtpLTGMTVLAIGMTLAVGPLTAAVMGAvpGHTGVASGVNNAVARIAGLLAIALLGVLLSA----------------------------------
     947 UniRef50_Q119R9        Major facilitator superfami...   173     7e-42  1  17.6% 19:381   31:393     ------------------MAILGGPGISPLLPSIAKNWNISPEHIGWVISAFFIPITIGTPISGILADRYGRKQILIPALILFAISGTLCSLAPNFQTLIGLRFVQGIGAAPLESLTLTLISDFYSGKLLTTAMAFKTMSVGLSLVIYPLISSGLTTW-GWRYPFLLYL-IAIPLSIWILFSLKNPAIPKQKSFNllRNIWQSFNNYQVRSLLIVIIVNffSLGPCLTYIPLFADRQLGASYIVIGIILASRGIFLAFASSQLGIFAKYLSELTLIKISFIIYCIAFIMIPTI---NNIWLLFIPGILLGLAHGMLVPSTQSLLGQLSPeyRAGFMAVTSSALSFGRTLGPILAGSMFYIGGMAGVFYSSSIVSLVIFVFI-------------
     948 UniRef50_Q5YMN1        Putative transporter n=1 Ta...   173     7e-42  1  19.1% 10:359    1:404     ---------MAALVVALLTVGLDLMVLNVALPTLAQDLGASTTQLQWIVNAYTLVFAALMLPAGGFGDRYGRKRLLLVGLVAFVAASAWAAYSGSTGSLIAARAVMGIGAAIIVPLSLGILPTLFGPDQRRRAIAVWVGALGVGLPLGPIVGGWLLQHFWWGSVFLINVPVGVAALVACVVLLPESADPHAPPLDWLGIilGLFANPAFTWPTLAATAGTFTLVGVLFVLPQYLQILRHYDAFGTGLRLVPLVLAIIIAAAAVDKIVTRVGAKIPIVTGMLIAAAGFVLASRITADSGYGFVAVCLGVVGLGAGLALAPAVDAVMASLPEHRSAaaGLLMAIRQVGAAFSVAVLGTLLT-----------------------------------
     949 UniRef50_A8GPK9        Bicyclomycin resistance pro...   173     7e-42  1  17.8%  9:385    3:380     --------LLITVIIMEILAGAEIDLFVPSFPEIQDTFNLSTFMMELLLGVNLTAYSITSLIVGNLGDRYGRRPIIILGLLIFNLGSLFCVFANNYESILFGRFLQGCGISSVAVLVYVVLADIYSVQEQQRLMGIINGNVALSMAIAPVIGSYVNLFWGWRGNFVLLLIVGLTSLILGMLFIPK-RKVNKKIRIALKEYIPIFKSPKAIYYILTMIFLEQGYWIFIGIAPILYMQNLGVTLEYFGLYQGAMAALFSIMSFSSGYCFKKFGIRNCFYFGVIFIILFLLgiLVIYNINHPLTITIVTLLLSLGVIYPINILWPLLLEAIPDGKARMTAMFTAARLILTAFGLQVVGLLYNGTFNPICITISIVTLFGLVTLPKLFK---------
     950 UniRef50_A5W2G3        Major facilitator superfami...   173     7e-42  1  22.7%  5:366    9:370     ----RRHLCSTLLILLCLLGVFPLDVILPSFPALSDEFRVDTKQIAYSVSFFAVGVAMAQIVIGPLSDGIGRKRLLLAGLSVSIVGALGCVFSTQYETFMAFRLVQALGCGSL-VLGQALVQDLYSGTQRNAMRILLTSASGLFISLSPLAGAFLQQSFGWKASFTVFVIIAAIVSLLSCVLLHDAPASHDRAPSM-SSYRVMLRDTDYLAHAMLSSLAFACHFSFIVIAPLLLMGRLELTAYQFSLVFIGYGLAYIVGGMAATYLNSRVSPQAQIKAGLLLiaGITLLMWEWVAGLSVLGVLLPMIVCTTGTTLLRPAATTQALARYPRQAGAAASLNTTLLFAGAGLTSSVVAGLESELPAWLG----------------------------
     951 UniRef50_D2EEE1        Major facilitator superfami...   173     7e-42  1  18.3%  4:374   17:438     ---KNENLILSVLVIGVLMASIDSTIVLLAFPAITQALHSNLSTVIWVILIYLLITAVAATQLGRIGDLFGRSRVFNSGIAIFTFFSFMCGIAPTDITLIIFRGFQAIGGAMMTANSGAIIADTFRREKLGKAYGFTGMGWNVGAMLGIVLGGIITTFIGYRYIFFINVPIGIVLLVLALKYIKDNKRENEKLDIAGMGIlsMFKNKVFKNSVLASMFQGLGFMGVAFMLIMYLQGVRGLSPFNASLLLLPGYVLSGVLSPFMGRYSDKYGARLLATLGLLVMIAGITVYFALTATSSVYIVLIGSAITGFGGAMFWPANNSAVMKSSEAGrgTASGVLRLFGSIG-IMGSFIIVIVTATLAIPRYLAFEIFVG--------------------
     952 UniRef50_A5F462        Multidrug resistance protei...   173     7e-42  1  19.5% 10:393   17:399     ---------LVYLSALSMLGFIATDMYLPAFKMMETAFATGPEQIALSLTVFLVGMALGQLLWGLASDKFGHRNTLIAGLLVFTLASAGLAFSSTVWQLLLLRFIQAIGVCAPAVIWQAMVIKRYPSSASQQLFATIMPLVALSPALAPQLGVLLADYFGWHSIFLTLTLMGIVLVVSTGLQTNEIAEP--KTTSIAQDIKGLLKSKTYLGNVMMFACASAAFFAYLTGMPEIMAQ-LGYQARDIGLSFIPQTIAFMVGGYLGKKAVQKYGDELVLKQLIALFTLSAAMIFVASQWtsIWPILAPFCLIAVANGAMYPIVVNRALSSAKQSPATAAGLQNSLQISVSSLSSALVAALASQAQPVTGIAIVLCTGGLWIGYILSNRQLREQFTT-
     953 UniRef50_Q5KC63        Multidrug transporter, puta...   252     1e-65  1  14.2%  2:389  124:572     -SKRYRWAITALIGVTALCPPFASVSYSTTVGEVVEAYGISRELAIAGISLFILGFGLGPLFWAPISEIYGRQIAFAASYPIFTIFNLGTALSHNTVALMVTRFFAGVFGSSPLTNAGAQVGDMWAVNERALATSVFALAPFLGPVLGPIVGGYVTERCGYRWVYWIQFIYAAVMTILSIIVVPETYAPTILRRrlCRPFEMLFTEVIVGCLSIYGALIYGILYLFFTAFPIVFQQTRGWTVGESGLSFLGMGVGLISGVILNPFLSSHfeARLPVCCIGAILAPIGLFWFAWTSAPPVHWIVPIIAcfGLAFLLIFTSMTNYLIDSYELYAASALAAQAVSRCMFGAIFPLFASQMYETLGLHWAGTLVAFLSLACAPMPFLFHRYGP-----
     954 UniRef50_A2QK70        Contig An04c0360, complete ...   233     1e-59  1  14.1%  3:392   68:511     --RWRKWYITLFASFLNVITTWSCGSFSSGATGIAEHFHVSTEVTTLCLSMYVLGYAIGPVLLAPLSEYFGRQPVYIVSWFIMSLFQMPLALAPNIGTIIVCRFIAGFAGGAPLTNTGGTISDLWERNHSGGPMAFYGLSSTFGPPMALVVSGYIGLNLNWHWIFWIMMAITGGTWIALVLTIPETRHSIILQrtLTRPFRFLFTEPITTFSAIYNGFLYGLVYLFNEAFPLVFGegHGFNVGQQGLCFLGMAIGPIIACALsrYYLRRveARMWMARVGSLLIPISLFWFGWTSYRSVHWIVPIIafFGAGLYIVILSILNYVVDSYQTYSASALAGVILVRNLVGAGFPLFATQMYEKLDYEWASSLLGFIAILLVPIPFIFFYKGRAIR--
     955 UniRef50_B8LVX1        Florfenicol exporter, putat...   219     2e-55  1  17.6%  3:394   60:507     --TARKITISLIISLSQLVCLMTTSVIAPALPQIATDLNLSDSEAQLAFSIFVLGQAFGPFVIAPMSEVFGRKPVWVVCSIFFILWNSVCPV-GNLRPLIIGRFLSGAGGSCGVSLAGPIAVDMFRQKDRGKSLALASLFPYLGPALGPIVGGLVSQYVSWPWLFWAMSIFCAAVLVAGLIFVRETCKPVLLRlgLKRPVQLLLTRPIIQILCLINGIGFGMYILVLSFYATVFIDQYHQSATASSLQYIAIALGSTLSTQTGGHLMDIIFARLllIVVGILILPIGLFWLGWSAQAHIAWImiGATIFVAGNFLGSQAALAYLFDEFSTHTASAGAAIRLLGNLMGFAFPLFAPQLYDGLGYGWGNSLLAFivVTVVPIPFVLWCWGEKLRAI
     956 UniRef50_C8WV76        Drug resistance transporter...   217     5e-55  1  13.4%  3:359   34:444     --HPHRTPIMIVMIFGAFVAILNQTLLNVALPHLMSAFNVDANTVQWLSTAYMLTNGVLIPITAFLMGTFTTRQLFISAMSLFLVGSFLCAIAPSFGVMVFGRIVQASGSAVMMPLLMTVILELFPPQQRGRAMGTMAIAMFFAPAVGPTLSGWIVTNWSWRWLFWIIIPLAFIDIVLAVAVLRNVAKPVRPKLDVPGFllRVFKYDVFTMTTIVGCIVNMAMFGAMILMPIYLQDIRGYTALQSGLMMLPGAILMGIMSPISGAIFDRVGARPLAVVGLAITTVTTWEFTKLNAQTGYGHIMLLYTVRMFGMSLLAMTVQTAGLNQLPRHlrHGTSAANTARTVASSVGTAVLVTIMT-----------------------------------
     957 UniRef50_O59698        Uncharacterized transporter...   215     3e-54  1  14.4%  4:392  135:571     ---WRKMKTTSIYAYASLTIAWGSSVLSPASATLAKKYHIGMTTSLLNVSLFMLGYCLGPICWAPMSEITGRKTPLYIGLFLFSVFQIAVATAQDIQTIMICRFFGGYGACVPLCVVAAAFADMYPNRYRGTAITIFAAVIFVGPLVAPIVGGFLtsYLGWRWTEYITSFMGFLSIILIYLFCEETyaRDIIMNYLLIPLKMLATEPIVFLVSLYCSFVYAIIYLLLEAYPVIFQEGRHFPLGVSALPYIGILVGVFIGCGINCLFEPWyeARLPPMMIGSFLFPAGIFWLAWSGYYTyhWIVPTllLTGAGILLIFLQCLNYLLDAYLFRAASVFAANVIMRSAVAGGFPLFAVQMFHNMGVGWAGSLLGFIATALIPMPFAFFFFGKKIR--
     958 UniRef50_C6D685        Drug resistance transporter...   212     2e-53  1  15.6%  2:359   15:425     -SIKSILLPLVAIILGCFMVILDTTAMNVALSKLVEDFHTQLPTLQWTVTGYMLAQAAVIPLAGWLSDRFGAKTVFLTSVILFTIGSLLCALPNDPQTLIMFRVIQGLGGGFVLPVAMAYVYRLSPPNKVGQVMGMLGVPILLAPAIGPILSGWLVEYHSWRWIFLINLPVGIISVLFGLWSLPKLATKKLAGLDIPGMilRVFRSIDFSFGIVVQWIVQFSLFGAIFLLPQFLQQGRGYGAFDTGLTLFPQALASACMMPIGGYLFDRIGVRWLVVIGLSLVSGAIFQYSHLDIHTGREDLLLPLIMAGSGMGLMMMPLNSHLINKTpeLVSRVTSLTSAMQQVISSLAVALLVTVLT-----------------------------------
     959 UniRef50_C4QYF8        Plasma membrane multidrug t...   210     1e-52  1  15.5%  6:392   97:538     -----KCFVVFEVGILTVAVYMGSAIYTPGIEDIMRDLNVSRTVATLPLTLFVIGYAVGPMIFSPMSEhiGRTTIYVWTLFIFAILQIPTALTTNIAGFCILRFIGGFFASPALATGPASVGDVIAIPHLPVGLGLWSICAVCGPSLGPLFGAIFSQLVSWRWCFWFLLITSGTLFIVLGFTLPETYVPTLLYRklWRPVDISFRDPVVLMINLYISMVYSIWYIWFEAFPIVFLEIYGFSLIGMGASFAGILIGVLICSACYCYACHVTFARRIiaIIGGCIMPTGIFILGWTATKSVHWIVPIigLFAAGGYLIFQTLFNYLAMSFPRYMASAFAGNDLFRSFSASVFPLFGHALYANLgvGWGSSVLGFITVAMIAIPVTFMRYGPRLR--
     960 UniRef50_B2W977        Benomyl/methotrexate resist...   209     2e-52  1  12.7%  1:379  131:521     MSKLRRWAIVLICAASSLCVQL------------EPEFGASRLVCTLGLSLFVAGLGTGPMILSPLSEFYGRRPIYICSFTFFLIWLIPCALARNIETMLVARFLDGLAGSAFLSVAGGTVGDMFGKHELSAPMMVYTASPFVGPEVGPLIAGFIVEKTTWRWCFYVLIIWSGVQLCLIVLFVPETYHPVLLRRKaiRPFQLLIFEPMCLNLCILSAILLGILYLFFGAFGLVFINNHGFSISQLGLSFLGLLVGMLTGIsiYGRLVRQREerLPSTIVGAWVVPIALL-GCWVQDSDLA-------------------------EQYPVYAASALAANSFARSYFAAAFPLFGVQMYNNLGYQWATTVLAFLALAMAP---------------
     961 UniRef50_B6H1P3        Pc13g01560 protein n=1 Tax=...   208     3e-52  1  15.1%  2:393  162:605     -TLRRRMLVTLLTALMGCVIFWSSTIDTTALPKTRKVYHTSFEVQTLPTAMFLIGCGVGALITAPISEVIGRNPVYIPTMIGFMLFNTGAGLAQTIVQRVVCRGLAGFFGSAPAVLSAATLVDVWSRIERVYAFPIYSIIIFIGPIVGPTPGSFAVDavSWRWVDWMTIIFAGLVLIPVVLFLPESYSphRLRASLYRPLLLFATEPIILIHSVYLTVLFMILYTFLAGYVSIYHMASHFSPTSTALAFLGILVGvmWLLRREIYRSRRRGEHRpmAMFGAPAVPISLFWMGWTAElsYWSPLVASVFYGFGTVCIFVSGYQYVSDAFESHATSALSSLQMTRLVGAGAMVIVAEIMYTNLGVGWTLTLWGCLSALFTPVPYLLYWRGYNLRQ-
     962 UniRef50_Q2UTE1        Synaptic vesicle transporte...   208     3e-52  1  18.5%  1:314  104:464     MSSVRKWVIVLIVCTGTLCVTCTSSIYTTTYTQMDPEFHTSTLISTVGLSSFVLGIGTGPLLTGPLSEHYGRRPIYLVAWSMFLIWTIPSAVAKNVQTIIVSRYFNGFTGGTFLSVAGGTAGDVFSRNQIQAPMALVSSVPFIGPSLGPVLGGFINSHLDWRWTYYIMIIWSAVLLVCMIFFAPETYHPIILRasLLRPFQLLFLEPMCLCLDIYSAILLGILYLFFGTFPMVFRTTYDMNLWQGGLTFVGIIVGMMIAAATTPLWSNIRErrLPPAIVGGILIPVGLFWFGWTTYSRIHWIVPIIGSAVFGGG--------------------------------------------------------------------------------
     963 UniRef50_A7EGD1        Putative uncharacterized pr...   207     5e-52  1  15.3%  2:393   72:478     -SPIRKWTTVSLLVITNFIAATCTSAFEPALPAIMADFHStdSIASLTVSIYTIGYCLGPLVIAPISELYGHVTVLYPGYIGFMLALAVCGSSKSLPLFIVFRAIMGLAAITFVLMGPAIVTDLILREKRGFALSIMSA--------GPV-------------VFGILFSLSLIIlvVLSRkiPKShpRDILKAAWIRPFKMLFLSPIVPFVGFYSALSNAYGMICFATLGTVFQNNYSFTPGQSGLAYFGLLFGFLFCQFTLARFSDRyeYRLPPMFIGAFLLPIGFFWYGWSLEYHTHWIIPILGSSVIAIGILFgpVQMYLVDTYTIYAASATGACTIIRSICSTLVPLSANPLYDHLGYGWGNSVLAFIAVGFVPIALLVLRFGERIRT-
     964 UniRef50_B2GGX6        Drug resistance efflux prot...   207     8e-52  1  19.1%  3:363   21:439     --HRDVLRALTGILAAFFMAMVTLTIIGTALPVIMADLGGDQTALSWTVTGTLLANAVTTPMWGKLADLFDKKKLLLMAIAIFVIGSGAAGIAGSIGMLVVARVIQGVGMGGLMALAQTILGTIIPPRERGRYAGYMGAVMAVATSVGPLLGGLIVDAFGWRWCFLIPVPLSLVAAVIIVRtlPEVSRDRSPRVDFLGmaWGSWESVLLIVLALVTAVAFVamFASTTYLGQYFQLGQGYTPTESGLLMLPQVVGSFLGSTIAGQLISRFGrkRILVVGAVVLAVGLFLGAGLTHTTPAWLVGIFICLVGLGVGTLNQNLVLAVQNTVgkDMGAASSAVAFFRTVGGAVAVSMFGALLTRHMA-------------------------------
     965 UniRef50_C1DVS6        Major facilitator family tr...   204     6e-51  1  15.8%  1:355   11:422     ITTLERALITFIVMSGAFMAILDTTIVDVVVPKMMGPLQTDLYGIQWVITAYMIASAVMLILSEWLDKVIGLRKVYIAGIVLFTFSSFMCGQAQNLDWMITARVFQGIGEALIMATAQTILFSVYPEEKKGMAMGIFGLGVSFAPALGPTLGGYITEYLNWRWVFFINIPFGILTTILAIFYLPETSMIREKAKLNFVSYFFlwFMSDVIVYLFIvfVGFSVFFlvFYLIPLYYENLKGLSTFDAGLHILAFAMFIAIFSPVAGILSDKWNERYVLYIATAIYLISSIFIlnLDYYTPKVRAALMTIPLGIAMGMFFAPVTTLALRKLGEKTSLGTGLMHYGRFVGGSFGTAIAT---------------------------------------
     966 UniRef50_C6XXE7        Drug resistance transporter...   204     6e-51  1  16.6%  5:359    7:418     ----KKWIITFTVITASLLELIDTTIVNVAIPQIQGNLGATLEDVAWLSTGYAVANVIVLPMSGWLGSRFGRKNYFLFSIVLFTVASFLCGNATNLEELIAFRILQGLAGGGLISTAQAILIETWPREDVGIATALFGLGAVVGPTVGPTIGGYLLEISTWPLIFYVNIPVGILAAYCTYMFVRETPKDGKGMPVDwtPYITALAVTSVLGLLLFifILGFGLYGSVFVFPVFCQNLLGFSPLQTGELLFPGGLCTIVMMPFIGIMLKkiPAQFMATIGMFLFFVFCSMLSKSTLQSGTNDFFLPLMIRGVGMALLFVPLTTLaqDLKGAEIGQGSGLNNMMRQLGGSFGIAALTTLIH-----------------------------------
     967 UniRef50_D0L8G5        Drug resistance transporter...   201     4e-50  1  17.6% 19:358    1:397     ------------------MIMLDQTVVTVALPSMTHDLGLSSSGQQWVVNAYVLAMAACVALGGKLGDRLGPVTCFCLGVVTFFAASVFCGLAPGGgwILSARAAQGVGAALMMPVSAKIVMEAFPITERGRAMAVYAGVSQIFLAVGPLIGGALTEWISWRAVFWLNVPVGLLALVLVAIAKPDNSRDRAARVSLRGaaVRLLARRAFTANLVTLGLVRFSLLATILFATLYLQDLLHMSPMKAGAAVLPLILPITVAAQLGGRWYDRRGNRPPVITGLAIATIGMACWSVALPHLDYVLQVPGMIITGFGLGLVFSPTNtaLSRVSAAERSQASGLVQTIRQLGGTLGVAVIGSIV------------------------------------
     968 UniRef50_B6GY21        Pc12g11990 protein n=3 Tax=...   201     4e-50  1  13.6%  3:392   76:505     --QWRKSMMTYIACGVTALAGYAAGEVSPASEELTELWGISTVVYNLSITVFCCGFALAPMVLAPFSEINGRRPIFIASGILFV-------GTQSFAGLLVARFFQGVGGSTFSTMVGGVISDIYHAQDRNTPMALFSGAALFGTGLAPLISGAIISHTTWRWVFYSHAIVSAAFVIAIYFFFKETRGSVLLSrsLYRPFHMLLTEPVVFFFSLWVSFSWAVLYLQFSSVPLIFRTNHNFTIEQTGAVFTSMCVGVIIITIISirIAMRFGkrLYFVCVESVLLPIGLFWFGWSSFPSVHWIVPAIAVGCATMGiiYLATFNYLADTYHRYASSAIAAQSCCRNLLGGIFPLVTNAMFTNLGYPEASSLLGGLGAALTLVPWVLALYGPTIR--
     969 UniRef50_C8X9A9        Drug resistance transporter...   199     1e-49  1  19.3%  1:362   19:441     LTHKQIRFILFGLMAGMLLAALDQTIVSTSIRVIADDLH-GLSAQAWVTTAYLITSTVTTPLYGKLSDIYGRRPMFLTAISIFIFGSLLCTFSTSMYELAAFRAIQGIGAGGLFSMALAILADIAPPRERAKYQGYFLAVFGMSSVVGPLVGGfiLGIAGWRWVFLVNVPIGILALVIVSITLHIPHMRHDHRVDWWGATALmwMSGSVLGLILLGIVGIAamFGALSTLPLYLQLVKGATPTESGLLLIPMMVGIMGGSVLSGQLTMRTGRYKipVMGTALLTASFFLMLTVDVDTGYPLLDLYFVMIGLGLGLCMQTLLIAVQNTVPadMGVATSSATFFRQLGGTLGVAVFLSLLFNSL--------------------------------
     970 UniRef50_P28873        Benomyl/methotrexate resist...   199     2e-49  1  12.1%  5:392  114:557     ----QKAFFIFQISFLTTSVYMGSAVYTPGIEELMHDFGIGRVVATLPLTLFVIGYGVGPLVFSPMSeiFGRTSIYIITLFLFVILQIPTALVNNIAGLCILRFLGGFFASPCLATGGASVADVVKFWNLPVGLAAWSLGAVCGPSFGPFFGSILTVKASWRWTFWFMCIISGFSFVMLCFTLPETFGKTLLYrtLWRPLEITVMEPVVLLINIYIAMVYSILYLFFEVFPIYFVGVKHFTLVELGTTYMSIVIGIVIAAFIYIPVIRQKFTKppIAIVGGILLTSGLFIFGWSANRTTHWVGPLFGAATtgAFLIFQTLFNFMGASfpHYIASVFASNDLFRSVIASVFPLFGAPLFDNLATpwGSSVLGFITLVMIAIPVLFYLNGPKLR--
     971 UniRef50_A5DNU8        Putative uncharacterized pr...   199     2e-49  1  15.9%  6:394   65:507     -----KAFFCFEIGFLCLSVYIGSSIYTAGMKDLQQEFGVGREVALLPMVLFVLGYGVGPLFFAPISEYygRSPVYITTLFLFAVLQIPTAMSQTITSICILRFFNGVFASPVLAMGAASVSDVIKTPYIPTVIGGWAVCSLCGPSLGPVLGAAINSRKGWRWCFWFLLIITGSSLLSFALFLPETYPPTLKFKrlLRSVEITVSEPVVLFINIYSALIYSILYLWYETFPMVFEDMYGFTPLLEGVSATSMLVGVILGsfIYFKFTKRyeVFLPMAVMGGFLLPAGIFIFAWSATPKAHwpLIGACIAGFANFIIFETLINYLGMSFPDYYASVIASNGLWRSVAASVAPLYAQPLYTNLavGWGSSVLGFIATAMILIPLVFYWNGPKVRSV
     972 UniRef50_B8I691        Drug resistance transporter...   197     4e-49  1  14.5%  3:354    7:422     --NKKRIIVLLIFLLGIFMGAIDSGIVSPARTVIKNSFGISESLSVWMVTIYTLAYAVAMPIVSKLSDRYGRKKIYLTSIIVFAVGSFLCGLSnnYTFFLIARVIQAIGGGGIMPIANAFIGNSFPPEKRGTALGFVGGVYGIATILGPTMGSSILDIAgwGWIFFINLPISLLILVLSY-NLKENLGDNNNKMDLKGSllFVICLPLFIllTLILGFITGVGLMAVVFIPQFAENILKIKTGNGGYLVTLMSVFAGISAPLGGKFIDKYSAKLVTVLGMICtfGAFFLAFFTTAYPSFVSIMVGLIFVGFGMGFTmtPLNYLMLSFVGeeSASALSTLSLIRSIGVAISPNIM----------------------------------------
     973 UniRef50_A2R5K0        Function: it is assumed n=2...   196     1e-48  1  13.0%  2:392   80:517     -STSRKLFMTFLVSLIAVAVTAASAIDACGVKEYSQYFHVSEVVGSLATGLFLIGFAFGSLLSGPFSETFGRNAIYSTTMLLFLVFVMASGLAPNLHSHLIFRFFAGLFASTPLTCAGGTVADLWNPLEKTYAFPAYAIPAFIGPMIGQIMGSYIPVTLGWRWLEWIMLIMGGVVMALVLLFQPETYggQRLKISVYRPFAMFYSELIIILMSLYLTIIYIVLFTFLEGYAYIFGDTYGLSEGLTNLCWAGMLVGTLLVSGVVPVVYSWTarLWYTMLGGAVAVPISLFWMGWTSNpsIWSPLIASVLFGYGITTIFIVAYMYLIDSYDTYSASALGFLVFTRYVVAGGVTVAGGPIYEALGVQYTLTILGSISAVMALVPYLLYFYGPMIR--
     974 UniRef50_Q2HEU3        Putative uncharacterized pr...   195     2e-48  1  17.7%  4:392   94:552     ---WEKRFIVFMVALASFFSPVSANIYFPALNTLAQDYRVSTTLINLTITVYMIFQGLAPSFTGSLSDNIGRRPLYIVCFVIYIGANIGLALQHQFAALMVLRCLQSSGSSGTIALGNAVVSDIASPAERGAYIGYVSLGGVVGVSLGAVLGGILSDFLGWRSIFWFLVICAGVVIILIALFLPEtlRHRRATAPNTTHPTTTPKSRDFviVLAANGVLFAGYLAMVSAIPSQFQQLYGFDDLHIGLCFIPGGVSAALSAIAVGYAVDWNFARHARRLGllVLASVSFIVYGWLLaaSVAGPLVLLLFACFGVNGFFTVLSVLMVDVYPQAPATATAANNLVRCWLGAGASAVIIPMIDAMTSGWAYTFIALVYLLLAPLLWVIMRWGPAWR--
     975 UniRef50_C5PB66        Major Facilitator Superfami...   195     3e-48  1  16.9%  1:360  142:563     MNRKRVIAIMGALCLALFLAALDMTIISTALPTIAAQFDANETSYTWMASSYLLANAACLPLWGKLSDIWGRKIIVLLANVVFLVGSLICALANSLAMFLVGRALQGIGGGGVIILGQICVSDLFSARERPVYYAMFGAVWAVAGSLGPVIGGALTQEVTWRWCFYINLPVGGVSLIILLLWlpKTPLVAGLQAIDWLGTLTIiwDSATTICLIVFGIVVLALFGLvyYLPIYFQTVLGVGPILSGVYILPQAIGLAVLSIAAAIVIRKTGQYLWIIRASALITTLGYGLFifKPYASWARIIIYQLISGIGIGpfQAPLIAIQSAMRPSDVASATSTFGFMRQLSTSTSLVLGGVVFQN----------------------------------
     976 UniRef50_C6D276        Major facilitator superfami...   195     3e-48  1  18.3% 12:393   13:461     -----------ALYVATFLAAIEGTIVSTAMPSITGELH-GIQQYSWIISIYLLATVITTPIYGKLSDLFGRKKMFIAGAGIFLLGSMLSGLASTMPQLIAFRAVQGLGAGALTTIPYTIIGDLYPFEQRAKVQGWMSSIWGIAGITGPLAGGLLVDYVSWRAIFYMNLPFGIVALVLLMVSMKEVSVKQKRHIDYPGiaLTILREpiILLSAAAIILLTLFYyvAIFYLPLWIQGVLGESATYSGMAMIPLSIGWPLGAILAGNFIARYGMRRIAITGSLFLIAGSAGFMLMNAHTSIVLFMIYTCLSGLSFGLSLTSFTVAVTSAVseLRGAAVGSNNFIRTLGQTVGIAMFGLLLNTgsLHRIFMILGIMSVMVLLSMFMLPKAGTEGSH-
     977 UniRef50_Q846X9        Putative monensin resistanc...   194     5e-48  1  19.6%  4:361    7:418     ---ARRWWAVGALVLASMVVGFDVTILSLALPAMADDLGANNVELQWFVTSYTLVFAAGMIPAGMLGDRFGRKKVLLTALVIFGIASLACAYATSSGTFIGARAVLGLGAALIMPTTLSLLPVMFSDEERPKAIGAVAGAAMLAYPLGPILGGYLLNHFWWGSVFLINVPVVILAFLAVSAWLPESKAKEAKPFDIGGLvlSLFRSARFTSGTMLGTVINFTMFGVLFTMPQYYQAVLGTDAMGSGFRLLPMVGGLLVGVTVANKVAKALGPKTAVGIGFALLAAALFYGATTDVSSGTGLAAAWTAAYGLGLGIALPTAMDAALGALSEdaGVGSGVNQSIRTLGGSFGAAILGSILNSG---------------------------------
     978 UniRef50_C7QG01        Drug resistance transporter...   191     3e-47  1  17.9%  5:356   24:430     ----RPGVTLLATCLALFLGQVDTTAVNLALPAIRHDLSGGISGLQWVVDAYNVTFAALLLTGGTLGDRFGRRRLFRTGVAVFVLGSTVCALAPGLPVLLAGRVTQGVGSGMMLPQSLAILATAFPgrERNKAMAAWSIVAGSGLAVGPTLGGLAVQTLGWQSIFWVNVPIGIAALVLTLRHVPESRNPRARTLDPLGQVLalLRRGQLPVAVIVAACMTFGMYGLFLLTSLMFQQERGASALGAGVAMLPLAVAATVLSPLTGRLVTRYGPRLPMTAGMTAMGTGVLIFAVAGADANLLVLEIAFTVIGIGLAltGPVVGVAVSAVASELAGLASGIANLARMFGATLGVAVQGS--------------------------------------
     979 UniRef50_C0S0Q7        Predicted protein n=6 Tax=O...   191     4e-47  1  15.5%  2:394   87:527     -SRKAKWVTTALTGGYCFLPTFSSTIFAPALLLVMADLGIKNPTLGAaiSIFVFAFSLGPLFAAPLSEIYGRTIVVSLGNVAFIAFSLGAGFAQNAVQLAVCRFFAGVGGSGGLAVFGGVLADIWDLEERTKASALMSTLLILGPVVGPACGGWISERASWRWTCWVPATAAAFLQVAALLYMRESYAPVLLERKLlrPVMYLLVDPVLFLLSLYFSSVFGEVYLLIVTFPEIFGEGYGHSAGIVGVDLLAQGVGNMIGLVVtgIIYKrpESRLVPAFPGALLLVAGLFLYGFSAlyHFIVPLVGFVVFAAGAMNIFMAIQLYIVDCFAYP---ASAYLFSVLSSREAIFPLFGSRLFETLGVDWGAGLLAFLSLGlvPFLPLIYLYGKKLREI
     980 UniRef50_C6CTB0        Drug resistance transporter...   188     3e-46  1  17.3%  1:359    3:416     VNKNNKTLILIGLLLGLIFAEMDETVVSTAMPTIIRELH-GLSLYGWVAGVYMLAMTIAMPILGRLADVFGRKKIYMSCMALFCLGSIVCGSADSMAQLLIGRGIQGIGAGGLMPIALVIIGESFPLEQRAKVQSLIGPLMILPQLIGPTIGGYFVGNLNWHWLFLINIPVAVIAVAFLFKGLHESKGEEKHTIDWAGAGTLvwSSPIIIGLLILSAvlMLGLMGGIATFPFFAQNVMGLTPTEAGYLMFAFMAGAIPSSIVNGFLITRVAYRNLFITCFILPLVGIFMLTQLAVSTTPVFVIIAFFVMGLGIGALFGGDNLIVQESvkKHSGVALGTVQLFQSLGATVGLSVFGSVLA-----------------------------------
     981 UniRef50_D1P1K9        Major facilitator family tr...   188     4e-46  1  16.9%  4:363    1:416     ---MKRIFLIVAVCLGTFMATLDISIVNVALPVIGQELNANLSMLQWIIDSYALCLSALILSVGPISDRYGRKKVWLTGIVIFTVGSLICAFSLSAQMLLFGRVIQGIAAAALIPGALSIITQAFSNdeRIKVIGIWSAVSALSLIIGPILGGFLVDTFEWSFIFMINLPIGLLTLLLGGLGIKESADPDKAALDPLGQLLSvwASLPTIAGLMIGGIAALGFVIvvFFIALFLQKGQGWGAFEAGLRMAPEFIAMALFSFSFGRLSRTLSVRNIMVIGFLLIATASMLLTRVNSDTEYLPIAAILFILGAGMGMATPAIGALVMASvkAYSGIASAVMNALRQTGMTLGIALLGTLMTHRAI-------------------------------
     982 UniRef50_C7ZFU0        Predicted protein n=1 Tax=N...   187     4e-46  1  14.8%  2:392  130:569     -SLGRRIGVTLQISVIALFVGAASGIDASVLPQAAASLGVSEVAESLATGLYLVGMGLGSLVAGPFSETFGRNAVYTVSMAVFMIWIMAAGLAPNFGAQITFRFLAGCSASTPLVCSGGSIADMYNSLEKTWSFPLYAITCFGGPMIGAVMGAYIgtAVSWRWTEWSMLISSGLVLVLVLLFMPETYGpsRLKVSMTRPFLM-LTEPIIIAMTLYISVLYIVLFTFLVGWPYIFEYTYDLGQGLTNLIFIAMFIGTYI-NFISVPFvgKTgrLWYAMLGAAVSIPISLFWLGWtsHISIWSAILAVVVFGYGVTGVFICVYMYIIDSYEIYAASALTFVALTRYVIAGGMTVVGIPFYENMGTHYTLTIMACISVVLAAIPYILYLYGHSIR--
     983 UniRef50_B1YHW2        Drug resistance transporter...   187     6e-46  1  12.5%  2:362    8:422     -TARPPYGILAVLMIGAFIAFLNNTLLNIALPSIMKDLEIETSTVQWLSTGFMLVNGILIPTSAFLIQKFSVRRLFLLAMTLFSAGTILAGFADAFPVLLAGRMIQASGSAIMMPLLMNVMLVSFPIEKRGTAMGFFGLIMMGAPAIGPTLSGWIIEHYDWRMLFHFITPIALIVLVAGFVLLRDVKERSGAKLDFMSVVLSSfrYPMFALSSAISIVVTIAMFSGMLLLPIYVQTIRGISPLDAGLMLLPGAILMAVMSPINGKLFDKIGGRPLAITGLFITVVTTYLFSQLKMDTTYTHLIVLYSLRMFGMSMVMMPVSTNGLNQLprYYPHGTAMNNTLQQVSGAIGTALLVTIMSTHA--------------------------------
     984 UniRef50_A2QYX0        Remark: TPO1 is a polyamine...   185     3e-45  1  15.9%  2:392   84:527     -SHARRVASTMCVCLIALVTTMASAIDSAVLSEASQHFGVSQVAESLATGLYLIGFGVGALIASPMSEIVGRFPVYIGALVIFGSWILGAALAPNFGSQLVFRFLAGLCGSAPLTVAGGSISDVWSTLEKTFGFPIFAIPGFGGPILGPVVGAYIGYsiSWRWSEWIMLIFDGLVIAIIFLFKRETFAPQllKRNFTRPWL-LLMEPIVIFFTFYLTIVYIVLFTFLDGYVYIFADTYGINEGLANICFLGLFIGILISMVlsGRMVDR-ESRLFFAQIGAPAIPIGLFWMGWTDYPsiWSPLAASIAVGFGVICIFLSAYMYIIDSYQQYAASALTFVALVRYLAAGGMTVVGIPMYRNLGTHWTLTVLGIISAVAAPIPYVLTFWGPSLR--
     985 UniRef50_UPI000050F7A1 drug resistance efflux prot...   184     5e-45  1  16.8%  1:363   14:433     MKTSAIILLFVGLMIAMFMFSLNQTVLATALPTIVGELD-GVDQMLWVSTAFMLASTIMMPIYGKVGDLFGRKPLFMFAISCFLLGSVFALIANDMGMLIFGRVLQGIGGGGMMILSQSIIASVVPARERGKYMGIMGSAFAVSSVAGPLIGGWLTEGPGWRWAFAINFPLGIIALFAAAIFLKVPKRAPGPRPKiwGGHDYEWGSWQINGLIIVGALSIVgmFGVLSYMPTYLQMVHGIDATVAGLMMVPMMGTMLISSTLIGFVVSRTgyKKYPLMGILIMAASLVLLSQLKAESAAWETMGCLALLGLGLGLSMQTLVLVVQNAFpaMVGTATASNNYFRQVGATLGMAFIGSVFTQRLL-------------------------------
     986 UniRef50_A5WEK3        Drug resistance transporter...   184     5e-45  1  16.4%  1:391   28:480     LSAVQAKFLPYVLAVALFMQILDATILNTALPEMALALGESPLKMQWAVISYALTLAIFIPISGFMADKYGTRKVFLTAIVLFSIGSIFCAMSPNLDILVASRILQGVGGAMMTPVARLILVKSYPRNQLLTVMNFAVIPALIAPLVGPLVGGYLVQYASWHWIFLINIPMGILGFLLGFKLVPDiyVRHARKAGNPIFPLSLFDVRTFRIGITGNLFTRLGISAVPYLLPLLLQVAFKYTPSQAGWLLTPIAVGAMGIKPWVSKIIQRFSYRKVLVTNTTILGILIILLAQLNASIPWYYIAPLLVIMGACNSMQFSAMNTITidLEGSQTSSGNSLMAVNQQLAISFGIAFGATILSVfaFHATYYVLGIITIISGLSFLRLKPEDGRG---
     987 UniRef50_A8L0G2        Drug resistance transporter...   184     5e-45  1  19.6%  7:364   54:467     ------RRLALTVTLGAIMAILDTTIVAVAINTLGRDFDASLSTISWVSTGYLLALAVVIPLTGWSVERFGATRMWNISLVLFLAGSALCGAAWSAGSLIVFRVLQGLGGGMIMPICMTLLASAAGPQRIGRVMNIVGVPALVAPILGPVIGGLLVDNLDWRWIFFVNLPIGAVALVASWRVLPRDDRGQSHHRLDVPGLLLifGALRVQISTAAGVVALVAffGGMFLLPLYFQVARGQSALAAGLSLVPQGVGAMIGMPIAGRIADRRGAGYVVPVGMAVCLLGTVAFTQVDAHTNTVALGALLFVRGLGFGASMMPAMSAavTLRPAAVPRATTTLNILQRVGGSIATALLAVELQHGITS------------------------------
     988 UniRef50_P94422        Uncharacterized MFS-type tr...   183     7e-45  1  16.1%  2:368    8:428     -KPFNRSVIVGILLAGAFVAILNQTLLITALPHIMRDFNVDANQAQWLTTSFMLTNGILIPITAFLIEKFTSRALLITAMSIFTAGTVVGAFAPNFPVLLTARIIQAAGAGIMMPLMQTVFLTIFPIEKRGQAMGMVGLVISFAPAIGPTLSGWAVEAFSWRSLFYIILPFAVIDLILASILMKNVTTLRKTQIDILSVIlrVFTFGVFSLTTLLGTLVFALLIGTETILPLYTQNVRDVTAFDTGLMLLPGAVVMGFMSPIIGRIFDRVGGRGLAIAGFCIIFLTSLPFMQLTDHTSLAWIVVLYTVRLLGTAMIMMPVTTAGINALPRhiPHGTAMNNTIRQVGGSIGTALLVSVMSNQAAHAGTT--------------------------
     989 UniRef50_A9WBL4        Drug resistance transporter...   183     1e-44  1  18.9%  1:376    1:431     MNEGRKWWALAAVGTGVLVSTIDGSIVNIALNTLVQAFASNLNVVEWVVLGYLLTLVCTLLIMGRLGDMYGKRRMYLIGFALFTIASLLCATAPSIAALIGFRVLQGIGAAMIQAVGPALLVTAFPARERGMALGAIGSFVAAGILIGPALGGVLLQYVGWEAIFFVNLPIGVLGWWLTIRSipDHTTRPGQRFDLIGAVLmmFRRLAFSLNLLAALILFLGISFNLLLTPLFFQLVYQFDLQRTGLMLMALPIALSLTSPISGRLSDRFGPRVLTIVGLLVTGCALLGLSTTTPVTPPLQMLSFLILLGFGVGLFQSPNNSTVlnAPPEALGVASGLLAVVRTVGQTGGIALAGAIWASQIFALNGGPVTPITAA------------------
     990 UniRef50_Q4K783        Drug resistance transporter...   181     5e-44  1  19.1%  7:377   15:440     ------RSVLIALMLAIFLGALDQTIVAVSMPAISAQFK-DVGLLAWVISGYMVAMTVAVPIYGKLGDLYGRRRLMLFGMGLFTLASLFCGLAQNMEQLVLARIFQGIGAGGMISVSQAIIGDIVPPRERGRYQGYFSSMYAVASVAGPVLGGYMTEFLSWRWVFLINLPLGLGAWWVAHRTlgLPVPQRKPIIDYLGTVLMIIGLTALLLglLAIAVIVLALFVwiVLMPLRFQSITGAGADSAALHLLPLAMGLPMGAYCAGRLTSVTGRYKPMILSGALLMPLSILGMALVPPQSELLSGLFMLLCGSAGGMQFPTSLVGTQNSVEQriGVATSTTNLFRALGGAVGVALMSALLLALLQDSSLAHLGGAGLMV-----------------
     991 UniRef50_C7Q7A2        Major facilitator superfami...   180     1e-43  1  16.8%  1:382   38:486     LSERRKNQALAVCLLVGFMTLLDVSIVNVALPSMQKGLSATPADLSWVVSGYALTFGLILVPAGVFGDMVGRRTAFLVGLAAFTVASGLCGIAPGAGFLVVARLVQGFASGILGPQISGLIQEMFSGAARARAFGYFGATVGLATAVGPLVGGLLIAAggWRWVFFVNLPIGVIAFALALRLIpaGMSKTRGRIDWLGVVLLGawWLVVLGVLLIIAFAQwgFTTIFFIFTLYVQNGLNYSALEAGLATTPFAIGSAVSATLGGRLVGKHGRPLVIllVGLGTAAAVLVVHWVHGRGAGIATAGPLLIAGVGSGLVIAPNLALSLSEVpmRAGTAGGVMQTGQRLGSALGIACVGAVFFSRVSHGKGFANAFQAGAVVAICF------------
     992 UniRef50_A7F6K7        Putative uncharacterized pr...   179     2e-43  1  12.2%  1:393   54:489     LSPVIKYAISIAVLYTAFVATFGNSTYTGGMPGVMTSFGTSKTLATIPISCYSAGLGIGALFSTAFSEVFGRRIVYRVTAPLALVFTLLGGCATNFGTVAIARALAGLFASPCLTVGGGIISDIwsLEKTGTIfaLFVLFVVAGTQTGPMAGAAIITNHSWRWEFWVSAILFGGSTIIAYL-LPETYQPQLLrtSLGRPLHMLLVEPTVFPTSLVMAITQSVVFSYFVSYATLFQEIYHHSPYAVGMAFFPLIVGSITAIPTIVIfaIRTgkRLYPAMLGSITLPISLFWLAWTGRADIPSIVPIlgLFGFSFVLTMLCLPVYHSDFYthYSASMLAALTFMRFFISASFPLITPTILDKLGFTWATSMLGFITIALIPIPWILYRFGPYLRT-
     993 UniRef50_C1P9E5        Drug resistance transporter...   178     4e-43  1  13.1%  3:360    8:421     --KKPPYLMIGVLFIGAFVSFLNNSLLNVALPSIMADLHidYSTIQWLATGYMLVSGVLVPASAFLLTRFTNRQLFITAMLIFTLGTALAAFAPNFGLLLTGRMIQAAGSSVMGPLLMNIMLVSFPIEKRGTAMGVFGLVMITAPAIGPTLSGYIVEYFDWRFLFEMILPLAVISLVLGIWKAENVMEQNKKATLDYLSVVLswTDPVVLTALIAGSVAlaAMFSGMILTPAYVQNVRGISPLDSGLMMLPGAIVMGIMSPITGKLFDQFGPRVLAVTGLSITAVSTYMLANLQIDSSYTYIILVYTLRMFGMSMVMMPIMTNGLNQLPSRLnhGTAVNNTAQQVSGSIGTAVFVTIMNA----------------------------------
     994 UniRef50_UPI000023F6A6 hypothetical protein FG1041...   177     7e-43  1  13.9%  4:392   46:449     ---WKKALQVVMLSSSAILASIGTSIMSPARNGLMAEFNVSSTVALLPLTMYVLALGFGPIIGGPLSETIGRYAIYAASVPIGAVFTIGAGFVHNIGALCFLRFMAGLCWAPVLAVAPGTLSETFTPKNRGPVSAVFILMPFLGPGLGPVIGAFVVNRKGWRWTQWTLVFFSILAMAVAAFA-HETFHPVIKRraVVRPIRMLLFEPITGFICLYVAAEFGTLFSFFAAVPYTFGRVYQFSIEESGLVFLSIVIGCLLgvLLYRKQASKYPprLYPSLIGSIGLPIGLFWFGWTARPGVSWASPAAAMIIFAWG------------------------NLLARYGFAGVFPLFTIQMYEKLGIDWASSLLGFVALVLLPVPWVLFKYGPTIR--
     995 UniRef50_Q7ND04        Gll2822 protein n=1 Tax=Glo...   176     1e-42  1  18.3%  5:359   19:428     ----NKWAILLAVSIGTFLVPLDITVVALALPDIESSLRTSFADLQWIINGYNLSFTAFLLAAGTLADRFGRRRLFLVGLALFTLTSLTCGLATTPLTLTLARSIQGLGGALLLISSLAILSQTfeGPERANAFGVWGLVMGVGASLGPMIGGLLVDLLSWRWIFLLNVPIGVGLVAFTLSKVDESRDPGAARVDWLGLTTFTSALFSLCFALIQgaFVGTSLLAASNGASffFQNVLGYSPLQAGLMLLPLTVPLLVCPPLGGRLAQVLPARLLLSGGMLMVGLGFVWMYGVNAGSPWTAFLPGFLLAGIGAGLINaiANVAIAVLPPQRSGMGSGITSTFRHGAHALGIALLGSLLT-----------------------------------
     996 UniRef50_A1TY99        Drug resistance transporter...   175     2e-42  1  15.7%  3:372   19:443     --PSYRWLVTATVMMGTIATILTATIVNVALPDIMGAFGMGQDKAQLLSTGFLAAMTGTMLLNAWMVDTLGQRATFMLAITIFIAASIMGGLAPAEGVLILARVLQGGAAGILQPLAMQTIFQVFPPEKRGSAMGIYGIGVVLAPALGPTLGGIMVDSFSWRYVFFMAVPFCFIGLFMAAILMPGRATSGPPRKFDWIGFGLmiSDPILRDFAIaaFIFGAGIFGSTFLIPLFVQTIQGYTPTRSGLLLMPAGLILALVFPIAGRLTDRTPAYATVMFGLVIFALSSFLMSNVDTNTSFWLFAWWIMLGRIGLGFIMPSLNAGALKALptLLSQGSGAINFVRQLGGAFGVNLLSIALERRSQLYVDSFTAA----------------------
     997 UniRef50_Q4PFR2        Putative uncharacterized pr...   175     3e-42  1  14.9%  4:392   76:509     ---WRKILILVLTMLPEFWLNVISSIYSFGAYEVASEFGVGEVASKVPAAVFLFGFAVGPIFAAPLSEDYGRVPVMVIGLAVVALFQIGCALAQNLATLIVLRFLAGCFGAVAF-NSIGTVSDLWHSDHQGWGVNTFALSAELGATAGPIIGAFIVKNAGWRWTFGVSGIVLAFLLAIFVLAVPETRapQLFKETVGRPLFMLFTEPIVFWFTLFDAVNYAVIYIFLIAYPLVFQQ-WGFDIGQQGLTFIGVLVGFLIAYGLfpRGIPTPEDRLLWGIPGGFLFPISLFFFAWTSFPPVPWIVPIIalFGVSSHTLFLIVSDYTVASYSIYAASAIAAQSFLREFMCGSFYLITEIMYSNVGYQWASSILAFIGVPLSVIPLVFYKFGPTIR--
     998 UniRef50_P46105        Probable actinorhodin trans...   174     5e-42  1  18.1%  4:368   38:467     ---ARRWAALGVILGAEIMDLLDGTVMNVAAPAVRADLGGSLSVIQWITVGYTLAFAVLLVVGGRLGDIYGRKRMFVVGAVGFTAASVLCSVAAGPEMLTAARFLQGGLGALMIPQGLGLIKQMFPPKETAAAFGAFGPAIGLGAVLGPIVAGFLVDatGWRSVFLINLPIGVAVIVGAVLLLPEGKAPVRPKFDVVGMAlrGWPAWAFVLMLAGAAVlfTGVSGMSLLLALHLQIGLGFSPTRAALTMTPWSVFLVVGAILTGAVLGSKFGRKALHGGLVVLALGVLIMLLtaGGLTSWELVPGIAVAGLGMGIMIGLLFDIALADVDKqaGTASGVLTAVQQLGFTVGVAVLGTLFFGLLGSQATA--------------------------
     999 UniRef50_B0CN15        Transmembrane efflux protei...   174     6e-42  1  19.6%  2:393    9:471     -SAKAGKTLLTLLCLAQFMLILDVAVVAVAVPSMQSQLNISAANIQWVSTAYGLAFGGFLVASGRAADLFGPKRILLIGLSLFTLASGLCGIAPNELTLFVARAVQGFGAALVSPAALSLVTTSfeGEERNKALGLWGAVSSGGAIAGQLLGGVLADLAGWRSIFLINVPLGLIVIVAVARMVRKDRSNDTGRIDMAGAGLlmFRNPNVRYGNMICMLTAGGATVSVFLGTLYMQQVIGMSPMMAGLGFAPVTLLILGVSMRMGPLVQKFGVKNLLLASAALFAVGSLLLSFVTVDGSYWvvFPGLAIGGVGAALSFAPSMILCTTGVpeEQGLASGLLGTSQQIGAALFLAILsaLTEGFQAGFLWSLAIPALIVLCLLALPRKKDEPQVEP-
    1000 UniRef50_C7ZPB3        Predicted protein n=2 Tax=S...   174     6e-42  1  14.1%  4:392   62:473     ---RKKVLQVVMISSAAFLASVGTSIMSAARNPLMTEFNVSSTVALLPLTMYVLALGFGPVIGGPLSETIGRYYIYAAGVPIGALFTIGAGLVHNMGGLCFLRFMAGLCWGPVLAVASGTLSETFTPRNRGPVSAVFILMPFLGPGFGPVIGSFIVNRKGWRWTQWALIFFAIFAMIFAALS-EETFHPAIKRkaVVRPVRMLFFEPITGFICLYVSAEFGTLFSFFAAVPYTFGKVYQFSIEESGLVFLSIVIGCLLgvFLYRTKAHKYPprLYPAMIGSIGLPIGLFWFAWTARPGVSWaaAAMIAFAWGNLCVF------------------VSTIHLARYGFAGVFPLFTIQMYQKLGIDWASSLLGFIALSLLPVPWVLFKYGPRIR--
         consensus/100%                                                                                      ......................................................................................................t.h.u...............................................................................................................................................................................................................................................................................................
         consensus/90%                                                                                       ............h....hh..hs.shh.ssh..h.ttht.s...h.h.hs.ahhs.sh...hhu.hu-hhGpp..hhhshhhhhh.shhshhs.sh..hhhhRhhtuhhss...s.s.shh.phh..tths.hhshh..h..hs.hhuPhhGuhh...hsWp.hhhh.h.hshh.hhh.hhhh.t..............hh.hh....h.h..hh..h..hhhh.hh...s.hh...hths....uh.hh...hh.hh...h...h..hht......hhh.hhh...hhh..h........hh..hhhhhhs..h.......hh.t......u.s.uh.thht.hh..hh..hh..h....................................
         consensus/80%                                                                                        .......hhhhh.hh.hhs.hs.shh.suhsth.tthths.t.hthshshahlshuhh..hhu.lu-hhGR+.hhhhuhhhahhhshhsuhu.sh..llhhRhhpuhsuuhhhshs.uhltchh..tptsthhuhh.hh.hhushhuPhlGuhlhthhsWchhFhh.h.huhhhhhhhhhhh.csh..t....thht.hhhhhtp..hhhh.hh.hhhhhhhhhhh.hhshhh.thhshs...huhhhh..shshhhss.hsshh.tpht.th.hhhhhhhhh.hhhhhhhh....shhhhh..hhhhhhuhshhh.sh.shhht.h.t.hu.u.uh.shhp.hhsshhshhhs.hhtt................................
         consensus/70%                                                                                        .....hhhhhhlhhhhhhsshs.shh.suhstltpphsss.s.hphslohahluhuhs.hhhG.luDhhGR+.hhhhuhhlahlsohhsuhu.shthLlhhRhlpGhuuushhshuhuhltDhasspptuphhuhhshshhlushluPhlGGhlhphhuW+hhFhh.h.huhhhhhhhhhhl.Eoh..thhthshhtshhhlhtp.hhhhhhhhhshhhsshashhhhhshhhtthhshsshthGlhhhshsluhhhss.hsshhhp+hs.phhhhhshhhhhsshhhhhhhsht.shhhhhhhhhhhshuhuhhhssh.shhhsshsp.tusAsuh.shhp.hhushhshhhs.hhtt................................

MView 1.51.1, Copyright © 1997-2009 Nigel P. Brown